"id:ID","label","identifier","notation","alt_label","pref_label","definition","extensible","uuid","uri"
"371","Action Taken with Study Treatment ","C49499","[ACN]","['Action Taken with Study Treatment']","","The reason that changes were made to the therapy under study. (NCI)","False","b6c3229e-8661-4cfc-8bc9-07ffb7f7c1fc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499"
"372","Dose Increased","C49503","DOSE INCREASED","[]","Dose Increased","An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)","False","e1dd6a1f-08ac-451a-a9a5-efbbcba8cd9c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499/C49503"
"373","Dose Not Changed","C49504","DOSE NOT CHANGED","[]","Dose Not Changed","An indication that a medication schedule was maintained. (NCI)","False","b752c735-9bb2-4321-a809-251337465a1f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499/C49504"
"374","Dose Reduced","C49505","DOSE REDUCED","[]","Dose Reduced","An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)","False","75332560-594c-4304-b974-bd1591778152","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499/C49505"
"375","Drug Interrupted","C49501","DRUG INTERRUPTED","[]","Drug Interrupted","An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)","False","21b69599-b720-43f1-abc0-83d333e2117f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499/C49501"
"376","Drug Withdrawn","C49502","DRUG WITHDRAWN","[]","Drug Withdrawn","An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)","False","b24400fb-c89b-4d66-a68c-7f088df87c8d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499/C49502"
"377","Not Applicable","C48660","","['NOT APPLICABLE']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","3b6446b2-a643-469b-a1a4-dc5e278b14d8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499/C48660"
"378","Unknown","C17998","U","['UNKNOWN', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","09c18a95-120d-45ee-bf48-d486b954aa3c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49499/C17998"
"379","Adverse Event Outcome","C49489","[OUT]","['Outcome of Event']","","A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)","False","cd1f7bd7-bd6a-4998-b1cb-00c00fbe3d0f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49489"
"380","Death Related to Adverse Event","C48275","5","['Grade 5', 'FATAL']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","65359f38-0267-45bc-8ab3-b5de0fcec738","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49489/C48275"
"381","Not Recovered or Not Resolved","C49494","NOT RECOVERED/NOT RESOLVED","[]","Not Recovered or Not Resolved","One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)","False","b9ea5cf3-c821-49ad-b9ff-7c8b5ba193b0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49489/C49494"
"382","Recovered or Resolved","C49498","RECOVERED/RESOLVED","[]","Recovered or Resolved","One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)","False","c0aaccdb-41a8-42cb-b87b-a1d65e3970e7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49489/C49498"
"383","Recovered or Resolved with Sequelae","C49495","RECOVERED/RESOLVED WITH SEQUELAE","[]","Recovered or Resolved with Sequelae","One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)","False","586a7123-c8bd-4eab-9249-11ecf3a7f0de","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49489/C49495"
"384","Recovering or Resolving","C49496","RECOVERING/RESOLVING","[]","Recovering or Resolving","One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)","False","5c8f9d6b-5e0e-4009-b1f3-89f649eb0776","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49489/C49496"
"385","Unknown","C17998","U","['UNKNOWN', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","63cadc99-b312-4ff8-98f9-0024310c99c2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49489/C17998"
"386","Age Group","C20587","[AGESPAN]","['Age Span']","","Subgroups of populations based on age. (NCI)","False","a292cc4f-b10d-4ee4-9295-2365b3de6cff","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587"
"387","Adolescent","C27954","ADOLESCENT (12-17 YEARS)","[]","Adolescent","A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)","False","1c4c39fc-4691-4f48-b5f6-9238a8d44454","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C27954"
"388","Adult 18-65 Years Old","C49685","ADULT (18-65)","[]","Adult 18-65 Years Old","A person from 18 years to 65 years of age. (NCI)","False","d522a440-2e0d-4edd-ae51-33f693b32adc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C49685"
"389","Children 2-11 Years Old","C49683","CHILDREN (2-11 YEARS)","[]","Children 2-11 Years Old","A person from 2 years to 11 years of age. (NCI)","False","5a1383c6-ee30-4d03-b402-211fda914c13","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C49683"
"390","Elderly","C16268","ELDERLY (> 65)","[]","Elderly","An age group comprised by people 65 years of age and older. (NCI) ","False","d2096304-dad0-419c-a280-1a8cdb87e190","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C16268"
"391","In Utero","C49641","IN UTERO","[]","In Utero","The period of time during which the embryo or foetus is present in the uterus of the female. Also describes the location of the embryo or foetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)","False","2d47a4b5-16e9-4d17-8903-44227a853e8d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C49641"
"392","Infant And Toddler","C49643","INFANT AND TODDLER (28 DAYS - 23 MONTHS)","[]","Infant And Toddler","A person from 28 days to 23 months of age. (NCI)","False","783e8c2a-ee9d-418a-bef1-b3efe4ae2bb1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C49643"
"393","Newborn","C16731","NEWBORN (0-27 DAYS)","[]","Newborn","An infant during the first month after birth. (NCI)","False","5e46cd4e-a875-4d06-a567-7971771fda31","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C16731"
"394","Preterm Newborn Infant","C49642","PRETERM NEWBORN INFANTS","[]","Preterm Newborn Infant","An infant born prior to completion of the normal gestation period. (NCI)","False","d29c38b3-8689-4309-98a7-3ae14074e898","dataset/cdisc/ct/sc/2007-03-06/sdtm/C20587/C49642"
"395","Age Unit","C50400","[AGEU]","['Age Units']","","Those units of time that are routinely used to express the age of a person. (NCI)","False","f3c9c13e-1a7e-4e79-99de-6c3496e1e843","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50400"
"396","Day","C25301","DAYS","[]","Day","The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day. (NCI)","False","82088283-2dda-4183-8786-439bb3b80e60","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50400/C25301"
"397","Hour","C25529","HOURS","[]","Hour","A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)","False","7eac7f30-b62e-413b-a008-16f7e90eabaa","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50400/C25529"
"398","Month","C29846","MONTHS","[]","Month","One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)","False","8d52f42f-1f14-495a-8bd1-2320705447e0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50400/C29846"
"399","Week","C29844","WEEKS","[]","Week","Any period of seven consecutive days. (NCI)","False","b28c0d64-3dcf-4017-967e-ca8719a0c2f9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50400/C29844"
"400","Year","C29848","YEARS","[]","Year","The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)","False","c971a829-c81b-4c2b-b94a-50bdc7314ec7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50400/C29848"
"401","Category for Inclusion and or Exclusion","C49480","[IECAT]","['Category for Inclusion/Exclusion']","","A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)","False","0d7e513e-435b-4bec-ba88-04f871c423f5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49480"
"402","Exclusion","C25370","EXCLUSION","[]","Exclusion","List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)","False","43817788-d9eb-4640-8eff-5425814baf9d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49480/C25370"
"403","Inclusion","C25532","INCLUSION","[]","Inclusion","The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study.  NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)","False","67b5847b-84ca-4ef5-b427-767166d692a1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49480/C25532"
"404","CDISC System Organ Class","C64388","[SOC]","['System Organ Class']","","Terms at the highest level of the CDISC system organ class terminology.","False","e49a6e0c-69af-4bd7-875f-b5022e30c474","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388"
"405","Hematopoietic and Lymphoid System Disorder","C35814","BLOOD AND LYMPHATIC SYSTEM DISORDERS","[]","Hematopoietic and Lymphoid System Disorder","Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","e260880b-977b-43e9-9ffe-1793aa75cca0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C35814"
"406","Heart Disorder","C3079","CARDIAC DISORDERS","[]","Heart Disorder","Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","c8d5e487-6700-4a2a-8b5c-28b777457a8e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C3079"
"407","Congenital, Familial and Genetic Disorder Class","C49399","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","[]","Congenital, Familial and Genetic Disorder Class","A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characterstic set of symptoms and signs. (NCI)","False","b7d9e267-f3a0-406a-9789-640151babd4b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C49399"
"408","Ear and Labyrinth Disorder Class","C49400","EAR AND LABYRINTH DISORDERS","[]","Ear and Labyrinth Disorder Class","Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)","False","96aa6de5-6ffe-429c-ba58-deec9f2ab0f8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C49400"
"409","Endocrine Disorder","C3009","ENDOCRINE DISORDERS","[]","Endocrine Disorder","Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","b90f63e0-4a12-421b-ad21-3602445610c4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C3009"
"410","Eye Disorder","C26767","EYE DISORDERS","[]","Eye Disorder","Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)","False","ba19277a-7c00-4614-8259-77c99585f03f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C26767"
"411","Gastrointestinal Disorder","C2990","GASTROINTESTINAL DISORDERS","[]","Gastrointestinal Disorder","Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)","False","d3024563-55ea-45af-afb3-e20563e73bc6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C2990"
"412","General Disorders and Administration Site Conditions Class","C49401","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","[]","General Disorders and Administration Site Conditions Class","A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)","False","43a827fc-2818-4917-971f-feadf6748417","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C49401"
"413","Liver and Biliary Tract Disorder","C3959","HEPATOBILIARY DISORDERS","[]","Liver and Biliary Tract Disorder","Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)","False","bc3198fb-6e74-4230-801a-b72d38b98ff7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C3959"
"414","Immune System Disorder","C3507","IMMUNE SYSTEM DISORDERS","[]","Immune System Disorder","A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)","False","0a90c6c8-a8b1-4cad-86d9-6ae112ab255a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C3507"
"415","Infectious Disorder","C26726","INFECTIONS AND INFESTATIONS","[]","Infectious Disorder","A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)","False","bed15a5a-b11d-40c8-ab06-35f659842174","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C26726"
"416","Injury, Poisoning and Procedural Complication Class","C49402","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","[]","Injury, Poisoning and Procedural Complication Class","A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)","False","dbe80516-13e6-41d5-8a8b-ff201f7e48b7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C49402"
"417","Investigation","C41198","INVESTIGATIONS","[]","Investigation","The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)","False","ab105c21-f9a5-4b26-96fe-83921c19dfd7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C41198"
"418","Metabolism and Nutrition Disorder Class","C49403","METABOLISM AND NUTRITION DISORDERS","[]","Metabolism and Nutrition Disorder Class","A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)","False","2b578206-6d9c-4601-9de3-660012f17ae9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C49403"
"419","Connective and Soft Tissue Disorder","C27574","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","[]","Connective and Soft Tissue Disorder","Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)","False","9c1b28ee-02b8-4616-916e-323c2865f6fd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C27574"
"420","Neoplasm","C3262","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","[]","Neoplasm","An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)","False","e04f5b9e-1cf6-4bae-a172-a62fa1d40192","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C3262"
"421","Nervous System Disorder","C26835","NERVOUS SYSTEM DISORDERS","[]","Nervous System Disorder","Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","9aca4a0b-0395-46fe-a6ff-fda2c8d7e09c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C26835"
"422","Pregnancy, Puerperium and Perinatal Condition Class","C49404","PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS","[]","Pregnancy, Puerperium and Perinatal Condition Class","A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)","False","9168b4f3-e717-463c-a388-2326e7ec7119","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C49404"
"423","Psychiatric Disorder","C2893","PSYCHIATRIC DISORDERS","[]","Psychiatric Disorder","Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)","False","57dcf068-2490-46ac-a9ad-bf2d54437243","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C2893"
"424","Urinary System Disorder","C3430","RENAL AND URINARY DISORDERS","[]","Urinary System Disorder","Disorders of any part of the urologic system. (NCI)","False","c1088b9f-55d4-4323-be54-57ed5f0939f9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C3430"
"425","Reproductive System and Breast Disorder Class","C49405","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","[]","Reproductive System and Breast Disorder Class","Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)","False","bd3e6d51-b7cd-4b0a-aa4e-c3231cb10bc0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C49405"
"426","Respiratory and Thoracic Disorder","C27669","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","[]","Respiratory and Thoracic Disorder","Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)","False","7e51d7eb-4b8e-4f5f-a444-ef6ac7d378c1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C27669"
"427","Skin Disorder","C3371","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","[]","Skin Disorder","Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)","False","72a16cd8-0fa5-4595-8595-53a6b4630c86","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C3371"
"428","Social Circumstances","C20188","SOCIAL CIRCUMSTANCES","[]","Social Circumstances","A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)","False","3ef0f3d6-bd59-4b88-b86e-7636240004c6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C20188"
"429","Procedure","C25218","SURGICAL AND MEDICAL PROCEDURES","[]","Procedure","A particular course of action intended to achieve a result. (NCI)","False","a0daf5d2-ad17-4f60-8e76-d9166103efbc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C25218"
"430","Vascular Disorder","C35117","VASCULAR DISORDERS","[]","Vascular Disorder","Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","044a40b7-a886-4b73-81ab-156388bf8fba","dataset/cdisc/ct/sc/2007-03-06/sdtm/C64388/C35117"
"431","Common Terminology Criteria for Adverse Events","C49704","[TOXGR]","['Standard Toxicity Grade']","","A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)","False","2487b7f8-fcff-4c09-b19d-0e37fa64552f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49704"
"432","Mild Adverse Event","C41338","1","['Grade 1', 'MILD']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","4d7e83df-61c5-48d4-be6a-dce145811fd7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49704/C41338"
"433","Moderate Adverse Event","C41339","2","['Grade 2', 'MODERATE']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","6adaa13f-b01f-4063-a8d7-5dbf50d344a5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49704/C41339"
"434","Severe Adverse Event","C41340","3","['Grade 3', 'SEVERE']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","849abc22-aada-4288-9560-f6b93c6f575f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49704/C41340"
"435","Life Threatening or Disabling Adverse Event","C41337","4","['Grade 4', '']","Life Threatening or Disabling Adverse Event","An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.","False","ee25942a-fb4b-4101-9bbb-82a5b1617ee1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49704/C41337"
"436","Death Related to Adverse Event","C48275","5","['Grade 5', 'FATAL']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","896618bd-b664-4826-9ca7-f5451821cb6e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49704/C48275"
"437","Control Type","C49647","[TCNTRL]","['Type of Control']","","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","0c53970a-c371-4d05-959d-b9f623668754","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49647"
"438","Active Control","C49649","ACTIVE","[]","Active Control","A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].","False","d2330f5a-ed4f-4c94-b817-a553cedb9400","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49647/C49649"
"439","None","C41132","NONE","[]","None","No person or thing, nobody, not any. (NCI)","False","7e859637-ac13-4c77-8116-b77271acba94","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49647/C41132"
"440","Placebo Control","C49648","PLACEBO","[]","Placebo Control","Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)","False","9f733777-b7a6-4d37-94a4-f7ed8c2ce140","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49647/C49648"
"441","Country","C25464","[COUNTRY]","['Country']","","A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)","False","59fa061f-ab28-40ec-ac41-0a94ca685792","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464"
"442","Aruba","C17884","ABW","['ARUBA']","Aruba","Island in the Caribbean Sea, north of Venezuela.","False","dba5992c-2b6e-4fa0-bfa5-db1e692295e7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17884"
"443","Afghanistan","C16267","AFG","['AFGHANISTAN']","Afghanistan","A country in Southern Asia, north and west of Pakistan, east of Iran.","False","fff282b3-034e-42a8-9caf-9fa53a3831d2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16267"
"444","Angola","C16292","AGO","['ANGOLA']","Angola","A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo.","False","333e8fd1-a8cd-45a5-b2c2-36144856d6c2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16292"
"445","Anguilla","C20133","AIA","['ANGUILLA']","Anguilla","An island in the Caribbean Sea, east of Puerto Rico.","False","eadf2e3b-c4d3-46ba-9e62-a7c41f16c9fc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20133"
"446","Aland Islands","C44481","ALA","['ALAND ISLANDS']","Aland Islands","An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland.","False","fa8af59e-7bea-4807-b5e1-57efba2b14d8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C44481"
"447","Albania","C16271","ALB","['ALBANIA']","Albania","A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro.","False","7c34f96a-99fc-4403-853a-360045b7354b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16271"
"448","Andorra","C16289","AND","['ANDORRA']","Andorra","A country in Southwestern Europe, between France and Spain.","False","fcc2432a-a5d0-43b2-a350-6d72f60cf82e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16289"
"449","Netherlands Antilles","C16904","ANT","['NETHERLANDS ANTILLES']","Netherlands Antilles","A country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands.","False","3295411b-739c-40f6-8126-70dedcdaa153","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16904"
"450","United Arab Emirates","C17232","ARE","['UNITED ARAB EMIRATES']","United Arab Emirates","A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia.","False","20199cb6-793c-405a-99f7-91a1d54711dd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17232"
"451","Argentina","C16305","ARG","['ARGENTINA']","Argentina","A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.","False","6e111d71-8cef-4f5f-95a0-944b52def294","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16305"
"452","Armenia","C16306","ARM","['ARMENIA']","Armenia","A country in Southwestern Asia, east of Turkey.","False","2cbaf667-9183-4c70-a6ae-71c0cd49b571","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16306"
"453","American Samoa","C17739","ASM","['AMERICAN SAMOA']","American Samoa","A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand.","False","7b52703d-6772-498c-b979-587efabcccef","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17739"
"454","Antarctica","C18007","ATA","['ANTARCTICA']","Antarctica","The continent lying mostly south of the Antarctic Circle.","False","f862d4a3-1495-48e1-ab90-85a8c69e337c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C18007"
"455","French Southern Territories","C20105","ATF","['FRENCH SOUTHERN TERRITORIES']","French Southern Territories","Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia.","False","4203cdfe-84a7-470f-8c8a-ae282fe09708","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20105"
"456","Antigua and Barbuda","C16303","ATG","['ANTIGUA AND BARBUDA']","Antigua and Barbuda","Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico.","False","74975bbc-e2cd-4455-b14e-8993441f3b43","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16303"
"457","Australia","C16311","AUS","['AUSTRALIA']","Australia","The continent between the Indian Ocean and the South Pacific Ocean.","False","1e821574-fa2e-410c-8e37-9956685d70cc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16311"
"458","Austria","C16312","AUT","['AUSTRIA']","Austria","A country in Central Europe, north of Italy and Slovenia.","False","9c87dec7-54a7-4ad6-9847-56b809525497","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16312"
"459","Azerbaijan","C16316","AZE","['AZERBAIJAN']","Azerbaijan","A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia.","False","0ce01041-baad-42b4-a7cb-f3fd93a915cd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16316"
"460","Burundi","C16371","BDI","['BURUNDI']","Burundi","A country in Central Africa, east of Democratic Republic of the Congo.","False","f12675a0-7038-4b40-9484-ca016f4cee84","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16371"
"461","Belgium","C16329","BEL","['BELGIUM']","Belgium","A country in Western Europe, bordering the North Sea, between France and the Netherlands.","False","2f79682e-b19d-422e-b32e-6aa10607ea7f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16329"
"462","Benin Republic","C16333","BEN","['BENIN REPUBLIC']","Benin Republic","A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo.","False","59d3cee5-be3c-45f7-9512-f230ef1a9ef4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16333"
"463","Burkina Faso","C16369","BFA","['BURKINA FASO']","Burkina Faso","A country in Western Africa, north of Ghana.","False","ec7770e2-3db4-4f17-ac73-81bb04094444","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16369"
"464","Bangladesh","C16323","BGD","['BANGLADESH']","Bangladesh","A country in Southern Asia, bordering the Bay of Bengal, between Burma and India.","False","c6e67ffb-fc43-4fa3-93fe-2e615463c47a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16323"
"465","Bulgaria","C16368","BGR","['BULGARIA']","Bulgaria","A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey.","False","8d7825bc-3752-4779-98b0-9c9e7a4b51c8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16368"
"466","Bahrain","C16322","BHR","['BAHRAIN']","Bahrain","An archipelago in the Persian Gulf, east of Saudi Arabia.","False","e1646559-ebab-41bc-9e2d-782a2e3a6b01","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16322"
"467","Bahamas","C16321","BHS","['BAHAMAS']","Bahamas","A chain of islands in the North Atlantic Ocean, southeast of Florida.","False","4db40e37-a61b-4773-88ab-25a7a6ce1ccb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16321"
"468","Bosnia-Herzegovina","C16361","BIH","['BOSNIA-HERZEGOVINA']","Bosnia-Herzegovina","A country in Southeastern Europe, bordering the Adriatic Sea and Croatia.","False","6db15e2e-14f2-4c47-b4fc-ba960183a2b5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16361"
"469","Belarus","C16372","BLR","['BELARUS']","Belarus","A country in Eastern Europe, east of Poland.","False","1d45ec86-3d17-4142-aedc-7c46f05a2d79","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16372"
"470","Belize","C16331","BLZ","['BELIZE']","Belize","A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico.","False","e8404ecf-be31-4761-b5e6-f8ae754f86b5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16331"
"471","Bermuda","C16334","BMU","['BERMUDA']","Bermuda","No Definition","False","dff380f2-fb80-4b73-8c9d-0aa510b117be","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16334"
"472","Bolivia","C16359","BOL","['BOLIVIA']","Bolivia","A country in Central South America, southwest of Brazil.","False","8cbc1b70-516b-4ee6-a471-fbd5ea8faa2e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16359"
"473","Brazil","C16364","BRA","['BRAZIL']","Brazil","A country in Eastern South America, bordering the Atlantic Ocean.","False","552f7887-7f9b-4521-bbf8-db0524d884bc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16364"
"474","Barbados","C16324","BRB","['BARBADOS']","Barbados","An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","624a8ed3-0d25-45c9-b37d-8e066ef53fab","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16324"
"475","Brunei Darussalam","C16367","BRN","['BRUNEI']","Brunei Darussalam","A country in Southeastern Asia, bordering the South China Sea and Malaysia.","False","62f7cbe0-3b41-416b-b21b-a7d2cc83cb92","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16367"
"476","Bhutan","C16336","BTN","['BHUTAN']","Bhutan","A country in Southern Asia, between China and India.","False","15c6bd04-2ab6-4a5d-84f9-df5905e254e8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16336"
"477","Bouvet Island","C20104","BVT","['BOUVET ISLAND']","Bouvet Island","An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa).","False","fc3eb719-5bc5-43e8-8d0a-7a9fefbb511d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20104"
"478","Botswana","C16363","BWA","['BOTSWANA']","Botswana","A country in Southern Africa, north of South Africa.","False","7746cf00-90ad-40a2-b2c0-d6d7fab7614d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16363"
"479","Central African Republic","C16409","CAF","['CENTRAL AFRICAN REPUBLIC']","Central African Republic","A country in Central Africa, north of Democratic Republic of the Congo.","False","8c4710dc-c879-42e4-9e53-0b25c9ae188e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16409"
"480","Canada","C16380","CAN","['CANADA']","Canada","A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US.","False","c73378e9-bdb2-4b49-aaa4-c56032678dd9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16380"
"481","Cocos (Keeling) Islands","C16445","CCK","['COCOS (KEELING) ISLANDS']","Cocos (Keeling) Islands","A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka.","False","c53f1c96-84a5-4675-9fb6-0d9e5552c63f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16445"
"482","Switzerland","C17181","CHE","['SWITZERLAND']","Switzerland","A country in Central Europe, east of France, north of Italy.","False","8925a9fa-59b9-451d-84c8-a9aadbaa430c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17181"
"483","Chile","C16427","CHL","['CHILE']","Chile","A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru.","False","55f37317-8215-4ffe-8834-a4375ea40f3f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16427"
"484","China","C16428","CHN","['CHINA']","China","A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam.","False","7dc1a17d-3a64-4c0e-8f12-5caa0d1fbd69","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16428"
"485","Cote d'Ivoire","C16762","CIV","[""COTE D'IVOIRE""]","Cote d'Ivoire","A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia.","False","93b92e29-f044-4c02-8935-d2e7e4800f84","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16762"
"486","Cameroon","C16379","CMR","['CAMEROON']","Cameroon","A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria.","False","722ff7e6-4b55-4a33-842f-9faf7b5ddece","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16379"
"487","Democratic Republic of the Congo","C17266","COD","['DEMOCRATIC REPUBLIC OF THE CONGO']","Democratic Republic of the Congo","A country in Central Africa, northeast of Angola.","False","6b3a3e16-3881-4d01-8228-24ba869297f8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17266"
"488","Congo","C16467","COG","['CONGO']","Congo","A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon.","False","9716f395-b337-4223-a6d4-5eba7067d13d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16467"
"489","Cook Islands","C16469","COK","['COOK ISLANDS']","Cook Islands","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","fbe8e88e-e316-4dd4-ae02-0d63584dae14","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16469"
"490","Colombia","C16449","COL","['COLOMBIA']","Colombia","A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama.","False","8044fab0-c6c1-4cba-a271-6ea5c9d62388","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16449"
"491","Comoros","C16458","COM","['COMOROS']","Comoros","A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique.","False","78e40a99-7a65-4775-9cfc-14906f6ad6f4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16458"
"492","Cape Verde","C16382","CPV","['CAPE VERDE']","Cape Verde","A group of islands in the North Atlantic Ocean, west of Senegal.","False","08d76689-44aa-412a-85e0-358f65814dd1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16382"
"493","Costa Rica","C16470","CRI","['COSTA RICA']","Costa Rica","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama.","False","5ac959f3-8d44-4c61-b4d1-9300d10e475b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16470"
"494","Cuba","C16477","CUB","['CUBA']","Cuba","An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida.","False","9b293f66-a1dc-4898-a0b4-07ad7af222b6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16477"
"495","Christmas Island","C44482","CXR","['CHRISTMAS ISLAND']","Christmas Island","An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia.","False","c94e4010-5e52-454c-8b38-6bf7fff74104","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C44482"
"496","Cayman Islands","C16391","CYM","['CAYMAN ISLANDS']","Cayman Islands","An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras.","False","54e90eda-a149-4ed2-aaf0-559cc2bc8b30","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16391"
"497","Cyprus","C16480","CYP","['CYPRUS']","Cyprus","An island in the Mediterranean Sea, south of Turkey.","False","38b03ecf-2512-4a3f-87cb-ab1564a989e0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16480"
"498","Czech Republic","C17668","CZE","['CZECH REPUBLIC']","Czech Republic","A country in Central Europe, southeast of Germany.","False","cb54cc58-7872-4e08-9c76-2ae4ebed3223","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17668"
"499","Germany","C16636","DEU","['GERMANY']","Germany","A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark.","False","fe39a2bc-c457-4b65-b6a5-49850370351b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16636"
"500","Djibouti","C16506","DJI","['DJIBOUTI']","Djibouti","A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia.","False","23043315-d54d-40ba-ad80-a50ee540f9c1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16506"
"501","Dominica","C16519","DMA","['DOMINICA']","Dominica","An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago.","False","a94e2a66-94ba-4805-b673-46e88e552e3c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16519"
"502","Denmark","C16496","DNK","['DENMARK']","Denmark","A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn).","False","0d55cdb6-5797-4287-b8f6-69f3fdcd07f2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16496"
"503","Dominican Republic","C16520","DOM","['DOMINICAN REPUBLIC']","Dominican Republic","A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti.","False","9dbcdc66-4db2-4a7b-8656-320a46d60269","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16520"
"504","Algeria","C16274","DZA","['ALGERIA']","Algeria","A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia.","False","05e05294-f50a-4139-a5cd-7b9016dc54ca","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16274"
"505","Ecuador","C16528","ECU","['ECUADOR']","Ecuador","A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.","False","ecc304d6-854b-49e8-8dd8-f12d91c6d3a8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16528"
"506","Egypt","C16530","EGY","['EGYPT']","Egypt","A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip.","False","e6af60b5-0bbb-44a4-9b7d-7ec6e8f93f71","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16530"
"507","Eritrea","C16558","ERI","['ERITREA']","Eritrea","A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan.","False","7a5f6af0-0258-4719-867b-2cd019ecab23","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16558"
"508","Western Sahara","C20113","ESH","['WESTERN SAHARA']","Western Sahara","A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.","False","97af931a-9763-4dc3-8be9-dd335afff136","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20113"
"509","Spain","C17152","ESP","['SPAIN']","Spain","A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France.","False","7aab50ff-818e-42ae-ae52-d0b3c4994011","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17152"
"510","Estonia","C16562","EST","['ESTONIA']","Estonia","A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia.","False","8931e15c-5d6a-4d88-b923-7ac64fe53eb3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16562"
"511","Ethiopia","C16563","ETH","['ETHIOPIA']","Ethiopia","A country in Eastern Africa, west of Somalia.","False","d60e1fe9-23d7-479c-8963-3f9bd761aefa","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16563"
"512","Finland","C16584","FIN","['FINLAND']","Finland","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia.","False","3713dd96-51d7-4804-8104-3c149b7c75a9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16584"
"513","Fiji","C16582","FJI","['FIJI']","Fiji","An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","176e8092-99f6-4f71-b2b3-ade802ae6e2b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16582"
"514","Falkland Islands","C17954","FLK","['FALKLAND ISLANDS']","Falkland Islands","Islands in the South Atlantic Ocean, east of southern Argentina.","False","d927cc11-389f-40b7-a644-22c2997464a9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17954"
"515","France","C16592","FRA","['FRANCE']","France","A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain.","False","6daa8485-776a-4a91-950c-e6ddb29d9ad4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16592"
"516","Faroe Islands","C16573","FRO","['FAROE ISLANDS']","Faroe Islands","An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway.","False","99161379-c40d-4b5f-8f40-001dd491d8bd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16573"
"517","Federated States of Micronesia","C17881","FSM","['MICRONESIA, FEDERATED STATES OF']","Federated States of Micronesia","An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia.","False","83f12ec8-8c3f-4197-b858-70b19afa64d0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17881"
"518","Gabon","C16596","GAB","['GABON']","Gabon","A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea.","False","fe5b51cf-996f-4d0c-932b-ed70155fafd9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16596"
"519","United Kingdom","C17233","GBR","['UNITED KINGDOM']","United Kingdom","A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France.","False","1899a897-ccbb-4063-9949-00cae3cddcba","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17233"
"520","Georgia","C16634","GEO","['GEORGIA']","Georgia","A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia.","False","3c6afbb1-0a26-4498-a22b-c17fc910c76f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16634"
"521","Guernsey","C64375","GGY","['GUERNSEY']","Guernsey","The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK.","False","e6e8e53a-ca92-4ce5-8b32-aa667dd6e24f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C64375"
"522","Ghana","C26330","GHA","['GHANA']","Ghana","A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo.","False","45fac7e1-de60-4c34-b5b6-344aac828067","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C26330"
"523","Gibraltar","C16638","GIB","['GIBRALTAR']","Gibraltar","A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain.","False","517fcd19-be4c-4274-9029-f3be9f7bc2b2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16638"
"524","Guinea","C16655","GIN","['GUINEA']","Guinea","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone.","False","607966c9-c6d8-46b7-94b4-4411e5a54308","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16655"
"525","Guadeloupe","C16651","GLP","['GUADELOUPE']","Guadeloupe","Islands in the eastern Caribbean Sea, southeast of Puerto Rico.","False","ff9d8a78-5395-4b34-8a71-84f3ad1730f9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16651"
"526","Gambia","C16598","GMB","['GAMBIA']","Gambia","A country in Western Africa, bordering the North Atlantic Ocean and Senegal.","False","cd975592-146f-4523-a321-edfdc71ff3b0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16598"
"527","Guinea-Bissau","C16656","GNB","['GUINEA-BISSAU']","Guinea-Bissau","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal.","False","66263ae4-9650-4704-9175-e11da67fcd52","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16656"
"528","Equatorial Guinea","C16557","GNQ","['EQUATORIAL GUINEA']","Equatorial Guinea","A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands.","False","0c422af8-f84f-4141-92fe-d6c01fcb82f5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16557"
"529","Greece","C16645","GRC","['GREECE']","Greece","A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey.","False","69952ed5-c406-4f74-981d-f2051c0ebc59","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16645"
"530","Grenada","C16647","GRD","['GRENADA']","Grenada","An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago.","False","173fb7bf-c963-490b-a48b-5d840a220a33","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16647"
"531","Greenland","C16646","GRL","['GREENLAND']","Greenland","An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.","False","78880754-6561-4db8-9243-b159115b4a00","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16646"
"532","Guatemala","C16654","GTM","['GUATEMALA']","Guatemala","A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico.","False","538d4acd-091d-4fcb-9da9-62326d664dfa","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16654"
"533","French Guiana","C16593","GUF","['FRENCH GUIANA']","French Guiana","A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname.","False","bc29538f-555e-4c07-82b9-12b6fdf79850","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16593"
"534","Guam","C16652","GUM","['GUAM']","Guam","Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","ddf01f0f-7fb0-4425-a83d-9a685af9bd95","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16652"
"535","Guyana","C16657","GUY","['GUYANA']","Guyana","A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.","False","295a241e-5d34-4079-b0cf-9ca1efba120b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16657"
"536","Hong Kong","C16695","HKG","['HONG KONG']","Hong Kong","A special administrative region of China, bordering the South China Sea and China.","False","4324ac46-8d9d-41a2-9d0b-fa1dc34b8c67","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16695"
"537","Heard Island and McDonald Islands","C20106","HMD","['HEARD ISLAND AND MCDONALD ISLANDS']","Heard Island and McDonald Islands","Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica.","False","2139a106-7c6f-4dc6-909b-951e04936e92","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20106"
"538","Honduras","C16694","HND","['HONDURAS']","Honduras","A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua.","False","20907919-bde2-470d-b042-a87997cccdd1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16694"
"539","Croatia","C16474","HRV","['CROATIA']","Croatia","A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia.","False","8fed9287-329c-4c0b-b0ab-b5959e4b8a7f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16474"
"540","Haiti","C16660","HTI","['HAITI']","Haiti","A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic.","False","cd968fb4-362c-4865-b1f3-78f327063a37","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16660"
"541","Hungary","C16699","HUN","['HUNGARY']","Hungary","A country in Central Europe, northwest of Romania.","False","1d167ce8-9243-4897-803d-c5c74cf6526b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16699"
"542","Indonesia","C16728","IDN","['INDONESIA']","Indonesia","A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean.","False","e6cd117a-df4e-494e-b8b4-75dfcd6d7d97","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16728"
"543","India","C16727","IND","['INDIA']","India","A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.","False","0e69a2f8-e908-4382-a7c3-22e16fd42340","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16727"
"544","British Indian Ocean Territory","C16365","IOT","['BRITISH INDIAN OCEAN TERRITORY']","British Indian Ocean Territory","An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia.","False","6353d9e0-3364-42fe-8978-bdc588134ca7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16365"
"545","Ireland","C16757","IRL","['IRELAND']","Ireland","A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain.","False","d1090cce-a8ee-47fb-a945-15cd6b91648e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16757"
"546","Iran","C16755","IRN","['IRAN']","Iran","A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.","False","a968b684-8eb0-4c54-824c-252f10592264","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16755"
"547","Iraq","C16756","IRQ","['IRAQ']","Iraq","A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait.","False","c603dc24-8d25-435a-9477-66b2ad0a1ed2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16756"
"548","Iceland","C16704","ISL","['ICELAND']","Iceland","A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK.","False","a8862d73-57be-4e6f-b8dc-60f1d8cedced","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16704"
"549","Israel","C16760","ISR","['ISRAEL']","Israel","A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon.","False","174f7cbc-976f-4202-8008-a27f3499caca","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16760"
"550","Italy","C16761","ITA","['ITALY']","Italy","A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.","False","e75185d1-bec1-4967-bd27-99a3f36c498c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16761"
"551","Jamaica","C16763","JAM","['JAMAICA']","Jamaica","An island in the Caribbean Sea, south of Cuba.","False","ccc8a7d1-ddfc-479e-b27b-0c9d6b6656fa","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16763"
"552","Jordan","C16765","JOR","['JORDAN']","Jordan","A country in the Middle East, northwest of Saudi Arabia.","False","ce24be35-076d-42d3-a2c4-5263829b7825","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16765"
"553","Japan","C16764","JPN","['JAPAN']","Japan","A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula.","False","99127bc1-4b36-436f-a8a6-50a05ab556ca","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16764"
"554","Jersey","C64374","JRE","['JERSEY']","Jersey","Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK.","False","273a9d1f-5c72-4ee1-bc1a-9af4c8fc2bb6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C64374"
"555","Kazakhstan","C20107","KAZ","['KAZAKHSTAN']","Kazakhstan","A country in Central Asia, northwest of China.","False","c92585b0-da97-4f7e-b7b8-628cdb69bf79","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20107"
"556","Kenya","C16769","KEN","['KENYA']","Kenya","A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania.","False","b6784b2b-8aef-440d-b563-110bde2012be","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16769"
"557","Kyrgyzstan","C16771","KGZ","['KYRGYZSTAN']","Kyrgyzstan","A country in Central Asia, west of China.","False","c4aa0170-e833-48d3-83c9-366e8926d3ed","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16771"
"558","Cambodia","C16378","KHM","['CAMBODIA']","Cambodia","A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos.","False","fc36d18d-359e-4beb-bfa6-3f18054b573b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16378"
"559","Kiribati","C16639","KIR","['KIRIBATI']","Kiribati","A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia.","False","1bcfcdc2-4869-428a-b35f-2b2c7dce3b74","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16639"
"560","Saint Kitts and Nevis","C17885","KNA","['SAINT KITTS AND NEVIS']","Saint Kitts and Nevis","Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago.","False","85b4dd92-9135-4eca-926b-6559f89d0d40","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17885"
"561","South Korea","C16774","KOR","['SOUTH KOREA']","South Korea","A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea.","False","9f64b6ea-2dbb-4454-948d-18448cc6096b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16774"
"562","Kuwait","C16775","KWT","['KUWAIT']","Kuwait","A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia.","False","fd4bda5d-67ec-461b-b722-b0e6ef9f4bcd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16775"
"563","Lao People's Democratic Republic","C16780","LAO","[""LAO PEOPLE'S DEMOCRATIC REPUBLIC""]","Lao People's Democratic Republic","A country in Southeastern Asia, northeast of Thailand, west of Vietnam.","False","1280496b-d3a8-4a78-bf27-3a9de0b51df6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16780"
"564","Lebanon","C16784","LBN","['LEBANON']","Lebanon","A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria.","False","23b708ac-5973-4d6a-ba9e-be9e2fa1bc3e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16784"
"565","Liberia","C16791","LBR","['LIBERIA']","Liberia","A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone.","False","0ce94cc1-1abc-487f-aade-d16b923990f9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16791"
"566","Libyan Arab Jamahiriya","C16793","LBY","['LIBYAN ARAB JAMAHIRIYA']","Libyan Arab Jamahiriya","A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia.","False","ad55d120-7734-4506-afbe-5a25a928964c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16793"
"567","Saint Lucia","C17113","LCA","['SAINT LUCIA']","Saint Lucia","A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago.","False","5c504a78-5176-404d-b311-68ce3302a6d8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17113"
"568","Liechtenstein","C16794","LIE","['LIECHTENSTEIN']","Liechtenstein","A country in Central Europe, between Austria and Switzerland.","False","5dc39687-ba33-48ff-84ff-7fbcd1f401dc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16794"
"569","Sri Lanka","C17163","LKA","['SRI LANKA']","Sri Lanka","A country in Southern Asia, occupying an island in the Indian Ocean, south of India.","False","5f5c1e80-0622-4f4b-aa34-2f8b0824e2a1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17163"
"570","Lesotho","C16787","LSO","['LESOTHO']","Lesotho","A country in Southern Africa, an enclave of South Africa.","False","786da644-97a2-429c-9b13-d09a0ed532a3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16787"
"571","Lithuania","C16799","LTU","['LITHUANIA']","Lithuania","A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia.","False","d624d422-d769-49ab-9b85-8f67b5e61c80","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16799"
"572","Luxembourg","C16803","LUX","['LUXEMBOURG']","Luxembourg","A country in Western Europe, between France, Belgium, and Germany.","False","171285ee-b489-44f4-a3d0-a107f2750e06","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16803"
"573","Latvia","C16783","LVA","['LATVIA']","Latvia","A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania.","False","cbcb1d07-09c8-4d74-a51a-dd6100d70d3c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16783"
"574","Macao","C16807","MAC","['MACAO']","Macao","A country in Eastern Asia, bordering the South China Sea and China.","False","60ef00c4-6b55-4a8e-adef-b14fac446245","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16807"
"575","Morocco","C16878","MAR","['MOROCCO']","Morocco","A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara.","False","8fe2a9b6-11f2-416d-bd3d-5963e1f379f0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16878"
"576","Monaco","C16874","MCO","['MONACO']","Monaco","A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.","False","250a0ae9-6f40-4a15-bfa0-9dc651b9340e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16874"
"577","Moldova","C16871","MDA","['MOLDOVA, REPUBLIC OF']","Moldova","A country in Eastern Europe, northeast of Romania.","False","a9043565-7361-4302-a249-727a79a1fdd5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16871"
"578","Madagascar","C16808","MDG","['MADAGASCAR']","Madagascar","A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique.","False","9ef7bf3b-2fae-4469-a73f-baffafd8001f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16808"
"579","Maldives","C16815","MDV","['MALDIVES']","Maldives","A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India.","False","b1447a1c-1164-4569-abd9-4393d527d739","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16815"
"580","Mexico","C16850","MEX","['MEXICO']","Mexico","A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US.","False","3f106afc-a535-41a4-b774-e992af7f1d5a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16850"
"581","Marshall Islands","C16822","MHL","['MARSHALL ISLANDS']","Marshall Islands","A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","23441b69-0d20-43fa-bf62-0b50b2065a6e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16822"
"582","Republic of Macedonia","C17654","MKD","['REPUBLIC OF MACEDONIA']","Republic of Macedonia","A country in Southeastern Europe, north of Greece.","False","a0236bb9-3cb5-4e39-9ae6-15481895097e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17654"
"583","Mali","C16816","MLI","['MALI']","Mali","A country in Western Africa, southwest of Algeria.","False","385245e8-831d-451c-a516-c2ea1c98ff72","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16816"
"584","Malta","C16817","MLT","['MALTA']","Malta","A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy).","False","f302de2d-fe8a-402b-a979-94f34cad9460","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16817"
"585","Myanmar","C16370","MMR","['MYANMAR']","Myanmar","A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand.","False","5e72b825-3fbe-4e50-a0dc-c4f52a65ed19","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16370"
"586","Montenegro","C64378","MNE","['MONTENEGRO']","Montenegro","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","243eab3f-ae54-4fe8-ac1e-65546bc034c3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C64378"
"587","Mongolia","C16875","MNG","['MONGOLIA']","Mongolia","A country in Northern Asia, between China and Russia.","False","f3f6acaf-50c5-464c-ad3a-3030938b7cb8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16875"
"588","Northern Mariana Islands","C17882","MNP","['NORTHERN MARIANA ISLANDS']","Northern Mariana Islands","A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","61371dd7-7aa2-4f6f-b637-f64fb7375c4e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17882"
"589","Mozambique","C16882","MOZ","['MOZAMBIQUE']","Mozambique","A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania.","False","20bafe13-7b1c-464d-be1e-63f56c2ff3e4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16882"
"590","Mauritania","C16826","MRT","['MAURITANIA']","Mauritania","A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara.","False","d09f6315-a43b-4664-8c08-ed3b419a99be","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16826"
"591","Montserrat","C16876","MSR","['MONTSERRAT']","Montserrat","A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico.","False","be5f3ce6-c179-45c4-afc1-5c668885c16c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16876"
"592","Martinique","C16823","MTQ","['MARTINIQUE']","Martinique","An island in the Caribbean Sea, north of Trinidad and Tobago.","False","aae432ef-6149-484b-a26c-1b676f9e2507","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16823"
"593","Mauritius","C16827","MUS","['MAURITIUS']","Mauritius","A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","31738980-b2dc-4c49-8bed-2296736f9e1f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16827"
"594","Malawi","C16813","MWI","['MALAWI']","Malawi","A country in Southern Africa, east of Zambia.","False","e0331050-d282-44e7-9ee1-be30cb87b6cc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16813"
"595","Malaysia","C16814","MYS","['MALAYSIA']","Malaysia","A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam.","False","9135e321-419c-4df4-a938-a59f4d72bbf9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16814"
"596","Mayotte","C16828","MYT","['MAYOTTE']","Mayotte","A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique.","False","dc842808-08ef-4d28-be74-0b719233f184","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16828"
"597","Namibia","C16891","NAM","['NAMIBIA']","Namibia","A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa.","False","7a6e7e55-c2b1-4293-bb5f-4e5a765883fe","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16891"
"598","New Caledonia","C16913","NCL","['NEW CALEDONIA']","New Caledonia","A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia.","False","978ff46c-e213-468c-a620-ecee3e07c285","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16913"
"599","Niger","C16916","NER","['NIGER']","Niger","A country in Western Africa, southeast of Algeria.","False","aad4256b-d37c-4794-9366-b7134df8ac59","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16916"
"600","Norfolk Island","C16919","NFK","['NORFOLK ISLAND']","Norfolk Island","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia.","False","56a1ad17-0728-475f-ad9c-8c2f00efca0c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16919"
"601","Nigeria","C16917","NGA","['NIGERIA']","Nigeria","A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon.","False","2b3a65bb-a4f3-4ce7-8da4-640e730fc37e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16917"
"602","Nicaragua","C16915","NIC","['NICARAGUA']","Nicaragua","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras.","False","9611a817-8975-44cd-a034-e0a3a79d221c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16915"
"603","Niue","C16918","NIU","['NIUE']","Niue","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga.","False","5b66a971-7f1d-4605-9eeb-7bf1358bb3ea","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16918"
"604","Netherlands","C16903","NLD","['NETHERLANDS']","Netherlands","A country in Western Europe, bordering the North Sea, between Belgium and Germany.","False","a2f87dc0-704a-4da1-951d-de1539bd2123","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16903"
"605","Norway","C16920","NOR","['NORWAY']","Norway","A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden.","False","8a3d3107-09f0-48ca-9783-cca23acb215a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16920"
"606","Nepal","C16901","NPL","['NEPAL']","Nepal","A country in Southern Asia, between China and India.","False","1ee2a87a-87e4-426a-8848-aa9075ed582d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16901"
"607","Nauru","C16896","NRU","['NAURU']","Nauru","A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands.","False","dc63fe9e-97d2-4cfc-8325-90a8f57895a1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16896"
"608","New Zealand","C16914","NZL","['NEW ZEALAND']","New Zealand","A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia.","False","66bf84f0-3f0c-48b3-8453-314fe0547979","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16914"
"609","Oman","C16933","OMN","['OMAN']","Oman","A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates.","False","1923e12b-7d6c-4683-af6e-456cbc29b6c3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16933"
"610","Pakistan","C16949","PAK","['PAKISTAN']","Pakistan","A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north.","False","71ed5348-6371-459c-b6e3-4cf248bf9011","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16949"
"611","Panama","C16951","PAN","['PANAMA']","Panama","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica.","False","dbfe013a-b7dd-423f-a978-4601bc434406","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16951"
"612","Pitcairn Island","C16993","PCN","['PITCAIRN']","Pitcairn Island","A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.","False","8def18fd-4c38-460c-8f44-faeba041666e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16993"
"613","Peru","C16972","PER","['PERU']","Peru","A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador.","False","c9582d49-48a2-4703-a8f7-571e2bda1593","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16972"
"614","Philippines","C16978","PHL","['PHILIPPINES']","Philippines","A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam.","False","5b3f91dc-a743-4ed7-8de6-182f37ecf352","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16978"
"615","Palau","C17733","PLW","['PALAU']","Palau","A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines.","False","56eb94dc-aedd-4423-b37b-1edc10099bc6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17733"
"616","Papua New Guinea","C16952","PNG","['PAPUA NEW GUINEA']","Papua New Guinea","A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia.","False","049fa7a3-cc16-43ee-839f-38051ce16f3e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16952"
"617","Poland","C17002","POL","['POLAND']","Poland","A country in Central Europe, east of Germany.","False","ec4ce7ad-cb37-4808-81ce-52cfe4b25b0b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17002"
"618","Puerto Rico","C17043","PRI","['PUERTO RICO']","Puerto Rico","An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic.","False","d5a8d61c-dd63-4061-8abd-ae4e04be689e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17043"
"619","North Korea","C16773","PRK","['NORTH KOREA']","North Korea","A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea.","False","3b162f72-a2eb-4f76-be33-0ef5ac053eb2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16773"
"620","Portugal","C17006","PRT","['PORTUGAL']","Portugal","A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain.","False","7599ed72-9c5b-4daf-9244-e0558b4a86eb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17006"
"621","Paraguay","C16953","PRY","['PARAGUAY']","Paraguay","A country in Central South America, northeast of Argentina.","False","8e5f65db-0381-43f1-bd3d-80bde4cfb828","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16953"
"622","Palestinian Territory, Occupied","C20110","PSE","['PALESTINIAN TERRITORY, OCCUPIED']","Palestinian Territory, Occupied","A collective name for the West Bank and the Gaza Strip, two territories in Palestine.","False","9d548dc6-f4ff-44c8-915d-e2467fda96c7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20110"
"623","French Polynesia","C16594","PYF","['FRENCH POLYNESIA']","French Polynesia","An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia.","False","a51fe3bd-931e-4249-80ed-aeb308b9da89","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16594"
"624","Qatar","C17045","QAT","['QATAR']","Qatar","A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia.","False","3c568327-a055-44cc-9330-18ffc7eda0c4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17045"
"625","Reunion","C17095","REU","['REUNION']","Reunion","An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","55173bb3-1755-4672-afc9-e46721276c4d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17095"
"626","Romania","C17108","ROU","['ROMANIA']","Romania","A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine.","False","eadd3c79-bf99-468a-b13e-72f600d29cdb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17108"
"627","Russia","C17111","RUS","['RUSSIAN FEDERATION']","Russia","A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean.","False","44bc5565-388f-49c9-afb7-ab272b656e3a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17111"
"628","Rwanda","C17112","RWA","['RWANDA']","Rwanda","A country in Central Africa, east of Democratic Republic of the Congo.","False","04721f91-b4ef-4a29-8340-55be8ec48f23","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17112"
"629","Saudi Arabia","C17117","SAU","['SAUDI ARABIA']","Saudi Arabia","A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen.","False","d089313b-549b-4fd5-b241-6a9033c5e2c2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17117"
"630","Serbia","C64377","SCG","['SERBIA']","Serbia","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","4a97cf5c-474e-4827-86db-b33ddf209559","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C64377"
"631","Sudan","C17170","SDN","['SUDAN']","Sudan","A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea.","False","b8b46be7-ac4b-4299-9657-bdd5efd1f732","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17170"
"632","Senegal","C17121","SEN","['SENEGAL']","Senegal","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania.","False","7ab3b9bd-4838-41b5-b69c-6b43af21a85f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17121"
"633","Singapore","C17134","SGP","['SINGAPORE']","Singapore","A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia.","False","69d1ff83-f0ab-426c-9f7b-9b2c89a0f74c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17134"
"634","South Georgia and the South Sandwich Islands","C20111","SGS","['SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS']","South Georgia and the South Sandwich Islands","A group of islands in the South Atlantic Ocean, east of the tip of South America.","False","a1366856-8d4b-46ef-a62e-d5c580462806","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20111"
"635","Saint Helena","C17164","SHN","['SAINT HELENA']","Saint Helena","Islands in the South Atlantic Ocean, about midway between South America and Africa.","False","2851f0b2-f364-4816-ad30-4dcc2b375b82","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17164"
"636","Svalbard and Jan Mayen","C17178","SJM","['SVALBARD AND JAN MAYEN']","Svalbard and Jan Mayen","Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway.","False","a8774575-ad44-4114-89de-6d279a6ae698","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17178"
"637","Solomon Islands","C17148","SLB","['SOLOMON ISLANDS']","Solomon Islands","A group of islands in the South Pacific Ocean, east of Papua New Guinea.","False","1d7fcdf7-d21f-4499-a730-4b27aebd2bae","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17148"
"638","Sierra Leone","C17130","SLE","['SIERRA LEONE']","Sierra Leone","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia.","False","99ec3ce8-3db8-42bb-b6d4-39af362d6752","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17130"
"639","El Salvador","C16532","SLV","['EL SALVADOR']","El Salvador","A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras.","False","00de0acb-0a03-49e1-ade9-f5a874ea670c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16532"
"640","San Marino","C17115","SMR","['SAN MARINO']","San Marino","A country in Southern Europe, an enclave in central Italy.","False","b7ca38bf-4abe-48a1-b54d-0a83188f0794","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17115"
"641","Somalia","C17149","SOM","['SOMALIA']","Somalia","A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia.","False","e7037031-9613-402d-9cc2-7cbd4a078088","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17149"
"642","Saint Pierre and Miquelon","C17165","SPM","['SAINT PIERRE AND MIQUELON']","Saint Pierre and Miquelon","A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada).","False","31490adc-c10d-4d6b-8905-144a7ba252e8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17165"
"643","Sao Tome and Principe","C17116","STP","['SAO TOME AND PRINCIPE']","Sao Tome and Principe","A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon.","False","c79dd2c6-d833-49d5-b78c-0c76fd4db06c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17116"
"644","Suriname","C17175","SUR","['SURINAME']","Suriname","A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana.","False","d363f367-44a1-4234-9f07-72eac2f0f981","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17175"
"645","Slovakia","C17669","SVK","['SLOVAKIA']","Slovakia","A country in Central Europe, south of Poland.","False","b335a376-03f1-4f7f-bd4a-d1c6c54a20e1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17669"
"646","Slovenia","C17138","SVN","['SLOVENIA']","Slovenia","A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia.","False","56a33a78-ff9c-4df4-a67e-33be3b77e076","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17138"
"647","Sweden","C17180","SWE","['SWEDEN']","Sweden","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway.","False","df1246d5-d3f8-42fd-bd15-3f169a261227","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17180"
"648","Swaziland","C17179","SWZ","['SWAZILAND']","Swaziland","A country in Southern Africa, between Mozambique and South Africa.","False","8bff8d47-bdb3-48f7-808c-d4cb5de33a1e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17179"
"649","Seychelles","C17129","SYC","['SEYCHELLES']","Seychelles","A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar.","False","02d8351c-bfb1-466c-87c6-f9d9673d820f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17129"
"650","Syria","C17182","SYR","['SYRIAN ARAB REPUBLIC']","Syria","A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey.","False","ff6c2767-fa9b-4ac6-be91-066496812d14","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17182"
"651","Turks and Caicos Islands","C17224","TCA","['TURKS AND CAICOS ISLANDS']","Turks and Caicos Islands","Two island groups in the North Atlantic Ocean, southeast of The Bahamas.","False","dc726f7f-fbd5-450a-8d06-b2c9675158db","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17224"
"652","Chad","C16412","TCD","['CHAD']","Chad","A country in Central Africa, south of Libya.","False","def623ad-c656-4703-8de7-fefb0d17626d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C16412"
"653","Togo","C17202","TGO","['TOGO']","Togo","A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana.","False","690a5320-11b3-45c4-9261-946c2e5380d3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17202"
"654","Thailand","C17192","THA","['THAILAND']","Thailand","A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma.","False","1ed491af-9ed5-4f8f-bcc6-fef73f1b74e3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17192"
"655","Tajikistan","C17183","TJK","['TAJIKISTAN']","Tajikistan","A country in Central Asia, west of China.","False","4210d572-6ca7-4d82-af07-17fb5c18e3b5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17183"
"656","Tokelau","C17704","TKL","['TOKELAU']","Tokelau","A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","8c17df68-a621-4868-ab1f-c3d178411597","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17704"
"657","Turkmenistan","C17223","TKM","['TURKMENISTAN']","Turkmenistan","A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan.","False","19fb92c4-c1b9-4929-9776-0ae0bd3578af","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17223"
"658","Timor-Leste","C17200","TLS","['TIMOR-LESTE']","Timor-Leste","A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco.","False","f2ab4bd2-4b32-4c23-bbb6-701d44fbf0e6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17200"
"659","Tonga","C17205","TON","['TONGA']","Tonga","An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","88e6ba80-9651-49f4-8814-b163f625aaf5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17205"
"660","Trinidad and Tobago","C17217","TTO","['TRINIDAD AND TOBAGO']","Trinidad and Tobago","Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","721a0f7d-1d1a-4022-abe8-b03778078060","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17217"
"661","Tunisia","C17221","TUN","['TUNISIA']","Tunisia","A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya.","False","3c8ac55b-723d-4870-bca7-7426661793c4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17221"
"662","Turkey","C17222","TUR","['TURKEY']","Turkey","A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria.","False","c37bd408-96d8-4f0c-a3a0-74d65d0ab9d8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17222"
"663","Tuvalu","C17225","TUV","['TUVALU']","Tuvalu","An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","1b1a961f-5cc7-4334-9546-f239680705a4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17225"
"664","Taiwan","C17184","TWN","['TAIWAN']","Taiwan","A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China.","False","b5dfd4c5-a2c8-4dd5-b83f-b3661250760e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17184"
"665","Tanzania","C17185","TZA","['TANZANIA, UNITED REPUBLIC OF']","Tanzania","A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique.","False","0acbae0d-d301-477d-8f50-9ba28edf7ebe","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17185"
"666","Uganda","C17228","UGA","['UGANDA']","Uganda","A country in Eastern Africa, west of Kenya.","False","803e976f-80eb-420f-b17a-37472b6854fc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17228"
"667","Ukraine","C17229","UKR","['UKRAINE']","Ukraine","A country in Eastern Europe, bordering the Black Sea, between Poland and Russia.","False","65c61311-8703-4f77-8854-95661a5539a2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17229"
"668","United States Minor Outlying Islands","C20112","UMI","['UNITED STATES MINOR OUTLYING ISLANDS']","United States Minor Outlying Islands","The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).","False","5c05a251-c032-49c7-89a8-e751d9cfbcf1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C20112"
"669","Uruguay","C17244","URY","['URUGUAY']","Uruguay","A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil.","False","030eeec5-9344-4004-8af9-df9c7e156a66","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17244"
"670","United States","C17234","USA","['UNITED STATES']","United States","A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico.","False","2b450315-7d9e-43d4-93c9-19eeb35e582c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17234"
"671","Uzbekistan","C17246","UZB","['UZBEKISTAN']","Uzbekistan","A country in Central Asia, north of Afghanistan.","False","25b91e5d-54e0-48d4-821b-bb0230c1e04c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17246"
"672","Holy See","C17249","VAT","['VATICAN CITY STATE']","Holy See","An enclave of Rome (Italy).","False","71ed4741-0011-41e2-a245-63c9dae98ef0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17249"
"673","Saint Vincent and the Grenadines","C17114","VCT","['SAINT VINCENT AND THE GRENADINES']","Saint Vincent and the Grenadines","A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago.","False","8e32e9ea-153f-46e1-a946-e773f7a5be52","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17114"
"674","Venezuela","C17250","VEN","['VENEZUELA']","Venezuela","A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana.","False","d0ffec4d-9ffe-42cb-b01e-b61ecbb0fba5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17250"
"675","British Virgin Islands","C17653","VGB","['VIRGIN ISLANDS,BRITISH']","British Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","b9234b6f-036b-4211-a67b-9f15d81f8edf","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17653"
"676","United States Virgin Islands","C17255","VIR","['VIRGIN ISLANDS, U.S.']","United States Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","f1b8c395-5021-49fd-ad46-86b3b7da5a50","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17255"
"677","Vietnam","C17252","VNM","['VIETNAM']","Vietnam","A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.","False","99bf7f20-6022-4249-bfa8-1d162aea7498","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17252"
"678","Vanuatu","C17247","VUT","['VANUATU']","Vanuatu","A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia.","False","00f50164-c430-4c41-be2f-ece731d63e66","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17247"
"679","Wallis and Futuna Islands","C17259","WLF","['WALLIS AND FUTUNA']","Wallis and Futuna Islands","Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","a9f892ae-279c-427a-a870-e73b5741eeae","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17259"
"680","Samoa","C17740","WSM","['SAMOA']","Samoa","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","6d24ae9f-497f-4db9-b25a-33acd9044792","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17740"
"681","Yemen","C17264","YEM","['YEMEN']","Yemen","A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia.","False","ce18ac68-0e2a-4cde-a7a9-d6c80ae1e4ec","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17264"
"682","South Africa","C17151","ZAF","['SOUTH AFRICA']","South Africa","A country in Southern Africa, at the southern tip of the continent of Africa.","False","9e4ee337-b8fb-4590-b312-2709ccc6c07e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17151"
"683","Zambia","C17267","ZMB","['ZAMBIA']","Zambia","A country in Southern Africa, east of Angola.","False","e63c3064-d385-45c2-a201-c00ac20bcfe3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17267"
"684","Zimbabwe","C17268","ZWE","['ZIMBABWE']","Zimbabwe","A country in Southern Africa, between South Africa and Zambia.","False","70ff380e-01e7-40fd-a58c-9c87a347cf95","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25464/C17268"
"685","Diagnosis Group","C49650","[TDIGRP]","['Diagnosis Group']","","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","8e9ff15f-4f81-4823-8c77-b54ff81b5383","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49650"
"686","Healthy Subject","C49651","HEALTHY SUBJECTS","[]","Healthy Subject","An individual who is or becomes a participant in a research study and has no significant health-related issues.  (NCI)","False","e569988f-5b11-4e3a-a4cd-84d7ef5e2ce8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49650/C49651"
"687","Dictionary Name","C50399","[DICTNAM]","['Name of Dictionary']","","A name given to a reference source that lists words and gives their meaning. (NCI)","False","4caf72f4-20ca-4b38-9976-5e19307675e4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399"
"688","Thesaurus of Adverse Reaction Term Coding Symbols","C49471","COSTART","['Coding Symbols for a Thesaurus of Adverse Reaction Terms']","Thesaurus of Adverse Reaction Term Coding Symbols","A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)","False","89ed2ced-7fa4-41fb-a58f-28b5a1936c64","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399/C49471"
"689","International Classification of Diseases","C49474","ICD","['International Classification of Diseases']","International Classification of Diseases","A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)","False","f5038c24-8b39-407f-9152-6e179bbfb0a5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399/C49474"
"690","Logical Observation Identifiers Names and Codes","C49476","LOINC","['Logical Observation Identifiers Names and Codes']","Logical Observation Identifiers Names and Codes","Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)","False","3ecdc2e6-05fc-42ca-8efb-ab4228c16aa0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399/C49476"
"691","MedDRA","C43820","MedDRA","['Medical Dictionary for Regulatory Activities']","MedDRA","MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)","False","43eda50d-e757-402c-b558-1ca408f110b4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399/C43820"
"692","Systematized Nomenclature of Medicine","C53489","SNOMED","['Systematized Nomenclature of Medicine']","Systematized Nomenclature of Medicine","A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)","False","5fd997e1-d69f-4078-a6b8-c84b398c6b5e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399/C53489"
"693","World Health Organization Adverse Reaction Terminology","C49468","WHOART","['World Health Organization Adverse Reaction Terms']","World Health Organization Adverse Reaction Terminology","A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)","False","f6975655-9418-43c5-a6d7-920584d98f11","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399/C49468"
"694","World Health Organization Drug Dictionary","C49475","WHODD","['World Health Organization Drug Dictionary']","World Health Organization Drug Dictionary","A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)","False","7271aaea-d6c2-41e4-8715-0ddfec22dd29","dataset/cdisc/ct/sc/2007-03-06/sdtm/C50399/C49475"
"695","Not Done","C49484","[ND]","['Not Done', 'ND']","","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","9335e332-53a6-4746-839e-eb7df82ee79a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49484"
"696","Not Done","C49484","NOT DONE","['Not Done', 'ND']","Not Done","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","80d7b4dd-22a2-4bd8-a0fc-a73623a3460c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49484/C49484"
"697","Patient Ethnic Group","C16564","[ETHNIC]","['Ethnicity']","","A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)","False","a393c9ab-4499-4e72-944f-77ff3fc31794","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16564"
"698","Hispanic or Latino","C17459","Hispanic or Latino","[]","Hispanic or Latino","A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)","False","df9adee7-dfcd-4472-a772-2b8cda357ca6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16564/C17459"
"699","Not Hispanic or Latino","C41222","Not Hispanic or Latino","[]","Not Hispanic or Latino","A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)","False","ea0bde1a-9d9d-4f58-8822-f8ce2fab472b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16564/C41222"
"700","Not Stated","C43234","Not reported","[]","Not Stated","Not provided or available","False","5ab83ed4-73fa-44da-9ca2-f879e0214942","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16564/C43234"
"701","Unknown","C17998","U","['UNKNOWN', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","9848918e-b3d8-4e24-80e1-6d677acf2f68","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16564/C17998"
"702","Patient Ethnic Group","C16960","[Patient]","[]","","A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary. (NCI)","False","88df1476-7eb7-4ef9-a58c-f17f329f06b0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16960"
"703","Hispanic or Latino","C17459","Hispanic or Latino","[]","Hispanic or Latino","A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)","False","09011669-36be-48a5-9842-8aaa42fde5de","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16960/C17459"
"704","Not Hispanic or Latino","C41222","Not Hispanic or Latino","[]","Not Hispanic or Latino","A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)","False","2ba1b799-4bd6-41dd-bf4c-2bfa65ca3f90","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16960/C41222"
"705","Not Stated","C43234","Not reported","[]","Not Stated","Not provided or available","False","5ba74241-3d5d-47b9-be97-2c3a6653cfff","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16960/C43234"
"706","Unknown","C17998","U","['UNKNOWN', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","72fe7739-1c59-4bb8-9ef4-309df53b1918","dataset/cdisc/ct/sc/2007-03-06/sdtm/C16960/C17998"
"707","Pharmaceutical Dosage Form","C42636","[FRM]","['Dose Form']","","The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.","False","c699a925-289b-4c84-b95a-d28728f28415","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636"
"708","Aerosol Dosage Form","C42887","AEROSOL","[]","Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)","False","a764c058-c467-4e20-b86b-e323f0e807e2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42887"
"709","Aerosol Foam Dosage Form","C42888","AEROSOL, FOAM","[]","Aerosol Foam Dosage Form","A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)","False","c64d376f-2e29-4b62-960c-789e39407c60","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42888"
"710","Metered Aerosol Dosage Form","C42960","AEROSOL, METERED","[]","Metered Aerosol Dosage Form","A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)","False","aeb96e9f-8193-4dee-b5e6-816fd302b0f6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42960"
"711","Powder Aerosol Dosage Form","C42971","AEROSOL, POWDER","[]","Powder Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)","False","7a9b3cfc-b619-4b26-9fb7-f8274f392280","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42971"
"712","Aerosol Spray Dosage Form","C42889","AEROSOL, SPRAY","[]","Aerosol Spray Dosage Form","An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)","False","4092d320-ddf1-4234-883d-c6e1df104eab","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42889"
"713","Chewable Bar Dosage Form","C42892","BAR, CHEWABLE","[]","Chewable Bar Dosage Form","A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)","False","4880049b-dfca-43b3-9fbb-abca03d23044","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42892"
"714","Bead Dosage Form","C42890","BEAD","[]","Bead Dosage Form","A solid dosage form in the shape of a small ball. (NCI)","False","5c82725b-8f92-4fa8-ba51-4f997bbc8bf5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42890"
"715","Extended Release Bead Implant Dosage Form","C43451","BEAD, IMPLANT, EXTENDED RELEASE","[]","Extended Release Bead Implant Dosage Form","A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form.  (NCI)","False","3c87666d-9ecb-4d94-9234-58e80f8ce191","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C43451"
"716","Block Dosage Form","C42891","BLOCK","[]","Block Dosage Form","Solid dosage form, usually in the shape of a square or rectangle. (NCI)","False","4c9ced11-650c-4fc5-a277-d5d3b523a93d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42891"
"717","Capsule Dosage Form","C25158","CAPSULE","[]","Capsule Dosage Form","A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)","False","f6975175-87b7-409d-85a0-90222836a99c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C25158"
"718","Coated Capsule Dosage Form","C42895","CAPSULE, COATED","[]","Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)","False","5f10452d-f775-4a13-9de3-77ea5b88b1c8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42895"
"719","Coated Pellets in Capsule Dosage Form","C42896","CAPSULE, COATED PELLETS","[]","Coated Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)","False","91552c66-2c60-4ff9-8d54-277a262d5e08","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42896"
"720","Extended Release Coated Capsule Dosage Form","C42917","CAPSULE, COATED, EXTENDED RELEASE","[]","Extended Release Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","dbf09033-eb26-46ab-abf2-1be31a48c72f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42917"
"721","Delayed Release Capsule Dosage Form","C42902","CAPSULE, DELAYED RELEASE","[]","Delayed Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","6c129955-36d2-4402-a06e-09a6349a2d29","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42902"
"722","Delayed Release Pellets in Capsule Dosage Form","C42904","CAPSULE, DELAYED RELEASE PELLETS","[]","Delayed Release Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","7516e90f-d0d9-4fe5-bb00-92705d2e27d0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42904"
"723","Extended Release Capsule Dosage Form","C42916","CAPSULE, EXTENDED RELEASE","[]","Extended Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","666abeb2-3599-4d0b-a659-feb56254f20e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42916"
"724","Extended Release Film Coated Capsule Dosage Form","C42928","CAPSULE, FILM COATED, EXTENDED RELEASE","[]","Extended Release Film Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","a93d387b-5cce-436d-ae84-159c47273289","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42928"
"725","Gelatin Coated Capsule Dosage Form","C42936","CAPSULE, GELATIN COATED","[]","Gelatin Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)","False","8c7fefc9-85e9-4608-b3b3-834291e32efc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42936"
"726","Liquid Filled Capsule Dosage Form","C42954","CAPSULE, LIQUID FILLED","[]","Liquid Filled Capsule Dosage Form","A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)","False","ba256329-a455-4063-a212-f75eab46f5ce","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42954"
"727","Cement Dosage Form","C45414","CEMENT","[]","Cement Dosage Form","A substance that serves to produce solid union between two surfaces. (NCI)","False","e51de29d-8694-4655-b8f5-ffa0984ed926","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C45414"
"728","Cigarette Dosage Form","C42678","CIGARETTE","[]","Cigarette Dosage Form","A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)","False","016f5b02-c1f3-48d5-8a0b-02d83609926a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42678"
"729","Cloth Dosage Form","C60884","CLOTH","[]","Cloth Dosage Form","ALT_DEFINITION:  A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)","False","4287c48b-f83d-4a3a-ad2e-79e7058e212d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60884"
"730","Concentrate Dosage Form","C60891","CONCENTRATE","[]","Concentrate Dosage Form","A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)","False","43a02b5b-6dd3-425c-b1dd-7fc6c515f9ac","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60891"
"731","Cone Dosage Form","C42900","CONE","[]","Cone Dosage Form","A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)","False","acac2576-81bf-4c44-9a35-b490d358786a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42900"
"732","Extended Release Core Dosage Form","C42919","CORE, EXTENDED RELEASE","[]","Extended Release Core Dosage Form","An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)","False","c42e6b23-e3a9-47c6-9e23-4d2d16b8fcf2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42919"
"733","Cream Dosage Form","C28944","CREAM","[]","Cream Dosage Form","A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)","False","ff2bd8ce-9053-48e9-a267-c412f67ab130","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C28944"
"734","Augmented Cream Dosage Form","C60897","CREAM, AUGMENTED","[]","Augmented Cream Dosage Form","A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","c502f13c-366d-47c9-8986-0390f7a7296a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60897"
"735","Crystal Dosage Form","C42901","CRYSTAL","[]","Crystal Dosage Form","A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.","False","46efc023-c8fb-4123-b108-db7051a5f317","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42901"
"736","Culture Dosage Form","C45415","CULTURE","[]","Culture Dosage Form","The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)","False","8e3868b5-8187-4ac4-bf1a-e5ebb669393f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C45415"
"737","Diaphragm Dosage Form","C47890","DIAPHRAGM","[]","Diaphragm Dosage Form","A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)","False","321b95e8-35ad-47ef-94f0-0f7d0c23307e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47890"
"738","Disc Dosage Form","C43525","DISC","[]","Disc Dosage Form","A circular plate-like organ or structure. (FDA)","False","6a7edceb-76e4-4007-972d-9ef378de4b6a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C43525"
"739","Douche Dosage Form","C42679","DOUCHE","[]","Douche Dosage Form","A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)","False","7c55ca4c-8c71-4e6a-9420-c973530a5350","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42679"
"740","Dressing Dosage Form","C42763","DRESSING","[]","Dressing Dosage Form","The application of various materials for protecting a wound.(FDA)","False","d8b66e93-f0a2-4803-90c2-e3beed847abb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42763"
"741","Drug Delivery System","C17423","DRUG DELIVERY SYSTEM","[]","Drug Delivery System","Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)","False","239d894b-2087-467e-801e-30570894af53","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C17423"
"742","Elixir Dosage Form","C42912","ELIXIR","[]","Elixir Dosage Form","A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)","False","977402de-9100-4d48-9b0b-f9d736edc6cd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42912"
"743","Emulsion Dosage Form","C42913","EMULSION","[]","Emulsion Dosage Form","A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)","False","69fee49b-897f-4db0-8047-995a715fe047","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42913"
"744","Enema Dosage Form","C42915","ENEMA","[]","Enema Dosage Form","A rectal preparation for therapeutic, diagnostic, or nutritive purposes.  (NCI)","False","3edbd09c-4bec-4c24-83c1-4ce30a1b9417","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42915"
"745","Extract Dosage Form","C42929","EXTRACT","[]","Extract Dosage Form","A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)","False","9028740c-e24e-452e-906b-382a291ae969","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42929"
"746","Extended Release Fiber Dosage Form","C60926","FIBER, EXTENDED RELEASE","[]","Extended Release Fiber Dosage Form","A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","5e19c17a-5609-44f4-bdad-60745ceb4b4a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60926"
"747","Film Dosage Form","C42932","FILM","[]","Film Dosage Form","A thin layer or coating. (NCI)","False","f331ffa7-b274-44b2-96be-541afcee6c26","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42932"
"748","Extended Release Film Dosage Form","C42920","FILM, EXTENDED RELEASE","[]","Extended Release Film Dosage Form","A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)","False","67529ad7-1996-4551-bab1-b1f39db3ecd4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42920"
"749","Soluble Film Dosage Form","C42984","FILM, SOLUBLE","[]","Soluble Film Dosage Form","A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)","False","c97a0bdc-c899-425c-8467-db0072929499","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42984"
"750","Dosage Form For Solution","C60927","FOR SOLUTION","[]","Dosage Form For Solution","A product, usually a solid, intended for solution prior to administration. (FDA)","False","65cfad3b-4a14-4fd6-b797-d042068b99b6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60927"
"751","Dosage Form For Suspension","C60928","FOR SUSPENSION","[]","Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration. (FDA)","False","3ebb1bf1-fb38-4e95-9297-82fe94a29569","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60928"
"752","Extended Release Dosage Form For Suspension","C60929","FOR SUSPENSION, EXTENDED RELEASE","[]","Extended Release Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)","False","0ffd1f34-174b-4e1a-ad3e-d7ec7bbb6b26","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60929"
"753","Gas Dosage Form","C42933","GAS","[]","Gas Dosage Form","Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)","False","5dba4d5b-af59-427c-a3a4-f1d28564c31f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42933"
"754","Gel Dosage Form","C42934","GEL","[]","Gel Dosage Form","A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2).  A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature.  It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)","False","93c81d9c-8e9a-43a6-869b-3f5be976ed80","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42934"
"755","Dentifrice Gel Dosage Form","C42906","GEL, DENTIFRICE","[]","Dentifrice Gel Dosage Form","A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)","False","5d70808a-dfe7-4124-8007-6c5e8f68c860","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42906"
"756","Metered Gel Dosage Form","C60930","GEL, METERED","[]","Metered Gel Dosage Form","A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)","False","ca883930-4322-45be-a5fa-33e9980cb524","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60930"
"757","Generator Dosage Form","C48193","GENERATOR","[]","Generator Dosage Form","An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)","False","19408143-f1d3-4080-844c-443ba3355e91","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C48193"
"758","Globule Dosage Form","C42937","GLOBULE","[]","Globule Dosage Form","Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)","False","a35daf88-ed64-4fd6-8314-659ecb5306bd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42937"
"759","Graft Dosage Form","C45416","GRAFT","[]","Graft Dosage Form","A slip of skin or of other tissue for implantation. (NCI)","False","8a40e76e-e86c-47f5-9d2f-cc14b51f71bd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C45416"
"760","Granule Dosage Form","C42938","GRANULE","[]","Granule Dosage Form","A small particle or grain. (NCI)","False","9d9de51e-ff24-4be4-88fd-f2545b127806","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42938"
"761","Delayed Release Granule Dosage Form","C42903","GRANULE, DELAYED RELEASE","[]","Delayed Release Granule Dosage Form","A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","75ffe844-6949-4ad4-a8dc-3ee822201162","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42903"
"762","Effervescent Granule Dosage Form","C42909","GRANULE, EFFERVESCENT","[]","Effervescent Granule Dosage Form","A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)","False","bb007779-b0f5-43f5-9f3d-bbca55ea6017","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42909"
"763","Granule For Solution Dosage Form","C42939","GRANULE, FOR SOLUTION","[]","Granule For Solution Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","de80b470-f144-40fd-8e80-8948c43047e3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42939"
"764","Granule For Suspension Dosage Form","C42940","GRANULE, FOR SUSPENSION","[]","Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","ac60a99d-6ddd-4fd9-b7a0-9bb4b01de6de","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42940"
"765","Extended Release Granule For Suspension Dosage Form","C42921","GRANULE, FOR SUSPENSION, EXTENDED RELEASE","[]","Extended Release Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)","False","16cfc041-f46a-48b3-81a2-3937ce65771d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42921"
"766","Gum Dosage Form","C42941","GUM","[]","Gum Dosage Form","A mucilaginous excretion from various plants. (NCI)","False","3952f636-641e-418c-a063-32ef8f7ffde2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42941"
"767","Chewing Gum Dosage Form","C42894","GUM, CHEWING","[]","Chewing Gum Dosage Form","A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)","False","138e295a-43b4-434f-b32e-853bb3387562","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42894"
"768","Resin Gum Dosage Form","C42978","GUM, RESIN","[]","Resin Gum Dosage Form","Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)","False","e86941b4-8532-4bc7-b9e4-5cd78ada6636","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42978"
"769","Implant Dosage Form","C42942","IMPLANT","[]","Implant Dosage Form","A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)","False","967d112a-638f-4f38-8255-5927a5f3f44e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42942"
"770","Inhalant Dosage Form","C42944","INHALANT","[]","Inhalant Dosage Form","A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)","False","e11cc242-d42d-41e0-be2e-118ef4930d2b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42944"
"771","Liposomal Injection Dosage Form","C60931","INJECTABLE, LIPOSOMAL","[]","Liposomal Injection Dosage Form","An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)","False","0f788128-7f23-4544-9476-044e517d5869","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60931"
"772","Injectable Dosage Form","C42946","INJECTION","[]","Injectable Dosage Form","A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)","False","3c25e99d-7c34-4047-b6c6-efd95c65bb2b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42946"
"773","Emulsion for Injection Dosage Form","C42914","INJECTION, EMULSION","[]","Emulsion for Injection Dosage Form","An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)","False","98c18c06-9cc8-4608-b82f-4b05b9b78c7a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42914"
"774","Injectable Lipid Complex Dosage Form","C42950","INJECTION, LIPID COMPLEX","[]","Injectable Lipid Complex Dosage Form","[definition pending](FDA)","False","01a6431e-1dfe-4aaf-b994-42e9f324058d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42950"
"775","Powder For Injectable Solution Dosage Form","C42974","INJECTION, POWDER, FOR SOLUTION","[]","Powder For Injectable Solution Dosage Form","A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)","False","d40e1e1a-69b1-48b3-b8a4-bef0d1db626f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42974"
"776","Powder For Injectable Suspension Dosage Form","C42976","INJECTION, POWDER, FOR SUSPENSION","[]","Powder For Injectable Suspension Dosage Form","A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)","False","58c19571-f19a-4c4b-862f-dd340e2af5fc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42976"
"777","Powder For Injectable Extended Release Suspension Dosage Form","C42977","INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE","[]","Powder For Injectable Extended Release Suspension Dosage Form","A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)","False","734e74c7-0903-4abd-ab73-9968b416e494","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42977"
"778","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","C42959","INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION","[]","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)","False","bd80885e-7c30-4de5-a128-7c212cb35a31","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42959"
"779","Lyophilized Powder For Injectable Solution Dosage Form","C42957","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","[]","Lyophilized Powder For Injectable Solution Dosage Form","A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)","False","d26a6ab4-fa08-4f6a-8383-9a02cebe9a23","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42957"
"780","Lyophilized Powder For Injectable Suspension Dosage Form","C42958","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION","[]","Lyophilized Powder For Injectable Suspension Dosage Form","A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization (""freeze drying""), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)","False","726c5800-2856-4bef-bdb1-31beacf85012","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42958"
"781","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","C42956","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE","[]","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)","False","20f58edb-9412-46ce-a8ae-f9e9b82dc168","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42956"
"782","Injectable Solution Dosage Form","C42945","INJECTION, SOLUTION","[]","Injectable Solution Dosage Form","A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)","False","5b5874aa-0333-41ba-8afa-ec53b792b037","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42945"
"783","Concentrate for Injectable Solution Dosage Form","C42899","INJECTION, SOLUTION, CONCENTRATE","[]","Concentrate for Injectable Solution Dosage Form","A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)","False","45771d98-306a-4d0a-a3cf-b44112407088","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42899"
"784","Injectable Suspension Dosage Form","C42995","INJECTION, SUSPENSION","[]","Injectable Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)","False","f8ec2f25-792c-4e0d-99d2-7da38bec94b8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42995"
"785","Injectable Extended Release Suspension Dosage Form","C42926","INJECTION, SUSPENSION, EXTENDED RELEASE","[]","Injectable Extended Release Suspension Dosage Form","A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","7c346ab3-2865-4628-be9c-281c3dd69528","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42926"
"786","Injectable Liposomal Suspension Dosage Form","C42951","INJECTION, SUSPENSION, LIPOSOMAL","[]","Injectable Liposomal Suspension Dosage Form","A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)","False","8c72d69b-bd46-45cf-b170-13f9afcfce4e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42951"
"787","Injectable Sonicated Suspension Dosage Form","C42988","INJECTION, SUSPENSION, SONICATED","[]","Injectable Sonicated Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)","False","49c6188a-ca04-4efc-b901-cf167bb2846d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42988"
"788","Insert Dosage Form","C60933","INSERT","[]","Insert Dosage Form","A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)","False","6ef881a3-9de7-4577-b8f7-25cefc74a182","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60933"
"789","Extended Release Insert Dosage Form","C42922","INSERT, EXTENDED RELEASE","[]","Extended Release Insert Dosage Form","A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)","False","0464cbf4-70ec-45cf-9200-ca2a85ba48b5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42922"
"790","Intrauterine Device Dosage Form","C47915","INTRAUTERINE DEVICE","[]","Intrauterine Device Dosage Form","A device inserted and left in the uterus to prevent effective conception. (NCI)","False","10205f82-8c22-499b-b1b1-591a5f2aa097","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47915"
"791","Irrigant Dosage Form","C42947","IRRIGANT","[]","Irrigant Dosage Form","A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)","False","a462eaa4-1705-4eec-86f8-94f3053fb5ea","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42947"
"792","Jelly Dosage Form","C42948","JELLY","[]","Jelly Dosage Form","A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)","False","89ca18b3-6e2c-4bdb-8994-4f122c56cf4f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42948"
"793","Kit Dosage Form","C47916","KIT","[]","Kit Dosage Form","A packaged collection of related material. (NCI)","False","8e84e987-351e-43ac-b9c1-5c13870fb259","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47916"
"794","Dental Liner Dosage Form","C45413","LINER, DENTAL","[]","Dental Liner Dosage Form","A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)","False","9f9ed2d5-0091-4cf8-bb77-2be0f456cd83","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C45413"
"795","Liniment Dosage Form","C42949","LINIMENT","[]","Liniment Dosage Form","A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)","False","65669fa0-2fda-4ce4-9a50-557b21f4518f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42949"
"796","Lipstick Dosage Form","C42952","LIPSTICK","[]","Lipstick Dosage Form","A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)","False","dc1bafef-e351-4d35-a7f0-e3f47ac59e11","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42952"
"797","Liquid Dosage Form","C42953","LIQUID","[]","Liquid Dosage Form","A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","974fa0fe-9565-4b64-9721-d149b0c1d48a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42953"
"798","Extended Release Liquid Dosage Form","C60934","LIQUID, EXTENDED RELEASE","[]","Extended Release Liquid Dosage Form","A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","3b77096a-f407-4182-bd5d-7558c6abe8ce","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60934"
"799","Lotion Dosage Form","C29167","LOTION","[]","Lotion Dosage Form","An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)","False","7f364204-57c1-4685-9c4c-4aa3417da947","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C29167"
"800","Augmented Lotion Dosage Form","C60957","LOTION. AUGMENTED","[]","Augmented Lotion Dosage Form","A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","838751f9-c373-4176-a532-c146d53e48e7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60957"
"801","Lotion Shampoo Dosage Form","C60958","LOTION/SHAMPOO","[]","Lotion Shampoo Dosage Form","A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)","False","36172983-00ed-46b6-b9f1-3d9eefad2a74","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60958"
"802","Lozenge Dosage Form","C42955","LOZENGE","[]","Lozenge Dosage Form","A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)","False","ec8aa831-99c3-4aa0-87ab-1acd536f73b9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42955"
"803","Mouthwash Dosage Form","C29269","MOUTHWASH","[]","Mouthwash Dosage Form","An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)","False","e8c84adb-e257-47f5-8374-e178c4e1c92c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C29269"
"804","Dosage Form Not Applicable","C48624","NOT APPLICABLE","[]","Dosage Form Not Applicable","The use of a dosage form term is not relevant or appropriate. (NCI)","False","42bb4d94-41f9-441e-8852-0eb17a554260","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C48624"
"805","Oil Dosage Form","C42965","OIL","[]","Oil Dosage Form","An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)","False","287533df-8819-4229-a702-c9f58cd255ce","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42965"
"806","Ointment Dosage Form","C42966","OINTMENT","[]","Ointment Dosage Form","A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)","False","8d044b7a-221b-4d61-a171-31e573692ef6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42966"
"807","Augmented Ointment Dosage Form","C60984","OINTMENT, AUGMENTED","[]","Augmented Ointment Dosage Form","An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","2bed879a-1e89-4d1b-a844-c940fc2eedd6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60984"
"808","Packing Dosage Form","C47887","PACKING","[]","Packing Dosage Form","A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)","False","f246873c-2aac-4439-b19e-7a0999d4eef8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47887"
"809","Paste Dosage Form","C42967","PASTE","[]","Paste Dosage Form","A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)","False","d3d7f64e-2cbf-450d-b523-5e38dcdaef74","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42967"
"810","Dentifrice Paste Dosage Form","C42907","PASTE, DENTIFRICE","[]","Dentifrice Paste Dosage Form","A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","523f2046-4cdb-4ba6-a84d-f8f9bef657d4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42907"
"811","Pastille Dosage Form","C60985","PASTILLE","[]","Pastille Dosage Form","An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)","False","b1045e4f-c85d-4281-9347-d1f13985d6f8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60985"
"812","Patch Dosage Form","C42968","PATCH","[]","Patch Dosage Form","A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body.  Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch.  Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body.  A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)","False","a64e717c-161e-4701-b460-813267017884","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42968"
"813","Extended Release Patch Dosage Form","C42923","PATCH, EXTENDED RELEASE","[]","Extended Release Patch Dosage Form","A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","f4cb0db5-0e23-49bd-b186-ff663937112e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42923"
"814","Electrically Controlled Extended Release Patch Dosage Form","C42911","PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED","[]","Electrically Controlled Extended Release Patch Dosage Form","A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","3dbec025-7cc6-4d76-888a-e89f80a57f9e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42911"
"815","Pellet Dosage Form","C42969","PELLET","[]","Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)","False","0c61ad71-5c37-40a8-91ab-2cb298de74ab","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42969"
"816","Implantable Pellet Dosage Form","C42943","PELLET, IMPLANTABLE","[]","Implantable Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)","False","33f7063a-4c4b-43e4-8456-81f88c8866b0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42943"
"817","Extended Release Coated Pellets Dosage Form","C42918","PELLETS, COATED, EXTENDED RELEASE","[]","Extended Release Coated Pellets Dosage Form","A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","fa5da57a-d365-4dae-9ba7-5c55ce740d86","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42918"
"818","Pill Dosage Form","C25394","PILL","[]","Pill Dosage Form","A dose of medicine in the form of a small pellet. (NCI)","False","da7b6d8e-9a3f-43f5-9c03-d0c99cd46e9d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C25394"
"819","Plaster Dosage Form","C42970","PLASTER","[]","Plaster Dosage Form","Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)","False","a5f74240-6e81-4a20-9d78-21953b5bc74a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42970"
"820","Poultice Dosage Form","C47913","POULTICE","[]","Poultice Dosage Form","A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)","False","652a18a8-549a-4a28-bad8-06533bb625f1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47913"
"821","Powder Dosage Form","C42972","POWDER","[]","Powder Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)","False","92077b88-d978-439e-90be-3a79b004f2da","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42972"
"822","Dentifrice Powder Dosage Form","C42908","POWDER, DENTIFRICE","[]","Dentifrice Powder Dosage Form","A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","0e398537-8c6c-4d8d-abf4-0f5b8fbfaba4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42908"
"823","Powder for Solution Dosage Form","C42973","POWDER, FOR SOLUTION","[]","Powder for Solution Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)","False","6413fd03-28cb-4a12-b4a8-9dacd77622d6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42973"
"824","Powder for Suspension Dosage Form","C42975","POWDER, FOR SUSPENSION","[]","Powder for Suspension Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)","False","01be4b82-6e43-4015-ad60-e3b208d0badb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42975"
"825","Metered Powder Dosage Form","C42961","POWDER, METERED","[]","Metered Powder Dosage Form","A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)","False","bc8d38ca-92fc-4463-be22-eb119fc5dc63","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42961"
"826","Ring Dosage Form","C60988","RING","[]","Ring Dosage Form","A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)","False","a116edd1-cf76-4811-9aaa-47e553314dc6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60988"
"827","Rinse Dosage Form","C42979","RINSE","[]","Rinse Dosage Form","A liquid used to cleanse by flushing. (NCI)","False","6ed9ec36-30db-4f9b-a9d5-3fe7cd1c5a90","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42979"
"828","Salve Dosage Form","C42980","SALVE","[]","Salve Dosage Form","A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)","False","92b689ad-3f1a-4c6b-b9d8-c1678781924a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42980"
"829","Shampoo Dosage Form","C42981","SHAMPOO","[]","Shampoo Dosage Form","A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","09ec2cc8-fd3f-4364-8e80-feaedc55b2dc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42981"
"830","Shampoo Suspension Dosage Form","C42982","SHAMPOO, SUSPENSION","[]","Shampoo Suspension Dosage Form","A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","0514b7c5-e744-4579-a6ed-d8e0db094021","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42982"
"831","Soap Dosage Form","C42983","SOAP","[]","Soap Dosage Form","Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)","False","2c2599bf-a209-4d6b-9765-3f2558306077","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42983"
"832","Solution Dosage Form","C42986","SOLUTION","[]","Solution Dosage Form","A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)","False","a4202329-6efd-4230-891a-b32171a3d5af","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42986"
"833","Concentrate for Solution Dosage Form","C42898","SOLUTION, CONCENTRATE","[]","Concentrate for Solution Dosage Form","A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)","False","904fc3fa-1f95-4649-ae38-9ef9e1036cd9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42898"
"834","Solution For Slush Dosage Form","C42987","SOLUTION, FOR SLUSH","[]","Solution For Slush Dosage Form","A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)","False","c148c542-369f-40ef-9522-e44aad0acca8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42987"
"835","Gel Forming Drops Solution Dosage Form","C60994","SOLUTION, GEL FORMING / DROPS","[]","Gel Forming Drops Solution Dosage Form","A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)","False","040dfe76-8449-40e1-adfb-1494d5d2c8f1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60994"
"836","Extended Release Gel Forming Solution Dosage Form","C42935","SOLUTION, GEL FORMING, EXTENDED RELEASE","[]","Extended Release Gel Forming Solution Dosage Form","A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency","False","56dbf396-2362-405b-9f70-f5c92550299d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42935"
"837","Drops Solution Dosage Form","C60992","SOLUTION/ DROPS","[]","Drops Solution Dosage Form","A solution which is usually administered in a drop-wise fashion. (FDA)","False","1dfce107-a0da-45e9-967f-ee6a82a83e0e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60992"
"838","Sponge Dosage Form","C47912","SPONGE","[]","Sponge Dosage Form","A porous, interlacing, absorbent material that contains a drug.  It is typically used for applying or introducing medication, or for cleansing.  A sponge usually retains its shape.(FDA)","False","fc741438-08bf-4c31-8a74-0ce419ef347d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47912"
"839","Spray Dosage Form","C42989","SPRAY","[]","Spray Dosage Form","A liquid minutely divided as by a jet of air or steam. (NCI)","False","15910316-e86c-45e8-a2b6-02b1d84692b1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42989"
"840","Metered Spray Dosage Form","C42962","SPRAY, METERED","[]","Metered Spray Dosage Form","A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)","False","39c73ebd-350e-4a49-89bc-a15a844a35ff","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42962"
"841","Spray Suspension Dosage Form","C42990","SPRAY, SUSPENSION","[]","Spray Suspension Dosage Form","A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)","False","f32e7784-2b0c-4745-88b4-cb624331526f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42990"
"842","Stick Dosage Form","C42991","STICK","[]","Stick Dosage Form","A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)","False","f32f3e5e-8ed2-41a5-a3bb-057cc1ac28f5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42991"
"843","Strip Dosage Form","C47914","STRIP","[]","Strip Dosage Form","A long narrow piece of material.","False","4fc583ce-6066-474d-9869-de99291e2464","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47914"
"844","Suppository Dosage Form","C42993","SUPPOSITORY","[]","Suppository Dosage Form","A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)","False","f6fb094d-5011-4e24-87e4-0be82742a52a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42993"
"845","Extended Release Suppository Dosage Form","C42924","SUPPOSITORY, EXTENDED RELEASE","[]","Extended Release Suppository Dosage Form","A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)","False","77a0ec05-b533-4db7-b93e-1fbdab8a0fc5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42924"
"846","Suspension Dosage Form","C42994","SUSPENSION","[]","Suspension Dosage Form","A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","917e6013-c57e-4c2f-9fd9-961fccbd4c67","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42994"
"847","Extended Release Suspension Dosage Form","C42925","SUSPENSION, EXTENDED RELEASE","[]","Extended Release Suspension Dosage Form","A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","cd9bbf49-87b5-4dcd-9284-3c2644812292","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42925"
"848","Drops Suspension Dosage Form","C60995","SUSPENSION/DROPS","[]","Drops Suspension Dosage Form","A suspension which is usually administered in a dropwise fashion. (FDA)","False","a2a6a829-7480-49d2-ad80-c59f57cf815a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60995"
"849","Suture Dosage Form","C47889","SUTURE","[]","Suture Dosage Form","A strand or fiber used to hold wound edges in apposition during healing. (NCI)","False","bddbb3ff-704a-4fcc-a261-5026bd171944","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47889"
"850","Swab Dosage Form","C47898","SWAB","[]","Swab Dosage Form","A small piece of relatively flat absorbent material that contains a drug.  A swab may also be attached to one end of a small stick.  A swab is typically used for applying medication or for cleansing. (NCI)","False","a382b029-7771-4cac-8941-35108ebe8779","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47898"
"851","Syrup Dosage Form","C42996","SYRUP","[]","Syrup Dosage Form","An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.  (NCI)","False","c7bb6f24-0cdc-43bb-a3d4-98e47fb28c9c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42996"
"852","Tablet Dosage Form","C42998","TABLET","[]","Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents.  (NCI)","False","f37d664a-4999-43c7-957a-4ba04aed4da9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42998"
"853","Chewable Tablet Dosage Form","C42893","TABLET, CHEWABLE","[]","Chewable Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)","False","d8335637-84fa-4852-ae6c-acc8f88199a0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42893"
"854","Coated Tablet Dosage Form","C42897","TABLET, COATED","[]","Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)","False","209cf9db-6459-4799-b7f8-019e41fd1f19","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42897"
"855","Tablet Coated Particles Dosage Form","C60997","TABLET, COATED PARTICLES","[]","Tablet Coated Particles Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)","False","baa51dcd-a227-4960-a59b-d70272bf7ada","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C60997"
"856","Delayed Release Tablet Dosage Form","C42905","TABLET, DELAYED RELEASE","[]","Delayed Release Tablet Dosage Form","A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","a4266431-5ebe-419e-9495-5dbc2c5d1e1c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42905"
"857","Delayed Release Particles Tablet Dosage Form","C42997","TABLET, DELAYED RELEASE PARTICLES","[]","Delayed Release Particles Tablet Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.  (NCI)","False","f9046289-28cc-42f9-b708-1ad579939821","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42997"
"858","Effervescent Tablet Dosage Form","C42910","TABLET, EFFERVESCENT","[]","Effervescent Tablet Dosage Form","A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)","False","a06aea0b-c271-4c03-a2b6-2381bc790a0e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42910"
"859","Extended Release Tablet Dosage Form","C42927","TABLET, EXTENDED RELEASE","[]","Extended Release Tablet Dosage Form","A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)","False","7678cbf6-3bb6-467f-ae94-b7b5dd3f59d1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42927"
"860","Film Coated Tablet Dosage Form","C42931","TABLET, FILM COATED","[]","Film Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)","False","519decb9-6914-4c9b-96c7-637b41c29ad3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42931"
"861","Film Coated Extended Release Tablet Dosage Form","C42930","TABLET, FILM COATED, EXTENDED RELEASE","[]","Film Coated Extended Release Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)","False","734b7637-fbe2-49be-b9af-f0f82d65669f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42930"
"862","Tablet For Solution Dosage Form","C61004","TABLET, FOR SOLUTION","[]","Tablet For Solution Dosage Form","A tablet that forms a solution when placed in a liquid. (FDA)","False","efb4756f-fb24-4bf0-b525-2449a07423d5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C61004"
"863","Tablet For Suspension Dosage Form","C61005","TABLET, FOR SUSPENSION","['TABLET, DISPERSIBLE']","Tablet For Suspension Dosage Form","A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).","False","5aac3102-3cbf-46be-b8d2-407dc43c2ec3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C61005"
"864","Multilayered Tablet Dosage Form","C42964","TABLET, MULTILAYER","[]","Multilayered Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)","False","21e838a5-e500-4528-b8c8-c7b4653655f2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42964"
"865","Multilayered Extended Release Tablet Dosage Form","C42963","TABLET, MULTILAYER, EXTENDED RELEASE","[]","Multilayered Extended Release Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)","False","453553f9-4a57-49dd-bd0a-b468ed78bd8e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42963"
"866","Orally Disintegrating Tablet Dosage Form","C42999","TABLET, ORALLY DISINTEGRATING","[]","Orally Disintegrating Tablet Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.  (NCI)","False","b9f76ef5-ae6d-44c6-8551-4b3856722a38","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42999"
"867","Tablet Orally Disintegrating Delayed Release Dosage Form","C61006","TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE","[]","Tablet Orally Disintegrating Delayed Release Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)","False","b7687f95-12f1-4a71-9dde-aa887edaf4e0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C61006"
"868","Soluble Tablet Dosage Form","C42985","TABLET, SOLUBLE","[]","Soluble Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)","False","cba1b629-ff3a-4e1a-9745-2bfa62eebc2b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42985"
"869","Sugar Coated Tablet Dosage Form","C42992","TABLET, SUGAR COATED","[]","Sugar Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)","False","5ec83e3e-332b-4258-9269-2127e3bdd827","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C42992"
"870","Tampon Dosage Form","C47892","TAMPON","[]","Tampon Dosage Form","A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)","False","5009d6d2-5200-4193-8ed4-623e837ffb8c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47892"
"871","Tape Dosage Form","C47897","TAPE","[]","Tape Dosage Form","A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)","False","51a9a1f3-c92b-401b-adf9-517bc7bf08f3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C47897"
"872","Tincture Dosage Form","C43000","TINCTURE","[]","Tincture Dosage Form","An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.  (NCI)","False","7529b85c-cd97-4b32-b788-22b9feef1eca","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C43000"
"873","Troche Dosage Form","C43001","TROCHE","[]","Troche Dosage Form","A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.  (NCI)","False","ce072d76-62f3-4dc1-8e6b-828c10cdb3ac","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C43001"
"874","Unassigned Dosage Form","C43002","UNASSIGNED","[]","Unassigned Dosage Form","A dosage form has yet to be assigned.  (NCI)","False","064df78e-8db7-4c3b-8820-beb269b0be0b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C43002"
"875","Wafer Dosage Form","C43003","WAFER","[]","Wafer Dosage Form","A thin slice of material containing a medicinal agent.  (NCI)","False","953c0327-7b78-44d8-bd31-8ad90266fb42","dataset/cdisc/ct/sc/2007-03-06/sdtm/C42636/C43003"
"876","Reason for Non-Completion","C49627","[NCOMPLT]","['Completion/Reason for Non-Completion']","","The reason that a subject was discontinued from a clinical trial.","False","0bff6d08-f3df-4e10-8a33-9c4b8db07fa5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627"
"877","Adverse Event","C41331","ADVERSE EVENT","[]","Adverse Event","Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience.  (CDISC glossary)","False","f45340f2-8875-46f7-a02a-46e8085a999d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C41331"
"878","Complete","C25250","COMPLETED","[]","Complete","To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)","False","fe0c1711-4cf6-42fe-b10b-1569dc90a7e2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C25250"
"879","Death","C28554","DEATH","[]","Death","The absence of life or state of being dead. (NCI)","False","bbda2bee-c59d-4780-bfc6-05a617e64bf0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C28554"
"880","Lack of Efficacy","C48226","LACK OF EFFICACY","[]","Lack of Efficacy","The lack of expected or desired effect related to a therapy. (NCI)","False","f41b1f45-28a7-42ce-b0c9-bc304be8f926","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C48226"
"881","Lost To Follow-up","C48227","LOST TO FOLLOW-UP","[]","Lost To Follow-up","The loss or lack of continuation of follow-up after a study has officially closed.  See Follow-up. (NCI)","False","37ca1274-ddef-4594-8636-805623335875","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C48227"
"882","Non-Compliance With Study Drug","C49631","NON-COMPLIANCE WITH STUDY DRUG","[]","Non-Compliance With Study Drug","An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)","False","2455d35d-ba72-494b-bf74-e72f1bd75ad7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C49631"
"883","Other","C17649","OTHER","['Other']","Other","Different than the one(s) previously specified or mentioned. (NCI)","False","a8949426-284d-4812-85e4-c8fab45f8997","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C17649"
"884","Physician Decision","C48250","PHYSICIAN DECISION","[]","Physician Decision","A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)","False","8528cf44-bc0a-44fc-9d82-c2b52b6707d1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C48250"
"885","Pregnancy","C25742","PREGNANCY","[]","Pregnancy","Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)","False","443d5303-b39d-403a-a765-98d0f68cd349","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C25742"
"886","Progressive Disease","C35571","PROGRESSIVE DISEASE","[]","Progressive Disease","A disease process that is increasing in scope or severity. (NCI)","False","cdb7aadf-6599-4792-b766-3297ae6e2c0e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C35571"
"887","Protocol Violation","C48251","PROTOCOL VIOLATION","[]","Protocol Violation","An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)","False","dbcd846f-1f64-4677-8e78-bdb4248a5995","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C48251"
"888","Recovery","C25746","RECOVERY","[]","Recovery","A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)","False","ae33faa2-799c-4049-b291-67c5e6511cd7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C25746"
"889","Trial Screen Failure","C49628","SCREEN FAILURE","[]","Trial Screen Failure","The potential subject who does not meet one or more criteria required for participation in a trial.","False","ef185831-e7a4-4cdf-8803-71c60258d5c6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C49628"
"890","Study Terminated By Sponsor","C49632","STUDY TERMINATED BY SPONSOR","[]","Study Terminated By Sponsor","An indication that a clinical study was stopped by its sponsor.  (NCI)","False","58eb9a80-ed4c-46ef-ad27-367c0b3fa450","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C49632"
"891","Technical Problem","C49633","TECHNICAL PROBLEMS","[]","Technical Problem","A problem with some technical aspect of a clinical study, usually related to an instrument.  (NCI)","False","4e3aa196-de26-444c-8645-ada6b5b43955","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C49633"
"892","Withdrawal by Subject","C49634","WITHDRAWAL BY SUBJECT","[]","Withdrawal by Subject","An indication that a study participant has removed itself from the study.  (NCI)","False","c15d218f-26d3-4d6b-8bce-dc9c1c16db49","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49627/C49634"
"893","Relation to Reference Period","C49638","[STENRF]","['Relation to Reference Period']","","The name of a code list that contains terms that reference timepoints within and without a defined time period.","False","752fa908-b663-487a-8a13-6c6d2d0f1338","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49638"
"894","Status Post","C38008","AFTER","[]","Status Post","The time period following a point or another period of time. (NCI)","False","64839dae-d919-4a5c-853c-da3a25257980","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49638/C38008"
"895","Prior","C25629","BEFORE","[]","Prior","Earlier in time or order. (NCI)","False","dfbdb1ab-c7c6-49e6-af03-cc33a00c3b94","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49638/C25629"
"896","During","C25490","DURING","[]","During","At some point in a given period of time. (NCI)","False","0dc6aadc-0638-4a35-bb48-df51afabef36","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49638/C25490"
"897","During Or After","C49640","DURING/AFTER","[]","During Or After","Within a certain period of time or after a certain point or period in time. (NCI)","False","95ecf764-5085-4109-95ef-53b5214325dd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49638/C49640"
"898","Unknown","C17998","U","['UNKNOWN', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","85c971a2-89e9-4c6c-8a2e-7b0828adc810","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49638/C17998"
"899","Route of Administration","C38114","[ROUTE]","['Route of Administration']","","The course by which a substance was administered in order to reach the site of action in the body.","False","6aae7053-54ab-4382-9cd1-43ac01fede6b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114"
"900","Auricular Route of Administration","C38192","AURICULAR (OTIC)","[]","Auricular Route of Administration","Administration to or by way of the ear.(FDA)","False","4e2ef82b-027d-4220-966b-b0fb73f9b29f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38192"
"901","Buccal Route of Administration","C38193","BUCCAL","[]","Buccal Route of Administration","Administration directed toward the cheek, generally from within the mouth.(FDA)","False","2ce7eac3-b633-4121-8019-de393416f385","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38193"
"902","Conjunctival Route of Administration","C38194","CONJUNCTIVAL","[]","Conjunctival Route of Administration","Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball.(FDA)","False","16cd4655-9540-4f81-9adb-108cb61e1f4a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38194"
"903","Cutaneous Route of Administration","C38675","CUTANEOUS","[]","Cutaneous Route of Administration","Administration to the skin.(FDA)","False","13e9ee5a-9178-4a7b-9c78-377002012003","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38675"
"904","Dental Route of Administration","C38197","DENTAL","[]","Dental Route of Administration","Administration to a tooth or teeth.(FDA)","False","d1a1f8a0-c42c-44ce-8bc4-2bcb534b9b3b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38197"
"905","Electro-osmosis Route of Administration","C38633","ELECTRO-OSMOSIS","[]","Electro-osmosis Route of Administration","Administration of through the diffusion of substance through a membrane in an electric field.(FDA)","False","eb0e7866-1a8f-4351-ac7f-56d820ff0d12","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38633"
"906","Endocervical Route of Administration","C38205","ENDOCERVICAL","[]","Endocervical Route of Administration","Administration within the canal of the cervix uteri. Synonymous with the term intracervical.(FDA)","False","48a91e69-c31b-4ea3-9daa-adf6d8d33896","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38205"
"907","Endosinusial Route of Administration","C38206","ENDOSINUSIAL","[]","Endosinusial Route of Administration","Administration within the nasal sinuses of the head.(FDA)","False","5cda3726-d6c0-49a6-a616-30487044133a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38206"
"908","Endotracheal Route of Administration","C38208","ENDOTRACHEAL","[]","Endotracheal Route of Administration","Administration directly into the trachea. Synonymous with the term intratracheal.(FDA)","False","0006c2fe-9694-4878-9fc3-c2af129c529e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38208"
"909","Enteral Route of Administration","C38209","ENTERAL","[]","Enteral Route of Administration","Administration directly into the intestines.(FDA)","False","a2d05b1b-a1da-4c0e-8f20-6ee6ec0c6b1e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38209"
"910","Epidural Route of Administration","C38210","EPIDURAL","[]","Epidural Route of Administration","Administration upon or over the dura mater.(FDA)","False","7dd318b8-e385-4a3d-a4df-d24878f5fbb3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38210"
"911","Extraamniotic Route of Administration","C38211","EXTRA-AMNIOTIC","[]","Extraamniotic Route of Administration","Administration to the outside of the membrane enveloping the fetus.(FDA)","False","66312783-8270-4f44-91b1-ffdfeb180729","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38211"
"912","Extracorporeal Circulation Route of Administration","C38212","EXTRACORPOREAL","[]","Extracorporeal Circulation Route of Administration","Administration outside of the body.(FDA)","False","fd154a6b-6c5a-481a-b33c-4290bdb1248f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38212"
"913","Administration Via Hemodialysis","C38200","HEMODIALYSIS","[]","Administration Via Hemodialysis","Administration through hemodialysate fluid.(FDA)","False","a8d30c4a-b86a-4765-a550-9bc603f33041","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38200"
"914","Infiltration Route of Administration","C38215","INFILTRATION","[]","Infiltration Route of Administration","Administration that results in substances passing into tissue spaces or into cells.(FDA)","False","cc8918cb-09ec-4443-a616-31193829cfca","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38215"
"915","Interstitial Route of Administration","C38219","INTERSTITIAL","[]","Interstitial Route of Administration","Administration to or in the interstices of a tissue.(FDA)","False","70136148-2143-4c0b-971d-a4f754c43460","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38219"
"916","Intraabdominal Route of Administration","C38220","INTRA-ABDOMINAL","[]","Intraabdominal Route of Administration","Administration within the abdomen.(FDA)","False","02136dab-4bd1-4db8-a6cc-1930c6f8b68d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38220"
"917","Intraamniotic Route of Administration","C38221","INTRA-AMNIOTIC","[]","Intraamniotic Route of Administration","Administration within the amnion.(FDA)","False","4246aad9-5377-4129-988e-ba1b08baf000","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38221"
"918","Intraarterial Route of Administration","C38222","INTRA-ARTERIAL","[]","Intraarterial Route of Administration","Administration within an artery or arteries.(FDA)","False","586bbd45-e8d7-4d10-9b79-0ddc96df68d2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38222"
"919","Intraarticular Route of Administration","C38223","INTRA-ARTICULAR","[]","Intraarticular Route of Administration","Administration within a joint.(FDA)","False","c6009510-5b74-4f3e-8d57-345074559f89","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38223"
"920","Intrabiliary Route of Administration","C38224","INTRABILIARY","[]","Intrabiliary Route of Administration","Administration within the bile, bile ducts or gallbladder.(FDA)","False","5bde7ec8-7d54-4a16-9862-fb6342fe6544","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38224"
"921","Intrabronchial Route of Administration","C38225","INTRABRONCHIAL","[]","Intrabronchial Route of Administration","Administration within a bronchus.(FDA)","False","d8e74bd1-0ee5-432c-b321-7790d2e5a1ae","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38225"
"922","Intrabursal Route of Administration","C38226","INTRABURSAL","[]","Intrabursal Route of Administration","Administration within a bursa.(FDA)","False","11b1f38c-b6f6-42da-b660-1d26156550ff","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38226"
"923","Intracardiac Route of Administration","C38227","INTRACARDIAC","[]","Intracardiac Route of Administration","Administration within the heart.(FDA)","False","47847a42-988a-4cca-83fa-27b7a5ae2193","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38227"
"924","Intracartilaginous Route of Administration","C38228","INTRACARTILAGINOUS","[]","Intracartilaginous Route of Administration","Administration within a cartilage; endochondral.(FDA)","False","93d8ab88-06b1-4f2a-8ee7-6f32f86743a4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38228"
"925","Intracaudal Route of Administration","C38229","INTRACAUDAL","[]","Intracaudal Route of Administration","Administration within the cauda equina.(FDA)","False","d4f35962-99c9-4d60-8064-4f051cc50c40","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38229"
"926","Intracavernous Route of Administration","C38230","INTRACAVERNOUS","[]","Intracavernous Route of Administration","Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.(FDA)","False","03d9a342-389f-4558-ad6c-c7a11362503a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38230"
"927","Intracavitary Route of Administration","C38231","INTRACAVITARY","[]","Intracavitary Route of Administration","Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound.(FDA)","False","e766e25e-8f18-4453-850a-338e66d29b28","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38231"
"928","Intracerebral Route of Administration","C38232","INTRACEREBRAL","[]","Intracerebral Route of Administration","Administration within the cerebrum.(FDA)","False","5c193c61-68e7-483d-83bc-63b67e6063d4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38232"
"929","Intracisternal Route of Administration","C38233","INTRACISTERNAL","[]","Intracisternal Route of Administration","Administration within the cisterna magna cerebellomedularis.(FDA)","False","734b01b8-d141-4692-a71d-4db26f848a5a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38233"
"930","Intracorneal Route of Administration","C38234","INTRACORNEAL","[]","Intracorneal Route of Administration","Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).(FDA)","False","a6d3f4af-47a0-46f4-8fa5-285825378930","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38234"
"931","Intracoronal Dental Route of Administration","C38217","INTRACORONAL, DENTAL","[]","Intracoronal Dental Route of Administration","Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck.(FDA)","False","cda3a1ce-4a20-4be0-a0d6-b330ede6b5c6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38217"
"932","Intracoronary Route of Administration","C38218","INTRACORONARY","[]","Intracoronary Route of Administration","Administration within the coronary arteries.(FDA)","False","3185d919-0591-4d49-9688-59de9f1395d0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38218"
"933","Intracorporus Cavernosum Route of Administration","C38235","INTRACORPORUS CAVERNOSUM","[]","Intracorporus Cavernosum Route of Administration","Administration within the dilatable spaces of the corporus cavernosa of the penis.(FDA)","False","042f1b78-f912-413f-810c-25a5d0bf2f34","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38235"
"934","Intradermal Route of Administration","C38238","INTRADERMAL","[]","Intradermal Route of Administration","Administration within the dermis.(FDA)","False","9271f203-3f99-4210-9204-4aa9cc5a3c7c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38238"
"935","Intradiscal Route of Administration","C38239","INTRADISCAL","[]","Intradiscal Route of Administration","Administration within a disc.(FDA)","False","7e6b839a-b7f3-4663-9204-b18d8ea90cfd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38239"
"936","Intraductal Route of Administration","C38240","INTRADUCTAL","[]","Intraductal Route of Administration","Administration within the duct of a gland.(FDA)","False","4ad32041-c5de-413a-98dc-368c748df072","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38240"
"937","Intraduodenal Route of Administration","C38241","INTRADUODENAL","[]","Intraduodenal Route of Administration","Administration within the duodenum.(FDA)","False","57d552da-1a5b-44ea-a646-ca1b752f0f95","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38241"
"938","Intradural Route of Administration","C38242","INTRADURAL","[]","Intradural Route of Administration","Administration within or beneath the dura.(FDA)","False","3db250ba-16fc-4e1b-90c2-33a23070a26d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38242"
"939","Intraepidermal Route of Administration","C38243","INTRAEPIDERMAL","[]","Intraepidermal Route of Administration","Administration within the epidermis.(FDA)","False","3e4013b2-46de-4e09-b1f9-30c14e82287c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38243"
"940","Intraesophageal Route of Administration","C38245","INTRAESOPHAGEAL","[]","Intraesophageal Route of Administration","Administration within the esophagus.(FDA)","False","80e8cfe7-ed7f-40e7-ab66-e38f4afaa0db","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38245"
"941","Intragastric Route of Administration","C38246","INTRAGASTRIC","[]","Intragastric Route of Administration","Administration within the stomach.(FDA)","False","355f4965-94cf-4395-8ef1-53ed78edde48","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38246"
"942","Intragingival Route of Administration","C38247","INTRAGINGIVAL","[]","Intragingival Route of Administration","Administration within the gingivae.(FDA)","False","4905793e-07f2-4642-806a-32ca10dbfe3a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38247"
"943","Intraileal Route of Administration","C38249","INTRAILEAL","[]","Intraileal Route of Administration","Administration within the distal portion of the small intestine, from the jejunum to the cecum.(FDA)","False","359a5eed-1785-4e37-a2cf-c1aeb7061cd6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38249"
"944","Intralesional Route of Administration","C38250","INTRALESIONAL","[]","Intralesional Route of Administration","Administration within or introduced directly into a localized lesion.(FDA)","False","e1231c96-f280-4d8a-8672-cd89f071496d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38250"
"945","Intraluminal Route of Administration","C38251","INTRALUMINAL","[]","Intraluminal Route of Administration","Administration within the lumen of a tube.(FDA)","False","0f959e47-76ce-4037-88bd-b4e24e84592d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38251"
"946","Intralymphatic Route of Administration","C38252","INTRALYMPHATIC","[]","Intralymphatic Route of Administration","Administration within the lymph.(FDA)","False","21e124cc-19a4-4877-8f24-f51d6487bcb6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38252"
"947","Intramedullary Route of Administration","C38253","INTRAMEDULLARY","[]","Intramedullary Route of Administration","Administration within the marrow cavity of a bone.(FDA)","False","99bb9833-dfd2-4a11-a8af-8b1e5bc193f7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38253"
"948","Intrameningeal Route of Administration","C38254","INTRAMENINGEAL","[]","Intrameningeal Route of Administration","Administration within the meninges (the three membranes that envelope the brain and spinal cord).(FDA)","False","c32c9844-7b4e-46e5-8d0e-1ec1951c6e0a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38254"
"949","Intramuscular Route of Administration","C28161","INTRAMUSCULAR","[]","Intramuscular Route of Administration","Administration within a muscle. (FDA)","False","6cbf8292-104f-4770-96b8-492274b66e0d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C28161"
"950","Intraocular Route of Administration","C38255","INTRAOCULAR","[]","Intraocular Route of Administration","Administration within the eye.(FDA)","False","592f5947-bad5-4a7e-bd14-a2d5a613270f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38255"
"951","Intraovarian Route of Administration","C38256","INTRAOVARIAN","[]","Intraovarian Route of Administration","Administration within the ovary.(FDA)","False","405ec119-4578-421d-8767-780692442eb9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38256"
"952","Intrapericardial Route of Administration","C38257","INTRAPERICARDIAL","[]","Intrapericardial Route of Administration","Administration within the pericardium.(FDA)","False","4fc03874-01f2-4085-8c0e-c5c25b3c4c87","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38257"
"953","Intraperitoneal Route of Administration","C38258","INTRAPERITONEAL","[]","Intraperitoneal Route of Administration","Administration within the peritoneal cavity.(FDA)","False","1e72fe92-4195-47ae-b45e-7a352fc7d22d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38258"
"954","Intrapleural Route of Administration","C38259","INTRAPLEURAL","[]","Intrapleural Route of Administration","Administration within the pleura.(FDA)","False","8da733f8-f784-474a-9200-dc85df714eda","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38259"
"955","Intraprostatic Route of Administration","C38260","INTRAPROSTATIC","[]","Intraprostatic Route of Administration","Administration within the prostate gland.(FDA)","False","ae47b906-5c80-4996-9fe0-5cf50bfcf655","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38260"
"956","Intrapulmonary Route of Administration","C38261","INTRAPULMONARY","[]","Intrapulmonary Route of Administration","Administration within the lungs or its bronchi.(FDA)","False","86a23ffc-0366-4290-8cc4-713787c881b3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38261"
"957","Intrasinal Route of Administration","C38262","INTRASINAL","[]","Intrasinal Route of Administration","Administration within the nasal or periorbital sinuses.(FDA)","False","d7f05dd7-49ce-4ba4-8e09-d92c1bc6b84f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38262"
"958","Intraspinal Route of Administration","C38263","INTRASPINAL","[]","Intraspinal Route of Administration","Administration within the vertebral column.(FDA)","False","f9464b79-8fa3-4802-9368-5662852bbbf4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38263"
"959","Intrasynovial Route of Administration","C38264","INTRASYNOVIAL","[]","Intrasynovial Route of Administration","Administration within the synovial cavity of a joint.(FDA)","False","0ac06966-acce-4420-b929-a64d9a51039a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38264"
"960","Intratendinous Route of Administration","C38265","INTRATENDINOUS","[]","Intratendinous Route of Administration","Administration within a tendon.(FDA)","False","25766488-a486-4ad0-a6cc-dcbefb01f124","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38265"
"961","Intratesticular Route of Administration","C38266","INTRATESTICULAR","[]","Intratesticular Route of Administration","Administration within the testicle.(FDA)","False","fa257fae-e240-41f1-a583-88d54444463d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38266"
"962","Intrathecal Route of Administration","C38267","INTRATHECAL","[]","Intrathecal Route of Administration","Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.(FDA)","False","961c3a40-ad9c-4fd1-8ff3-477b75d15fd0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38267"
"963","Endothoracic Route of Administration","C38207","INTRATHORACIC","[]","Endothoracic Route of Administration","Administration within the thorax (internal to the ribs); synonymous with the term endothoracic.(FDA)","False","ce7b2033-5956-4345-a5be-8255f320ab95","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38207"
"964","Intratubular Route of Administration","C38268","INTRATUBULAR","[]","Intratubular Route of Administration","Administration within the tubules of an organ.(FDA)","False","4b3fc9ae-4064-438e-a528-bf14bb6b7dc1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38268"
"965","Intratumoral Route of Administration","C38269","INTRATUMOR","['Intratumor Route of Administration']","Intratumoral Route of Administration","Administration within a tumor.(FDA)","False","6be82178-277e-429a-9620-8eb2a5190f53","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38269"
"966","Intratympanic Route of Administration","C38270","INTRATYMPANIC","[]","Intratympanic Route of Administration","Administration within the auris media.(FDA)","False","cce2a64d-5cae-4fe0-a013-87a945b49395","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38270"
"967","Intrauterine Route of Administration","C38272","INTRAUTERINE","[]","Intrauterine Route of Administration","Administration within the uterus.(FDA)","False","0df04aa5-25ac-41cb-8ad3-d3225bc41fb4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38272"
"968","Intravascular Route of Administration","C38273","INTRAVASCULAR","[]","Intravascular Route of Administration","Administration within a vessel or vessels.(FDA)","False","4ea338f4-98cd-4d13-a575-f214c23cb8d9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38273"
"969","Intravenous Route of Administration","C38276","INTRAVENOUS","[]","Intravenous Route of Administration","Administration within or into a vein or veins.(FDA)","False","afc9e430-505b-4662-9093-24ea6aa77d62","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38276"
"970","Intravenous Bolus","C38274","INTRAVENOUS BOLUS","[]","Intravenous Bolus","Administration within or into a vein or veins all at once.(FDA)","False","5fdc2c17-c881-4d26-8d96-179b8be3a0c4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38274"
"971","Intravenous Drip","C38279","INTRAVENOUS DRIP","[]","Intravenous Drip","Administration within or into a vein or veins over a sustained period of time.(FDA)","False","3f65e521-1b9c-4eb7-9afa-ec30c7e5f625","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38279"
"972","Intraventricular Route of Administration","C38277","INTRAVENTRICULAR","[]","Intraventricular Route of Administration","Administration within a ventricle.(FDA)","False","e65e461a-8655-447f-b1e3-e27d1ea118c5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38277"
"973","Intravesical Route of Administration","C38278","INTRAVESICAL","[]","Intravesical Route of Administration","Administration within the bladder.(FDA)","False","81208218-9f6e-4214-9847-0e1dc6c2b33d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38278"
"974","Intravitreal Route of Administration","C38280","INTRAVITREAL","[]","Intravitreal Route of Administration","Administration within the vitreous body of the eye.(FDA)","False","f1605970-1b9d-489e-b022-03fe0aa2e82e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38280"
"975","Iontophoresis Route of Administration","C38203","IONTOPHORESIS","[]","Iontophoresis Route of Administration","Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body.(FDA)","False","95912aac-c76e-4251-a928-640f7d4025c0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38203"
"976","Irrigation-Route of Administration","C38281","IRRIGATION","[]","Irrigation-Route of Administration","Administration to bathe or flush open wounds or body cavities.(FDA)","False","97854065-de51-4d65-aba1-830eb9dd45f1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38281"
"977","Laryngeal Route of Administration","C38282","LARYNGEAL","[]","Laryngeal Route of Administration","Administration directly upon the larynx.(FDA)","False","6e3ebb5b-20b7-48ce-9543-f6f9c13bc9b6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38282"
"978","Nasal Route of Administration","C38284","NASAL","[]","Nasal Route of Administration","Administration to the nose; administered by way of the nose.(FDA)","False","5610325a-8c3d-4817-9dea-452e828e458e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38284"
"979","Nasogastric Route of Administration","C38285","NASOGASTRIC","[]","Nasogastric Route of Administration","Administration through the nose and into the stomach, usually by means of a tube.(FDA)","False","13fd345e-043f-4382-b901-2b495d51ebdf","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38285"
"980","Route of Administration Not Applicable","C48623","NOT APPLICABLE","[]","Route of Administration Not Applicable","Routes of administration are not applicable.(FDA)","False","153421f8-1903-46db-99cd-a40efcefc0ca","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C48623"
"981","Occlusive Dressing Technique","C38286","OCCLUSIVE DRESSING TECHNIQUE","[]","Occlusive Dressing Technique","Administration by the topical route which is then covered by a dressing which occludes the area.(FDA)","False","6ef8ef93-35ea-47c9-9f1f-0b8f1fd6d0fa","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38286"
"982","Ophthalmic Route of Administration","C38287","OPHTHALMIC","[]","Ophthalmic Route of Administration","Administration to the external eye.(FDA)","False","3a5e3990-83c9-443c-b2fe-ada9e6580300","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38287"
"983","Oral Route of Administration","C38288","ORAL","[]","Oral Route of Administration","Administration to or by way of the mouth.(FDA)","False","56b4df9f-6b99-4dd6-88f1-ef08cdf3491d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38288"
"984","Oropharyngeal Route of Administration","C38289","OROPHARYNGEAL","[]","Oropharyngeal Route of Administration","Administration directly to the mouth and pharynx.(FDA)","False","88d21092-663e-4898-9f1e-fbf3455569cd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38289"
"985","Other Route of Administration","C38290","OTHER","[]","Other Route of Administration","Administration is different from others on this list.(FDA)","False","68633237-a857-4001-bee4-ce2a73345f72","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38290"
"986","Parenteral Route of Administration","C38291","PARENTERAL","[]","Parenteral Route of Administration","Administration by injection, infusion, or implantation.(FDA)","False","ba06c18f-c66b-4218-8332-2d0fc05f4b66","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38291"
"987","Percutaneous Route of Administration","C38676","PERCUTANEOUS","[]","Percutaneous Route of Administration","Administration through the skin.(FDA)","False","4aab5197-0304-4e3a-bbeb-3a7669acc421","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38676"
"988","Periarticular Route of Administration","C38292","PERIARTICULAR","[]","Periarticular Route of Administration","Administration around a joint.(FDA)","False","f8fcfe68-81cf-4a64-b0bb-bba531a464de","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38292"
"989","Peridural Route of Administration","C38677","PERIDURAL","[]","Peridural Route of Administration","Administration to the outside of the dura mater of the spinal cord.(FDA)","False","1aaa530e-c84d-4c22-a9e0-28eee306df3b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38677"
"990","Perineural Route of Administration","C38293","PERINEURAL","[]","Perineural Route of Administration","Administration surrounding a nerve or nerves.(FDA)","False","0edc2d77-16b4-4130-82b5-f1a2079d3784","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38293"
"991","Periodontal Route of Administration","C38294","PERIODONTAL","[]","Periodontal Route of Administration","Administration around a tooth.(FDA)","False","5b698efc-655b-4935-891a-707fa0580ffa","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38294"
"992","Rectal Route of Administration","C38295","RECTAL","[]","Rectal Route of Administration","Administration to the rectum.(FDA)","False","5db8b292-803b-4678-aed5-900be78139c2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38295"
"993","Inhalation Route of Administration","C38216","RESPIRATORY (INHALATION)","[]","Inhalation Route of Administration","Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)","False","b68eabdd-c70a-4c8e-949b-9b921a7ada43","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38216"
"994","Retrobulbar Route of Administration","C38296","RETROBULBAR","[]","Retrobulbar Route of Administration","Administration behind the pons or behind the eyeball.(FDA)","False","fb5534c9-4944-4c19-96e4-ab669f13f046","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38296"
"995","Soft Tissue Route Of Administration","C38198","SOFT TISSUE","[]","Soft Tissue Route Of Administration","Administration into any soft tissue.(FDA)","False","8f5a5a42-f555-401b-96b2-0be431db5a91","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38198"
"996","Subarachnoid Route of Administration","C38297","SUBARACHNOID","[]","Subarachnoid Route of Administration","Administration beneath the arachnoid.(FDA)","False","a8420b03-4b1c-441d-9c16-73e520761f86","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38297"
"997","Subconjunctival Route of Administration","C38298","SUBCONJUNCTIVAL","[]","Subconjunctival Route of Administration","Administration beneath the conjunctiva.(FDA)","False","5012b769-ba1d-4c84-a59e-181a1b3c6b2f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38298"
"998","Subcutaneous Route of Administration","C38299","SUBCUTANEOUS","[]","Subcutaneous Route of Administration","Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)","False","a70a9adb-713d-4df2-bab1-427afdae18d3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38299"
"999","Sublingual Route of Administration","C38300","SUBLINGUAL","[]","Sublingual Route of Administration","Administration beneath the tongue.(FDA)","False","d339fe3e-4954-41bf-9e41-3df25821d87e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38300"
"1000","Submucosal Route of Administration","C38301","SUBMUCOSAL","[]","Submucosal Route of Administration","Administration beneath the mucous membrane.(FDA)","False","73befd16-3793-4f4d-80cc-0f1b1bce998f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38301"
"1001","Topical Route of Administration","C38304","TOPICAL","[]","Topical Route of Administration","Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.(FDA)","False","1e67e220-b867-4232-8f61-198d1ff4e363","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38304"
"1002","Transdermal Route of Administration","C38305","TRANSDERMAL","[]","Transdermal Route of Administration","Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)","False","d6e2cb17-093e-4197-9e9b-b1c1a92e61c7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38305"
"1003","Mucosal Route of Administration","C38283","TRANSMUCOSAL","[]","Mucosal Route of Administration","Administration across the mucosa.(FDA)","False","b95ce7de-7bb5-49f9-a5c7-5444931f7efa","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38283"
"1004","Transplacental Route of Administration","C38307","TRANSPLACENTAL","[]","Transplacental Route of Administration","Administration through or across the placenta.(FDA)","False","e9855adb-41ca-4149-af7c-a7b4fa62e869","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38307"
"1005","Transtracheal Route of Administration","C38308","TRANSTRACHEAL","[]","Transtracheal Route of Administration","Administration through the wall of the trachea.(FDA)","False","ce1b10d0-a820-43f4-ae16-3702d2b6bedb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38308"
"1006","Transtympanic Route of Administration","C38309","TRANSTYMPANIC","[]","Transtympanic Route of Administration","Administration across or through the tympanic cavity.(FDA)","False","987ccad1-14c6-4082-8b94-98cdf5cdb7ce","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38309"
"1007","Unassigned Route of Administration","C38310","UNASSIGNED","[]","Unassigned Route of Administration","Route of administration has not yet been assigned.(FDA)","False","4c02bcd4-cfed-4b85-9ab7-87d9df77c7ce","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38310"
"1008","Unknown Route of Administration","C38311","UNKNOWN","[]","Unknown Route of Administration","Route of administration is unknown.(FDA)","False","75f49e7e-e0e0-4e61-8325-97bdb16019a8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38311"
"1009","Ureteral Route of Administration","C38312","URETERAL","[]","Ureteral Route of Administration","Administration into the ureter.(FDA)","False","ce3a613d-58c3-4cc2-a614-c7fb52369407","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38312"
"1010","Intraurethral Route of Administration","C38271","URETHRAL","[]","Intraurethral Route of Administration","Administration into the urethra.(FDA)","False","d2c28125-7bd8-4a6b-9241-de77019e14f9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38271"
"1011","Vaginal Route of Administration","C38313","VAGINAL","[]","Vaginal Route of Administration","Administration into the vagina.(FDA)","False","01163449-7750-4445-adbf-ef5cdb860539","dataset/cdisc/ct/sc/2007-03-06/sdtm/C38114/C38313"
"1012","Severity/Intensity Scale for Adverse Events","C49705","[AESEV]","['Severity/Intensity of an Adverse Event']","","A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)","False","8975980f-dec9-438a-ae51-222384d93ed8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49705"
"1013","Mild Adverse Event","C41338","1","['Grade 1', 'MILD']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","73ea4088-b9ad-4cbe-ae05-89ab940b58af","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49705/C41338"
"1014","Moderate Adverse Event","C41339","2","['Grade 2', 'MODERATE']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","addb38a7-02bd-44dc-b096-8f594c516a0f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49705/C41339"
"1015","Severe Adverse Event","C41340","3","['Grade 3', 'SEVERE']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","a986b52f-5e48-41e6-9800-cfae66d18a5a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49705/C41340"
"1016","Sex","C28421","[SEX]","['Sex']","","The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)","False","aade8667-5baf-4807-a28d-c2ebf540179c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C28421"
"1017","Female","C16576","F","['Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","156451f9-c046-4080-85ef-b2f80115f041","dataset/cdisc/ct/sc/2007-03-06/sdtm/C28421/C16576"
"1018","Male","C20197","M","['Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","68a2765c-ed89-4bdf-8f15-d6bb21a72646","dataset/cdisc/ct/sc/2007-03-06/sdtm/C28421/C20197"
"1019","Unknown","C17998","U","['UNKNOWN', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","876ee819-4b1d-44b4-bbac-239a32547ed1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C28421/C17998"
"1020","Intersex","C45908","UN","['Undifferentiated']","Intersex","A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)","False","9d2ef411-9a53-4cad-b06c-2477263da518","dataset/cdisc/ct/sc/2007-03-06/sdtm/C28421/C45908"
"1021","Sex of Study Group","C49696","[SEXPOP]","['Sex of Participants']",""," The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","8ce3fe0e-3338-4aa6-b8fd-3664f1c6cc8f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49696"
"1022","Both","C49636","BOTH","[]","Both","One and the other; relating to or being two in conjunction. (NCI)","False","041d2538-3e56-419f-85c6-bb2282f47922","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49696/C49636"
"1023","Female","C16576","F","['Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","6c6ba3cd-cdf3-4b3f-bd5d-084bfa2a790f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49696/C16576"
"1024","Male","C20197","M","['Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","d9597703-08bb-4b4b-8f20-cef9b2b0723c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49696/C20197"
"1025","Size","C25681","[SIZE]","['Size']","Size","The physical magnitude of something. (NCI)","False","fff3d927-692f-4167-a4ed-31889922c845","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25681"
"1026","Large","C49508","LARGE","[]","Large","Of considerable or relatively great size, extent, or capacity. (NCI)","False","72106237-326a-4108-9914-86c215b5574e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25681/C49508"
"1027","Medium","C49507","MEDIUM","[]","Medium","Mid-way between small and large in number, quantity, magnitude or extent. (NCI)","False","46fd6040-9611-4122-8135-81ffc47d0159","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25681/C49507"
"1028","Small","C25376","SMALL","[]","Small","Limited in number, quantity, magnitude or extent. (NCI)","False","0ae2d5b6-31d5-43f6-bf30-55fc9d0d2423","dataset/cdisc/ct/sc/2007-03-06/sdtm/C25681/C25376"
"1029","Submission Domain Abbreviation","C49558","[DOMAIN]","['Domain Abbreviation']","","A unique, 2-character domain code used in the regulatory submission process.  The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)","False","57eddbcd-e5e2-4e25-89ad-053e412ae537","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558"
"1030","Analysis Dataset Domain","C49563","AD","['Analysis Dataset']","Analysis Dataset Domain","Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.","False","c8ae75c7-055f-44d2-965a-a1703fb156c0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49563"
"1031","Adverse Event Domain","C49562","AE","['Adverse Events']","Adverse Event Domain","Adverse events may be captured either as free text or a pre-specified list of terms.","False","09eb4256-dcc9-46ce-bda6-e00b1ed2a420","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49562"
"1032","Autopsy Domain","C49565","AU","['Autopsy']","Autopsy Domain","Additional data about deaths, specific to findings from autopsies.","False","2996f571-de32-4b7c-9adc-f855eb8088eb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49565"
"1033","Bone Mineral Density Data Domain","C49566","BM","['Bone Mineral Density (BMD) Data']","Bone Mineral Density Data Domain","Findings resulting from evaluations of bone mineral density.","False","2f69be4c-9fd0-43fb-8240-63991299dbf3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49566"
"1034","Biopsy Domain","C49567","BR","['Biopsy']","Biopsy Domain","Findings resulting from biopsies.","False","b631321e-96d1-465b-8be7-a2bd3797b502","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49567"
"1035","Concomitant Medication Domain","C49568","CM","['Concomitant Meds']","Concomitant Medication Domain","Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.","False","229167fd-a173-4edf-b1b0-342eae576e24","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49568"
"1036","Comment Domain","C49569","CO","['Comments']","Comment Domain","The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.","False","66208ca9-f096-4270-8da4-398420c0b28e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49569"
"1037","Drug Accountability Domain","C49578","DA","['Drug Accountability']","Drug Accountability Domain","Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.","False","0b0c5841-cdf6-47ad-b975-9f0419b0061d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49578"
"1038","Disease Characteristics Domain","C49570","DC","['Disease Characteristics']","Disease Characteristics Domain","Data related to the characteristics of a specific disease state under study for a subject.","False","4df7549d-a62c-4920-a8e1-b526e3a3f9b1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49570"
"1039","Demographics Domain","C49572","DM","['Demographics']","Demographics Domain","The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study.  It is the parent domain for all other observations for human clinical subjects","False","5555ebb3-e094-4b80-aad6-4430292cab27","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49572"
"1040","Disposition Domain","C49576","DS","['Disposition']","Disposition Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)","False","28eeecc3-349c-4fac-bb8b-8346447717da","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49576"
"1041","Protocol Deviations Domain","C49585","DV","['Protocol Deviations']","Protocol Deviations Domain","The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.","False","300b5ad4-21f9-406e-a4a2-9691f4c6379e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49585"
"1042","Electroencephalogram Domain","C49625","EE","['Electroencephalogram']","Electroencephalogram Domain","Findings resulting from electroencephalogram (EEG) tests.","False","51ae0607-ede2-4a17-b504-353c8bda10b5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49625"
"1043","Electrocardiogram Domain","C49626","EG","['Electrocardiogram']","Electrocardiogram Domain","Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.","False","caff5182-f208-4403-990a-e77ea8219c73","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49626"
"1044","Exposure Domain","C49587","EX","['Exposure']","Exposure Domain","The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.","False","7bc07273-26b8-4b86-9733-5a1837baa1d5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49587"
"1045","Family History Domain","C49588","FH","['Family History']","Family History Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)","False","947d93fa-42c9-435f-afe1-14387740e6bc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49588"
"1046","Healthcare Resource Utilization Domain","C49589","HU","['Healthcare Resource Utilization']","Healthcare Resource Utilization Domain","Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.","False","9266771a-4341-4f35-89f8-a73ff8d4d5ab","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49589"
"1047","Inclusion Exclusion Domain","C61536","IE","['Inclusion/Exclusion']","Inclusion Exclusion Domain","The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.","False","7390023d-c31d-4b77-8826-64afb677e14a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C61536"
"1048","Laboratory Data Domain","C49592","LB","['Laboratory Data']","Laboratory Data Domain","Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.","False","135b8124-a5ec-43fc-84ef-2c10b4dd85e3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49592"
"1049","Microbiology Specimen Domain","C49602","MB","['Microbiology']","Microbiology Specimen Domain","Microbiology specimen findings, including gram stain results, and organisms found.","False","2e395011-72c8-43a3-9d5d-dfc683e78574","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49602"
"1050","Medical History Domain","C49603","MH","['Medical History']","Medical History Domain","The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.","False","21c1109e-f2d1-490d-82f0-9e3b7bdc9ab1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49603"
"1051","Meal Data Domain","C49604","ML","['Meal Data']","Meal Data Domain","Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.","False","824f96e6-c161-463a-b881-e800b38490f3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49604"
"1052","Microbiology Susceptibility Domain","C61531","MS","['Microbiology Susceptibility']","Microbiology Susceptibility Domain","This includes microbiology susceptibility test results, plus results of any other organism-related tests.","False","9e43ca80-b2e9-413e-91c9-f6935be3879a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C61531"
"1053","Organ Measurement Domain","C49605","OM","['Organ Measurements']","Organ Measurement Domain","Findings from organ measurement evaluations.","False","df47da19-f48b-459c-b18d-0d57eab4945e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49605"
"1054","Pharmacokinetic Concentration Domain","C49606","PC","['Pharmacokinetic Concentration']","Pharmacokinetic Concentration Domain","Concentrations of drugs/metabolites in fluids or tissues as a function of time.","False","32f5f9d2-bb23-4617-8710-f2a053e080c3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49606"
"1055","Physical Exam Domain","C49608","PE","['Physical Exam']","Physical Exam Domain","Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.","False","c1ea705b-b145-4048-8a29-1882816b58ff","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49608"
"1056","Pharmacogenomics Domain","C61529","PG","['Pharmacogenomics']","Pharmacogenomics Domain","Pharmacogenomics findings that initially focus on genotype and gene expression data.","False","504d66a6-aad5-4286-8097-f0c2d4715fde","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C61529"
"1057","Pharmacokinetic Parameters Domain","C49607","PP","['Pharmacokinetic Parameters']","Pharmacokinetic Parameters Domain","Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.","False","84221864-d961-42f6-86d3-1ff8484366ab","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49607"
"1058","Questionnaire Domain","C49609","QS","['Questionnaires']","Questionnaire Domain","Questionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).","False","0ee2db72-6af5-4045-aeb7-69f6cf37b809","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49609"
"1059","Subject Characteristics Domain","C49610","SC","['Subject Characteristics']","Subject Characteristics Domain","The subject characteristics domain is for data not collected in other domains that is subject-related. Examples: subject initials, other race details, eye color, childbearing status, etc.","False","af07b33f-1ef8-4940-a751-08f5689dda2b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49610"
"1060","Subject Element Domain","C49616","SE","['Subject Element']","Subject Element Domain","The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.","False","4c8f6829-4306-4a22-b741-d473886ed4e9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49616"
"1061","Surgery Domain","C49611","SG","['Surgery']","Surgery Domain","Surgical information.","False","1a48e4d6-1a56-4f1f-8d5d-b811f93cb105","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49611"
"1062","Skin Test Domain","C49612","SK","['Skin Test']","Skin Test Domain","Findings from diagnostic skin tests.","False","d9aaca19-b79e-4d45-b9da-c5e3493081a0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49612"
"1063","Sleep Polysomnography Domain","C49613","SL","['Sleep Polysomnography Data']","Sleep Polysomnography Domain","Findings from diagnostic sleep tests (polysomnography).","False","25a5b3a1-9141-49c5-85e7-31cb68d94dcd","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49613"
"1064","Stress Exercise Test Data Domain","C49614","ST","['Stress (Exercise) Test Data']","Stress Exercise Test Data Domain","Findings from exercise stress tests.","False","2e65cef2-0e69-4338-a346-fa93f29750a3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49614"
"1065","Substance Use Domain","C49615","SU","['Substance Use']","Substance Use Domain","The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.","False","239edacf-2675-46c8-ab2e-b13aaf048326","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49615"
"1066","Subject Visits Domain","C49617","SV","['Subject Visits']","Subject Visits Domain","The subject visits table describes the actual start and end data/time for each visit of each individual subject.","False","403527f0-4689-446d-92f0-121f1294dc8f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49617"
"1067","Trial Arms Domain","C49618","TA","['Trial Arms']","Trial Arms Domain","The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.","False","4c43efda-9871-4b2f-b382-08e29f44bfa5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49618"
"1068","Trial Elements Domain","C49619","TE","['Trial Elements']","Trial Elements Domain","The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.","False","06db4302-dee1-4a5c-95d2-bbc3013d2fc7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49619"
"1069","Trial Inclusion and Exclusion Criteria Domain","C49620","TI","['Trial Inclusion/Exclusion Criteria']","Trial Inclusion and Exclusion Criteria Domain","The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.","False","fc78f8c4-2f6e-48f0-bb71-ff866402e502","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49620"
"1070","Trial Summary Domain","C53483","TS","['Trial Summary']","Trial Summary Domain","The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.","False","28b250e3-2ccd-4165-bf2e-976a45155195","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C53483"
"1071","Trial Visits Domain","C49621","TV","['Trial Visits']","Trial Visits Domain","The trial visits table describes the planned order and number of visits in the study within each arm.","False","67a752d5-caff-4aaa-ba12-a591c56b9587","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49621"
"1072","Vital Signs Domain","C49622","VS","['Vital Signs']","Vital Signs Domain","Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.","False","0946f90a-a11c-4192-9b8c-09d3e73f561c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49558/C49622"
"1073","Trial Blinding Schema","C49658","[TBLIND]","['Trial Blinding Schema']","","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","04ba3401-01d2-4c80-a122-15ec87cea96d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49658"
"1074","Double Blind Study","C15228","DOUBLE BLIND","[]","Double Blind Study","A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)","False","019473a9-786e-4951-aab0-ca09947d79db","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49658/C15228"
"1075","Open Label Study","C49659","OPEN LABEL","[]","Open Label Study","A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)","False","fa8f4e89-51ff-49c0-ad8d-01c06a8df04d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49658/C49659"
"1076","Single Blind Study","C28233","SINGLE BLIND","[]","Single Blind Study"," A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)","False","01909e6f-da4b-41c4-a12d-831e355cc5d4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49658/C28233"
"1077","Trial Indication Type","C49652","[TINDTP]","['Trial Indication Type']","","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)","False","4450c14e-cc93-49a9-859a-68fb43ae5ded","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49652"
"1078","Cure Study","C49654","CURE","[]","Cure Study","A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition.  (NCI)","False","c3e3db15-87ec-4774-887f-b0bb35e63725","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49652/C49654"
"1079","Diagnosis Study","C49653","DIAGNOSIS","[]","Diagnosis Study","A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition.  (NCI)","False","980447e0-1544-4209-a0a1-501efdf6ac0e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49652/C49653"
"1080","Adverse Effect Mitigation Study","C49655","MITIGATION","[]","Adverse Effect Mitigation Study","A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen.  (NCI)","False","1f843eda-5513-43b1-9d3a-5f426c8910f5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49652/C49655"
"1081","Prevention Study","C49657","PREVENTION","[]","Prevention Study","A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.","False","bf3ea78e-3dc0-457e-b844-909c978c42e9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49652/C49657"
"1082","Treatment Study","C49656","TREATMENT","[]","Treatment Study","A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.","False","a9b91ef3-486f-40c2-8bed-3fa796607a10","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49652/C49656"
"1083","Trial Phase","C48281","[TPHASE]","['Trial Phase']",""," Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","4911e4b4-a456-4c2d-b728-ca4a366445a5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281"
"1084","Phase I Trial","C15600","1","['Trial Phase 1']","Phase I Trial","The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drugs pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes.  [After FDA CDER Handbook, ICH E8] (CDISC glossary)","False","0c899613-ce14-40ec-838e-129c18490f0f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C15600"
"1085","Phase I/II Trial","C15693","1-2","['Trial Phase 1-2']","Phase I/II Trial","A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.","False","4d80e1dc-1dfc-42f9-895f-6b430afe5eeb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C15693"
"1086","Phase II Trial","C15601","2","['Trial Phase 2']","Phase II Trial","Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","9b183c5e-717e-41bd-ad62-54ae81f50ddc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C15601"
"1087","Phase II/III Trial","C15694","2-3","['Trial Phase 2-3']","Phase II/III Trial","A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.","False","1550824a-c858-4483-aeb1-7abea317b038","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C15694"
"1088","Phase II A Trial","C49686","2A","['Trial Phase 2A']","Phase II A Trial","A clinical research protocol generally refered to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)","False","d128ad0d-2f7c-467c-ab2d-e261794f910e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C49686"
"1089","Phase II B Trial","C49688","2B","['Trial Phase 2B']","Phase II B Trial","A clinical research protocol generally refered to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)","False","24ec34e1-ebdb-4d5a-ac35-cb5b097d6101","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C49688"
"1090","Phase III Trial","C15602","3","['Trial Phase 3']","Phase III Trial","Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefitrisk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","c14d0257-1c4f-4b39-afff-72c91967d149","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C15602"
"1091","Phase IIIA Trial","C49687","3A","['Trial Phase 3A']","Phase IIIA Trial","A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.","False","bd96331e-4cb8-4503-a998-2e0647c57288","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C49687"
"1092","Phase III B Trial","C49689","3B","['Trial Phase 3B']","Phase III B Trial","A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.","False","1c9f358a-1c30-4c99-a688-0b32607e44e0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C49689"
"1093","Phase IV Trial","C15603","4","['Trial Phase 4']","Phase IV Trial","Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drugs risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","4cd66d43-1df4-4451-a590-92d611c28f40","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C15603"
"1094","Phase V Trial","C47865","5","['Trial Phase 5']","Phase V Trial","Postmarketing surveillance is sometimes referred to as Phase V.","False","b2d0f3b0-f651-4c7e-9f4b-8b2260d5e513","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C47865"
"1095","Not Applicable","C48660","","['NOT APPLICABLE']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","0a504280-6111-4171-ac39-0ceb8c4ba461","dataset/cdisc/ct/sc/2007-03-06/sdtm/C48281/C48660"
"1096","Trial Summary Parameter","C49691","[TSPARM]","['Trial Summary Parameter']","","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","3422e806-7744-4deb-b036-59756020695c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691"
"1097","Test Product Added to Existing Treatment","C49703","ADDON","['Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","278955dd-8709-4c8c-b33b-7a78bd22bab6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49703"
"1098","Adverse Event Dictionary","C49700","AEDICT","['Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","bd852a68-0386-4729-8a2e-774d6121c7a4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49700"
"1099","Planned Maximum Age of Subjects","C49694","AGEMAX","['Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","be06f24f-159c-4f5f-9012-d3436f680da5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49694"
"1100","Planned Minimum Age of Subjects","C49693","AGEMIN","['Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","b0acd48b-a984-410f-bf16-4ceaf8abb161","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49693"
"1101","Age Group","C20587","AGESPAN","['Age Span']","Age Group","Subgroups of populations based on age. (NCI)","False","797ab497-72b1-43f6-a04c-f9325f36adcb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C20587"
"1102","Age Unit","C50400","AGEU","['Age Units']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","1e2d0015-e3ff-48c4-ac7e-df8872c1d305","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C50400"
"1103","Dose","C25488","DOSE","['Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","6eb8e0ab-d486-4c78-b6c8-4ca660c6ecbc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C25488"
"1104","Drug Dictionary","C49701","DRUGDICT","['Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","cb35b303-b1dd-4fbd-a953-128565948f52","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49701"
"1105","Trial Length","C49697","LENGTH","['Length of Trial']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","0153f3ae-584b-4f52-85b7-aea33dffe37f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49697"
"1106","Medical History Dictionary","C49702","MHDICT","['Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","b93722af-6ca3-4b8d-88e1-d92451b81f59","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49702"
"1107","Planned Subject Number","C49692","PLANSUB","['Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","b569b1fc-56ab-4cce-bfb4-d985750a52de","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49692"
"1108","Randomization","C25196","RANDOM","['Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","622d7272-e1e6-44ed-8705-1e280cc3ca66","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C25196"
"1109","Route of Administration","C38114","ROUTE","['Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","2656a7a7-babc-431f-8fb7-6c9ed5aa0963","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C38114"
"1110","Sex of Study Group","C49696","SEXPOP","['Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","169c3c0e-b211-40ed-a64f-a43b51d07692","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49696"
"1111","Study Stop Rules","C49698","STOPRULE","['Stopping Rules for the Study']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","be0417ef-cdd7-4204-8739-d2d3bb9a19b7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49698"
"1112","Trial Blinding Schema","C49658","TBLIND","['Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","4b82ba0e-16d4-4b24-a380-d9199c7dad64","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49658"
"1113","Control Type","C49647","TCNTRL","['Type of Control']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","6deec5a1-2f16-4b0a-8eed-83b538bcecee","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49647"
"1114","Diagnosis Group","C49650","TDIGRP","['Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","35bf5267-4069-496e-ac5c-5207805bcf6f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49650"
"1115","Trial Indication Type","C49652","TINDTP","['Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","d22d8acd-f8a7-43aa-8b0e-e83b8cb83892","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49652"
"1116","Trial Title","C49802","TITLE","['Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","9e43001a-4e45-4ee4-8cd1-fa9b74fdd55b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49802"
"1117","Trial Phase","C48281","TPHASE","['Trial Phase']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","d2eb26b5-14cc-4b0b-b85b-80683f7c22cb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C48281"
"1118","Trial Type","C49660","TTYPE","['Type of Trial']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","55a9b356-ce36-49ea-8c8c-9da4461d0e58","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49691/C49660"
"1119","Trial Type","C49660","[TTYPE]","['Type of Trial']","","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","3726ccf0-c984-4707-93ed-d31578fd9b64","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660"
"1120","Bioavailability Study","C49664","BIO-AVAILABILITY","[]","Bioavailability Study","A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)","False","94a65d96-ffb4-4fbe-924a-612b440cbb30","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C49664"
"1121","Therapeutic Equivalency Study","C49665","BIO-EQUIVALENCE","[]","Therapeutic Equivalency Study","A study most often used to compare the efficacy of different formulations to treat a given disease.  It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)","False","846cfb20-2fd5-4865-89e1-ccc6a661f459","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C49665"
"1122","Efficacy Study","C49666","EFFICACY","[]","Efficacy Study","A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)","False","ae98b788-922a-4dec-ac77-5e61b08e911f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C49666"
"1123","Pharmacodynamic Study","C49662","PHARMACODYNAMIC","[]","Pharmacodynamic Study","A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)","False","5fd4aeae-9e4f-4674-9893-4fe1f1407958","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C49662"
"1124","Pharmacoeconomic Study","C39493","PHARMACOECONOMIC","[]","Pharmacoeconomic Study","A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)","False","3b2313ac-8aaf-4a8f-8651-4ef8c9dc830a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C39493"
"1125","Pharmacogenomic Study","C49661","PHARMACOGENOMIC","[]","Pharmacogenomic Study","A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)","False","9c505b8e-3128-4c3b-ba06-0d155cbdc8e2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C49661"
"1126","Pharmacokinetic Study","C49663","PHARMACOKINETIC","[]","Pharmacokinetic Study","A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)","False","23f5130d-230a-4f0e-bd27-4c5685cd1f49","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C49663"
"1127","Safety Study","C49667","SAFETY","[]","Safety Study","A study of the relative safety of treatment of a disease. Usually this is a Phase I or II trial. (NCI)","False","b6fbf798-45dc-4014-a9d1-904fbbb92f35","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49660/C49667"
"1128","Units for Vital Signs Results","C49675","[VSRESU]","['Units for Vital Signs Results']","","The unit used to record and describe the result of a test investigating a vital sign. (NCI)","False","38909ce3-6979-4b3e-9a76-19fadb3ff067","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675"
"1129","Percentage","C25613","%","['Percentage']","Percentage","A fraction or ratio with 100 understood as the denominator. (NCI)","False","d2cbad00-d2e6-47c4-a2a3-94471a8c1181","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C25613"
"1130","Beats per Minute","C49673","BEATS/MIN","['Beats per Minute']","Beats per Minute","The number of heartbeats measured per minute time. (NCI)","False","88275108-0da9-4ff8-8722-f0c23d856899","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C49673"
"1131","Breaths per Minute","C49674","BREATHS/MIN","['Breaths per Minute']","Breaths per Minute","The number of breaths (inhalation and exhalation) taken per minute time. (NCI)","False","2f3cd004-9426-41f5-ad66-8e0de6592ef8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C49674"
"1132","Degree Celsius","C42559","C","['Degree Celsius']","Degree Celsius","A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)","False","fe2ff806-31f3-44ce-b7c0-75169dc07de5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C42559"
"1133","Centimeter","C49668","cm","['Centimeter']","Centimeter","A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)","False","ef7bad56-d5ea-4890-b3a0-3c1463b153f6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C49668"
"1134","Degree Fahrenheit","C44277","F","['Degree Fahrenheit']","Degree Fahrenheit","The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724.  In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)","False","1a13fc3c-3685-4d21-9c13-449a30bc9b3c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C44277"
"1135","Gram","C48155","g","['Gram']","Gram","A metric unit of mass equal to one one thousandth of a kilogram. (NCI)","False","f9ace666-e5a4-4d91-83d1-54994c96259b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C48155"
"1136","Inch","C48500","IN","['Inch']","Inch","A traditional unit of length equal to 2.54 centimeters. (NCI)","False","39f0fb06-0394-470b-ae3a-c1ac7d892007","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C48500"
"1137","Kilogram","C28252","kg","['Kilogram']","Kilogram","The basic SI unit of mass.  It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)","False","0f2249db-1fa6-46c9-a93b-4610811a318e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C28252"
"1138","Kilogram Per Square Meter","C49671","kg/m2","['Kilogram Per Square Meter']","Kilogram Per Square Meter","The SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)","False","70ec14c5-fa5b-49bf-acd1-5dea545c7ab6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C49671"
"1139","Pound","C48531","LB","['Pound']","Pound","A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)","False","e603eeef-5e7a-4e13-82ce-3d1453b64453","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C48531"
"1140","Square Meter","C42569","m2","['Square Meter']","Square Meter","The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)","False","dfe2da5d-25e6-4cec-a8da-68f08b3d393b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C42569"
"1141","Millimeter of Mercury","C49670","mmHG","['Millimeter of Mercury']","Millimeter of Mercury","A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)","False","b385c4cc-f975-4093-810a-f2d7122495f5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C49670"
"1142","Ohm","C42554","ohm","[]","Ohm","A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens. (NCI)","False","1b2c0203-eab2-4825-8b48-6ddeab3aa826","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49675/C42554"
"1143","Vital Signs","C49672","[VSTEST]","['Vital Signs Test Name']","","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","957bbb90-c084-4c08-8235-d52e980cf854","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672"
"1144","Body Mass Index","C16358","BMI","['Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","36ea7437-e626-4b60-9966-48311d21016b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C16358"
"1145","Adipose Tissue","C12472","BODYFAT","['Body Fat']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","3c9f8867-3cd0-481c-93fb-bc0b4b00119e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C12472"
"1146","Body Surface Area","C25157","BSA","['Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","a56ae4e4-5131-4240-8f65-4719289167a5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C25157"
"1147","Diastolic Blood Pressure","C25299","DIABP","['Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","73a00889-6864-4cd6-ad9b-bd7f78e0f2c3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C25299"
"1148","Body Frame Size","C49680","FRMSIZE","['Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","891c4659-9ecd-4098-af53-3b152748fe3d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C49680"
"1149","Height","C25347","HEIGHT","['Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","b8e45cb5-4794-4c39-ae40-c9c6f67ebaf4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C25347"
"1150","Heart Rate","C49677","HR","['Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","a03b282e-431a-45fe-b61c-0112f24cd716","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C49677"
"1151","Mean Arterial Pressure","C49679","MAP","['Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","2cd4c3f9-e26a-480c-9d2d-54389340ee41","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C49679"
"1152","Pulse Rate","C49676","PULSE","['Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","d898903e-2617-4f53-8752-88db51636a9d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C49676"
"1153","Respiratory Rate","C49678","RESP","['Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","be82b342-3b8d-4df4-ba23-e4dab0f89c8d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C49678"
"1154","Systolic Blood Pressure","C25298","SYSBP","['Systolic Blood Pressure']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","336beef2-12a1-4d37-947c-aa16602cb37a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C25298"
"1155","Temperature","C25206","TEMP","['Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","769e8374-e17a-427d-8143-137c71c2cb1d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C25206"
"1156","Weight","C25208","WEIGHT","['Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","b0edc46a-3818-41cd-b46c-1b564838ce0f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49672/C25208"
"1157","Yes, No, Unknown, or Not Applicable Response","C49486","[NY]","['No Yes Response']","","A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.","False","a57539b3-3fd2-4907-846a-c1a565272c89","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49486"
"1158","No","C49487","N","['No']","No","The non-affirmative response to a question. (NCI)","False","4db34840-73d2-47c8-9eae-b231a8c6c6b7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49486/C49487"
"1159","Not Applicable","C48660","","['NOT APPLICABLE']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","bba4c427-038c-47e3-b0f3-a4141dab5c95","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49486/C48660"
"1160","Unknown","C17998","U","['UNKNOWN', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","3fe07461-266d-4f5b-9425-7f42516d1479","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49486/C17998"
"1161","Yes","C49488","Y","['Yes']","Yes","The affirmative response to a question. (NCI)","False","2d6593f3-8a12-44d9-8173-a3b4028f887d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C49486/C49488"
"1162","CDISC SDTM Laboratory Test Terminology","C65047","[LABTEST]","[]","","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","e328e744-a826-4205-989a-d5d08c0bcda9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047"
"1163","Anisocytosis","C35266","ANISO","['Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","79f054ca-11f9-498d-a47b-3bed30c886a0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C35266"
"1164","Poikilocytosis","C35267","POIKILO","['Poikilocytosis']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","f29edda9-8d7e-4d52-985d-2f2235a5097b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C35267"
"1165","Total Bilirubin","C38037","BILI","['Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","53a22daf-71c0-4c88-aa9b-040642163405","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C38037"
"1166","Partial Thromboplastin Time","C38462","APTT","['Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","1b8075e1-aab3-47da-b54f-fe765dcb22b4","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C38462"
"1167","Plasma Glucose Measurement","C41376","GLUC","['Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","d17eb3fa-687a-448a-8470-920ce82d1ffb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C41376"
"1168","pH","C45997","PH","['pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","97716410-a95f-410b-96ef-8d94066943b3","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C45997"
"1169","Erythrocyte Count","C51946","RBC","['Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","7cc7593b-f7c2-4384-b709-5c58d26818c0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C51946"
"1170","Reticulocyte Count","C51947","RETI","['Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","4d4fc1ea-5dd1-4c17-b61c-40624d709fcc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C51947"
"1171","Leukocyte Count","C51948","WBC","['Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","40a76998-0783-46f2-b2c8-9921e936578f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C51948"
"1172","Lymphocyte Count","C51949","LYM","['Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","bec3aaf3-ab91-463f-8b34-77a982ee7125","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C51949"
"1173","Platelet Count","C51951","PLAT","['Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","c9d89008-97e5-44d8-9cce-9ee02ba151c6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C51951"
"1174","Blood Urea Nitrogen Measurement","C61019","BUN","['Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","586c1a6a-880f-4e2f-92b8-0d8d4d3499ce","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C61019"
"1175","Serum Total Cholesterol Measurement","C61032","CHOL","['Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","d4a04663-cef5-448c-b762-f4a94b79e5f8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C61032"
"1176","Serum HDL Cholesterol Measurement","C61041","HDL","['HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","c6c07cf3-3b3a-4138-b8f7-8522265c3046","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C61041"
"1177","Serum LDL Cholesterol Measurement","C61042","LDL","['LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","0f66f0a2-36b9-4509-b50e-4d3ddcfcfe21","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C61042"
"1178","Prothrombin Time","C62656","PT","['Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","dc1bc88d-e830-41f7-8158-f7b7f9d8cd15","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C62656"
"1179","Absolute Neutrophil Count","C63321","NEUT","['Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","8a68bc24-23cd-42a5-a578-f13659cbe1bb","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C63321"
"1180","Albumin Measurement","C64431","ALB","['Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","f59b02a4-2c1a-4d2f-bc8e-a05eaba70929","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64431"
"1181","Alkaline Phosphatase Measurement","C64432","ALP","['Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","f2343846-6dca-4c73-8fe0-a7f6d170e4d9","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64432"
"1182","Alanine Aminotransferase Measurement","C64433","ALT","['Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","222f8d46-6fe8-40d9-bd08-20d6c6121897","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64433"
"1183","Amylase Measurement","C64434","AMYLASE","['Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","d0dee378-4755-448a-91df-d12a399e3446","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64434"
"1184","Aspartate Aminotransferase Measurement","C64467","AST","['Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","23baf30d-adff-4678-ba72-33c1f9dd45ae","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64467"
"1185","Bacterial Count","C64469","BACT","['Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","430d6cea-c9b0-432e-a5c9-4335600d222c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64469"
"1186","Total Basophil Count","C64470","BASO","['Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","9494144f-9ee2-4b27-8de8-7c236ae9f60f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64470"
"1187","Basophil To Leukocyte Ratio","C64471","BASOLE","['Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","d78c40d7-cd31-4b68-a944-e04368d79c88","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64471"
"1188","Direct Bilirubin Measurement","C64481","BILDIR","['Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","0a66aea9-0866-4d36-904c-e8ba18862d97","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64481"
"1189","Indirect Bilirubin Measurement","C64483","BILIND","['Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","97697d7c-de1c-483f-b84a-26a2874736d2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64483"
"1190","Blast To Leukocyte Ratio","C64487","BLASTLE","['Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","c7af8000-0346-4a6d-a3e7-a561c1a850cc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64487"
"1191","Calcium Measurement","C64488","CA","['Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","0ba451aa-6b17-49a9-8ab6-3095433853b1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64488"
"1192","Creatine Kinase Measurement","C64489","CK","['Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","0fe067c9-08cd-46bb-a105-f23a64587dbc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64489"
"1193","Creatine Kinase BB Measurement","C64490","CKBB","['Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","857fa016-0aba-477f-a416-80dc8b296466","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64490"
"1194","Creatine Kinase MB Measurement","C64491","CKMB","['Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","d61c1832-4572-4bd6-93f2-a88c73222538","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64491"
"1195","Creatine Kinase MM Measurement","C64494","CKMM","['Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","6ec4c68d-05cb-418d-8561-1b5c2c664599","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64494"
"1196","Chloride Measurement","C64495","CL","['Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","d93be603-18ba-4d6e-a686-c2746b71d67d","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64495"
"1197","Carbon Dioxide Measurement","C64545","CO2","['Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","e2d4edc4-835f-4b12-9e58-2e9d70c469c0","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64545"
"1198","Color Assessment","C64546","COLOR","['Color']","Color Assessment","A measurement of the color of a biological specimen.","False","55e634fc-c145-4caf-8a49-d6bc6bf9cd91","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64546"
"1199","Creatinine Measurement","C64547","CREAT","['Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","4c2c33db-6126-4c46-8ff1-5cb1de31895f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64547"
"1200","C-Reactive Protein Measurement","C64548","CRP","['C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","c41472fc-b40b-4615-a9b1-26c9a28543f1","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64548"
"1201","Elliptocyte Count","C64549","ELLIPCY","['Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","c01d4111-dca9-45b2-9b9c-4579735ca24b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64549"
"1202","Eosinophil Count","C64550","EOS","['Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","b6ff067b-13b7-4986-b365-38e10540281f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64550"
"1203","Eosinophil To Leukocyte Ratio","C64604","EOSLE","['Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","921eb3f7-888e-4966-aebc-d388b33c6574","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64604"
"1204","Epithelial Cell Count","C64605","EPIC","['Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","af03a608-4447-472b-8da2-0aaab19a220c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64605"
"1205","Fibrinogen Measurement","C64606","FIBRINO","['Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","ffa67974-2a5f-4f2e-aa1e-3897f3a3f315","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64606"
"1206","Hematocrit","C64796","HCT","['Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","fbdbe399-469f-4d77-8bd2-6c33fdfd85e8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64796"
"1207","Erythrocyte Mean Corpuscular Hemoglobin","C64797","MCH","['Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","9ecb4eab-e807-44a2-a941-e775c45dfa3c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64797"
"1208","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","MCHC","['Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","dbe12465-4721-4383-90d0-33f7988e55b8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64798"
"1209","Erythrocyte Mean Corpuscular Volume","C64799","MCV","['Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","497aba64-d61e-407e-bcbe-76197bf94922","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64799"
"1210","Erythrocyte Distribution Width Measurement","C64800","RDW","['Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","74ec5120-2039-4725-a09f-7b3bc70ec9c5","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64800"
"1211","Dacryocyte Analysis","C64801","TEARDCY","['Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","06658194-8ba7-4e1a-9b90-1ebea730e300","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64801"
"1212","Hypochromia","C64802","HYPO","['Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","79513fa4-66c6-4e1c-bf2a-c92f9ab4c1df","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64802"
"1213","Polychromasia","C64803","POLYCHR","['Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","6db6aba3-9f67-42a1-93fa-140308bce62a","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64803"
"1214","International Normalized Ratio of Prothrombin Time","C64805","INR","['Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","627bdf54-058b-40a8-b438-66a387f82977","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64805"
"1215","Serum VLDL Cholesterol Measurement","C64806","VLDL","['VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","de9a3965-548f-47de-91d8-70c629c9f625","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64806"
"1216","Triacylglycerol Lipase Measurement","C64807","LIPASE","['Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","8d78423f-d679-4577-ada1-0ad49f7da215","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64807"
"1217","Sodium Measurement","C64809","","['Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","28191e88-c68b-4ce7-91cb-223c6be0d239","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64809"
"1218","Nitrite Measurement","C64810","NITRITE","['Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","6fbd6e4e-41bc-4db7-93b7-530e1871f03e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64810"
"1219","Triglyceride Measurement","C64812","TRIG","['Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","76ef61cc-20fb-4d5d-a1df-658fe284b712","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64812"
"1220","Thyrotropin Measurement","C64813","TSH","['Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","c5940489-a9cd-4c6b-a498-354626b4e480","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64813"
"1221","Urate Measurement","C64814","URATE","['Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","c12628cc-cb97-4094-ad2b-35ce7d8efd3c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64814"
"1222","Urea Measurement","C64815","UREA","['Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","ab615737-ceb8-44d7-8ce5-416bf00a098e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64815"
"1223","Urobilinogen Measurement","C64816","UROBIL","['Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","634230e8-75dc-4ba9-8b61-8ee77cb24485","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64816"
"1224","Vitamin B12 Measurement","C64817","VITB12","['Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","4d2229be-aecb-46b8-b755-2748cf4d9f21","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64817"
"1225","Atypical Lymphocyte Count","C64818","LYMAT","['Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","c376fa5a-d2d4-466c-b206-f59f8978a00e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64818"
"1226","Atypical Lymphocyte To Leukocyte Ratio","C64819","LYMATLE","['Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","d242ad82-397e-4c64-9742-5e788435cbe6","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64819"
"1227","Lymphocyte To Leukocyte Ratio","C64820","LYMLE","['Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","35fb2cae-7c8a-4600-b742-7aa013851048","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64820"
"1228","Macrocyte Count","C64821","MACROCY","['Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","0729a7fb-b031-45dc-b646-4dba3cb2780c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64821"
"1229","Microcyte Count","C64822","MICROCY","['Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","1b37d553-3f2e-4cd6-a387-d8e617616b01","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64822"
"1230","Monocyte Count","C64823","MONO","['Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","e7177e2e-1381-486d-b33e-036db269bd76","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64823"
"1231","Monocyte To Leukocyte Ratio","C64824","MONOLE","['Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","34331cd0-123d-44a5-a05f-c7f3f9c9ca09","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64824"
"1232","Myeloblast To Leukocyte Ratio","C64825","MYBLALE","['Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","0c4870e0-e2e8-43d2-9461-6939f16ea4fe","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64825"
"1233","Myelocyte To Leukocyte Ratio","C64826","MYCYLE","['Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","b0c03974-a2c1-4cfa-863c-354969dcfbed","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64826"
"1234","Neutrophil To Leukocyte Ratio","C64827","NEUTLE","['Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","350d9c04-e279-470e-a954-34e0398cdbb8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64827"
"1235","Reticulocyte To Erythrocyte Ratio","C64828","RETIRBC","['Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","2785eeea-a587-4b9a-a53f-557a1c653a43","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64828"
"1236","Prolymphocyte To Leukocyte Ratio","C64829","PRLYMLE","['Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","8a24eda4-1254-4279-8ebb-191c2f2ae03e","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64829"
"1237","Neutrophil Band Form Count","C64830","NEUTB","['Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","59eb0a85-0084-42ac-9ea8-d271f3dc4b8f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64830"
"1238","Neutrophil Band Form To Leukocyte Ratio","C64831","NEUTBLE","['Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","6a73be0c-c65b-478a-8266-101f422589e2","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64831"
"1239","Specific Gravity","C64832","SPGRAV","['Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","b3dc1d3f-7fe2-44fa-8977-1ca0122f8d9c","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64832"
"1240","Magnesium Measurement","C64840","MG","['Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","6e0f0a08-8db6-481f-b72e-1086bb42d56f","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64840"
"1241","Gamma Glutamyl Transpeptidase Measurement","C64847","GGT","['Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","61e6eb8b-46cd-49bb-a4a1-f158f69e22fc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64847"
"1242","Hemoglobin Measurement","C64848","HGB","['Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","de1ce8b3-83fb-467a-9613-0da7ff9c4b8b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64848"
"1243","Glycosylated Hemoglobin Measurement","C64849","HBA1C","['Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","68e9a200-b957-4ed9-bbc8-3e97ffd2afbc","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64849"
"1244","Hepatitis B Virus Surface Antigen Measurement","C64850","HBSAG","['Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","c220fa7f-df27-45e9-99d1-6bec609d06d8","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64850"
"1245","Choriogonadotropin Beta Measurement","C64851","HCG","['Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","a257cc72-26b9-4a02-bf69-085345b0a4e7","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64851"
"1246","Potassium Measurement","C64853","K","['Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","5a7d419f-f3e8-4078-a96d-8f772d4b306b","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64853"
"1247","Ketone Measurement","C64854","KETONES","['Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","a159e87c-febf-44fc-b40e-b714815cdb81","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64854"
"1248","Lactate Dehydrogenase Measurement","C64855","LDH","['Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","672abc25-3a96-47bf-aae3-b70f9e42b819","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64855"
"1249","Leukocyte Esterase Measurement","C64856","LEUKASE","['Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","7b8cd80d-c4f7-4085-a0f7-a92b4303e818","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64856"
"1250","Phosphate Measurement","C64857","PHOS","['Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","a9454ec7-0429-42a2-9d1b-dbe0bbcb9e26","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64857"
"1251","Total Protein Measurement","C64858","PROT","['Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","598bb99d-5a08-43ba-9045-3d385c984642","dataset/cdisc/ct/sc/2007-03-06/sdtm/C65047/C64858"
"1252","Action Taken with Study Treatment ","C66767","ACN","['ACN', 'Action Taken with Study Treatment']","CDISC SDTM Action Taken with Study Treatment Terminology","The reason that changes were made to the therapy under study. (NCI)","False","bb5ce3d2-4adc-4619-ab98-3112ac96b1bf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767"
"1253","Dose Increased","C49503","DOSE INCREASED","['DOSE INCREASED']","Dose Increased","An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)","False","b2de194f-3134-42e7-ae80-5cb4e042eec0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767/C49503"
"1254","Dose Not Changed","C49504","DOSE NOT CHANGED","['DOSE NOT CHANGED']","Dose Not Changed","An indication that a medication schedule was maintained. (NCI)","False","3c049a8c-5341-4b9b-a959-f3d27ec1ac3d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767/C49504"
"1255","Dose Reduced","C49505","DOSE REDUCED","['DOSE REDUCED']","Dose Reduced","An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)","False","03733da8-65fc-48c5-8494-a050a382dc3d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767/C49505"
"1256","Drug Interrupted","C49501","DRUG INTERRUPTED","['DRUG INTERRUPTED']","Drug Interrupted","An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)","False","0d1ce630-2be0-4cc1-b912-10abd40299c2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767/C49501"
"1257","Drug Withdrawn","C49502","DRUG WITHDRAWN","['DRUG WITHDRAWN']","Drug Withdrawn","An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)","False","26ea39bd-3edf-423d-8bcb-8a1325412561","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767/C49502"
"1258","Not Applicable","C48660","NOT APPLICABLE","['NOT APPLICABLE', 'NA']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","c1078b20-7360-412c-8352-f4cc4053da77","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767/C48660"
"1259","Unknown","C17998","UNKNOWN","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","104d5590-f38e-4909-9586-4dfaf8b3ebde","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66767/C17998"
"1260","Outcome of Event","C66768","OUT","['OUT', 'Outcome of Event']","CDISC SDTM Adverse Event Outcome Terminology","A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)","False","3095014e-37d4-4ebe-8a3a-f7bd7fac63de","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66768"
"1261","Death Related to Adverse Event","C48275","FATAL","['FATAL', 'Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","8d7d18de-7906-4367-b5a1-bbd1dccf41cf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66768/C48275"
"1262","Not Recovered or Not Resolved","C49494","NOT RECOVERED/NOT RESOLVED","['NOT RECOVERED/NOT RESOLVED']","Not Recovered or Not Resolved","One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)","False","2dc497ad-0bd2-4a33-b4ea-fc1412e3f29b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66768/C49494"
"1263","Recovered or Resolved","C49498","RECOVERED/RESOLVED","['RECOVERED/RESOLVED']","Recovered or Resolved","One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)","False","718f37f8-8bfb-40a3-bf9b-a28d9bd11fab","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66768/C49498"
"1264","Recovered or Resolved with Sequelae","C49495","RECOVERED/RESOLVED WITH SEQUELAE","['RECOVERED/RESOLVED WITH SEQUELAE']","Recovered or Resolved with Sequelae","One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)","False","9815c8bd-6cf2-4a9d-811f-cdc8b61a0527","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66768/C49495"
"1265","Recovering or Resolving","C49496","RECOVERING/RESOLVING","['RECOVERING/RESOLVING']","Recovering or Resolving","One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)","False","28685924-2a77-4a93-ba90-f4c7e40816c0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66768/C49496"
"1266","Unknown","C17998","UNKNOWN","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","8b9a3aae-02fa-4634-bc39-a687b8af18b6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66768/C17998"
"1267","Age Span","C66780","AGESPAN","['AGESPAN', 'Age Span']","CDISC SDTM Age GroupTerminology","Subgroups of populations based on age. (NCI)","False","4c6bb48c-219e-42d6-9254-956612cd8a35","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780"
"1268","Adolescent","C27954","ADOLESCENT (12-17 YEARS)","['ADOLESCENT (12-17 YEARS)']","Adolescent","A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)","False","22d2f7d8-d613-405a-8f13-2b47e548a311","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C27954"
"1269","Adult 18-65 Years Old","C49685","ADULT (18-65)","['ADULT (18-65)']","Adult 18-65 Years Old","A person from 18 years to 65 years of age. (NCI)","False","8e80e4c0-a9f7-431a-9d83-04bd2312a4f4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C49685"
"1270","Children 2-11 Years Old","C49683","CHILDREN (2-11 YEARS)","['CHILDREN (2-11 YEARS)']","Children 2-11 Years Old","A person from 2 years to 11 years of age. (NCI)","False","0b80f251-e59e-4108-b396-b4c505cd3b57","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C49683"
"1271","Elderly","C16268","ELDERLY (> 65)","['ELDERLY (> 65)']","Elderly","An age group comprised by people 65 years of age and older. (NCI) ","False","046c003a-1109-4604-8854-7f7cd9c2d741","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C16268"
"1272","In Utero","C49641","IN UTERO","['IN UTERO']","In Utero","The period of time during which the embryo or foetus is present in the uterus of the female. Also describes the location of the embryo or foetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)","False","e66ff48d-00cf-4c8a-8c31-42bf34dc44e8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C49641"
"1273","Infant And Toddler","C49643","INFANT AND TODDLER (28 DAYS - 23 MONTHS)","['INFANT AND TODDLER (28 DAYS - 23 MONTHS)']","Infant And Toddler","A person from 28 days to 23 months of age. (NCI)","False","f7442e3b-6586-45d6-a5b2-0a60b15a8f0e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C49643"
"1274","Newborn","C16731","NEWBORN (0-27 DAYS)","['NEWBORN (0-27 DAYS)']","Newborn","An infant during the first month after birth. (NCI)","False","70857d5b-525b-4d9e-9cb7-90c05ed40aaf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C16731"
"1275","Preterm Newborn Infant","C49642","PRETERM NEWBORN INFANTS","['PRETERM NEWBORN INFANTS']","Preterm Newborn Infant","An infant born prior to completion of the normal gestation period. (NCI)","False","1351321b-dfe7-4bf5-9b62-20afb10c34bd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66780/C49642"
"1276","Age Unit","C66781","AGEU","['AGEU', 'Age Unit']","CDISC SDTM Age UnitTerminology","Those units of time that are routinely used to express the age of a person. (NCI)","False","b90ca117-c237-486c-9cb0-bee00c8a8f5e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66781"
"1277","Day","C25301","DAYS","['DAYS']","Day","The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day. (NCI)","False","051cd916-94d2-42a7-be23-03089ab95886","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66781/C25301"
"1278","Hour","C25529","HOURS","['HOURS']","Hour","A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)","False","3fe3e4a1-d31b-4259-b1a9-46ec2c4070c0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66781/C25529"
"1279","Month","C29846","MONTHS","['MONTHS']","Month","One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)","False","b7203d22-4d76-4281-8d28-c5fb2030c25c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66781/C29846"
"1280","Week","C29844","WEEKS","['WEEKS']","Week","Any period of seven consecutive days. (NCI)","False","11cb4bdb-0a7f-497d-9824-f7831b67e943","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66781/C29844"
"1281","Year","C29848","YEARS","['YEARS']","Year","The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)","False","c82458bc-40ba-4b1d-86c4-53c2e3a36ff4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66781/C29848"
"1282","Category for Inclusion/Exclusion","C66797","IECAT","['IECAT', 'Category for Inclusion/Exclusion']","CDISC SDTM Category of Inclusion And Or ExclusionTerminology","A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)","False","9528defd-9a33-425d-a158-782d5e2e950b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66797"
"1283","Exclusion","C25370","EXCLUSION","['EXCLUSION']","Exclusion","List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)","False","92c8c205-3b39-47c7-9e90-18eb3f4a5958","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66797/C25370"
"1284","Inclusion","C25532","INCLUSION","['INCLUSION']","Inclusion","The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study.  NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)","False","f51ba1a3-affb-4b91-ae26-94b9e0390d34","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66797/C25532"
"1285","CDISC System Organ Class","C66783","SOC","['SOC', 'CDISC System Organ Class']","CDISC SDTM System Organ Class Terminology","Terms at the highest level of the CDISC system organ class terminology.","False","a5194b1e-a685-4cc7-8dab-51c6d8f35918","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783"
"1286","Hematopoietic and Lymphoid System Disorder","C35814","BLOOD AND LYMPHATIC SYSTEM DISORDERS","['BLOOD AND LYMPHATIC SYSTEM DISORDERS']","Hematopoietic and Lymphoid System Disorder","Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","7a62ac5e-d1d0-48cd-a0d0-73d6b6bf4f5a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C35814"
"1287","Heart Disorder","C3079","CARDIAC DISORDERS","['CARDIAC DISORDERS']","Heart Disorder","Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","45ea890c-eb47-470c-b308-97933a601238","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C3079"
"1288","Congenital, Familial and Genetic Disorder Class","C49399","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","['CONGENITAL, FAMILIAL AND GENETIC DISORDERS']","Congenital, Familial and Genetic Disorder Class","A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characterstic set of symptoms and signs. (NCI)","False","cfe7b26f-9946-4e57-9e35-4692cd8268ec","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C49399"
"1289","Ear and Labyrinth Disorder Class","C49400","EAR AND LABYRINTH DISORDERS","['EAR AND LABYRINTH DISORDERS']","Ear and Labyrinth Disorder Class","Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)","False","709ae792-a494-4989-8882-58628ce0f58b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C49400"
"1290","Endocrine Disorder","C3009","ENDOCRINE DISORDERS","['ENDOCRINE DISORDERS']","Endocrine Disorder","Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","9f66a472-d600-4627-920c-32100cabe2ad","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C3009"
"1291","Eye Disorder","C26767","EYE DISORDERS","['EYE DISORDERS']","Eye Disorder","Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)","False","f221892e-a195-4149-9469-489d3272424e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C26767"
"1292","Gastrointestinal Disorder","C2990","GASTROINTESTINAL DISORDERS","['GASTROINTESTINAL DISORDERS']","Gastrointestinal Disorder","Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)","False","c1cc9eb7-1d3e-4999-b66f-934058498846","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C2990"
"1293","General Disorders and Administration Site Conditions Class","C49401","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","['GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS']","General Disorders and Administration Site Conditions Class","A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)","False","6f6e5754-9efb-410a-a095-ee8ae94d2e1c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C49401"
"1294","Liver and Biliary Tract Disorder","C3959","HEPATOBILIARY DISORDERS","['HEPATOBILIARY DISORDERS']","Liver and Biliary Tract Disorder","Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)","False","87681a1b-3507-4878-9172-abad15fac764","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C3959"
"1295","Immune System Disorder","C3507","IMMUNE SYSTEM DISORDERS","['IMMUNE SYSTEM DISORDERS']","Immune System Disorder","A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)","False","aa9ba08c-4c7d-438f-a8e6-d85b4a7bfb37","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C3507"
"1296","Infectious Disorder","C26726","INFECTIONS AND INFESTATIONS","['INFECTIONS AND INFESTATIONS']","Infectious Disorder","A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)","False","ab5b84b3-76f1-4749-8aa9-f6c51cc813b1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C26726"
"1297","Injury, Poisoning and Procedural Complication Class","C49402","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","['INJURY, POISONING AND PROCEDURAL COMPLICATIONS']","Injury, Poisoning and Procedural Complication Class","A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)","False","0ca3bf11-2ee2-40d0-96bb-5d6e4fefbcd1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C49402"
"1298","Investigation","C41198","INVESTIGATIONS","['INVESTIGATIONS']","Investigation","The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)","False","4b38cfe7-b654-42a4-a44f-e4018cc00fe1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C41198"
"1299","Metabolism and Nutrition Disorder Class","C49403","METABOLISM AND NUTRITION DISORDERS","['METABOLISM AND NUTRITION DISORDERS']","Metabolism and Nutrition Disorder Class","A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)","False","525388a7-3557-4c55-83ed-66a1d24f95b4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C49403"
"1300","Connective and Soft Tissue Disorder","C27574","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","['MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS']","Connective and Soft Tissue Disorder","Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)","False","05cf1a84-d527-459f-a3bb-5d963b12db8c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C27574"
"1301","Neoplasm","C3262","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","['NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)']","Neoplasm","An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)","False","ec9cfa35-5602-4078-98f9-cd2c55474912","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C3262"
"1302","Nervous System Disorder","C26835","NERVOUS SYSTEM DISORDERS","['NERVOUS SYSTEM DISORDERS']","Nervous System Disorder","Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","cf23e2c3-9f56-43d9-aacb-9a062e33c0d5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C26835"
"1303","Pregnancy, Puerperium and Perinatal Condition Class","C49404","PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS","['PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS']","Pregnancy, Puerperium and Perinatal Condition Class","A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)","False","eacaed6a-a0fd-43ff-bfdc-a8c840666b6a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C49404"
"1304","Psychiatric Disorder","C2893","PSYCHIATRIC DISORDERS","['PSYCHIATRIC DISORDERS']","Psychiatric Disorder","Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)","False","64d560bc-f0c2-48cb-a575-01b63d75b12b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C2893"
"1305","Urinary System Disorder","C3430","RENAL AND URINARY DISORDERS","['RENAL AND URINARY DISORDERS']","Urinary System Disorder","Disorders of any part of the urologic system. (NCI)","False","712f5f8f-a916-4b4a-88b8-ef98ea1c26f0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C3430"
"1306","Reproductive System and Breast Disorder Class","C49405","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","['REPRODUCTIVE SYSTEM AND BREAST DISORDERS']","Reproductive System and Breast Disorder Class","Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)","False","d2603a67-3ce0-4c42-a724-00cae7feb881","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C49405"
"1307","Respiratory and Thoracic Disorder","C27669","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","['RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS']","Respiratory and Thoracic Disorder","Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)","False","888114b9-91ec-477e-af14-551784d76219","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C27669"
"1308","Skin Disorder","C3371","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","['SKIN AND SUBCUTANEOUS TISSUE DISORDERS']","Skin Disorder","Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)","False","12e5812a-c64a-459c-b021-488130a54821","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C3371"
"1309","Social Circumstances","C20188","SOCIAL CIRCUMSTANCES","['SOCIAL CIRCUMSTANCES']","Social Circumstances","A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)","False","a57d008b-91cd-4021-b19f-1209ef7e7731","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C20188"
"1310","Procedure","C25218","SURGICAL AND MEDICAL PROCEDURES","['SURGICAL AND MEDICAL PROCEDURES']","Procedure","A particular course of action intended to achieve a result. (NCI)","False","e29d119a-8e9b-42fd-8ace-6ebc16cd4404","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C25218"
"1311","Vascular Disorder","C35117","VASCULAR DISORDERS","['VASCULAR DISORDERS']","Vascular Disorder","Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","ccda3ab3-67b0-4815-a637-6910ae1d9212","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66783/C35117"
"1312","Common Terminology Criteria for Adverse Events","C66784","TOXGR","['TOXGR', 'Common Terminology Criteria for Adverse Events']","CDISC SDTM CommonTerminology Criteria for Adverse Event Grade Terminology","A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)","False","8832d59a-e296-4f48-9e88-01a6dce96b20","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66784"
"1313","Mild Adverse Event","C41338","1","['MILD', 'Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","54bff968-2703-4790-af08-9804c766de32","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66784/C41338"
"1314","Moderate Adverse Event","C41339","2","['MODERATE', 'Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","f7ea6cd5-a851-445d-adab-7aec3b32fabd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66784/C41339"
"1315","Severe Adverse Event","C41340","3","['SEVERE', 'Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","71a38df7-973b-4e9c-9c34-d254a4ef843c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66784/C41340"
"1316","Life Threatening or Disabling Adverse Event","C41337","4","['LIFE THREATENING', 'Grade 4', '4']","Life Threatening or Disabling Adverse Event","An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.","False","8f29baca-4cbb-4716-ac6f-f9d3b9d878a5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66784/C41337"
"1317","Death Related to Adverse Event","C48275","5","['FATAL', 'Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","2e4c2440-87d2-4b78-9b40-40e6768ba059","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66784/C48275"
"1318","Control Type","C49647","TCNTRL","['TCNTRL', 'Control Type', 'Type of Control']","CDISC SDTM Control Type Terminology","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","43f4f32e-76dd-496b-8b6a-4468041f4448","dataset/cdisc/ct/sc/2007-04-20/sdtm/C49647"
"1319","Active Control","C49649","ACTIVE","['ACTIVE']","Active Control","A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].","False","da6ce909-4520-4e08-84ee-6a3599efb87d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C49647/C49649"
"1320","None","C41132","NONE","['NONE']","None","No person or thing, nobody, not any. (NCI)","False","3fd34052-a352-4fa6-a326-bf6df19a6299","dataset/cdisc/ct/sc/2007-04-20/sdtm/C49647/C41132"
"1321","Placebo Control","C49648","PLACEBO","['PLACEBO']","Placebo Control","Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)","False","b1d2087f-9d28-4c26-914e-0975a16afb1b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C49647/C49648"
"1322","Country","C66786","COUNTRY","['COUNTRY', 'Country']","CDISC SDTM Country Terminology","A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)","False","3b9ab203-79ca-4fcd-9cc0-b08a65bc7cea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786"
"1323","Aruba","C17884","ABW","['ABW', 'ARUBA']","Aruba","Island in the Caribbean Sea, north of Venezuela.","False","b8573641-3432-4a68-8bec-4752477a46c0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17884"
"1324","Afghanistan","C16267","AFG","['AFG', 'AFGHANISTAN']","Afghanistan","A country in Southern Asia, north and west of Pakistan, east of Iran.","False","e9f68098-a416-4e9b-b4d8-953a9d358e80","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16267"
"1325","Angola","C16292","AGO","['AGO', 'ANGOLA']","Angola","A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo.","False","e1b53f69-9b0d-4bbd-a8ce-8c80c19fbabc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16292"
"1326","Anguilla","C20133","AIA","['AIA', 'ANGUILLA']","Anguilla","An island in the Caribbean Sea, east of Puerto Rico.","False","1e4ecf88-77a0-4e2b-96b9-0b53f564d172","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20133"
"1327","Aland Islands","C44481","ALA","['ALA', 'ALAND ISLANDS']","Aland Islands","An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland.","False","251a16ea-136d-4485-88a1-0ceb621ea987","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C44481"
"1328","Albania","C16271","ALB","['ALB', 'ALBANIA']","Albania","A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro.","False","b6b600cf-9643-4000-89d0-c863f8ecd810","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16271"
"1329","Andorra","C16289","AND","['AND', 'ANDORRA']","Andorra","A country in Southwestern Europe, between France and Spain.","False","02f5b2cc-bc7a-438f-9573-dd0aa622d9a2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16289"
"1330","Netherlands Antilles","C16904","ANT","['ANT', 'NETHERLANDS ANTILLES']","Netherlands Antilles","A country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands.","False","6b6289ae-7061-4111-a790-619bd69b982d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16904"
"1331","United Arab Emirates","C17232","ARE","['ARE', 'UNITED ARAB EMIRATES']","United Arab Emirates","A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia.","False","9d10b7e8-8454-45bb-9f50-0654003e4053","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17232"
"1332","Argentina","C16305","ARG","['ARG', 'ARGENTINA']","Argentina","A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.","False","abfac639-0ce9-4739-9393-799f8dde06ae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16305"
"1333","Armenia","C16306","ARM","['ARM', 'ARMENIA']","Armenia","A country in Southwestern Asia, east of Turkey.","False","52c5a7c6-e55c-4a30-909e-f8b21c1c15b9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16306"
"1334","American Samoa","C17739","ASM","['ASM', 'AMERICAN SAMOA']","American Samoa","A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand.","False","18e6233d-383f-49d8-9148-a20418aae308","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17739"
"1335","Antarctica","C18007","ATA","['ATA', 'ANTARCTICA']","Antarctica","The continent lying mostly south of the Antarctic Circle.","False","2fe93aa1-a70b-498a-b554-a5b1d34cdb91","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C18007"
"1336","French Southern Territories","C20105","ATF","['ATF', 'FRENCH SOUTHERN TERRITORIES']","French Southern Territories","Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia.","False","c7701a6c-5435-4e60-b6bf-cee8006b27c3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20105"
"1337","Antigua and Barbuda","C16303","ATG","['ATG', 'ANTIGUA AND BARBUDA']","Antigua and Barbuda","Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico.","False","aeedaca6-16eb-442e-9604-72bc76600d59","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16303"
"1338","Australia","C16311","AUS","['AUS', 'AUSTRALIA']","Australia","The continent between the Indian Ocean and the South Pacific Ocean.","False","059b7a4b-1a30-49e2-98ef-21f5dc8f823e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16311"
"1339","Austria","C16312","AUT","['AUT', 'AUSTRIA']","Austria","A country in Central Europe, north of Italy and Slovenia.","False","6b7080e7-eb48-4418-a3d1-927bb1dc60fb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16312"
"1340","Azerbaijan","C16316","AZE","['AZE', 'AZERBAIJAN']","Azerbaijan","A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia.","False","30985a80-5d78-44e3-87d4-3a095f3f6649","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16316"
"1341","Burundi","C16371","BDI","['BDI', 'BURUNDI']","Burundi","A country in Central Africa, east of Democratic Republic of the Congo.","False","360c321e-a103-43d9-bbfb-ecc462264cc0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16371"
"1342","Belgium","C16329","BEL","['BEL', 'BELGIUM']","Belgium","A country in Western Europe, bordering the North Sea, between France and the Netherlands.","False","f3a0682c-a591-45c1-9579-5c3866895a4d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16329"
"1343","Benin Republic","C16333","BEN","['BEN', 'BENIN REPUBLIC']","Benin Republic","A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo.","False","b5701c3a-31c7-4c64-b2e0-d35421d170af","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16333"
"1344","Burkina Faso","C16369","BFA","['BFA', 'BURKINA FASO']","Burkina Faso","A country in Western Africa, north of Ghana.","False","624682b5-2aa1-4ab1-a474-bc4db6e7507d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16369"
"1345","Bangladesh","C16323","BGD","['BGD', 'BANGLADESH']","Bangladesh","A country in Southern Asia, bordering the Bay of Bengal, between Burma and India.","False","7ed7251e-e938-4a37-9aa1-ec9f87f65655","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16323"
"1346","Bulgaria","C16368","BGR","['BGR', 'BULGARIA']","Bulgaria","A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey.","False","98bd5ab6-1a97-4393-bbbf-714a507944c7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16368"
"1347","Bahrain","C16322","BHR","['BHR', 'BAHRAIN']","Bahrain","An archipelago in the Persian Gulf, east of Saudi Arabia.","False","3db8ed07-6fe3-44a1-a64f-6f00f503a7b2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16322"
"1348","Bahamas","C16321","BHS","['BHS', 'BAHAMAS']","Bahamas","A chain of islands in the North Atlantic Ocean, southeast of Florida.","False","35d29dcd-2f02-4f31-afab-4b465b4bd7e7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16321"
"1349","Bosnia-Herzegovina","C16361","BIH","['BIH', 'BOSNIA-HERZEGOVINA']","Bosnia-Herzegovina","A country in Southeastern Europe, bordering the Adriatic Sea and Croatia.","False","79413307-f509-453e-996c-963070bf3cab","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16361"
"1350","Belarus","C16372","BLR","['BLR', 'BELARUS']","Belarus","A country in Eastern Europe, east of Poland.","False","a5f51c27-f2ee-4a51-b290-0300ceed3a38","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16372"
"1351","Belize","C16331","BLZ","['BLZ', 'BELIZE']","Belize","A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico.","False","08972337-4fc5-4706-85f8-a30bdac31b08","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16331"
"1352","Bermuda","C16334","BMU","['BMU', 'BERMUDA']","Bermuda","No Definition","False","21495e58-b9cb-43e5-a576-e0e6adecea7a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16334"
"1353","Bolivia","C16359","BOL","['BOL', 'BOLIVIA']","Bolivia","A country in Central South America, southwest of Brazil.","False","9e2d894d-a2d6-4d9d-9053-b68241ec4d8b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16359"
"1354","Brazil","C16364","BRA","['BRA', 'BRAZIL']","Brazil","A country in Eastern South America, bordering the Atlantic Ocean.","False","4c439126-9b84-41c1-a62b-b77631121a38","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16364"
"1355","Barbados","C16324","BRB","['BRB', 'BARBADOS']","Barbados","An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","f6ca5953-7394-402b-a1b7-3b9e431eebf5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16324"
"1356","Brunei Darussalam","C16367","BRN","['BRN', 'BRUNEI']","Brunei Darussalam","A country in Southeastern Asia, bordering the South China Sea and Malaysia.","False","5f7c61da-f834-48f5-a4c7-ec8460fee785","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16367"
"1357","Bhutan","C16336","BTN","['BTN', 'BHUTAN']","Bhutan","A country in Southern Asia, between China and India.","False","4ebecaa8-b20b-4cf6-b0cc-a8f04df33a06","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16336"
"1358","Bouvet Island","C20104","BVT","['BVT', 'BOUVET ISLAND']","Bouvet Island","An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa).","False","0f4f8014-90da-45c5-84c1-2fda30c912f7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20104"
"1359","Botswana","C16363","BWA","['BWA', 'BOTSWANA']","Botswana","A country in Southern Africa, north of South Africa.","False","26f52154-4bd8-40ec-bfc8-22049071949d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16363"
"1360","Central African Republic","C16409","CAF","['CAF', 'CENTRAL AFRICAN REPUBLIC']","Central African Republic","A country in Central Africa, north of Democratic Republic of the Congo.","False","701cfe18-283b-4a9c-90b0-9b69472e4bba","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16409"
"1361","Canada","C16380","CAN","['CAN', 'CANADA']","Canada","A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US.","False","275c8443-f0b0-4521-979e-0f6342cb68ce","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16380"
"1362","Cocos (Keeling) Islands","C16445","CCK","['CCK', 'COCOS (KEELING) ISLANDS']","Cocos (Keeling) Islands","A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka.","False","52dfac6e-d6e9-4bb3-b4a3-eba117e4ff7b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16445"
"1363","Switzerland","C17181","CHE","['CHE', 'SWITZERLAND']","Switzerland","A country in Central Europe, east of France, north of Italy.","False","7ee400a1-5ce3-4cd7-bfc1-a78bed388641","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17181"
"1364","Chile","C16427","CHL","['CHL', 'CHILE']","Chile","A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru.","False","d6095cc7-1305-4d40-a28f-904abe7cc2ff","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16427"
"1365","China","C16428","CHN","['CHN', 'CHINA']","China","A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam.","False","83b1ca91-39cd-450d-8e85-45f9139df022","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16428"
"1366","Cote d'Ivoire","C16762","CIV","['CIV', ""COTE D'IVOIRE""]","Cote d'Ivoire","A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia.","False","c3bf776d-803c-4862-a745-d56c25b6c441","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16762"
"1367","Cameroon","C16379","CMR","['CMR', 'CAMEROON']","Cameroon","A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria.","False","2b1362c4-b946-4417-9126-0b62cb070048","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16379"
"1368","Democratic Republic of the Congo","C17266","COD","['COD', 'DEMOCRATIC REPUBLIC OF THE CONGO']","Democratic Republic of the Congo","A country in Central Africa, northeast of Angola.","False","0505ebf8-1ae0-431d-b85f-16417b0dd9ab","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17266"
"1369","Congo","C16467","COG","['COG', 'CONGO']","Congo","A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon.","False","a0036980-f7ca-4cc7-a895-e319498c2cb0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16467"
"1370","Cook Islands","C16469","COK","['COK', 'COOK ISLANDS']","Cook Islands","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","79a9034f-6972-4f89-a82e-d59dad981df9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16469"
"1371","Colombia","C16449","COL","['COL', 'COLOMBIA']","Colombia","A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama.","False","c62249f7-0fad-4871-8085-e47a37acbc60","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16449"
"1372","Comoros","C16458","COM","['COM', 'COMOROS']","Comoros","A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique.","False","a2a7ef5d-00f4-4cd6-97c0-ccb76fa47044","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16458"
"1373","Cape Verde","C16382","CPV","['CPV', 'CAPE VERDE']","Cape Verde","A group of islands in the North Atlantic Ocean, west of Senegal.","False","41f52782-6057-4980-8447-840f3db4cb04","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16382"
"1374","Costa Rica","C16470","CRI","['CRI', 'COSTA RICA']","Costa Rica","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama.","False","09521950-7f09-4ef0-ab31-24d180880e42","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16470"
"1375","Cuba","C16477","CUB","['CUB', 'CUBA']","Cuba","An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida.","False","c3df6606-bef9-42f1-a4a9-3de77a2b9e5c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16477"
"1376","Christmas Island","C44482","CXR","['CXR', 'CHRISTMAS ISLAND']","Christmas Island","An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia.","False","74312d32-4ee5-4787-96d8-a9a5069f66ae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C44482"
"1377","Cayman Islands","C16391","CYM","['CYM', 'CAYMAN ISLANDS']","Cayman Islands","An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras.","False","7ccd7d4b-d337-49aa-a01f-8f9874c84976","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16391"
"1378","Cyprus","C16480","CYP","['CYP', 'CYPRUS']","Cyprus","An island in the Mediterranean Sea, south of Turkey.","False","26c46580-db2f-4710-b373-878b1b13941f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16480"
"1379","Czech Republic","C17668","CZE","['CZE', 'CZECH REPUBLIC']","Czech Republic","A country in Central Europe, southeast of Germany.","False","10d536c3-96ac-4a16-afb3-d5a35d4d892d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17668"
"1380","Germany","C16636","DEU","['DEU', 'GERMANY']","Germany","A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark.","False","81638bc9-550d-4c46-a29b-eccc54e8d1c0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16636"
"1381","Djibouti","C16506","DJI","['DJI', 'DJIBOUTI']","Djibouti","A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia.","False","c231605d-d903-4f8d-9430-4532538f8f1b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16506"
"1382","Dominica","C16519","DMA","['DMA', 'DOMINICA']","Dominica","An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago.","False","08882915-0873-41aa-b9a8-b27620bb7d4e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16519"
"1383","Denmark","C16496","DNK","['DNK', 'DENMARK']","Denmark","A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn).","False","7a344212-296a-4b58-8b04-815743994073","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16496"
"1384","Dominican Republic","C16520","DOM","['DOM', 'DOMINICAN REPUBLIC']","Dominican Republic","A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti.","False","85503e06-c4dd-4009-b4be-2b19ca6dbe4d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16520"
"1385","Algeria","C16274","DZA","['DZA', 'ALGERIA']","Algeria","A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia.","False","4262e1e3-23b1-4bc4-a51b-3a783d1a5731","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16274"
"1386","Ecuador","C16528","ECU","['ECU', 'ECUADOR']","Ecuador","A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.","False","36393dee-e497-41de-bc70-c6dfcbaf9cf2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16528"
"1387","Egypt","C16530","EGY","['EGY', 'EGYPT']","Egypt","A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip.","False","431d596f-6aaa-40d7-823c-64d5e3fcab2c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16530"
"1388","Eritrea","C16558","ERI","['ERI', 'ERITREA']","Eritrea","A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan.","False","e6168fdf-922d-4ef4-a335-99fc220e1b40","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16558"
"1389","Western Sahara","C20113","ESH","['ESH', 'WESTERN SAHARA']","Western Sahara","A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.","False","dbea9297-52c3-412a-99b7-e080d7360073","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20113"
"1390","Spain","C17152","ESP","['ESP', 'SPAIN']","Spain","A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France.","False","7f74751b-b99b-4c8c-80c0-d3f5c7ed0c2b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17152"
"1391","Estonia","C16562","EST","['EST', 'ESTONIA']","Estonia","A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia.","False","c4be158c-c2d5-4563-8d0d-724dc585ae8c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16562"
"1392","Ethiopia","C16563","ETH","['ETH', 'ETHIOPIA']","Ethiopia","A country in Eastern Africa, west of Somalia.","False","2cf97ad0-2771-4f28-85f9-e9e76b316cc6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16563"
"1393","Finland","C16584","FIN","['FIN', 'FINLAND']","Finland","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia.","False","658c69d4-198c-4879-a66f-982ac8c2e32c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16584"
"1394","Fiji","C16582","FJI","['FJI', 'FIJI']","Fiji","An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","2bafa362-4893-47a8-a709-6ce3e5ddd026","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16582"
"1395","Falkland Islands","C17954","FLK","['FLK', 'FALKLAND ISLANDS']","Falkland Islands","Islands in the South Atlantic Ocean, east of southern Argentina.","False","cb1a6cbb-772c-479c-af5d-e618381281d7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17954"
"1396","France","C16592","FRA","['FRA', 'FRANCE']","France","A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain.","False","5ab707ab-10bd-47b6-b44b-11fe5bac9c98","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16592"
"1397","Faroe Islands","C16573","FRO","['FRO', 'FAROE ISLANDS']","Faroe Islands","An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway.","False","f697042d-1697-4bfa-9b03-3bf2279286ea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16573"
"1398","Federated States of Micronesia","C17881","FSM","['FSM', 'MICRONESIA, FEDERATED STATES OF']","Federated States of Micronesia","An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia.","False","7e930adf-f8d7-48fe-a787-5808ad835436","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17881"
"1399","Gabon","C16596","GAB","['GAB', 'GABON']","Gabon","A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea.","False","ecc998cf-ff8e-4bd9-bb29-bd9f0945f40e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16596"
"1400","United Kingdom","C17233","GBR","['GBR', 'UNITED KINGDOM']","United Kingdom","A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France.","False","86cdf26c-bd31-47d0-86fa-c1482548d57f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17233"
"1401","Georgia","C16634","GEO","['GEO', 'GEORGIA']","Georgia","A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia.","False","77af5f4b-c1e0-4fc8-bf8e-9d838f79e144","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16634"
"1402","Guernsey","C64375","GGY","['GGY', 'GUERNSEY']","Guernsey","The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK.","False","365638fa-8d3b-4ab3-bca7-a2929da348f1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C64375"
"1403","Ghana","C26330","GHA","['GHA', 'GHANA']","Ghana","A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo.","False","ac0ee110-8f5f-4426-9226-882ee5ccfea9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C26330"
"1404","Gibraltar","C16638","GIB","['GIB', 'GIBRALTAR']","Gibraltar","A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain.","False","e4a4d9f6-9217-4fa2-b3b4-7d61ea28e5a3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16638"
"1405","Guinea","C16655","GIN","['GIN', 'GUINEA']","Guinea","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone.","False","27a1f240-1c8d-4418-81f5-d40adbfcfb87","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16655"
"1406","Guadeloupe","C16651","GLP","['GLP', 'GUADELOUPE']","Guadeloupe","Islands in the eastern Caribbean Sea, southeast of Puerto Rico.","False","7250bb7b-3112-475e-a444-0a22c18868f8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16651"
"1407","Gambia","C16598","GMB","['GMB', 'GAMBIA']","Gambia","A country in Western Africa, bordering the North Atlantic Ocean and Senegal.","False","e70e8a48-9e4a-48a4-bf83-2fb8f62e5e8a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16598"
"1408","Guinea-Bissau","C16656","GNB","['GNB', 'GUINEA-BISSAU']","Guinea-Bissau","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal.","False","5988b70d-91c8-4123-881a-f1c06f25f799","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16656"
"1409","Equatorial Guinea","C16557","GNQ","['GNQ', 'EQUATORIAL GUINEA']","Equatorial Guinea","A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands.","False","34bc1f7c-e633-4902-ad11-de69663bbd39","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16557"
"1410","Greece","C16645","GRC","['GRC', 'GREECE']","Greece","A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey.","False","134395f5-331d-438f-ae6c-49b1be645d7b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16645"
"1411","Grenada","C16647","GRD","['GRD', 'GRENADA']","Grenada","An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago.","False","33dec1c3-6dcd-4fa1-aca3-ef6e1bb6be86","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16647"
"1412","Greenland","C16646","GRL","['GRL', 'GREENLAND']","Greenland","An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.","False","5ab99567-4842-44a7-9434-287cf3cf9321","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16646"
"1413","Guatemala","C16654","GTM","['GTM', 'GUATEMALA']","Guatemala","A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico.","False","a064f402-fbc1-4f4e-ba98-2d6e7e1e8b69","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16654"
"1414","French Guiana","C16593","GUF","['GUF', 'FRENCH GUIANA']","French Guiana","A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname.","False","5c63cc91-e6b3-40a2-8a2c-63a895ad3c2b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16593"
"1415","Guam","C16652","GUM","['GUM', 'GUAM']","Guam","Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","b7c1e066-67cb-4edd-9852-deb4b5333b3f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16652"
"1416","Guyana","C16657","GUY","['GUY', 'GUYANA']","Guyana","A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.","False","5573b5c3-f9f9-4d3e-8bcf-44529929f7b2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16657"
"1417","Hong Kong","C16695","HKG","['HKG', 'HONG KONG']","Hong Kong","A special administrative region of China, bordering the South China Sea and China.","False","dcfc0e4d-c95b-4101-9480-a0aafa375fe4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16695"
"1418","Heard Island and McDonald Islands","C20106","HMD","['HMD', 'HEARD ISLAND AND MCDONALD ISLANDS']","Heard Island and McDonald Islands","Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica.","False","04253e4d-ee3e-4972-a2a3-2074d0078749","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20106"
"1419","Honduras","C16694","HND","['HND', 'HONDURAS']","Honduras","A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua.","False","cdfd5758-da4b-4b38-ac36-6f499b9611b5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16694"
"1420","Croatia","C16474","HRV","['HRV', 'CROATIA']","Croatia","A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia.","False","48177bcb-ecbb-472d-9d21-2269a00c0b58","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16474"
"1421","Haiti","C16660","HTI","['HTI', 'HAITI']","Haiti","A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic.","False","2e3f48bc-d698-4b8d-90b5-a3db25eefaa1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16660"
"1422","Hungary","C16699","HUN","['HUN', 'HUNGARY']","Hungary","A country in Central Europe, northwest of Romania.","False","c4a4c19c-7aac-4f37-b591-c2c1d49f3971","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16699"
"1423","Indonesia","C16728","IDN","['IDN', 'INDONESIA']","Indonesia","A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean.","False","7f75dd49-0589-4fb9-ac21-a2c333249fab","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16728"
"1424","India","C16727","IND","['IND', 'INDIA']","India","A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.","False","542a7d2e-0b77-4e8f-a678-6b7e9800bfcc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16727"
"1425","British Indian Ocean Territory","C16365","IOT","['IOT', 'BRITISH INDIAN OCEAN TERRITORY']","British Indian Ocean Territory","An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia.","False","e96f57da-f381-422b-bb1f-65de5ca802f2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16365"
"1426","Ireland","C16757","IRL","['IRL', 'IRELAND']","Ireland","A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain.","False","640fef8b-72e1-4bfb-8b52-28dccd32b9e7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16757"
"1427","Iran","C16755","IRN","['IRN', 'IRAN']","Iran","A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.","False","204103c1-1829-4d3d-8b04-af8df45b58e6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16755"
"1428","Iraq","C16756","IRQ","['IRQ', 'IRAQ']","Iraq","A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait.","False","1c46a300-7fe4-4623-a06c-4755228de858","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16756"
"1429","Iceland","C16704","ISL","['ISL', 'ICELAND']","Iceland","A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK.","False","258a5902-c216-4a02-b7ed-287b24b44552","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16704"
"1430","Israel","C16760","ISR","['ISR', 'ISRAEL']","Israel","A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon.","False","6d301840-b2ca-465c-bd94-497b9c7e139b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16760"
"1431","Italy","C16761","ITA","['ITA', 'ITALY']","Italy","A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.","False","bb6b8b37-fa94-456e-9661-2ff0c7f00034","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16761"
"1432","Jamaica","C16763","JAM","['JAM', 'JAMAICA']","Jamaica","An island in the Caribbean Sea, south of Cuba.","False","366ed530-c31f-4ee3-99d2-4973c5c36585","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16763"
"1433","Jordan","C16765","JOR","['JOR', 'JORDAN']","Jordan","A country in the Middle East, northwest of Saudi Arabia.","False","cf30f908-912f-4da3-b5f1-71ee83132927","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16765"
"1434","Japan","C16764","JPN","['JPN', 'JAPAN']","Japan","A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula.","False","55040377-0d48-4e0d-82ea-90b4ddb8ff62","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16764"
"1435","Jersey","C64374","JRE","['JRE', 'JERSEY']","Jersey","Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK.","False","0e7c62ee-7973-47bd-a984-39bb6845a294","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C64374"
"1436","Kazakhstan","C20107","KAZ","['KAZ', 'KAZAKHSTAN']","Kazakhstan","A country in Central Asia, northwest of China.","False","40b3c2ec-b8e3-4eae-887c-6df902261b92","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20107"
"1437","Kenya","C16769","KEN","['KEN', 'KENYA']","Kenya","A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania.","False","c2d8a0f4-49ba-4403-a2e5-3c02b8ee0972","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16769"
"1438","Kyrgyzstan","C16771","KGZ","['KGZ', 'KYRGYZSTAN']","Kyrgyzstan","A country in Central Asia, west of China.","False","e9fc7c2a-f0d6-4a31-9439-baf499ed158b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16771"
"1439","Cambodia","C16378","KHM","['KHM', 'CAMBODIA']","Cambodia","A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos.","False","c3b0e5a5-2ce8-44aa-bf4a-87392ca66731","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16378"
"1440","Kiribati","C16639","KIR","['KIR', 'KIRIBATI']","Kiribati","A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia.","False","623a8fd7-d123-4410-9938-962235037d0f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16639"
"1441","Saint Kitts and Nevis","C17885","KNA","['KNA', 'SAINT KITTS AND NEVIS']","Saint Kitts and Nevis","Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago.","False","b707c1d8-02cc-47e7-a3a7-5169cb14d1cd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17885"
"1442","South Korea","C16774","KOR","['KOR', 'SOUTH KOREA']","South Korea","A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea.","False","982506b2-0873-45b9-91be-7537cbfab82a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16774"
"1443","Kuwait","C16775","KWT","['KWT', 'KUWAIT']","Kuwait","A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia.","False","275cab58-d782-4de9-9e12-d9b3d5f90a5b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16775"
"1444","Lao People's Democratic Republic","C16780","LAO","['LAO', ""LAO PEOPLE'S DEMOCRATIC REPUBLIC""]","Lao People's Democratic Republic","A country in Southeastern Asia, northeast of Thailand, west of Vietnam.","False","fb0e11e3-4ef3-4a56-ba60-2e16256cf910","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16780"
"1445","Lebanon","C16784","LBN","['LBN', 'LEBANON']","Lebanon","A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria.","False","6f240577-8b7e-4014-97ce-b5e64bf3c9f4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16784"
"1446","Liberia","C16791","LBR","['LBR', 'LIBERIA']","Liberia","A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone.","False","f8d0d707-4431-4268-8f3e-60458bc692bf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16791"
"1447","Libyan Arab Jamahiriya","C16793","LBY","['LBY', 'LIBYAN ARAB JAMAHIRIYA']","Libyan Arab Jamahiriya","A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia.","False","e04e4cc9-d70b-479b-b995-3bb49a5c0137","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16793"
"1448","Saint Lucia","C17113","LCA","['LCA', 'SAINT LUCIA']","Saint Lucia","A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago.","False","91913a97-59f0-4fe5-bca0-f06817c4a084","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17113"
"1449","Liechtenstein","C16794","LIE","['LIE', 'LIECHTENSTEIN']","Liechtenstein","A country in Central Europe, between Austria and Switzerland.","False","e80ff384-aaa1-4d3c-a7ed-2781e094b1c7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16794"
"1450","Sri Lanka","C17163","LKA","['LKA', 'SRI LANKA']","Sri Lanka","A country in Southern Asia, occupying an island in the Indian Ocean, south of India.","False","bae9c1f7-13c9-4a60-811f-e5d34f3d0e2f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17163"
"1451","Lesotho","C16787","LSO","['LSO', 'LESOTHO']","Lesotho","A country in Southern Africa, an enclave of South Africa.","False","9cd12e1f-dbfd-432c-b317-60daa04aafe0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16787"
"1452","Lithuania","C16799","LTU","['LTU', 'LITHUANIA']","Lithuania","A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia.","False","e3c67d02-db86-4e11-8fe7-4a3e0fa6a24e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16799"
"1453","Luxembourg","C16803","LUX","['LUX', 'LUXEMBOURG']","Luxembourg","A country in Western Europe, between France, Belgium, and Germany.","False","59d67d7b-7bce-49aa-8075-8b6ba39da8af","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16803"
"1454","Latvia","C16783","LVA","['LVA', 'LATVIA']","Latvia","A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania.","False","dd9f6cfd-2874-4196-aa8d-187dfa17ffb2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16783"
"1455","Macao","C16807","MAC","['MAC', 'MACAO']","Macao","A country in Eastern Asia, bordering the South China Sea and China.","False","68576629-4028-4c39-beba-232383fdaf5b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16807"
"1456","Morocco","C16878","MAR","['MAR', 'MOROCCO']","Morocco","A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara.","False","c3c3d4b8-8764-4871-a9fa-664e8ab9db87","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16878"
"1457","Monaco","C16874","MCO","['MCO', 'MONACO']","Monaco","A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.","False","bb1f5b72-718e-40fb-97dd-fb6659c2c198","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16874"
"1458","Moldova","C16871","MDA","['MDA', 'MOLDOVA, REPUBLIC OF']","Moldova","A country in Eastern Europe, northeast of Romania.","False","82f6e98b-17a0-4bd0-ae0a-3979e0163b37","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16871"
"1459","Madagascar","C16808","MDG","['MDG', 'MADAGASCAR']","Madagascar","A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique.","False","00c34b8a-084d-44ca-b6d4-c8fca91707a2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16808"
"1460","Maldives","C16815","MDV","['MDV', 'MALDIVES']","Maldives","A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India.","False","df5e1424-1bb0-46c9-9452-a2fb9bc38efa","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16815"
"1461","Mexico","C16850","MEX","['MEX', 'MEXICO']","Mexico","A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US.","False","b2069cc0-36cd-47a5-9d34-4093b0c34cab","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16850"
"1462","Marshall Islands","C16822","MHL","['MHL', 'MARSHALL ISLANDS']","Marshall Islands","A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","1996db58-5931-4a38-9bb4-238a6caa73ed","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16822"
"1463","Republic of Macedonia","C17654","MKD","['MKD', 'REPUBLIC OF MACEDONIA']","Republic of Macedonia","A country in Southeastern Europe, north of Greece.","False","5b43a336-907e-4d6d-a6e2-b33b67bf1eef","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17654"
"1464","Mali","C16816","MLI","['MLI', 'MALI']","Mali","A country in Western Africa, southwest of Algeria.","False","95daa3cf-e753-4124-89ce-e4f3a815f4ca","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16816"
"1465","Malta","C16817","MLT","['MLT', 'MALTA']","Malta","A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy).","False","dc80aa6b-f3c2-425d-a249-873cbd374ddc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16817"
"1466","Myanmar","C16370","MMR","['MMR', 'MYANMAR']","Myanmar","A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand.","False","0d2ae819-f21d-43c7-8a6a-8fb10459d873","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16370"
"1467","Montenegro","C64378","MNE","['MNE', 'MONTENEGRO']","Montenegro","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","d0e935c6-5c6b-47eb-aef2-73f2fc21b5b5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C64378"
"1468","Mongolia","C16875","MNG","['MNG', 'MONGOLIA']","Mongolia","A country in Northern Asia, between China and Russia.","False","13b5ac7e-3f8f-45c2-b9a7-2fbcd65a85fc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16875"
"1469","Northern Mariana Islands","C17882","MNP","['MNP', 'NORTHERN MARIANA ISLANDS']","Northern Mariana Islands","A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","5b244a99-186f-4edc-a282-1f04a8d5f9d7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17882"
"1470","Mozambique","C16882","MOZ","['MOZ', 'MOZAMBIQUE']","Mozambique","A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania.","False","fa732377-27db-47c1-ab5d-f3d1cda01744","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16882"
"1471","Mauritania","C16826","MRT","['MRT', 'MAURITANIA']","Mauritania","A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara.","False","797f7b3c-5cff-47b7-8a27-597cb58302f7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16826"
"1472","Montserrat","C16876","MSR","['MSR', 'MONTSERRAT']","Montserrat","A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico.","False","aeb86a83-75df-47c8-a565-03a0f5480e58","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16876"
"1473","Martinique","C16823","MTQ","['MTQ', 'MARTINIQUE']","Martinique","An island in the Caribbean Sea, north of Trinidad and Tobago.","False","92ccb1c9-86ad-4922-b329-bd5581d39f9d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16823"
"1474","Mauritius","C16827","MUS","['MUS', 'MAURITIUS']","Mauritius","A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","a1a80a74-432d-40fb-9e96-7d902ed5dcd2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16827"
"1475","Malawi","C16813","MWI","['MWI', 'MALAWI']","Malawi","A country in Southern Africa, east of Zambia.","False","df5439ae-386e-44fa-8104-77be1eec153f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16813"
"1476","Malaysia","C16814","MYS","['MYS', 'MALAYSIA']","Malaysia","A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam.","False","c8193e6b-039a-45f3-a916-2bc303353628","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16814"
"1477","Mayotte","C16828","MYT","['MYT', 'MAYOTTE']","Mayotte","A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique.","False","8c8e9275-bb72-4e9a-a377-5b0feddf5cc7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16828"
"1478","Namibia","C16891","NAM","['NAM', 'NAMIBIA']","Namibia","A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa.","False","0361020c-4b97-49b7-9527-e464d977a491","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16891"
"1479","New Caledonia","C16913","NCL","['NCL', 'NEW CALEDONIA']","New Caledonia","A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia.","False","03701673-ba43-44ea-97d4-5210ade09868","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16913"
"1480","Niger","C16916","NER","['NER', 'NIGER']","Niger","A country in Western Africa, southeast of Algeria.","False","8216a85d-85da-4ee6-b96c-4f01a6b19c4c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16916"
"1481","Norfolk Island","C16919","NFK","['NFK', 'NORFOLK ISLAND']","Norfolk Island","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia.","False","f409cd10-982c-4738-b643-ead916687771","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16919"
"1482","Nigeria","C16917","NGA","['NGA', 'NIGERIA']","Nigeria","A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon.","False","29063863-81c7-463b-bb52-cb2b1b6480f3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16917"
"1483","Nicaragua","C16915","NIC","['NIC', 'NICARAGUA']","Nicaragua","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras.","False","dee89d4c-0be1-413a-b365-427550da21b0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16915"
"1484","Niue","C16918","NIU","['NIU', 'NIUE']","Niue","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga.","False","a8de1f0d-38f7-4770-b99a-555d4c907386","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16918"
"1485","Netherlands","C16903","NLD","['NLD', 'NETHERLANDS']","Netherlands","A country in Western Europe, bordering the North Sea, between Belgium and Germany.","False","8906d0cd-7cdd-41b7-8afc-30788495c70c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16903"
"1486","Norway","C16920","NOR","['NOR', 'NORWAY']","Norway","A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden.","False","990b44e4-f2a7-4b17-acdf-8e06ea6de77e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16920"
"1487","Nepal","C16901","NPL","['NPL', 'NEPAL']","Nepal","A country in Southern Asia, between China and India.","False","d6393252-f468-4312-a675-9e6e560683e3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16901"
"1488","Nauru","C16896","NRU","['NRU', 'NAURU']","Nauru","A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands.","False","b245b3c9-838a-4fd4-8f27-9dec48cae5d1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16896"
"1489","New Zealand","C16914","NZL","['NZL', 'NEW ZEALAND']","New Zealand","A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia.","False","9fe67dcb-2cf9-4ec6-8678-13d07edb37e1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16914"
"1490","Oman","C16933","OMN","['OMN', 'OMAN']","Oman","A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates.","False","3f909bd2-29dc-4562-9d24-e519dc8ad7ae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16933"
"1491","Pakistan","C16949","PAK","['PAK', 'PAKISTAN']","Pakistan","A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north.","False","1ba8c280-7eb4-46cf-ac99-9bfbc874f6f8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16949"
"1492","Panama","C16951","PAN","['PAN', 'PANAMA']","Panama","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica.","False","3f0c5307-d9a7-419a-ba56-7ec1f7bfbdd0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16951"
"1493","Pitcairn Island","C16993","PCN","['PCN', 'PITCAIRN']","Pitcairn Island","A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.","False","e0555d16-74e4-41c5-8426-1b09153405a3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16993"
"1494","Peru","C16972","PER","['PER', 'PERU']","Peru","A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador.","False","83d03939-209e-4331-adcf-6986d9b18bf9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16972"
"1495","Philippines","C16978","PHL","['PHL', 'PHILIPPINES']","Philippines","A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam.","False","ca1c6fef-d2bd-4a62-a403-956d8362d23e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16978"
"1496","Palau","C17733","PLW","['PLW', 'PALAU']","Palau","A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines.","False","54c1f3b3-0868-477d-9862-8a3993ed8eb3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17733"
"1497","Papua New Guinea","C16952","PNG","['PNG', 'PAPUA NEW GUINEA']","Papua New Guinea","A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia.","False","4cb01f7e-ee60-4779-b6e9-1115bc54dcd3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16952"
"1498","Poland","C17002","POL","['POL', 'POLAND']","Poland","A country in Central Europe, east of Germany.","False","6de5a206-e84d-403e-b1aa-9562f3273cad","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17002"
"1499","Puerto Rico","C17043","PRI","['PRI', 'PUERTO RICO']","Puerto Rico","An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic.","False","55ee29a0-ddb5-476d-a451-cea054f8a9a3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17043"
"1500","North Korea","C16773","PRK","['PRK', 'NORTH KOREA']","North Korea","A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea.","False","a32f1197-1f99-4eae-9dec-ea2c8b13020d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16773"
"1501","Portugal","C17006","PRT","['PRT', 'PORTUGAL']","Portugal","A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain.","False","b4a7a1f6-8340-4aad-91db-a60b49f07da1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17006"
"1502","Paraguay","C16953","PRY","['PRY', 'PARAGUAY']","Paraguay","A country in Central South America, northeast of Argentina.","False","c7fa150e-a3aa-48ff-8154-0e0c362dadea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16953"
"1503","Palestinian Territory, Occupied","C20110","PSE","['PSE', 'PALESTINIAN TERRITORY, OCCUPIED']","Palestinian Territory, Occupied","A collective name for the West Bank and the Gaza Strip, two territories in Palestine.","False","4b691afd-a986-4276-b420-310566b9b78d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20110"
"1504","French Polynesia","C16594","PYF","['PYF', 'FRENCH POLYNESIA']","French Polynesia","An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia.","False","ac59e64a-50dd-4239-94a5-e19e48d0c652","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16594"
"1505","Qatar","C17045","QAT","['QAT', 'QATAR']","Qatar","A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia.","False","9661f0f5-dd6d-4a6c-a5a9-f4e71cbe9236","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17045"
"1506","Reunion","C17095","REU","['REU', 'REUNION']","Reunion","An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","cd3f5c86-b039-4421-aba6-cd7fcb749f64","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17095"
"1507","Romania","C17108","ROU","['ROU', 'ROMANIA']","Romania","A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine.","False","6a15917b-4fae-4e0a-adb3-e1d72b21a101","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17108"
"1508","Russia","C17111","RUS","['RUS', 'RUSSIAN FEDERATION']","Russia","A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean.","False","85388d01-ea7b-42bf-9245-f91c47133f0b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17111"
"1509","Rwanda","C17112","RWA","['RWA', 'RWANDA']","Rwanda","A country in Central Africa, east of Democratic Republic of the Congo.","False","4993613a-d6a8-4174-831e-ec8c75ff5a7a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17112"
"1510","Saudi Arabia","C17117","SAU","['SAU', 'SAUDI ARABIA']","Saudi Arabia","A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen.","False","c050772d-0d03-406a-9332-47a427c48530","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17117"
"1511","Serbia","C64377","SCG","['SCG', 'SERBIA']","Serbia","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","dd5d9c7c-ea94-4fc3-9f60-949d5deead19","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C64377"
"1512","Sudan","C17170","SDN","['SDN', 'SUDAN']","Sudan","A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea.","False","d9cb59eb-d38c-4caa-b62c-38959d5d4e2a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17170"
"1513","Senegal","C17121","SEN","['SEN', 'SENEGAL']","Senegal","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania.","False","553a0bcd-3798-49d6-85f3-f1d3233750b6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17121"
"1514","Singapore","C17134","SGP","['SGP', 'SINGAPORE']","Singapore","A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia.","False","3f1d11dc-d1f3-4394-b9be-536913d85d3a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17134"
"1515","South Georgia and the South Sandwich Islands","C20111","SGS","['SGS', 'SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS']","South Georgia and the South Sandwich Islands","A group of islands in the South Atlantic Ocean, east of the tip of South America.","False","23ada2a4-6f5e-48a4-8d10-2bd286dee9c9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20111"
"1516","Saint Helena","C17164","SHN","['SHN', 'SAINT HELENA']","Saint Helena","Islands in the South Atlantic Ocean, about midway between South America and Africa.","False","643203c5-7359-4b8c-bc94-744cacfe1046","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17164"
"1517","Svalbard and Jan Mayen","C17178","SJM","['SJM', 'SVALBARD AND JAN MAYEN']","Svalbard and Jan Mayen","Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway.","False","88ed72cb-0ba4-429a-8dd4-e83f4b720146","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17178"
"1518","Solomon Islands","C17148","SLB","['SLB', 'SOLOMON ISLANDS']","Solomon Islands","A group of islands in the South Pacific Ocean, east of Papua New Guinea.","False","90a6344b-64dc-4b0f-8a2a-7e15acde5406","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17148"
"1519","Sierra Leone","C17130","SLE","['SLE', 'SIERRA LEONE']","Sierra Leone","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia.","False","29220ef2-5feb-4520-86e3-dc9af5a3bb67","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17130"
"1520","El Salvador","C16532","SLV","['SLV', 'EL SALVADOR']","El Salvador","A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras.","False","43020563-e9be-4952-8f85-e8eac149ccde","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16532"
"1521","San Marino","C17115","SMR","['SMR', 'SAN MARINO']","San Marino","A country in Southern Europe, an enclave in central Italy.","False","eb8b7e4b-44ce-4f00-a179-4c87980b6e17","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17115"
"1522","Somalia","C17149","SOM","['SOM', 'SOMALIA']","Somalia","A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia.","False","36305659-2923-4b25-b157-4758069c051e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17149"
"1523","Saint Pierre and Miquelon","C17165","SPM","['SPM', 'SAINT PIERRE AND MIQUELON']","Saint Pierre and Miquelon","A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada).","False","89e84270-5dc7-4651-93ee-5dbffe386eb1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17165"
"1524","Sao Tome and Principe","C17116","STP","['STP', 'SAO TOME AND PRINCIPE']","Sao Tome and Principe","A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon.","False","a40ac0ad-a048-41f3-8696-20407fd47e61","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17116"
"1525","Suriname","C17175","SUR","['SUR', 'SURINAME']","Suriname","A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana.","False","5fcf73bf-f5c2-4ad9-ba69-16e4f5dc414a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17175"
"1526","Slovakia","C17669","SVK","['SVK', 'SLOVAKIA']","Slovakia","A country in Central Europe, south of Poland.","False","682541ea-772d-4171-a4d7-0c61827dc488","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17669"
"1527","Slovenia","C17138","SVN","['SVN', 'SLOVENIA']","Slovenia","A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia.","False","b0584f1f-0cd1-41bd-a501-237da37fb4fb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17138"
"1528","Sweden","C17180","SWE","['SWE', 'SWEDEN']","Sweden","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway.","False","c088221f-80f1-4af7-b4b2-d513349c6f0c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17180"
"1529","Swaziland","C17179","SWZ","['SWZ', 'SWAZILAND']","Swaziland","A country in Southern Africa, between Mozambique and South Africa.","False","91baa018-a018-4037-9d8c-0b9bb1d10a20","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17179"
"1530","Seychelles","C17129","SYC","['SYC', 'SEYCHELLES']","Seychelles","A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar.","False","170db352-a750-4cb3-a171-143ce163db5a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17129"
"1531","Syria","C17182","SYR","['SYR', 'SYRIAN ARAB REPUBLIC']","Syria","A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey.","False","aa86d89e-fbe0-4063-a77a-c64e874d64d8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17182"
"1532","Turks and Caicos Islands","C17224","TCA","['TCA', 'TURKS AND CAICOS ISLANDS']","Turks and Caicos Islands","Two island groups in the North Atlantic Ocean, southeast of The Bahamas.","False","f6aa136a-713a-4877-aeb7-6d514300c7b9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17224"
"1533","Chad","C16412","TCD","['TCD', 'CHAD']","Chad","A country in Central Africa, south of Libya.","False","d71ce57c-dee3-447c-bb0d-f591983d8a1d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C16412"
"1534","Togo","C17202","TGO","['TGO', 'TOGO']","Togo","A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana.","False","4d43483d-5e72-4ec7-ae63-efdd220d79b8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17202"
"1535","Thailand","C17192","THA","['THA', 'THAILAND']","Thailand","A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma.","False","459bf8af-c169-494a-9605-64e46ab6e887","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17192"
"1536","Tajikistan","C17183","TJK","['TJK', 'TAJIKISTAN']","Tajikistan","A country in Central Asia, west of China.","False","c262dd82-1e88-48af-8a07-5eb979c17803","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17183"
"1537","Tokelau","C17704","TKL","['TKL', 'TOKELAU']","Tokelau","A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","39224650-607e-482c-b3d9-0da7398c0927","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17704"
"1538","Turkmenistan","C17223","TKM","['TKM', 'TURKMENISTAN']","Turkmenistan","A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan.","False","08afe424-b60b-4382-acc9-c778f5b76310","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17223"
"1539","Timor-Leste","C17200","TLS","['TLS', 'TIMOR-LESTE']","Timor-Leste","A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco.","False","c436545c-280a-4b13-ace4-212df2df327c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17200"
"1540","Tonga","C17205","TON","['TON', 'TONGA']","Tonga","An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","2bcdc4a5-a13c-42b6-8f38-4531ce312bb8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17205"
"1541","Trinidad and Tobago","C17217","TTO","['TTO', 'TRINIDAD AND TOBAGO']","Trinidad and Tobago","Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","93232109-a833-4e50-8aad-737665e9028a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17217"
"1542","Tunisia","C17221","TUN","['TUN', 'TUNISIA']","Tunisia","A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya.","False","b52c8519-cad3-4ba9-8e66-215e8c46f83b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17221"
"1543","Turkey","C17222","TUR","['TUR', 'TURKEY']","Turkey","A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria.","False","358678d2-90cf-404f-bf2d-f6795c11a332","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17222"
"1544","Tuvalu","C17225","TUV","['TUV', 'TUVALU']","Tuvalu","An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","3e514440-32e5-41d2-9d6c-aea5b3d1ecaf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17225"
"1545","Taiwan","C17184","TWN","['TWN', 'TAIWAN']","Taiwan","A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China.","False","299ea12b-7b5d-4d96-9785-533d8d16da6e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17184"
"1546","Tanzania","C17185","TZA","['TZA', 'TANZANIA, UNITED REPUBLIC OF']","Tanzania","A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique.","False","b83c85ba-9a65-46d3-9a56-6b762bf3c536","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17185"
"1547","Uganda","C17228","UGA","['UGA', 'UGANDA']","Uganda","A country in Eastern Africa, west of Kenya.","False","10c0adf2-7f0d-40af-9ee9-7b87c44e7b6e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17228"
"1548","Ukraine","C17229","UKR","['UKR', 'UKRAINE']","Ukraine","A country in Eastern Europe, bordering the Black Sea, between Poland and Russia.","False","e426d524-ff0b-47bf-a584-2c8cacd870d1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17229"
"1549","United States Minor Outlying Islands","C20112","UMI","['UMI', 'UNITED STATES MINOR OUTLYING ISLANDS']","United States Minor Outlying Islands","The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).","False","bba1e0ab-6016-4866-9225-c9d63de37197","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C20112"
"1550","Uruguay","C17244","URY","['URY', 'URUGUAY']","Uruguay","A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil.","False","c38898e1-519c-417c-80fd-ec01bde41529","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17244"
"1551","United States","C17234","USA","['USA', 'UNITED STATES']","United States","A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico.","False","80a97df4-326b-4e0f-a054-7c0a2a171dbc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17234"
"1552","Uzbekistan","C17246","UZB","['UZB', 'UZBEKISTAN']","Uzbekistan","A country in Central Asia, north of Afghanistan.","False","17c99ee9-85ed-4f81-a6f1-466ec989728c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17246"
"1553","Holy See","C17249","VAT","['VAT', 'VATICAN CITY STATE']","Holy See","An enclave of Rome (Italy).","False","e462845c-2cd5-4a7c-a464-e46e52c72bee","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17249"
"1554","Saint Vincent and the Grenadines","C17114","VCT","['VCT', 'SAINT VINCENT AND THE GRENADINES']","Saint Vincent and the Grenadines","A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago.","False","0eddf9f3-6255-45a0-965d-ba462dcbd3f4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17114"
"1555","Venezuela","C17250","VEN","['VEN', 'VENEZUELA']","Venezuela","A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana.","False","acbd73b6-d23d-4074-ad62-dfa44190f443","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17250"
"1556","British Virgin Islands","C17653","VGB","['VGB', 'VIRGIN ISLANDS,BRITISH']","British Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","e7638215-0b31-4804-8a66-7b50aae8e1fb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17653"
"1557","United States Virgin Islands","C17255","VIR","['VIR', 'VIRGIN ISLANDS, U.S.']","United States Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","e98ab0af-73e7-415f-a98a-1c881c672b95","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17255"
"1558","Vietnam","C17252","VNM","['VNM', 'VIETNAM']","Vietnam","A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.","False","96614ca1-b684-4f35-a6b1-ef0894aa8c65","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17252"
"1559","Vanuatu","C17247","VUT","['VUT', 'VANUATU']","Vanuatu","A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia.","False","57d7b0ce-37a9-40e5-b1c7-a329271fd785","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17247"
"1560","Wallis and Futuna Islands","C17259","WLF","['WLF', 'WALLIS AND FUTUNA']","Wallis and Futuna Islands","Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","6558bebf-07db-44ae-87f3-b4e1113182bd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17259"
"1561","Samoa","C17740","WSM","['WSM', 'SAMOA']","Samoa","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","669df80b-a507-4c1a-abc1-c2f47305cadf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17740"
"1562","Yemen","C17264","YEM","['YEM', 'YEMEN']","Yemen","A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia.","False","addf98a1-8785-4d8a-8b55-2f9863cf2953","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17264"
"1563","South Africa","C17151","ZAF","['ZAF', 'SOUTH AFRICA']","South Africa","A country in Southern Africa, at the southern tip of the continent of Africa.","False","6eac72d2-88de-423c-89df-6f41010020f5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17151"
"1564","Zambia","C17267","ZMB","['ZMB', 'ZAMBIA']","Zambia","A country in Southern Africa, east of Angola.","False","25737e80-fa26-4fab-b9e8-eece02df94e9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17267"
"1565","Zimbabwe","C17268","ZWE","['ZWE', 'ZIMBABWE']","Zimbabwe","A country in Southern Africa, between South Africa and Zambia.","False","8b0061c1-9bf3-4dd7-885a-f1d83d7c513d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66786/C17268"
"1566","Diagnosis Group","C66787","TDIGRP","['TDIGRP', 'Diagnosis Group']","CDISC SDTM Diagnosis Group Terminology","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","cadf9e61-3ee2-4009-a6b5-450077280495","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66787"
"1567","Healthy Subject","C49651","HEALTHY SUBJECTS","['HEALTHY SUBJECTS']","Healthy Subject","An individual who is or becomes a participant in a research study and has no significant health-related issues.  (NCI)","False","229b4bc6-4f1a-4c45-8ee8-6cb49259f6ea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66787/C49651"
"1568","Dictionary Name","C66788","DICTNAM","['DICTNAM', 'Dictionary Name', 'Name of Dictionary']","CDISC SDTM Dictionary Name Terminology","A name given to a reference source that lists words and gives their meaning. (NCI)","False","04696a79-f5d7-497c-a72d-1cf132fdaedc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788"
"1569","Thesaurus of Adverse Reaction Term Coding Symbols","C49471","COSTART","['COSTART', 'Coding Symbols for a Thesaurus of Adverse Reaction Terms']","Thesaurus of Adverse Reaction Term Coding Symbols","A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)","False","a4441902-3115-4429-a320-a751212ad57e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788/C49471"
"1570","International Classification of Diseases","C49474","ICD","['ICD', 'International Classification of Diseases']","International Classification of Diseases","A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)","False","d35f9e9a-d16b-4599-85fb-057d4881c9f3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788/C49474"
"1571","Logical Observation Identifiers Names and Codes","C49476","LOINC","['LOINC', 'Logical Observation Identifiers Names and Codes']","Logical Observation Identifiers Names and Codes","Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)","False","6f3fef50-cd7d-4e4a-9ba0-93c2442747d4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788/C49476"
"1572","MedDRA","C43820","MedDRA","['MedDRA', 'Medical Dictionary for Regulatory Activities']","MedDRA","MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)","False","27fd4b16-daf2-4afd-b765-1bf11dc4a454","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788/C43820"
"1573","Systematized Nomenclature of Medicine","C53489","SNOMED","['SNOMED', 'Systematized Nomenclature of Medicine']","Systematized Nomenclature of Medicine","A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)","False","1b237297-8218-4733-9118-b4d6ffcc70da","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788/C53489"
"1574","World Health Organization Adverse Reaction Terminology","C49468","WHOART","['WHOART', 'World Health Organization Adverse Reaction Terms']","World Health Organization Adverse Reaction Terminology","A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)","False","dba2d221-216a-48b9-9ba7-558d3b147fb2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788/C49468"
"1575","World Health Organization Drug Dictionary","C49475","WHODD","['WHODD', 'World Health Organization Drug Dictionary']","World Health Organization Drug Dictionary","A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)","False","c8dcc19e-dec4-45d2-81cd-bc596ff9d6d2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66788/C49475"
"1576","Not Done","C66789","ND","['ND', 'Not Done']","CDISC SDTM Not DoneTerminology","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","9dd1422f-5113-4938-b67d-8b44bd138ebd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66789"
"1577","Not Done","C49484","NOT DONE","['NOT DONE']","Not Done","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","12c819d3-d967-48b8-b021-c6a21495af8c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66789/C49484"
"1578","Patient Ethnic Group ","C66790","ETHNIC","['ETHNIC', 'Patient Ethnic Group']","CDISC SDTM Patient Ethnic GroupTerminology","A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)","False","5d088c37-bf51-40d6-8b56-848dc8453ab3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66790"
"1579","Hispanic or Latino","C17459","HISPANIC OR LATINO","['HISPANIC OR LATINO']","Hispanic or Latino","A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)","False","95ab69aa-0c9a-4c5f-804c-8ecb68824058","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66790/C17459"
"1580","Not Hispanic or Latino","C41222","NOT HISPANIC OR LATINO","['NOT HISPANIC OR LATINO']","Not Hispanic or Latino","A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)","False","dc621c85-e5b9-4d4a-92cf-e86074dab6ee","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66790/C41222"
"1581","Not Stated","C43234","Not reported","['Not reported']","Not Stated","Not provided or available","False","10d4b854-da8b-4321-bdf7-beb45a99d18a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66790/C43234"
"1582","Unknown","C17998","UNKNOWN","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","bf45fa43-e675-45ff-9617-c41592b7f70f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66790/C17998"
"1583","Pharmaceutical Dosage Form","C66726","FRM","['FRM', 'Pharmaceutical Dosage Form', 'Dose Form']","CDISC SDTM Pharmaceutical Dosage FormTerminology","The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.","False","0e797583-664c-4b33-ba69-2c18261fbe1f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726"
"1584","Aerosol Dosage Form","C42887","AEROSOL","['AEROSOL']","Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)","False","9f02715e-9f52-4c36-a349-90fc44ef9ecc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42887"
"1585","Aerosol Foam Dosage Form","C42888","AEROSOL, FOAM","['AEROSOL, FOAM']","Aerosol Foam Dosage Form","A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)","False","a0275241-74f3-442e-8ef2-45d684ccafff","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42888"
"1586","Metered Aerosol Dosage Form","C42960","AEROSOL, METERED","['AEROSOL, METERED']","Metered Aerosol Dosage Form","A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)","False","3d48520d-f60d-4791-889d-af0238564da0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42960"
"1587","Powder Aerosol Dosage Form","C42971","AEROSOL, POWDER","['AEROSOL, POWDER']","Powder Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)","False","c40e1f3a-50e3-4212-98b9-85c9f1ffdded","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42971"
"1588","Aerosol Spray Dosage Form","C42889","AEROSOL, SPRAY","['AEROSOL, SPRAY']","Aerosol Spray Dosage Form","An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)","False","b3d95596-774c-42b9-8c49-c42be26e3936","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42889"
"1589","Chewable Bar Dosage Form","C42892","BAR, CHEWABLE","['BAR, CHEWABLE']","Chewable Bar Dosage Form","A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)","False","00ae2185-262c-4936-bc39-4550ea1159d3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42892"
"1590","Bead Dosage Form","C42890","BEAD","['BEAD']","Bead Dosage Form","A solid dosage form in the shape of a small ball. (NCI)","False","da55d89f-49cf-4f70-80b8-2c2629c8c35c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42890"
"1591","Extended Release Bead Implant Dosage Form","C43451","BEAD, IMPLANT, EXTENDED RELEASE","['BEAD, IMPLANT, EXTENDED RELEASE']","Extended Release Bead Implant Dosage Form","A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form.  (NCI)","False","f5995d4d-fb9c-4a4c-93cd-0fe0e1b1f992","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C43451"
"1592","Block Dosage Form","C42891","BLOCK","['BLOCK']","Block Dosage Form","Solid dosage form, usually in the shape of a square or rectangle. (NCI)","False","b5dd9c10-0987-4bdc-af4c-6404e9564fea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42891"
"1593","Capsule Dosage Form","C25158","CAPSULE","['CAPSULE']","Capsule Dosage Form","A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)","False","88a021dd-8530-4ef8-9e83-f2294bd88416","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C25158"
"1594","Coated Capsule Dosage Form","C42895","CAPSULE, COATED","['CAPSULE, COATED']","Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)","False","444319a7-d803-4aae-8c69-e9aecdc4aef1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42895"
"1595","Coated Pellets in Capsule Dosage Form","C42896","CAPSULE, COATED PELLETS","['CAPSULE, COATED PELLETS']","Coated Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)","False","7f2f7b5c-bf86-47f0-b9e9-c1c2cb77f309","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42896"
"1596","Extended Release Coated Capsule Dosage Form","C42917","CAPSULE, COATED, EXTENDED RELEASE","['CAPSULE, COATED, EXTENDED RELEASE']","Extended Release Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","eb89ed4f-450b-4e4c-b2e6-101187c4dcc9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42917"
"1597","Delayed Release Capsule Dosage Form","C42902","CAPSULE, DELAYED RELEASE","['CAPSULE, DELAYED RELEASE']","Delayed Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","51806b43-e9b6-4c2b-be23-eca728098149","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42902"
"1598","Delayed Release Pellets in Capsule Dosage Form","C42904","CAPSULE, DELAYED RELEASE PELLETS","['CAPSULE, DELAYED RELEASE PELLETS']","Delayed Release Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","6bc90f66-21dc-494d-a904-e6b610c9f90d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42904"
"1599","Extended Release Capsule Dosage Form","C42916","CAPSULE, EXTENDED RELEASE","['CAPSULE, EXTENDED RELEASE']","Extended Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","291e119b-51da-458d-929d-c62a7d42b0b5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42916"
"1600","Extended Release Film Coated Capsule Dosage Form","C42928","CAPSULE, FILM COATED, EXTENDED RELEASE","['CAPSULE, FILM COATED, EXTENDED RELEASE']","Extended Release Film Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","077bb753-5962-477c-9ed7-75755194fd33","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42928"
"1601","Gelatin Coated Capsule Dosage Form","C42936","CAPSULE, GELATIN COATED","['CAPSULE, GELATIN COATED']","Gelatin Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)","False","f4e64b64-78a6-4a3b-bef4-a019859109ae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42936"
"1602","Liquid Filled Capsule Dosage Form","C42954","CAPSULE, LIQUID FILLED","['CAPSULE, LIQUID FILLED']","Liquid Filled Capsule Dosage Form","A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)","False","392770df-e5a9-4517-becb-df9b7473db42","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42954"
"1603","Cement Dosage Form","C45414","CEMENT","['CEMENT']","Cement Dosage Form","A substance that serves to produce solid union between two surfaces. (NCI)","False","00591c91-0b4f-4794-8eb0-04df490dc58b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C45414"
"1604","Cigarette Dosage Form","C42678","CIGARETTE","['CIGARETTE']","Cigarette Dosage Form","A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)","False","f8ca355a-7115-41b9-a112-526f60f0f39d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42678"
"1605","Cloth Dosage Form","C60884","CLOTH","['CLOTH']","Cloth Dosage Form","ALT_DEFINITION:  A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)","False","04fd2e7b-b940-41cb-a38b-b00b09b4905f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60884"
"1606","Concentrate Dosage Form","C60891","CONCENTRATE","['CONCENTRATE']","Concentrate Dosage Form","A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)","False","55fbf0d5-9dcb-4599-a565-46d03fb7e60e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60891"
"1607","Cone Dosage Form","C42900","CONE","['CONE']","Cone Dosage Form","A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)","False","14d94d05-1e98-4a0c-ae7d-45e9012e81b2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42900"
"1608","Extended Release Core Dosage Form","C42919","CORE, EXTENDED RELEASE","['CORE, EXTENDED RELEASE']","Extended Release Core Dosage Form","An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)","False","e73c30f7-e9e5-405b-9254-fc060a39f5fc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42919"
"1609","Cream Dosage Form","C28944","CREAM","['CREAM']","Cream Dosage Form","A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)","False","5469e280-f4c2-4e02-85bb-8bb33cca66b7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C28944"
"1610","Augmented Cream Dosage Form","C60897","CREAM, AUGMENTED","['CREAM, AUGMENTED']","Augmented Cream Dosage Form","A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","04a214b5-2b13-455d-80fd-2b9902545df9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60897"
"1611","Crystal Dosage Form","C42901","CRYSTAL","['CRYSTAL']","Crystal Dosage Form","A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.","False","3a173745-b916-42c3-a37a-e77b18a2eb20","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42901"
"1612","Culture Dosage Form","C45415","CULTURE","['CULTURE']","Culture Dosage Form","The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)","False","0f5b0466-98bf-4e55-baa6-e67e6fc5cb50","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C45415"
"1613","Diaphragm Dosage Form","C47890","DIAPHRAGM","['DIAPHRAGM']","Diaphragm Dosage Form","A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)","False","ee197bd5-d47b-4d25-b930-8a3acb7d0eac","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47890"
"1614","Disc Dosage Form","C43525","DISC","['DISC']","Disc Dosage Form","A circular plate-like organ or structure. (FDA)","False","b752b775-e4f8-44ad-8d22-41bf30b64c69","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C43525"
"1615","Douche Dosage Form","C42679","DOUCHE","['DOUCHE']","Douche Dosage Form","A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)","False","49a256ac-1871-4041-ab70-829a59f76822","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42679"
"1616","Dressing Dosage Form","C42763","DRESSING","['DRESSING']","Dressing Dosage Form","The application of various materials for protecting a wound.(FDA)","False","f5efb622-10f7-41e8-8004-e1ab14517ed5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42763"
"1617","Drug Delivery System","C17423","DRUG DELIVERY SYSTEM","['DRUG DELIVERY SYSTEM']","Drug Delivery System","Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)","False","93cf3ee7-2d30-40df-b2b6-7755188f803b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C17423"
"1618","Elixir Dosage Form","C42912","ELIXIR","['ELIXIR']","Elixir Dosage Form","A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)","False","df6bdb38-fd5a-4bd4-ad60-56cf7d2c4cc1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42912"
"1619","Emulsion Dosage Form","C42913","EMULSION","['EMULSION']","Emulsion Dosage Form","A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)","False","08f9fb18-9943-44cf-8448-136a996b05c6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42913"
"1620","Enema Dosage Form","C42915","ENEMA","['ENEMA']","Enema Dosage Form","A rectal preparation for therapeutic, diagnostic, or nutritive purposes.  (NCI)","False","167a0736-0ca9-4e85-8baa-2e7daa2354bc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42915"
"1621","Extract Dosage Form","C42929","EXTRACT","['EXTRACT']","Extract Dosage Form","A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)","False","a0d80fab-42a9-4a72-8ba6-635d0ed34631","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42929"
"1622","Extended Release Fiber Dosage Form","C60926","FIBER, EXTENDED RELEASE","['FIBER, EXTENDED RELEASE']","Extended Release Fiber Dosage Form","A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","9516078a-948d-4607-a26d-4b3392f7eba7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60926"
"1623","Film Dosage Form","C42932","FILM","['FILM']","Film Dosage Form","A thin layer or coating. (NCI)","False","bdbc2b3b-b9db-43a2-ad82-220e2927542a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42932"
"1624","Extended Release Film Dosage Form","C42920","FILM, EXTENDED RELEASE","['FILM, EXTENDED RELEASE']","Extended Release Film Dosage Form","A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)","False","183d1bce-3267-4d86-91cd-bca1029cbe20","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42920"
"1625","Soluble Film Dosage Form","C42984","FILM, SOLUBLE","['FILM, SOLUBLE']","Soluble Film Dosage Form","A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)","False","2f10b91f-0078-467f-92b6-3aff344861a9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42984"
"1626","Dosage Form For Solution","C60927","FOR SOLUTION","['FOR SOLUTION']","Dosage Form For Solution","A product, usually a solid, intended for solution prior to administration. (FDA)","False","a1667a50-57b9-45a3-bda1-47dae800f7cb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60927"
"1627","Dosage Form For Suspension","C60928","FOR SUSPENSION","['FOR SUSPENSION']","Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration. (FDA)","False","467088d6-8a14-490c-bb8d-d53f2be46326","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60928"
"1628","Extended Release Dosage Form For Suspension","C60929","FOR SUSPENSION, EXTENDED RELEASE","['FOR SUSPENSION, EXTENDED RELEASE']","Extended Release Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)","False","eb82b6c4-064f-4d6d-9138-7f3fb4d89fb4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60929"
"1629","Gas Dosage Form","C42933","GAS","['GAS']","Gas Dosage Form","Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)","False","c82949dd-1500-4d1e-9b3c-bdc1d3e9652b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42933"
"1630","Gel Dosage Form","C42934","GEL","['GEL']","Gel Dosage Form","A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2).  A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature.  It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)","False","254d4d34-9d8f-4de4-b785-19727331d2c0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42934"
"1631","Dentifrice Gel Dosage Form","C42906","GEL, DENTIFRICE","['GEL, DENTIFRICE']","Dentifrice Gel Dosage Form","A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)","False","d492a3e7-8154-41ad-96d3-307bedaadbd3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42906"
"1632","Metered Gel Dosage Form","C60930","GEL, METERED","['GEL, METERED']","Metered Gel Dosage Form","A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)","False","40ad41d9-0eef-43ee-8733-ad2439385a0b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60930"
"1633","Generator Dosage Form","C48193","GENERATOR","['GENERATOR']","Generator Dosage Form","An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)","False","ea5d7171-ddfc-4b76-9671-68df9a042c9c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C48193"
"1634","Globule Dosage Form","C42937","GLOBULE","['GLOBULE']","Globule Dosage Form","Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)","False","17878970-e036-4f9b-9045-eaf84b8e1ee4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42937"
"1635","Graft Dosage Form","C45416","GRAFT","['GRAFT']","Graft Dosage Form","A slip of skin or of other tissue for implantation. (NCI)","False","964d5ddf-5f23-437d-80a6-e4362479661d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C45416"
"1636","Granule Dosage Form","C42938","GRANULE","['GRANULE']","Granule Dosage Form","A small particle or grain. (NCI)","False","885dbd9b-73b2-4f07-8d03-5e89d8f6543b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42938"
"1637","Delayed Release Granule Dosage Form","C42903","GRANULE, DELAYED RELEASE","['GRANULE, DELAYED RELEASE']","Delayed Release Granule Dosage Form","A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","ec986152-05fb-460b-914f-19c56173a3dd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42903"
"1638","Effervescent Granule Dosage Form","C42909","GRANULE, EFFERVESCENT","['GRANULE, EFFERVESCENT']","Effervescent Granule Dosage Form","A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)","False","68539733-2fe4-4975-a43e-2fab923e455a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42909"
"1639","Granule For Solution Dosage Form","C42939","GRANULE, FOR SOLUTION","['GRANULE, FOR SOLUTION']","Granule For Solution Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","57d828ff-8b54-41f3-ae19-974215be8131","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42939"
"1640","Granule For Suspension Dosage Form","C42940","GRANULE, FOR SUSPENSION","['GRANULE, FOR SUSPENSION']","Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","1322c12c-19c9-4e1b-89d5-1a3757abcc63","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42940"
"1641","Extended Release Granule For Suspension Dosage Form","C42921","GRANULE, FOR SUSPENSION, EXTENDED RELEASE","['GRANULE, FOR SUSPENSION, EXTENDED RELEASE']","Extended Release Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)","False","004c58eb-77c0-496a-a46c-d14bef4eb4c2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42921"
"1642","Gum Dosage Form","C42941","GUM","['GUM']","Gum Dosage Form","A mucilaginous excretion from various plants. (NCI)","False","ff9318fc-a360-47c3-bf73-4b3898855b4c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42941"
"1643","Chewing Gum Dosage Form","C42894","GUM, CHEWING","['GUM, CHEWING']","Chewing Gum Dosage Form","A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)","False","e7cd0ce5-7fa2-41bd-9ad1-574e49d70b3e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42894"
"1644","Resin Gum Dosage Form","C42978","GUM, RESIN","['GUM, RESIN']","Resin Gum Dosage Form","Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)","False","37bd3998-257c-4e5a-8cc9-fe167c007d64","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42978"
"1645","Implant Dosage Form","C42942","IMPLANT","['IMPLANT']","Implant Dosage Form","A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)","False","5e27bc39-bfe2-463c-af6d-47310a3053f5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42942"
"1646","Inhalant Dosage Form","C42944","INHALANT","['INHALANT']","Inhalant Dosage Form","A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)","False","8793fe3c-ffeb-4544-bab3-8d215ab074af","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42944"
"1647","Liposomal Injection Dosage Form","C60931","INJECTABLE, LIPOSOMAL","['INJECTABLE, LIPOSOMAL']","Liposomal Injection Dosage Form","An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)","False","dcc9c85b-761d-47ca-8238-513d881ad6d2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60931"
"1648","Injectable Dosage Form","C42946","INJECTION","['INJECTION']","Injectable Dosage Form","A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)","False","85316cb5-71a7-4941-b921-37b213e0c873","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42946"
"1649","Emulsion for Injection Dosage Form","C42914","INJECTION, EMULSION","['INJECTION, EMULSION']","Emulsion for Injection Dosage Form","An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)","False","0ee822c7-d5a1-494b-8ee0-3dcd5953b712","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42914"
"1650","Injectable Lipid Complex Dosage Form","C42950","INJECTION, LIPID COMPLEX","['INJECTION, LIPID COMPLEX']","Injectable Lipid Complex Dosage Form","[definition pending](FDA)","False","66f64dbb-6022-4825-9cfa-cdb48d38217f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42950"
"1651","Powder For Injectable Solution Dosage Form","C42974","INJECTION, POWDER, FOR SOLUTION","['INJECTION, POWDER, FOR SOLUTION']","Powder For Injectable Solution Dosage Form","A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)","False","00e8dd95-b5ac-4622-9cac-2fb8cdbe1a92","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42974"
"1652","Powder For Injectable Suspension Dosage Form","C42976","INJECTION, POWDER, FOR SUSPENSION","['INJECTION, POWDER, FOR SUSPENSION']","Powder For Injectable Suspension Dosage Form","A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)","False","faa6d65a-0ca7-44ae-ac73-67b8fcd73441","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42976"
"1653","Powder For Injectable Extended Release Suspension Dosage Form","C42977","INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE","['INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE']","Powder For Injectable Extended Release Suspension Dosage Form","A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)","False","67401ebe-5666-4d30-b195-28f0efb92b34","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42977"
"1654","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","C42959","INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION","['INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION']","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)","False","55a1d19f-96da-4ec7-9b76-cfecae7dc190","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42959"
"1655","Lyophilized Powder For Injectable Solution Dosage Form","C42957","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","['INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION']","Lyophilized Powder For Injectable Solution Dosage Form","A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)","False","860332fd-420d-4bfd-83cb-583b0eb06923","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42957"
"1656","Lyophilized Powder For Injectable Suspension Dosage Form","C42958","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION","['INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION']","Lyophilized Powder For Injectable Suspension Dosage Form","A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization (""freeze drying""), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)","False","b7bff156-fcfd-46d8-a09b-0e3104a1c940","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42958"
"1657","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","C42956","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE","['INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE']","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)","False","e3e9f62e-cc55-441f-9262-ec74a0ac862a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42956"
"1658","Injectable Solution Dosage Form","C42945","INJECTION, SOLUTION","['INJECTION, SOLUTION']","Injectable Solution Dosage Form","A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)","False","68b0855d-da21-420b-b606-d06f6cbcec86","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42945"
"1659","Concentrate for Injectable Solution Dosage Form","C42899","INJECTION, SOLUTION, CONCENTRATE","['INJECTION, SOLUTION, CONCENTRATE']","Concentrate for Injectable Solution Dosage Form","A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)","False","35792fe5-7a43-4664-b97d-c1826fc4d0a5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42899"
"1660","Injectable Suspension Dosage Form","C42995","INJECTION, SUSPENSION","['INJECTION, SUSPENSION']","Injectable Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)","False","082451d9-3aa1-42a2-bc03-6b83fb1e7da5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42995"
"1661","Injectable Extended Release Suspension Dosage Form","C42926","INJECTION, SUSPENSION, EXTENDED RELEASE","['INJECTION, SUSPENSION, EXTENDED RELEASE']","Injectable Extended Release Suspension Dosage Form","A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","4e444b63-4be1-4ca5-a390-a7189aa783b2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42926"
"1662","Injectable Liposomal Suspension Dosage Form","C42951","INJECTION, SUSPENSION, LIPOSOMAL","['INJECTION, SUSPENSION, LIPOSOMAL']","Injectable Liposomal Suspension Dosage Form","A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)","False","3cfd9965-00ae-47cb-b4b5-72cf9def272f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42951"
"1663","Injectable Sonicated Suspension Dosage Form","C42988","INJECTION, SUSPENSION, SONICATED","['INJECTION, SUSPENSION, SONICATED']","Injectable Sonicated Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)","False","8ff4278c-73ec-40d4-846e-089cf4a88db1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42988"
"1664","Insert Dosage Form","C60933","INSERT","['INSERT']","Insert Dosage Form","A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)","False","06f608a4-608b-4989-aafa-0a0cd5088102","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60933"
"1665","Extended Release Insert Dosage Form","C42922","INSERT, EXTENDED RELEASE","['INSERT, EXTENDED RELEASE']","Extended Release Insert Dosage Form","A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)","False","babd49f2-ec8b-4b3c-821e-0ab83244613b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42922"
"1666","Intrauterine Device Dosage Form","C47915","INTRAUTERINE DEVICE","['INTRAUTERINE DEVICE']","Intrauterine Device Dosage Form","A device inserted and left in the uterus to prevent effective conception. (NCI)","False","c30f01e5-da9e-4561-8d3b-2e88983610ff","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47915"
"1667","Irrigant Dosage Form","C42947","IRRIGANT","['IRRIGANT']","Irrigant Dosage Form","A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)","False","50f195cf-1a32-441c-8277-e6678334e1e0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42947"
"1668","Jelly Dosage Form","C42948","JELLY","['JELLY']","Jelly Dosage Form","A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)","False","38f1c874-e3af-4622-80f3-474a2dd9c9e4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42948"
"1669","Kit Dosage Form","C47916","KIT","['KIT']","Kit Dosage Form","A packaged collection of related material. (NCI)","False","ee920e96-242c-4a29-980d-a0d30078e84f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47916"
"1670","Dental Liner Dosage Form","C45413","LINER, DENTAL","['LINER, DENTAL']","Dental Liner Dosage Form","A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)","False","cac602b3-3905-4ba5-ba2c-3dff98740e86","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C45413"
"1671","Liniment Dosage Form","C42949","LINIMENT","['LINIMENT']","Liniment Dosage Form","A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)","False","7d51d386-278b-4cdb-93f2-7b4b82c97010","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42949"
"1672","Lipstick Dosage Form","C42952","LIPSTICK","['LIPSTICK']","Lipstick Dosage Form","A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)","False","1e4660ac-4c79-4cf3-8838-5da125fd52b5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42952"
"1673","Liquid Dosage Form","C42953","LIQUID","['LIQUID']","Liquid Dosage Form","A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","08104d37-3c75-4f29-a817-34ef96352523","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42953"
"1674","Extended Release Liquid Dosage Form","C60934","LIQUID, EXTENDED RELEASE","['LIQUID, EXTENDED RELEASE']","Extended Release Liquid Dosage Form","A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","037127f7-9b72-41ca-ad8c-ac84f1cb1c56","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60934"
"1675","Lotion Dosage Form","C29167","LOTION","['LOTION']","Lotion Dosage Form","An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)","False","6c3c0c36-678d-41dc-95cc-2ca710cbf3ce","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C29167"
"1676","Augmented Lotion Dosage Form","C60957","LOTION. AUGMENTED","['LOTION. AUGMENTED']","Augmented Lotion Dosage Form","A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","27f3371c-76f8-4929-aab9-2b9bb99d6f9a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60957"
"1677","Lotion Shampoo Dosage Form","C60958","LOTION/SHAMPOO","['LOTION/SHAMPOO']","Lotion Shampoo Dosage Form","A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)","False","bc1c834c-4799-40de-9a60-c62a323f6583","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60958"
"1678","Lozenge Dosage Form","C42955","LOZENGE","['LOZENGE']","Lozenge Dosage Form","A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)","False","d71f5833-fd07-4744-b4c5-734620f4b181","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42955"
"1679","Mouthwash Dosage Form","C29269","MOUTHWASH","['MOUTHWASH']","Mouthwash Dosage Form","An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)","False","9a968fef-fb48-4ccb-b85e-bd72492143c2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C29269"
"1680","Dosage Form Not Applicable","C48624","NOT APPLICABLE","['NOT APPLICABLE']","Dosage Form Not Applicable","The use of a dosage form term is not relevant or appropriate. (NCI)","False","4b857eb0-7ec1-4bcd-a819-75af3b397a71","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C48624"
"1681","Oil Dosage Form","C42965","OIL","['OIL']","Oil Dosage Form","An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)","False","eface3a9-4e3d-4930-a528-7f9fe0642143","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42965"
"1682","Ointment Dosage Form","C42966","OINTMENT","['OINTMENT']","Ointment Dosage Form","A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)","False","3229e3bf-9cfc-4c18-922e-11ce52c4484c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42966"
"1683","Augmented Ointment Dosage Form","C60984","OINTMENT, AUGMENTED","['OINTMENT, AUGMENTED']","Augmented Ointment Dosage Form","An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","2598fa21-777f-496f-8da0-b82c998cb1fa","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60984"
"1684","Packing Dosage Form","C47887","PACKING","['PACKING']","Packing Dosage Form","A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)","False","21237546-2b9a-4b77-b79c-230518e1ac8c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47887"
"1685","Paste Dosage Form","C42967","PASTE","['PASTE']","Paste Dosage Form","A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)","False","495b1ff1-be92-488d-a286-aea13604f2d2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42967"
"1686","Dentifrice Paste Dosage Form","C42907","PASTE, DENTIFRICE","['PASTE, DENTIFRICE']","Dentifrice Paste Dosage Form","A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","4eeeaf2f-59ab-4a43-b127-c6b0e6ef7f1d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42907"
"1687","Pastille Dosage Form","C60985","PASTILLE","['PASTILLE']","Pastille Dosage Form","An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)","False","93acfcf7-2de2-4e43-b6e8-3cb048c47d23","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60985"
"1688","Patch Dosage Form","C42968","PATCH","['PATCH']","Patch Dosage Form","A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body.  Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch.  Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body.  A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)","False","0f211851-d586-43d3-bfd8-3414e746b2d5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42968"
"1689","Extended Release Patch Dosage Form","C42923","PATCH, EXTENDED RELEASE","['PATCH, EXTENDED RELEASE']","Extended Release Patch Dosage Form","A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","5815cafd-4144-4714-8dec-a552eccbee38","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42923"
"1690","Electrically Controlled Extended Release Patch Dosage Form","C42911","PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED","['PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED']","Electrically Controlled Extended Release Patch Dosage Form","A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","52f011b1-2004-4485-947d-66310e45d00d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42911"
"1691","Pellet Dosage Form","C42969","PELLET","['PELLET']","Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)","False","2b607f93-f9b4-476a-af4d-c4e095b49df9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42969"
"1692","Implantable Pellet Dosage Form","C42943","PELLET, IMPLANTABLE","['PELLET, IMPLANTABLE']","Implantable Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)","False","744a0d69-548b-425f-a3d8-17ad46adc0af","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42943"
"1693","Extended Release Coated Pellets Dosage Form","C42918","PELLETS, COATED, EXTENDED RELEASE","['PELLETS, COATED, EXTENDED RELEASE']","Extended Release Coated Pellets Dosage Form","A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","5fd1008c-9df1-4dae-88a9-d18890897458","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42918"
"1694","Pill Dosage Form","C25394","PILL","['PILL']","Pill Dosage Form","A dose of medicine in the form of a small pellet. (NCI)","False","d2334030-2964-456b-b11a-18177487e235","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C25394"
"1695","Plaster Dosage Form","C42970","PLASTER","['PLASTER']","Plaster Dosage Form","Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)","False","2a4a10c6-6e27-49bc-8908-ce0420554c95","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42970"
"1696","Poultice Dosage Form","C47913","POULTICE","['POULTICE']","Poultice Dosage Form","A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)","False","c3f5d431-0b70-4f53-bf3b-17dde6cb97ee","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47913"
"1697","Powder Dosage Form","C42972","POWDER","['POWDER']","Powder Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)","False","18534217-c239-4dd2-b6d6-07faf3ffa2fe","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42972"
"1698","Dentifrice Powder Dosage Form","C42908","POWDER, DENTIFRICE","['POWDER, DENTIFRICE']","Dentifrice Powder Dosage Form","A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","e7c3a3ec-dca8-4487-a9e7-eddf7a99fe65","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42908"
"1699","Powder for Solution Dosage Form","C42973","POWDER, FOR SOLUTION","['POWDER, FOR SOLUTION']","Powder for Solution Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)","False","051c2d82-72d0-45fa-8b30-dad06a55d43f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42973"
"1700","Powder for Suspension Dosage Form","C42975","POWDER, FOR SUSPENSION","['POWDER, FOR SUSPENSION']","Powder for Suspension Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)","False","1ced1f02-f65c-480d-985f-cdcaf3a99df0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42975"
"1701","Metered Powder Dosage Form","C42961","POWDER, METERED","['POWDER, METERED']","Metered Powder Dosage Form","A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)","False","4800f650-1782-4b7b-b9c9-50621f97191d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42961"
"1702","Ring Dosage Form","C60988","RING","['RING']","Ring Dosage Form","A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)","False","147c8d69-3c03-440e-82a6-c33aa0a45f57","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60988"
"1703","Rinse Dosage Form","C42979","RINSE","['RINSE']","Rinse Dosage Form","A liquid used to cleanse by flushing. (NCI)","False","8decdbf6-87ae-47b4-b936-2b2f66242677","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42979"
"1704","Salve Dosage Form","C42980","SALVE","['SALVE']","Salve Dosage Form","A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)","False","e76b3071-3642-4ea9-a3a2-0ca129b5eb88","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42980"
"1705","Shampoo Dosage Form","C42981","SHAMPOO","['SHAMPOO']","Shampoo Dosage Form","A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","500860ca-a297-4f57-b028-77f1d398ce8d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42981"
"1706","Shampoo Suspension Dosage Form","C42982","SHAMPOO, SUSPENSION","['SHAMPOO, SUSPENSION']","Shampoo Suspension Dosage Form","A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","61807109-e797-4e85-9df7-9ed2f77567e0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42982"
"1707","Soap Dosage Form","C42983","SOAP","['SOAP']","Soap Dosage Form","Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)","False","ac88a335-3368-43a4-a7a1-1c7538a84ae6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42983"
"1708","Solution Dosage Form","C42986","SOLUTION","['SOLUTION']","Solution Dosage Form","A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)","False","8725137f-eefc-47b3-9191-8b71ad661149","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42986"
"1709","Concentrate for Solution Dosage Form","C42898","SOLUTION, CONCENTRATE","['SOLUTION, CONCENTRATE']","Concentrate for Solution Dosage Form","A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)","False","5ca095e5-4ad2-4892-80f8-70c8d083d3e6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42898"
"1710","Solution For Slush Dosage Form","C42987","SOLUTION, FOR SLUSH","['SOLUTION, FOR SLUSH']","Solution For Slush Dosage Form","A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)","False","7b839274-2e0f-4fb2-8173-6ee571f52c27","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42987"
"1711","Gel Forming Drops Solution Dosage Form","C60994","SOLUTION, GEL FORMING / DROPS","['SOLUTION, GEL FORMING / DROPS']","Gel Forming Drops Solution Dosage Form","A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)","False","5f4a820a-2e69-4656-8adb-0316153b339d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60994"
"1712","Extended Release Gel Forming Solution Dosage Form","C42935","SOLUTION, GEL FORMING, EXTENDED RELEASE","['SOLUTION, GEL FORMING, EXTENDED RELEASE']","Extended Release Gel Forming Solution Dosage Form","A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency","False","93ac29b0-2201-4054-b531-625df7a0d408","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42935"
"1713","Drops Solution Dosage Form","C60992","SOLUTION/ DROPS","['SOLUTION/ DROPS']","Drops Solution Dosage Form","A solution which is usually administered in a drop-wise fashion. (FDA)","False","ca18a8a3-fdb5-476b-9bfc-b3ecd72434f6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60992"
"1714","Sponge Dosage Form","C47912","SPONGE","['SPONGE']","Sponge Dosage Form","A porous, interlacing, absorbent material that contains a drug.  It is typically used for applying or introducing medication, or for cleansing.  A sponge usually retains its shape.(FDA)","False","90c39075-22ac-457f-9fc0-a1e9f9740527","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47912"
"1715","Spray Dosage Form","C42989","SPRAY","['SPRAY']","Spray Dosage Form","A liquid minutely divided as by a jet of air or steam. (NCI)","False","676bf43a-ce22-4a5b-a530-abcc2f9c4c35","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42989"
"1716","Metered Spray Dosage Form","C42962","SPRAY, METERED","['SPRAY, METERED']","Metered Spray Dosage Form","A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)","False","280e85ef-c388-44f4-a384-fc2079078e40","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42962"
"1717","Spray Suspension Dosage Form","C42990","SPRAY, SUSPENSION","['SPRAY, SUSPENSION']","Spray Suspension Dosage Form","A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)","False","53ed2c54-abf3-4283-ae4a-d697ac73f498","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42990"
"1718","Stick Dosage Form","C42991","STICK","['STICK']","Stick Dosage Form","A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)","False","5e38a423-1dcc-4d72-82e2-0d6f14d63d73","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42991"
"1719","Strip Dosage Form","C47914","STRIP","['STRIP']","Strip Dosage Form","A long narrow piece of material.","False","1a9a51e4-efaf-4537-b118-91f2aee3fbfc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47914"
"1720","Suppository Dosage Form","C42993","SUPPOSITORY","['SUPPOSITORY']","Suppository Dosage Form","A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)","False","b5f6414b-e8f5-4424-a1cf-ab20f84d8f60","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42993"
"1721","Extended Release Suppository Dosage Form","C42924","SUPPOSITORY, EXTENDED RELEASE","['SUPPOSITORY, EXTENDED RELEASE']","Extended Release Suppository Dosage Form","A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)","False","d564ea40-0ee4-49ab-8996-29159a36cdc0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42924"
"1722","Suspension Dosage Form","C42994","SUSPENSION","['SUSPENSION']","Suspension Dosage Form","A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","c061ef0f-3419-4d4c-ae95-c606d576bb23","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42994"
"1723","Extended Release Suspension Dosage Form","C42925","SUSPENSION, EXTENDED RELEASE","['SUSPENSION, EXTENDED RELEASE']","Extended Release Suspension Dosage Form","A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","accb7663-6061-4fe2-bedd-97d6b85dfaf1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42925"
"1724","Drops Suspension Dosage Form","C60995","SUSPENSION/DROPS","['SUSPENSION/DROPS']","Drops Suspension Dosage Form","A suspension which is usually administered in a dropwise fashion. (FDA)","False","82cba32d-05dc-4b10-ac74-686b91c6fcae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60995"
"1725","Suture Dosage Form","C47889","SUTURE","['SUTURE']","Suture Dosage Form","A strand or fiber used to hold wound edges in apposition during healing. (NCI)","False","b1801d4e-8a98-4918-85c1-9624852a7090","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47889"
"1726","Swab Dosage Form","C47898","SWAB","['SWAB']","Swab Dosage Form","A small piece of relatively flat absorbent material that contains a drug.  A swab may also be attached to one end of a small stick.  A swab is typically used for applying medication or for cleansing. (NCI)","False","808fc4d3-f711-4dc7-8424-68928f4fb708","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47898"
"1727","Syrup Dosage Form","C42996","SYRUP","['SYRUP']","Syrup Dosage Form","An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.  (NCI)","False","120ea04c-ded3-4559-bafe-949e12245705","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42996"
"1728","Tablet Dosage Form","C42998","TABLET","['TABLET']","Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents.  (NCI)","False","d7b8920a-55eb-428a-9840-2c103bbb23c1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42998"
"1729","Chewable Tablet Dosage Form","C42893","TABLET, CHEWABLE","['TABLET, CHEWABLE']","Chewable Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)","False","9016ff77-21ba-49a4-b10b-4d70fb79f237","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42893"
"1730","Coated Tablet Dosage Form","C42897","TABLET, COATED","['TABLET, COATED']","Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)","False","7bb202bf-1dbf-4135-abb1-47bb3c4bcd00","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42897"
"1731","Tablet Coated Particles Dosage Form","C60997","TABLET, COATED PARTICLES","['TABLET, COATED PARTICLES']","Tablet Coated Particles Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)","False","fe8bd0e0-41f3-49b2-9658-3913943b691d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C60997"
"1732","Delayed Release Tablet Dosage Form","C42905","TABLET, DELAYED RELEASE","['TABLET, DELAYED RELEASE']","Delayed Release Tablet Dosage Form","A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","10e11d30-0c71-4412-b3c9-540babdecbbc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42905"
"1733","Delayed Release Particles Tablet Dosage Form","C42997","TABLET, DELAYED RELEASE PARTICLES","['TABLET, DELAYED RELEASE PARTICLES']","Delayed Release Particles Tablet Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.  (NCI)","False","83699b3d-540b-4079-b6f7-6d7bdf256772","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42997"
"1734","Effervescent Tablet Dosage Form","C42910","TABLET, EFFERVESCENT","['TABLET, EFFERVESCENT']","Effervescent Tablet Dosage Form","A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)","False","081474df-ee65-4572-b613-f6563f5cb4f8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42910"
"1735","Extended Release Tablet Dosage Form","C42927","TABLET, EXTENDED RELEASE","['TABLET, EXTENDED RELEASE']","Extended Release Tablet Dosage Form","A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)","False","73d2e991-23c5-4dd2-9a84-2e875ce2cff1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42927"
"1736","Film Coated Tablet Dosage Form","C42931","TABLET, FILM COATED","['TABLET, FILM COATED']","Film Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)","False","c7a86cf1-13eb-4eb8-b947-83e261268b43","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42931"
"1737","Film Coated Extended Release Tablet Dosage Form","C42930","TABLET, FILM COATED, EXTENDED RELEASE","['TABLET, FILM COATED, EXTENDED RELEASE']","Film Coated Extended Release Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)","False","dcbdb147-517f-42f8-97d7-5af85a3905d6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42930"
"1738","Tablet For Solution Dosage Form","C61004","TABLET, FOR SOLUTION","['TABLET, FOR SOLUTION']","Tablet For Solution Dosage Form","A tablet that forms a solution when placed in a liquid. (FDA)","False","61b387f7-b268-44e5-be13-fba524fc13cb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C61004"
"1739","Tablet For Suspension Dosage Form","C61005","TABLET, FOR SUSPENSION","['TABLET, FOR SUSPENSION', 'TABLET, DISPERSIBLE']","Tablet For Suspension Dosage Form","A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).","False","c1cb76a1-94fc-48f4-a621-a23fc852f65a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C61005"
"1740","Multilayered Tablet Dosage Form","C42964","TABLET, MULTILAYER","['TABLET, MULTILAYER']","Multilayered Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)","False","e8e9240c-802d-46d3-a6f1-d162564f02e8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42964"
"1741","Multilayered Extended Release Tablet Dosage Form","C42963","TABLET, MULTILAYER, EXTENDED RELEASE","['TABLET, MULTILAYER, EXTENDED RELEASE']","Multilayered Extended Release Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)","False","575fbe8d-8df9-4b2a-af9e-6ff7215b2122","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42963"
"1742","Orally Disintegrating Tablet Dosage Form","C42999","TABLET, ORALLY DISINTEGRATING","['TABLET, ORALLY DISINTEGRATING']","Orally Disintegrating Tablet Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.  (NCI)","False","52f5d65a-f53d-45a8-a94f-0c12233357f1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42999"
"1743","Tablet Orally Disintegrating Delayed Release Dosage Form","C61006","TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE","['TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE']","Tablet Orally Disintegrating Delayed Release Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)","False","c18adbbd-80ce-4eed-86cb-bfd05735c530","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C61006"
"1744","Soluble Tablet Dosage Form","C42985","TABLET, SOLUBLE","['TABLET, SOLUBLE']","Soluble Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)","False","3de4c98e-46f9-48d2-a1b4-80da7f580fb4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42985"
"1745","Sugar Coated Tablet Dosage Form","C42992","TABLET, SUGAR COATED","['TABLET, SUGAR COATED']","Sugar Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)","False","8d807d8e-2c08-4633-b318-6621640e93f2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C42992"
"1746","Tampon Dosage Form","C47892","TAMPON","['TAMPON']","Tampon Dosage Form","A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)","False","2fed97f1-272a-4045-a6db-e2ef752b50f3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47892"
"1747","Tape Dosage Form","C47897","TAPE","['TAPE']","Tape Dosage Form","A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)","False","40fa6447-a276-405e-917e-ccd912b518ab","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C47897"
"1748","Tincture Dosage Form","C43000","TINCTURE","['TINCTURE']","Tincture Dosage Form","An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.  (NCI)","False","f17bdccc-93c9-4755-8707-a598b9cbd87d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C43000"
"1749","Troche Dosage Form","C43001","TROCHE","['TROCHE']","Troche Dosage Form","A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.  (NCI)","False","e72dd953-f839-4cc8-9fe4-21195d812737","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C43001"
"1750","Unassigned Dosage Form","C43002","UNASSIGNED","['UNASSIGNED']","Unassigned Dosage Form","A dosage form has yet to be assigned.  (NCI)","False","7bf048ce-d8dd-4f8b-91b0-0a1b56c6b525","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C43002"
"1751","Wafer Dosage Form","C43003","WAFER","['WAFER']","Wafer Dosage Form","A thin slice of material containing a medicinal agent.  (NCI)","False","da65816c-d91b-4881-98ca-6c3d6f41ebe3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66726/C43003"
"1752","Completion/Reason for Non-Completion","C66727","NCOMPLT","['NCOMPLT', 'Completion/Reason for Non-Completion']","CDISC SDTM Reason for Non-Completion Terminology","The reason that a subject was discontinued from a clinical trial.","False","1b6a8bf7-b2b3-4dc1-9888-9503aab7541a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727"
"1753","Adverse Event","C41331","ADVERSE EVENT","['ADVERSE EVENT']","Adverse Event","Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience.  (CDISC glossary)","False","0d0359c8-2c82-40fa-84f0-ac8fe7deed8a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C41331"
"1754","Complete","C25250","COMPLETED","['COMPLETED']","Complete","To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)","False","4b4a78ba-189f-4035-bf65-de7f4fe68d20","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C25250"
"1755","Death","C28554","DEATH","['DEATH']","Death","The absence of life or state of being dead. (NCI)","False","fe9331ed-5b26-44a3-bc51-ab9ac8d0c8dc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C28554"
"1756","Lack of Efficacy","C48226","LACK OF EFFICACY","['LACK OF EFFICACY']","Lack of Efficacy","The lack of expected or desired effect related to a therapy. (NCI)","False","7346bd07-8236-402e-8640-5ced56ec1da2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C48226"
"1757","Lost To Follow-up","C48227","LOST TO FOLLOW-UP","['LOST TO FOLLOW-UP']","Lost To Follow-up","The loss or lack of continuation of follow-up after a study has officially closed.  See Follow-up. (NCI)","False","b2f22836-c687-4918-9123-3ea1850ffd29","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C48227"
"1758","Non-Compliance With Study Drug","C49631","NON-COMPLIANCE WITH STUDY DRUG","['NON-COMPLIANCE WITH STUDY DRUG']","Non-Compliance With Study Drug","An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)","False","fd360cba-67cb-4fe0-8a21-4e3179749cdc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C49631"
"1759","Other","C17649","OTHER","['OTHER', 'Other']","Other","Different than the one(s) previously specified or mentioned. (NCI)","False","5f8ae8db-3c99-4e08-a206-4a74c811f03c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C17649"
"1760","Physician Decision","C48250","PHYSICIAN DECISION","['PHYSICIAN DECISION']","Physician Decision","A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)","False","7751aba5-2dfd-4d1e-acee-66e602f9726b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C48250"
"1761","Pregnancy","C25742","PREGNANCY","['PREGNANCY']","Pregnancy","Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)","False","076569a2-8cf1-4ca2-8814-f5a6d0ea7a84","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C25742"
"1762","Progressive Disease","C35571","PROGRESSIVE DISEASE","['PROGRESSIVE DISEASE']","Progressive Disease","A disease process that is increasing in scope or severity. (NCI)","False","b3b33e62-b593-40bc-84df-28242072afb8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C35571"
"1763","Protocol Violation","C48251","PROTOCOL VIOLATION","['PROTOCOL VIOLATION']","Protocol Violation","An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)","False","fcced389-aaf5-4861-b912-876b24edf35a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C48251"
"1764","Recovery","C25746","RECOVERY","['RECOVERY']","Recovery","A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)","False","e4e5e5b3-5c91-4a8f-a499-bb0e2edebedc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C25746"
"1765","Trial Screen Failure","C49628","SCREEN FAILURE","['SCREEN FAILURE']","Trial Screen Failure","The potential subject who does not meet one or more criteria required for participation in a trial.","False","23cd3c40-9e08-4406-89c6-33b86eff0e04","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C49628"
"1766","Study Terminated By Sponsor","C49632","STUDY TERMINATED BY SPONSOR","['STUDY TERMINATED BY SPONSOR']","Study Terminated By Sponsor","An indication that a clinical study was stopped by its sponsor.  (NCI)","False","4b33e755-f2bd-4c8f-ab7d-b221f0a5b713","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C49632"
"1767","Technical Problem","C49633","TECHNICAL PROBLEMS","['TECHNICAL PROBLEMS']","Technical Problem","A problem with some technical aspect of a clinical study, usually related to an instrument.  (NCI)","False","30f1f3eb-f677-4822-9bac-5c6c9b0c0d75","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C49633"
"1768","Withdrawal by Subject","C49634","WITHDRAWAL BY SUBJECT","['WITHDRAWAL BY SUBJECT']","Withdrawal by Subject","An indication that a study participant has removed itself from the study.  (NCI)","False","7b68a07b-d66a-4c76-9872-c721b6f20a71","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66727/C49634"
"1769","Relation to Reference Period","C66728","STENRF","['STENRF', 'Relation to Reference Period']","CDISC SDTM Relation to Reference Period Terminology","The name of a code list that contains terms that reference timepoints within and without a defined time period.","False","e2730b77-b60e-487d-b90d-72effc483034","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66728"
"1770","Status Post","C38008","AFTER","['AFTER']","Status Post","The time period following a point or another period of time. (NCI)","False","c1eb1365-8c6a-47d2-969f-11cde592d857","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66728/C38008"
"1771","Prior","C25629","BEFORE","['BEFORE']","Prior","Earlier in time or order. (NCI)","False","4af183f9-d92e-4eea-b90a-54929430716e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66728/C25629"
"1772","During","C25490","DURING","['DURING']","During","At some point in a given period of time. (NCI)","False","7a49a036-1548-4bb5-99d3-64b48db77526","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66728/C25490"
"1773","During Or After","C49640","DURING/AFTER","['DURING/AFTER']","During Or After","Within a certain period of time or after a certain point or period in time. (NCI)","False","f062cd04-b54a-4142-aefd-9d1db2fd5418","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66728/C49640"
"1774","Unknown","C17998","U","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","bc27752a-df07-457a-849d-d2170769d23c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66728/C17998"
"1775","Route of Administration","C66729","ROUTE","['ROUTE', 'Route of Administration']","CDISC SDTM Route of Administration Terminology","The course by which a substance was administered in order to reach the site of action in the body.","False","1b8c1cbe-54a0-40d7-b19f-1e215ca09f75","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729"
"1776","Auricular Route of Administration","C38192","AURICULAR (OTIC)","['AURICULAR (OTIC)']","Auricular Route of Administration","Administration to or by way of the ear.(FDA)","False","c29f1815-f478-4afc-b5aa-59494e12f056","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38192"
"1777","Buccal Route of Administration","C38193","BUCCAL","['BUCCAL']","Buccal Route of Administration","Administration directed toward the cheek, generally from within the mouth.(FDA)","False","558c59f7-26d7-489b-8376-d2e67554e9bd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38193"
"1778","Conjunctival Route of Administration","C38194","CONJUNCTIVAL","['CONJUNCTIVAL']","Conjunctival Route of Administration","Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball.(FDA)","False","8c7eb252-01f8-43d1-946b-81da7e3a19cd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38194"
"1779","Cutaneous Route of Administration","C38675","CUTANEOUS","['CUTANEOUS']","Cutaneous Route of Administration","Administration to the skin.(FDA)","False","b757afe8-9120-41bd-85bd-45925fbb0c17","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38675"
"1780","Dental Route of Administration","C38197","DENTAL","['DENTAL']","Dental Route of Administration","Administration to a tooth or teeth.(FDA)","False","b5a90bf9-2ea4-4a55-8258-15126c3abc55","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38197"
"1781","Electro-osmosis Route of Administration","C38633","ELECTRO-OSMOSIS","['ELECTRO-OSMOSIS']","Electro-osmosis Route of Administration","Administration of through the diffusion of substance through a membrane in an electric field.(FDA)","False","ae69c78e-9ee3-4687-b750-3fa65bb0d0c2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38633"
"1782","Endocervical Route of Administration","C38205","ENDOCERVICAL","['ENDOCERVICAL']","Endocervical Route of Administration","Administration within the canal of the cervix uteri. Synonymous with the term intracervical.(FDA)","False","9230021d-4196-4b67-8d89-628c1d2d7b3b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38205"
"1783","Endosinusial Route of Administration","C38206","ENDOSINUSIAL","['ENDOSINUSIAL']","Endosinusial Route of Administration","Administration within the nasal sinuses of the head.(FDA)","False","e78b7a78-bdc2-4e12-b747-5136d56655d0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38206"
"1784","Endotracheal Route of Administration","C38208","ENDOTRACHEAL","['ENDOTRACHEAL']","Endotracheal Route of Administration","Administration directly into the trachea. Synonymous with the term intratracheal.(FDA)","False","42b685ab-7733-44d6-88b6-a97a6cdb9a9a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38208"
"1785","Enteral Route of Administration","C38209","ENTERAL","['ENTERAL']","Enteral Route of Administration","Administration directly into the intestines.(FDA)","False","b9579375-0fdd-46c0-bd7d-a9e06d133f98","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38209"
"1786","Epidural Route of Administration","C38210","EPIDURAL","['EPIDURAL']","Epidural Route of Administration","Administration upon or over the dura mater.(FDA)","False","1410c0f3-c791-4a25-920f-59984bae86a6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38210"
"1787","Extraamniotic Route of Administration","C38211","EXTRA-AMNIOTIC","['EXTRA-AMNIOTIC']","Extraamniotic Route of Administration","Administration to the outside of the membrane enveloping the fetus.(FDA)","False","9648ea39-a625-46e5-b83c-4e07dcf4f5a3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38211"
"1788","Extracorporeal Circulation Route of Administration","C38212","EXTRACORPOREAL","['EXTRACORPOREAL']","Extracorporeal Circulation Route of Administration","Administration outside of the body.(FDA)","False","d8dc8633-0773-4d8a-b570-57ee1a6e842c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38212"
"1789","Administration Via Hemodialysis","C38200","HEMODIALYSIS","['HEMODIALYSIS']","Administration Via Hemodialysis","Administration through hemodialysate fluid.(FDA)","False","c426453f-3bdd-41dd-97dc-cac6e03dc92d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38200"
"1790","Infiltration Route of Administration","C38215","INFILTRATION","['INFILTRATION']","Infiltration Route of Administration","Administration that results in substances passing into tissue spaces or into cells.(FDA)","False","9c7ff584-971a-4c20-bad3-a6857ea5056f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38215"
"1791","Interstitial Route of Administration","C38219","INTERSTITIAL","['INTERSTITIAL']","Interstitial Route of Administration","Administration to or in the interstices of a tissue.(FDA)","False","2dfbddaf-5ee5-4d2b-a479-8e3e7af87bb9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38219"
"1792","Intraabdominal Route of Administration","C38220","INTRA-ABDOMINAL","['INTRA-ABDOMINAL']","Intraabdominal Route of Administration","Administration within the abdomen.(FDA)","False","44f2baff-0847-4e56-8b29-1e7fbd42ced2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38220"
"1793","Intraamniotic Route of Administration","C38221","INTRA-AMNIOTIC","['INTRA-AMNIOTIC']","Intraamniotic Route of Administration","Administration within the amnion.(FDA)","False","6575932c-3cec-42e4-88e6-19446cdabb63","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38221"
"1794","Intraarterial Route of Administration","C38222","INTRA-ARTERIAL","['INTRA-ARTERIAL']","Intraarterial Route of Administration","Administration within an artery or arteries.(FDA)","False","74126cb2-77c2-4afe-b8b2-d98ea0d0a921","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38222"
"1795","Intraarticular Route of Administration","C38223","INTRA-ARTICULAR","['INTRA-ARTICULAR']","Intraarticular Route of Administration","Administration within a joint.(FDA)","False","e9176216-f231-4e4f-9c0a-b39b131c3c2a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38223"
"1796","Intrabiliary Route of Administration","C38224","INTRABILIARY","['INTRABILIARY']","Intrabiliary Route of Administration","Administration within the bile, bile ducts or gallbladder.(FDA)","False","cdbe0f99-1e2d-47ed-b69e-ceed3adc231d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38224"
"1797","Intrabronchial Route of Administration","C38225","INTRABRONCHIAL","['INTRABRONCHIAL']","Intrabronchial Route of Administration","Administration within a bronchus.(FDA)","False","2f26b872-7de3-4338-a778-e9ef6b4f1c35","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38225"
"1798","Intrabursal Route of Administration","C38226","INTRABURSAL","['INTRABURSAL']","Intrabursal Route of Administration","Administration within a bursa.(FDA)","False","424d82f8-4240-481d-9f60-1fc237bf9d36","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38226"
"1799","Intracardiac Route of Administration","C38227","INTRACARDIAC","['INTRACARDIAC']","Intracardiac Route of Administration","Administration within the heart.(FDA)","False","472e53a9-02bc-4e81-94f4-5196783265b9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38227"
"1800","Intracartilaginous Route of Administration","C38228","INTRACARTILAGINOUS","['INTRACARTILAGINOUS']","Intracartilaginous Route of Administration","Administration within a cartilage; endochondral.(FDA)","False","872602a8-0616-4d3c-951a-48d7c3ebeeca","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38228"
"1801","Intracaudal Route of Administration","C38229","INTRACAUDAL","['INTRACAUDAL']","Intracaudal Route of Administration","Administration within the cauda equina.(FDA)","False","5994894e-3de7-4fe3-b928-0cc78eeb0a00","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38229"
"1802","Intracavernous Route of Administration","C38230","INTRACAVERNOUS","['INTRACAVERNOUS']","Intracavernous Route of Administration","Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.(FDA)","False","fa5f7e0e-3b4e-4357-ab9c-628c52ca3296","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38230"
"1803","Intracavitary Route of Administration","C38231","INTRACAVITARY","['INTRACAVITARY']","Intracavitary Route of Administration","Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound.(FDA)","False","7b514bcb-a1d9-4aed-9c3d-0e7e3b885511","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38231"
"1804","Intracerebral Route of Administration","C38232","INTRACEREBRAL","['INTRACEREBRAL']","Intracerebral Route of Administration","Administration within the cerebrum.(FDA)","False","7dfcb2b6-6bf5-46b5-8117-b4cc7a7aef5c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38232"
"1805","Intracisternal Route of Administration","C38233","INTRACISTERNAL","['INTRACISTERNAL']","Intracisternal Route of Administration","Administration within the cisterna magna cerebellomedularis.(FDA)","False","8d463bd0-35a7-4169-ac0e-d85def6f92ea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38233"
"1806","Intracorneal Route of Administration","C38234","INTRACORNEAL","['INTRACORNEAL']","Intracorneal Route of Administration","Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).(FDA)","False","29f5b7fc-a8e7-4cbb-a1dd-62e1971e4fe3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38234"
"1807","Intracoronal Dental Route of Administration","C38217","INTRACORONAL, DENTAL","['INTRACORONAL, DENTAL']","Intracoronal Dental Route of Administration","Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck.(FDA)","False","10623cd9-e802-4dd6-bbf5-20b2a78cfca4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38217"
"1808","Intracoronary Route of Administration","C38218","INTRACORONARY","['INTRACORONARY']","Intracoronary Route of Administration","Administration within the coronary arteries.(FDA)","False","951efa73-93dd-4841-a0d9-f8ebe08422c3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38218"
"1809","Intracorporus Cavernosum Route of Administration","C38235","INTRACORPORUS CAVERNOSUM","['INTRACORPORUS CAVERNOSUM']","Intracorporus Cavernosum Route of Administration","Administration within the dilatable spaces of the corporus cavernosa of the penis.(FDA)","False","f29542ed-701c-48a5-ba32-890cc1dea94f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38235"
"1810","Intradermal Route of Administration","C38238","INTRADERMAL","['INTRADERMAL']","Intradermal Route of Administration","Administration within the dermis.(FDA)","False","20df4c0c-3593-4156-9013-b384eaf3fdeb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38238"
"1811","Intradiscal Route of Administration","C38239","INTRADISCAL","['INTRADISCAL']","Intradiscal Route of Administration","Administration within a disc.(FDA)","False","6c17173e-9bd9-424a-85c3-41441740bf93","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38239"
"1812","Intraductal Route of Administration","C38240","INTRADUCTAL","['INTRADUCTAL']","Intraductal Route of Administration","Administration within the duct of a gland.(FDA)","False","1b982088-ed83-4875-b9f9-a31c08eae4e8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38240"
"1813","Intraduodenal Route of Administration","C38241","INTRADUODENAL","['INTRADUODENAL']","Intraduodenal Route of Administration","Administration within the duodenum.(FDA)","False","1e529b7c-7623-470d-b651-ff48b7316963","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38241"
"1814","Intradural Route of Administration","C38242","INTRADURAL","['INTRADURAL']","Intradural Route of Administration","Administration within or beneath the dura.(FDA)","False","145a116d-bf15-4e0f-95ef-422fbda1d6b4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38242"
"1815","Intraepidermal Route of Administration","C38243","INTRAEPIDERMAL","['INTRAEPIDERMAL']","Intraepidermal Route of Administration","Administration within the epidermis.(FDA)","False","a4b63512-c3f0-4bec-9902-53e371a04c84","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38243"
"1816","Intraesophageal Route of Administration","C38245","INTRAESOPHAGEAL","['INTRAESOPHAGEAL']","Intraesophageal Route of Administration","Administration within the esophagus.(FDA)","False","2a85b9f6-9419-4336-8164-393128781e3b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38245"
"1817","Intragastric Route of Administration","C38246","INTRAGASTRIC","['INTRAGASTRIC']","Intragastric Route of Administration","Administration within the stomach.(FDA)","False","3d723d8b-d623-4699-b2af-518c8575d1a8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38246"
"1818","Intragingival Route of Administration","C38247","INTRAGINGIVAL","['INTRAGINGIVAL']","Intragingival Route of Administration","Administration within the gingivae.(FDA)","False","d2ac1da0-b75e-4db3-aebc-5926690aad8a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38247"
"1819","Intraileal Route of Administration","C38249","INTRAILEAL","['INTRAILEAL']","Intraileal Route of Administration","Administration within the distal portion of the small intestine, from the jejunum to the cecum.(FDA)","False","609847ea-e17f-4fc5-a35c-efbc3596806f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38249"
"1820","Intralesional Route of Administration","C38250","INTRALESIONAL","['INTRALESIONAL']","Intralesional Route of Administration","Administration within or introduced directly into a localized lesion.(FDA)","False","22609078-bcd8-44c0-be5c-9177b9bf428e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38250"
"1821","Intraluminal Route of Administration","C38251","INTRALUMINAL","['INTRALUMINAL']","Intraluminal Route of Administration","Administration within the lumen of a tube.(FDA)","False","23f8ef67-61c2-49c6-8764-21709bbbeba7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38251"
"1822","Intralymphatic Route of Administration","C38252","INTRALYMPHATIC","['INTRALYMPHATIC']","Intralymphatic Route of Administration","Administration within the lymph.(FDA)","False","a3f3b6de-beaf-429d-a9f5-398e30ccd4a1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38252"
"1823","Intramedullary Route of Administration","C38253","INTRAMEDULLARY","['INTRAMEDULLARY']","Intramedullary Route of Administration","Administration within the marrow cavity of a bone.(FDA)","False","e1d2dd19-87ca-4fb7-a326-07b67467b0fd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38253"
"1824","Intrameningeal Route of Administration","C38254","INTRAMENINGEAL","['INTRAMENINGEAL']","Intrameningeal Route of Administration","Administration within the meninges (the three membranes that envelope the brain and spinal cord).(FDA)","False","dfcbb8be-5a17-4c27-9bd1-d35c03b9d908","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38254"
"1825","Intramuscular Route of Administration","C28161","INTRAMUSCULAR","['INTRAMUSCULAR']","Intramuscular Route of Administration","Administration within a muscle. (FDA)","False","016cfba8-67ae-4fdb-9a7c-a275dfad9cdd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C28161"
"1826","Intraocular Route of Administration","C38255","INTRAOCULAR","['INTRAOCULAR']","Intraocular Route of Administration","Administration within the eye.(FDA)","False","4238b3cf-3b64-408f-b9eb-67988fc20c39","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38255"
"1827","Intraovarian Route of Administration","C38256","INTRAOVARIAN","['INTRAOVARIAN']","Intraovarian Route of Administration","Administration within the ovary.(FDA)","False","4b3bf730-939d-4295-b890-20055e65146f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38256"
"1828","Intrapericardial Route of Administration","C38257","INTRAPERICARDIAL","['INTRAPERICARDIAL']","Intrapericardial Route of Administration","Administration within the pericardium.(FDA)","False","8879a00c-0085-4446-a318-2d4069bb619d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38257"
"1829","Intraperitoneal Route of Administration","C38258","INTRAPERITONEAL","['INTRAPERITONEAL']","Intraperitoneal Route of Administration","Administration within the peritoneal cavity.(FDA)","False","78f38f82-fe1c-4347-9d04-c2d48e5fb195","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38258"
"1830","Intrapleural Route of Administration","C38259","INTRAPLEURAL","['INTRAPLEURAL']","Intrapleural Route of Administration","Administration within the pleura.(FDA)","False","2ea2b31e-856c-4f11-8ef0-50a37a63da71","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38259"
"1831","Intraprostatic Route of Administration","C38260","INTRAPROSTATIC","['INTRAPROSTATIC']","Intraprostatic Route of Administration","Administration within the prostate gland.(FDA)","False","f668544c-f8e3-430d-ad45-001ea27ce324","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38260"
"1832","Intrapulmonary Route of Administration","C38261","INTRAPULMONARY","['INTRAPULMONARY']","Intrapulmonary Route of Administration","Administration within the lungs or its bronchi.(FDA)","False","c279cc63-9c98-4527-a09f-21117423d9f7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38261"
"1833","Intrasinal Route of Administration","C38262","INTRASINAL","['INTRASINAL']","Intrasinal Route of Administration","Administration within the nasal or periorbital sinuses.(FDA)","False","eedb2d09-d2e5-474b-9470-fb075e9a4b76","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38262"
"1834","Intraspinal Route of Administration","C38263","INTRASPINAL","['INTRASPINAL']","Intraspinal Route of Administration","Administration within the vertebral column.(FDA)","False","8be818e8-bcfb-4735-82bb-0b22dc2bea6b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38263"
"1835","Intrasynovial Route of Administration","C38264","INTRASYNOVIAL","['INTRASYNOVIAL']","Intrasynovial Route of Administration","Administration within the synovial cavity of a joint.(FDA)","False","aeadbcd0-00cb-4269-8994-6d0e75458950","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38264"
"1836","Intratendinous Route of Administration","C38265","INTRATENDINOUS","['INTRATENDINOUS']","Intratendinous Route of Administration","Administration within a tendon.(FDA)","False","3475869f-f2ce-433e-81bc-e42894b8a774","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38265"
"1837","Intratesticular Route of Administration","C38266","INTRATESTICULAR","['INTRATESTICULAR']","Intratesticular Route of Administration","Administration within the testicle.(FDA)","False","f728ac1a-4249-4f87-97ac-62eb0a630782","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38266"
"1838","Intrathecal Route of Administration","C38267","INTRATHECAL","['INTRATHECAL']","Intrathecal Route of Administration","Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.(FDA)","False","7a7e8510-77ea-4d38-8fa7-6a4d8589b12e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38267"
"1839","Endothoracic Route of Administration","C38207","INTRATHORACIC","['INTRATHORACIC']","Endothoracic Route of Administration","Administration within the thorax (internal to the ribs); synonymous with the term endothoracic.(FDA)","False","9d0e26e8-5fe1-4123-91df-b49696e3f92f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38207"
"1840","Intratubular Route of Administration","C38268","INTRATUBULAR","['INTRATUBULAR']","Intratubular Route of Administration","Administration within the tubules of an organ.(FDA)","False","1399e3f7-4ae9-4d29-b748-6dc4fe5698b3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38268"
"1841","Intratumoral Route of Administration","C38269","INTRATUMOR","['INTRATUMOR', 'Intratumor Route of Administration']","Intratumoral Route of Administration","Administration within a tumor.(FDA)","False","6f965b45-8bc8-41a1-803f-21f6273d7ab7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38269"
"1842","Intratympanic Route of Administration","C38270","INTRATYMPANIC","['INTRATYMPANIC']","Intratympanic Route of Administration","Administration within the auris media.(FDA)","False","81f49485-d66a-40e2-90d8-2271984d3148","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38270"
"1843","Intrauterine Route of Administration","C38272","INTRAUTERINE","['INTRAUTERINE']","Intrauterine Route of Administration","Administration within the uterus.(FDA)","False","f4484a4f-7000-457b-9fba-687e3053c384","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38272"
"1844","Intravascular Route of Administration","C38273","INTRAVASCULAR","['INTRAVASCULAR']","Intravascular Route of Administration","Administration within a vessel or vessels.(FDA)","False","93a4f0b9-092d-4143-852f-d97acd723064","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38273"
"1845","Intravenous Route of Administration","C38276","INTRAVENOUS","['INTRAVENOUS']","Intravenous Route of Administration","Administration within or into a vein or veins.(FDA)","False","b5e76134-8024-4ae9-8f4c-4afef7585dcd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38276"
"1846","Intravenous Bolus","C38274","INTRAVENOUS BOLUS","['INTRAVENOUS BOLUS']","Intravenous Bolus","Administration within or into a vein or veins all at once.(FDA)","False","64909d44-61a4-4aab-bbc7-352471d9eb1b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38274"
"1847","Intravenous Drip","C38279","INTRAVENOUS DRIP","['INTRAVENOUS DRIP']","Intravenous Drip","Administration within or into a vein or veins over a sustained period of time.(FDA)","False","1d3febca-6be0-41a2-b843-685f8283160e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38279"
"1848","Intraventricular Route of Administration","C38277","INTRAVENTRICULAR","['INTRAVENTRICULAR']","Intraventricular Route of Administration","Administration within a ventricle.(FDA)","False","b8bd27a4-eaa8-41fe-8279-8ad410df4894","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38277"
"1849","Intravesical Route of Administration","C38278","INTRAVESICAL","['INTRAVESICAL']","Intravesical Route of Administration","Administration within the bladder.(FDA)","False","ca082239-592a-4619-83c0-f139ba66945a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38278"
"1850","Intravitreal Route of Administration","C38280","INTRAVITREAL","['INTRAVITREAL']","Intravitreal Route of Administration","Administration within the vitreous body of the eye.(FDA)","False","76b0be65-fd93-4aea-bd1a-d91b7294340e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38280"
"1851","Iontophoresis Route of Administration","C38203","IONTOPHORESIS","['IONTOPHORESIS']","Iontophoresis Route of Administration","Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body.(FDA)","False","f00739b9-5560-4af8-8dc5-06657a31905c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38203"
"1852","Irrigation-Route of Administration","C38281","IRRIGATION","['IRRIGATION']","Irrigation-Route of Administration","Administration to bathe or flush open wounds or body cavities.(FDA)","False","3b593d34-d0b6-43b9-852b-9acb7778ea4f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38281"
"1853","Laryngeal Route of Administration","C38282","LARYNGEAL","['LARYNGEAL']","Laryngeal Route of Administration","Administration directly upon the larynx.(FDA)","False","14f5824b-cf5c-44c3-86b8-70f99832362c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38282"
"1854","Nasal Route of Administration","C38284","NASAL","['NASAL']","Nasal Route of Administration","Administration to the nose; administered by way of the nose.(FDA)","False","858c486b-61dc-4600-88f7-75c33eb61e0b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38284"
"1855","Nasogastric Route of Administration","C38285","NASOGASTRIC","['NASOGASTRIC']","Nasogastric Route of Administration","Administration through the nose and into the stomach, usually by means of a tube.(FDA)","False","6b69c3f8-a86a-4002-85b8-8df4096a2d04","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38285"
"1856","Route of Administration Not Applicable","C48623","NOT APPLICABLE","['NOT APPLICABLE']","Route of Administration Not Applicable","Routes of administration are not applicable.(FDA)","False","bb7ab0cf-0a32-47b5-8c1f-124fecfdb312","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C48623"
"1857","Occlusive Dressing Technique","C38286","OCCLUSIVE DRESSING TECHNIQUE","['OCCLUSIVE DRESSING TECHNIQUE']","Occlusive Dressing Technique","Administration by the topical route which is then covered by a dressing which occludes the area.(FDA)","False","00717c0c-4d19-491d-87c5-716b24fbcc2a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38286"
"1858","Ophthalmic Route of Administration","C38287","OPHTHALMIC","['OPHTHALMIC']","Ophthalmic Route of Administration","Administration to the external eye.(FDA)","False","5e574a62-c1d9-4ef3-9c2a-2ffc8a04bcf3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38287"
"1859","Oral Route of Administration","C38288","ORAL","['ORAL']","Oral Route of Administration","Administration to or by way of the mouth.(FDA)","False","41b399a6-7c22-4f33-8f9d-c63a12c5bae5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38288"
"1860","Oropharyngeal Route of Administration","C38289","OROPHARYNGEAL","['OROPHARYNGEAL']","Oropharyngeal Route of Administration","Administration directly to the mouth and pharynx.(FDA)","False","938d25c6-1bc3-4098-8b88-7b438e893cce","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38289"
"1861","Other Route of Administration","C38290","OTHER","['OTHER']","Other Route of Administration","Administration is different from others on this list.(FDA)","False","2ef23b3a-df2a-4ef1-9e15-bd4c32994a1b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38290"
"1862","Parenteral Route of Administration","C38291","PARENTERAL","['PARENTERAL']","Parenteral Route of Administration","Administration by injection, infusion, or implantation.(FDA)","False","7b9c2afe-1f29-413a-b8cb-88ad897bf99e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38291"
"1863","Percutaneous Route of Administration","C38676","PERCUTANEOUS","['PERCUTANEOUS']","Percutaneous Route of Administration","Administration through the skin.(FDA)","False","188f86b7-7448-47fd-9261-e35b2db50635","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38676"
"1864","Periarticular Route of Administration","C38292","PERIARTICULAR","['PERIARTICULAR']","Periarticular Route of Administration","Administration around a joint.(FDA)","False","b159436e-2659-4086-8097-98d321b21b24","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38292"
"1865","Peridural Route of Administration","C38677","PERIDURAL","['PERIDURAL']","Peridural Route of Administration","Administration to the outside of the dura mater of the spinal cord.(FDA)","False","dd0dd096-c695-49eb-82aa-0d92fccfef0a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38677"
"1866","Perineural Route of Administration","C38293","PERINEURAL","['PERINEURAL']","Perineural Route of Administration","Administration surrounding a nerve or nerves.(FDA)","False","0e019629-94a8-4123-8a4b-0757467af8d6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38293"
"1867","Periodontal Route of Administration","C38294","PERIODONTAL","['PERIODONTAL']","Periodontal Route of Administration","Administration around a tooth.(FDA)","False","31d979a1-39aa-4e0c-bd8b-a4008fcd77dd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38294"
"1868","Rectal Route of Administration","C38295","RECTAL","['RECTAL']","Rectal Route of Administration","Administration to the rectum.(FDA)","False","914724cf-35a6-4737-8904-a4566e80192f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38295"
"1869","Inhalation Route of Administration","C38216","RESPIRATORY (INHALATION)","['RESPIRATORY (INHALATION)']","Inhalation Route of Administration","Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)","False","622a5f19-6218-427b-ab02-cc4d9dc268cd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38216"
"1870","Retrobulbar Route of Administration","C38296","RETROBULBAR","['RETROBULBAR']","Retrobulbar Route of Administration","Administration behind the pons or behind the eyeball.(FDA)","False","f23777e8-5905-4087-ac64-a0babfc32f5e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38296"
"1871","Soft Tissue Route Of Administration","C38198","SOFT TISSUE","['SOFT TISSUE']","Soft Tissue Route Of Administration","Administration into any soft tissue.(FDA)","False","9ffeb778-3d43-4b02-b38e-511cb84f8a82","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38198"
"1872","Subarachnoid Route of Administration","C38297","SUBARACHNOID","['SUBARACHNOID']","Subarachnoid Route of Administration","Administration beneath the arachnoid.(FDA)","False","070ffb70-0120-4fe1-a988-b50cae29e312","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38297"
"1873","Subconjunctival Route of Administration","C38298","SUBCONJUNCTIVAL","['SUBCONJUNCTIVAL']","Subconjunctival Route of Administration","Administration beneath the conjunctiva.(FDA)","False","6bebcbea-3040-4387-a2d3-f509b1a1024a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38298"
"1874","Subcutaneous Route of Administration","C38299","SUBCUTANEOUS","['SUBCUTANEOUS']","Subcutaneous Route of Administration","Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)","False","0500f95c-fd04-4447-af0a-cf51222817a1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38299"
"1875","Sublingual Route of Administration","C38300","SUBLINGUAL","['SUBLINGUAL']","Sublingual Route of Administration","Administration beneath the tongue.(FDA)","False","ebc5b83b-5dfd-412e-9555-23b7d840c373","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38300"
"1876","Submucosal Route of Administration","C38301","SUBMUCOSAL","['SUBMUCOSAL']","Submucosal Route of Administration","Administration beneath the mucous membrane.(FDA)","False","1bc9ac8a-fdc8-4161-91d4-ab86ef1f01b1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38301"
"1877","Topical Route of Administration","C38304","TOPICAL","['TOPICAL']","Topical Route of Administration","Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.(FDA)","False","458ecfdd-7332-4bee-af29-8ed8d274be11","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38304"
"1878","Transdermal Route of Administration","C38305","TRANSDERMAL","['TRANSDERMAL']","Transdermal Route of Administration","Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)","False","b5b73c17-737e-4c8e-b4e2-c4df4585f0f9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38305"
"1879","Mucosal Route of Administration","C38283","TRANSMUCOSAL","['TRANSMUCOSAL']","Mucosal Route of Administration","Administration across the mucosa.(FDA)","False","79afcc08-f3be-4895-9dc5-98da2b878e25","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38283"
"1880","Transplacental Route of Administration","C38307","TRANSPLACENTAL","['TRANSPLACENTAL']","Transplacental Route of Administration","Administration through or across the placenta.(FDA)","False","26328eaa-5255-45be-8d5d-2a7d7c381069","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38307"
"1881","Transtracheal Route of Administration","C38308","TRANSTRACHEAL","['TRANSTRACHEAL']","Transtracheal Route of Administration","Administration through the wall of the trachea.(FDA)","False","6f4190fc-a1d3-42b2-b8db-feaef7b11ee5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38308"
"1882","Transtympanic Route of Administration","C38309","TRANSTYMPANIC","['TRANSTYMPANIC']","Transtympanic Route of Administration","Administration across or through the tympanic cavity.(FDA)","False","7c848dbe-317c-4c6f-b274-eabb709cf001","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38309"
"1883","Unassigned Route of Administration","C38310","UNASSIGNED","['UNASSIGNED']","Unassigned Route of Administration","Route of administration has not yet been assigned.(FDA)","False","117c126a-8524-422a-b03e-da702087cc47","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38310"
"1884","Unknown Route of Administration","C38311","UNKNOWN","['UNKNOWN']","Unknown Route of Administration","Route of administration is unknown.(FDA)","False","3bcdd129-f0ac-47f8-91e9-d320bdca2bc3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38311"
"1885","Ureteral Route of Administration","C38312","URETERAL","['URETERAL']","Ureteral Route of Administration","Administration into the ureter.(FDA)","False","d8355280-dd69-4010-8df2-e863337f4110","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38312"
"1886","Intraurethral Route of Administration","C38271","URETHRAL","['URETHRAL']","Intraurethral Route of Administration","Administration into the urethra.(FDA)","False","4d990373-e62b-4bc1-807d-1f95b1b61a7b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38271"
"1887","Vaginal Route of Administration","C38313","VAGINAL","['VAGINAL']","Vaginal Route of Administration","Administration into the vagina.(FDA)","False","80f8d3f1-a8bb-4517-bcba-de01af665d2b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66729/C38313"
"1888","Severity/Intensity Scale for Adverse Events","C66769","AESEV","['AESEV', 'Severity/Intensity Scale for Adverse Events']","CDISC SDTM Severity Intensity Scale for Adverse Event Terminology","A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)","False","0a2e1f5b-7cea-4767-b99d-0459f2ed06fe","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66769"
"1889","Mild Adverse Event","C41338","MILD","['MILD', 'Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","fa99428e-f115-4508-b133-e41939eb4bb2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66769/C41338"
"1890","Moderate Adverse Event","C41339","MODERATE","['MODERATE', 'Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","dd21dda2-7c67-4bb8-9001-47d737e43582","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66769/C41339"
"1891","Severe Adverse Event","C41340","SEVERE","['SEVERE', 'Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","4c8a308e-24b7-42bf-9d60-b636e6de0931","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66769/C41340"
"1892","Sex","C66731","SEX","['SEX', 'Sex']","CDISC SDTM Sex of Individual Terminology","The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)","False","e0393a80-8862-49d1-a6eb-a5322bc8943b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66731"
"1893","Female","C16576","F","['F', 'Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","9fdf52c1-a25c-41fe-9ba0-e182c0a5b8c2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66731/C16576"
"1894","Male","C20197","M","['M', 'Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","176466b2-79ad-4a81-8e0a-79f9bdb340ba","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66731/C20197"
"1895","Unknown","C17998","U","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","9bf6b289-4dab-46bd-a8af-81cefda3bca2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66731/C17998"
"1896","Intersex","C45908","UN","['UN', 'Undifferentiated']","Intersex","A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)","False","8d479b93-785a-49a0-a11d-8d28ba70f710","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66731/C45908"
"1897","Sex of Participants","C66732","SEXPOP","['SEXPOP', 'Sex of Participants']","CDISC SDTM Sex of Study Group Terminology","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","a415c260-2c16-4257-9066-c52006b35808","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66732"
"1898","Both","C49636","BOTH","['BOTH']","Both","One and the other; relating to or being two in conjunction. (NCI)","False","69e71c67-d4eb-4782-b860-b9e5e5e447e1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66732/C49636"
"1899","Female","C16576","F","['F', 'Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","89d81acf-c706-42d8-9205-af6ce6c4923b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66732/C16576"
"1900","Male","C20197","M","['M', 'Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","2904b051-1f51-400e-a94e-3acf09956e1d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66732/C20197"
"1901","Size","C66733","SIZE","['SIZE', 'Size']","CDISC SDTM Size Terminology","The physical magnitude of something. (NCI)","False","e8085d78-469a-4f72-901f-36d6f2506793","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66733"
"1902","Large","C49508","LARGE","['LARGE']","Large","Of considerable or relatively great size, extent, or capacity. (NCI)","False","271b67d1-8e10-45b3-ad0f-b9da1bcde060","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66733/C49508"
"1903","Medium","C49507","MEDIUM","['MEDIUM']","Medium","Mid-way between small and large in number, quantity, magnitude or extent. (NCI)","False","45d3b5e3-c171-4fc8-b4c7-c991d266e244","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66733/C49507"
"1904","Small","C25376","SMALL","['SMALL']","Small","Limited in number, quantity, magnitude or extent. (NCI)","False","5e66b777-276b-4946-acab-28ba1d41706b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66733/C25376"
"1905","Domain Abbreviation","C66734","DOMAIN","['DOMAIN', 'Domain Abbreviation']","CDISC SDTM Submission Domain Abbreviation Terminology","A unique, 2-character domain code used in the regulatory submission process.  The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)","False","3835f768-ea8b-4654-b411-8c67ed4b4c0e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734"
"1906","Analysis Dataset Domain","C49563","AD","['AD', 'Analysis Dataset']","Analysis Dataset Domain","Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.","False","f70156b3-d3ef-4b74-a20b-6c0f615065c6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49563"
"1907","Adverse Event Domain","C49562","AE","['AE', 'Adverse Events']","Adverse Event Domain","Adverse events may be captured either as free text or a pre-specified list of terms.","False","cfbb9704-2fc8-49cc-a042-e395a8233291","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49562"
"1908","Autopsy Domain","C49565","AU","['AU', 'Autopsy']","Autopsy Domain","Additional data about deaths, specific to findings from autopsies.","False","7cda8bd4-beee-4c2b-8050-cbe628d1a066","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49565"
"1909","Bone Mineral Density Data Domain","C49566","BM","['BM', 'Bone Mineral Density (BMD) Data']","Bone Mineral Density Data Domain","Findings resulting from evaluations of bone mineral density.","False","43e0bd99-7400-4fba-b250-7711b98d9489","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49566"
"1910","Biopsy Domain","C49567","BR","['BR', 'Biopsy']","Biopsy Domain","Findings resulting from biopsies.","False","ae5217cc-b55c-4ff6-823a-6dadeb1f6005","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49567"
"1911","Concomitant Medication Domain","C49568","CM","['CM', 'Concomitant Meds']","Concomitant Medication Domain","Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.","False","aeefe692-f6cd-4c85-8e34-c7e3d0da6b33","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49568"
"1912","Comment Domain","C49569","CO","['CO', 'Comments']","Comment Domain","The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.","False","0251ae23-5d25-46f2-9242-a7e7618908c7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49569"
"1913","Drug Accountability Domain","C49578","DA","['DA', 'Drug Accountability']","Drug Accountability Domain","Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.","False","b5677efb-9f3c-4221-b054-199241c2d4aa","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49578"
"1914","Disease Characteristics Domain","C49570","DC","['DC', 'Disease Characteristics']","Disease Characteristics Domain","Data related to the characteristics of a specific disease state under study for a subject.","False","68761ce8-41e2-45cd-a375-42adf6f1d648","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49570"
"1915","Demographics Domain","C49572","DM","['DM', 'Demographics']","Demographics Domain","The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study.  It is the parent domain for all other observations for human clinical subjects","False","fb0702f8-5b6f-4ebe-840f-f6d86fea8f6d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49572"
"1916","Disposition Domain","C49576","DS","['DS', 'Disposition']","Disposition Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)","False","024e9436-599b-4b90-a70d-9bd5810792bd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49576"
"1917","Protocol Deviations Domain","C49585","DV","['DV', 'Protocol Deviations']","Protocol Deviations Domain","The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.","False","c1bef870-3207-486c-9d32-9d18aafd7831","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49585"
"1918","Electroencephalogram Domain","C49625","EE","['EE', 'Electroencephalogram']","Electroencephalogram Domain","Findings resulting from electroencephalogram (EEG) tests.","False","bbf9fe4d-5717-403c-b4f5-6fadd2b89e38","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49625"
"1919","Electrocardiogram Domain","C49626","EG","['EG', 'Electrocardiogram']","Electrocardiogram Domain","Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.","False","8fb1a65d-a4d2-45e2-9c97-175097f93b48","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49626"
"1920","Exposure Domain","C49587","EX","['EX', 'Exposure']","Exposure Domain","The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.","False","f34b638e-c207-41f3-a9a6-55b90ca8c6b5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49587"
"1921","Family History Domain","C49588","FH","['FH', 'Family History']","Family History Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)","False","7ba30586-99da-4053-88e2-8e9fc9b042b7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49588"
"1922","Healthcare Resource Utilization Domain","C49589","HU","['HU', 'Healthcare Resource Utilization']","Healthcare Resource Utilization Domain","Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.","False","ea5994e4-726e-4ae6-a87f-ab51ca83c2a4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49589"
"1923","Inclusion Exclusion Domain","C61536","IE","['IE', 'Inclusion/Exclusion']","Inclusion Exclusion Domain","The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.","False","3d571f56-b8bf-4de4-bf61-1e4c5b7a5a25","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C61536"
"1924","Laboratory Data Domain","C49592","LB","['LB', 'Laboratory Data']","Laboratory Data Domain","Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.","False","2d6bc5c3-d02d-405f-a296-c4cae224a538","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49592"
"1925","Microbiology Specimen Domain","C49602","MB","['MB', 'Microbiology']","Microbiology Specimen Domain","Microbiology specimen findings, including gram stain results, and organisms found.","False","d93e8ec9-b852-4128-9086-68432b895aae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49602"
"1926","Medical History Domain","C49603","MH","['MH', 'Medical History']","Medical History Domain","The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.","False","8ac3ac1c-7528-426f-9eb7-8ef62ae6afc2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49603"
"1927","Meal Data Domain","C49604","ML","['ML', 'Meal Data']","Meal Data Domain","Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.","False","6c197087-a6bf-4eb7-b5b6-ca7b31b5ff9b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49604"
"1928","Microbiology Susceptibility Domain","C61531","MS","['MS', 'Microbiology Susceptibility']","Microbiology Susceptibility Domain","This includes microbiology susceptibility test results, plus results of any other organism-related tests.","False","9fa22dfa-6191-426a-9f78-5e5ef29288c2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C61531"
"1929","Organ Measurement Domain","C49605","OM","['OM', 'Organ Measurements']","Organ Measurement Domain","Findings from organ measurement evaluations.","False","feb676de-6f47-4bf7-b99f-8c851e993b2b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49605"
"1930","Pharmacokinetic Concentration Domain","C49606","PC","['PC', 'Pharmacokinetic Concentration']","Pharmacokinetic Concentration Domain","Concentrations of drugs/metabolites in fluids or tissues as a function of time.","False","ac0e0762-aeb7-4954-ae8e-6cd27bb37a5c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49606"
"1931","Physical Exam Domain","C49608","PE","['PE', 'Physical Exam']","Physical Exam Domain","Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.","False","9ee653d8-c54f-48f8-b592-6c489fde1b48","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49608"
"1932","Pharmacogenomics Domain","C61529","PG","['PG', 'Pharmacogenomics']","Pharmacogenomics Domain","Pharmacogenomics findings that initially focus on genotype and gene expression data.","False","fffbab74-319e-49b2-a31c-6e5f55f9c5d7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C61529"
"1933","Pharmacokinetic Parameters Domain","C49607","PP","['PP', 'Pharmacokinetic Parameters']","Pharmacokinetic Parameters Domain","Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.","False","b8dfb1ea-f55d-4ddf-9261-adc8970c6122","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49607"
"1934","Questionnaire Domain","C49609","QS","['QS', 'Questionnaires']","Questionnaire Domain","Questionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).","False","992f4932-73da-4e8a-b35b-ac679e8577c3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49609"
"1935","Subject Characteristics Domain","C49610","SC","['SC', 'Subject Characteristics']","Subject Characteristics Domain","The subject characteristics domain is for data not collected in other domains that is subject-related. Examples: subject initials, other race details, eye color, childbearing status, etc.","False","2abdeae2-80e1-4959-aa7b-1ea24e3e2a02","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49610"
"1936","Subject Element Domain","C49616","SE","['SE', 'Subject Element']","Subject Element Domain","The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.","False","c4516492-d4de-49f6-bfeb-12e04ce5ea02","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49616"
"1937","Surgery Domain","C49611","SG","['SG', 'Surgery']","Surgery Domain","Surgical information.","False","67160b0e-c93a-4771-aeca-d1a5bee7efe2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49611"
"1938","Skin Test Domain","C49612","SK","['SK', 'Skin Test']","Skin Test Domain","Findings from diagnostic skin tests.","False","fe49ab23-5eea-4af2-8c83-d83d76802986","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49612"
"1939","Sleep Polysomnography Domain","C49613","SL","['SL', 'Sleep Polysomnography Data']","Sleep Polysomnography Domain","Findings from diagnostic sleep tests (polysomnography).","False","9c1a6243-a573-4154-bb2e-3f8396e741fa","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49613"
"1940","Stress Exercise Test Data Domain","C49614","ST","['ST', 'Stress (Exercise) Test Data']","Stress Exercise Test Data Domain","Findings from exercise stress tests.","False","8a3e20e3-08ca-4902-980a-199a8e1b9337","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49614"
"1941","Substance Use Domain","C49615","SU","['SU', 'Substance Use']","Substance Use Domain","The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.","False","2495c6bd-75a6-48bc-b087-5bd4591534af","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49615"
"1942","Subject Visits Domain","C49617","SV","['SV', 'Subject Visits']","Subject Visits Domain","The subject visits table describes the actual start and end data/time for each visit of each individual subject.","False","cfaeffaf-e301-41b4-a387-765ac8b1ea93","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49617"
"1943","Trial Arms Domain","C49618","TA","['TA', 'Trial Arms']","Trial Arms Domain","The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.","False","d266f820-c8c7-4e82-adcd-e5577ad3662f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49618"
"1944","Trial Elements Domain","C49619","TE","['TE', 'Trial Elements']","Trial Elements Domain","The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.","False","83b87305-b72c-4e30-ab25-b69125aa2374","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49619"
"1945","Trial Inclusion and Exclusion Criteria Domain","C49620","TI","['TI', 'Trial Inclusion/Exclusion Criteria']","Trial Inclusion and Exclusion Criteria Domain","The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.","False","a672247a-f3f8-4c21-a27d-94ab79f0287f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49620"
"1946","Trial Summary Domain","C53483","TS","['TS', 'Trial Summary']","Trial Summary Domain","The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.","False","bf7ec5a5-e8c4-4ffe-816b-d5f8fdef035e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C53483"
"1947","Trial Visits Domain","C49621","TV","['TV', 'Trial Visits']","Trial Visits Domain","The trial visits table describes the planned order and number of visits in the study within each arm.","False","12184b95-951e-4a2d-a8ee-5a3322423409","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49621"
"1948","Vital Signs Domain","C49622","VS","['VS', 'Vital Signs']","Vital Signs Domain","Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.","False","6bf78494-1470-44a3-95c0-ba32fd9383b4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66734/C49622"
"1949","Trial Blinding Schema","C66735","TBLIND","['TBLIND', 'Trial Blinding Schema']","CDISC SDTM Trial Blinding Schema Terminology","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","5c04468e-9ede-44ab-b9af-261a62fe1e0b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66735"
"1950","Double Blind Study","C15228","DOUBLE BLIND","['DOUBLE BLIND']","Double Blind Study","A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)","False","6f66f245-a32f-4d65-bb10-312c5e12a461","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66735/C15228"
"1951","Open Label Study","C49659","OPEN LABEL","['OPEN LABEL']","Open Label Study","A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)","False","1576e5c4-aaa8-4b63-b7f4-a022255fa4ca","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66735/C49659"
"1952","Single Blind Study","C28233","SINGLE BLIND","['SINGLE BLIND']","Single Blind Study","A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)","False","453d0cce-19cf-4083-85d0-a49f063cb8f3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66735/C28233"
"1953","Trial Indication Type","C66736","TINDTP","['TINDTP', 'Trial Indication Type']","CDISC SDTM Trial Indication Type Terminology","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)","False","eb27829a-0d9d-4d16-85af-4695e20663c1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66736"
"1954","Cure Study","C49654","CURE","['CURE']","Cure Study","A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition.  (NCI)","False","7cd58e05-ce10-4f0f-b315-c0b8fe19bf79","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66736/C49654"
"1955","Diagnosis Study","C49653","DIAGNOSIS","['DIAGNOSIS']","Diagnosis Study","A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition.  (NCI)","False","1565ee62-0956-40ff-9d66-fe2be0381929","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66736/C49653"
"1956","Adverse Effect Mitigation Study","C49655","MITIGATION","['MITIGATION']","Adverse Effect Mitigation Study","A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen.  (NCI)","False","0b58c925-3a86-4e3c-b476-6b8d569f212a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66736/C49655"
"1957","Prevention Study","C49657","PREVENTION","['PREVENTION']","Prevention Study","A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.","False","1a7dba63-35af-45b8-a463-3cd2d8502f3e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66736/C49657"
"1958","Treatment Study","C49656","TREATMENT","['TREATMENT']","Treatment Study","A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.","False","6efc845a-a902-4bd1-b8db-a0f0f39642fd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66736/C49656"
"1959","Trial Phase","C66737","TPHASE","['TPHASE', 'Trial Phase']","CDISC SDTM Trial Phase Terminology","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","96e34c0c-e82d-4ff6-a357-bd54e47d895f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737"
"1960","Phase I Trial","C15600","Phase I Trial","['Phase I Trial', 'Trial Phase 1', '1']","Phase I Trial","The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drugs pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes.  [After FDA CDER Handbook, ICH E8] (CDISC glossary)","False","68566db7-c833-4d47-a12f-0157ff70c5b1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C15600"
"1961","Phase I/II Trial","C15693","Phase I/II Trial","['Phase I/II Trial', 'Trial Phase 1-2', '1-2']","Phase I/II Trial","A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.","False","bf848792-5cc2-4f0f-ad4b-ddfa7c79c99d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C15693"
"1962","Phase II Trial","C15601","Phase II Trial","['Phase II Trial', 'Trial Phase 2', '2']","Phase II Trial","Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","290ae332-aa5b-4c7b-a98c-0288e18f4001","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C15601"
"1963","Phase II/III Trial","C15694","Phase II/III Trial","['Phase II/III Trial', 'Trial Phase 2-3', '2-3']","Phase II/III Trial","A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.","False","f1f0cf7b-28d4-4e3e-92e1-dd8bd0ee3db6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C15694"
"1964","Phase II A Trial","C49686","Phase II A Trial","['Phase II A Trial', 'Trial Phase 2A', '2A']","Phase II A Trial","A clinical research protocol generally refered to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)","False","7a2faf3a-7d30-4030-921b-2c4fa37cc82f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C49686"
"1965","Phase II B Trial","C49688","Phase II B Trial","['Phase II B Trial', 'Trial Phase 2B', '2B']","Phase II B Trial","A clinical research protocol generally refered to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)","False","eecddd95-a84b-427c-b577-730c49b2c556","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C49688"
"1966","Phase III Trial","C15602","Phase III Trial","['Phase III Trial', 'Trial Phase 3', '3']","Phase III Trial","Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefitrisk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","07f718b4-5542-4a61-8113-5d2e5e633ed0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C15602"
"1967","Phase IIIA Trial","C49687","Phase IIIA Trial","['Phase IIIA Trial', 'Trial Phase 3A', '3A']","Phase IIIA Trial","A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.","False","ef741a32-465a-4f2e-b287-284a68941100","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C49687"
"1968","Phase III B Trial","C49689","Phase III B Trial","['Phase III B Trial', 'Trial Phase 3B', '3B']","Phase III B Trial","A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.","False","b89783e5-64f2-41ac-8fbc-d1ed62acf5b2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C49689"
"1969","Phase IV Trial","C15603","Phase IV Trial","['Phase IV Trial', 'Trial Phase 4', '4']","Phase IV Trial","Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drugs risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","80166391-268f-4b39-b1b1-c3cb842cf6ef","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C15603"
"1970","Phase V Trial","C47865","Phase V Trial","['Phase V Trial', 'Trial Phase 5', '5']","Phase V Trial","Postmarketing surveillance is sometimes referred to as Phase V.","False","d990042e-b6e3-4716-ac88-2862e12d405e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C47865"
"1971","Not Applicable","C48660","","['NOT APPLICABLE', 'NA']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","5fa76b0d-aa44-4844-9e32-2118f0d12ac7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66737/C48660"
"1972","Trial Summary Parameter Test Code","C66738","TSPARMCD","['TSPARMCD', 'Trial Summary Parameter Test Code']","CDISC SDTM Trial Summary Parameter Terminology by Code","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","94de4daf-ba2d-43fb-85a0-dbcee3d3cdf6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738"
"1973","Test Product Added to Existing Treatment","C49703","ADDON","['ADDON', 'Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","0ad46f56-9b30-4cff-9f3b-39a8f4fd2eb8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49703"
"1974","Adverse Event Dictionary","C49700","AEDICT","['AEDICT', 'Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","09663fcb-6a26-4ed9-b9c7-7c50814af057","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49700"
"1975","Planned Maximum Age of Subjects","C49694","AGEMAX","['AGEMAX', 'Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","c145c092-25c9-4184-b204-3335bbd3eeb7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49694"
"1976","Planned Minimum Age of Subjects","C49693","AGEMIN","['AGEMIN', 'Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","eba775d2-14f8-4d75-afbd-e681741daf0d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49693"
"1977","Age Group","C20587","AGESPAN","['AGESPAN', 'Age Group']","Age Group","Subgroups of populations based on age. (NCI)","False","1ef4df6d-6df5-415f-ade2-bdfe0e4b7109","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C20587"
"1978","Age Unit","C50400","AGEU","['AGEU', 'Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","2af37bf1-fa46-43e0-bd15-72293fb89db0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C50400"
"1979","Dose","C25488","DOSE","['DOSE', 'Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","1fc21507-c6b3-4269-b5f5-28a642029daf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C25488"
"1980","Drug Dictionary","C49701","DRUGDICT","['DRUGDICT', 'Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","867a4641-ff20-400f-8a3c-1a887c59add5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49701"
"1981","Trial Length","C49697","LENGTH","['LENGTH', 'Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","a00b7dfd-ae63-40ae-baad-fe93b55719d1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49697"
"1982","Medical History Dictionary","C49702","MHDICT","['MHDICT', 'Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","a14be6ce-ab30-4c5e-ae48-b0c5a7607a23","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49702"
"1983","Planned Subject Number","C49692","PLANSUB","['PLANSUB', 'Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","4c1d6c05-ed0c-4334-baf1-3e96515b70a9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49692"
"1984","Randomization","C25196","RANDOM","['RANDOM', 'Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","7fa462d0-c667-4f83-8547-19c4f30a6a0d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C25196"
"1985","Route of Administration","C38114","ROUTE","['ROUTE', 'Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","1c396ad9-e8e0-416d-9f1a-0f2a7a221105","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C38114"
"1986","Sex of Study Group","C49696","SEXPOP","['SEXPOP', 'Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","fa2ae52c-3d20-468f-a634-cf4e04b77e5e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49696"
"1987","Study Stop Rules","C49698","STOPRULE","['STOPRULE', 'Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","0edd834a-894c-485a-b72e-96ffaa750bfb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49698"
"1988","Trial Blinding Schema","C49658","TBLIND","['TBLIND', 'Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","8e0e449e-0239-4322-a2af-8c1a4106f43d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49658"
"1989","Control Type","C49647","TCNTRL","['TCNTRL', 'Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","f17c4ec9-b516-4cd3-90e3-4008bb3a3672","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49647"
"1990","Diagnosis Group","C49650","TDIGRP","['TDIGRP', 'Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","7a955288-c8cb-48da-aa59-4d131f22b375","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49650"
"1991","Trial Indication Type","C49652","TINDTP","['TINDTP', 'Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","59079df9-6638-4729-89c7-4bbe71a89e6f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49652"
"1992","Trial Title","C49802","TITLE","['TITLE', 'Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","b108662a-768d-4c68-889e-b57c2af1c83b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49802"
"1993","Trial Phase","C48281","TPHASE","['TPHASE', 'Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","fabdec6e-047b-41f2-aac3-2203faaef345","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C48281"
"1994","Trial Type","C49660","TTYPE","['TTYPE', 'Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","ec72515f-5887-4080-b985-b82a95bc82a5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66738/C49660"
"1995","Trial Summary Parameter Test Name","C67152","TSPARM","['TSPARM', 'Trial Summary Parameter Test Name']","CDISC SDTM Trial Summary Parameter Terminology by Name","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","f9b1967e-b797-4713-b028-d533f70f1fe5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152"
"1996","Test Product Added to Existing Treatment","C49703","Added on to Existing Treatments","['ADDON', 'Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","e5a7d2e3-f59f-4db1-a29b-96154f706851","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49703"
"1997","Adverse Event Dictionary","C49700","Adverse Event Dictionary","['AEDICT', 'Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","c3d70d95-ea91-4bc2-9f6e-10ecd09b0e25","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49700"
"1998","Planned Maximum Age of Subjects","C49694","Planned Maximum Age of Subjects","['AGEMAX', 'Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","cc76c125-8597-4bbb-ab33-f54d0c56a614","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49694"
"1999","Planned Minimum Age of Subjects","C49693","Planned Minimum Age of Subjects","['AGEMIN', 'Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","3157b206-11fa-4818-a29b-2a0db55d2c18","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49693"
"2000","Age Group","C20587","Age Span","['AGESPAN', 'Age Group']","Age Group","Subgroups of populations based on age. (NCI)","False","986c885b-66d2-4e72-8837-8ce5f5af9461","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C20587"
"2001","Age Unit","C50400","Age Unit","['AGEU', 'Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","0cce05d1-9084-47d3-b1aa-867a06bc7910","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C50400"
"2002","Dose","C25488","Dose per Administration","['DOSE', 'Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","9bbc8859-ffe7-483c-87ed-30d817bdf5c3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C25488"
"2003","Drug Dictionary","C49701","Drug Dictionary","['DRUGDICT', 'Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","71b67155-e2d9-46d2-9889-bbb127082a16","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49701"
"2004","Trial Length","C49697","Trial Length","['LENGTH', 'Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","0aff48eb-ce55-4df5-8909-e48604bb4cfd","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49697"
"2005","Medical History Dictionary","C49702","Medical History Dictionary","['MHDICT', 'Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","a837423f-5820-4930-b1b9-5735c5d47c3a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49702"
"2006","Planned Subject Number","C49692","Planned Number of Subjects","['PLANSUB', 'Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","31f194e4-c91f-48a4-86fd-6058adc1b877","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49692"
"2007","Randomization","C25196","Trial is Randomized","['RANDOM', 'Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","f7941ebd-f15a-4091-ab74-27b5941ca905","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C25196"
"2008","Route of Administration","C38114","Route of Administration","['ROUTE', 'Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","e26a7a49-8ed5-4562-841f-0febd954a3bc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C38114"
"2009","Sex of Study Group","C49696","Sex of Participants","['SEXPOP', 'Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","d6e3cd1c-71af-4f2b-9143-a3536f13d83d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49696"
"2010","Study Stop Rules","C49698","Study Stop Rules","['STOPRULE', 'Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","f34f0f81-0803-4dab-80a2-e78e6a7fde0c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49698"
"2011","Trial Blinding Schema","C49658","Trial Blinding Schema","['TBLIND', 'Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","f30be869-7869-4a3e-b9ee-180410aca2e9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49658"
"2012","Control Type","C49647","Control Type","['TCNTRL', 'Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","8fc9d944-8360-4733-b361-a811cc9dcf88","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49647"
"2013","Diagnosis Group","C49650","Diagnosis Group","['TDIGRP', 'Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","73f126d9-fddd-4320-b6b6-edd38a519f23","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49650"
"2014","Trial Indication Type","C49652","Trial Indication Type","['TINDTP', 'Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","b7782360-12ed-4e74-be4d-05b13df82122","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49652"
"2015","Trial Title","C49802","Trial Title","['TITLE', 'Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","da8383b8-4c9d-4f5b-8fc4-c75e75834e34","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49802"
"2016","Trial Phase","C48281","Trial Phase Classification","['TPHASE', 'Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","f08f4fbf-c426-4bf8-a1f6-64c04bf1995f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C48281"
"2017","Trial Type","C49660","Trial Type","['TTYPE', 'Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","7249213c-fd89-47c5-a27f-e4f3d50f315b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67152/C49660"
"2018","Trial Type","C66739","TTYPE","['TTYPE', 'Trial Type']","CDISC SDTM Trial Type Terminology","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","4f45ddde-b07f-46e4-a290-7e59efedd1ec","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739"
"2019","Bioavailability Study","C49664","BIO-AVAILABILITY","['BIO-AVAILABILITY']","Bioavailability Study","A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)","False","05d4233d-fdda-45c7-a10a-85acc2c9a92b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C49664"
"2020","Therapeutic Equivalency Study","C49665","BIO-EQUIVALENCE","['BIO-EQUIVALENCE']","Therapeutic Equivalency Study","A study most often used to compare the efficacy of different formulations to treat a given disease.  It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)","False","32bdd6f0-e16d-441d-8fe5-6c0e181f587c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C49665"
"2021","Efficacy Study","C49666","EFFICACY","['EFFICACY']","Efficacy Study","A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)","False","e0a01815-2336-4da3-82fb-4f7070da878c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C49666"
"2022","Pharmacodynamic Study","C49662","PHARMACODYNAMIC","['PHARMACODYNAMIC']","Pharmacodynamic Study","A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)","False","798872a5-19cd-4389-a99b-875e4d5f0671","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C49662"
"2023","Pharmacoeconomic Study","C39493","PHARMACOECONOMIC","['PHARMACOECONOMIC']","Pharmacoeconomic Study","A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)","False","7bcb8904-2953-4647-a850-667282a0ab7d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C39493"
"2024","Pharmacogenomic Study","C49661","PHARMACOGENOMIC","['PHARMACOGENOMIC']","Pharmacogenomic Study","A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)","False","f2d960e7-6de4-4d92-adf4-d279aaed8f6a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C49661"
"2025","Pharmacokinetic Study","C49663","PHARMACOKINETIC","['PHARMACOKINETIC']","Pharmacokinetic Study","A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)","False","405054e3-1b2d-40c9-af6a-3d16913d9b98","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C49663"
"2026","Safety Study","C49667","SAFETY","['SAFETY']","Safety Study","A study of the relative safety of treatment of a disease. Usually this is a Phase I or II trial. (NCI)","False","cebe38d8-a43b-454d-b5cc-018ed076176c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66739/C49667"
"2027","Units for Vital Signs Results","C66770","VSRESU","['VSRESU', 'Units for Vital Signs Results']","CDISC SDTM Unit for Vital Sign Result Terminology","The unit used to record and describe the result of a test investigating a vital sign. (NCI)","False","0f3ecafd-257e-4019-9e37-c842473378e2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770"
"2028","Percentage","C25613","%","['%', 'Percentage']","Percentage","A fraction or ratio with 100 understood as the denominator. (NCI)","False","9bea12d7-1e82-4891-80ce-7ac845b1c65c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C25613"
"2029","Beats per Minute","C49673","BEATS/MIN","['BEATS/MIN', 'Beats per Minute']","Beats per Minute","The number of heartbeats measured per minute time. (NCI)","False","d80bdb00-1049-4ad2-a03e-1bb9637b2bf9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C49673"
"2030","Breaths per Minute","C49674","BREATHS/MIN","['BREATHS/MIN', 'Breaths per Minute']","Breaths per Minute","The number of breaths (inhalation and exhalation) taken per minute time. (NCI)","False","b52eeef9-c0fa-46c3-8155-c6bcef72f6f0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C49674"
"2031","Degree Celsius","C42559","C","['C', 'Degree Celsius']","Degree Celsius","A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)","False","98ff0501-ff6e-495b-ae4c-f329e0b26f40","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C42559"
"2032","Centimeter","C49668","cm","['cm', 'Centimeter']","Centimeter","A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)","False","6fc0c7fa-c88d-4461-9f89-4a2d25a50db8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C49668"
"2033","Degree Fahrenheit","C44277","F","['F', 'Degree Fahrenheit']","Degree Fahrenheit","The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724.  In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)","False","848118b8-946f-41a1-b71c-50ca3ed1f91f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C44277"
"2034","Gram","C48155","g","['g', 'Gram']","Gram","A metric unit of mass equal to one one thousandth of a kilogram. (NCI)","False","af5bd956-e2eb-459a-83a2-38f4375510b8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C48155"
"2035","Inch","C48500","IN","['Inch']","Inch","A traditional unit of length equal to 2.54 centimeters. (NCI)","False","59f26cc5-cdf6-49e5-a152-f45c7a9f6abf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C48500"
"2036","Kilogram","C28252","kg","['kg', 'Kilogram']","Kilogram","The basic SI unit of mass.  It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)","False","4148d30b-f743-4d03-af8b-69275cdde391","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C28252"
"2037","Kilogram Per Square Meter","C49671","kg/m2","['kg/m2', 'Kilogram Per Square Meter']","Kilogram Per Square Meter","The SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)","False","c2bd78c2-2b94-449c-9460-98620818aa84","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C49671"
"2038","Pound","C48531","LB","['LB', 'Pound']","Pound","A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)","False","530a3256-d94c-4fa7-bd6e-7bc84d4310a7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C48531"
"2039","Square Meter","C42569","m2","['m2', 'Square Meter']","Square Meter","The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)","False","658e8c44-6c38-477f-9e8d-26953ff069be","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C42569"
"2040","Millimeter of Mercury","C49670","mmHg","['mmHg', 'Millimeter of Mercury']","Millimeter of Mercury","A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)","False","7b24a1de-c5c3-40de-9d43-131c83e901a1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C49670"
"2041","Ohm","C42554","ohm","['ohm']","Ohm","A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens. (NCI)","False","1fc08a8e-c71d-4e11-912d-f672fa0fe23f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66770/C42554"
"2042","Vital Signs Test Code","C66741","VSTESTCD","['VSTESTCD', 'Vital Signs Test Code']","CDISC SDTM Vital Sign Terminology by Code","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","74127b86-67a7-433c-a216-0c1b80772d42","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741"
"2043","Body Mass Index","C16358","BMI","['BMI', 'Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","c25a9815-6eb1-46e7-82f7-fa2a22c62e3d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C16358"
"2044","Adipose Tissue","C12472","BODYFAT","['BODYFAT', 'Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","d7539793-760a-4e28-a58d-0ed2ddf5f8f6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C12472"
"2045","Body Surface Area","C25157","BSA","['BSA', 'Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","86debb3f-c69d-44d5-b35a-5940a7750c09","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C25157"
"2046","Diastolic Blood Pressure","C25299","DIABP","['DIABP', 'Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","a27a0743-765e-4cfa-98f4-b46da1553ba1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C25299"
"2047","Body Frame Size","C49680","FRMSIZE","['FRMSIZE', 'Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","97e5b3ea-9f61-450a-8ab6-60b8e422a3af","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C49680"
"2048","Height","C25347","HEIGHT","['HEIGHT', 'Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","69ad9cfa-5cae-410b-9670-afc35e581207","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C25347"
"2049","Heart Rate","C49677","HR","['HR', 'Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","de2d1817-2fb5-480d-b567-4b8d5c383326","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C49677"
"2050","Mean Arterial Pressure","C49679","MAP","['MAP', 'Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","7a4642bf-b7e9-4fdd-b6a0-5fa6c4856757","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C49679"
"2051","Pulse Rate","C49676","PULSE","['PULSE', 'Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","5fb39dc2-ad4c-45de-8657-75a7a90be6c4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C49676"
"2052","Respiratory Rate","C49678","RESP","['RESP', 'Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","894e1508-4a88-412e-bb7e-8d306d5ebd8e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C49678"
"2053","Systolic Blood Pressure","C25298","SYSBP","['SYSBP', 'Systolic Blood Pressure']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","0f405ca5-752b-4283-9129-4570d7050266","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C25298"
"2054","Temperature","C25206","TEMP","['TEMP', 'Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","bb5b4407-c7db-400d-bec7-3b1cc9e3f3d9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C25206"
"2055","Weight","C25208","WEIGHT","['WEIGHT', 'Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","390bf14e-5749-432a-8260-d45f7170f20d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66741/C25208"
"2056","Vital Signs Test Name ","C67153","VSTEST","['VSTEST', 'Vital Signs Test Name']","CDISC SDTM Vital Sign Terminology  by Name","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","21ea3800-fdbb-42f9-a96f-df4781e783a4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153"
"2057","Body Mass Index","C16358","Body Mass Index","['BMI', 'Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","d110b40a-64d7-49c3-874f-4684454c1cb6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C16358"
"2058","Adipose Tissue","C12472","Body Fat","['BODYFAT', 'Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","11712818-3b8a-46ba-9d81-6867366c32bf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C12472"
"2059","Body Surface Area","C25157","Body Surface Area","['BSA', 'Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","64229090-38a5-4281-b096-3d8fb03c3f43","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C25157"
"2060","Diastolic Blood Pressure","C25299","Diastolic Blood Pressure","['DIABP', 'Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","4c3d5267-0c5f-4fc9-afc1-bc62ecb28921","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C25299"
"2061","Body Frame Size","C49680","Frame Size","['FRMSIZE', 'Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","f358a51f-5f1f-4e2d-9e9d-6b3192a3ef42","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C49680"
"2062","Height","C25347","Height","['HEIGHT', 'Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","da173589-bec5-4739-afad-178235684dcc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C25347"
"2063","Heart Rate","C49677","Heart Rate","['HR', 'Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","e5c487c6-9b94-4d94-b430-e05472c5f678","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C49677"
"2064","Mean Arterial Pressure","C49679","Mean Arterial Pressure","['MAP', 'Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","1897d2a5-7177-4df1-b18c-326911a369bf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C49679"
"2065","Pulse Rate","C49676","Pulse Rate","['PULSE', 'Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","6d92ba0f-0664-4681-91a0-bbba133189bc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C49676"
"2066","Respiratory Rate","C49678","Respiratory Rate","['RESP', 'Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","967a9fc5-cac4-453e-b029-c9ed07774db5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C49678"
"2067","Systolic Blood Pressure","C25298","Systolic Blood Pressure","['SYSBP', 'Systolic Blood Pressure']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","6debc345-6e06-4ef7-bd20-7b93eeea4ebb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C25298"
"2068","Temperature","C25206","Temperature","['TEMP', 'Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","cd1acf2f-196f-4780-8fc5-f1e9bab186e4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C25206"
"2069","Weight","C25208","Weight","['WEIGHT', 'Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","d94b2e47-1438-4dfe-8e68-397c187d86e7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67153/C25208"
"2070","No Yes Response","C66742","NY","['NY', 'No Yes Response']","CDISC SDTM Yes No Unknown or Not Applicable Response Terminology","A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.","False","9a19fe31-f422-4b73-9e29-62480f4c068a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66742"
"2071","No","C49487","N","['N', 'No']","No","The non-affirmative response to a question. (NCI)","False","f418f136-679b-4d03-ba36-1dce4dcf6eaf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66742/C49487"
"2072","Not Applicable","C48660","","['NOT APPLICABLE', 'NA']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","52003abb-5890-4920-b6da-c50807b87b54","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66742/C48660"
"2073","Unknown","C17998","U","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","ea21bf2d-49f1-4bd7-8696-f2bb9e918604","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66742/C17998"
"2074","Yes","C49488","Y","['Y', 'Yes']","Yes","The affirmative response to a question. (NCI)","False","00713dd6-d1ed-4b5f-87d9-47efe8fef68f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C66742/C49488"
"2075","Laboratory Test Code","C65047","LBTESTCD","['LBTESTCD', 'Laboratory Test Code']","CDISC SDTM Laboratory Test Terminology by Code","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","8a4898b6-c02c-4e95-9a07-b9aa7ff5e120","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047"
"2076","Anisocytosis","C35266","ANISO","['ANISO', 'Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","4ed4f7cb-d742-4fd0-a825-28dc5089186d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C35266"
"2077","Poikilocytosis","C35267","POIKILO","['POIKILO', 'Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","b9e1a9ac-5937-4478-8487-7cae5b320d56","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C35267"
"2078","Total Bilirubin","C38037","BILI","['BILI', 'Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","0b635eae-9632-4814-a0d0-0f27784d5da7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C38037"
"2079","Partial Thromboplastin Time","C38462","APTT","['APTT', 'Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","edaffb51-c141-4362-9eae-1936c5a26886","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C38462"
"2080","Plasma Glucose Measurement","C41376","GLUC","['GLUC', 'Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","b92b503f-91ad-42ce-b558-d21938f81bea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C41376"
"2081","pH","C45997","PH","['PH', 'pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","ed8c9c8a-6741-4f07-97f6-c2371870febc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C45997"
"2082","Erythrocyte Count","C51946","RBC","['RBC', 'Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","91de2ede-42c6-47f3-b397-222482f78c34","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C51946"
"2083","Reticulocyte Count","C51947","RETI","['RETI', 'Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","d79d892b-65cd-4b5a-9702-0645c8ae7727","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C51947"
"2084","Leukocyte Count","C51948","WBC","['WBC', 'Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","3d0321b7-1d36-4cee-8194-76fc43078926","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C51948"
"2085","Lymphocyte Count","C51949","LYM","['LYM', 'Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","b43ac57c-42ad-4f5c-b648-2146ea8383f7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C51949"
"2086","Platelet Count","C51951","PLAT","['PLAT', 'Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","821a3f37-d965-4f02-bbcd-e084e3713483","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C51951"
"2087","Blood Urea Nitrogen Measurement","C61019","BUN","['BUN', 'Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","9b2c9861-77c2-44d3-b112-8dbf6091283d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C61019"
"2088","Serum Total Cholesterol Measurement","C61032","CHOL","['CHOL', 'Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","2ffff5bc-ae73-4208-a782-1255c6b2fe86","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C61032"
"2089","Serum HDL Cholesterol Measurement","C61041","HDL","['HDL', 'HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","767e2a81-b405-4d23-aae3-f7e73aa320a9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C61041"
"2090","Serum LDL Cholesterol Measurement","C61042","LDL","['LDL', 'LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","63804166-a950-4656-aa65-3157d669b1e7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C61042"
"2091","Prothrombin Time","C62656","PT","['PT', 'Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","ee3797a6-e8a9-42c4-9c85-bd26ed92319c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C62656"
"2092","Absolute Neutrophil Count","C63321","NEUT","['NEUT', 'Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","ab722ab5-9c82-47dd-b1db-521af202fac6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C63321"
"2093","Albumin Measurement","C64431","ALB","['ALB', 'Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","c4bba107-7483-459d-92ee-f5ac00cebaea","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64431"
"2094","Alkaline Phosphatase Measurement","C64432","ALP","['ALP', 'Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","8f916822-f2e9-4118-b775-3d1512ecb9f0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64432"
"2095","Alanine Aminotransferase Measurement","C64433","ALT","['ALT', 'Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","4009f4ac-6d30-48dd-8508-050c2501d53f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64433"
"2096","Amylase Measurement","C64434","AMYLASE","['AMYLASE', 'Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","f54a8dfe-d19f-4751-ac20-269a3aef348b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64434"
"2097","Aspartate Aminotransferase Measurement","C64467","AST","['AST', 'Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","844a25b1-5d08-4b35-84e3-a619bf6e3366","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64467"
"2098","Bacterial Count","C64469","BACT","['BACT', 'Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","577f2531-b5d8-4252-a2f2-1ff1ed9f50df","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64469"
"2099","Total Basophil Count","C64470","BASO","['BASO', 'Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","7947fcf6-bb73-4543-8e06-a77716d3bfb8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64470"
"2100","Basophil To Leukocyte Ratio","C64471","BASOLE","['BASOLE', 'Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","7413be64-a084-45ef-a616-5f05d11619bf","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64471"
"2101","Direct Bilirubin Measurement","C64481","BILDIR","['BILDIR', 'Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","73959f2e-e25a-43e5-bf60-e31e4beec338","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64481"
"2102","Indirect Bilirubin Measurement","C64483","BILIND","['BILIND', 'Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","62f5f762-ee70-4590-81d4-9fa08ddb5372","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64483"
"2103","Blast To Leukocyte Ratio","C64487","BLASTLE","['BLASTLE', 'Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","05a42563-ebf3-40a4-8e04-7b7e99e2bf5d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64487"
"2104","Calcium Measurement","C64488","CA","['CA', 'Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","a67b84b4-88bb-403e-9954-2c9c7f5ec9fa","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64488"
"2105","Creatine Kinase Measurement","C64489","CK","['CK', 'Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","dce29343-4b6f-4fe7-beba-1813db9f32d2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64489"
"2106","Creatine Kinase BB Measurement","C64490","CKBB","['CKBB', 'Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","36638477-bf38-4760-a6be-381b631df685","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64490"
"2107","Creatine Kinase MB Measurement","C64491","CKMB","['CKMB', 'Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","a6daa1d3-e42e-4f94-acb7-8ff4d0e52269","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64491"
"2108","Creatine Kinase MM Measurement","C64494","CKMM","['CKMM', 'Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","6946262c-ba22-43f5-951a-fe222e845975","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64494"
"2109","Chloride Measurement","C64495","CL","['CL', 'Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","d8cdff15-2ad3-4cd0-9229-442e9a2b2a52","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64495"
"2110","Carbon Dioxide Measurement","C64545","CO2","['CO2', 'Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","36495dfa-53c5-4aad-938b-8798c025f7fb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64545"
"2111","Color Assessment","C64546","COLOR","['COLOR', 'Color']","Color Assessment","A measurement of the color of a biological specimen.","False","628d3da3-2d00-487d-bb24-d4e15071c090","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64546"
"2112","Creatinine Measurement","C64547","CREAT","['CREAT', 'Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","23f63f60-c926-4cf9-a78f-25bfff604cbc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64547"
"2113","C-Reactive Protein Measurement","C64548","CRP","['CRP', 'C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","4398db70-f307-41fe-a672-cc3ed6a103c8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64548"
"2114","Elliptocyte Count","C64549","ELLIPCY","['ELLIPCY', 'Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","ae418e14-7ff6-47e8-bd10-1dbc41086837","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64549"
"2115","Eosinophil Count","C64550","EOS","['EOS', 'Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","c9bd0597-9019-4ffe-aee2-f1fc72d39b1d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64550"
"2116","Eosinophil To Leukocyte Ratio","C64604","EOSLE","['EOSLE', 'Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","bc35ab0e-0474-4dd3-aa18-b7c150afb26d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64604"
"2117","Epithelial Cell Count","C64605","EPIC","['EPIC', 'Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","28718cf4-370e-43b6-a427-7db73b21a18e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64605"
"2118","Fibrinogen Measurement","C64606","FIBRINO","['FIBRINO', 'Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","768e09bb-ea50-4821-add7-a22ed3f4e37c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64606"
"2119","Hematocrit","C64796","HCT","['HCT', 'Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","735ad354-71bd-4f4d-b54a-d46db12b3ca9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64796"
"2120","Erythrocyte Mean Corpuscular Hemoglobin","C64797","MCH","['MCH', 'Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","7b883392-31eb-4d4a-abda-0337f7b06fe7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64797"
"2121","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","MCHC","['MCHC', 'Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","5b6d34b6-fc2e-459d-a208-e48c47323a23","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64798"
"2122","Erythrocyte Mean Corpuscular Volume","C64799","MCV","['MCV', 'Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","1406e110-21b0-492b-ad8b-4d87f9f9eb6a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64799"
"2123","Erythrocyte Distribution Width Measurement","C64800","RDW","['RDW', 'Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","f4459555-175a-4b99-9003-9eae8304f36c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64800"
"2124","Dacryocyte Analysis","C64801","TEARDCY","['TEARDCY', 'Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","d8686023-2da2-4d04-aaed-7251e2b77c8b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64801"
"2125","Hypochromia","C64802","HYPO","['HYPO', 'Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","8c8bb5e7-3c2f-46d9-96b2-9cbfbd89bf3e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64802"
"2126","Polychromasia","C64803","POLYCHR","['POLYCHR', 'Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","9bdac90a-6555-4245-899e-046faa2173b6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64803"
"2127","International Normalized Ratio of Prothrombin Time","C64805","INR","['INR', 'Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","7d1a088f-125b-4cfb-afa8-895fed2dd06c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64805"
"2128","Serum VLDL Cholesterol Measurement","C64806","VLDL","['VLDL', 'VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","bc305de5-cd93-4105-a263-e42581d06177","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64806"
"2129","Triacylglycerol Lipase Measurement","C64807","LIPASE","['LIPASE', 'Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","ffa6e209-d27e-49a4-b650-71d40d781b17","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64807"
"2130","Sodium Measurement","C64809","SODIUM","['SODIUM', 'Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","d0062789-c177-490a-b0a0-88dbf403bb17","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64809"
"2131","Nitrite Measurement","C64810","NITRITE","['NITRITE', 'Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","6b6a8f4d-4ade-4cff-8a36-3f9ef6e79cf5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64810"
"2132","Triglyceride Measurement","C64812","TRIG","['TRIG', 'Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","f8eaf794-56ed-4a0f-9727-77c710eb0782","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64812"
"2133","Thyrotropin Measurement","C64813","TSH","['TSH', 'Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","a8e9d7d1-7523-433d-a5ac-2ad0a661fbe3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64813"
"2134","Urate Measurement","C64814","URATE","['URATE', 'Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","225c1757-f2e8-4ff8-8930-9083cbf0fc78","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64814"
"2135","Urea Measurement","C64815","UREA","['UREA', 'Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","7108c71a-2217-4d7c-b6e7-03004682a8f3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64815"
"2136","Urobilinogen Measurement","C64816","UROBIL","['UROBIL', 'Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","e871cbb8-8e3a-4f4c-988d-c3484b297c5f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64816"
"2137","Vitamin B12 Measurement","C64817","VITB12","['VITB12', 'Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","77849a65-124d-48ba-97a9-4f93c8cc28e3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64817"
"2138","Atypical Lymphocyte Count","C64818","LYMAT","['LYMAT', 'Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","0efd884b-6b72-4b95-95c1-60c8c116e7f6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64818"
"2139","Atypical Lymphocyte To Leukocyte Ratio","C64819","LYMATLE","['LYMATLE', 'Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","189a3aa0-fe81-4219-9c55-77be7c89aa03","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64819"
"2140","Lymphocyte To Leukocyte Ratio","C64820","LYMLE","['LYMLE', 'Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","2518323e-efe4-4501-a9c9-afd1849fd29e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64820"
"2141","Macrocyte Count","C64821","MACROCY","['MACROCY', 'Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","360b8cf5-7a34-4046-816d-b2dc2151eeff","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64821"
"2142","Microcyte Count","C64822","MICROCY","['MICROCY', 'Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","3451ae75-3f7f-47fe-bffa-a748c22f4f20","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64822"
"2143","Monocyte Count","C64823","MONO","['MONO', 'Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","d4ddf7b5-8db6-4d21-9151-dd5f59e6b2a3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64823"
"2144","Monocyte To Leukocyte Ratio","C64824","MONOLE","['MONOLE', 'Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","ea6fd17e-69d8-4bf7-94de-7665575f8228","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64824"
"2145","Myeloblast To Leukocyte Ratio","C64825","MYBLALE","['MYBLALE', 'Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","8b13701b-a541-49d0-898f-f9de23d2dc24","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64825"
"2146","Myelocyte To Leukocyte Ratio","C64826","MYCYLE","['MYCYLE', 'Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","884d9c80-69b2-4fdd-af2e-e5cf143d3112","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64826"
"2147","Neutrophil To Leukocyte Ratio","C64827","NEUTLE","['NEUTLE', 'Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","04b16ee9-092c-474e-9024-ed39ec557a0e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64827"
"2148","Reticulocyte To Erythrocyte Ratio","C64828","RETIRBC","['RETIRBC', 'Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","f52d93ea-f600-4121-ac4e-7d5a2a05e53e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64828"
"2149","Prolymphocyte To Leukocyte Ratio","C64829","PRLYMLE","['PRLYMLE', 'Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","cdc4a9a3-0cbc-4cd5-8ac9-63b612f3e7d0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64829"
"2150","Neutrophil Band Form Count","C64830","NEUTB","['NEUTB', 'Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","c4421445-9583-44c6-9774-99b65f257b9b","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64830"
"2151","Neutrophil Band Form To Leukocyte Ratio","C64831","NEUTBLE","['NEUTBLE', 'Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","7cf9fb25-4c4c-4949-b55c-bf79d9328e33","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64831"
"2152","Specific Gravity","C64832","SPGRAV","['SPGRAV', 'Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","6bcf885e-720d-4a53-a161-a1a07cb2d72c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64832"
"2153","Magnesium Measurement","C64840","MG","['MG', 'Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","f57adf00-9f04-4228-81ad-7b90216c18c7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64840"
"2154","Gamma Glutamyl Transpeptidase Measurement","C64847","GGT","['GGT', 'Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","5f22c13d-5d38-47ef-b360-f3e70856ec8c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64847"
"2155","Hemoglobin Measurement","C64848","HGB","['HGB', 'Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","2a933f17-d125-47d7-8aad-07ec0f878fe9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64848"
"2156","Glycosylated Hemoglobin Measurement","C64849","HBA1C","['HBA1C', 'Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","9716e514-7883-4bee-bd53-7d5f230eb66d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64849"
"2157","Hepatitis B Virus Surface Antigen Measurement","C64850","HBSAG","['HBSAG', 'Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","faee76f8-d97c-45c9-a683-8f5992603c89","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64850"
"2158","Choriogonadotropin Beta Measurement","C64851","HCG","['HCG', 'Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","1e70d8d3-cb21-4111-a47c-fff16e8c0e3d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64851"
"2159","Potassium Measurement","C64853","K","['K', 'Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","74757b52-da7b-458c-a761-4385fda56368","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64853"
"2160","Ketone Measurement","C64854","KETONES","['KETONES', 'Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","b873d1f7-222f-4d30-827f-65bf03a7deff","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64854"
"2161","Lactate Dehydrogenase Measurement","C64855","LDH","['LDH', 'Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","6346a743-34a4-47c5-b4bd-1b44f1a221d5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64855"
"2162","Leukocyte Esterase Measurement","C64856","LEUKASE","['LEUKASE', 'Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","8d1ab2e0-d108-4450-b8a9-fefb67006605","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64856"
"2163","Phosphate Measurement","C64857","PHOS","['PHOS', 'Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","8ffa3168-d2ed-4ac7-87b9-7b87725e78b3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64857"
"2164","Total Protein Measurement","C64858","PROT","['PROT', 'Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","5f306e22-a7e3-414d-baba-0c3f368ab117","dataset/cdisc/ct/sc/2007-04-20/sdtm/C65047/C64858"
"2165","Laboratory Test Name ","C67154","LBTEST","['LBTEST', 'Laboratory Test Name']","CDISC SDTM Laboratory Test Terminology by Name","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","8efc120d-c363-4c9d-b155-88e73c70e95c","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154"
"2166","Anisocytosis","C35266","Anisocytosis","['ANISO', 'Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","394e3d0f-4211-420c-b528-ea3586d25911","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C35266"
"2167","Poikilocytosis","C35267","Poikilocytes","['POIKILO', 'Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","f37e4109-5278-4f82-9571-20ef419546a9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C35267"
"2168","Total Bilirubin","C38037","Bilirubin","['BILI', 'Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","f3cddcc7-62d0-44d7-b180-bb08b1815b31","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C38037"
"2169","Partial Thromboplastin Time","C38462","Activated Partial Thromboplastin Time","['APTT', 'Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","0da62b8b-412a-4bef-8f1d-a74048ee5f2a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C38462"
"2170","Plasma Glucose Measurement","C41376","Glucose","['GLUC', 'Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","b68df749-4b6a-4024-8cd9-fd2ef0936bde","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C41376"
"2171","pH","C45997","pH","['PH', 'pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","db3cc00b-2736-4d12-8d16-c55c0a7b958a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C45997"
"2172","Erythrocyte Count","C51946","Erythrocytes","['RBC', 'Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","35d3433a-e444-468b-89b4-eb19806295a1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C51946"
"2173","Reticulocyte Count","C51947","Reticulocytes","['RETI', 'Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","33811841-efb2-4409-b014-3c3f983c5eb7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C51947"
"2174","Leukocyte Count","C51948","Leukocytes","['WBC', 'Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","80b1dc07-9320-4496-af0b-6dadefa88d54","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C51948"
"2175","Lymphocyte Count","C51949","Lymphocytes","['LYM', 'Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","cdab2b13-060b-413a-ac62-9b10014659f5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C51949"
"2176","Platelet Count","C51951","Platelet","['PLAT', 'Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","9d300b49-979e-4410-9fc9-851ee9c1b6ae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C51951"
"2177","Blood Urea Nitrogen Measurement","C61019","Blood Urea Nitrogen","['BUN', 'Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","41646647-1384-4931-a1d4-0c3c87f9b6b2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C61019"
"2178","Serum Total Cholesterol Measurement","C61032","Cholesterol","['CHOL', 'Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","c4bc2118-61b1-4a55-81e6-f11dbdc77e22","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C61032"
"2179","Serum HDL Cholesterol Measurement","C61041","HDL Cholesterol","['HDL', 'HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","d3fc0ab9-1ad2-443c-8bd8-0cbf3ed5649e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C61041"
"2180","Serum LDL Cholesterol Measurement","C61042","LDL Cholesterol","['LDL', 'LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","83547ec2-8821-4f62-8479-a9e9a7b91ad7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C61042"
"2181","Prothrombin Time","C62656","Prothrombin Time","['PT', 'Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","64e16367-0c64-4c78-a2be-58706a113a22","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C62656"
"2182","Absolute Neutrophil Count","C63321","Neutrophils","['NEUT', 'Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","8d003d7e-5dc4-48c4-9e40-f3dedf2e14a1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C63321"
"2183","Albumin Measurement","C64431","Albumin","['ALB', 'Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","42f784b7-b7fd-4a13-987f-19356788c255","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64431"
"2184","Alkaline Phosphatase Measurement","C64432","Alkaline Phosphatase","['ALP', 'Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","56827084-ed8c-4951-99a0-bd80b8ff2cb8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64432"
"2185","Alanine Aminotransferase Measurement","C64433","Alanine Aminotransferase","['ALT', 'Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","6f5d16ae-59cb-4dc2-9463-6be49b8a3035","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64433"
"2186","Amylase Measurement","C64434","Amylase","['AMYLASE', 'Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","01c3d364-aced-4bc1-89b3-45aee235d5c2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64434"
"2187","Aspartate Aminotransferase Measurement","C64467","Aspartate Aminotransferase","['AST', 'Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","d62b1c4e-7c90-4f50-8538-63421f0f0b29","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64467"
"2188","Bacterial Count","C64469","Bacteria","['BACT', 'Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","76c32b30-b3d6-4574-8236-7dec3911bce6","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64469"
"2189","Total Basophil Count","C64470","Basophils","['BASO', 'Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","00915385-bafa-4f46-a127-5983bee0efb0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64470"
"2190","Basophil To Leukocyte Ratio","C64471","Basophils/Leukocytes","['BASOLE', 'Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","66bc68df-668e-4a1c-a2c8-5c369c97d5da","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64471"
"2191","Direct Bilirubin Measurement","C64481","Direct Bilirubin","['BILDIR', 'Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","669af099-0975-496e-879b-c40f2c7b398a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64481"
"2192","Indirect Bilirubin Measurement","C64483","Indirect Bilirubin","['BILIND', 'Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","fa14e7cf-8321-4478-a515-635806bc2af8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64483"
"2193","Blast To Leukocyte Ratio","C64487","Blasts/Leukocytes","['BLASTLE', 'Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","fa5cacb4-ffc0-4d44-8f34-bbe0c81814f3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64487"
"2194","Calcium Measurement","C64488","Calcium","['CA', 'Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","8425423c-c9a7-4dc8-9f75-3fe1b7913887","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64488"
"2195","Creatine Kinase Measurement","C64489","Creatine Kinase","['CK', 'Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","b24b6e71-8cf0-4eb4-8356-3096caefd265","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64489"
"2196","Creatine Kinase BB Measurement","C64490","Creatine Kinase BB","['CKBB', 'Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","c9b8568f-19bd-4ca4-a8e7-40f5d67d2ebc","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64490"
"2197","Creatine Kinase MB Measurement","C64491","Creatine Kinase MB","['CKMB', 'Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","c032b73c-f520-4816-9e6c-d9bac50a19d7","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64491"
"2198","Creatine Kinase MM Measurement","C64494","Creatine Kinase MM","['CKMM', 'Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","6490b9f3-1ea5-4f87-ad48-5d442f4de1bb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64494"
"2199","Chloride Measurement","C64495","Chloride","['CL', 'Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","98c8e42d-304d-4c08-b1ad-4ffb0092db16","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64495"
"2200","Carbon Dioxide Measurement","C64545","Carbon Dioxide","['CO2', 'Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","41599429-6825-45ce-b676-17ee6714be3d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64545"
"2201","Color Assessment","C64546","Color","['COLOR', 'Color']","Color Assessment","A measurement of the color of a biological specimen.","False","731a2420-098a-4be4-925b-985806e676e3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64546"
"2202","Creatinine Measurement","C64547","Creatinine","['CREAT', 'Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","6b25c65a-8e27-45f2-98b6-b60eb984b8b8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64547"
"2203","C-Reactive Protein Measurement","C64548","C Reactive Protein","['CRP', 'C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","be53cc5f-cdee-41ac-8d44-1e6c44e98f41","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64548"
"2204","Elliptocyte Count","C64549","Elliptocytes","['ELLIPCY', 'Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","88874cac-446b-45cd-a913-975631d13120","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64549"
"2205","Eosinophil Count","C64550","Eosinophils","['EOS', 'Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","7069e970-f340-4814-bed7-c08c9083bd46","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64550"
"2206","Eosinophil To Leukocyte Ratio","C64604","Eosinophils/Leukocytes","['EOSLE', 'Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","96e086af-4324-45af-8494-ae5f86748a48","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64604"
"2207","Epithelial Cell Count","C64605","Epithelial Cells","['EPIC', 'Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","635526fb-8343-4a96-98ef-9d3079626870","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64605"
"2208","Fibrinogen Measurement","C64606","Fibrinogen","['FIBRINO', 'Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","cebc57e7-3ab6-4ea3-b4cd-e98b03504730","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64606"
"2209","Hematocrit","C64796","Hematocrit","['HCT', 'Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","174288e0-e7ba-451c-87bb-66aea97b0bd5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64796"
"2210","Erythrocyte Mean Corpuscular Hemoglobin","C64797","Ery. Mean Corpuscular Hemoglobin","['MCH', 'Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","dedf0f54-af13-4fa5-8d7e-68dc9a375f4d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64797"
"2211","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","Ery. Mean Corpuscular HB Concentration","['MCHC', 'Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","7549a26f-783a-4a3b-90dc-6427e412a34d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64798"
"2212","Erythrocyte Mean Corpuscular Volume","C64799","Ery. Mean Corpuscular Volume","['MCV', 'Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","04f0309d-6825-43e5-a05d-b98b2590db68","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64799"
"2213","Erythrocyte Distribution Width Measurement","C64800","Erythrocytes Distribution Width","['RDW', 'Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","cb1b4508-e9e1-4aa9-b9a0-64e052f5d19f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64800"
"2214","Dacryocyte Analysis","C64801","Dacryocytes","['TEARDCY', 'Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","84b2bb33-7b42-49b4-9b19-25c449502555","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64801"
"2215","Hypochromia","C64802","Hypochromia","['HYPO', 'Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","feb01de6-67db-4296-9e39-9cffa6cb1fba","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64802"
"2216","Polychromasia","C64803","Polychromasia","['POLYCHR', 'Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","0f0e708d-9ad0-4484-94be-1c54e9c42628","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64803"
"2217","International Normalized Ratio of Prothrombin Time","C64805","Prothrombin Intl. Normalized Ratio","['INR', 'Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","ba70b475-a469-41ba-bb25-80cc3fd6a1eb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64805"
"2218","Serum VLDL Cholesterol Measurement","C64806","VLDL Cholesterol","['VLDL', 'VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","9298ec36-f45d-4162-9fc6-af830dfa2be4","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64806"
"2219","Triacylglycerol Lipase Measurement","C64807","Triacylglycerol Lipase","['LIPASE', 'Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","e877704f-9c03-4c27-8f12-ccc4728f36a3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64807"
"2220","Sodium Measurement","C64809","Sodium","['SODIUM', 'Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","b17c7d7e-b09e-4c75-b20c-965d28ccceeb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64809"
"2221","Nitrite Measurement","C64810","Nitrite","['NITRITE', 'Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","ed74ca64-4d24-41da-b595-88e5b593c8f8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64810"
"2222","Triglyceride Measurement","C64812","Triglycerides","['TRIG', 'Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","5e928baa-d3ac-4c46-ba22-9a5a339ff322","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64812"
"2223","Thyrotropin Measurement","C64813","Thyrotropin","['TSH', 'Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","b162db88-80d4-40fe-bb61-ef3d1d4fa644","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64813"
"2224","Urate Measurement","C64814","Urate","['URATE', 'Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","e9c27ef8-0736-4b3f-9d37-1243c9afff37","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64814"
"2225","Urea Measurement","C64815","Urea","['UREA', 'Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","b57083fe-19be-4778-a527-1245e83f8e79","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64815"
"2226","Urobilinogen Measurement","C64816","Urobilinogen","['UROBIL', 'Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","7207b188-0e51-4d9d-96f2-c35dc07c3f4e","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64816"
"2227","Vitamin B12 Measurement","C64817","Vitamin B12","['VITB12', 'Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","2b8aade5-d6cd-4306-bdc8-13592ec74fa8","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64817"
"2228","Atypical Lymphocyte Count","C64818","Lymphocytes Atypical","['LYMAT', 'Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","dab2197e-4f2a-47c8-8ce1-68fbcf9cf8e9","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64818"
"2229","Atypical Lymphocyte To Leukocyte Ratio","C64819","Lymphocytes Atypical/Leukocytes","['LYMATLE', 'Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","c38d65fe-aff8-4ea7-a529-b628a0553798","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64819"
"2230","Lymphocyte To Leukocyte Ratio","C64820","Lymphocytes/Leukocytes","['LYMLE', 'Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","b2c1bf2d-1a54-49d2-8234-dfa24bdd7fe2","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64820"
"2231","Macrocyte Count","C64821","Macrocytes","['MACROCY', 'Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","1f1cfa69-d7d9-4ae3-91cb-bef14af153c0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64821"
"2232","Microcyte Count","C64822","Microcytes","['MICROCY', 'Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","9f1c1405-0bae-433e-8fa1-20790d81a065","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64822"
"2233","Monocyte Count","C64823","Monocytes","['MONO', 'Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","128de9df-dbde-46ae-992f-6239fbcb1904","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64823"
"2234","Monocyte To Leukocyte Ratio","C64824","Monocytes/Leukocytes","['MONOLE', 'Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","ee4288ae-06d1-40f6-b7c5-cf501145419a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64824"
"2235","Myeloblast To Leukocyte Ratio","C64825","Myeloblasts/Leukocytes","['MYBLALE', 'Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","d75e34ce-b588-4175-b7cd-59b094365790","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64825"
"2236","Myelocyte To Leukocyte Ratio","C64826","Myelocytes/Leukocytes","['MYCYLE', 'Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","b552a1cb-2ab7-486b-a385-1cebd1615230","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64826"
"2237","Neutrophil To Leukocyte Ratio","C64827","Neutrophils/Leukocytes","['NEUTLE', 'Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","8b36086d-1798-4522-917b-226ae067c48f","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64827"
"2238","Reticulocyte To Erythrocyte Ratio","C64828","Reticulocytes/Erythrocytes","['RETIRBC', 'Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","3f12d8bd-9ea7-45dc-bc21-c189b95fa99a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64828"
"2239","Prolymphocyte To Leukocyte Ratio","C64829","Prolymphocytes/Leukocytes","['PRLYMLE', 'Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","8567e4b1-3d99-4441-991a-d7b745a05de5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64829"
"2240","Neutrophil Band Form Count","C64830","Neutrophils Band Form","['NEUTB', 'Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","857f3d31-837f-43b2-a7ca-42e8cf4dfa7a","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64830"
"2241","Neutrophil Band Form To Leukocyte Ratio","C64831","Neutrophils Band Form/Leukocytes","['NEUTBLE', 'Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","47f1a36f-c3ce-4f85-9615-3c61752174a1","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64831"
"2242","Specific Gravity","C64832","Specific Gravity","['SPGRAV', 'Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","54a14592-9384-409f-b73a-473dbfc14487","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64832"
"2243","Magnesium Measurement","C64840","Magnesium","['MG', 'Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","19ae6b95-0962-4e76-853e-876ac854b0d3","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64840"
"2244","Gamma Glutamyl Transpeptidase Measurement","C64847","Gamma Glutamyl Transferase","['GGT', 'Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","368b8cc4-bec4-4c8e-8984-612eeccbb319","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64847"
"2245","Hemoglobin Measurement","C64848","Hemoglobin","['HGB', 'Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","d8dbae0e-535d-44b1-aabb-a402a4be1e30","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64848"
"2246","Glycosylated Hemoglobin Measurement","C64849","Hemoglobin A1C","['HBA1C', 'Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","ce937254-c193-49b4-b0e4-32a2eafde45d","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64849"
"2247","Hepatitis B Virus Surface Antigen Measurement","C64850","Hepatitis B Virus Surface Antigen","['HBSAG', 'Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","48dd893f-eab5-4586-b5fd-2580bfc59951","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64850"
"2248","Choriogonadotropin Beta Measurement","C64851","Choriogonadotropin Beta","['HCG', 'Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","e319b87f-fbbe-4d54-80dd-8187821248cb","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64851"
"2249","Potassium Measurement","C64853","Potassium","['K', 'Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","d6a60498-888a-4f6d-858e-a860095e7c66","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64853"
"2250","Ketone Measurement","C64854","Ketones","['KETONES', 'Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","7b383b16-d197-40cf-b511-c7052137c5ab","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64854"
"2251","Lactate Dehydrogenase Measurement","C64855","Lactate Dehydrogenase","['LDH', 'Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","05c98328-dff9-4f24-abfe-78cbf27c0da0","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64855"
"2252","Leukocyte Esterase Measurement","C64856","Leukocyte Esterase","['LEUKASE', 'Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","111aebde-acfd-4dea-90ca-4784f912e3d5","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64856"
"2253","Phosphate Measurement","C64857","Phosphate","['PHOS', 'Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","8f34688f-aee5-4aa7-a0dd-a82c78fdcbae","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64857"
"2254","Total Protein Measurement","C64858","Protein","['PROT', 'Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","26ee3033-a1a5-4464-9376-06ef337d9fee","dataset/cdisc/ct/sc/2007-04-20/sdtm/C67154/C64858"
"2255","Action Taken with Study Treatment ","C66767","ACN","['ACN', 'Action Taken with Study Treatment']","CDISC SDTM Action Taken with Study Treatment Terminology","The reason that changes were made to the therapy under study. (NCI)","False","7fb0dd8f-ad58-45f5-b7b6-e035116aa42c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767"
"2256","Dose Increased","C49503","DOSE INCREASED","['DOSE INCREASED']","Dose Increased","An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)","False","3f68253c-91fe-47d2-9f81-e0701e15fece","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767/C49503"
"2257","Dose Not Changed","C49504","DOSE NOT CHANGED","['DOSE NOT CHANGED']","Dose Not Changed","An indication that a medication schedule was maintained. (NCI)","False","d0f50400-db53-4932-a8fe-228f1fc8bce8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767/C49504"
"2258","Dose Reduced","C49505","DOSE REDUCED","['DOSE REDUCED']","Dose Reduced","An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)","False","8f41288f-6fcd-4028-a387-fd78bdd20ea6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767/C49505"
"2259","Drug Interrupted","C49501","DRUG INTERRUPTED","['DRUG INTERRUPTED']","Drug Interrupted","An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)","False","c605324a-5a9c-441e-9a81-0c2cfde3cb27","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767/C49501"
"2260","Drug Withdrawn","C49502","DRUG WITHDRAWN","['DRUG WITHDRAWN']","Drug Withdrawn","An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)","False","9418558a-cc8f-4f6e-9a76-b4b06435aaf2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767/C49502"
"2261","Not Applicable","C48660","NOT APPLICABLE","['NOT APPLICABLE', 'NA']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","40160894-0f23-4b1c-b7f9-06649dfa0139","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767/C48660"
"2262","Unknown","C17998","UNKNOWN","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","f536ec3b-fe5c-4d3d-93d4-d4f9cd495485","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66767/C17998"
"2263","Outcome of Event","C66768","OUT","['OUT', 'Outcome of Event']","CDISC SDTM Adverse Event Outcome Terminology","A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)","False","c5aacd1a-4131-40a3-98a6-ed3a68d480f6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66768"
"2264","Death Related to Adverse Event","C48275","FATAL","['FATAL', 'Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","54f32abc-6dcc-40e7-a6c8-72b9bead377a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66768/C48275"
"2265","Not Recovered or Not Resolved","C49494","NOT RECOVERED/NOT RESOLVED","['NOT RECOVERED/NOT RESOLVED']","Not Recovered or Not Resolved","One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)","False","43ce7d62-0079-4c7b-970f-ffa5aec7ab44","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66768/C49494"
"2266","Recovered or Resolved","C49498","RECOVERED/RESOLVED","['RECOVERED/RESOLVED']","Recovered or Resolved","One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)","False","181a84d9-beda-42f9-b00f-7d39dcc6a819","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66768/C49498"
"2267","Recovered or Resolved with Sequelae","C49495","RECOVERED/RESOLVED WITH SEQUELAE","['RECOVERED/RESOLVED WITH SEQUELAE']","Recovered or Resolved with Sequelae","One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)","False","d6babb6d-9593-4702-a804-6856c48836cf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66768/C49495"
"2268","Recovering or Resolving","C49496","RECOVERING/RESOLVING","['RECOVERING/RESOLVING']","Recovering or Resolving","One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)","False","1e283ae0-e40c-421d-8c6f-e30c407c6688","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66768/C49496"
"2269","Unknown","C17998","UNKNOWN","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","e34d73b2-9870-433f-ba3b-495870fc9790","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66768/C17998"
"2270","Age Span","C66780","AGESPAN","['AGESPAN', 'Age Span']","CDISC SDTM Age GroupTerminology","Subgroups of populations based on age. (NCI)","False","2f0a4462-376f-478e-8e37-aac74a5287b2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780"
"2271","Adolescent","C27954","ADOLESCENT (12-17 YEARS)","['ADOLESCENT (12-17 YEARS)']","Adolescent","A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)","False","0901d116-aed2-4ba1-8afd-db1979129fab","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C27954"
"2272","Adult 18-65 Years Old","C49685","ADULT (18-65)","['ADULT (18-65)']","Adult 18-65 Years Old","A person from 18 years to 65 years of age. (NCI)","False","c3416c07-6247-403a-ac5f-c3c949779919","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C49685"
"2273","Children 2-11 Years Old","C49683","CHILDREN (2-11 YEARS)","['CHILDREN (2-11 YEARS)']","Children 2-11 Years Old","A person from 2 years to 11 years of age. (NCI)","False","7c9a2e35-8005-4b21-8d4a-b3618b3f34ab","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C49683"
"2274","Elderly","C16268","ELDERLY (> 65)","['ELDERLY (> 65)']","Elderly","An age group comprised by people 65 years of age and older. (NCI) ","False","1c6b7868-55e1-4a6d-95c0-ed93d9684cf1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C16268"
"2275","In Utero","C49641","IN UTERO","['IN UTERO']","In Utero","The period of time during which the embryo or foetus is present in the uterus of the female. Also describes the location of the embryo or foetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)","False","f5618c64-2013-4b0e-aaa8-2d489b04c97d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C49641"
"2276","Infant And Toddler","C49643","INFANT AND TODDLER (28 DAYS - 23 MONTHS)","['INFANT AND TODDLER (28 DAYS - 23 MONTHS)']","Infant And Toddler","A person from 28 days to 23 months of age. (NCI)","False","959564b9-1d34-406c-8398-c316e9cc3b7e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C49643"
"2277","Newborn","C16731","NEWBORN (0-27 DAYS)","['NEWBORN (0-27 DAYS)']","Newborn","An infant during the first month after birth. (NCI)","False","c4a1c570-83a3-421c-8e1c-f62756ec84b1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C16731"
"2278","Preterm Newborn Infant","C49642","PRETERM NEWBORN INFANTS","['PRETERM NEWBORN INFANTS']","Preterm Newborn Infant","An infant born prior to completion of the normal gestation period. (NCI)","False","afbfd535-415d-4504-b19f-8095a7b5126b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66780/C49642"
"2279","Age Unit","C66781","AGEU","['AGEU', 'Age Unit']","CDISC SDTM Age UnitTerminology","Those units of time that are routinely used to express the age of a person. (NCI)","False","343f6a1a-e86a-4872-86bd-ca73d0dca575","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66781"
"2280","Day","C25301","DAYS","['DAYS']","Day","The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day. (NCI)","False","a40503fe-d638-44e7-a3a7-8dc0f8714acc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66781/C25301"
"2281","Hour","C25529","HOURS","['HOURS']","Hour","A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)","False","9b9b1411-deb5-4807-8ce9-e907cba04181","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66781/C25529"
"2282","Month","C29846","MONTHS","['MONTHS']","Month","One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)","False","e41378ce-9511-4cd6-9278-bcfda3f8995f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66781/C29846"
"2283","Week","C29844","WEEKS","['WEEKS']","Week","Any period of seven consecutive days. (NCI)","False","be0c30c1-5e8d-491b-8e2d-b3edc4a24701","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66781/C29844"
"2284","Year","C29848","YEARS","['YEARS']","Year","The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)","False","77a99aa2-ba55-430b-8279-d3dc9f6c1eec","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66781/C29848"
"2285","Category for Inclusion/Exclusion","C66797","IECAT","['IECAT', 'Category for Inclusion/Exclusion']","CDISC SDTM Category of Inclusion And Or ExclusionTerminology","A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)","False","50b9ce70-fdb1-4937-aff9-989eb5e20c1c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66797"
"2286","Exclusion","C25370","EXCLUSION","['EXCLUSION']","Exclusion","List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)","False","bc3f95c0-3c47-4408-8a8d-75ad5cb0e34a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66797/C25370"
"2287","Inclusion","C25532","INCLUSION","['INCLUSION']","Inclusion","The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study.  NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)","False","0c7aab8d-0397-41a1-b651-992a14e87475","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66797/C25532"
"2288","CDISC System Organ Class","C66783","SOC","['SOC', 'CDISC System Organ Class']","CDISC SDTM System Organ Class Terminology","Terms at the highest level of the CDISC system organ class terminology.","False","3dc71601-925f-45f8-bd68-8ff2f92824da","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783"
"2289","Hematopoietic and Lymphoid System Disorder","C35814","BLOOD AND LYMPHATIC SYSTEM DISORDERS","['BLOOD AND LYMPHATIC SYSTEM DISORDERS']","Hematopoietic and Lymphoid System Disorder","Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","70c527b8-05ab-4f74-a2b6-88a3c04d839d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C35814"
"2290","Heart Disorder","C3079","CARDIAC DISORDERS","['CARDIAC DISORDERS']","Heart Disorder","Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","b7acb8c2-2e96-4311-bdf0-6235af8abc0a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C3079"
"2291","Congenital, Familial and Genetic Disorder Class","C49399","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","['CONGENITAL, FAMILIAL AND GENETIC DISORDERS']","Congenital, Familial and Genetic Disorder Class","A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characterstic set of symptoms and signs. (NCI)","False","94878eaa-f814-4489-be42-b6247297c00c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C49399"
"2292","Ear and Labyrinth Disorder Class","C49400","EAR AND LABYRINTH DISORDERS","['EAR AND LABYRINTH DISORDERS']","Ear and Labyrinth Disorder Class","Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)","False","036b5468-3cb6-4897-b890-5af2a303ad93","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C49400"
"2293","Endocrine Disorder","C3009","ENDOCRINE DISORDERS","['ENDOCRINE DISORDERS']","Endocrine Disorder","Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","73ce25ad-cb01-4bf8-9057-66bfdb599485","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C3009"
"2294","Eye Disorder","C26767","EYE DISORDERS","['EYE DISORDERS']","Eye Disorder","Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)","False","a77a21b0-0034-46e4-a2b8-2a5ffd2284b0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C26767"
"2295","Gastrointestinal Disorder","C2990","GASTROINTESTINAL DISORDERS","['GASTROINTESTINAL DISORDERS']","Gastrointestinal Disorder","Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)","False","1f1e8f12-3ce3-496c-b22f-1c93acd8f390","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C2990"
"2296","General Disorders and Administration Site Conditions Class","C49401","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","['GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS']","General Disorders and Administration Site Conditions Class","A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)","False","ff2b55c7-bb79-402e-b76d-f96ba9d91b01","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C49401"
"2297","Liver and Biliary Tract Disorder","C3959","HEPATOBILIARY DISORDERS","['HEPATOBILIARY DISORDERS']","Liver and Biliary Tract Disorder","Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)","False","61ee7977-7348-40de-979d-eee7f1495c8e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C3959"
"2298","Immune System Disorder","C3507","IMMUNE SYSTEM DISORDERS","['IMMUNE SYSTEM DISORDERS']","Immune System Disorder","A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)","False","d5deffb6-1b37-4a88-b391-3bb9e4a40e39","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C3507"
"2299","Infectious Disorder","C26726","INFECTIONS AND INFESTATIONS","['INFECTIONS AND INFESTATIONS']","Infectious Disorder","A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)","False","90158e82-f348-47ed-ae71-5987e2686be8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C26726"
"2300","Injury, Poisoning and Procedural Complication Class","C49402","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","['INJURY, POISONING AND PROCEDURAL COMPLICATIONS']","Injury, Poisoning and Procedural Complication Class","A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)","False","907cea52-f5b1-4b8a-bfdc-8845a7928646","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C49402"
"2301","Investigation","C41198","INVESTIGATIONS","['INVESTIGATIONS']","Investigation","The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)","False","31da9f8f-8d22-4edb-81ca-c37cf3a6f9bc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C41198"
"2302","Metabolism and Nutrition Disorder Class","C49403","METABOLISM AND NUTRITION DISORDERS","['METABOLISM AND NUTRITION DISORDERS']","Metabolism and Nutrition Disorder Class","A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)","False","07c948d9-9f29-4bbf-9420-f87d6a65a9e8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C49403"
"2303","Connective and Soft Tissue Disorder","C27574","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","['MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS']","Connective and Soft Tissue Disorder","Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)","False","7b27d3f5-d76a-45c1-9cf7-79c488514e7a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C27574"
"2304","Neoplasm","C3262","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","['NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)']","Neoplasm","An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)","False","60451431-dba0-4eb8-93bd-04292064f4e2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C3262"
"2305","Nervous System Disorder","C26835","NERVOUS SYSTEM DISORDERS","['NERVOUS SYSTEM DISORDERS']","Nervous System Disorder","Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","47d591c4-0c11-4f60-8626-9f7067d59fcc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C26835"
"2306","Pregnancy, Puerperium and Perinatal Condition Class","C49404","PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS","['PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS']","Pregnancy, Puerperium and Perinatal Condition Class","A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)","False","0f55f948-8ebc-4c0a-8e09-ab43f06d050a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C49404"
"2307","Psychiatric Disorder","C2893","PSYCHIATRIC DISORDERS","['PSYCHIATRIC DISORDERS']","Psychiatric Disorder","Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)","False","1915572e-5a69-4ab9-85b2-7223f81b55ce","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C2893"
"2308","Urinary System Disorder","C3430","RENAL AND URINARY DISORDERS","['RENAL AND URINARY DISORDERS']","Urinary System Disorder","Disorders of any part of the urologic system. (NCI)","False","020e22fe-b2c7-4b67-a466-d73e496064f5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C3430"
"2309","Reproductive System and Breast Disorder Class","C49405","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","['REPRODUCTIVE SYSTEM AND BREAST DISORDERS']","Reproductive System and Breast Disorder Class","Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)","False","047b3067-aaa9-48ba-a22a-0a35b3e5f167","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C49405"
"2310","Respiratory and Thoracic Disorder","C27669","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","['RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS']","Respiratory and Thoracic Disorder","Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)","False","02a2b9a0-92d9-4d61-a8e8-24310096221a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C27669"
"2311","Skin Disorder","C3371","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","['SKIN AND SUBCUTANEOUS TISSUE DISORDERS']","Skin Disorder","Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)","False","dbb84ddf-bf61-42b9-9fc8-8ea0adeb2bf3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C3371"
"2312","Social Circumstances","C20188","SOCIAL CIRCUMSTANCES","['SOCIAL CIRCUMSTANCES']","Social Circumstances","A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)","False","c402d4f9-a320-4217-9a2c-3439e10b7742","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C20188"
"2313","Procedure","C25218","SURGICAL AND MEDICAL PROCEDURES","['SURGICAL AND MEDICAL PROCEDURES']","Procedure","A particular course of action intended to achieve a result. (NCI)","False","b961f024-a407-45c2-913a-10fb8238d44e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C25218"
"2314","Vascular Disorder","C35117","VASCULAR DISORDERS","['VASCULAR DISORDERS']","Vascular Disorder","Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","946ef9ab-bad0-418c-91bb-aad32b836abf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66783/C35117"
"2315","Common Terminology Criteria for Adverse Events","C66784","TOXGR","['TOXGR', 'Common Terminology Criteria for Adverse Events']","CDISC SDTM CommonTerminology Criteria for Adverse Event Grade Terminology","A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)","False","83940e52-f5cb-43c0-925f-98e561279b5e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66784"
"2316","Mild Adverse Event","C41338","1","['MILD', 'Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","448269aa-5d9c-4ddb-ad7f-2c1401d87d13","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66784/C41338"
"2317","Moderate Adverse Event","C41339","2","['MODERATE', 'Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","155034bd-fac6-48f3-808d-0f351a531400","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66784/C41339"
"2318","Severe Adverse Event","C41340","3","['SEVERE', 'Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","d36580aa-f769-4f4e-99a2-509e8120ff62","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66784/C41340"
"2319","Life Threatening or Disabling Adverse Event","C41337","4","['LIFE THREATENING', 'Grade 4', '4']","Life Threatening or Disabling Adverse Event","An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.","False","547d298f-3b66-4970-a229-2a0e66cccd7f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66784/C41337"
"2320","Death Related to Adverse Event","C48275","5","['FATAL', 'Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","4fc965c7-6322-466f-8b81-089fb879f674","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66784/C48275"
"2321","Control Type","C66785","TCNTRL","['TCNTRL', 'Control Type', 'Type of Control']","CDISC SDTM Control Type Terminology","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","3a75fcad-af50-4020-9040-a830272a1a09","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66785"
"2322","Active Control","C49649","ACTIVE","['ACTIVE']","Active Control","A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].","False","88200f42-3952-40a0-9738-615b1c1ae4e7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66785/C49649"
"2323","None","C41132","NONE","['NONE']","None","No person or thing, nobody, not any. (NCI)","False","8ddccf24-3b23-4ef9-b556-8dae6245e469","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66785/C41132"
"2324","Placebo Control","C49648","PLACEBO","['PLACEBO']","Placebo Control","Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)","False","cb5b762f-f592-4022-a071-6334a9ce2195","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66785/C49648"
"2325","Country","C66786","COUNTRY","['COUNTRY', 'Country']","CDISC SDTM Country Terminology","A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)","False","436ef718-4bfa-4ac0-8fba-0175ea050c21","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786"
"2326","Aruba","C17884","ABW","['ABW', 'ARUBA']","Aruba","Island in the Caribbean Sea, north of Venezuela.","False","00355bf5-60f9-455d-b30b-29c8d588dd2e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17884"
"2327","Afghanistan","C16267","AFG","['AFG', 'AFGHANISTAN']","Afghanistan","A country in Southern Asia, north and west of Pakistan, east of Iran.","False","d563219b-6deb-4cf2-8af7-690fab84a325","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16267"
"2328","Angola","C16292","AGO","['AGO', 'ANGOLA']","Angola","A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo.","False","cd7a40b1-0c8c-468a-9293-d0f68140e001","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16292"
"2329","Anguilla","C20133","AIA","['AIA', 'ANGUILLA']","Anguilla","An island in the Caribbean Sea, east of Puerto Rico.","False","0b8dc41d-17d8-439f-8159-107a3a73714a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20133"
"2330","Aland Islands","C44481","ALA","['ALA', 'ALAND ISLANDS']","Aland Islands","An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland.","False","ba3c6581-f231-4445-9bde-f32b17a2d2dd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C44481"
"2331","Albania","C16271","ALB","['ALB', 'ALBANIA']","Albania","A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro.","False","6b762815-c6df-4e0c-a1d1-b47d809ba5b3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16271"
"2332","Andorra","C16289","AND","['AND', 'ANDORRA']","Andorra","A country in Southwestern Europe, between France and Spain.","False","96de730f-c677-4cae-a2e7-633a64133928","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16289"
"2333","Netherlands Antilles","C16904","ANT","['ANT', 'NETHERLANDS ANTILLES']","Netherlands Antilles","A country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands.","False","a1e17094-d456-49f8-ae1e-dc97af531489","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16904"
"2334","United Arab Emirates","C17232","ARE","['ARE', 'UNITED ARAB EMIRATES']","United Arab Emirates","A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia.","False","1a05e1eb-8045-42e2-8d8b-5a8608ecf3f9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17232"
"2335","Argentina","C16305","ARG","['ARG', 'ARGENTINA']","Argentina","A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.","False","b3f801a5-417f-41c2-951e-99fac6778703","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16305"
"2336","Armenia","C16306","ARM","['ARM', 'ARMENIA']","Armenia","A country in Southwestern Asia, east of Turkey.","False","40989645-26b9-42e2-a664-3779b06e6902","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16306"
"2337","American Samoa","C17739","ASM","['ASM', 'AMERICAN SAMOA']","American Samoa","A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand.","False","3ee88c46-abad-47ce-aef6-31c2a914b056","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17739"
"2338","Antarctica","C18007","ATA","['ATA', 'ANTARCTICA']","Antarctica","The continent lying mostly south of the Antarctic Circle.","False","4ad8a091-0e35-4824-bbb3-6a0a260f4114","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C18007"
"2339","French Southern Territories","C20105","ATF","['ATF', 'FRENCH SOUTHERN TERRITORIES']","French Southern Territories","Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia.","False","0dfd02ae-b57f-4069-be0c-82bcfa0dd71b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20105"
"2340","Antigua and Barbuda","C16303","ATG","['ATG', 'ANTIGUA AND BARBUDA']","Antigua and Barbuda","Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico.","False","ba9e177d-674a-40d9-ab99-6165db79a080","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16303"
"2341","Australia","C16311","AUS","['AUS', 'AUSTRALIA']","Australia","The continent between the Indian Ocean and the South Pacific Ocean.","False","22a4f494-54ac-4d46-97a9-0b1317aa1f67","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16311"
"2342","Austria","C16312","AUT","['AUT', 'AUSTRIA']","Austria","A country in Central Europe, north of Italy and Slovenia.","False","21383f95-2ad8-42f8-b403-a81daa31b093","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16312"
"2343","Azerbaijan","C16316","AZE","['AZE', 'AZERBAIJAN']","Azerbaijan","A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia.","False","75a66fea-b652-499e-8683-ca157e3c0dae","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16316"
"2344","Burundi","C16371","BDI","['BDI', 'BURUNDI']","Burundi","A country in Central Africa, east of Democratic Republic of the Congo.","False","32d6dbfa-871d-4421-811f-2eb04ce10065","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16371"
"2345","Belgium","C16329","BEL","['BEL', 'BELGIUM']","Belgium","A country in Western Europe, bordering the North Sea, between France and the Netherlands.","False","269e1ecf-6bc1-4806-b0ac-9731754faabe","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16329"
"2346","Benin Republic","C16333","BEN","['BEN', 'BENIN REPUBLIC']","Benin Republic","A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo.","False","8da79159-8a71-4a31-a47b-1a1ef7770c91","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16333"
"2347","Burkina Faso","C16369","BFA","['BFA', 'BURKINA FASO']","Burkina Faso","A country in Western Africa, north of Ghana.","False","a352c662-a913-4fff-ada5-19e567d85ff0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16369"
"2348","Bangladesh","C16323","BGD","['BGD', 'BANGLADESH']","Bangladesh","A country in Southern Asia, bordering the Bay of Bengal, between Burma and India.","False","3d4abf6d-2f93-496f-b17f-97229e7ad6ca","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16323"
"2349","Bulgaria","C16368","BGR","['BGR', 'BULGARIA']","Bulgaria","A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey.","False","68c682b5-7d20-46cf-8994-a1a44d6039d0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16368"
"2350","Bahrain","C16322","BHR","['BHR', 'BAHRAIN']","Bahrain","An archipelago in the Persian Gulf, east of Saudi Arabia.","False","fd535623-fc40-4d8f-92a4-91651c5e4370","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16322"
"2351","Bahamas","C16321","BHS","['BHS', 'BAHAMAS']","Bahamas","A chain of islands in the North Atlantic Ocean, southeast of Florida.","False","61fc4495-aef7-4073-b324-3a39734f3fa1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16321"
"2352","Bosnia-Herzegovina","C16361","BIH","['BIH', 'BOSNIA-HERZEGOVINA']","Bosnia-Herzegovina","A country in Southeastern Europe, bordering the Adriatic Sea and Croatia.","False","c865e12d-c5e8-432e-8e58-9de82de8366b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16361"
"2353","Belarus","C16372","BLR","['BLR', 'BELARUS']","Belarus","A country in Eastern Europe, east of Poland.","False","3421709e-2a80-474e-be7d-821c2c99be63","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16372"
"2354","Belize","C16331","BLZ","['BLZ', 'BELIZE']","Belize","A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico.","False","ba62e92f-d129-4d2b-9031-d6159e3359cb","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16331"
"2355","Bermuda","C16334","BMU","['BMU', 'BERMUDA']","Bermuda","No Definition","False","2bcb75c9-a9a1-4e2f-ae57-ce334f8f6576","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16334"
"2356","Bolivia","C16359","BOL","['BOL', 'BOLIVIA']","Bolivia","A country in Central South America, southwest of Brazil.","False","bc02189f-97f8-474f-bb73-2b035cdf9eeb","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16359"
"2357","Brazil","C16364","BRA","['BRA', 'BRAZIL']","Brazil","A country in Eastern South America, bordering the Atlantic Ocean.","False","b5c88f58-4932-498c-b2a9-9191d8dd5efe","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16364"
"2358","Barbados","C16324","BRB","['BRB', 'BARBADOS']","Barbados","An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","ffc8a20b-1c41-45a2-92b9-6ae106889dca","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16324"
"2359","Brunei Darussalam","C16367","BRN","['BRN', 'BRUNEI']","Brunei Darussalam","A country in Southeastern Asia, bordering the South China Sea and Malaysia.","False","287ea1a6-bf10-4cf1-8866-2017ff3c0af2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16367"
"2360","Bhutan","C16336","BTN","['BTN', 'BHUTAN']","Bhutan","A country in Southern Asia, between China and India.","False","db2c375f-0236-451c-83e1-a13b290dc6da","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16336"
"2361","Bouvet Island","C20104","BVT","['BVT', 'BOUVET ISLAND']","Bouvet Island","An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa).","False","0bf697ec-3b80-476b-8a0b-d7fccfb5bc7e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20104"
"2362","Botswana","C16363","BWA","['BWA', 'BOTSWANA']","Botswana","A country in Southern Africa, north of South Africa.","False","38cee3d5-14b0-46f3-8bae-9ee0e7c456e8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16363"
"2363","Central African Republic","C16409","CAF","['CAF', 'CENTRAL AFRICAN REPUBLIC']","Central African Republic","A country in Central Africa, north of Democratic Republic of the Congo.","False","17b336ba-4d2a-4af9-b8d5-199f828aee65","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16409"
"2364","Canada","C16380","CAN","['CAN', 'CANADA']","Canada","A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US.","False","eb4c18e2-d59a-498e-80d5-ab9648af083b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16380"
"2365","Cocos (Keeling) Islands","C16445","CCK","['CCK', 'COCOS (KEELING) ISLANDS']","Cocos (Keeling) Islands","A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka.","False","36c4e071-bc91-4af7-a356-93979333a7c3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16445"
"2366","Switzerland","C17181","CHE","['CHE', 'SWITZERLAND']","Switzerland","A country in Central Europe, east of France, north of Italy.","False","723ebce8-4feb-4d59-b0bf-64f7399fc1ba","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17181"
"2367","Chile","C16427","CHL","['CHL', 'CHILE']","Chile","A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru.","False","6f0d9e83-bf01-47a7-a703-28be50a2cae1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16427"
"2368","China","C16428","CHN","['CHN', 'CHINA']","China","A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam.","False","440e4c4a-a967-4d7c-84a4-7a84afe1a846","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16428"
"2369","Cote d'Ivoire","C16762","CIV","['CIV', ""COTE D'IVOIRE""]","Cote d'Ivoire","A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia.","False","cce7abfe-5fc2-4848-a606-939faf49ef85","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16762"
"2370","Cameroon","C16379","CMR","['CMR', 'CAMEROON']","Cameroon","A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria.","False","268af0b6-e886-4ecf-9b3c-e0ffe76bfa15","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16379"
"2371","Democratic Republic of the Congo","C17266","COD","['COD', 'DEMOCRATIC REPUBLIC OF THE CONGO']","Democratic Republic of the Congo","A country in Central Africa, northeast of Angola.","False","fa03e872-5d4d-4340-85ff-0848a5c2ddc8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17266"
"2372","Congo","C16467","COG","['COG', 'CONGO']","Congo","A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon.","False","4c24469c-2c4c-4d10-8d1a-2049f29e202a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16467"
"2373","Cook Islands","C16469","COK","['COK', 'COOK ISLANDS']","Cook Islands","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","06a6582d-31a3-4235-a660-a1037af5975b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16469"
"2374","Colombia","C16449","COL","['COL', 'COLOMBIA']","Colombia","A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama.","False","e774b858-2a0b-4265-933a-a8635f7c7d60","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16449"
"2375","Comoros","C16458","COM","['COM', 'COMOROS']","Comoros","A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique.","False","a8f94806-80e4-4f05-9192-6b4bc35f4278","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16458"
"2376","Cape Verde","C16382","CPV","['CPV', 'CAPE VERDE']","Cape Verde","A group of islands in the North Atlantic Ocean, west of Senegal.","False","d84917c2-404a-472e-b79d-b6f5d1d6861c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16382"
"2377","Costa Rica","C16470","CRI","['CRI', 'COSTA RICA']","Costa Rica","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama.","False","a3c56224-65af-41fc-ad3b-1ec8b208e5b6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16470"
"2378","Cuba","C16477","CUB","['CUB', 'CUBA']","Cuba","An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida.","False","6eb968aa-8d59-4acc-b869-4b0e72c638de","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16477"
"2379","Christmas Island","C44482","CXR","['CXR', 'CHRISTMAS ISLAND']","Christmas Island","An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia.","False","2bcf163a-ce29-45f6-a3b7-4f29732ec7f2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C44482"
"2380","Cayman Islands","C16391","CYM","['CYM', 'CAYMAN ISLANDS']","Cayman Islands","An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras.","False","133509ff-c8e4-49a2-b273-00c94a139d5b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16391"
"2381","Cyprus","C16480","CYP","['CYP', 'CYPRUS']","Cyprus","An island in the Mediterranean Sea, south of Turkey.","False","35723d78-6504-404b-b79a-f94f3d796b82","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16480"
"2382","Czech Republic","C17668","CZE","['CZE', 'CZECH REPUBLIC']","Czech Republic","A country in Central Europe, southeast of Germany.","False","78736869-145e-4e49-8788-4495b11d0641","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17668"
"2383","Germany","C16636","DEU","['DEU', 'GERMANY']","Germany","A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark.","False","91b14aac-7862-480c-9d9f-84d8c6953a37","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16636"
"2384","Djibouti","C16506","DJI","['DJI', 'DJIBOUTI']","Djibouti","A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia.","False","9e0ae921-964d-46cb-a800-f0dfb03fd5dc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16506"
"2385","Dominica","C16519","DMA","['DMA', 'DOMINICA']","Dominica","An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago.","False","3fd0f3ab-b838-49b1-bcb6-e2ee31fab86e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16519"
"2386","Denmark","C16496","DNK","['DNK', 'DENMARK']","Denmark","A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn).","False","e712dbc0-1a86-4c8e-a779-9c33ec9a1c98","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16496"
"2387","Dominican Republic","C16520","DOM","['DOM', 'DOMINICAN REPUBLIC']","Dominican Republic","A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti.","False","cdd20d8d-e23e-44d4-bf18-2db26eb95174","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16520"
"2388","Algeria","C16274","DZA","['DZA', 'ALGERIA']","Algeria","A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia.","False","445e19ac-4178-4693-8777-bcc8f75f2f18","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16274"
"2389","Ecuador","C16528","ECU","['ECU', 'ECUADOR']","Ecuador","A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.","False","e5a36641-0c6e-46ad-8013-25f29f65c94c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16528"
"2390","Egypt","C16530","EGY","['EGY', 'EGYPT']","Egypt","A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip.","False","88802a19-7121-4df5-b05c-359574becb36","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16530"
"2391","Eritrea","C16558","ERI","['ERI', 'ERITREA']","Eritrea","A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan.","False","131ed193-6e54-4efb-acf8-602a54774feb","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16558"
"2392","Western Sahara","C20113","ESH","['ESH', 'WESTERN SAHARA']","Western Sahara","A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.","False","bed7e42e-733d-450f-bafe-1c820feb6f7a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20113"
"2393","Spain","C17152","ESP","['ESP', 'SPAIN']","Spain","A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France.","False","6e10aa70-74c4-4016-8cf1-7e1f20783144","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17152"
"2394","Estonia","C16562","EST","['EST', 'ESTONIA']","Estonia","A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia.","False","f3f1bb51-cbb2-410e-86d1-a1a04ac8f9cf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16562"
"2395","Ethiopia","C16563","ETH","['ETH', 'ETHIOPIA']","Ethiopia","A country in Eastern Africa, west of Somalia.","False","6f8f2f9e-cd62-4802-81eb-3efb315c2362","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16563"
"2396","Finland","C16584","FIN","['FIN', 'FINLAND']","Finland","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia.","False","003081d2-1a77-4e29-9b99-19603854b0b8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16584"
"2397","Fiji","C16582","FJI","['FJI', 'FIJI']","Fiji","An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","a13b5f73-174d-4e82-b29b-b7e6a920906f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16582"
"2398","Falkland Islands","C17954","FLK","['FLK', 'FALKLAND ISLANDS']","Falkland Islands","Islands in the South Atlantic Ocean, east of southern Argentina.","False","d3741d47-3641-4958-9767-ac03cc15dd05","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17954"
"2399","France","C16592","FRA","['FRA', 'FRANCE']","France","A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain.","False","d1d18b68-6328-4d83-a71e-44e72d96585e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16592"
"2400","Faroe Islands","C16573","FRO","['FRO', 'FAROE ISLANDS']","Faroe Islands","An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway.","False","97b37ba2-62f3-4cab-ab23-97eb4e12b4f3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16573"
"2401","Federated States of Micronesia","C17881","FSM","['FSM', 'MICRONESIA, FEDERATED STATES OF']","Federated States of Micronesia","An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia.","False","93f4c056-c44a-41f1-8306-693c489462b9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17881"
"2402","Gabon","C16596","GAB","['GAB', 'GABON']","Gabon","A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea.","False","78e081ca-f060-4f24-a5d0-8fa3797a2673","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16596"
"2403","United Kingdom","C17233","GBR","['GBR', 'UNITED KINGDOM']","United Kingdom","A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France.","False","ecde1cef-c38d-40c6-8ccc-599893b03be4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17233"
"2404","Georgia","C16634","GEO","['GEO', 'GEORGIA']","Georgia","A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia.","False","e053a482-766e-43d5-97c3-6fe4702687e3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16634"
"2405","Guernsey","C64375","GGY","['GGY', 'GUERNSEY']","Guernsey","The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK.","False","3390b859-637b-4ca2-9f0c-54c1614a2d07","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C64375"
"2406","Ghana","C26330","GHA","['GHA', 'GHANA']","Ghana","A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo.","False","619d0b43-26ad-4634-9807-fafd5738e00d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C26330"
"2407","Gibraltar","C16638","GIB","['GIB', 'GIBRALTAR']","Gibraltar","A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain.","False","000c47d0-4bae-482d-a14d-2e29a662b0bc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16638"
"2408","Guinea","C16655","GIN","['GIN', 'GUINEA']","Guinea","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone.","False","fec250fd-1ed1-4397-a4a0-cc315fe42606","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16655"
"2409","Guadeloupe","C16651","GLP","['GLP', 'GUADELOUPE']","Guadeloupe","Islands in the eastern Caribbean Sea, southeast of Puerto Rico.","False","9cb5cd1b-0196-498c-844b-fa3fcaca0811","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16651"
"2410","Gambia","C16598","GMB","['GMB', 'GAMBIA']","Gambia","A country in Western Africa, bordering the North Atlantic Ocean and Senegal.","False","57d561ad-3c8b-429b-a81d-b7f532e5d16d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16598"
"2411","Guinea-Bissau","C16656","GNB","['GNB', 'GUINEA-BISSAU']","Guinea-Bissau","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal.","False","386b61f0-da28-4d96-91fb-ed125dee397a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16656"
"2412","Equatorial Guinea","C16557","GNQ","['GNQ', 'EQUATORIAL GUINEA']","Equatorial Guinea","A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands.","False","397a88f2-147c-4beb-b407-e5d21ce2c82c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16557"
"2413","Greece","C16645","GRC","['GRC', 'GREECE']","Greece","A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey.","False","797361e0-dfec-4e40-8e6e-c63a3c5dd5a5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16645"
"2414","Grenada","C16647","GRD","['GRD', 'GRENADA']","Grenada","An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago.","False","8437fd03-60f1-42c5-b6fb-97d5b10865fc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16647"
"2415","Greenland","C16646","GRL","['GRL', 'GREENLAND']","Greenland","An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.","False","e61281ee-27fd-4100-8452-5f6d67b0c32a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16646"
"2416","Guatemala","C16654","GTM","['GTM', 'GUATEMALA']","Guatemala","A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico.","False","d7532a88-7826-4b7b-91f6-82f58775d0cd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16654"
"2417","French Guiana","C16593","GUF","['GUF', 'FRENCH GUIANA']","French Guiana","A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname.","False","46a08669-747d-4434-a7ef-8657a608cb15","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16593"
"2418","Guam","C16652","GUM","['GUM', 'GUAM']","Guam","Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","4b012e05-ae90-48fa-9078-e8c69ef30ea0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16652"
"2419","Guyana","C16657","GUY","['GUY', 'GUYANA']","Guyana","A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.","False","2d3457ca-6357-4deb-82f2-f90e2288e070","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16657"
"2420","Hong Kong","C16695","HKG","['HKG', 'HONG KONG']","Hong Kong","A special administrative region of China, bordering the South China Sea and China.","False","2dcf4a49-fdd6-4f20-bbd6-a2dc4a066331","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16695"
"2421","Heard Island and McDonald Islands","C20106","HMD","['HMD', 'HEARD ISLAND AND MCDONALD ISLANDS']","Heard Island and McDonald Islands","Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica.","False","f6b1229e-f553-43eb-bdbd-cf06f69c4934","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20106"
"2422","Honduras","C16694","HND","['HND', 'HONDURAS']","Honduras","A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua.","False","fb554aee-a347-48bb-84f8-e02f7868d836","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16694"
"2423","Croatia","C16474","HRV","['HRV', 'CROATIA']","Croatia","A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia.","False","4392c751-40d6-436d-8072-112c29dd44b3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16474"
"2424","Haiti","C16660","HTI","['HTI', 'HAITI']","Haiti","A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic.","False","7398304a-c4e0-4753-bcc8-db0465272591","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16660"
"2425","Hungary","C16699","HUN","['HUN', 'HUNGARY']","Hungary","A country in Central Europe, northwest of Romania.","False","95962683-92cd-45d7-891b-9c58ebc13ea0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16699"
"2426","Indonesia","C16728","IDN","['IDN', 'INDONESIA']","Indonesia","A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean.","False","fc05742d-2d9a-4377-8b4d-3c29c097fe2d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16728"
"2427","India","C16727","IND","['IND', 'INDIA']","India","A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.","False","1e73b12d-5fef-479b-b9e5-e7292d64ed27","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16727"
"2428","British Indian Ocean Territory","C16365","IOT","['IOT', 'BRITISH INDIAN OCEAN TERRITORY']","British Indian Ocean Territory","An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia.","False","a1692953-a773-4bf1-8796-9cc32ced2efc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16365"
"2429","Ireland","C16757","IRL","['IRL', 'IRELAND']","Ireland","A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain.","False","bd7b92f8-5328-4371-bfc3-154e6a5b43db","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16757"
"2430","Iran","C16755","IRN","['IRN', 'IRAN']","Iran","A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.","False","003c429a-b67d-4170-9c18-c585fdc92256","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16755"
"2431","Iraq","C16756","IRQ","['IRQ', 'IRAQ']","Iraq","A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait.","False","763cf2d1-7963-4dc0-8d4b-90392b4d0bb4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16756"
"2432","Iceland","C16704","ISL","['ISL', 'ICELAND']","Iceland","A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK.","False","64cf4d8f-1adc-4ac1-b762-ac11adc5226c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16704"
"2433","Israel","C16760","ISR","['ISR', 'ISRAEL']","Israel","A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon.","False","29e31a4c-05d1-4dbf-8d66-9129097b221f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16760"
"2434","Italy","C16761","ITA","['ITA', 'ITALY']","Italy","A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.","False","37eca326-2d4a-450c-81fe-450c790389c7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16761"
"2435","Jamaica","C16763","JAM","['JAM', 'JAMAICA']","Jamaica","An island in the Caribbean Sea, south of Cuba.","False","a5854c1e-1c2b-4da3-90fe-ce7236c74ed9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16763"
"2436","Jordan","C16765","JOR","['JOR', 'JORDAN']","Jordan","A country in the Middle East, northwest of Saudi Arabia.","False","de16f12c-6beb-4ce4-8e35-e153400b1a77","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16765"
"2437","Japan","C16764","JPN","['JPN', 'JAPAN']","Japan","A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula.","False","63e6220c-b733-4cb4-84e7-93c1faeae734","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16764"
"2438","Jersey","C64374","JRE","['JRE', 'JERSEY']","Jersey","Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK.","False","79c99dd9-47f8-413b-9f8f-a4a74c3a0d6a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C64374"
"2439","Kazakhstan","C20107","KAZ","['KAZ', 'KAZAKHSTAN']","Kazakhstan","A country in Central Asia, northwest of China.","False","cce37663-d3c4-4cbd-83dd-98adb325f588","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20107"
"2440","Kenya","C16769","KEN","['KEN', 'KENYA']","Kenya","A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania.","False","2106205a-23cf-4173-aefb-abde0bd68e3a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16769"
"2441","Kyrgyzstan","C16771","KGZ","['KGZ', 'KYRGYZSTAN']","Kyrgyzstan","A country in Central Asia, west of China.","False","ea8cea36-5458-407e-b63d-14e85642c06e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16771"
"2442","Cambodia","C16378","KHM","['KHM', 'CAMBODIA']","Cambodia","A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos.","False","a98d402f-e4b7-4007-88f9-549c5cf87a53","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16378"
"2443","Kiribati","C16639","KIR","['KIR', 'KIRIBATI']","Kiribati","A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia.","False","7010e239-c804-40ce-a86e-19a4d93e82ec","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16639"
"2444","Saint Kitts and Nevis","C17885","KNA","['KNA', 'SAINT KITTS AND NEVIS']","Saint Kitts and Nevis","Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago.","False","6a3ad9c0-e096-4ad2-8e84-fdb0f87b46a5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17885"
"2445","South Korea","C16774","KOR","['KOR', 'SOUTH KOREA']","South Korea","A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea.","False","b037f8d9-48e6-4373-ad9a-df0be96c5c4f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16774"
"2446","Kuwait","C16775","KWT","['KWT', 'KUWAIT']","Kuwait","A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia.","False","d0b6f90d-ab58-4b1e-803d-8754bda1222b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16775"
"2447","Lao People's Democratic Republic","C16780","LAO","['LAO', ""LAO PEOPLE'S DEMOCRATIC REPUBLIC""]","Lao People's Democratic Republic","A country in Southeastern Asia, northeast of Thailand, west of Vietnam.","False","5fc687d2-eb2e-4b51-beda-0906e99c3f8e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16780"
"2448","Lebanon","C16784","LBN","['LBN', 'LEBANON']","Lebanon","A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria.","False","c90df2a1-4a4e-4240-94f0-479d07575c88","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16784"
"2449","Liberia","C16791","LBR","['LBR', 'LIBERIA']","Liberia","A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone.","False","8e7d2449-bb90-4a9e-8909-6fc2ab98fdab","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16791"
"2450","Libyan Arab Jamahiriya","C16793","LBY","['LBY', 'LIBYAN ARAB JAMAHIRIYA']","Libyan Arab Jamahiriya","A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia.","False","049baf9f-a40f-4082-bf01-002d60dad409","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16793"
"2451","Saint Lucia","C17113","LCA","['LCA', 'SAINT LUCIA']","Saint Lucia","A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago.","False","0d1d3c02-2321-4a40-bf1b-0d89c1ffa60b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17113"
"2452","Liechtenstein","C16794","LIE","['LIE', 'LIECHTENSTEIN']","Liechtenstein","A country in Central Europe, between Austria and Switzerland.","False","e1037e3b-9eaf-4370-8950-0ed56bc0e06a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16794"
"2453","Sri Lanka","C17163","LKA","['LKA', 'SRI LANKA']","Sri Lanka","A country in Southern Asia, occupying an island in the Indian Ocean, south of India.","False","fa8a299f-b1a7-44e9-9221-0d8370d712a4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17163"
"2454","Lesotho","C16787","LSO","['LSO', 'LESOTHO']","Lesotho","A country in Southern Africa, an enclave of South Africa.","False","85b634ce-12e7-4ef4-a11a-602144266b72","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16787"
"2455","Lithuania","C16799","LTU","['LTU', 'LITHUANIA']","Lithuania","A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia.","False","ba34f521-6ed9-4ac3-ace8-617d9ae85b12","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16799"
"2456","Luxembourg","C16803","LUX","['LUX', 'LUXEMBOURG']","Luxembourg","A country in Western Europe, between France, Belgium, and Germany.","False","00eb09cd-a02a-481c-9377-35cbf382fe5b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16803"
"2457","Latvia","C16783","LVA","['LVA', 'LATVIA']","Latvia","A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania.","False","e3ba7cc4-7eb3-4150-8faf-4573ef2bb93a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16783"
"2458","Macao","C16807","MAC","['MAC', 'MACAO']","Macao","A country in Eastern Asia, bordering the South China Sea and China.","False","fcbe894d-3323-4c3e-b907-b333f9365763","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16807"
"2459","Morocco","C16878","MAR","['MAR', 'MOROCCO']","Morocco","A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara.","False","83101ff1-fb4d-415e-bba9-a15c6315b808","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16878"
"2460","Monaco","C16874","MCO","['MCO', 'MONACO']","Monaco","A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.","False","dbd92603-dd72-4881-b18f-f91b61e155e2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16874"
"2461","Moldova","C16871","MDA","['MDA', 'MOLDOVA, REPUBLIC OF']","Moldova","A country in Eastern Europe, northeast of Romania.","False","48905126-b858-42a1-98c6-fc50eb07f589","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16871"
"2462","Madagascar","C16808","MDG","['MDG', 'MADAGASCAR']","Madagascar","A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique.","False","2f1f53e4-4f11-4c3e-9e09-919400ade629","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16808"
"2463","Maldives","C16815","MDV","['MDV', 'MALDIVES']","Maldives","A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India.","False","703377b4-2bac-47fa-9bbc-2ce99afbc01a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16815"
"2464","Mexico","C16850","MEX","['MEX', 'MEXICO']","Mexico","A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US.","False","a4332981-dfa8-4604-8023-1eb07f853c53","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16850"
"2465","Marshall Islands","C16822","MHL","['MHL', 'MARSHALL ISLANDS']","Marshall Islands","A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","6c03da64-7a02-498f-aca5-ed549c62044d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16822"
"2466","Republic of Macedonia","C17654","MKD","['MKD', 'REPUBLIC OF MACEDONIA']","Republic of Macedonia","A country in Southeastern Europe, north of Greece.","False","aca5e0d2-b5b9-4eec-9cc2-5432c1f35212","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17654"
"2467","Mali","C16816","MLI","['MLI', 'MALI']","Mali","A country in Western Africa, southwest of Algeria.","False","6644b550-d2e3-4819-98ca-a72f0bbb2438","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16816"
"2468","Malta","C16817","MLT","['MLT', 'MALTA']","Malta","A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy).","False","e660bff3-801f-41cf-8bdd-5d60c7efa464","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16817"
"2469","Myanmar","C16370","MMR","['MMR', 'MYANMAR']","Myanmar","A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand.","False","e53f3552-bed8-4683-a6b3-b43c2c220345","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16370"
"2470","Montenegro","C64378","MNE","['MNE', 'MONTENEGRO']","Montenegro","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","bf63a846-2154-4832-a7a2-b48c9e896157","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C64378"
"2471","Mongolia","C16875","MNG","['MNG', 'MONGOLIA']","Mongolia","A country in Northern Asia, between China and Russia.","False","3b7152b1-4063-43dd-b5b1-c98369dddc47","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16875"
"2472","Northern Mariana Islands","C17882","MNP","['MNP', 'NORTHERN MARIANA ISLANDS']","Northern Mariana Islands","A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","407767b6-3dd6-4875-b737-9e03b8506da6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17882"
"2473","Mozambique","C16882","MOZ","['MOZ', 'MOZAMBIQUE']","Mozambique","A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania.","False","a55ebe25-6d38-4677-898e-bb4e84b783b5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16882"
"2474","Mauritania","C16826","MRT","['MRT', 'MAURITANIA']","Mauritania","A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara.","False","927ae964-e66b-441d-8274-65cac4d65681","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16826"
"2475","Montserrat","C16876","MSR","['MSR', 'MONTSERRAT']","Montserrat","A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico.","False","c49415fa-e733-4967-9388-fac1fb3b720c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16876"
"2476","Martinique","C16823","MTQ","['MTQ', 'MARTINIQUE']","Martinique","An island in the Caribbean Sea, north of Trinidad and Tobago.","False","2dde9877-85fb-43f6-b1a5-b54d570fb45a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16823"
"2477","Mauritius","C16827","MUS","['MUS', 'MAURITIUS']","Mauritius","A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","e8b65676-9302-40e4-9f53-7d41ba259767","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16827"
"2478","Malawi","C16813","MWI","['MWI', 'MALAWI']","Malawi","A country in Southern Africa, east of Zambia.","False","9a105695-c194-45b5-91d9-1729d8e3bf0a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16813"
"2479","Malaysia","C16814","MYS","['MYS', 'MALAYSIA']","Malaysia","A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam.","False","5d36b2b7-b953-41d8-a086-f4e809f6e983","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16814"
"2480","Mayotte","C16828","MYT","['MYT', 'MAYOTTE']","Mayotte","A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique.","False","fc331c3e-79df-4940-98db-9f27012c9ff7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16828"
"2481","Namibia","C16891","NAM","['NAM', 'NAMIBIA']","Namibia","A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa.","False","699f2969-0176-43ec-a73c-0118bb9ea387","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16891"
"2482","New Caledonia","C16913","NCL","['NCL', 'NEW CALEDONIA']","New Caledonia","A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia.","False","0e8ac61f-3a62-4bea-8e82-50a76c4c5a46","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16913"
"2483","Niger","C16916","NER","['NER', 'NIGER']","Niger","A country in Western Africa, southeast of Algeria.","False","697aed8f-3149-454e-8646-9031dd22b3b5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16916"
"2484","Norfolk Island","C16919","NFK","['NFK', 'NORFOLK ISLAND']","Norfolk Island","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia.","False","d0ed5a7d-ac3a-4fe0-828e-4b353c29e24f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16919"
"2485","Nigeria","C16917","NGA","['NGA', 'NIGERIA']","Nigeria","A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon.","False","30e0dbe7-fd05-4786-9754-326041ebd3d2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16917"
"2486","Nicaragua","C16915","NIC","['NIC', 'NICARAGUA']","Nicaragua","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras.","False","d1884087-b301-4e92-866d-862f2a56e1b4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16915"
"2487","Niue","C16918","NIU","['NIU', 'NIUE']","Niue","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga.","False","f6c6bf04-aacc-4eaf-86f6-34446944e722","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16918"
"2488","Netherlands","C16903","NLD","['NLD', 'NETHERLANDS']","Netherlands","A country in Western Europe, bordering the North Sea, between Belgium and Germany.","False","b2e466b9-ac91-47d9-993b-7f7bf1a51088","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16903"
"2489","Norway","C16920","NOR","['NOR', 'NORWAY']","Norway","A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden.","False","7e65980e-5ffa-4842-9e0c-42cbd447bb0e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16920"
"2490","Nepal","C16901","NPL","['NPL', 'NEPAL']","Nepal","A country in Southern Asia, between China and India.","False","f9378d9c-c7ca-405b-af00-5b47a02cf284","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16901"
"2491","Nauru","C16896","NRU","['NRU', 'NAURU']","Nauru","A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands.","False","9c34d1dc-c32c-4b0d-aa96-3c6830fd053c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16896"
"2492","New Zealand","C16914","NZL","['NZL', 'NEW ZEALAND']","New Zealand","A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia.","False","a1f6730c-1f94-41d4-ae4f-ed65572f1072","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16914"
"2493","Oman","C16933","OMN","['OMN', 'OMAN']","Oman","A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates.","False","a070ff55-8a12-4b49-9acf-9745486eaaf6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16933"
"2494","Pakistan","C16949","PAK","['PAK', 'PAKISTAN']","Pakistan","A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north.","False","21301f97-943a-490d-b2cb-f09c9b80c225","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16949"
"2495","Panama","C16951","PAN","['PAN', 'PANAMA']","Panama","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica.","False","412900af-a7b3-423d-a8fb-4bd53e67ae75","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16951"
"2496","Pitcairn Island","C16993","PCN","['PCN', 'PITCAIRN']","Pitcairn Island","A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.","False","22269601-4060-4032-b360-902414686b8a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16993"
"2497","Peru","C16972","PER","['PER', 'PERU']","Peru","A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador.","False","9f8bc23c-215c-46ef-b6d2-b6e5b7ec31cd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16972"
"2498","Philippines","C16978","PHL","['PHL', 'PHILIPPINES']","Philippines","A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam.","False","2d56c1ba-5e44-442d-9581-a56ad0ddff58","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16978"
"2499","Palau","C17733","PLW","['PLW', 'PALAU']","Palau","A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines.","False","873bebb6-19c9-422e-a2c1-a8bbd4a97712","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17733"
"2500","Papua New Guinea","C16952","PNG","['PNG', 'PAPUA NEW GUINEA']","Papua New Guinea","A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia.","False","cc60f331-bbea-4818-967a-ff333aa87dd0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16952"
"2501","Poland","C17002","POL","['POL', 'POLAND']","Poland","A country in Central Europe, east of Germany.","False","c05c2c3a-7bb3-48db-8a00-856f9abaaf43","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17002"
"2502","Puerto Rico","C17043","PRI","['PRI', 'PUERTO RICO']","Puerto Rico","An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic.","False","2dd6cce6-c67b-4f31-87f4-f1a8baf7e780","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17043"
"2503","North Korea","C16773","PRK","['PRK', 'NORTH KOREA']","North Korea","A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea.","False","c08b5949-6e03-47b0-ad49-ef1e62e378ba","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16773"
"2504","Portugal","C17006","PRT","['PRT', 'PORTUGAL']","Portugal","A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain.","False","c4672ab2-a01a-4692-9f71-1e3dc66ac08f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17006"
"2505","Paraguay","C16953","PRY","['PRY', 'PARAGUAY']","Paraguay","A country in Central South America, northeast of Argentina.","False","53fea92e-e9eb-432c-9cc6-875d6f852d50","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16953"
"2506","Palestinian Territory, Occupied","C20110","PSE","['PSE', 'PALESTINIAN TERRITORY, OCCUPIED']","Palestinian Territory, Occupied","A collective name for the West Bank and the Gaza Strip, two territories in Palestine.","False","5826fc3f-8d2e-4b40-afc2-f86981ad842e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20110"
"2507","French Polynesia","C16594","PYF","['PYF', 'FRENCH POLYNESIA']","French Polynesia","An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia.","False","701256e1-b088-4d04-85e4-030545b2161e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16594"
"2508","Qatar","C17045","QAT","['QAT', 'QATAR']","Qatar","A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia.","False","7a521967-b617-4762-8ea7-3ffa5353d391","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17045"
"2509","Reunion","C17095","REU","['REU', 'REUNION']","Reunion","An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","9ca747dd-04bb-42d3-b294-f36f9528b409","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17095"
"2510","Romania","C17108","ROU","['ROU', 'ROMANIA']","Romania","A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine.","False","d5572330-a006-4245-8aca-05c03025ddf7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17108"
"2511","Russia","C17111","RUS","['RUS', 'RUSSIAN FEDERATION']","Russia","A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean.","False","58d16624-d665-41f7-9e7a-0d6e684bc5f1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17111"
"2512","Rwanda","C17112","RWA","['RWA', 'RWANDA']","Rwanda","A country in Central Africa, east of Democratic Republic of the Congo.","False","c289e55b-94e5-43b7-8aa0-1552e152ad3e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17112"
"2513","Saudi Arabia","C17117","SAU","['SAU', 'SAUDI ARABIA']","Saudi Arabia","A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen.","False","31815554-4f6e-4799-a962-89e1e42bf054","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17117"
"2514","Serbia","C64377","SCG","['SCG', 'SERBIA']","Serbia","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","e28b2cf0-bb43-4389-8fa2-cacdd7bba9d5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C64377"
"2515","Sudan","C17170","SDN","['SDN', 'SUDAN']","Sudan","A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea.","False","723073e9-3716-430a-8f2d-b396cf951b47","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17170"
"2516","Senegal","C17121","SEN","['SEN', 'SENEGAL']","Senegal","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania.","False","65f06bef-5c65-4e27-8059-43942c26e83f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17121"
"2517","Singapore","C17134","SGP","['SGP', 'SINGAPORE']","Singapore","A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia.","False","ff42f91d-4e05-4489-ad56-b5ab41c81d46","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17134"
"2518","South Georgia and the South Sandwich Islands","C20111","SGS","['SGS', 'SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS']","South Georgia and the South Sandwich Islands","A group of islands in the South Atlantic Ocean, east of the tip of South America.","False","e59f7835-6c65-4abf-a7d2-5d37d83b9255","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20111"
"2519","Saint Helena","C17164","SHN","['SHN', 'SAINT HELENA']","Saint Helena","Islands in the South Atlantic Ocean, about midway between South America and Africa.","False","546fc001-6d52-4d94-b7ab-afbd101abd68","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17164"
"2520","Svalbard and Jan Mayen","C17178","SJM","['SJM', 'SVALBARD AND JAN MAYEN']","Svalbard and Jan Mayen","Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway.","False","80d041b5-097c-425f-bd4e-be45476700f9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17178"
"2521","Solomon Islands","C17148","SLB","['SLB', 'SOLOMON ISLANDS']","Solomon Islands","A group of islands in the South Pacific Ocean, east of Papua New Guinea.","False","c6746fe2-d23d-4c7d-9fb7-4e05b8b012b9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17148"
"2522","Sierra Leone","C17130","SLE","['SLE', 'SIERRA LEONE']","Sierra Leone","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia.","False","a2e85d08-13d6-4d23-90b0-332e8ccb9873","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17130"
"2523","El Salvador","C16532","SLV","['SLV', 'EL SALVADOR']","El Salvador","A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras.","False","79a17e0e-0e03-48f4-a3e0-a39e9002d41d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16532"
"2524","San Marino","C17115","SMR","['SMR', 'SAN MARINO']","San Marino","A country in Southern Europe, an enclave in central Italy.","False","8de6b059-9ad8-44f0-8663-97c61c7c0eea","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17115"
"2525","Somalia","C17149","SOM","['SOM', 'SOMALIA']","Somalia","A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia.","False","c0cfd443-8818-4c25-b281-c67f0c1f8e15","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17149"
"2526","Saint Pierre and Miquelon","C17165","SPM","['SPM', 'SAINT PIERRE AND MIQUELON']","Saint Pierre and Miquelon","A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada).","False","41ebcbdd-1c12-4d9c-9390-af0947219b4b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17165"
"2527","Sao Tome and Principe","C17116","STP","['STP', 'SAO TOME AND PRINCIPE']","Sao Tome and Principe","A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon.","False","bcc25aea-68a9-4dfa-bc5a-6854f9db4c35","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17116"
"2528","Suriname","C17175","SUR","['SUR', 'SURINAME']","Suriname","A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana.","False","7ff5e3fb-5dfb-42e6-9cf6-2e98a447df95","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17175"
"2529","Slovakia","C17669","SVK","['SVK', 'SLOVAKIA']","Slovakia","A country in Central Europe, south of Poland.","False","94e9fef3-068d-4a7a-91d9-67814d93b118","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17669"
"2530","Slovenia","C17138","SVN","['SVN', 'SLOVENIA']","Slovenia","A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia.","False","1d01bbcd-7ff9-49c7-a183-d27dda7c87ae","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17138"
"2531","Sweden","C17180","SWE","['SWE', 'SWEDEN']","Sweden","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway.","False","cdee8735-d366-4637-9d6b-41c6c9b89314","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17180"
"2532","Swaziland","C17179","SWZ","['SWZ', 'SWAZILAND']","Swaziland","A country in Southern Africa, between Mozambique and South Africa.","False","07833cde-104b-41a3-b2cb-208fb0895a4b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17179"
"2533","Seychelles","C17129","SYC","['SYC', 'SEYCHELLES']","Seychelles","A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar.","False","12f58e15-38ad-4e99-84f4-39cac0227779","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17129"
"2534","Syria","C17182","SYR","['SYR', 'SYRIAN ARAB REPUBLIC']","Syria","A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey.","False","8c5f3906-1138-41eb-a185-4c386b4b1393","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17182"
"2535","Turks and Caicos Islands","C17224","TCA","['TCA', 'TURKS AND CAICOS ISLANDS']","Turks and Caicos Islands","Two island groups in the North Atlantic Ocean, southeast of The Bahamas.","False","9163bd64-384c-4a75-b3ff-40850b0813df","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17224"
"2536","Chad","C16412","TCD","['TCD', 'CHAD']","Chad","A country in Central Africa, south of Libya.","False","147a31b1-124b-4dd5-b46a-d00281163275","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C16412"
"2537","Togo","C17202","TGO","['TGO', 'TOGO']","Togo","A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana.","False","0aeb9ac2-5d25-4a5f-89b8-64397f18a30b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17202"
"2538","Thailand","C17192","THA","['THA', 'THAILAND']","Thailand","A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma.","False","feb3d23f-1ab4-4615-8d20-95524abf61ee","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17192"
"2539","Tajikistan","C17183","TJK","['TJK', 'TAJIKISTAN']","Tajikistan","A country in Central Asia, west of China.","False","b75c6d8d-89c0-45a9-8bcf-1c5b3432bf4c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17183"
"2540","Tokelau","C17704","TKL","['TKL', 'TOKELAU']","Tokelau","A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","298d2dc8-7b54-4105-868d-c37c06a9fe43","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17704"
"2541","Turkmenistan","C17223","TKM","['TKM', 'TURKMENISTAN']","Turkmenistan","A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan.","False","6ca8cc43-77ba-4cbd-9306-c390b6aa94a8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17223"
"2542","Timor-Leste","C17200","TLS","['TLS', 'TIMOR-LESTE']","Timor-Leste","A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco.","False","2e2d1d01-a8aa-4835-8975-0f0336d11119","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17200"
"2543","Tonga","C17205","TON","['TON', 'TONGA']","Tonga","An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","474be542-8887-4248-b170-74c3424699e7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17205"
"2544","Trinidad and Tobago","C17217","TTO","['TTO', 'TRINIDAD AND TOBAGO']","Trinidad and Tobago","Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","39c2e072-ad2c-4179-a84e-bfa0631192b4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17217"
"2545","Tunisia","C17221","TUN","['TUN', 'TUNISIA']","Tunisia","A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya.","False","c25cb9dd-aba9-40f5-84b2-146686fe4987","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17221"
"2546","Turkey","C17222","TUR","['TUR', 'TURKEY']","Turkey","A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria.","False","2e9d14b0-79e0-4f96-8de9-6c4ad626ea97","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17222"
"2547","Tuvalu","C17225","TUV","['TUV', 'TUVALU']","Tuvalu","An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","47f8faed-6076-4211-93ad-a0a100e9bd61","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17225"
"2548","Taiwan","C17184","TWN","['TWN', 'TAIWAN']","Taiwan","A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China.","False","e04106d9-590d-444c-8dbc-988a22bf5a5c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17184"
"2549","Tanzania","C17185","TZA","['TZA', 'TANZANIA, UNITED REPUBLIC OF']","Tanzania","A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique.","False","764f02e6-459c-40d8-9987-2cf08b6ed21f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17185"
"2550","Uganda","C17228","UGA","['UGA', 'UGANDA']","Uganda","A country in Eastern Africa, west of Kenya.","False","49fbecf5-c63f-4d57-a015-ecf52ea69053","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17228"
"2551","Ukraine","C17229","UKR","['UKR', 'UKRAINE']","Ukraine","A country in Eastern Europe, bordering the Black Sea, between Poland and Russia.","False","4752fb11-dcae-4516-8f87-a40dea51820b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17229"
"2552","United States Minor Outlying Islands","C20112","UMI","['UMI', 'UNITED STATES MINOR OUTLYING ISLANDS']","United States Minor Outlying Islands","The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).","False","90eebf7e-9b9b-4eae-95fa-1ddd7c84b146","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C20112"
"2553","Uruguay","C17244","URY","['URY', 'URUGUAY']","Uruguay","A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil.","False","e87a94e9-8918-430a-859f-08bc506e96ca","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17244"
"2554","United States","C17234","USA","['USA', 'UNITED STATES']","United States","A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico.","False","dc85a04d-3b0d-4460-8ceb-0613196fba54","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17234"
"2555","Uzbekistan","C17246","UZB","['UZB', 'UZBEKISTAN']","Uzbekistan","A country in Central Asia, north of Afghanistan.","False","21890cd7-8dfd-4c72-a9c5-ea7bfd4381ff","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17246"
"2556","Holy See","C17249","VAT","['VAT', 'VATICAN CITY STATE']","Holy See","An enclave of Rome (Italy).","False","e479009f-7bd0-4c84-bd21-5cb19685d68a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17249"
"2557","Saint Vincent and the Grenadines","C17114","VCT","['VCT', 'SAINT VINCENT AND THE GRENADINES']","Saint Vincent and the Grenadines","A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago.","False","80db0a38-cfff-40cb-b695-c127f85102a6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17114"
"2558","Venezuela","C17250","VEN","['VEN', 'VENEZUELA']","Venezuela","A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana.","False","abb93e53-5a45-4f3a-a1a5-ad4661957fa8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17250"
"2559","British Virgin Islands","C17653","VGB","['VGB', 'VIRGIN ISLANDS,BRITISH']","British Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","57f89366-10d1-4032-bdaa-825d004fe928","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17653"
"2560","United States Virgin Islands","C17255","VIR","['VIR', 'VIRGIN ISLANDS, U.S.']","United States Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","acf74627-c0ae-4379-94c9-2ca7b056f53c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17255"
"2561","Vietnam","C17252","VNM","['VNM', 'VIETNAM']","Vietnam","A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.","False","e0eb7f05-79f9-4e40-a976-ae157751e471","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17252"
"2562","Vanuatu","C17247","VUT","['VUT', 'VANUATU']","Vanuatu","A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia.","False","6dd95ecf-730c-4417-8f14-becf916e8928","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17247"
"2563","Wallis and Futuna Islands","C17259","WLF","['WLF', 'WALLIS AND FUTUNA']","Wallis and Futuna Islands","Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","7fd32d76-cda1-4bb4-b02b-57b6eaa762a9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17259"
"2564","Samoa","C17740","WSM","['WSM', 'SAMOA']","Samoa","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","894a392d-5555-4780-963f-afafb762d31e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17740"
"2565","Yemen","C17264","YEM","['YEM', 'YEMEN']","Yemen","A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia.","False","956cb5c7-f7ea-4029-9fa4-9f8f7ce4311b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17264"
"2566","South Africa","C17151","ZAF","['ZAF', 'SOUTH AFRICA']","South Africa","A country in Southern Africa, at the southern tip of the continent of Africa.","False","0d7c0064-539a-47d7-9d19-406fe782fa2f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17151"
"2567","Zambia","C17267","ZMB","['ZMB', 'ZAMBIA']","Zambia","A country in Southern Africa, east of Angola.","False","d3c2e300-2a75-4b54-8df8-1ac02a665dd0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17267"
"2568","Zimbabwe","C17268","ZWE","['ZWE', 'ZIMBABWE']","Zimbabwe","A country in Southern Africa, between South Africa and Zambia.","False","a3cd2ffc-69aa-4e12-bc23-49aa3eb5d1cf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66786/C17268"
"2569","Diagnosis Group","C66787","TDIGRP","['TDIGRP', 'Diagnosis Group']","CDISC SDTM Diagnosis Group Terminology","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","cbac95a0-ba74-4859-a809-d760772884cb","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66787"
"2570","Healthy Subject","C49651","HEALTHY SUBJECTS","['HEALTHY SUBJECTS']","Healthy Subject","An individual who is or becomes a participant in a research study and has no significant health-related issues.  (NCI)","False","ee915b35-4c5b-4021-8a6b-8103567c1ce8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66787/C49651"
"2571","Dictionary Name","C66788","DICTNAM","['DICTNAM', 'Dictionary Name', 'Name of Dictionary']","CDISC SDTM Dictionary Name Terminology","A name given to a reference source that lists words and gives their meaning. (NCI)","False","4582a2bc-7e3e-431d-947b-98f1c435a878","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788"
"2572","Thesaurus of Adverse Reaction Term Coding Symbols","C49471","COSTART","['COSTART', 'Coding Symbols for a Thesaurus of Adverse Reaction Terms']","Thesaurus of Adverse Reaction Term Coding Symbols","A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)","False","365330dd-7bb7-42fa-a3f3-0323cf70d3b3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788/C49471"
"2573","International Classification of Diseases","C49474","ICD","['ICD', 'International Classification of Diseases']","International Classification of Diseases","A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)","False","9c29338f-1afe-4aae-b158-4eb440a38ee6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788/C49474"
"2574","Logical Observation Identifiers Names and Codes","C49476","LOINC","['LOINC', 'Logical Observation Identifiers Names and Codes']","Logical Observation Identifiers Names and Codes","Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)","False","bf79b25f-3682-4bf0-be07-de2015f0c620","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788/C49476"
"2575","MedDRA","C43820","MedDRA","['MedDRA', 'Medical Dictionary for Regulatory Activities']","MedDRA","MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)","False","ebaa5e6d-a982-4466-970d-17e631fa0faf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788/C43820"
"2576","Systematized Nomenclature of Medicine","C53489","SNOMED","['SNOMED', 'Systematized Nomenclature of Medicine']","Systematized Nomenclature of Medicine","A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)","False","6ac7fd38-57d2-461e-8e7f-988042bd799d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788/C53489"
"2577","World Health Organization Adverse Reaction Terminology","C49468","WHOART","['WHOART', 'World Health Organization Adverse Reaction Terms']","World Health Organization Adverse Reaction Terminology","A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)","False","2af6d9c9-1c8d-4fa8-a953-04915dbcb5c1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788/C49468"
"2578","World Health Organization Drug Dictionary","C49475","WHODD","['WHODD', 'World Health Organization Drug Dictionary']","World Health Organization Drug Dictionary","A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)","False","f067ee37-f2da-4cf4-88aa-daddd4cc3dca","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66788/C49475"
"2579","Not Done","C66789","ND","['ND', 'Not Done']","CDISC SDTM Not DoneTerminology","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","c19b3062-6cd2-40c9-a5e7-0867fd17bfee","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66789"
"2580","Not Done","C49484","NOT DONE","['NOT DONE']","Not Done","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","95772a50-1874-4bb9-ba3e-e8849bb393e0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66789/C49484"
"2581","Patient Ethnic Group ","C66790","ETHNIC","['ETHNIC', 'Patient Ethnic Group']","CDISC SDTM Patient Ethnic GroupTerminology","A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)","False","525f0152-9f9a-4217-9676-644a6934ea09","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66790"
"2582","Hispanic or Latino","C17459","HISPANIC OR LATINO","['HISPANIC OR LATINO']","Hispanic or Latino","A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)","False","69543256-ea62-438b-8d49-2571a91d4e10","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66790/C17459"
"2583","Not Hispanic or Latino","C41222","NOT HISPANIC OR LATINO","['NOT HISPANIC OR LATINO']","Not Hispanic or Latino","A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)","False","148e2d14-376b-4427-a280-0ff56953749e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66790/C41222"
"2584","Not Stated","C43234","Not reported","['Not reported']","Not Stated","Not provided or available","False","c1dd56d3-a0f4-42ec-abda-361129f9e2ca","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66790/C43234"
"2585","Unknown","C17998","UNKNOWN","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","4ff63a99-180c-49a3-85c8-85d631733a1b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66790/C17998"
"2586","Pharmaceutical Dosage Form","C66726","FRM","['FRM', 'Pharmaceutical Dosage Form', 'Dose Form']","CDISC SDTM Pharmaceutical Dosage FormTerminology","The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.","False","360bbdeb-a0d3-4e48-a0dd-4cf6096bbaa1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726"
"2587","Aerosol Dosage Form","C42887","AEROSOL","['AEROSOL']","Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)","False","a6d7cb1d-3e40-4830-b01a-205d632ceb15","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42887"
"2588","Aerosol Foam Dosage Form","C42888","AEROSOL, FOAM","['AEROSOL, FOAM']","Aerosol Foam Dosage Form","A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)","False","94bd2101-920f-4fbb-af08-a1a0e5aff2e7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42888"
"2589","Metered Aerosol Dosage Form","C42960","AEROSOL, METERED","['AEROSOL, METERED']","Metered Aerosol Dosage Form","A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)","False","1d9ed969-bb04-4b47-9a7a-bdf4549493e8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42960"
"2590","Powder Aerosol Dosage Form","C42971","AEROSOL, POWDER","['AEROSOL, POWDER']","Powder Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)","False","e437eb30-4210-487e-b09d-6c91635ed4b8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42971"
"2591","Aerosol Spray Dosage Form","C42889","AEROSOL, SPRAY","['AEROSOL, SPRAY']","Aerosol Spray Dosage Form","An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)","False","639ddcd5-a530-4756-9060-2f5f97b4218e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42889"
"2592","Chewable Bar Dosage Form","C42892","BAR, CHEWABLE","['BAR, CHEWABLE']","Chewable Bar Dosage Form","A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)","False","2116934e-ac4c-4020-a152-fb9eedb22a7a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42892"
"2593","Bead Dosage Form","C42890","BEAD","['BEAD']","Bead Dosage Form","A solid dosage form in the shape of a small ball. (NCI)","False","df5a8a8e-efab-41a9-819b-e4eec8aa8e51","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42890"
"2594","Extended Release Bead Implant Dosage Form","C43451","BEAD, IMPLANT, EXTENDED RELEASE","['BEAD, IMPLANT, EXTENDED RELEASE']","Extended Release Bead Implant Dosage Form","A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form.  (NCI)","False","642ef089-4a02-4f68-9020-9a920acb333e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C43451"
"2595","Block Dosage Form","C42891","BLOCK","['BLOCK']","Block Dosage Form","Solid dosage form, usually in the shape of a square or rectangle. (NCI)","False","b503274c-c142-4fbf-94ac-4a87a2931e1e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42891"
"2596","Capsule Dosage Form","C25158","CAPSULE","['CAPSULE']","Capsule Dosage Form","A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)","False","04f0f5f1-606c-4ef7-bc87-612a830dc4db","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C25158"
"2597","Coated Capsule Dosage Form","C42895","CAPSULE, COATED","['CAPSULE, COATED']","Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)","False","73447998-2a4e-4073-8979-05801d88329a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42895"
"2598","Coated Pellets in Capsule Dosage Form","C42896","CAPSULE, COATED PELLETS","['CAPSULE, COATED PELLETS']","Coated Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)","False","627ea1b5-43a5-44f8-ae97-8d774a23f18e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42896"
"2599","Extended Release Coated Capsule Dosage Form","C42917","CAPSULE, COATED, EXTENDED RELEASE","['CAPSULE, COATED, EXTENDED RELEASE']","Extended Release Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","26e541e6-0638-42f4-924f-e7f9e7013ae5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42917"
"2600","Delayed Release Capsule Dosage Form","C42902","CAPSULE, DELAYED RELEASE","['CAPSULE, DELAYED RELEASE']","Delayed Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","627f37d9-bc56-4672-b4c8-cce7390a6fb7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42902"
"2601","Delayed Release Pellets in Capsule Dosage Form","C42904","CAPSULE, DELAYED RELEASE PELLETS","['CAPSULE, DELAYED RELEASE PELLETS']","Delayed Release Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","6379fd30-a6d0-4b38-8bad-c4c556bd118e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42904"
"2602","Extended Release Capsule Dosage Form","C42916","CAPSULE, EXTENDED RELEASE","['CAPSULE, EXTENDED RELEASE']","Extended Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","84d7f9fa-a455-4ec9-99ee-8c564744d574","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42916"
"2603","Extended Release Film Coated Capsule Dosage Form","C42928","CAPSULE, FILM COATED, EXTENDED RELEASE","['CAPSULE, FILM COATED, EXTENDED RELEASE']","Extended Release Film Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","56c639e9-d55d-46b4-9b5d-178c2157e9f6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42928"
"2604","Gelatin Coated Capsule Dosage Form","C42936","CAPSULE, GELATIN COATED","['CAPSULE, GELATIN COATED']","Gelatin Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)","False","034e42d5-6784-44a4-8ee3-3d154ab39c25","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42936"
"2605","Liquid Filled Capsule Dosage Form","C42954","CAPSULE, LIQUID FILLED","['CAPSULE, LIQUID FILLED']","Liquid Filled Capsule Dosage Form","A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)","False","a1d5ed78-992d-4851-9cf9-d099eec691ee","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42954"
"2606","Cement Dosage Form","C45414","CEMENT","['CEMENT']","Cement Dosage Form","A substance that serves to produce solid union between two surfaces. (NCI)","False","5e62d57c-382b-4e77-bbb6-80c26bf2f735","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C45414"
"2607","Cigarette Dosage Form","C42678","CIGARETTE","['CIGARETTE']","Cigarette Dosage Form","A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)","False","601f377a-d258-4ecf-81bf-7b6e7732b9d1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42678"
"2608","Cloth Dosage Form","C60884","CLOTH","['CLOTH']","Cloth Dosage Form","ALT_DEFINITION:  A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)","False","32b67c16-c288-4f7f-8bb0-ca9cbcb8fd5e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60884"
"2609","Concentrate Dosage Form","C60891","CONCENTRATE","['CONCENTRATE']","Concentrate Dosage Form","A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)","False","f953adfc-f538-4121-8913-7d6dc7a26529","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60891"
"2610","Cone Dosage Form","C42900","CONE","['CONE']","Cone Dosage Form","A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)","False","7975fbbc-86a0-46ef-bd85-51d8fce8a7f7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42900"
"2611","Extended Release Core Dosage Form","C42919","CORE, EXTENDED RELEASE","['CORE, EXTENDED RELEASE']","Extended Release Core Dosage Form","An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)","False","e603b1ea-cea6-44b5-9dcc-ff3d36c60ce3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42919"
"2612","Cream Dosage Form","C28944","CREAM","['CREAM']","Cream Dosage Form","A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)","False","982af06d-e8a7-4ca7-92cb-a6a634caaea5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C28944"
"2613","Augmented Cream Dosage Form","C60897","CREAM, AUGMENTED","['CREAM, AUGMENTED']","Augmented Cream Dosage Form","A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","49a41912-98a8-408c-ad82-86223572eb53","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60897"
"2614","Crystal Dosage Form","C42901","CRYSTAL","['CRYSTAL']","Crystal Dosage Form","A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.","False","6767aac8-5169-4639-9d51-eaf8b862d22b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42901"
"2615","Culture Dosage Form","C45415","CULTURE","['CULTURE']","Culture Dosage Form","The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)","False","bcb7972a-68d8-4517-9587-c02343a3b745","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C45415"
"2616","Diaphragm Dosage Form","C47890","DIAPHRAGM","['DIAPHRAGM']","Diaphragm Dosage Form","A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)","False","b8c12818-829e-4e1c-ad9f-1b266bf14276","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47890"
"2617","Disc Dosage Form","C43525","DISC","['DISC']","Disc Dosage Form","A circular plate-like organ or structure. (FDA)","False","e43086d7-2c28-4ec6-adb0-2ddd4cf1c5a0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C43525"
"2618","Douche Dosage Form","C42679","DOUCHE","['DOUCHE']","Douche Dosage Form","A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)","False","dbd91223-d705-4252-9302-7e629302e538","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42679"
"2619","Dressing Dosage Form","C42763","DRESSING","['DRESSING']","Dressing Dosage Form","The application of various materials for protecting a wound.(FDA)","False","77f6cb53-54e6-44de-a5f9-5d42c8f43c60","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42763"
"2620","Drug Delivery System","C17423","DRUG DELIVERY SYSTEM","['DRUG DELIVERY SYSTEM']","Drug Delivery System","Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)","False","b3bf140b-f277-4365-9724-3c1c499672c9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C17423"
"2621","Elixir Dosage Form","C42912","ELIXIR","['ELIXIR']","Elixir Dosage Form","A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)","False","3cb29ab1-ddee-4711-8033-e4b61296ad4a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42912"
"2622","Emulsion Dosage Form","C42913","EMULSION","['EMULSION']","Emulsion Dosage Form","A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)","False","d560314f-876c-4b18-8a84-32f94ac42c2c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42913"
"2623","Enema Dosage Form","C42915","ENEMA","['ENEMA']","Enema Dosage Form","A rectal preparation for therapeutic, diagnostic, or nutritive purposes.  (NCI)","False","eb5491af-5e7f-4329-81f4-3c0bda7b53f8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42915"
"2624","Extract Dosage Form","C42929","EXTRACT","['EXTRACT']","Extract Dosage Form","A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)","False","6b9189cb-d074-4d8e-94a5-90d9118bda83","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42929"
"2625","Extended Release Fiber Dosage Form","C60926","FIBER, EXTENDED RELEASE","['FIBER, EXTENDED RELEASE']","Extended Release Fiber Dosage Form","A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","5bd189f1-1fc0-4a94-b00e-cbbbb0fed904","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60926"
"2626","Film Dosage Form","C42932","FILM","['FILM']","Film Dosage Form","A thin layer or coating. (NCI)","False","a7b86c74-77be-4b32-8e8b-8e0999bc3aa0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42932"
"2627","Extended Release Film Dosage Form","C42920","FILM, EXTENDED RELEASE","['FILM, EXTENDED RELEASE']","Extended Release Film Dosage Form","A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)","False","aaeac617-43f8-45f8-bf24-a219690c6dea","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42920"
"2628","Soluble Film Dosage Form","C42984","FILM, SOLUBLE","['FILM, SOLUBLE']","Soluble Film Dosage Form","A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)","False","598c2efc-1c2f-40a6-a4e2-dd021203b153","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42984"
"2629","Dosage Form For Solution","C60927","FOR SOLUTION","['FOR SOLUTION']","Dosage Form For Solution","A product, usually a solid, intended for solution prior to administration. (FDA)","False","031647a6-cd02-44f4-83b5-c63fc4184170","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60927"
"2630","Dosage Form For Suspension","C60928","FOR SUSPENSION","['FOR SUSPENSION']","Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration. (FDA)","False","6593e6f1-8051-45c3-acdc-05c9e0bf8574","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60928"
"2631","Extended Release Dosage Form For Suspension","C60929","FOR SUSPENSION, EXTENDED RELEASE","['FOR SUSPENSION, EXTENDED RELEASE']","Extended Release Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)","False","c52a49d5-c2f2-48a1-b5af-b58c562d59fd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60929"
"2632","Gas Dosage Form","C42933","GAS","['GAS']","Gas Dosage Form","Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)","False","d13707ae-3426-40f1-a544-a3118c8ada86","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42933"
"2633","Gel Dosage Form","C42934","GEL","['GEL']","Gel Dosage Form","A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2).  A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature.  It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)","False","62e7ba23-0f70-4608-854d-1b09abe02f96","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42934"
"2634","Dentifrice Gel Dosage Form","C42906","GEL, DENTIFRICE","['GEL, DENTIFRICE']","Dentifrice Gel Dosage Form","A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)","False","8d77a387-1e6c-4a52-80d2-c0701b84c4cf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42906"
"2635","Metered Gel Dosage Form","C60930","GEL, METERED","['GEL, METERED']","Metered Gel Dosage Form","A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)","False","cc6c47b9-bb20-43cb-ace3-b8e92387da8e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60930"
"2636","Generator Dosage Form","C48193","GENERATOR","['GENERATOR']","Generator Dosage Form","An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)","False","9277192c-4e4b-4ac2-8bc6-56a5544c1150","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C48193"
"2637","Globule Dosage Form","C42937","GLOBULE","['GLOBULE']","Globule Dosage Form","Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)","False","2c889bbe-a184-42fc-adfb-127dde24b38c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42937"
"2638","Graft Dosage Form","C45416","GRAFT","['GRAFT']","Graft Dosage Form","A slip of skin or of other tissue for implantation. (NCI)","False","19051c23-ed55-41fc-9fb5-563bf738007d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C45416"
"2639","Granule Dosage Form","C42938","GRANULE","['GRANULE']","Granule Dosage Form","A small particle or grain. (NCI)","False","7eb38290-7920-45e8-9b55-ded25eb12a3d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42938"
"2640","Delayed Release Granule Dosage Form","C42903","GRANULE, DELAYED RELEASE","['GRANULE, DELAYED RELEASE']","Delayed Release Granule Dosage Form","A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","aabacb1f-65d0-46de-8a99-7fc69b7e285a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42903"
"2641","Effervescent Granule Dosage Form","C42909","GRANULE, EFFERVESCENT","['GRANULE, EFFERVESCENT']","Effervescent Granule Dosage Form","A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)","False","69bdca20-62d5-4f66-a2c5-c8662a699551","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42909"
"2642","Granule For Solution Dosage Form","C42939","GRANULE, FOR SOLUTION","['GRANULE, FOR SOLUTION']","Granule For Solution Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","fb8ff1d8-4715-44da-9bee-d31c617039e4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42939"
"2643","Granule For Suspension Dosage Form","C42940","GRANULE, FOR SUSPENSION","['GRANULE, FOR SUSPENSION']","Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","225b78d3-cad8-49ae-a83d-9b2888b91dbc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42940"
"2644","Extended Release Granule For Suspension Dosage Form","C42921","GRANULE, FOR SUSPENSION, EXTENDED RELEASE","['GRANULE, FOR SUSPENSION, EXTENDED RELEASE']","Extended Release Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)","False","af970a77-6ec2-4a9d-9299-377f54215b97","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42921"
"2645","Gum Dosage Form","C42941","GUM","['GUM']","Gum Dosage Form","A mucilaginous excretion from various plants. (NCI)","False","5cb3f378-f766-483c-ab84-a0a7805f6af0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42941"
"2646","Chewing Gum Dosage Form","C42894","GUM, CHEWING","['GUM, CHEWING']","Chewing Gum Dosage Form","A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)","False","bf41b235-f70c-4e47-975b-cc8e2184f4d3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42894"
"2647","Resin Gum Dosage Form","C42978","GUM, RESIN","['GUM, RESIN']","Resin Gum Dosage Form","Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)","False","8b426b15-4cce-4ce2-97ce-af1acaa0454e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42978"
"2648","Implant Dosage Form","C42942","IMPLANT","['IMPLANT']","Implant Dosage Form","A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)","False","96751011-e368-4d38-96a0-17639fd832b5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42942"
"2649","Inhalant Dosage Form","C42944","INHALANT","['INHALANT']","Inhalant Dosage Form","A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)","False","aa704d01-41da-482e-bccb-e26487750b27","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42944"
"2650","Liposomal Injection Dosage Form","C60931","INJECTABLE, LIPOSOMAL","['INJECTABLE, LIPOSOMAL']","Liposomal Injection Dosage Form","An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)","False","21b72d86-edb0-4e96-ac2d-0938e8cb0f6e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60931"
"2651","Injectable Dosage Form","C42946","INJECTION","['INJECTION']","Injectable Dosage Form","A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)","False","00456c6d-2b04-49b0-83bd-b97849b278e6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42946"
"2652","Emulsion for Injection Dosage Form","C42914","INJECTION, EMULSION","['INJECTION, EMULSION']","Emulsion for Injection Dosage Form","An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)","False","43bbfc8b-2862-4cb2-a637-66a514d17a76","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42914"
"2653","Injectable Lipid Complex Dosage Form","C42950","INJECTION, LIPID COMPLEX","['INJECTION, LIPID COMPLEX']","Injectable Lipid Complex Dosage Form","[definition pending](FDA)","False","49fbbf5a-1a27-4751-ac41-520b518ff84a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42950"
"2654","Powder For Injectable Solution Dosage Form","C42974","INJECTION, POWDER, FOR SOLUTION","['INJECTION, POWDER, FOR SOLUTION']","Powder For Injectable Solution Dosage Form","A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)","False","17d20dff-9393-43ac-96a4-e49f7a3e00d4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42974"
"2655","Powder For Injectable Suspension Dosage Form","C42976","INJECTION, POWDER, FOR SUSPENSION","['INJECTION, POWDER, FOR SUSPENSION']","Powder For Injectable Suspension Dosage Form","A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)","False","7f07334f-6435-416c-8143-9c41491f1fb0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42976"
"2656","Powder For Injectable Extended Release Suspension Dosage Form","C42977","INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE","['INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE']","Powder For Injectable Extended Release Suspension Dosage Form","A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)","False","500e390e-1e48-4208-a924-e1179d684068","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42977"
"2657","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","C42959","INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION","['INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION']","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)","False","e300737b-53a1-446d-b33c-7d4f315f13a8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42959"
"2658","Lyophilized Powder For Injectable Solution Dosage Form","C42957","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","['INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION']","Lyophilized Powder For Injectable Solution Dosage Form","A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)","False","f578d68d-6a96-4a8c-8edf-96e2b17c40aa","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42957"
"2659","Lyophilized Powder For Injectable Suspension Dosage Form","C42958","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION","['INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION']","Lyophilized Powder For Injectable Suspension Dosage Form","A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization (""freeze drying""), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)","False","d63f81e7-eba8-41d8-a02f-25f54886aeb0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42958"
"2660","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","C42956","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE","['INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE']","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)","False","317ddb6c-e8c6-4b39-8c1b-1305a463a89b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42956"
"2661","Injectable Solution Dosage Form","C42945","INJECTION, SOLUTION","['INJECTION, SOLUTION']","Injectable Solution Dosage Form","A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)","False","19add925-4af7-4bd5-a836-de1955584c4d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42945"
"2662","Concentrate for Injectable Solution Dosage Form","C42899","INJECTION, SOLUTION, CONCENTRATE","['INJECTION, SOLUTION, CONCENTRATE']","Concentrate for Injectable Solution Dosage Form","A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)","False","0292e4f8-e894-48f4-abc3-d18820ab3f0e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42899"
"2663","Injectable Suspension Dosage Form","C42995","INJECTION, SUSPENSION","['INJECTION, SUSPENSION']","Injectable Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)","False","d78cf750-11b2-4fdf-8d50-f329c54b11e4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42995"
"2664","Injectable Extended Release Suspension Dosage Form","C42926","INJECTION, SUSPENSION, EXTENDED RELEASE","['INJECTION, SUSPENSION, EXTENDED RELEASE']","Injectable Extended Release Suspension Dosage Form","A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","ce844392-0bbf-42cf-8f93-2daa5dc36e75","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42926"
"2665","Injectable Liposomal Suspension Dosage Form","C42951","INJECTION, SUSPENSION, LIPOSOMAL","['INJECTION, SUSPENSION, LIPOSOMAL']","Injectable Liposomal Suspension Dosage Form","A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)","False","08ff2dcc-0ae9-4f5f-8bbd-4142b4ddc016","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42951"
"2666","Injectable Sonicated Suspension Dosage Form","C42988","INJECTION, SUSPENSION, SONICATED","['INJECTION, SUSPENSION, SONICATED']","Injectable Sonicated Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)","False","258b9f0a-d069-41b3-84ab-03ca251cb0f7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42988"
"2667","Insert Dosage Form","C60933","INSERT","['INSERT']","Insert Dosage Form","A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)","False","ac703061-f39f-45e7-8ce3-2b330db48b08","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60933"
"2668","Extended Release Insert Dosage Form","C42922","INSERT, EXTENDED RELEASE","['INSERT, EXTENDED RELEASE']","Extended Release Insert Dosage Form","A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)","False","6068123a-c490-49c3-880f-d8bea446f01c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42922"
"2669","Intrauterine Device Dosage Form","C47915","INTRAUTERINE DEVICE","['INTRAUTERINE DEVICE']","Intrauterine Device Dosage Form","A device inserted and left in the uterus to prevent effective conception. (NCI)","False","2d0e7c93-6657-4230-972f-f59aff4f17d2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47915"
"2670","Irrigant Dosage Form","C42947","IRRIGANT","['IRRIGANT']","Irrigant Dosage Form","A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)","False","7602a965-d465-4790-9779-c1d3ac9cf434","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42947"
"2671","Jelly Dosage Form","C42948","JELLY","['JELLY']","Jelly Dosage Form","A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)","False","8c7db154-c510-4c1b-9ce5-a0f8fcab0151","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42948"
"2672","Kit Dosage Form","C47916","KIT","['KIT']","Kit Dosage Form","A packaged collection of related material. (NCI)","False","ee72c994-c74f-4cc6-9cd2-40234eddfe6b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47916"
"2673","Dental Liner Dosage Form","C45413","LINER, DENTAL","['LINER, DENTAL']","Dental Liner Dosage Form","A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)","False","a538ee6a-43eb-4899-aee1-6041060b46d0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C45413"
"2674","Liniment Dosage Form","C42949","LINIMENT","['LINIMENT']","Liniment Dosage Form","A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)","False","88119ce0-3cf4-471d-bbd8-8d72b493df27","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42949"
"2675","Lipstick Dosage Form","C42952","LIPSTICK","['LIPSTICK']","Lipstick Dosage Form","A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)","False","f4b64d31-9774-4044-a6ee-a31f96305351","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42952"
"2676","Liquid Dosage Form","C42953","LIQUID","['LIQUID']","Liquid Dosage Form","A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","8ecbdecc-cb9b-4e14-9c8c-9e4c2243bc34","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42953"
"2677","Extended Release Liquid Dosage Form","C60934","LIQUID, EXTENDED RELEASE","['LIQUID, EXTENDED RELEASE']","Extended Release Liquid Dosage Form","A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","bacc84dd-ac8b-441e-be2e-4f642ffa1118","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60934"
"2678","Lotion Dosage Form","C29167","LOTION","['LOTION']","Lotion Dosage Form","An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)","False","ab6cf5dd-fa26-4c66-b2b4-b5dca13fa219","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C29167"
"2679","Augmented Lotion Dosage Form","C60957","LOTION. AUGMENTED","['LOTION. AUGMENTED']","Augmented Lotion Dosage Form","A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","b57eb914-d465-4f5b-9bc1-f9319f0e841e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60957"
"2680","Lotion Shampoo Dosage Form","C60958","LOTION/SHAMPOO","['LOTION/SHAMPOO']","Lotion Shampoo Dosage Form","A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)","False","16ac81ab-2840-49d3-9eaf-9dc8e922f30c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60958"
"2681","Lozenge Dosage Form","C42955","LOZENGE","['LOZENGE']","Lozenge Dosage Form","A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)","False","671e9382-1629-45d1-b859-b09105ff2958","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42955"
"2682","Mouthwash Dosage Form","C29269","MOUTHWASH","['MOUTHWASH']","Mouthwash Dosage Form","An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)","False","eaa6e05d-1fe7-4a61-9790-e88b02a3d2cc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C29269"
"2683","Dosage Form Not Applicable","C48624","NOT APPLICABLE","['NOT APPLICABLE']","Dosage Form Not Applicable","The use of a dosage form term is not relevant or appropriate. (NCI)","False","16eb6e8d-a23e-4d4a-a517-c1191bd8dc6f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C48624"
"2684","Oil Dosage Form","C42965","OIL","['OIL']","Oil Dosage Form","An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)","False","561308a7-6426-489d-9bd2-70f0a75519d9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42965"
"2685","Ointment Dosage Form","C42966","OINTMENT","['OINTMENT']","Ointment Dosage Form","A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)","False","c37405c1-52fe-4d03-8d80-8d87432a677f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42966"
"2686","Augmented Ointment Dosage Form","C60984","OINTMENT, AUGMENTED","['OINTMENT, AUGMENTED']","Augmented Ointment Dosage Form","An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","ac7dcffb-50e8-49f9-9507-d3bd025e4f82","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60984"
"2687","Packing Dosage Form","C47887","PACKING","['PACKING']","Packing Dosage Form","A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)","False","55edce3e-5d37-4d5c-aa82-eb68248cb44f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47887"
"2688","Paste Dosage Form","C42967","PASTE","['PASTE']","Paste Dosage Form","A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)","False","5a81669c-7e10-4565-9d59-5e63186a1d9a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42967"
"2689","Dentifrice Paste Dosage Form","C42907","PASTE, DENTIFRICE","['PASTE, DENTIFRICE']","Dentifrice Paste Dosage Form","A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","4e8f87f6-5949-4bd0-8d23-de553bb80736","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42907"
"2690","Pastille Dosage Form","C60985","PASTILLE","['PASTILLE']","Pastille Dosage Form","An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)","False","51787d66-b3f4-4784-bef7-7cd5a45a8e64","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60985"
"2691","Patch Dosage Form","C42968","PATCH","['PATCH']","Patch Dosage Form","A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body.  Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch.  Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body.  A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)","False","06b6df77-5ada-409f-a0f0-1b813e87359d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42968"
"2692","Extended Release Patch Dosage Form","C42923","PATCH, EXTENDED RELEASE","['PATCH, EXTENDED RELEASE']","Extended Release Patch Dosage Form","A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","4785d964-9939-424c-bcf0-23fccc7956de","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42923"
"2693","Electrically Controlled Extended Release Patch Dosage Form","C42911","PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED","['PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED']","Electrically Controlled Extended Release Patch Dosage Form","A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","548b6450-fb80-4a5a-80ca-697b954913df","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42911"
"2694","Pellet Dosage Form","C42969","PELLET","['PELLET']","Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)","False","77cfb0a4-ca4a-4c30-b9cf-97a8576d5c48","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42969"
"2695","Implantable Pellet Dosage Form","C42943","PELLET, IMPLANTABLE","['PELLET, IMPLANTABLE']","Implantable Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)","False","a3301c27-9bf4-41ae-acc8-3f38428f4015","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42943"
"2696","Extended Release Coated Pellets Dosage Form","C42918","PELLETS, COATED, EXTENDED RELEASE","['PELLETS, COATED, EXTENDED RELEASE']","Extended Release Coated Pellets Dosage Form","A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","4ad67bfa-fecd-428a-afbd-b74fe0f0f5c1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42918"
"2697","Pill Dosage Form","C25394","PILL","['PILL']","Pill Dosage Form","A dose of medicine in the form of a small pellet. (NCI)","False","0017506d-2f13-4a26-869d-5a8df496a901","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C25394"
"2698","Plaster Dosage Form","C42970","PLASTER","['PLASTER']","Plaster Dosage Form","Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)","False","671e18b1-7fee-44dd-aa01-08d63bb55b23","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42970"
"2699","Poultice Dosage Form","C47913","POULTICE","['POULTICE']","Poultice Dosage Form","A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)","False","b76b5e10-096e-4149-aeab-86541b53fa66","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47913"
"2700","Powder Dosage Form","C42972","POWDER","['POWDER']","Powder Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)","False","8a9fd8d5-807f-4526-8153-c20f0a0b39aa","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42972"
"2701","Dentifrice Powder Dosage Form","C42908","POWDER, DENTIFRICE","['POWDER, DENTIFRICE']","Dentifrice Powder Dosage Form","A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","7802bd1e-99e5-4d32-838f-09230333067d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42908"
"2702","Powder for Solution Dosage Form","C42973","POWDER, FOR SOLUTION","['POWDER, FOR SOLUTION']","Powder for Solution Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)","False","6ea160a3-ad71-4906-bf5e-6abab2be4a73","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42973"
"2703","Powder for Suspension Dosage Form","C42975","POWDER, FOR SUSPENSION","['POWDER, FOR SUSPENSION']","Powder for Suspension Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)","False","d0202e7b-37fe-4020-80c6-2c047c6034c0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42975"
"2704","Metered Powder Dosage Form","C42961","POWDER, METERED","['POWDER, METERED']","Metered Powder Dosage Form","A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)","False","30597259-6d06-4c0c-b608-796c2df8ea84","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42961"
"2705","Ring Dosage Form","C60988","RING","['RING']","Ring Dosage Form","A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)","False","572aaefa-e8d5-480a-bcfd-13f0181ec582","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60988"
"2706","Rinse Dosage Form","C42979","RINSE","['RINSE']","Rinse Dosage Form","A liquid used to cleanse by flushing. (NCI)","False","8311d12b-cf74-4772-ab57-14901b428ebe","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42979"
"2707","Salve Dosage Form","C42980","SALVE","['SALVE']","Salve Dosage Form","A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)","False","f96d8034-090f-4860-8d5a-f056dc63ca92","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42980"
"2708","Shampoo Dosage Form","C42981","SHAMPOO","['SHAMPOO']","Shampoo Dosage Form","A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","346ec282-51b5-4864-b7f6-ad97489deb27","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42981"
"2709","Shampoo Suspension Dosage Form","C42982","SHAMPOO, SUSPENSION","['SHAMPOO, SUSPENSION']","Shampoo Suspension Dosage Form","A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","b576add6-2b0a-4c34-9884-74a179892397","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42982"
"2710","Soap Dosage Form","C42983","SOAP","['SOAP']","Soap Dosage Form","Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)","False","0c1024b3-8059-4b64-a8ad-b6ec82440875","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42983"
"2711","Solution Dosage Form","C42986","SOLUTION","['SOLUTION']","Solution Dosage Form","A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)","False","67da5c7e-f4e9-4f5c-b066-25df1c5e5c02","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42986"
"2712","Concentrate for Solution Dosage Form","C42898","SOLUTION, CONCENTRATE","['SOLUTION, CONCENTRATE']","Concentrate for Solution Dosage Form","A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)","False","34f51234-462e-42ac-a9a4-d45375b2c6d7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42898"
"2713","Solution For Slush Dosage Form","C42987","SOLUTION, FOR SLUSH","['SOLUTION, FOR SLUSH']","Solution For Slush Dosage Form","A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)","False","771d7b21-47f7-4e7b-838c-7339d53e5f6b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42987"
"2714","Gel Forming Drops Solution Dosage Form","C60994","SOLUTION, GEL FORMING / DROPS","['SOLUTION, GEL FORMING / DROPS']","Gel Forming Drops Solution Dosage Form","A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)","False","f546f702-6b70-4fef-9ec4-be631ba4c362","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60994"
"2715","Extended Release Gel Forming Solution Dosage Form","C42935","SOLUTION, GEL FORMING, EXTENDED RELEASE","['SOLUTION, GEL FORMING, EXTENDED RELEASE']","Extended Release Gel Forming Solution Dosage Form","A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency","False","b41f5b3a-f6cf-403c-aff9-73bbdb13acc5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42935"
"2716","Drops Solution Dosage Form","C60992","SOLUTION/ DROPS","['SOLUTION/ DROPS']","Drops Solution Dosage Form","A solution which is usually administered in a drop-wise fashion. (FDA)","False","6f12718f-2422-4e4c-bf07-5022ddd93ab6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60992"
"2717","Sponge Dosage Form","C47912","SPONGE","['SPONGE']","Sponge Dosage Form","A porous, interlacing, absorbent material that contains a drug.  It is typically used for applying or introducing medication, or for cleansing.  A sponge usually retains its shape.(FDA)","False","1be8630e-3753-4f5b-8afe-2144ca5924c8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47912"
"2718","Spray Dosage Form","C42989","SPRAY","['SPRAY']","Spray Dosage Form","A liquid minutely divided as by a jet of air or steam. (NCI)","False","895ac8be-6dfd-4daf-8247-b2f6acbfbc9b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42989"
"2719","Metered Spray Dosage Form","C42962","SPRAY, METERED","['SPRAY, METERED']","Metered Spray Dosage Form","A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)","False","833c1f3e-4113-416b-9f52-965219f0bf10","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42962"
"2720","Spray Suspension Dosage Form","C42990","SPRAY, SUSPENSION","['SPRAY, SUSPENSION']","Spray Suspension Dosage Form","A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)","False","2a1a9ead-1457-4bfe-95a9-d3e102d8e951","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42990"
"2721","Stick Dosage Form","C42991","STICK","['STICK']","Stick Dosage Form","A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)","False","01e8d115-37d0-4bc1-80bb-9cf8846f715d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42991"
"2722","Strip Dosage Form","C47914","STRIP","['STRIP']","Strip Dosage Form","A long narrow piece of material.","False","c7d27aa9-8239-4fa7-bcc6-8b16bcf516af","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47914"
"2723","Suppository Dosage Form","C42993","SUPPOSITORY","['SUPPOSITORY']","Suppository Dosage Form","A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)","False","21242610-d1b4-483a-b034-acba187f1d04","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42993"
"2724","Extended Release Suppository Dosage Form","C42924","SUPPOSITORY, EXTENDED RELEASE","['SUPPOSITORY, EXTENDED RELEASE']","Extended Release Suppository Dosage Form","A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)","False","ecf4296b-1235-4cbf-b9e9-bd9be4f40f04","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42924"
"2725","Suspension Dosage Form","C42994","SUSPENSION","['SUSPENSION']","Suspension Dosage Form","A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","6eaaccc3-f8e2-4a0c-9e2b-f33cafde70e8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42994"
"2726","Extended Release Suspension Dosage Form","C42925","SUSPENSION, EXTENDED RELEASE","['SUSPENSION, EXTENDED RELEASE']","Extended Release Suspension Dosage Form","A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","a437bbe6-8495-4099-a584-a0aeade461c2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42925"
"2727","Drops Suspension Dosage Form","C60995","SUSPENSION/DROPS","['SUSPENSION/DROPS']","Drops Suspension Dosage Form","A suspension which is usually administered in a dropwise fashion. (FDA)","False","04fe773d-ce59-4cf6-950e-3072457106bc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60995"
"2728","Suture Dosage Form","C47889","SUTURE","['SUTURE']","Suture Dosage Form","A strand or fiber used to hold wound edges in apposition during healing. (NCI)","False","b18652dc-23ce-4b0b-9046-b20fe8f0a84e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47889"
"2729","Swab Dosage Form","C47898","SWAB","['SWAB']","Swab Dosage Form","A small piece of relatively flat absorbent material that contains a drug.  A swab may also be attached to one end of a small stick.  A swab is typically used for applying medication or for cleansing. (NCI)","False","c2790707-a047-4cc8-804e-ba452033478f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47898"
"2730","Syrup Dosage Form","C42996","SYRUP","['SYRUP']","Syrup Dosage Form","An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.  (NCI)","False","b16e84eb-112d-4bf2-8412-8a57f0c1914c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42996"
"2731","Tablet Dosage Form","C42998","TABLET","['TABLET']","Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents.  (NCI)","False","6f532961-75de-42da-8bad-cded8dc5244d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42998"
"2732","Chewable Tablet Dosage Form","C42893","TABLET, CHEWABLE","['TABLET, CHEWABLE']","Chewable Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)","False","60d64580-585c-4f0f-bee2-7a8d111e61fc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42893"
"2733","Coated Tablet Dosage Form","C42897","TABLET, COATED","['TABLET, COATED']","Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)","False","4d8ebfc3-8a66-4d19-9a7b-c06f7171ccc1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42897"
"2734","Tablet Coated Particles Dosage Form","C60997","TABLET, COATED PARTICLES","['TABLET, COATED PARTICLES']","Tablet Coated Particles Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)","False","d5c29df6-66c4-4db9-aa49-025ed76634e4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C60997"
"2735","Delayed Release Tablet Dosage Form","C42905","TABLET, DELAYED RELEASE","['TABLET, DELAYED RELEASE']","Delayed Release Tablet Dosage Form","A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","e8e8f81e-7f14-4597-9150-46db0af20619","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42905"
"2736","Delayed Release Particles Tablet Dosage Form","C42997","TABLET, DELAYED RELEASE PARTICLES","['TABLET, DELAYED RELEASE PARTICLES']","Delayed Release Particles Tablet Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.  (NCI)","False","c4c723d8-a630-48bc-bc5f-d2a43e7fe354","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42997"
"2737","Effervescent Tablet Dosage Form","C42910","TABLET, EFFERVESCENT","['TABLET, EFFERVESCENT']","Effervescent Tablet Dosage Form","A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)","False","a586e146-fdee-41f1-975f-3a4651cda225","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42910"
"2738","Extended Release Tablet Dosage Form","C42927","TABLET, EXTENDED RELEASE","['TABLET, EXTENDED RELEASE']","Extended Release Tablet Dosage Form","A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)","False","258e64a6-1c19-4bfd-bcdf-20f965b41334","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42927"
"2739","Film Coated Tablet Dosage Form","C42931","TABLET, FILM COATED","['TABLET, FILM COATED']","Film Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)","False","86fee8e8-88a2-445f-b00c-829ea057a531","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42931"
"2740","Film Coated Extended Release Tablet Dosage Form","C42930","TABLET, FILM COATED, EXTENDED RELEASE","['TABLET, FILM COATED, EXTENDED RELEASE']","Film Coated Extended Release Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)","False","10c649ec-f095-429e-b71f-ea9e83d33281","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42930"
"2741","Tablet For Solution Dosage Form","C61004","TABLET, FOR SOLUTION","['TABLET, FOR SOLUTION']","Tablet For Solution Dosage Form","A tablet that forms a solution when placed in a liquid. (FDA)","False","2357c6b7-e69f-49f7-82ae-28482dbab231","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C61004"
"2742","Tablet For Suspension Dosage Form","C61005","TABLET, FOR SUSPENSION","['TABLET, FOR SUSPENSION', 'TABLET, DISPERSIBLE']","Tablet For Suspension Dosage Form","A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).","False","7d7acf57-4b69-40c9-b9bd-a0da1393fb51","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C61005"
"2743","Multilayered Tablet Dosage Form","C42964","TABLET, MULTILAYER","['TABLET, MULTILAYER']","Multilayered Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)","False","13c1da59-e69a-467a-890f-37ba5817af1a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42964"
"2744","Multilayered Extended Release Tablet Dosage Form","C42963","TABLET, MULTILAYER, EXTENDED RELEASE","['TABLET, MULTILAYER, EXTENDED RELEASE']","Multilayered Extended Release Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)","False","50d2a0b6-ae6d-4bca-b1e9-7662e76ed531","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42963"
"2745","Orally Disintegrating Tablet Dosage Form","C42999","TABLET, ORALLY DISINTEGRATING","['TABLET, ORALLY DISINTEGRATING']","Orally Disintegrating Tablet Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.  (NCI)","False","92aac8bd-43ad-4652-82cc-40c242c9d5a3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42999"
"2746","Tablet Orally Disintegrating Delayed Release Dosage Form","C61006","TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE","['TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE']","Tablet Orally Disintegrating Delayed Release Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)","False","7cab56fb-87d2-4358-803d-9e48b7dd8003","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C61006"
"2747","Soluble Tablet Dosage Form","C42985","TABLET, SOLUBLE","['TABLET, SOLUBLE']","Soluble Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)","False","d6c3f04a-2e68-47bc-9a3d-80ff4068a378","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42985"
"2748","Sugar Coated Tablet Dosage Form","C42992","TABLET, SUGAR COATED","['TABLET, SUGAR COATED']","Sugar Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)","False","bccd8b21-9f10-4485-b3aa-5830cf422505","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C42992"
"2749","Tampon Dosage Form","C47892","TAMPON","['TAMPON']","Tampon Dosage Form","A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)","False","3d854920-8696-48fd-91a3-b92ce611d2e5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47892"
"2750","Tape Dosage Form","C47897","TAPE","['TAPE']","Tape Dosage Form","A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)","False","f27efd84-5ed7-42c8-ad5a-95730939a907","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C47897"
"2751","Tincture Dosage Form","C43000","TINCTURE","['TINCTURE']","Tincture Dosage Form","An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.  (NCI)","False","d855b3a4-f8aa-4bd5-8516-a878114b945e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C43000"
"2752","Troche Dosage Form","C43001","TROCHE","['TROCHE']","Troche Dosage Form","A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.  (NCI)","False","fca000e6-f7ad-43dd-b640-887110914251","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C43001"
"2753","Unassigned Dosage Form","C43002","UNASSIGNED","['UNASSIGNED']","Unassigned Dosage Form","A dosage form has yet to be assigned.  (NCI)","False","f9a016ef-ed95-4d2f-a994-4849b9982a0f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C43002"
"2754","Wafer Dosage Form","C43003","WAFER","['WAFER']","Wafer Dosage Form","A thin slice of material containing a medicinal agent.  (NCI)","False","a27bee01-472d-4e34-8688-0896bf5f2e62","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66726/C43003"
"2755","Completion/Reason for Non-Completion","C66727","NCOMPLT","['NCOMPLT', 'Completion/Reason for Non-Completion']","CDISC SDTM Reason for Non-Completion Terminology","The reason that a subject was discontinued from a clinical trial.","False","3165cc41-187d-4f9c-9da0-07c2587ea3f9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727"
"2756","Adverse Event","C41331","ADVERSE EVENT","['ADVERSE EVENT']","Adverse Event","Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience.  (CDISC glossary)","False","1fe1d1e5-5b25-4692-b50d-a45edc3c1919","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C41331"
"2757","Complete","C25250","COMPLETED","['COMPLETED']","Complete","To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)","False","6639c8cd-f928-46b5-b23c-99dc0d9f0693","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C25250"
"2758","Death","C28554","DEATH","['DEATH']","Death","The absence of life or state of being dead. (NCI)","False","cb89329f-06b4-4e49-96bb-4b15462e5293","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C28554"
"2759","Lack of Efficacy","C48226","LACK OF EFFICACY","['LACK OF EFFICACY']","Lack of Efficacy","The lack of expected or desired effect related to a therapy. (NCI)","False","7f10db44-8c75-45ef-8b7c-4aa56abec304","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C48226"
"2760","Lost To Follow-up","C48227","LOST TO FOLLOW-UP","['LOST TO FOLLOW-UP']","Lost To Follow-up","The loss or lack of continuation of follow-up after a study has officially closed.  See Follow-up. (NCI)","False","b5b735e5-3b92-480d-b310-2d8cc02bc281","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C48227"
"2761","Non-Compliance With Study Drug","C49631","NON-COMPLIANCE WITH STUDY DRUG","['NON-COMPLIANCE WITH STUDY DRUG']","Non-Compliance With Study Drug","An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)","False","587232f2-4b89-497a-b87a-51b2842babc6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C49631"
"2762","Other","C17649","OTHER","['OTHER', 'Other']","Other","Different than the one(s) previously specified or mentioned. (NCI)","False","a9defc9c-6f9e-42c5-91a5-7d04c1cfe309","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C17649"
"2763","Physician Decision","C48250","PHYSICIAN DECISION","['PHYSICIAN DECISION']","Physician Decision","A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)","False","e8bb8773-a7e9-4894-8594-6a17b1905de9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C48250"
"2764","Pregnancy","C25742","PREGNANCY","['PREGNANCY']","Pregnancy","Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)","False","72a0f5b6-c570-417b-88d7-c11ee0656d4e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C25742"
"2765","Progressive Disease","C35571","PROGRESSIVE DISEASE","['PROGRESSIVE DISEASE']","Progressive Disease","A disease process that is increasing in scope or severity. (NCI)","False","b68539c6-776c-4f2c-8b40-5ee9b6055b8d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C35571"
"2766","Protocol Violation","C48251","PROTOCOL VIOLATION","['PROTOCOL VIOLATION']","Protocol Violation","An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)","False","5e04d826-eb97-4fe3-b392-3b9d90f1049b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C48251"
"2767","Recovery","C25746","RECOVERY","['RECOVERY']","Recovery","A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)","False","2b0cf18e-0288-4141-9ace-115c5a51fc9f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C25746"
"2768","Trial Screen Failure","C49628","SCREEN FAILURE","['SCREEN FAILURE']","Trial Screen Failure","The potential subject who does not meet one or more criteria required for participation in a trial.","False","b9388005-7167-4b73-aabf-4cbcfd4472cf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C49628"
"2769","Study Terminated By Sponsor","C49632","STUDY TERMINATED BY SPONSOR","['STUDY TERMINATED BY SPONSOR']","Study Terminated By Sponsor","An indication that a clinical study was stopped by its sponsor.  (NCI)","False","a926d91b-e2de-4e8d-bbee-fdf6f309bcb2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C49632"
"2770","Technical Problem","C49633","TECHNICAL PROBLEMS","['TECHNICAL PROBLEMS']","Technical Problem","A problem with some technical aspect of a clinical study, usually related to an instrument.  (NCI)","False","17cc6bce-7274-4430-affc-256083b84bba","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C49633"
"2771","Withdrawal by Subject","C49634","WITHDRAWAL BY SUBJECT","['WITHDRAWAL BY SUBJECT']","Withdrawal by Subject","An indication that a study participant has removed itself from the study.  (NCI)","False","751159ff-81f8-4239-b134-f7c3c9d9509b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66727/C49634"
"2772","Relation to Reference Period","C66728","STENRF","['STENRF', 'Relation to Reference Period']","CDISC SDTM Relation to Reference Period Terminology","The name of a code list that contains terms that reference timepoints within and without a defined time period.","False","5da3d980-de9e-471d-81a5-5b3433dda5ec","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66728"
"2773","Status Post","C38008","AFTER","['AFTER']","Status Post","The time period following a point or another period of time. (NCI)","False","0415acab-96b6-49eb-ae5b-f5c2480da00f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66728/C38008"
"2774","Prior","C25629","BEFORE","['BEFORE']","Prior","Earlier in time or order. (NCI)","False","2484d629-7c5f-4a7d-819c-9ac6fd4ce730","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66728/C25629"
"2775","During","C25490","DURING","['DURING']","During","At some point in a given period of time. (NCI)","False","2d37517c-e54a-4dd3-afb7-dcea7c840444","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66728/C25490"
"2776","During Or After","C49640","DURING/AFTER","['DURING/AFTER']","During Or After","Within a certain period of time or after a certain point or period in time. (NCI)","False","67d2937f-43bc-4cd2-bd2f-5f097685c023","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66728/C49640"
"2777","Unknown","C17998","U","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","b97e3786-cf65-4472-8cd3-80cc35741bc4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66728/C17998"
"2778","Route of Administration","C66729","ROUTE","['ROUTE', 'Route of Administration']","CDISC SDTM Route of Administration Terminology","The course by which a substance was administered in order to reach the site of action in the body.","False","f6c4e1fa-b99c-494d-9b1b-e91f6b38fe9f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729"
"2779","Auricular Route of Administration","C38192","AURICULAR (OTIC)","['AURICULAR (OTIC)']","Auricular Route of Administration","Administration to or by way of the ear.(FDA)","False","02db8760-845c-45da-804c-bcf6a23b3162","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38192"
"2780","Buccal Route of Administration","C38193","BUCCAL","['BUCCAL']","Buccal Route of Administration","Administration directed toward the cheek, generally from within the mouth.(FDA)","False","c4ca89f8-91e3-46cc-8c75-869e294887bd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38193"
"2781","Conjunctival Route of Administration","C38194","CONJUNCTIVAL","['CONJUNCTIVAL']","Conjunctival Route of Administration","Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball.(FDA)","False","2cdc79b0-2182-4541-971c-a6ccd9a3383d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38194"
"2782","Cutaneous Route of Administration","C38675","CUTANEOUS","['CUTANEOUS']","Cutaneous Route of Administration","Administration to the skin.(FDA)","False","2bb5e6f8-c50c-4008-9c78-087068871761","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38675"
"2783","Dental Route of Administration","C38197","DENTAL","['DENTAL']","Dental Route of Administration","Administration to a tooth or teeth.(FDA)","False","cfacd29b-f26c-4676-ac7b-95df3e552c67","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38197"
"2784","Electro-osmosis Route of Administration","C38633","ELECTRO-OSMOSIS","['ELECTRO-OSMOSIS']","Electro-osmosis Route of Administration","Administration of through the diffusion of substance through a membrane in an electric field.(FDA)","False","e65bfc27-b00d-45e1-952f-d74307b261e8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38633"
"2785","Endocervical Route of Administration","C38205","ENDOCERVICAL","['ENDOCERVICAL']","Endocervical Route of Administration","Administration within the canal of the cervix uteri. Synonymous with the term intracervical.(FDA)","False","b3439bee-d569-4cb1-81e2-5ff6fedd999b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38205"
"2786","Endosinusial Route of Administration","C38206","ENDOSINUSIAL","['ENDOSINUSIAL']","Endosinusial Route of Administration","Administration within the nasal sinuses of the head.(FDA)","False","d2dd4b71-2bd1-4657-8081-177b578276e2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38206"
"2787","Endotracheal Route of Administration","C38208","ENDOTRACHEAL","['ENDOTRACHEAL']","Endotracheal Route of Administration","Administration directly into the trachea. Synonymous with the term intratracheal.(FDA)","False","fa145700-1469-4098-b741-5b434b448514","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38208"
"2788","Enteral Route of Administration","C38209","ENTERAL","['ENTERAL']","Enteral Route of Administration","Administration directly into the intestines.(FDA)","False","b62b4f32-3aab-40b4-8970-e66a37b3c40c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38209"
"2789","Epidural Route of Administration","C38210","EPIDURAL","['EPIDURAL']","Epidural Route of Administration","Administration upon or over the dura mater.(FDA)","False","9a85e80b-8ebb-4313-937e-ad8ad6e88345","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38210"
"2790","Extraamniotic Route of Administration","C38211","EXTRA-AMNIOTIC","['EXTRA-AMNIOTIC']","Extraamniotic Route of Administration","Administration to the outside of the membrane enveloping the fetus.(FDA)","False","2678a59a-592d-4158-bc16-2f35327f3bb2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38211"
"2791","Extracorporeal Circulation Route of Administration","C38212","EXTRACORPOREAL","['EXTRACORPOREAL']","Extracorporeal Circulation Route of Administration","Administration outside of the body.(FDA)","False","5659cd50-4a30-467d-8437-663643a4f7f4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38212"
"2792","Administration Via Hemodialysis","C38200","HEMODIALYSIS","['HEMODIALYSIS']","Administration Via Hemodialysis","Administration through hemodialysate fluid.(FDA)","False","103fc04d-1bb5-4cd0-998f-51dedcf9d93e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38200"
"2793","Infiltration Route of Administration","C38215","INFILTRATION","['INFILTRATION']","Infiltration Route of Administration","Administration that results in substances passing into tissue spaces or into cells.(FDA)","False","ebb0ba48-939f-4f9e-a2a4-9dcbab85fdb2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38215"
"2794","Interstitial Route of Administration","C38219","INTERSTITIAL","['INTERSTITIAL']","Interstitial Route of Administration","Administration to or in the interstices of a tissue.(FDA)","False","5ebf4f24-88ee-4fca-8600-2062b41a8720","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38219"
"2795","Intraabdominal Route of Administration","C38220","INTRA-ABDOMINAL","['INTRA-ABDOMINAL']","Intraabdominal Route of Administration","Administration within the abdomen.(FDA)","False","162e4920-2dc3-4a49-b441-d92e6508f613","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38220"
"2796","Intraamniotic Route of Administration","C38221","INTRA-AMNIOTIC","['INTRA-AMNIOTIC']","Intraamniotic Route of Administration","Administration within the amnion.(FDA)","False","26af339c-28a0-47b1-8b20-7f4ffd8abdf7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38221"
"2797","Intraarterial Route of Administration","C38222","INTRA-ARTERIAL","['INTRA-ARTERIAL']","Intraarterial Route of Administration","Administration within an artery or arteries.(FDA)","False","df462e5a-a761-48e3-ae15-35272605d9e3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38222"
"2798","Intraarticular Route of Administration","C38223","INTRA-ARTICULAR","['INTRA-ARTICULAR']","Intraarticular Route of Administration","Administration within a joint.(FDA)","False","38a5886a-0187-40b2-a354-59450ec3336a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38223"
"2799","Intrabiliary Route of Administration","C38224","INTRABILIARY","['INTRABILIARY']","Intrabiliary Route of Administration","Administration within the bile, bile ducts or gallbladder.(FDA)","False","31b7d79d-19a4-4f33-8c7a-bade92da7a33","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38224"
"2800","Intrabronchial Route of Administration","C38225","INTRABRONCHIAL","['INTRABRONCHIAL']","Intrabronchial Route of Administration","Administration within a bronchus.(FDA)","False","37b7e55d-9185-43e2-a083-6d21144c86e2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38225"
"2801","Intrabursal Route of Administration","C38226","INTRABURSAL","['INTRABURSAL']","Intrabursal Route of Administration","Administration within a bursa.(FDA)","False","597a1b29-75c1-47fe-b79d-cb0124babea7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38226"
"2802","Intracardiac Route of Administration","C38227","INTRACARDIAC","['INTRACARDIAC']","Intracardiac Route of Administration","Administration within the heart.(FDA)","False","b8118b69-fcd6-4e09-9a54-1379e0eeeac3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38227"
"2803","Intracartilaginous Route of Administration","C38228","INTRACARTILAGINOUS","['INTRACARTILAGINOUS']","Intracartilaginous Route of Administration","Administration within a cartilage; endochondral.(FDA)","False","6c580085-1628-4dcc-9d1d-4bffb7f6bd3d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38228"
"2804","Intracaudal Route of Administration","C38229","INTRACAUDAL","['INTRACAUDAL']","Intracaudal Route of Administration","Administration within the cauda equina.(FDA)","False","a913c5cd-ec71-4956-9b0f-d87d255cb3b6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38229"
"2805","Intracavernous Route of Administration","C38230","INTRACAVERNOUS","['INTRACAVERNOUS']","Intracavernous Route of Administration","Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.(FDA)","False","1acfeeeb-142a-4645-8c9a-6cbe0c825baf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38230"
"2806","Intracavitary Route of Administration","C38231","INTRACAVITARY","['INTRACAVITARY']","Intracavitary Route of Administration","Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound.(FDA)","False","a88a5726-4ebe-446d-be2f-ad079f927dee","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38231"
"2807","Intracerebral Route of Administration","C38232","INTRACEREBRAL","['INTRACEREBRAL']","Intracerebral Route of Administration","Administration within the cerebrum.(FDA)","False","46d3ac77-ea19-4c00-9756-f66fe1b0140e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38232"
"2808","Intracisternal Route of Administration","C38233","INTRACISTERNAL","['INTRACISTERNAL']","Intracisternal Route of Administration","Administration within the cisterna magna cerebellomedularis.(FDA)","False","c3f5495d-ea37-4c9b-8f7a-dc266685cd94","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38233"
"2809","Intracorneal Route of Administration","C38234","INTRACORNEAL","['INTRACORNEAL']","Intracorneal Route of Administration","Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).(FDA)","False","876f5b3b-55ca-4f36-af7c-da143a912071","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38234"
"2810","Intracoronal Dental Route of Administration","C38217","INTRACORONAL, DENTAL","['INTRACORONAL, DENTAL']","Intracoronal Dental Route of Administration","Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck.(FDA)","False","9e5c0286-d65b-4673-9091-635842695968","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38217"
"2811","Intracoronary Route of Administration","C38218","INTRACORONARY","['INTRACORONARY']","Intracoronary Route of Administration","Administration within the coronary arteries.(FDA)","False","61c45160-26b3-4c5e-b511-635936d7540f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38218"
"2812","Intracorporus Cavernosum Route of Administration","C38235","INTRACORPORUS CAVERNOSUM","['INTRACORPORUS CAVERNOSUM']","Intracorporus Cavernosum Route of Administration","Administration within the dilatable spaces of the corporus cavernosa of the penis.(FDA)","False","fdca8f20-5e2f-4623-a578-bc2ce0b8e4b1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38235"
"2813","Intradermal Route of Administration","C38238","INTRADERMAL","['INTRADERMAL']","Intradermal Route of Administration","Administration within the dermis.(FDA)","False","19aa5fa0-75c2-4848-8664-9adcc8379242","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38238"
"2814","Intradiscal Route of Administration","C38239","INTRADISCAL","['INTRADISCAL']","Intradiscal Route of Administration","Administration within a disc.(FDA)","False","f6b61019-8ccb-4cca-915a-ff30d98ca678","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38239"
"2815","Intraductal Route of Administration","C38240","INTRADUCTAL","['INTRADUCTAL']","Intraductal Route of Administration","Administration within the duct of a gland.(FDA)","False","178e66a9-5490-4f3c-8409-3c43e0f9f884","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38240"
"2816","Intraduodenal Route of Administration","C38241","INTRADUODENAL","['INTRADUODENAL']","Intraduodenal Route of Administration","Administration within the duodenum.(FDA)","False","b5d949ba-af03-4cfe-bc4c-ad2b9b35b9c4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38241"
"2817","Intradural Route of Administration","C38242","INTRADURAL","['INTRADURAL']","Intradural Route of Administration","Administration within or beneath the dura.(FDA)","False","9d4404de-a56a-40cb-9614-e1b10283dbfe","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38242"
"2818","Intraepidermal Route of Administration","C38243","INTRAEPIDERMAL","['INTRAEPIDERMAL']","Intraepidermal Route of Administration","Administration within the epidermis.(FDA)","False","5a0c7f8e-d512-4984-9f10-57f17e4c137d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38243"
"2819","Intraesophageal Route of Administration","C38245","INTRAESOPHAGEAL","['INTRAESOPHAGEAL']","Intraesophageal Route of Administration","Administration within the esophagus.(FDA)","False","74ad9a6c-b59d-45ff-8a22-118b5868c79b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38245"
"2820","Intragastric Route of Administration","C38246","INTRAGASTRIC","['INTRAGASTRIC']","Intragastric Route of Administration","Administration within the stomach.(FDA)","False","44f2ac9e-5407-4a2e-bc70-d2e47538afad","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38246"
"2821","Intragingival Route of Administration","C38247","INTRAGINGIVAL","['INTRAGINGIVAL']","Intragingival Route of Administration","Administration within the gingivae.(FDA)","False","6d0e6bde-f671-43d8-a179-5febde4c49d7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38247"
"2822","Intraileal Route of Administration","C38249","INTRAILEAL","['INTRAILEAL']","Intraileal Route of Administration","Administration within the distal portion of the small intestine, from the jejunum to the cecum.(FDA)","False","a2043878-4b61-4508-86c9-ed3a6a57207f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38249"
"2823","Intralesional Route of Administration","C38250","INTRALESIONAL","['INTRALESIONAL']","Intralesional Route of Administration","Administration within or introduced directly into a localized lesion.(FDA)","False","a456ae7d-31be-4c9b-b6b1-772f18488c5f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38250"
"2824","Intraluminal Route of Administration","C38251","INTRALUMINAL","['INTRALUMINAL']","Intraluminal Route of Administration","Administration within the lumen of a tube.(FDA)","False","adbf8c58-e53e-4e19-982c-324ff5e8bc05","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38251"
"2825","Intralymphatic Route of Administration","C38252","INTRALYMPHATIC","['INTRALYMPHATIC']","Intralymphatic Route of Administration","Administration within the lymph.(FDA)","False","5852cddd-a989-4a1c-acb5-7e7c0fe375ae","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38252"
"2826","Intramedullary Route of Administration","C38253","INTRAMEDULLARY","['INTRAMEDULLARY']","Intramedullary Route of Administration","Administration within the marrow cavity of a bone.(FDA)","False","4ba2bca4-2887-47b1-84eb-c598af873938","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38253"
"2827","Intrameningeal Route of Administration","C38254","INTRAMENINGEAL","['INTRAMENINGEAL']","Intrameningeal Route of Administration","Administration within the meninges (the three membranes that envelope the brain and spinal cord).(FDA)","False","c1155dd0-a7d2-454a-876b-336351ebbbc1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38254"
"2828","Intramuscular Route of Administration","C28161","INTRAMUSCULAR","['INTRAMUSCULAR']","Intramuscular Route of Administration","Administration within a muscle. (FDA)","False","012138c2-705f-4bd0-9b04-329819788733","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C28161"
"2829","Intraocular Route of Administration","C38255","INTRAOCULAR","['INTRAOCULAR']","Intraocular Route of Administration","Administration within the eye.(FDA)","False","601ced22-91fb-4837-8f38-b58658409c5c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38255"
"2830","Intraovarian Route of Administration","C38256","INTRAOVARIAN","['INTRAOVARIAN']","Intraovarian Route of Administration","Administration within the ovary.(FDA)","False","d12aed02-230f-48a8-ad88-19b804901f48","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38256"
"2831","Intrapericardial Route of Administration","C38257","INTRAPERICARDIAL","['INTRAPERICARDIAL']","Intrapericardial Route of Administration","Administration within the pericardium.(FDA)","False","497bd8bc-8fbd-4ec9-9bd9-056795e83ed6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38257"
"2832","Intraperitoneal Route of Administration","C38258","INTRAPERITONEAL","['INTRAPERITONEAL']","Intraperitoneal Route of Administration","Administration within the peritoneal cavity.(FDA)","False","8da7d36e-3c16-43d9-84b4-67436c92ca60","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38258"
"2833","Intrapleural Route of Administration","C38259","INTRAPLEURAL","['INTRAPLEURAL']","Intrapleural Route of Administration","Administration within the pleura.(FDA)","False","07f87582-c026-4dc1-9224-7089b370e39f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38259"
"2834","Intraprostatic Route of Administration","C38260","INTRAPROSTATIC","['INTRAPROSTATIC']","Intraprostatic Route of Administration","Administration within the prostate gland.(FDA)","False","da92acdd-369e-423e-90e4-425ae38396ef","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38260"
"2835","Intrapulmonary Route of Administration","C38261","INTRAPULMONARY","['INTRAPULMONARY']","Intrapulmonary Route of Administration","Administration within the lungs or its bronchi.(FDA)","False","ff3b109c-62a0-44b5-8516-7c6ae7f1b68f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38261"
"2836","Intrasinal Route of Administration","C38262","INTRASINAL","['INTRASINAL']","Intrasinal Route of Administration","Administration within the nasal or periorbital sinuses.(FDA)","False","cdea2962-aace-4987-9a37-f47ff5b242d0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38262"
"2837","Intraspinal Route of Administration","C38263","INTRASPINAL","['INTRASPINAL']","Intraspinal Route of Administration","Administration within the vertebral column.(FDA)","False","8e4ec795-82fa-4d04-89c9-90710fba0ddf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38263"
"2838","Intrasynovial Route of Administration","C38264","INTRASYNOVIAL","['INTRASYNOVIAL']","Intrasynovial Route of Administration","Administration within the synovial cavity of a joint.(FDA)","False","9fed16ff-d687-4b38-a77a-512fe9be6ef4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38264"
"2839","Intratendinous Route of Administration","C38265","INTRATENDINOUS","['INTRATENDINOUS']","Intratendinous Route of Administration","Administration within a tendon.(FDA)","False","3c95076f-77c2-4754-8ebc-7152f494e372","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38265"
"2840","Intratesticular Route of Administration","C38266","INTRATESTICULAR","['INTRATESTICULAR']","Intratesticular Route of Administration","Administration within the testicle.(FDA)","False","9426353a-e634-44b6-a8ab-3df469696fe0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38266"
"2841","Intrathecal Route of Administration","C38267","INTRATHECAL","['INTRATHECAL']","Intrathecal Route of Administration","Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.(FDA)","False","1afc3f5d-63ee-4366-8c53-a44fe4a9767e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38267"
"2842","Endothoracic Route of Administration","C38207","INTRATHORACIC","['INTRATHORACIC']","Endothoracic Route of Administration","Administration within the thorax (internal to the ribs); synonymous with the term endothoracic.(FDA)","False","134911be-04fb-4bd4-b6d4-801eb5f26c30","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38207"
"2843","Intratubular Route of Administration","C38268","INTRATUBULAR","['INTRATUBULAR']","Intratubular Route of Administration","Administration within the tubules of an organ.(FDA)","False","29c0de3b-151b-4143-a291-20441767c122","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38268"
"2844","Intratumoral Route of Administration","C38269","INTRATUMOR","['INTRATUMOR', 'Intratumor Route of Administration']","Intratumoral Route of Administration","Administration within a tumor.(FDA)","False","c3286032-d762-4f1f-95c5-99d3a5ebb04f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38269"
"2845","Intratympanic Route of Administration","C38270","INTRATYMPANIC","['INTRATYMPANIC']","Intratympanic Route of Administration","Administration within the auris media.(FDA)","False","5358ad5b-d81b-4ba4-bb45-93e6afd1f478","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38270"
"2846","Intrauterine Route of Administration","C38272","INTRAUTERINE","['INTRAUTERINE']","Intrauterine Route of Administration","Administration within the uterus.(FDA)","False","5691114d-dda4-47d8-9aee-384d8dfcbe64","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38272"
"2847","Intravascular Route of Administration","C38273","INTRAVASCULAR","['INTRAVASCULAR']","Intravascular Route of Administration","Administration within a vessel or vessels.(FDA)","False","bd032864-b090-4a8d-90b9-b706d26a15ca","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38273"
"2848","Intravenous Route of Administration","C38276","INTRAVENOUS","['INTRAVENOUS']","Intravenous Route of Administration","Administration within or into a vein or veins.(FDA)","False","def8a5b6-c3f2-46a1-a4fb-f30b8675ecd3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38276"
"2849","Intravenous Bolus","C38274","INTRAVENOUS BOLUS","['INTRAVENOUS BOLUS']","Intravenous Bolus","Administration within or into a vein or veins all at once.(FDA)","False","525d821a-c7f7-4c02-be0e-05887aac05c7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38274"
"2850","Intravenous Drip","C38279","INTRAVENOUS DRIP","['INTRAVENOUS DRIP']","Intravenous Drip","Administration within or into a vein or veins over a sustained period of time.(FDA)","False","65873d1f-469b-48ad-9c18-741852b19fb0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38279"
"2851","Intraventricular Route of Administration","C38277","INTRAVENTRICULAR","['INTRAVENTRICULAR']","Intraventricular Route of Administration","Administration within a ventricle.(FDA)","False","e4a84fd6-5ad8-48fa-a184-f154540dd77f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38277"
"2852","Intravesical Route of Administration","C38278","INTRAVESICAL","['INTRAVESICAL']","Intravesical Route of Administration","Administration within the bladder.(FDA)","False","b35f83bd-6385-4d8f-ad37-952f54307888","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38278"
"2853","Intravitreal Route of Administration","C38280","INTRAVITREAL","['INTRAVITREAL']","Intravitreal Route of Administration","Administration within the vitreous body of the eye.(FDA)","False","9e97995b-175c-4156-a252-ba0266c22aa2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38280"
"2854","Iontophoresis Route of Administration","C38203","IONTOPHORESIS","['IONTOPHORESIS']","Iontophoresis Route of Administration","Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body.(FDA)","False","6a75882e-fcd8-4d10-8a5d-18f41f760854","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38203"
"2855","Irrigation-Route of Administration","C38281","IRRIGATION","['IRRIGATION']","Irrigation-Route of Administration","Administration to bathe or flush open wounds or body cavities.(FDA)","False","b40ea930-7fc4-437b-8fb4-7da81d43a949","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38281"
"2856","Laryngeal Route of Administration","C38282","LARYNGEAL","['LARYNGEAL']","Laryngeal Route of Administration","Administration directly upon the larynx.(FDA)","False","e1d9fdd6-c19f-4aa6-a073-af47edb1a086","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38282"
"2857","Nasal Route of Administration","C38284","NASAL","['NASAL']","Nasal Route of Administration","Administration to the nose; administered by way of the nose.(FDA)","False","ae6785ca-158f-43c9-b9a7-6994529dd3f7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38284"
"2858","Nasogastric Route of Administration","C38285","NASOGASTRIC","['NASOGASTRIC']","Nasogastric Route of Administration","Administration through the nose and into the stomach, usually by means of a tube.(FDA)","False","e955cf09-c45e-44ce-9919-e08a01a745b9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38285"
"2859","Route of Administration Not Applicable","C48623","NOT APPLICABLE","['NOT APPLICABLE']","Route of Administration Not Applicable","Routes of administration are not applicable.(FDA)","False","5d95f245-8e17-4238-892d-75db444f4fb5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C48623"
"2860","Occlusive Dressing Technique","C38286","OCCLUSIVE DRESSING TECHNIQUE","['OCCLUSIVE DRESSING TECHNIQUE']","Occlusive Dressing Technique","Administration by the topical route which is then covered by a dressing which occludes the area.(FDA)","False","2da1b3b4-d063-4b77-8f8c-585f8af159a6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38286"
"2861","Ophthalmic Route of Administration","C38287","OPHTHALMIC","['OPHTHALMIC']","Ophthalmic Route of Administration","Administration to the external eye.(FDA)","False","21416c1f-6414-49fd-aec7-4176a1b020c5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38287"
"2862","Oral Route of Administration","C38288","ORAL","['ORAL']","Oral Route of Administration","Administration to or by way of the mouth.(FDA)","False","0603ccce-9c13-4296-b01f-9258e4e1470a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38288"
"2863","Oropharyngeal Route of Administration","C38289","OROPHARYNGEAL","['OROPHARYNGEAL']","Oropharyngeal Route of Administration","Administration directly to the mouth and pharynx.(FDA)","False","54a51d03-1bae-4214-a2fb-72c0a9c12fde","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38289"
"2864","Other Route of Administration","C38290","OTHER","['OTHER']","Other Route of Administration","Administration is different from others on this list.(FDA)","False","46cd8006-82ce-465a-965f-a2bdbabd6650","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38290"
"2865","Parenteral Route of Administration","C38291","PARENTERAL","['PARENTERAL']","Parenteral Route of Administration","Administration by injection, infusion, or implantation.(FDA)","False","ff281977-03ee-4e5f-89ca-e2fc5f17d711","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38291"
"2866","Percutaneous Route of Administration","C38676","PERCUTANEOUS","['PERCUTANEOUS']","Percutaneous Route of Administration","Administration through the skin.(FDA)","False","ddac444d-b146-47ae-833d-301b4e3d82e7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38676"
"2867","Periarticular Route of Administration","C38292","PERIARTICULAR","['PERIARTICULAR']","Periarticular Route of Administration","Administration around a joint.(FDA)","False","05ab1a33-76a7-40fe-9fb3-c6b665148208","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38292"
"2868","Peridural Route of Administration","C38677","PERIDURAL","['PERIDURAL']","Peridural Route of Administration","Administration to the outside of the dura mater of the spinal cord.(FDA)","False","a3b09238-4bf1-43a0-932f-d18a33bb09ec","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38677"
"2869","Perineural Route of Administration","C38293","PERINEURAL","['PERINEURAL']","Perineural Route of Administration","Administration surrounding a nerve or nerves.(FDA)","False","2a98df83-0479-409d-aa8d-d6c6d057ba73","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38293"
"2870","Periodontal Route of Administration","C38294","PERIODONTAL","['PERIODONTAL']","Periodontal Route of Administration","Administration around a tooth.(FDA)","False","c97a6e59-bee5-4198-a634-62a47922ce7e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38294"
"2871","Rectal Route of Administration","C38295","RECTAL","['RECTAL']","Rectal Route of Administration","Administration to the rectum.(FDA)","False","e0d7788b-da47-48ea-90d4-6f883ffe1cc3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38295"
"2872","Inhalation Route of Administration","C38216","RESPIRATORY (INHALATION)","['RESPIRATORY (INHALATION)']","Inhalation Route of Administration","Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)","False","81f49611-aba0-436d-b7ba-d633239b3bc9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38216"
"2873","Retrobulbar Route of Administration","C38296","RETROBULBAR","['RETROBULBAR']","Retrobulbar Route of Administration","Administration behind the pons or behind the eyeball.(FDA)","False","3cbf466c-265e-473f-90b7-bdedf59e9172","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38296"
"2874","Soft Tissue Route Of Administration","C38198","SOFT TISSUE","['SOFT TISSUE']","Soft Tissue Route Of Administration","Administration into any soft tissue.(FDA)","False","19d15d1f-a90d-4cc0-bd90-02e2f5d80081","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38198"
"2875","Subarachnoid Route of Administration","C38297","SUBARACHNOID","['SUBARACHNOID']","Subarachnoid Route of Administration","Administration beneath the arachnoid.(FDA)","False","71046851-77f3-4a0e-8157-d6c29f543c7c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38297"
"2876","Subconjunctival Route of Administration","C38298","SUBCONJUNCTIVAL","['SUBCONJUNCTIVAL']","Subconjunctival Route of Administration","Administration beneath the conjunctiva.(FDA)","False","c741e398-2d41-40e7-9209-67d83555257b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38298"
"2877","Subcutaneous Route of Administration","C38299","SUBCUTANEOUS","['SUBCUTANEOUS']","Subcutaneous Route of Administration","Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)","False","a08f192d-bc0e-4a79-8341-77e9db2eb767","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38299"
"2878","Sublingual Route of Administration","C38300","SUBLINGUAL","['SUBLINGUAL']","Sublingual Route of Administration","Administration beneath the tongue.(FDA)","False","79e5efd7-9ef2-4f87-baf7-b09a9e4947c8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38300"
"2879","Submucosal Route of Administration","C38301","SUBMUCOSAL","['SUBMUCOSAL']","Submucosal Route of Administration","Administration beneath the mucous membrane.(FDA)","False","2ab1ae47-2b63-40f7-9eb5-9f97bbab2cbd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38301"
"2880","Topical Route of Administration","C38304","TOPICAL","['TOPICAL']","Topical Route of Administration","Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.(FDA)","False","838c25fb-8b3e-4c10-a007-ff4256e85d0c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38304"
"2881","Transdermal Route of Administration","C38305","TRANSDERMAL","['TRANSDERMAL']","Transdermal Route of Administration","Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)","False","f8a7a1a2-e324-4ccb-b105-6e802937fffe","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38305"
"2882","Mucosal Route of Administration","C38283","TRANSMUCOSAL","['TRANSMUCOSAL']","Mucosal Route of Administration","Administration across the mucosa.(FDA)","False","c9469f37-6ccd-45da-bc2c-a0bb94339c9e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38283"
"2883","Transplacental Route of Administration","C38307","TRANSPLACENTAL","['TRANSPLACENTAL']","Transplacental Route of Administration","Administration through or across the placenta.(FDA)","False","c537f41c-57a2-4e92-a939-c4d1104eae36","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38307"
"2884","Transtracheal Route of Administration","C38308","TRANSTRACHEAL","['TRANSTRACHEAL']","Transtracheal Route of Administration","Administration through the wall of the trachea.(FDA)","False","38f98f97-c797-45b9-9960-83514cb45755","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38308"
"2885","Transtympanic Route of Administration","C38309","TRANSTYMPANIC","['TRANSTYMPANIC']","Transtympanic Route of Administration","Administration across or through the tympanic cavity.(FDA)","False","101bcb2b-fcfc-408f-9b6b-b4d9d8c244f4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38309"
"2886","Unassigned Route of Administration","C38310","UNASSIGNED","['UNASSIGNED']","Unassigned Route of Administration","Route of administration has not yet been assigned.(FDA)","False","6d94269a-4598-4fee-8454-68b36ec1129f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38310"
"2887","Unknown Route of Administration","C38311","UNKNOWN","['UNKNOWN']","Unknown Route of Administration","Route of administration is unknown.(FDA)","False","20c7ec21-a617-49d7-bd61-503e16495854","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38311"
"2888","Ureteral Route of Administration","C38312","URETERAL","['URETERAL']","Ureteral Route of Administration","Administration into the ureter.(FDA)","False","f80f07f8-d1cc-4a5b-8945-0973f6832e49","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38312"
"2889","Intraurethral Route of Administration","C38271","URETHRAL","['URETHRAL']","Intraurethral Route of Administration","Administration into the urethra.(FDA)","False","301f971b-d422-4796-aac5-6303c0fd2415","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38271"
"2890","Vaginal Route of Administration","C38313","VAGINAL","['VAGINAL']","Vaginal Route of Administration","Administration into the vagina.(FDA)","False","a94eccf1-ac07-46eb-b66b-717f8aec4195","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66729/C38313"
"2891","Severity/Intensity Scale for Adverse Events","C66769","AESEV","['AESEV', 'Severity/Intensity Scale for Adverse Events']","CDISC SDTM Severity Intensity Scale for Adverse Event Terminology","A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)","False","5b43b43b-7406-4199-bec7-c27dfd14fc0b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66769"
"2892","Mild Adverse Event","C41338","MILD","['MILD', 'Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","33efa8f7-e9bc-413d-925d-b568bef71f00","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66769/C41338"
"2893","Moderate Adverse Event","C41339","MODERATE","['MODERATE', 'Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","5933c0c3-7b31-48e8-96b0-b90ccd267535","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66769/C41339"
"2894","Severe Adverse Event","C41340","SEVERE","['SEVERE', 'Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","eb14e6f3-9ae4-4f60-81a3-91cd8156e1b1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66769/C41340"
"2895","Sex","C66731","SEX","['SEX', 'Sex']","CDISC SDTM Sex of Individual Terminology","The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)","False","468d4660-75ac-4e57-9b5a-492fec36f7a2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66731"
"2896","Female","C16576","F","['F', 'Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","2e2d7737-2bd4-4e31-a010-30c5d5d402ad","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66731/C16576"
"2897","Male","C20197","M","['M', 'Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","f059f679-19ff-424e-9310-26046db5ab0f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66731/C20197"
"2898","Unknown","C17998","U","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","f9f25b85-e43a-4da3-84ba-3936889c5ab6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66731/C17998"
"2899","Intersex","C45908","UN","['UN', 'Undifferentiated']","Intersex","A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)","False","ba22967b-6c50-414c-bbe0-5570518c8ea0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66731/C45908"
"2900","Sex of Participants","C66732","SEXPOP","['SEXPOP', 'Sex of Participants']","CDISC SDTM Sex of Study Group Terminology","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","450964ef-234a-4569-8a1c-6b7f8d12015e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66732"
"2901","Both","C49636","BOTH","['BOTH']","Both","One and the other; relating to or being two in conjunction. (NCI)","False","e82d79fb-efa0-4aa5-bfc6-846913193e92","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66732/C49636"
"2902","Female","C16576","F","['F', 'Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","270bc99e-4c79-4342-a6d5-bb0afa5008da","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66732/C16576"
"2903","Male","C20197","M","['M', 'Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","3ad5f2f4-ee27-41ae-a97e-0c6fafeac1b9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66732/C20197"
"2904","Size","C66733","SIZE","['SIZE', 'Size']","CDISC SDTM Size Terminology","The physical magnitude of something. (NCI)","False","58d86bde-3c3e-4ef1-ac9d-e2434bdc3913","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66733"
"2905","Large","C49508","LARGE","['LARGE']","Large","Of considerable or relatively great size, extent, or capacity. (NCI)","False","1e73feea-4762-4c7f-b476-b97cc855d143","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66733/C49508"
"2906","Medium","C49507","MEDIUM","['MEDIUM']","Medium","Mid-way between small and large in number, quantity, magnitude or extent. (NCI)","False","df230b23-3943-4822-a9b9-1b2fbabae775","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66733/C49507"
"2907","Small","C25376","SMALL","['SMALL']","Small","Limited in number, quantity, magnitude or extent. (NCI)","False","7d889e94-5e2c-4d92-98e2-d4cf26dd33c1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66733/C25376"
"2908","Domain Abbreviation","C66734","DOMAIN","['DOMAIN', 'Domain Abbreviation']","CDISC SDTM Submission Domain Abbreviation Terminology","A unique, 2-character domain code used in the regulatory submission process.  The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)","False","75efe9f1-cd7e-4e6e-8586-2a2fca93e322","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734"
"2909","Analysis Dataset Domain","C49563","AD","['AD', 'Analysis Dataset']","Analysis Dataset Domain","Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.","False","3f53213a-40a7-49db-973f-d26d5c6394a5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49563"
"2910","Adverse Event Domain","C49562","AE","['AE', 'Adverse Events']","Adverse Event Domain","Adverse events may be captured either as free text or a pre-specified list of terms.","False","743d5cef-3a9f-4308-9331-f1cf0d42252d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49562"
"2911","Autopsy Domain","C49565","AU","['AU', 'Autopsy']","Autopsy Domain","Additional data about deaths, specific to findings from autopsies.","False","7559010a-3d23-4b88-b5cf-dd8b68c69ac3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49565"
"2912","Bone Mineral Density Data Domain","C49566","BM","['BM', 'Bone Mineral Density (BMD) Data']","Bone Mineral Density Data Domain","Findings resulting from evaluations of bone mineral density.","False","9f5d3588-d35e-4ab9-b1b6-040472fa53ec","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49566"
"2913","Biopsy Domain","C49567","BR","['BR', 'Biopsy']","Biopsy Domain","Findings resulting from biopsies.","False","b6d01fdf-f798-47bd-9049-c3feddc0f3d3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49567"
"2914","Concomitant Medication Domain","C49568","CM","['CM', 'Concomitant Meds']","Concomitant Medication Domain","Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.","False","56f626a2-816a-455d-97a5-3cf367f7fce4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49568"
"2915","Comment Domain","C49569","CO","['CO', 'Comments']","Comment Domain","The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.","False","9170ce0c-b35d-454a-b0bb-806183c13c2b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49569"
"2916","Drug Accountability Domain","C49578","DA","['DA', 'Drug Accountability']","Drug Accountability Domain","Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.","False","7b863313-ef7f-40ad-8398-03e19e2c0724","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49578"
"2917","Disease Characteristics Domain","C49570","DC","['DC', 'Disease Characteristics']","Disease Characteristics Domain","Data related to the characteristics of a specific disease state under study for a subject.","False","f7bc80a5-2a1c-4624-b04e-4687ab9442f8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49570"
"2918","Demographics Domain","C49572","DM","['DM', 'Demographics']","Demographics Domain","The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study.  It is the parent domain for all other observations for human clinical subjects","False","ce144ddf-a467-4932-94ef-70a61b171753","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49572"
"2919","Disposition Domain","C49576","DS","['DS', 'Disposition']","Disposition Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)","False","3beb553d-d8d0-4b4a-a888-1709d9414924","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49576"
"2920","Protocol Deviations Domain","C49585","DV","['DV', 'Protocol Deviations']","Protocol Deviations Domain","The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.","False","1aab04c8-3287-417b-b933-a6942f2cb754","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49585"
"2921","Electroencephalogram Domain","C49625","EE","['EE', 'Electroencephalogram']","Electroencephalogram Domain","Findings resulting from electroencephalogram (EEG) tests.","False","ed882fe4-008f-4b47-b75b-838e2703c69e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49625"
"2922","Electrocardiogram Domain","C49626","EG","['EG', 'Electrocardiogram']","Electrocardiogram Domain","Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.","False","301875fc-2be4-4e62-9868-086402498063","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49626"
"2923","Exposure Domain","C49587","EX","['EX', 'Exposure']","Exposure Domain","The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.","False","725e142f-2cb7-427c-b149-8dd7fd9f6a6c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49587"
"2924","Family History Domain","C49588","FH","['FH', 'Family History']","Family History Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)","False","72aa7484-f30d-43ce-aac1-2335b0ea5070","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49588"
"2925","Healthcare Resource Utilization Domain","C49589","HU","['HU', 'Healthcare Resource Utilization']","Healthcare Resource Utilization Domain","Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.","False","0a4273f0-39d6-4a73-92df-1cc7ed06535d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49589"
"2926","Inclusion Exclusion Domain","C61536","IE","['IE', 'Inclusion/Exclusion']","Inclusion Exclusion Domain","The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.","False","b0f69100-329f-445d-9e59-a3a25589cb98","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C61536"
"2927","Laboratory Data Domain","C49592","LB","['LB', 'Laboratory Data']","Laboratory Data Domain","Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.","False","3e873c2d-6ba3-4148-8b7d-5753275b787d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49592"
"2928","Microbiology Specimen Domain","C49602","MB","['MB', 'Microbiology']","Microbiology Specimen Domain","Microbiology specimen findings, including gram stain results, and organisms found.","False","027ac588-97f7-415c-9bda-872ad91ff5fd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49602"
"2929","Medical History Domain","C49603","MH","['MH', 'Medical History']","Medical History Domain","The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.","False","5dc0fb0e-02fe-4737-b5cb-b0e428122070","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49603"
"2930","Meal Data Domain","C49604","ML","['ML', 'Meal Data']","Meal Data Domain","Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.","False","0e3d5773-86d1-471b-87f6-da4713e0e878","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49604"
"2931","Microbiology Susceptibility Domain","C61531","MS","['MS', 'Microbiology Susceptibility']","Microbiology Susceptibility Domain","This includes microbiology susceptibility test results, plus results of any other organism-related tests.","False","2deb3819-7b99-4d79-bf87-af1e94f8761f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C61531"
"2932","Organ Measurement Domain","C49605","OM","['OM', 'Organ Measurements']","Organ Measurement Domain","Findings from organ measurement evaluations.","False","44d0d599-4dca-4c77-96bd-ebcce3165e00","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49605"
"2933","Pharmacokinetic Concentration Domain","C49606","PC","['PC', 'Pharmacokinetic Concentration']","Pharmacokinetic Concentration Domain","Concentrations of drugs/metabolites in fluids or tissues as a function of time.","False","0a3d13dd-4015-4a89-b394-066fc600c482","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49606"
"2934","Physical Exam Domain","C49608","PE","['PE', 'Physical Exam']","Physical Exam Domain","Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.","False","9772435d-dc69-42b5-af7e-7cb7ef70cf60","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49608"
"2935","Pharmacogenomics Domain","C61529","PG","['PG', 'Pharmacogenomics']","Pharmacogenomics Domain","Pharmacogenomics findings that initially focus on genotype and gene expression data.","False","8794573e-6bc8-45e7-a415-0b83d01a8d91","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C61529"
"2936","Pharmacokinetic Parameters Domain","C49607","PP","['PP', 'Pharmacokinetic Parameters']","Pharmacokinetic Parameters Domain","Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.","False","8b09c97e-daee-486a-8af9-10f106fadac7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49607"
"2937","Questionnaire Domain","C49609","QS","['QS', 'Questionnaires']","Questionnaire Domain","Questionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).","False","a3585706-967d-418f-ae19-972397429b80","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49609"
"2938","Subject Characteristics Domain","C49610","SC","['SC', 'Subject Characteristics']","Subject Characteristics Domain","The subject characteristics domain is for data not collected in other domains that is subject-related. Examples: subject initials, other race details, eye color, childbearing status, etc.","False","0f9bddc9-1805-4b11-8e5a-f6546ade60b6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49610"
"2939","Subject Element Domain","C49616","SE","['SE', 'Subject Element']","Subject Element Domain","The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.","False","abf94c6d-968a-4ff9-904a-34c112dee8f9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49616"
"2940","Surgery Domain","C49611","SG","['SG', 'Surgery']","Surgery Domain","Surgical information.","False","523a8a76-6fd5-4f9d-970d-c141282a1aff","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49611"
"2941","Skin Test Domain","C49612","SK","['SK', 'Skin Test']","Skin Test Domain","Findings from diagnostic skin tests.","False","e96aff5d-33d7-4ba1-860f-40c1ef86e4a0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49612"
"2942","Sleep Polysomnography Domain","C49613","SL","['SL', 'Sleep Polysomnography Data']","Sleep Polysomnography Domain","Findings from diagnostic sleep tests (polysomnography).","False","da364066-1a7d-4d05-be97-3b1a99f77dca","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49613"
"2943","Stress Exercise Test Data Domain","C49614","ST","['ST', 'Stress (Exercise) Test Data']","Stress Exercise Test Data Domain","Findings from exercise stress tests.","False","2e19b678-46f1-4dfc-842d-423a1b27b46a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49614"
"2944","Substance Use Domain","C49615","SU","['SU', 'Substance Use']","Substance Use Domain","The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.","False","0e363daa-2f8d-4897-acd7-9081692eb760","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49615"
"2945","Subject Visits Domain","C49617","SV","['SV', 'Subject Visits']","Subject Visits Domain","The subject visits table describes the actual start and end data/time for each visit of each individual subject.","False","514efc15-f789-4819-bfed-e24df2790314","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49617"
"2946","Trial Arms Domain","C49618","TA","['TA', 'Trial Arms']","Trial Arms Domain","The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.","False","772175d3-523b-409e-8c54-6038ae15fca2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49618"
"2947","Trial Elements Domain","C49619","TE","['TE', 'Trial Elements']","Trial Elements Domain","The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.","False","81d31bc9-6051-48e4-87b2-9f70caeb3d69","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49619"
"2948","Trial Inclusion and Exclusion Criteria Domain","C49620","TI","['TI', 'Trial Inclusion/Exclusion Criteria']","Trial Inclusion and Exclusion Criteria Domain","The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.","False","83b447a8-4e81-4b7f-81c9-3a7f53ed3b01","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49620"
"2949","Trial Summary Domain","C53483","TS","['TS', 'Trial Summary']","Trial Summary Domain","The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.","False","36198ed7-5cee-436a-8ddb-8c4a0e1bedcc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C53483"
"2950","Trial Visits Domain","C49621","TV","['TV', 'Trial Visits']","Trial Visits Domain","The trial visits table describes the planned order and number of visits in the study within each arm.","False","bab7d756-1888-49ed-9030-1a7ace667a93","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49621"
"2951","Vital Signs Domain","C49622","VS","['VS', 'Vital Signs']","Vital Signs Domain","Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.","False","65c0e882-7282-4833-bc95-f003f75c725c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66734/C49622"
"2952","Trial Blinding Schema","C66735","TBLIND","['TBLIND', 'Trial Blinding Schema']","CDISC SDTM Trial Blinding Schema Terminology","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","aada5f51-08e3-457a-97df-7460b1a422bf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66735"
"2953","Double Blind Study","C15228","DOUBLE BLIND","['DOUBLE BLIND']","Double Blind Study","A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)","False","d4a999ff-21fe-43a4-a2e2-4726a44841f1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66735/C15228"
"2954","Open Label Study","C49659","OPEN LABEL","['OPEN LABEL']","Open Label Study","A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)","False","14776d89-1bd7-421f-80ef-52f9a7850b5b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66735/C49659"
"2955","Single Blind Study","C28233","SINGLE BLIND","['SINGLE BLIND']","Single Blind Study","A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)","False","30a67e4e-3e0f-4203-b6d1-41e99e6d70f8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66735/C28233"
"2956","Trial Indication Type","C66736","TINDTP","['TINDTP', 'Trial Indication Type']","CDISC SDTM Trial Indication Type Terminology","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)","False","6b2d0903-70ea-4b7f-a7e8-11bdfe97053b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66736"
"2957","Cure Study","C49654","CURE","['CURE']","Cure Study","A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition.  (NCI)","False","488445e4-c1f7-4d08-82ec-50e9ad10a9d1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66736/C49654"
"2958","Diagnosis Study","C49653","DIAGNOSIS","['DIAGNOSIS']","Diagnosis Study","A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition.  (NCI)","False","ebe3d478-6872-4535-abe6-1b3cb44d97c4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66736/C49653"
"2959","Adverse Effect Mitigation Study","C49655","MITIGATION","['MITIGATION']","Adverse Effect Mitigation Study","A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen.  (NCI)","False","02451792-f403-4f01-be95-ba02f45bba34","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66736/C49655"
"2960","Prevention Study","C49657","PREVENTION","['PREVENTION']","Prevention Study","A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.","False","e8084c8d-be08-42d7-87b8-c9dcc3766b7e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66736/C49657"
"2961","Treatment Study","C49656","TREATMENT","['TREATMENT']","Treatment Study","A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.","False","ba5e6060-ac97-489e-9f2d-def319bd541a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66736/C49656"
"2962","Trial Phase","C66737","TPHASE","['TPHASE', 'Trial Phase']","CDISC SDTM Trial Phase Terminology","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","b4ce19fc-22ee-4845-a91b-684467ddfcf8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737"
"2963","Phase I Trial","C15600","Phase I Trial","['Phase I Trial', 'Trial Phase 1', '1']","Phase I Trial","The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drugs pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes.  [After FDA CDER Handbook, ICH E8] (CDISC glossary)","False","dd25c49b-c475-43f4-a105-5e5469d1a13c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C15600"
"2964","Phase I/II Trial","C15693","Phase I/II Trial","['Phase I/II Trial', 'Trial Phase 1-2', '1-2']","Phase I/II Trial","A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.","False","3ca33b5f-3f79-4871-a30a-265a7d61c3c1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C15693"
"2965","Phase II Trial","C15601","Phase II Trial","['Phase II Trial', 'Trial Phase 2', '2']","Phase II Trial","Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","905c478b-22bc-4ccd-8303-6473b04620e6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C15601"
"2966","Phase II/III Trial","C15694","Phase II/III Trial","['Phase II/III Trial', 'Trial Phase 2-3', '2-3']","Phase II/III Trial","A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.","False","01815e5b-ba97-4ca1-9248-4d6e41d21fe3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C15694"
"2967","Phase IIa Trial","C49686","Phase IIa Trial","['Phase II A Trial', 'Trial Phase 2A', '2A']","Phase IIa Trial","A clinical research protocol generally refered to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)","False","14b1b384-e004-4d57-a52b-3a0bc8d90c88","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C49686"
"2968","Phase IIb Trial","C49688","Phase IIb Trial","['Phase II B Trial', 'Trial Phase 2B', '2B']","Phase IIb Trial","A clinical research protocol generally refered to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)","False","01602945-b447-4149-aa43-eaa57d206380","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C49688"
"2969","Phase III Trial","C15602","Phase III Trial","['Phase III Trial', 'Trial Phase 3', '3']","Phase III Trial","Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefitrisk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","9dcf4245-7ed3-4e0c-86c7-9ce80e844661","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C15602"
"2970","Phase IIIa Trial","C49687","Phase IIIaTrial","['Phase III A Trial', 'Trial Phase 3A', '3A']","Phase IIIa Trial","A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.","False","7e402914-dc26-431b-a273-aed1cfb1817a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C49687"
"2971","Phase IIIb Trial","C49689","Phase IIIb Trial","['Phase III B Trial', 'Trial Phase 3B', '3B']","Phase IIIb Trial","A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.","False","eb6b47a7-4786-4980-979c-528941555a86","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C49689"
"2972","Phase IV Trial","C15603","Phase IV Trial","['Phase IV Trial', 'Trial Phase 4', '4']","Phase IV Trial","Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drugs risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","75f7c474-ba4d-43e7-bf05-61e4dc828e1b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C15603"
"2973","Phase V Trial","C47865","Phase V Trial","['Phase V Trial', 'Trial Phase 5', '5']","Phase V Trial","Postmarketing surveillance is sometimes referred to as Phase V.","False","3684a952-e4d1-4d09-bec0-e8316a9ab3ef","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C47865"
"2974","Not Applicable","C48660","","['NOT APPLICABLE', 'NA']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","43f9f070-e009-4375-97db-1642bea8962d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66737/C48660"
"2975","Trial Summary Parameter Test Code","C66738","TSPARMCD","['TSPARMCD', 'Trial Summary Parameter Test Code']","CDISC SDTM Trial Summary Parameter Terminology by Code","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","f28d0dc7-575f-481b-b3b8-02088475bc39","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738"
"2976","Test Product Added to Existing Treatment","C49703","ADDON","['ADDON', 'Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","ba679aa1-82ce-4b62-9a08-6f7294fb2b1f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49703"
"2977","Adverse Event Dictionary","C49700","AEDICT","['AEDICT', 'Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","1813ccc4-b2a2-44ec-b4af-8a7317ca6c47","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49700"
"2978","Planned Maximum Age of Subjects","C49694","AGEMAX","['AGEMAX', 'Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","74b168a7-173e-4caa-911b-4e961cf9dfcc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49694"
"2979","Planned Minimum Age of Subjects","C49693","AGEMIN","['AGEMIN', 'Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","dd4be48e-751c-4223-90fc-1cb7ac8b0be5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49693"
"2980","Age Group","C20587","AGESPAN","['AGESPAN', 'Age Group']","Age Group","Subgroups of populations based on age. (NCI)","False","e172d50e-2803-4871-bf98-ec938e0917a4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C20587"
"2981","Age Unit","C50400","AGEU","['AGEU', 'Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","063c13da-c4d6-4449-9a5d-003d55f35aaf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C50400"
"2982","Dose","C25488","DOSE","['DOSE', 'Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","80548cba-6be0-4ed8-8a9a-dc9fa7db9a6d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C25488"
"2983","Drug Dictionary","C49701","DRUGDICT","['DRUGDICT', 'Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","cc3700ce-0281-462d-9438-91d0a52531ce","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49701"
"2984","Trial Length","C49697","LENGTH","['LENGTH', 'Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","e2de974c-c94a-4a5b-9034-2a2e323f24e8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49697"
"2985","Medical History Dictionary","C49702","MHDICT","['MHDICT', 'Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","0753afe8-1488-4540-9394-4d8e54f9608d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49702"
"2986","Planned Subject Number","C49692","PLANSUB","['PLANSUB', 'Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","544504e4-9457-4f02-9712-3118dacad0c1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49692"
"2987","Randomization","C25196","RANDOM","['RANDOM', 'Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","7c873e67-f8d8-43cc-9d93-a59860137f92","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C25196"
"2988","Route of Administration","C38114","ROUTE","['ROUTE', 'Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","8a5a4611-d429-41f8-a587-f2be865d5b6a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C38114"
"2989","Sex of Study Group","C49696","SEXPOP","['SEXPOP', 'Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","690cd9d2-21f9-44a2-b2fd-fc4254402b5d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49696"
"2990","Study Stop Rules","C49698","STOPRULE","['STOPRULE', 'Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","9cd9c4e0-e037-4d94-9af2-dc18a1fa4249","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49698"
"2991","Trial Blinding Schema","C49658","TBLIND","['TBLIND', 'Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","82b22207-5351-4e9e-9d08-5102f93b617a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49658"
"2992","Control Type","C49647","TCNTRL","['TCNTRL', 'Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","afd2bba3-be87-46d9-8ed4-580d0cb8d65a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49647"
"2993","Diagnosis Group","C49650","TDIGRP","['TDIGRP', 'Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","ab6e399b-b6c9-4f7c-a964-e8b7f6a1fbb0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49650"
"2994","Trial Indication Type","C49652","TINDTP","['TINDTP', 'Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","263b6948-c41c-49cc-b4a5-42ab5fc6c0ec","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49652"
"2995","Trial Title","C49802","TITLE","['TITLE', 'Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","22ce3b4c-ee8f-4284-9ec8-df47581fe363","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49802"
"2996","Trial Phase","C48281","TPHASE","['TPHASE', 'Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","1a2dd514-06da-4e49-a082-d19bc43684ba","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C48281"
"2997","Trial Type","C49660","TTYPE","['TTYPE', 'Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","2a0cffeb-a836-478a-9ba3-548eb34b086d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66738/C49660"
"2998","Trial Summary Parameter Test Name","C67152","TSPARM","['TSPARM', 'Trial Summary Parameter Test Name']","CDISC SDTM Trial Summary Parameter Terminology by Name","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","8c34f6d9-85b8-4109-8454-649fe7e8c13e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152"
"2999","Test Product Added to Existing Treatment","C49703","Added on to Existing Treatments","['ADDON', 'Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","fe936aaa-c8be-4b6b-b2f4-32a40f96bb91","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49703"
"3000","Adverse Event Dictionary","C49700","Adverse Event Dictionary","['AEDICT', 'Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","922dd7c5-326d-462f-b34a-abb3bd72f7b2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49700"
"3001","Planned Maximum Age of Subjects","C49694","Planned Maximum Age of Subjects","['AGEMAX', 'Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","900d1217-c5df-43e7-974a-14ea85928fd8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49694"
"3002","Planned Minimum Age of Subjects","C49693","Planned Minimum Age of Subjects","['AGEMIN', 'Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","95b4c7d4-b0d6-4b5e-bb40-8fd41a1f952c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49693"
"3003","Age Group","C20587","Age Span","['AGESPAN', 'Age Group']","Age Group","Subgroups of populations based on age. (NCI)","False","380d2f40-a6a6-4d04-b7bd-e0d13a44172d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C20587"
"3004","Age Unit","C50400","Age Unit","['AGEU', 'Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","f34a2187-f796-4b35-b056-3469cd89b0bd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C50400"
"3005","Dose","C25488","Dose per Administration","['DOSE', 'Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","9cdfe00c-9daa-46ab-97de-dde9a31a8582","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C25488"
"3006","Drug Dictionary","C49701","Drug Dictionary","['DRUGDICT', 'Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","6d3e11b5-73af-4212-afbb-8222b183587f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49701"
"3007","Trial Length","C49697","Trial Length","['LENGTH', 'Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","ed069622-2b43-41db-93aa-87962dcb2b31","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49697"
"3008","Medical History Dictionary","C49702","Medical History Dictionary","['MHDICT', 'Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","d7da5e87-2877-415b-80f7-2fc36c990999","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49702"
"3009","Planned Subject Number","C49692","Planned Number of Subjects","['PLANSUB', 'Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","e98a03ad-568c-446c-907f-48f08ca55abf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49692"
"3010","Randomization","C25196","Trial is Randomized","['RANDOM', 'Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","22d4ee3d-133d-4a9d-bec4-72d2096f26c3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C25196"
"3011","Route of Administration","C38114","Route of Administration","['ROUTE', 'Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","79989918-3b6d-4244-a939-7406465abaee","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C38114"
"3012","Sex of Study Group","C49696","Sex of Participants","['SEXPOP', 'Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","8ef7364e-9337-433d-8734-8b260c7c3d4f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49696"
"3013","Study Stop Rules","C49698","Study Stop Rules","['STOPRULE', 'Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","34a0b288-df6e-41d4-b390-1a0dbfed42dd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49698"
"3014","Trial Blinding Schema","C49658","Trial Blinding Schema","['TBLIND', 'Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","9f9af323-4d6e-47c3-905b-6c13d198606b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49658"
"3015","Control Type","C49647","Control Type","['TCNTRL', 'Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","2d4c6256-01ca-4560-b488-64f5fc805c4d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49647"
"3016","Diagnosis Group","C49650","Diagnosis Group","['TDIGRP', 'Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","22314ffe-8346-4836-a4a5-7561d0218cc1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49650"
"3017","Trial Indication Type","C49652","Trial Indication Type","['TINDTP', 'Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","868d6efc-bcdc-4012-a2a1-d5abc4d008a8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49652"
"3018","Trial Title","C49802","Trial Title","['TITLE', 'Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","df54bf70-0a77-45bb-b2af-39dd2f74a627","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49802"
"3019","Trial Phase","C48281","Trial Phase Classification","['TPHASE', 'Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","1cff6dcc-1026-4390-8a69-4784896f9229","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C48281"
"3020","Trial Type","C49660","Trial Type","['TTYPE', 'Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","26c97b76-4f7b-4196-9ba7-cd94b11d1175","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67152/C49660"
"3021","Trial Type","C66739","TTYPE","['TTYPE', 'Trial Type']","CDISC SDTM Trial Type Terminology","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","0282b401-03a4-4b0f-820f-357a60c4cbc7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739"
"3022","Bioavailability Study","C49664","BIO-AVAILABILITY","['BIO-AVAILABILITY']","Bioavailability Study","A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)","False","56f7b587-f0ce-4e07-9c0d-b6ebf34915f5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C49664"
"3023","Therapeutic Equivalency Study","C49665","BIO-EQUIVALENCE","['BIO-EQUIVALENCE']","Therapeutic Equivalency Study","A study most often used to compare the efficacy of different formulations to treat a given disease.  It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)","False","25e203ab-4a3a-483f-9226-d68e70f93ef3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C49665"
"3024","Efficacy Study","C49666","EFFICACY","['EFFICACY']","Efficacy Study","A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)","False","b3f2f044-538b-43de-b107-8f16ce4fae14","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C49666"
"3025","Pharmacodynamic Study","C49662","PHARMACODYNAMIC","['PHARMACODYNAMIC']","Pharmacodynamic Study","A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)","False","5127ebdf-a876-42fa-8405-4db6c8859154","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C49662"
"3026","Pharmacoeconomic Study","C39493","PHARMACOECONOMIC","['PHARMACOECONOMIC']","Pharmacoeconomic Study","A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)","False","a8d0b819-d312-49f2-bf0d-26b17f0e7e8b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C39493"
"3027","Pharmacogenomic Study","C49661","PHARMACOGENOMIC","['PHARMACOGENOMIC']","Pharmacogenomic Study","A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)","False","b1b72abf-5fda-4f3d-a43c-de0cd7278a32","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C49661"
"3028","Pharmacokinetic Study","C49663","PHARMACOKINETIC","['PHARMACOKINETIC']","Pharmacokinetic Study","A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)","False","c629b699-a9b4-441f-84dc-182e11f9dcb9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C49663"
"3029","Safety Study","C49667","SAFETY","['SAFETY']","Safety Study","A study of the relative safety of treatment of a disease. Usually this is a Phase I or II trial. (NCI)","False","3c9e91d3-3d7f-4c87-a5ed-8c6f92be5b35","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66739/C49667"
"3030","Units for Vital Signs Results","C66770","VSRESU","['VSRESU', 'Units for Vital Signs Results']","CDISC SDTM Unit for Vital Sign Result Terminology","The unit used to record and describe the result of a test investigating a vital sign. (NCI)","False","4319f153-7281-4cdb-b247-0a7df926239e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770"
"3031","Percentage","C25613","%","['%', 'Percentage']","Percentage","A fraction or ratio with 100 understood as the denominator. (NCI)","False","fd387c99-0757-472d-8459-6091099185f9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C25613"
"3032","Beats per Minute","C49673","BEATS/MIN","['BEATS/MIN', 'Beats per Minute']","Beats per Minute","The number of heartbeats measured per minute time. (NCI)","False","82f1ce4a-c69b-4b4e-80fc-02037d571e2b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C49673"
"3033","Breaths per Minute","C49674","BREATHS/MIN","['BREATHS/MIN', 'Breaths per Minute']","Breaths per Minute","The number of breaths (inhalation and exhalation) taken per minute time. (NCI)","False","c980530e-e54d-405e-8aae-425ea1efcdc1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C49674"
"3034","Degree Celsius","C42559","C","['C', 'Degree Celsius']","Degree Celsius","A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)","False","0ec77c9f-8e6f-421d-aba6-ac2fc1e434ad","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C42559"
"3035","Centimeter","C49668","cm","['cm', 'Centimeter']","Centimeter","A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)","False","4d8609d7-a11f-454e-b280-91fe24d7c832","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C49668"
"3036","Degree Fahrenheit","C44277","F","['F', 'Degree Fahrenheit']","Degree Fahrenheit","The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724.  In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)","False","ea7e2413-e318-41e1-8c40-ab3cc249fb58","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C44277"
"3037","Gram","C48155","g","['g', 'Gram']","Gram","A metric unit of mass equal to one one thousandth of a kilogram. (NCI)","False","b8d29fc4-670d-46e7-917e-e13d1a6567e1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C48155"
"3038","Inch","C48500","IN","['Inch']","Inch","A traditional unit of length equal to 2.54 centimeters. (NCI)","False","742abeaf-4bcc-40ab-8026-d67d751da61c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C48500"
"3039","Kilogram","C28252","kg","['kg', 'Kilogram']","Kilogram","The basic SI unit of mass.  It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)","False","ceb74927-ba33-4476-842b-ad98adacb42f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C28252"
"3040","Kilogram Per Square Meter","C49671","kg/m2","['kg/m2', 'Kilogram Per Square Meter']","Kilogram Per Square Meter","The SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)","False","236b7ae2-db88-4a59-8624-ccdc4734ca96","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C49671"
"3041","Pound","C48531","LB","['LB', 'Pound']","Pound","A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)","False","d75bcc37-3b62-4b68-9511-ade2e84d303c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C48531"
"3042","Square Meter","C42569","m2","['m2', 'Square Meter']","Square Meter","The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)","False","df56a211-cda8-4d39-b8fe-e7a4adaf3302","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C42569"
"3043","Millimeter of Mercury","C49670","mmHg","['mmHg', 'Millimeter of Mercury']","Millimeter of Mercury","A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)","False","cd686cd2-c290-426b-b1aa-b9752d26ecb5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C49670"
"3044","Ohm","C42554","ohm","['ohm']","Ohm","A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens. (NCI)","False","e9c26ea2-a2a6-434d-9cd0-162c9242573d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66770/C42554"
"3045","Vital Signs Test Code","C66741","VSTESTCD","['VSTESTCD', 'Vital Signs Test Code']","CDISC SDTM Vital Sign Terminology by Code","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","aeb9344b-f082-4b15-9d6b-f501c9a61a31","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741"
"3046","Body Mass Index","C16358","BMI","['BMI', 'Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","44ddb002-ef23-4cdf-a024-b14b6400e4c8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C16358"
"3047","Adipose Tissue","C12472","BODYFAT","['BODYFAT', 'Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","4b373abc-e516-4ff0-adfe-080d703ab710","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C12472"
"3048","Body Surface Area","C25157","BSA","['BSA', 'Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","31912264-d3a9-48b5-b66f-3db9178b2305","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C25157"
"3049","Diastolic Blood Pressure","C25299","DIABP","['DIABP', 'Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","415c90b0-b930-46ab-8bd3-77c388bdf031","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C25299"
"3050","Body Frame Size","C49680","FRMSIZE","['FRMSIZE', 'Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","3a60796a-b17f-4f5e-ba0f-aa2dc6dd5d40","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C49680"
"3051","Height","C25347","HEIGHT","['HEIGHT', 'Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","f2865dd1-e2a0-4161-8c72-840a59ae9caa","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C25347"
"3052","Heart Rate","C49677","HR","['HR', 'Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","b8c8e6a6-6139-4255-a195-6188e07008aa","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C49677"
"3053","Mean Arterial Pressure","C49679","MAP","['MAP', 'Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","63d19c6e-918f-42a6-a68e-53fc35ed1ff1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C49679"
"3054","Pulse Rate","C49676","PULSE","['PULSE', 'Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","f0933cd2-8f63-41dd-80ee-faefa37d1bd4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C49676"
"3055","Respiratory Rate","C49678","RESP","['RESP', 'Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","20d71d1f-0c6b-4f15-af00-f3e7ddee4ce2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C49678"
"3056","Systolic Blood Pressure","C25298","SYSBP","['SYSBP', 'Systolic Blood Pressure']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","efe84825-e239-46f9-a331-4fe2b6955e89","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C25298"
"3057","Temperature","C25206","TEMP","['TEMP', 'Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","3efce6a5-4902-429f-940f-c9aa839ac88c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C25206"
"3058","Weight","C25208","WEIGHT","['WEIGHT', 'Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","93407255-dbad-45e1-aeba-f4c5bdadc7a5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66741/C25208"
"3059","Vital Signs Test Name ","C67153","VSTEST","['VSTEST', 'Vital Signs Test Name']","CDISC SDTM Vital Sign Terminology  by Name","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","711ad26b-2b5e-4dab-8168-69273cc26684","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153"
"3060","Body Mass Index","C16358","Body Mass Index","['BMI', 'Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","b880a4e9-efc7-426b-b4ad-b2c0ff102758","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C16358"
"3061","Adipose Tissue","C12472","Body Fat","['BODYFAT', 'Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","49172b96-7ef8-4156-af5e-3fe711dd6cf5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C12472"
"3062","Body Surface Area","C25157","Body Surface Area","['BSA', 'Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","724bcf5d-3bc7-48eb-aa52-9169fb7195bf","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C25157"
"3063","Diastolic Blood Pressure","C25299","Diastolic Blood Pressure","['DIABP', 'Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","f0269275-46b6-4af0-937a-4ae4dbb9439d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C25299"
"3064","Body Frame Size","C49680","Frame Size","['FRMSIZE', 'Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","e35adfdc-afd4-4fa3-be18-d3eec804c869","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C49680"
"3065","Height","C25347","Height","['HEIGHT', 'Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","34b93dfe-fd66-4a10-993c-5d9e947efeb8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C25347"
"3066","Heart Rate","C49677","Heart Rate","['HR', 'Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","f68fc02f-f04e-4b70-877e-19f648e70796","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C49677"
"3067","Mean Arterial Pressure","C49679","Mean Arterial Pressure","['MAP', 'Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","11afe3f9-2b55-43af-856a-66adfe630ea3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C49679"
"3068","Pulse Rate","C49676","Pulse Rate","['PULSE', 'Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","8b19b8bc-5132-4014-9e7a-b1192548db9a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C49676"
"3069","Respiratory Rate","C49678","Respiratory Rate","['RESP', 'Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","97e4016b-4fa7-43df-a81c-cb784800efff","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C49678"
"3070","Systolic Blood Pressure","C25298","Systolic Blood Pressure","['SYSBP', 'Systolic Blood Pressure']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","b23c8e4e-3d4f-4ac0-a78f-b163c6b07e2d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C25298"
"3071","Temperature","C25206","Temperature","['TEMP', 'Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","6ff7ee97-eb77-470f-8d21-9dfc8e92667d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C25206"
"3072","Weight","C25208","Weight","['WEIGHT', 'Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","d5fb93e8-0382-478b-a85c-bd4a870a48e1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67153/C25208"
"3073","No Yes Response","C66742","NY","['NY', 'No Yes Response']","CDISC SDTM Yes No Unknown or Not Applicable Response Terminology","A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.","False","90d6cf57-d718-4dd1-808d-7d8c08408513","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66742"
"3074","No","C49487","N","['N', 'No']","No","The non-affirmative response to a question. (NCI)","False","5c9d565a-2446-4ece-b0c2-3400a706a384","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66742/C49487"
"3075","Not Applicable","C48660","","['NOT APPLICABLE', 'NA']","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","48219743-6933-4c25-b336-5c18be461a26","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66742/C48660"
"3076","Unknown","C17998","U","['UNKNOWN', 'U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","fddb7b5a-e3c7-4edb-b152-0b7cad8f9279","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66742/C17998"
"3077","Yes","C49488","Y","['Y', 'Yes']","Yes","The affirmative response to a question. (NCI)","False","1e8faa0f-723b-4dca-914b-034ef96aa1d4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C66742/C49488"
"3078","Laboratory Test Code","C65047","LBTESTCD","['LBTESTCD', 'Laboratory Test Code']","CDISC SDTM Laboratory Test Terminology by Code","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","25d0989c-9f75-44eb-98f1-3203051cb2d5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047"
"3079","Anisocytosis","C35266","ANISO","['ANISO', 'Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","e95ee3d8-9a9f-4e25-a9f5-b362bdbb56da","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C35266"
"3080","Poikilocytosis","C35267","POIKILO","['POIKILO', 'Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","a1bae85f-2d03-43fe-81d3-4a27e9d6db73","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C35267"
"3081","Total Bilirubin","C38037","BILI","['BILI', 'Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","50ec4adb-236b-4ecc-8098-a1e3def47a08","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C38037"
"3082","Partial Thromboplastin Time","C38462","APTT","['APTT', 'Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","df75b855-5968-452e-84ea-bdacc5082427","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C38462"
"3083","Plasma Glucose Measurement","C41376","GLUC","['GLUC', 'Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","248094e9-43b2-4426-8180-7752e7518535","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C41376"
"3084","pH","C45997","PH","['PH', 'pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","6ba24832-a48a-4f9c-8750-8b9f93f71ed0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C45997"
"3085","Erythrocyte Count","C51946","RBC","['RBC', 'Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","cb13ae95-3d4b-4d68-a5cc-4bc4f436aaed","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C51946"
"3086","Reticulocyte Count","C51947","RETI","['RETI', 'Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","edbee54d-3874-45bf-a04f-6ba559031e8a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C51947"
"3087","Leukocyte Count","C51948","WBC","['WBC', 'Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","9ca74dbb-7065-4aac-86ba-c9230f8db010","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C51948"
"3088","Lymphocyte Count","C51949","LYM","['LYM', 'Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","73387b40-4967-4d13-a91d-f1ac6a6b5a25","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C51949"
"3089","Platelet Count","C51951","PLAT","['PLAT', 'Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","91ebf4c4-02ec-498a-b823-92bbab87aa72","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C51951"
"3090","Blood Urea Nitrogen Measurement","C61019","BUN","['BUN', 'Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","57111bee-db9e-4091-99f1-5572e76415fb","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C61019"
"3091","Serum Total Cholesterol Measurement","C61032","CHOL","['CHOL', 'Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","e07aee7c-02d3-4a36-9a65-c9a378741092","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C61032"
"3092","Serum HDL Cholesterol Measurement","C61041","HDL","['HDL', 'HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","134d7de3-659c-4d68-a5f8-cfbd2ea735b6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C61041"
"3093","Serum LDL Cholesterol Measurement","C61042","LDL","['LDL', 'LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","fcdb0b85-39c1-4055-b7f0-3af289dd1f1f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C61042"
"3094","Prothrombin Time","C62656","PT","['PT', 'Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","7c4f8c36-f655-4eac-8d9a-ed206c09a1b3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C62656"
"3095","Absolute Neutrophil Count","C63321","NEUT","['NEUT', 'Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","dfd6ca3d-63c4-40b2-a2c2-cf0fe2c898af","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C63321"
"3096","Albumin Measurement","C64431","ALB","['ALB', 'Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","3aee3ec7-53d5-4f79-be87-5445b8773618","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64431"
"3097","Alkaline Phosphatase Measurement","C64432","ALP","['ALP', 'Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","745fdc11-6234-4f4d-bd60-e6f13cc9e57e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64432"
"3098","Alanine Aminotransferase Measurement","C64433","ALT","['ALT', 'Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","841a66e0-1b65-4c6f-904b-bf4ed68cb445","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64433"
"3099","Amylase Measurement","C64434","AMYLASE","['AMYLASE', 'Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","61e917bc-7970-49c0-9f09-0a0bf3f17e95","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64434"
"3100","Aspartate Aminotransferase Measurement","C64467","AST","['AST', 'Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","1992767f-8952-4be8-9ef7-bde5d146bda0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64467"
"3101","Bacterial Count","C64469","BACT","['BACT', 'Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","00735484-46a9-4901-9ff7-dfcf8f3ee98b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64469"
"3102","Total Basophil Count","C64470","BASO","['BASO', 'Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","7ba97173-c5f6-41db-a84e-3a7394a3f238","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64470"
"3103","Basophil To Leukocyte Ratio","C64471","BASOLE","['BASOLE', 'Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","a04a36a3-6de6-45a4-8879-14ab41b74e63","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64471"
"3104","Direct Bilirubin Measurement","C64481","BILDIR","['BILDIR', 'Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","a6f794c3-958f-47fa-96bb-583e5828d22a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64481"
"3105","Indirect Bilirubin Measurement","C64483","BILIND","['BILIND', 'Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","89eeb47d-3c7a-41fb-830a-8f31b92d18d0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64483"
"3106","Blast To Leukocyte Ratio","C64487","BLASTLE","['BLASTLE', 'Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","8d51a957-e940-4a6f-84f9-d934114dc8e7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64487"
"3107","Calcium Measurement","C64488","CA","['CA', 'Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","3c7ec06b-8bf5-49d7-93c2-6105db521173","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64488"
"3108","Creatine Kinase Measurement","C64489","CK","['CK', 'Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","18136630-b302-4cda-bcde-fbb5568957e0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64489"
"3109","Creatine Kinase BB Measurement","C64490","CKBB","['CKBB', 'Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","9f33eb6b-bf4e-4bbe-8606-8d210e05b997","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64490"
"3110","Creatine Kinase MB Measurement","C64491","CKMB","['CKMB', 'Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","8ac6a6e5-2200-43a5-8384-974305066506","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64491"
"3111","Creatine Kinase MM Measurement","C64494","CKMM","['CKMM', 'Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","81361d90-8917-4898-a0e3-8fd85f271102","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64494"
"3112","Chloride Measurement","C64495","CL","['CL', 'Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","f554bdc6-f591-4fb0-b83c-67698efaa5a8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64495"
"3113","Carbon Dioxide Measurement","C64545","CO2","['CO2', 'Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","a8125a52-f024-44d9-98a1-17e9737eb4e3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64545"
"3114","Color Assessment","C64546","COLOR","['COLOR', 'Color']","Color Assessment","A measurement of the color of a biological specimen.","False","b2b19022-8370-418f-bca1-5a4b1caff6b5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64546"
"3115","Creatinine Measurement","C64547","CREAT","['CREAT', 'Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","34dc218e-e295-4ddc-bc5d-e9adbe7cf4d5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64547"
"3116","C-Reactive Protein Measurement","C64548","CRP","['CRP', 'C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","f3dd6ff4-d601-4c06-8225-830fe76654e1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64548"
"3117","Elliptocyte Count","C64549","ELLIPCY","['ELLIPCY', 'Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","6545af02-70aa-4bde-9f4e-ec324a3d2c4f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64549"
"3118","Eosinophil Count","C64550","EOS","['EOS', 'Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","95357e14-0996-45d7-a3ef-02abf045e5e9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64550"
"3119","Eosinophil To Leukocyte Ratio","C64604","EOSLE","['EOSLE', 'Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","e4d5bb9b-8adb-43d3-bf89-dce8c33849fa","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64604"
"3120","Epithelial Cell Count","C64605","EPIC","['EPIC', 'Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","6598e254-99a3-4af1-be6c-7d12e77a416e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64605"
"3121","Fibrinogen Measurement","C64606","FIBRINO","['FIBRINO', 'Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","4f4c05e3-7a62-4d5c-b068-a36929c1d909","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64606"
"3122","Hematocrit","C64796","HCT","['HCT', 'Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","610de34a-9ce0-4de3-a63e-c500780b4336","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64796"
"3123","Erythrocyte Mean Corpuscular Hemoglobin","C64797","MCH","['MCH', 'Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","8ef54eba-ec92-480d-828b-66c083711b12","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64797"
"3124","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","MCHC","['MCHC', 'Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","959d57f3-e23b-466d-9bde-3388740b43a1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64798"
"3125","Erythrocyte Mean Corpuscular Volume","C64799","MCV","['MCV', 'Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","bb1557dd-f663-4144-87e7-4c499552a373","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64799"
"3126","Erythrocyte Distribution Width Measurement","C64800","RDW","['RDW', 'Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","1f210836-3603-46d1-85f6-9f8d98dab53e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64800"
"3127","Dacryocyte Analysis","C64801","TEARDCY","['TEARDCY', 'Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","c3ec1e4c-7f38-42f0-a034-d0754743316c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64801"
"3128","Hypochromia","C64802","HYPO","['HYPO', 'Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","3a8c7b1a-66ab-46fd-afe9-675ef12b5c5a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64802"
"3129","Polychromasia","C64803","POLYCHR","['POLYCHR', 'Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","789d123b-6064-441c-adb1-becd1f98427f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64803"
"3130","International Normalized Ratio of Prothrombin Time","C64805","INR","['INR', 'Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","ff056dcd-dfc2-4aeb-bada-780b6dab8488","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64805"
"3131","Serum VLDL Cholesterol Measurement","C64806","VLDL","['VLDL', 'VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","f1ef9844-6873-4af9-bfdf-f4f3c2c83438","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64806"
"3132","Triacylglycerol Lipase Measurement","C64807","LIPASE","['LIPASE', 'Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","af2811d5-2c26-4eaf-a5b9-e2aa04c7a13f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64807"
"3133","Sodium Measurement","C64809","SODIUM","['SODIUM', 'Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","a7573156-1f3d-4363-92b0-38e0d85886ef","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64809"
"3134","Nitrite Measurement","C64810","NITRITE","['NITRITE', 'Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","d43e363e-45c3-465d-90e5-8a7dc1c74307","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64810"
"3135","Triglyceride Measurement","C64812","TRIG","['TRIG', 'Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","f103008c-8b3f-444d-af27-015286155e38","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64812"
"3136","Thyrotropin Measurement","C64813","TSH","['TSH', 'Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","268ed68a-365f-46ba-9758-f75fe115324b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64813"
"3137","Urate Measurement","C64814","URATE","['URATE', 'Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","69450c2b-648c-45c2-8bfd-08fec0f7f6eb","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64814"
"3138","Urea Measurement","C64815","UREA","['UREA', 'Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","a92610c1-1e4d-4de3-80ad-692566a2891f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64815"
"3139","Urobilinogen Measurement","C64816","UROBIL","['UROBIL', 'Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","b3b4a55e-ab0b-45f6-a9bf-c7401eba73a7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64816"
"3140","Vitamin B12 Measurement","C64817","VITB12","['VITB12', 'Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","43fd1247-8a84-413e-bd26-bd69ca956f7b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64817"
"3141","Atypical Lymphocyte Count","C64818","LYMAT","['LYMAT', 'Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","5aa0c8fa-1c04-4358-b19b-4240d4f0ef3b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64818"
"3142","Atypical Lymphocyte To Leukocyte Ratio","C64819","LYMATLE","['LYMATLE', 'Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","ade3dc5d-b913-48e9-82c8-c37af8429ddc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64819"
"3143","Lymphocyte To Leukocyte Ratio","C64820","LYMLE","['LYMLE', 'Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","29988c64-5639-4b2a-8eee-686b3516ca39","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64820"
"3144","Macrocyte Count","C64821","MACROCY","['MACROCY', 'Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","4b1e33b4-ca5c-4a72-89fb-ae7c97d1d8f0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64821"
"3145","Microcyte Count","C64822","MICROCY","['MICROCY', 'Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","737cd9c9-2674-48ae-9939-6fb36fef0a61","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64822"
"3146","Monocyte Count","C64823","MONO","['MONO', 'Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","301abbfd-ccf9-4e23-90ea-8fc915e875a7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64823"
"3147","Monocyte To Leukocyte Ratio","C64824","MONOLE","['MONOLE', 'Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","c8445458-d89b-45f9-9190-0cf05a4ff70c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64824"
"3148","Myeloblast To Leukocyte Ratio","C64825","MYBLALE","['MYBLALE', 'Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","e6c4ceba-2426-4855-baf0-b3b97715c322","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64825"
"3149","Myelocyte To Leukocyte Ratio","C64826","MYCYLE","['MYCYLE', 'Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","21f10e6c-598a-424c-ab0a-771114e868ae","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64826"
"3150","Neutrophil To Leukocyte Ratio","C64827","NEUTLE","['NEUTLE', 'Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","87948a95-b133-40d5-ab35-d9fe6ee11949","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64827"
"3151","Reticulocyte To Erythrocyte Ratio","C64828","RETIRBC","['RETIRBC', 'Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","a0f9f0bf-9d46-47c0-b9cc-624c40f5ca2d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64828"
"3152","Prolymphocyte To Leukocyte Ratio","C64829","PRLYMLE","['PRLYMLE', 'Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","c8d50038-c324-4cf3-aa2e-a35eac8c2bec","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64829"
"3153","Neutrophil Band Form Count","C64830","NEUTB","['NEUTB', 'Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","ff3a50de-8f95-4ad0-ae0a-9d4bf93e82d1","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64830"
"3154","Neutrophil Band Form To Leukocyte Ratio","C64831","NEUTBLE","['NEUTBLE', 'Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","6932e1bf-657e-420e-8d2b-30d0edbf7aef","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64831"
"3155","Specific Gravity","C64832","SPGRAV","['SPGRAV', 'Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","237e07a0-ca14-4889-930e-0eee372fa0ab","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64832"
"3156","Magnesium Measurement","C64840","MG","['MG', 'Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","ae217664-fb4a-4f8a-bea1-472efe66ec74","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64840"
"3157","Gamma Glutamyl Transpeptidase Measurement","C64847","GGT","['GGT', 'Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","8b4728e0-671f-44f5-87ac-c98c6b386cc7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64847"
"3158","Hemoglobin Measurement","C64848","HGB","['HGB', 'Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","5f01f26d-ad47-41a1-b413-f8c1b8816043","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64848"
"3159","Glycosylated Hemoglobin Measurement","C64849","HBA1C","['HBA1C', 'Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","66faa03f-f1aa-4713-906f-8063e51435b8","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64849"
"3160","Hepatitis B Virus Surface Antigen Measurement","C64850","HBSAG","['HBSAG', 'Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","c79ceb70-c83f-4e20-a276-9006d0ca3151","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64850"
"3161","Choriogonadotropin Beta Measurement","C64851","HCG","['HCG', 'Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","e013b863-a7b2-4370-a3ef-1f0d72185637","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64851"
"3162","Potassium Measurement","C64853","K","['K', 'Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","45296888-46e5-4cf0-bf05-65ef8562f709","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64853"
"3163","Ketone Measurement","C64854","KETONES","['KETONES', 'Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","b36618b6-d6f1-4783-9709-a47e3623e6c9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64854"
"3164","Lactate Dehydrogenase Measurement","C64855","LDH","['LDH', 'Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","e0d3af49-2a46-43d8-a5d7-76b5c0816a78","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64855"
"3165","Leukocyte Esterase Measurement","C64856","LEUKASE","['LEUKASE', 'Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","4a346d16-4651-436a-909c-1f55a4b8a8c5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64856"
"3166","Phosphate Measurement","C64857","PHOS","['PHOS', 'Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","d3d923b8-7cbc-4f64-901c-40db6204f438","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64857"
"3167","Total Protein Measurement","C64858","PROT","['PROT', 'Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","81997c57-29ef-4a72-a484-a71b3ef7686e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C65047/C64858"
"3168","Laboratory Test Name ","C67154","LBTEST","['LBTEST', 'Laboratory Test Name']","CDISC SDTM Laboratory Test Terminology by Name","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","b24f5efb-42f8-42da-be6a-2ca406d61246","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154"
"3169","Anisocytosis","C35266","Anisocytosis","['ANISO', 'Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","32b84ee7-67a3-4d7f-ab8b-352988a1541f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C35266"
"3170","Poikilocytosis","C35267","Poikilocytes","['POIKILO', 'Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","b5fad86d-c4d5-4075-b9da-86489d1ee539","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C35267"
"3171","Total Bilirubin","C38037","Bilirubin","['BILI', 'Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","69871739-286c-4870-9fc2-1a7586752569","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C38037"
"3172","Partial Thromboplastin Time","C38462","Activated Partial Thromboplastin Time","['APTT', 'Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","16f3c3a7-f17e-4212-ac65-135d90bda45b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C38462"
"3173","Plasma Glucose Measurement","C41376","Glucose","['GLUC', 'Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","07f38671-7dcb-4613-a193-466b4f4dcfee","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C41376"
"3174","pH","C45997","pH","['PH', 'pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","bf461083-9688-40ba-a7b8-b183847a6e84","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C45997"
"3175","Erythrocyte Count","C51946","Erythrocytes","['RBC', 'Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","0f8ea01e-6b37-41ce-b835-7ac461c180cd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C51946"
"3176","Reticulocyte Count","C51947","Reticulocytes","['RETI', 'Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","76098968-10a8-47a2-abf6-0ca512131ff4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C51947"
"3177","Leukocyte Count","C51948","Leukocytes","['WBC', 'Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","c6a24c74-4bdb-42f4-9527-457c2755106e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C51948"
"3178","Lymphocyte Count","C51949","Lymphocytes","['LYM', 'Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","e0eba3e4-b6ae-48f6-9cf5-ea32b129c313","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C51949"
"3179","Platelet Count","C51951","Platelet","['PLAT', 'Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","8b7ea269-d722-4ba5-9f61-47356adb0407","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C51951"
"3180","Blood Urea Nitrogen Measurement","C61019","Blood Urea Nitrogen","['BUN', 'Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","a36de179-bc82-4137-942e-dbb1b134a5a5","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C61019"
"3181","Serum Total Cholesterol Measurement","C61032","Cholesterol","['CHOL', 'Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","af2dd1a2-a282-4a4c-81a8-aec59709def7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C61032"
"3182","Serum HDL Cholesterol Measurement","C61041","HDL Cholesterol","['HDL', 'HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","e00323c3-940f-4c21-8fa6-f08f1428e740","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C61041"
"3183","Serum LDL Cholesterol Measurement","C61042","LDL Cholesterol","['LDL', 'LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","5acba6cc-abe1-4df2-896c-38d23d1bf531","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C61042"
"3184","Prothrombin Time","C62656","Prothrombin Time","['PT', 'Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","2a96abfd-628d-490c-8b3f-57d354a5dc61","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C62656"
"3185","Absolute Neutrophil Count","C63321","Neutrophils","['NEUT', 'Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","798e93c4-42e4-4a4e-b75e-8fef13a67d55","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C63321"
"3186","Albumin Measurement","C64431","Albumin","['ALB', 'Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","2fbbb2ad-71d0-4cd2-93a3-2c16eda044ad","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64431"
"3187","Alkaline Phosphatase Measurement","C64432","Alkaline Phosphatase","['ALP', 'Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","532f4827-c890-4783-994b-f98ae390146d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64432"
"3188","Alanine Aminotransferase Measurement","C64433","Alanine Aminotransferase","['ALT', 'Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","b86c27eb-5033-4161-957e-b11cbe0f2394","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64433"
"3189","Amylase Measurement","C64434","Amylase","['AMYLASE', 'Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","763b0b59-39f7-4abc-811c-fca68011e466","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64434"
"3190","Aspartate Aminotransferase Measurement","C64467","Aspartate Aminotransferase","['AST', 'Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","6fe4b508-eab9-4ee2-8a61-e0735a63ec2d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64467"
"3191","Bacterial Count","C64469","Bacteria","['BACT', 'Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","6be03332-e29f-4995-869b-2c185d4f7b1e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64469"
"3192","Total Basophil Count","C64470","Basophils","['BASO', 'Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","5ff54da2-ffb3-485d-b787-a7eb76475af0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64470"
"3193","Basophil To Leukocyte Ratio","C64471","Basophils/Leukocytes","['BASOLE', 'Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","b87e21dd-d908-4016-823a-05a3a6ce57ea","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64471"
"3194","Direct Bilirubin Measurement","C64481","Direct Bilirubin","['BILDIR', 'Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","37b531e2-7290-4bb4-b8a7-550c483cbace","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64481"
"3195","Indirect Bilirubin Measurement","C64483","Indirect Bilirubin","['BILIND', 'Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","857bc331-60a5-4965-b4ef-85a4a3aa01e0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64483"
"3196","Blast To Leukocyte Ratio","C64487","Blasts/Leukocytes","['BLASTLE', 'Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","fc4acf71-093a-4c76-b057-d7e423d7a7de","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64487"
"3197","Calcium Measurement","C64488","Calcium","['CA', 'Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","edacf7b1-465d-4554-b983-439032f985b3","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64488"
"3198","Creatine Kinase Measurement","C64489","Creatine Kinase","['CK', 'Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","c0ae0bfd-92ff-4489-87d0-bc571d89fc05","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64489"
"3199","Creatine Kinase BB Measurement","C64490","Creatine Kinase BB","['CKBB', 'Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","3916f441-8a6c-4d14-aabf-91cae59634c9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64490"
"3200","Creatine Kinase MB Measurement","C64491","Creatine Kinase MB","['CKMB', 'Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","67ab6a7f-6b38-482f-9519-b20609be5ac4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64491"
"3201","Creatine Kinase MM Measurement","C64494","Creatine Kinase MM","['CKMM', 'Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","402889c3-3085-4768-a82a-b429008cde47","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64494"
"3202","Chloride Measurement","C64495","Chloride","['CL', 'Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","5df74e6a-3583-4f8e-9b20-d57dfb097509","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64495"
"3203","Carbon Dioxide Measurement","C64545","Carbon Dioxide","['CO2', 'Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","4cc478ba-607f-454d-a109-06c413821b22","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64545"
"3204","Color Assessment","C64546","Color","['COLOR', 'Color']","Color Assessment","A measurement of the color of a biological specimen.","False","729feac8-8c43-40ad-98a3-5863e7dce2d7","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64546"
"3205","Creatinine Measurement","C64547","Creatinine","['CREAT', 'Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","9805e377-3fc4-4eb8-a297-4732d7e02037","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64547"
"3206","C-Reactive Protein Measurement","C64548","C Reactive Protein","['CRP', 'C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","2cb35d74-553a-4617-b7db-08fcb8ca1761","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64548"
"3207","Elliptocyte Count","C64549","Elliptocytes","['ELLIPCY', 'Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","1ce3d413-750a-40d7-9237-526ea8cc1e33","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64549"
"3208","Eosinophil Count","C64550","Eosinophils","['EOS', 'Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","4971d423-0ea2-49eb-a890-972cadb836ed","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64550"
"3209","Eosinophil To Leukocyte Ratio","C64604","Eosinophils/Leukocytes","['EOSLE', 'Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","b453a030-f5f7-48da-9cba-7aaa12f45492","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64604"
"3210","Epithelial Cell Count","C64605","Epithelial Cells","['EPIC', 'Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","81ee6e33-c917-4f6c-90ab-7dd9fb4ce402","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64605"
"3211","Fibrinogen Measurement","C64606","Fibrinogen","['FIBRINO', 'Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","e5209adc-2f0b-4d54-a176-e69560674821","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64606"
"3212","Hematocrit","C64796","Hematocrit","['HCT', 'Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","e52974c5-6cb1-4a28-b78a-203c74de74d0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64796"
"3213","Erythrocyte Mean Corpuscular Hemoglobin","C64797","Ery. Mean Corpuscular Hemoglobin","['MCH', 'Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","6c64f75b-52b0-49da-a61e-9c714737d436","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64797"
"3214","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","Ery. Mean Corpuscular HB Concentration","['MCHC', 'Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","b2322037-f337-4544-b9a5-6135aee123e4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64798"
"3215","Erythrocyte Mean Corpuscular Volume","C64799","Ery. Mean Corpuscular Volume","['MCV', 'Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","aaf5a873-da01-4e6a-ba15-a196082f5d7a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64799"
"3216","Erythrocyte Distribution Width Measurement","C64800","Erythrocytes Distribution Width","['RDW', 'Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","20f68a47-bf3c-4171-879f-dc2c5f312f84","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64800"
"3217","Dacryocyte Analysis","C64801","Dacryocytes","['TEARDCY', 'Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","a9dc927e-ea25-420f-8886-1fbe29aa8b00","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64801"
"3218","Hypochromia","C64802","Hypochromia","['HYPO', 'Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","3e6e6881-138d-48ca-b0a5-c4a3cc5c93f0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64802"
"3219","Polychromasia","C64803","Polychromasia","['POLYCHR', 'Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","a7f2f4be-f08e-46cc-84bd-6542decaec77","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64803"
"3220","International Normalized Ratio of Prothrombin Time","C64805","Prothrombin Intl. Normalized Ratio","['INR', 'Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","c5f12a53-c602-47e7-965b-f339dd7502c6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64805"
"3221","Serum VLDL Cholesterol Measurement","C64806","VLDL Cholesterol","['VLDL', 'VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","34f617e1-052b-45af-a253-21d9e3ef3806","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64806"
"3222","Triacylglycerol Lipase Measurement","C64807","Triacylglycerol Lipase","['LIPASE', 'Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","99644ad3-26ed-4796-8852-c6c2f1e662c4","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64807"
"3223","Sodium Measurement","C64809","Sodium","['SODIUM', 'Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","80cc3338-6f98-4746-baaf-e42d879fd374","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64809"
"3224","Nitrite Measurement","C64810","Nitrite","['NITRITE', 'Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","4a638e3e-50fa-4f0e-bcbf-2be4da6ec69f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64810"
"3225","Triglyceride Measurement","C64812","Triglycerides","['TRIG', 'Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","b0a438eb-b4fb-4e90-82b0-f14364eb6ec2","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64812"
"3226","Thyrotropin Measurement","C64813","Thyrotropin","['TSH', 'Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","6d2de180-638b-47f6-a02e-e3b800b7360a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64813"
"3227","Urate Measurement","C64814","Urate","['URATE', 'Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","9d6fbedf-5670-489a-b219-3925f19ba570","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64814"
"3228","Urea Measurement","C64815","Urea","['UREA', 'Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","87f863c7-30f1-4f28-8c23-8b84962c701d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64815"
"3229","Urobilinogen Measurement","C64816","Urobilinogen","['UROBIL', 'Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","b8f52fdc-959d-4094-a72a-fb55c848390f","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64816"
"3230","Vitamin B12 Measurement","C64817","Vitamin B12","['VITB12', 'Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","73a152e2-4924-4f97-b014-33535f8a6ee9","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64817"
"3231","Atypical Lymphocyte Count","C64818","Lymphocytes Atypical","['LYMAT', 'Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","592587ff-f360-4dfd-a53d-258cd5a38d68","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64818"
"3232","Atypical Lymphocyte To Leukocyte Ratio","C64819","Lymphocytes Atypical/Leukocytes","['LYMATLE', 'Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","6ec6be96-5b6b-44d1-bd3d-0d50b98ae371","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64819"
"3233","Lymphocyte To Leukocyte Ratio","C64820","Lymphocytes/Leukocytes","['LYMLE', 'Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","c2bce562-fb5f-4b22-bb3b-d8270d60a851","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64820"
"3234","Macrocyte Count","C64821","Macrocytes","['MACROCY', 'Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","e326c353-f36e-4d87-bed7-abecc283bfdc","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64821"
"3235","Microcyte Count","C64822","Microcytes","['MICROCY', 'Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","f8033837-8110-46b2-a07d-1be55f0532cd","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64822"
"3236","Monocyte Count","C64823","Monocytes","['MONO', 'Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","67990891-fe38-46a4-9176-64b185d96818","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64823"
"3237","Monocyte To Leukocyte Ratio","C64824","Monocytes/Leukocytes","['MONOLE', 'Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","939d255c-718e-4371-97e4-abbf5a4e28a6","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64824"
"3238","Myeloblast To Leukocyte Ratio","C64825","Myeloblasts/Leukocytes","['MYBLALE', 'Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","48c87d69-a3a8-48d1-83b4-d5174a300555","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64825"
"3239","Myelocyte To Leukocyte Ratio","C64826","Myelocytes/Leukocytes","['MYCYLE', 'Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","342d90d1-71bf-4ad8-8df4-fe6a184df093","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64826"
"3240","Neutrophil To Leukocyte Ratio","C64827","Neutrophils/Leukocytes","['NEUTLE', 'Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","cf56f0d3-90d4-4df9-9256-723c60562eff","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64827"
"3241","Reticulocyte To Erythrocyte Ratio","C64828","Reticulocytes/Erythrocytes","['RETIRBC', 'Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","e80b4466-b4ef-4410-a73e-4cd09ac44fce","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64828"
"3242","Prolymphocyte To Leukocyte Ratio","C64829","Prolymphocytes/Leukocytes","['PRLYMLE', 'Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","e3f97110-121d-454f-b77a-cc807be2a68a","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64829"
"3243","Neutrophil Band Form Count","C64830","Neutrophils Band Form","['NEUTB', 'Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","05e469c2-f697-419d-9a60-8422528c3d0c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64830"
"3244","Neutrophil Band Form To Leukocyte Ratio","C64831","Neutrophils Band Form/Leukocytes","['NEUTBLE', 'Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","b05b7220-2a76-4f2a-8f74-08c6d0730b0c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64831"
"3245","Specific Gravity","C64832","Specific Gravity","['SPGRAV', 'Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","5dcec3c7-3691-4318-830d-2e5bf74f18d0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64832"
"3246","Magnesium Measurement","C64840","Magnesium","['MG', 'Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","18cfd672-e6b7-4613-b64f-7e00942842fb","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64840"
"3247","Gamma Glutamyl Transpeptidase Measurement","C64847","Gamma Glutamyl Transferase","['GGT', 'Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","5afb7317-6129-4dd2-ba19-7370e371604e","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64847"
"3248","Hemoglobin Measurement","C64848","Hemoglobin","['HGB', 'Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","0ca97398-5851-4064-9d85-b7222190a6d0","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64848"
"3249","Glycosylated Hemoglobin Measurement","C64849","Hemoglobin A1C","['HBA1C', 'Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","aab85ac0-9f51-433f-b312-e93193286342","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64849"
"3250","Hepatitis B Virus Surface Antigen Measurement","C64850","Hepatitis B Virus Surface Antigen","['HBSAG', 'Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","4e187e82-5ddc-43af-a570-2f39961b5366","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64850"
"3251","Choriogonadotropin Beta Measurement","C64851","Choriogonadotropin Beta","['HCG', 'Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","86c59ada-e282-499c-9ac5-c38fbc98206b","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64851"
"3252","Potassium Measurement","C64853","Potassium","['K', 'Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","ebab91da-f22e-4a8f-b70a-b53852cc4428","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64853"
"3253","Ketone Measurement","C64854","Ketones","['KETONES', 'Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","f867de26-4f79-4ef5-b2bf-ba74a032876c","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64854"
"3254","Lactate Dehydrogenase Measurement","C64855","Lactate Dehydrogenase","['LDH', 'Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","8e74e9fe-b41c-4c43-8730-5e80c082a276","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64855"
"3255","Leukocyte Esterase Measurement","C64856","Leukocyte Esterase","['LEUKASE', 'Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","3e8388b4-08fc-4164-91f1-2844d3e9cb55","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64856"
"3256","Phosphate Measurement","C64857","Phosphate","['PHOS', 'Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","a0284a91-2502-4a2d-8a3a-e8e7fa44bd7d","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64857"
"3257","Total Protein Measurement","C64858","Protein","['PROT', 'Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","9eab2580-af79-41bc-92b2-5c00a3d0aa12","dataset/cdisc/ct/sc/2007-04-26/sdtm/C67154/C64858"
"3258","Action Taken with Study Treatment ","C66767","ACN","['Action Taken with Study Treatment']","CDISC SDTM Action Taken with Study Treatment Terminology","The reason that changes were made to the therapy under study. (NCI)","False","ea907e59-fe73-45fe-a7a8-4af564a087e2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767"
"3259","Dose Increased","C49503","DOSE INCREASED","[]","Dose Increased","An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)","False","f72d8851-ff7e-4d0c-b0be-def108ff8e3b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767/C49503"
"3260","Dose Not Changed","C49504","DOSE NOT CHANGED","[]","Dose Not Changed","An indication that a medication schedule was maintained. (NCI)","False","5f55a60c-22f4-4736-a8f3-1cd11540bca5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767/C49504"
"3261","Dose Reduced","C49505","DOSE REDUCED","[]","Dose Reduced","An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)","False","a73ad2cc-adb3-4ed8-b930-e13f35ffe3a4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767/C49505"
"3262","Drug Interrupted","C49501","DRUG INTERRUPTED","[]","Drug Interrupted","An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)","False","463dc5d1-b449-410a-ae2f-93d0690f7fec","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767/C49501"
"3263","Drug Withdrawn","C49502","DRUG WITHDRAWN","[]","Drug Withdrawn","An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)","False","2af4f58e-5edc-428c-830d-ffa0cee99a43","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767/C49502"
"3264","Not Applicable","C48660","NOT APPLICABLE","[]","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","56b67865-9bf1-4ee8-b470-d286c2352604","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767/C48660"
"3265","Unknown","C17998","UNKNOWN","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","3c4395b9-dc6f-4ba0-bec1-234d8f52df7b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66767/C17998"
"3266","Outcome of Event","C66768","OUT","['Outcome of Event']","CDISC SDTM Adverse Event Outcome Terminology","A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)","False","8428ec15-6290-43e0-b93e-c2e6bdcbe81b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66768"
"3267","Death Related to Adverse Event","C48275","FATAL","['Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","fe8044f5-aaf4-40e1-8b7a-d7302180c6bf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66768/C48275"
"3268","Not Recovered or Not Resolved","C49494","NOT RECOVERED/NOT RESOLVED","[]","Not Recovered or Not Resolved","One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)","False","126f8c33-89be-431f-9048-8b9603b1e58f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66768/C49494"
"3269","Recovered or Resolved","C49498","RECOVERED/RESOLVED","[]","Recovered or Resolved","One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)","False","e3d834af-0c97-47c7-bc95-90ae7c120d0b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66768/C49498"
"3270","Recovered or Resolved with Sequelae","C49495","RECOVERED/RESOLVED WITH SEQUELAE","[]","Recovered or Resolved with Sequelae","One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)","False","b25f607f-39a6-4dfa-85ba-e7896c9d56fe","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66768/C49495"
"3271","Recovering or Resolving","C49496","RECOVERING/RESOLVING","[]","Recovering or Resolving","One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)","False","1f6a3a5d-9c33-49f5-9e0a-0d95d32caa8a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66768/C49496"
"3272","Unknown","C17998","UNKNOWN","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","a223d782-eac5-4df0-a76b-bddbcc21e0d2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66768/C17998"
"3273","Age Span","C66780","AGESPAN","['Age Span']","CDISC SDTM Age GroupTerminology","Subgroups of populations based on age. (NCI)","False","2f8e2acd-b7d2-4ad5-a7d2-b3344800aacb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780"
"3274","Adolescent","C27954","ADOLESCENT (12-17 YEARS)","[]","Adolescent","A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)","False","4597a399-b68e-4c99-bb82-60e4ec07c24d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C27954"
"3275","Adult 18-65 Years Old","C49685","ADULT (18-65)","[]","Adult 18-65 Years Old","A person from 18 years to 65 years of age. (NCI)","False","70467d68-e983-4d4e-a151-8408c0516047","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C49685"
"3276","Children 2-11 Years Old","C49683","CHILDREN (2-11 YEARS)","[]","Children 2-11 Years Old","A person from 2 years to 11 years of age. (NCI)","False","68b38355-2932-47a6-9221-bd277dccc71c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C49683"
"3277","Elderly","C16268","ELDERLY (> 65)","[]","Elderly","An age group comprised by people 65 years of age and older. (NCI) ","False","65ce14e1-3bc7-452e-a6de-b232c6774926","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C16268"
"3278","In Utero","C49641","IN UTERO","[]","In Utero","The period of time during which the embryo or foetus is present in the uterus of the female. Also describes the location of the embryo or foetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)","False","5e5fbf96-779d-461e-ae1f-2dda64989a0f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C49641"
"3279","Infant And Toddler","C49643","INFANT AND TODDLER (28 DAYS - 23 MONTHS)","[]","Infant And Toddler","A person from 28 days to 23 months of age. (NCI)","False","d1be3bdd-ab20-49a0-a1bf-d41772c8ee00","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C49643"
"3280","Newborn","C16731","NEWBORN (0-27 DAYS)","[]","Newborn","An infant during the first month after birth. (NCI)","False","bb1ce2e8-7d66-4483-a407-9825135af6d4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C16731"
"3281","Preterm Newborn Infant","C49642","PRETERM NEWBORN INFANTS","[]","Preterm Newborn Infant","An infant born prior to completion of the normal gestation period. (NCI)","False","a89faa00-228b-4ecb-887b-6ce2b3c3e527","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66780/C49642"
"3282","Age Unit","C66781","AGEU","['Age Unit']","CDISC SDTM Age UnitTerminology","Those units of time that are routinely used to express the age of a person. (NCI)","False","ff173780-4575-4293-aed6-e2f02ef9ae9c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66781"
"3283","Day","C25301","DAYS","[]","Day","The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day. (NCI)","False","d6740b0d-1efb-49fd-8f05-37e25c862bff","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66781/C25301"
"3284","Hour","C25529","HOURS","[]","Hour","A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)","False","5ac93d28-bd7c-4552-af01-aae4b47abcb9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66781/C25529"
"3285","Month","C29846","MONTHS","[]","Month","One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)","False","790f59f0-5faa-41ff-aa67-a089619c21bf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66781/C29846"
"3286","Week","C29844","WEEKS","[]","Week","Any period of seven consecutive days. (NCI)","False","477dc12c-5d50-4861-b807-f68622af6e06","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66781/C29844"
"3287","Year","C29848","YEARS","[]","Year","The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)","False","a2e0cb55-2a6f-4ff9-866f-817f68873d52","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66781/C29848"
"3288","Category for Inclusion/Exclusion","C66797","IECAT","['Category for Inclusion/Exclusion']","CDISC SDTM Category of Inclusion And Or ExclusionTerminology","A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)","False","0896495d-3a17-4deb-9b68-c343da7895a8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66797"
"3289","Exclusion","C25370","EXCLUSION","[]","Exclusion","List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)","False","76b61fcc-d59a-4998-8a2d-eea8f262a2e2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66797/C25370"
"3290","Inclusion","C25532","INCLUSION","[]","Inclusion","The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study.  NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)","False","d6108f0c-702e-4bc4-b6c9-35146dd2db4e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66797/C25532"
"3291","CDISC System Organ Class","C66783","SOC","['CDISC System Organ Class']","CDISC SDTM System Organ Class Terminology","Terms at the highest level of the CDISC system organ class terminology.","False","f3bc92f5-a244-4d09-9cc8-cda66ebfc1c5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783"
"3292","Hematopoietic and Lymphoid System Disorder","C35814","BLOOD AND LYMPHATIC SYSTEM DISORDERS","[]","Hematopoietic and Lymphoid System Disorder","Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","26f7088b-378e-4dbe-8fe4-d9130ef897fd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C35814"
"3293","Heart Disorder","C3079","CARDIAC DISORDERS","[]","Heart Disorder","Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","7b639f57-975e-49a8-8a4a-831c65c4fc03","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C3079"
"3294","Congenital, Familial and Genetic Disorder Class","C49399","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","[]","Congenital, Familial and Genetic Disorder Class","A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characterstic set of symptoms and signs. (NCI)","False","fa88c3fe-38e8-4c1f-8507-6c9ad402c57d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C49399"
"3295","Ear and Labyrinth Disorder Class","C49400","EAR AND LABYRINTH DISORDERS","[]","Ear and Labyrinth Disorder Class","Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)","False","0902acfd-5958-487d-9b58-3b5abfbcd2bb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C49400"
"3296","Endocrine Disorder","C3009","ENDOCRINE DISORDERS","[]","Endocrine Disorder","Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","22af50ca-1cc4-4d23-a96c-92059b462cd1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C3009"
"3297","Eye Disorder","C26767","EYE DISORDERS","[]","Eye Disorder","Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)","False","b68414d5-66a0-4bf5-a457-951ad5e1ba5d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C26767"
"3298","Gastrointestinal Disorder","C2990","GASTROINTESTINAL DISORDERS","[]","Gastrointestinal Disorder","Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)","False","dd4374c7-b6f5-41f8-b072-034a0b54609a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C2990"
"3299","General Disorders and Administration Site Conditions Class","C49401","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","[]","General Disorders and Administration Site Conditions Class","A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)","False","0aa125cb-bd02-43bb-9f63-7c62fe9c05f4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C49401"
"3300","Liver and Biliary Tract Disorder","C3959","HEPATOBILIARY DISORDERS","[]","Liver and Biliary Tract Disorder","Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)","False","2fe353b8-e37a-4fc8-8694-7183752c3214","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C3959"
"3301","Immune System Disorder","C3507","IMMUNE SYSTEM DISORDERS","[]","Immune System Disorder","A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)","False","5b0e7f80-d5f7-4760-a7db-08723a00f4d6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C3507"
"3302","Infectious Disorder","C26726","INFECTIONS AND INFESTATIONS","[]","Infectious Disorder","A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)","False","0fe2635d-0a8c-40e6-b8b7-7e4766dbb7a1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C26726"
"3303","Injury, Poisoning and Procedural Complication Class","C49402","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","[]","Injury, Poisoning and Procedural Complication Class","A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)","False","be57c018-ddc5-4ee5-aae0-c37ac411673a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C49402"
"3304","Investigation","C41198","INVESTIGATIONS","[]","Investigation","The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)","False","49d9ccf0-5976-4e97-bf4b-b4d9870f9fe4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C41198"
"3305","Metabolism and Nutrition Disorder Class","C49403","METABOLISM AND NUTRITION DISORDERS","[]","Metabolism and Nutrition Disorder Class","A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)","False","1dd0eb55-51b3-4b5f-bc58-a3dfd75d1eed","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C49403"
"3306","Connective and Soft Tissue Disorder","C27574","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","[]","Connective and Soft Tissue Disorder","Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)","False","26630efb-083b-44ed-be08-5a52aacdfce9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C27574"
"3307","Neoplasm","C3262","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","[]","Neoplasm","An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)","False","c3b0388a-512a-4fa7-87dd-65eb675b3b35","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C3262"
"3308","Nervous System Disorder","C26835","NERVOUS SYSTEM DISORDERS","[]","Nervous System Disorder","Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","b6e7cb1c-11d5-4c8f-88dd-cefe2817df0f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C26835"
"3309","Pregnancy, Puerperium and Perinatal Condition Class","C49404","PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS","[]","Pregnancy, Puerperium and Perinatal Condition Class","A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)","False","456d494b-ed42-453c-a459-7142790d291a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C49404"
"3310","Psychiatric Disorder","C2893","PSYCHIATRIC DISORDERS","[]","Psychiatric Disorder","Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)","False","46754676-5e7d-4534-83be-73a71818c55a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C2893"
"3311","Urinary System Disorder","C3430","RENAL AND URINARY DISORDERS","[]","Urinary System Disorder","Disorders of any part of the urologic system. (NCI)","False","c9e934db-9ca7-4663-b73d-e5c1813be119","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C3430"
"3312","Reproductive System and Breast Disorder Class","C49405","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","[]","Reproductive System and Breast Disorder Class","Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)","False","5149cce1-4430-434f-ac62-20c1d7237d46","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C49405"
"3313","Respiratory and Thoracic Disorder","C27669","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","[]","Respiratory and Thoracic Disorder","Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)","False","8d3cadde-8517-4c7d-bb8e-52a98a119912","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C27669"
"3314","Skin Disorder","C3371","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","[]","Skin Disorder","Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)","False","5c9782bc-6ce7-454d-b2f3-dbffafc00f9b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C3371"
"3315","Social Circumstances","C20188","SOCIAL CIRCUMSTANCES","[]","Social Circumstances","A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)","False","c73b2d5c-3a95-447b-a2ae-030c89254595","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C20188"
"3316","Procedure","C25218","SURGICAL AND MEDICAL PROCEDURES","[]","Procedure","A particular course of action intended to achieve a result. (NCI)","False","d5df5a91-f507-48bd-b0fc-f54ac78a9f6c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C25218"
"3317","Vascular Disorder","C35117","VASCULAR DISORDERS","[]","Vascular Disorder","Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","381b7e94-89cb-4560-b8d4-b3c65713f581","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66783/C35117"
"3318","Common Terminology Criteria for Adverse Events","C66784","TOXGR","['Common Terminology Criteria for Adverse Events']","CDISC SDTM CommonTerminology Criteria for Adverse Event Grade Terminology","A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)","False","78f0a13c-b6df-49e0-9ffc-06698da2b0e7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66784"
"3319","Mild Adverse Event","C41338","1","['Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","ff1fb55a-e7b2-4967-a562-db603af3f33e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66784/C41338"
"3320","Moderate Adverse Event","C41339","2","['Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","c2410efd-fc56-4742-a20e-a931f913f1ce","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66784/C41339"
"3321","Severe Adverse Event","C41340","3","['Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","b201ff20-92b5-4a35-b620-8196d3172b19","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66784/C41340"
"3322","Life Threatening or Disabling Adverse Event","C41337","4","['Grade 4', '4']","Life Threatening or Disabling Adverse Event","An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.","False","50812970-9a25-45aa-88c5-2eb42aa2071b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66784/C41337"
"3323","Death Related to Adverse Event","C48275","5","['Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","5a223ace-e6c3-4531-ae11-ae3cdc297a20","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66784/C48275"
"3324","Control Type","C66785","TCNTRL","['Control Type', 'Type of Control']","CDISC SDTM Control Type Terminology","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","defa87fe-a845-4ee9-bb4a-d80106235452","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66785"
"3325","Active Control","C49649","ACTIVE","[]","Active Control","A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].","False","bd2580c8-dac2-4a02-8aa5-122ff2891e75","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66785/C49649"
"3326","None","C41132","NONE","[]","None","No person or thing, nobody, not any. (NCI)","False","cfa1a285-8af4-4aa0-aab8-a9d896648371","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66785/C41132"
"3327","Placebo Control","C49648","PLACEBO","[]","Placebo Control","Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)","False","90472308-daea-4869-b8b9-82047fae7e9a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66785/C49648"
"3328","Country","C66786","COUNTRY","['Country']","CDISC SDTM Country Terminology","A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)","False","0855ba69-e12f-42bd-8b2d-f75f3bfc1a1f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786"
"3329","Aruba","C17884","ABW","['ARUBA']","Aruba","Island in the Caribbean Sea, north of Venezuela.","False","6388c0f6-9fcc-429d-a7ab-b8e1240f4bfa","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17884"
"3330","Afghanistan","C16267","AFG","['AFGHANISTAN']","Afghanistan","A country in Southern Asia, north and west of Pakistan, east of Iran.","False","0d99e6a5-fd3f-4739-b642-ccc31b4b7691","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16267"
"3331","Angola","C16292","AGO","['ANGOLA']","Angola","A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo.","False","1a562a63-bd9c-43c8-9c9c-ed03a9ac05e9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16292"
"3332","Anguilla","C20133","AIA","['ANGUILLA']","Anguilla","An island in the Caribbean Sea, east of Puerto Rico.","False","f677de99-1098-47e8-a4f9-69fb87d000e1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20133"
"3333","Aland Islands","C44481","ALA","['ALAND ISLANDS']","Aland Islands","An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland.","False","7a3a222e-a0b7-4b8c-ad71-e8af633167ab","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C44481"
"3334","Albania","C16271","ALB","['ALBANIA']","Albania","A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro.","False","3a2b6200-6483-49cc-9ff5-cf6db30ab2aa","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16271"
"3335","Andorra","C16289","AND","['ANDORRA']","Andorra","A country in Southwestern Europe, between France and Spain.","False","8c682556-0cc7-4477-b6c4-15897edd8146","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16289"
"3336","Netherlands Antilles","C16904","ANT","['NETHERLANDS ANTILLES']","Netherlands Antilles","A country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands.","False","3bc8d6f2-2ff6-4c8d-ab24-d9bde007d3c3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16904"
"3337","United Arab Emirates","C17232","ARE","['UNITED ARAB EMIRATES']","United Arab Emirates","A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia.","False","5ce00661-6975-410c-bc5c-265a8206e4c0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17232"
"3338","Argentina","C16305","ARG","['ARGENTINA']","Argentina","A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.","False","031542fd-7ea4-43fe-bf33-5956e3b82e7e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16305"
"3339","Armenia","C16306","ARM","['ARMENIA']","Armenia","A country in Southwestern Asia, east of Turkey.","False","14d62a05-abab-4e12-98e4-b558ae0f3387","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16306"
"3340","American Samoa","C17739","ASM","['AMERICAN SAMOA']","American Samoa","A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand.","False","6503fbd6-ebd3-486b-a75c-45e3fa567a61","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17739"
"3341","Antarctica","C18007","ATA","['ANTARCTICA']","Antarctica","The continent lying mostly south of the Antarctic Circle.","False","73cf5541-3ff7-44c9-866c-d19c22778068","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C18007"
"3342","French Southern Territories","C20105","ATF","['FRENCH SOUTHERN TERRITORIES']","French Southern Territories","Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia.","False","11d0864a-4481-45d0-9648-829e48e95f30","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20105"
"3343","Antigua and Barbuda","C16303","ATG","['ANTIGUA AND BARBUDA']","Antigua and Barbuda","Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico.","False","c9ef4f24-c9f9-4b8d-b695-3e4fab4afb12","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16303"
"3344","Australia","C16311","AUS","['AUSTRALIA']","Australia","The continent between the Indian Ocean and the South Pacific Ocean.","False","ab866fcd-3262-407f-a6c3-9962d294746e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16311"
"3345","Austria","C16312","AUT","['AUSTRIA']","Austria","A country in Central Europe, north of Italy and Slovenia.","False","43ee5e58-d56f-413b-80a7-5e6493dedfef","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16312"
"3346","Azerbaijan","C16316","AZE","['AZERBAIJAN']","Azerbaijan","A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia.","False","02d08b3d-4e32-4d0b-a6af-d425aef11217","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16316"
"3347","Burundi","C16371","BDI","['BURUNDI']","Burundi","A country in Central Africa, east of Democratic Republic of the Congo.","False","7928745e-4ecd-4621-8d15-ef1d5a6c4962","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16371"
"3348","Belgium","C16329","BEL","['BELGIUM']","Belgium","A country in Western Europe, bordering the North Sea, between France and the Netherlands.","False","1296e519-2e92-400d-aeab-93d7ce066c36","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16329"
"3349","Benin Republic","C16333","BEN","['BENIN REPUBLIC']","Benin Republic","A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo.","False","cd2fe06c-f94b-4082-a2da-2434651a4e7f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16333"
"3350","Burkina Faso","C16369","BFA","['BURKINA FASO']","Burkina Faso","A country in Western Africa, north of Ghana.","False","4298f64c-1019-4ba9-a274-ca79813980b8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16369"
"3351","Bangladesh","C16323","BGD","['BANGLADESH']","Bangladesh","A country in Southern Asia, bordering the Bay of Bengal, between Burma and India.","False","10f3580d-a896-4112-ad10-83536f60c995","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16323"
"3352","Bulgaria","C16368","BGR","['BULGARIA']","Bulgaria","A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey.","False","905f677f-c754-4fac-a4ec-9b4ce34a2aa0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16368"
"3353","Bahrain","C16322","BHR","['BAHRAIN']","Bahrain","An archipelago in the Persian Gulf, east of Saudi Arabia.","False","d8f89566-2eb2-4d1b-b908-04dcff58f6e6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16322"
"3354","Bahamas","C16321","BHS","['BAHAMAS']","Bahamas","A chain of islands in the North Atlantic Ocean, southeast of Florida.","False","8272d566-c6dd-4f33-916c-407c04586f2f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16321"
"3355","Bosnia-Herzegovina","C16361","BIH","['BOSNIA-HERZEGOVINA']","Bosnia-Herzegovina","A country in Southeastern Europe, bordering the Adriatic Sea and Croatia.","False","5e191467-c983-46b3-97b0-c4ee7e14a1e6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16361"
"3356","Belarus","C16372","BLR","['BELARUS']","Belarus","A country in Eastern Europe, east of Poland.","False","2d9993a0-8dfe-4b13-a903-e359fbdd1ba4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16372"
"3357","Belize","C16331","BLZ","['BELIZE']","Belize","A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico.","False","c7f37df3-c03c-4d29-8c3f-8c43a46a9c3c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16331"
"3358","Bermuda","C16334","BMU","['BERMUDA']","Bermuda","No Definition","False","1a01d16d-a156-4907-8046-8a35a28e8c01","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16334"
"3359","Bolivia","C16359","BOL","['BOLIVIA']","Bolivia","A country in Central South America, southwest of Brazil.","False","3f02ee94-6754-43ad-b555-43638abcbe53","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16359"
"3360","Brazil","C16364","BRA","['BRAZIL']","Brazil","A country in Eastern South America, bordering the Atlantic Ocean.","False","b4019a9f-fb82-4262-93c9-2ccc01784955","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16364"
"3361","Barbados","C16324","BRB","['BARBADOS']","Barbados","An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","a7d58763-071b-4659-befc-60efb6cd635e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16324"
"3362","Brunei Darussalam","C16367","BRN","['BRUNEI']","Brunei Darussalam","A country in Southeastern Asia, bordering the South China Sea and Malaysia.","False","011f8b59-dae6-40bd-99f0-58044ec3ceeb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16367"
"3363","Bhutan","C16336","BTN","['BHUTAN']","Bhutan","A country in Southern Asia, between China and India.","False","945369ad-9b50-41f7-8a7a-b4ec8abd3f85","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16336"
"3364","Bouvet Island","C20104","BVT","['BOUVET ISLAND']","Bouvet Island","An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa).","False","bc2d8e20-3bf5-4c22-aa8f-94154391c825","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20104"
"3365","Botswana","C16363","BWA","['BOTSWANA']","Botswana","A country in Southern Africa, north of South Africa.","False","72bd76ec-a0ce-4fc2-abdf-794226a55803","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16363"
"3366","Central African Republic","C16409","CAF","['CENTRAL AFRICAN REPUBLIC']","Central African Republic","A country in Central Africa, north of Democratic Republic of the Congo.","False","205d29e6-35dd-44ca-abfc-a3f9cbe0dc86","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16409"
"3367","Canada","C16380","CAN","['CANADA']","Canada","A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US.","False","f4d4abb2-6a6c-4d98-ae8f-ed8e6bda38d0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16380"
"3368","Cocos (Keeling) Islands","C16445","CCK","['COCOS (KEELING) ISLANDS']","Cocos (Keeling) Islands","A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka.","False","ef881f74-46fb-4958-9daa-827338d756af","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16445"
"3369","Switzerland","C17181","CHE","['SWITZERLAND']","Switzerland","A country in Central Europe, east of France, north of Italy.","False","84380ea0-b388-4eb3-8a52-21a8ef7e19d8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17181"
"3370","Chile","C16427","CHL","['CHILE']","Chile","A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru.","False","670160cf-e0b8-4e85-a404-3076bc9a0003","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16427"
"3371","China","C16428","CHN","['CHINA']","China","A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam.","False","bd5c90ac-945d-4fcc-a4fe-e64ac1519804","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16428"
"3372","Cote d'Ivoire","C16762","CIV","[""COTE D'IVOIRE""]","Cote d'Ivoire","A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia.","False","e8239199-ccdc-4f43-9c37-395ad2b8f4bc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16762"
"3373","Cameroon","C16379","CMR","['CAMEROON']","Cameroon","A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria.","False","7ff16f10-efa8-4556-9f60-21da08bfc3e1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16379"
"3374","Democratic Republic of the Congo","C17266","COD","['DEMOCRATIC REPUBLIC OF THE CONGO']","Democratic Republic of the Congo","A country in Central Africa, northeast of Angola.","False","7bb18ff2-32c8-4e6c-a03a-50ae4ebc77d1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17266"
"3375","Congo","C16467","COG","['CONGO']","Congo","A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon.","False","d9581804-4755-477e-bd56-194827ca8e8b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16467"
"3376","Cook Islands","C16469","COK","['COOK ISLANDS']","Cook Islands","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","4154a625-0b99-49c0-a440-e7d9d4448eb7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16469"
"3377","Colombia","C16449","COL","['COLOMBIA']","Colombia","A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama.","False","bf7b3c68-6642-445d-9363-39e606245f34","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16449"
"3378","Comoros","C16458","COM","['COMOROS']","Comoros","A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique.","False","42440fc1-4a45-4cdc-9b92-bc10e5299030","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16458"
"3379","Cape Verde","C16382","CPV","['CAPE VERDE']","Cape Verde","A group of islands in the North Atlantic Ocean, west of Senegal.","False","269f3cad-4af7-45e8-94f2-00ba492af251","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16382"
"3380","Costa Rica","C16470","CRI","['COSTA RICA']","Costa Rica","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama.","False","46f5f286-4527-4d79-8ec2-59fcc9aa6613","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16470"
"3381","Cuba","C16477","CUB","['CUBA']","Cuba","An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida.","False","43d33339-aa10-42e8-b146-b4a171d06f40","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16477"
"3382","Christmas Island","C44482","CXR","['CHRISTMAS ISLAND']","Christmas Island","An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia.","False","9ac6dd8d-efb2-4299-a78f-e0f5f7ede7fd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C44482"
"3383","Cayman Islands","C16391","CYM","['CAYMAN ISLANDS']","Cayman Islands","An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras.","False","db0b3497-c48e-42f1-94df-2e4fc20dc9ba","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16391"
"3384","Cyprus","C16480","CYP","['CYPRUS']","Cyprus","An island in the Mediterranean Sea, south of Turkey.","False","92a5da4c-9450-488e-8a1f-2edb4985ea4e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16480"
"3385","Czech Republic","C17668","CZE","['CZECH REPUBLIC']","Czech Republic","A country in Central Europe, southeast of Germany.","False","642d1030-faf3-4333-acc3-d7ff94b90da3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17668"
"3386","Germany","C16636","DEU","['GERMANY']","Germany","A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark.","False","0fbfc27f-9eab-4bc6-8b36-de1367240377","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16636"
"3387","Djibouti","C16506","DJI","['DJIBOUTI']","Djibouti","A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia.","False","1dc61055-c854-4114-92bb-7934a9257494","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16506"
"3388","Dominica","C16519","DMA","['DOMINICA']","Dominica","An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago.","False","0caf52ef-815b-41c9-8bda-ef82d1c52b5e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16519"
"3389","Denmark","C16496","DNK","['DENMARK']","Denmark","A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn).","False","77de4be2-c6c1-40fb-84d8-184a40f3bc32","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16496"
"3390","Dominican Republic","C16520","DOM","['DOMINICAN REPUBLIC']","Dominican Republic","A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti.","False","e83dea36-b142-4711-8a4d-a2e6cc2eb30f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16520"
"3391","Algeria","C16274","DZA","['ALGERIA']","Algeria","A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia.","False","7f878b23-e17b-4963-9e95-7ad216e8552b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16274"
"3392","Ecuador","C16528","ECU","['ECUADOR']","Ecuador","A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.","False","4d2188e6-4cc7-4fa1-a30e-1c69fccd6029","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16528"
"3393","Egypt","C16530","EGY","['EGYPT']","Egypt","A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip.","False","50c1a154-cee4-4b7e-880e-aa41523cb489","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16530"
"3394","Eritrea","C16558","ERI","['ERITREA']","Eritrea","A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan.","False","68e93fed-d685-4a36-bfa7-68263595d291","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16558"
"3395","Western Sahara","C20113","ESH","['WESTERN SAHARA']","Western Sahara","A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.","False","51f9716c-7add-499a-bdda-aa41f2c1be7c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20113"
"3396","Spain","C17152","ESP","['SPAIN']","Spain","A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France.","False","9a218216-b7ca-44e7-abf6-5a80f81b91f2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17152"
"3397","Estonia","C16562","EST","['ESTONIA']","Estonia","A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia.","False","033e90c7-730b-4da2-87be-e02cf625636f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16562"
"3398","Ethiopia","C16563","ETH","['ETHIOPIA']","Ethiopia","A country in Eastern Africa, west of Somalia.","False","277cba23-67f2-41a1-b0ac-02964820c93b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16563"
"3399","Finland","C16584","FIN","['FINLAND']","Finland","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia.","False","226c6cee-65b1-4a94-86ee-6d40338cac5e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16584"
"3400","Fiji","C16582","FJI","['FIJI']","Fiji","An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","364b6e27-9f16-4480-9c39-8b556a0693a6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16582"
"3401","Falkland Islands","C17954","FLK","['FALKLAND ISLANDS']","Falkland Islands","Islands in the South Atlantic Ocean, east of southern Argentina.","False","dd318f2d-e6da-4fd5-8d7b-3c5947b79fbb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17954"
"3402","France","C16592","FRA","['FRANCE']","France","A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain.","False","dd296a70-131d-43a4-a97c-bb035de08f1c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16592"
"3403","Faroe Islands","C16573","FRO","['FAROE ISLANDS']","Faroe Islands","An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway.","False","2e0157a8-f309-47c3-a21d-28b1c106d9f6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16573"
"3404","Federated States of Micronesia","C17881","FSM","['MICRONESIA, FEDERATED STATES OF']","Federated States of Micronesia","An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia.","False","ff08dc18-29e7-452c-bfbd-d836ebad0f0c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17881"
"3405","Gabon","C16596","GAB","['GABON']","Gabon","A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea.","False","b03cc4d7-ab85-4212-9092-96d98d87bad1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16596"
"3406","United Kingdom","C17233","GBR","['UNITED KINGDOM']","United Kingdom","A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France.","False","9104a841-7a8a-4908-8939-050a8f306adf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17233"
"3407","Georgia","C16634","GEO","['GEORGIA']","Georgia","A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia.","False","6b294bba-ee1d-446c-bc04-6b6b41cf9d2f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16634"
"3408","Guernsey","C64375","GGY","['GUERNSEY']","Guernsey","The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK.","False","0f95163d-433b-483b-9c5f-ad449d7ab907","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C64375"
"3409","Ghana","C26330","GHA","['GHANA']","Ghana","A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo.","False","a53e8e4d-2d6f-4dde-b510-f683fa68cbeb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C26330"
"3410","Gibraltar","C16638","GIB","['GIBRALTAR']","Gibraltar","A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain.","False","531fd28f-e90e-42ec-ab04-6c3527c5e2f3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16638"
"3411","Guinea","C16655","GIN","['GUINEA']","Guinea","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone.","False","297caa64-3af6-4a62-964b-6170d8761cba","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16655"
"3412","Guadeloupe","C16651","GLP","['GUADELOUPE']","Guadeloupe","Islands in the eastern Caribbean Sea, southeast of Puerto Rico.","False","2d5af142-e25d-47ba-8363-09fc7645fa73","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16651"
"3413","Gambia","C16598","GMB","['GAMBIA']","Gambia","A country in Western Africa, bordering the North Atlantic Ocean and Senegal.","False","88e0232f-331f-4858-b2b4-34237d885c59","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16598"
"3414","Guinea-Bissau","C16656","GNB","['GUINEA-BISSAU']","Guinea-Bissau","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal.","False","a9160f33-6124-4de9-97a0-c50f5cd435ec","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16656"
"3415","Equatorial Guinea","C16557","GNQ","['EQUATORIAL GUINEA']","Equatorial Guinea","A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands.","False","b213c25f-a859-4481-9684-f904b70907f5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16557"
"3416","Greece","C16645","GRC","['GREECE']","Greece","A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey.","False","542b32e8-f224-4c3b-94f9-8da8a44629f9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16645"
"3417","Grenada","C16647","GRD","['GRENADA']","Grenada","An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago.","False","1e1f98c1-c854-484e-91ea-f21ff586536a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16647"
"3418","Greenland","C16646","GRL","['GREENLAND']","Greenland","An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.","False","0f26ceb0-a724-4523-b909-5101960bef54","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16646"
"3419","Guatemala","C16654","GTM","['GUATEMALA']","Guatemala","A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico.","False","7eb1f106-6943-41aa-93cd-6f0c85a0e480","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16654"
"3420","French Guiana","C16593","GUF","['FRENCH GUIANA']","French Guiana","A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname.","False","02c4b513-3f98-493d-ac1c-f35219931f70","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16593"
"3421","Guam","C16652","GUM","['GUAM']","Guam","Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","c52f6d5e-3eeb-4016-a16b-c555152e6b0c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16652"
"3422","Guyana","C16657","GUY","['GUYANA']","Guyana","A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.","False","066bc8f3-e0d5-4b26-8e19-758568c7b662","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16657"
"3423","Hong Kong","C16695","HKG","['HKG', 'HONG KONG']","Hong Kong","A special administrative region of China, bordering the South China Sea and China.","False","d9f19e50-3c86-486d-a471-22812a984cb8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16695"
"3424","Heard Island and McDonald Islands","C20106","HMD","['HEARD ISLAND AND MCDONALD ISLANDS']","Heard Island and McDonald Islands","Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica.","False","8a0b8b1e-b5bd-4f4d-87ca-973669d0b4bc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20106"
"3425","Honduras","C16694","HND","['HONDURAS']","Honduras","A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua.","False","dff6ce28-c895-424f-8ede-f4842459a1c6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16694"
"3426","Croatia","C16474","HRV","['CROATIA']","Croatia","A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia.","False","0c2b8df3-a672-45db-9ed8-a53561cbe24a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16474"
"3427","Haiti","C16660","HTI","['HAITI']","Haiti","A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic.","False","32234878-d6e9-4046-b562-00b49964e387","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16660"
"3428","Hungary","C16699","HUN","['HUNGARY']","Hungary","A country in Central Europe, northwest of Romania.","False","29e5ba15-0441-4b24-9755-3922e1253c41","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16699"
"3429","Indonesia","C16728","IDN","['INDONESIA']","Indonesia","A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean.","False","53249f57-d506-406d-902b-54190c67564b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16728"
"3430","India","C16727","IND","['INDIA']","India","A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.","False","69fa2e2e-8494-42cf-892c-9641d77282fb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16727"
"3431","British Indian Ocean Territory","C16365","IOT","['BRITISH INDIAN OCEAN TERRITORY']","British Indian Ocean Territory","An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia.","False","bd5ddb28-45a9-4c75-b6b0-1af2b64f97fb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16365"
"3432","Ireland","C16757","IRL","['IRELAND']","Ireland","A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain.","False","c4bc7b5f-bf0e-415f-9ddb-733c504faab3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16757"
"3433","Iran","C16755","IRN","['IRAN']","Iran","A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.","False","5e757c4d-09c0-41ac-a487-6df24321f437","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16755"
"3434","Iraq","C16756","IRQ","['IRAQ']","Iraq","A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait.","False","45bc1240-887c-44f7-b613-304bfd5cfdbd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16756"
"3435","Iceland","C16704","ISL","['ICELAND']","Iceland","A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK.","False","b39e271c-b38d-47b1-b9b5-bc8e14af283e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16704"
"3436","Israel","C16760","ISR","['ISRAEL']","Israel","A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon.","False","2fdf2407-7ba5-41fa-8f24-7948d8e33c99","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16760"
"3437","Italy","C16761","ITA","['ITALY']","Italy","A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.","False","3e27c5c9-57a1-41c4-9168-5059f86e25d9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16761"
"3438","Jamaica","C16763","JAM","['JAMAICA']","Jamaica","An island in the Caribbean Sea, south of Cuba.","False","65510361-874e-43e7-a292-4b7339e89fe3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16763"
"3439","Jordan","C16765","JOR","['JORDAN']","Jordan","A country in the Middle East, northwest of Saudi Arabia.","False","5edc7c5e-92f6-49cb-a065-e8d567f66f0d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16765"
"3440","Japan","C16764","JPN","['JAPAN']","Japan","A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula.","False","ef788f2b-9511-4fbd-9082-73ec6f22da5c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16764"
"3441","Jersey","C64374","JRE","['JERSEY']","Jersey","Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK.","False","7dd0fd92-bb3b-405e-8a88-5635f8a8520c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C64374"
"3442","Kazakhstan","C20107","KAZ","['KAZAKHSTAN']","Kazakhstan","A country in Central Asia, northwest of China.","False","dc9fba5a-a4d8-4364-b9f5-40a1763c1ce3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20107"
"3443","Kenya","C16769","KEN","['KENYA']","Kenya","A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania.","False","ecaea023-ffca-4d4a-ab8c-7776be969195","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16769"
"3444","Kyrgyzstan","C16771","KGZ","['KYRGYZSTAN']","Kyrgyzstan","A country in Central Asia, west of China.","False","67a94d5e-6b94-49ff-83fd-369c181c3b91","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16771"
"3445","Cambodia","C16378","KHM","['CAMBODIA']","Cambodia","A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos.","False","81b3036d-3f2f-4ec2-bc41-42654b0f80b6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16378"
"3446","Kiribati","C16639","KIR","['KIRIBATI']","Kiribati","A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia.","False","07e8ab42-338d-4b6c-9526-bf6c5e1914d5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16639"
"3447","Saint Kitts and Nevis","C17885","KNA","['SAINT KITTS AND NEVIS']","Saint Kitts and Nevis","Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago.","False","bd44f6c2-93f7-44cf-8fd5-e902d35321ac","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17885"
"3448","South Korea","C16774","KOR","['SOUTH KOREA']","South Korea","A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea.","False","3209e3e4-b676-4b95-b058-d166cbdbfe30","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16774"
"3449","Kuwait","C16775","KWT","['KUWAIT']","Kuwait","A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia.","False","6be23da3-83a4-46cd-8bfb-350a0f9da033","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16775"
"3450","Lao People's Democratic Republic","C16780","LAO","[""LAO PEOPLE'S DEMOCRATIC REPUBLIC""]","Lao People's Democratic Republic","A country in Southeastern Asia, northeast of Thailand, west of Vietnam.","False","456847ac-868a-4add-8714-efe404b89ab4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16780"
"3451","Lebanon","C16784","LBN","['LEBANON']","Lebanon","A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria.","False","fccc800e-b545-4c08-9b90-f8504eb0055b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16784"
"3452","Liberia","C16791","LBR","['LIBERIA']","Liberia","A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone.","False","affb9bb1-0f82-4ee4-8e2f-c7f5d1d98187","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16791"
"3453","Libyan Arab Jamahiriya","C16793","LBY","['LIBYAN ARAB JAMAHIRIYA']","Libyan Arab Jamahiriya","A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia.","False","7f28736a-054d-4ac8-abeb-1ddbb8b8dbf4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16793"
"3454","Saint Lucia","C17113","LCA","['SAINT LUCIA']","Saint Lucia","A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago.","False","6e8035ae-9c9f-4aa5-8bf4-c4ae61a790d2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17113"
"3455","Liechtenstein","C16794","LIE","['LIECHTENSTEIN']","Liechtenstein","A country in Central Europe, between Austria and Switzerland.","False","91339259-8286-4006-9984-9b6532f178a6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16794"
"3456","Sri Lanka","C17163","LKA","['SRI LANKA']","Sri Lanka","A country in Southern Asia, occupying an island in the Indian Ocean, south of India.","False","e2dcad92-eba4-4a1c-923c-8c06b061a493","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17163"
"3457","Lesotho","C16787","LSO","['LESOTHO']","Lesotho","A country in Southern Africa, an enclave of South Africa.","False","3a02dfd1-fbba-4175-a05e-c405c1cc39bb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16787"
"3458","Lithuania","C16799","LTU","['LITHUANIA']","Lithuania","A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia.","False","26453b09-3472-4e4d-81f0-db980731183c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16799"
"3459","Luxembourg","C16803","LUX","['LUXEMBOURG']","Luxembourg","A country in Western Europe, between France, Belgium, and Germany.","False","0f0b6ffc-7d78-4c66-8654-cfe73a167ee4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16803"
"3460","Latvia","C16783","LVA","['LATVIA']","Latvia","A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania.","False","cb66f851-7a32-42e9-b066-b4bf29176a57","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16783"
"3461","Macao","C16807","MAC","['MACAO']","Macao","A country in Eastern Asia, bordering the South China Sea and China.","False","ede0bbad-c11e-4356-a34d-7755d5f58a2a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16807"
"3462","Morocco","C16878","MAR","['MOROCCO']","Morocco","A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara.","False","203780f8-ef87-434b-8818-aeb5087c57f7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16878"
"3463","Monaco","C16874","MCO","['MONACO']","Monaco","A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.","False","84d8c986-a677-43ac-beb8-8b4acdaff9dc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16874"
"3464","Moldova","C16871","MDA","['MOLDOVA, REPUBLIC OF']","Moldova","A country in Eastern Europe, northeast of Romania.","False","a8180154-9ed7-4f68-8f2d-236729368d51","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16871"
"3465","Madagascar","C16808","MDG","['MADAGASCAR']","Madagascar","A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique.","False","e2397b98-2cb1-4916-a6fe-39ee10e0090d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16808"
"3466","Maldives","C16815","MDV","['MALDIVES']","Maldives","A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India.","False","0d9ccf7e-3d78-4af0-b3a2-6358852c9a69","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16815"
"3467","Mexico","C16850","MEX","['MEXICO']","Mexico","A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US.","False","04ffa0a3-52d1-4975-817e-61036c30832a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16850"
"3468","Marshall Islands","C16822","MHL","['MARSHALL ISLANDS']","Marshall Islands","A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","ce5e1949-f3d5-4e4f-a381-e6706e2b3259","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16822"
"3469","Republic of Macedonia","C17654","MKD","['REPUBLIC OF MACEDONIA']","Republic of Macedonia","A country in Southeastern Europe, north of Greece.","False","902fb0ec-aacd-4769-88e3-724828856619","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17654"
"3470","Mali","C16816","MLI","['MALI']","Mali","A country in Western Africa, southwest of Algeria.","False","96a512f6-fedc-4312-951a-040edb87f6b5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16816"
"3471","Malta","C16817","MLT","['MALTA']","Malta","A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy).","False","f83f4417-ee33-404d-b0eb-e8949b694c2e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16817"
"3472","Myanmar","C16370","MMR","['MYANMAR']","Myanmar","A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand.","False","27387ce5-520b-444d-9b33-a2545af495be","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16370"
"3473","Montenegro","C64378","MNE","['MONTENEGRO']","Montenegro","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","e6fc62c5-8aff-4388-9d90-d9944b0938c9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C64378"
"3474","Mongolia","C16875","MNG","['MONGOLIA']","Mongolia","A country in Northern Asia, between China and Russia.","False","991d8319-c97b-4617-8deb-d42202831d77","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16875"
"3475","Northern Mariana Islands","C17882","MNP","['NORTHERN MARIANA ISLANDS']","Northern Mariana Islands","A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","bad7b116-1047-49cb-8d21-c0a9636ba8b3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17882"
"3476","Mozambique","C16882","MOZ","['MOZAMBIQUE']","Mozambique","A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania.","False","dc100c99-b8db-4eba-ae6a-c54d218e751b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16882"
"3477","Mauritania","C16826","MRT","['MAURITANIA']","Mauritania","A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara.","False","59662f74-5cfc-42ae-91c2-06b84b0e4518","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16826"
"3478","Montserrat","C16876","MSR","['MONTSERRAT']","Montserrat","A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico.","False","27d5f8ef-1c5e-4117-8a24-2fc22fbf81fb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16876"
"3479","Martinique","C16823","MTQ","['MARTINIQUE']","Martinique","An island in the Caribbean Sea, north of Trinidad and Tobago.","False","b2d9fd79-42fa-4112-9331-0eedc6c1510d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16823"
"3480","Mauritius","C16827","MUS","['MAURITIUS']","Mauritius","A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","9751a3bd-ebdb-4eb4-b0c2-1f6ce176ad9e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16827"
"3481","Malawi","C16813","MWI","['MALAWI']","Malawi","A country in Southern Africa, east of Zambia.","False","740c0138-aa62-4af0-a8de-a941c413a685","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16813"
"3482","Malaysia","C16814","MYS","['MALAYSIA']","Malaysia","A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam.","False","293ee824-21c0-478c-a2cc-1a70ff0b1897","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16814"
"3483","Mayotte","C16828","MYT","['MAYOTTE']","Mayotte","A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique.","False","f2e0459c-9a96-4831-ac43-521ceb185ca8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16828"
"3484","Namibia","C16891","NAM","['NAMIBIA']","Namibia","A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa.","False","29951e30-a215-4770-827e-26d2ab6a02e0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16891"
"3485","New Caledonia","C16913","NCL","['NEW CALEDONIA']","New Caledonia","A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia.","False","d469678b-7455-407f-be72-0139949b66c2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16913"
"3486","Niger","C16916","NER","['NIGER']","Niger","A country in Western Africa, southeast of Algeria.","False","9c2cb236-d0af-4fcb-b507-41c028cca96f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16916"
"3487","Norfolk Island","C16919","NFK","['NORFOLK ISLAND']","Norfolk Island","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia.","False","b9d0213a-e561-46f3-a312-e715672f14d7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16919"
"3488","Nigeria","C16917","NGA","['NIGERIA']","Nigeria","A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon.","False","c1c431ff-66e5-4ea1-8b05-92a902a02320","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16917"
"3489","Nicaragua","C16915","NIC","['NICARAGUA']","Nicaragua","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras.","False","23642ce5-cc92-45f1-a324-1bdd88173549","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16915"
"3490","Niue","C16918","NIU","['NIUE']","Niue","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga.","False","873fbdbc-bb22-4b59-9d72-bc440edea57e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16918"
"3491","Netherlands","C16903","NLD","['NETHERLANDS']","Netherlands","A country in Western Europe, bordering the North Sea, between Belgium and Germany.","False","eccae4ec-4cea-42ea-b906-32ec1d85ec85","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16903"
"3492","Norway","C16920","NOR","['NORWAY']","Norway","A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden.","False","e78d21e3-1cc8-4cb1-8413-ee2921a2f22c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16920"
"3493","Nepal","C16901","NPL","['NEPAL']","Nepal","A country in Southern Asia, between China and India.","False","0c3f4232-7ccb-4047-b22c-a83b08429eb1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16901"
"3494","Nauru","C16896","NRU","['NAURU']","Nauru","A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands.","False","7d263257-3ed4-4ec5-90f6-763482d780ab","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16896"
"3495","New Zealand","C16914","NZL","['NEW ZEALAND']","New Zealand","A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia.","False","16e43d5e-bb27-4625-a689-17e41924eeb6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16914"
"3496","Oman","C16933","OMN","['OMAN']","Oman","A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates.","False","3ca45d8c-9ddd-4514-8c97-382c1a4f4af2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16933"
"3497","Pakistan","C16949","PAK","['PAKISTAN']","Pakistan","A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north.","False","4ee49556-f5b6-41f0-bd63-186631e7c58e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16949"
"3498","Panama","C16951","PAN","['PANAMA']","Panama","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica.","False","ccf46be4-e063-49f4-9b30-995923ca8e5f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16951"
"3499","Pitcairn Island","C16993","PCN","['PITCAIRN']","Pitcairn Island","A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.","False","c65056dd-8927-445b-923e-d23f971d6d49","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16993"
"3500","Peru","C16972","PER","['PERU']","Peru","A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador.","False","ae8ae473-9b61-4799-b991-a67402ea990e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16972"
"3501","Philippines","C16978","PHL","['PHILIPPINES']","Philippines","A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam.","False","f433aacb-e1b2-47ba-8335-ca4814136285","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16978"
"3502","Palau","C17733","PLW","['PALAU']","Palau","A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines.","False","fa7a6443-7c53-42dd-b2bd-770ebfba58cc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17733"
"3503","Papua New Guinea","C16952","PNG","['PAPUA NEW GUINEA']","Papua New Guinea","A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia.","False","fcdba004-9602-4b2f-b227-f5e095d19e63","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16952"
"3504","Poland","C17002","POL","['POLAND']","Poland","A country in Central Europe, east of Germany.","False","3a69f205-0f87-4d62-aab7-54ffc1ab62d6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17002"
"3505","Puerto Rico","C17043","PRI","['PUERTO RICO']","Puerto Rico","An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic.","False","682e45bc-73bf-4b2a-a765-0ccd65a00387","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17043"
"3506","North Korea","C16773","PRK","['NORTH KOREA']","North Korea","A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea.","False","4ebe64bd-8bf5-439a-9472-4ec20b947e75","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16773"
"3507","Portugal","C17006","PRT","['PORTUGAL']","Portugal","A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain.","False","7277382b-eb5c-4391-aeb6-05c1b70566e7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17006"
"3508","Paraguay","C16953","PRY","['PARAGUAY']","Paraguay","A country in Central South America, northeast of Argentina.","False","4b2894ee-b04f-4df1-b004-89f333733a07","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16953"
"3509","Palestinian Territory, Occupied","C20110","PSE","['PALESTINIAN TERRITORY, OCCUPIED']","Palestinian Territory, Occupied","A collective name for the West Bank and the Gaza Strip, two territories in Palestine.","False","23add507-45d1-4c48-b15d-624a3a253eef","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20110"
"3510","French Polynesia","C16594","PYF","['FRENCH POLYNESIA']","French Polynesia","An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia.","False","2b99796f-f5e0-4eb7-b8cb-0b81866ac524","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16594"
"3511","Qatar","C17045","QAT","['QATAR']","Qatar","A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia.","False","8739f9d3-95dd-4ec2-911d-c4a6c6820d88","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17045"
"3512","Reunion","C17095","REU","['REUNION']","Reunion","An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","1a9886a2-7956-416d-9ed4-5b6a4d3beddb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17095"
"3513","Romania","C17108","ROU","['ROMANIA']","Romania","A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine.","False","6e7de4e8-3c03-4eeb-aabb-ac1accbb74eb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17108"
"3514","Russia","C17111","RUS","['RUSSIAN FEDERATION']","Russia","A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean.","False","1b3925e2-5fc5-4e3c-a270-3b116956d411","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17111"
"3515","Rwanda","C17112","RWA","['RWANDA']","Rwanda","A country in Central Africa, east of Democratic Republic of the Congo.","False","9c24f0a3-623f-40f4-8186-fd7c24ac8d59","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17112"
"3516","Saudi Arabia","C17117","SAU","['SAUDI ARABIA']","Saudi Arabia","A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen.","False","9ef333fc-a4b2-40e3-91c0-7ecef6119981","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17117"
"3517","Serbia","C64377","SCG","['SERBIA']","Serbia","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","3c070f7b-f3a3-4f22-b29b-e9c6b10a73bd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C64377"
"3518","Sudan","C17170","SDN","['SUDAN']","Sudan","A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea.","False","4c2d38b1-0b32-4c00-ac25-71101041084e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17170"
"3519","Senegal","C17121","SEN","['SENEGAL']","Senegal","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania.","False","4db87a53-3fcf-4ef5-a208-0bc3cd27b837","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17121"
"3520","Singapore","C17134","SGP","['SINGAPORE']","Singapore","A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia.","False","5afeb293-ca41-466f-8a8c-5b420afdc7fc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17134"
"3521","South Georgia and the South Sandwich Islands","C20111","SGS","['SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS']","South Georgia and the South Sandwich Islands","A group of islands in the South Atlantic Ocean, east of the tip of South America.","False","5255a47c-4224-49bd-8094-be816b535318","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20111"
"3522","Saint Helena","C17164","SHN","['SAINT HELENA']","Saint Helena","Islands in the South Atlantic Ocean, about midway between South America and Africa.","False","44c71661-fcd6-46d5-956e-12bfc70f9ca8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17164"
"3523","Svalbard and Jan Mayen","C17178","SJM","['SVALBARD AND JAN MAYEN']","Svalbard and Jan Mayen","Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway.","False","03714e3e-923e-4876-934b-a0ff6bde190b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17178"
"3524","Solomon Islands","C17148","SLB","['SOLOMON ISLANDS']","Solomon Islands","A group of islands in the South Pacific Ocean, east of Papua New Guinea.","False","2e69bb0c-0179-465d-8c61-f850ad030dfd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17148"
"3525","Sierra Leone","C17130","SLE","['SIERRA LEONE']","Sierra Leone","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia.","False","58cc04de-b57f-4d53-b1e8-6584bd5fdbed","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17130"
"3526","El Salvador","C16532","SLV","['EL SALVADOR']","El Salvador","A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras.","False","ca1ddfd5-e300-465d-bde7-d696f0b30462","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16532"
"3527","San Marino","C17115","SMR","['SAN MARINO']","San Marino","A country in Southern Europe, an enclave in central Italy.","False","33a0bafe-4434-4546-9bf3-0305b0a44e5c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17115"
"3528","Somalia","C17149","SOM","['SOMALIA']","Somalia","A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia.","False","a217ef8b-af8f-43f6-b873-a31288eba807","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17149"
"3529","Saint Pierre and Miquelon","C17165","SPM","['SAINT PIERRE AND MIQUELON']","Saint Pierre and Miquelon","A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada).","False","d78e582b-0b4a-4fca-b56d-126b9769be73","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17165"
"3530","Sao Tome and Principe","C17116","STP","['SAO TOME AND PRINCIPE']","Sao Tome and Principe","A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon.","False","effd5d7f-f3ff-4b09-be11-2cf92c008591","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17116"
"3531","Suriname","C17175","SUR","['SURINAME']","Suriname","A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana.","False","4241e39d-3907-44ca-ad09-6d7bf56cd187","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17175"
"3532","Slovakia","C17669","SVK","['SLOVAKIA']","Slovakia","A country in Central Europe, south of Poland.","False","f8e15f15-9c06-44b4-9f4b-1a5f19899c15","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17669"
"3533","Slovenia","C17138","SVN","['SLOVENIA']","Slovenia","A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia.","False","2484fbcf-ca1f-4781-9584-7e95715af8c4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17138"
"3534","Sweden","C17180","SWE","['SWEDEN']","Sweden","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway.","False","49b74dbb-13ad-4009-abc0-6f4678dd76d9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17180"
"3535","Swaziland","C17179","SWZ","['SWAZILAND']","Swaziland","A country in Southern Africa, between Mozambique and South Africa.","False","6aa4519d-ccfa-434a-8773-be177e24d771","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17179"
"3536","Seychelles","C17129","SYC","['SEYCHELLES']","Seychelles","A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar.","False","1a718672-d832-4252-8865-4616aafe959d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17129"
"3537","Syria","C17182","SYR","['SYRIAN ARAB REPUBLIC']","Syria","A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey.","False","3ad42456-21a2-4ad8-9f92-339a319e19db","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17182"
"3538","Turks and Caicos Islands","C17224","TCA","['TURKS AND CAICOS ISLANDS']","Turks and Caicos Islands","Two island groups in the North Atlantic Ocean, southeast of The Bahamas.","False","44146849-293b-46ea-8867-62671bca46bd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17224"
"3539","Chad","C16412","TCD","['CHAD']","Chad","A country in Central Africa, south of Libya.","False","fe207539-fa4e-4dde-b490-76914c71c45c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C16412"
"3540","Togo","C17202","TGO","['TOGO']","Togo","A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana.","False","b9a5ac2d-11db-4943-9d3e-d7292543209c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17202"
"3541","Thailand","C17192","THA","['THAILAND']","Thailand","A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma.","False","69f19fb6-4ab2-4c61-abbd-1fe5a9aa89bb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17192"
"3542","Tajikistan","C17183","TJK","['TAJIKISTAN']","Tajikistan","A country in Central Asia, west of China.","False","51cea02b-43cf-4e25-b21c-f9a7379dff48","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17183"
"3543","Tokelau","C17704","TKL","['TOKELAU']","Tokelau","A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","28072f6c-b0d9-4580-a8c8-9ceceb1c18ec","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17704"
"3544","Turkmenistan","C17223","TKM","['TURKMENISTAN']","Turkmenistan","A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan.","False","847195f0-f5b7-4042-ba15-775d79b2bb06","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17223"
"3545","Timor-Leste","C17200","TLS","['TIMOR-LESTE']","Timor-Leste","A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco.","False","473e87eb-eb60-4f06-8406-ec859a48770c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17200"
"3546","Tonga","C17205","TON","['TONGA']","Tonga","An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","614ba629-84b7-4b74-9839-4160a5cc1ce9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17205"
"3547","Trinidad and Tobago","C17217","TTO","['TRINIDAD AND TOBAGO']","Trinidad and Tobago","Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","85499106-a06a-4f3b-98f0-fbc4ef8b7702","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17217"
"3548","Tunisia","C17221","TUN","['TUNISIA']","Tunisia","A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya.","False","3825affe-13f8-465c-9645-3768f9f64f61","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17221"
"3549","Turkey","C17222","TUR","['TURKEY']","Turkey","A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria.","False","04ae2032-d896-4f2a-84fa-472867e3ede2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17222"
"3550","Tuvalu","C17225","TUV","['TUVALU']","Tuvalu","An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","a41bb7d2-db7c-47f9-8e27-f5a17096f2f0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17225"
"3551","Taiwan","C17184","TWN","['TAIWAN']","Taiwan","A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China.","False","0133959e-f2ce-4cbe-bd85-74f84b7aae37","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17184"
"3552","Tanzania","C17185","TZA","['TANZANIA, UNITED REPUBLIC OF']","Tanzania","A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique.","False","f823f09f-0bf8-4551-ae92-3bd8c8b56f92","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17185"
"3553","Uganda","C17228","UGA","['UGANDA']","Uganda","A country in Eastern Africa, west of Kenya.","False","52df783c-4c33-4364-894e-2240db886a82","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17228"
"3554","Ukraine","C17229","UKR","['UKRAINE']","Ukraine","A country in Eastern Europe, bordering the Black Sea, between Poland and Russia.","False","b77e7ed7-5893-471e-9c97-f99fe8d5430c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17229"
"3555","United States Minor Outlying Islands","C20112","UMI","['UNITED STATES MINOR OUTLYING ISLANDS']","United States Minor Outlying Islands","The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).","False","64d4ffcd-a0d6-4f12-bd01-4c81f420707a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C20112"
"3556","Uruguay","C17244","URY","['URUGUAY']","Uruguay","A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil.","False","f222594c-c24a-4e57-9ad4-b9d016826474","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17244"
"3557","United States","C17234","USA","['UNITED STATES']","United States","A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico.","False","1475d141-2c21-4957-816b-362da53e9ca0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17234"
"3558","Uzbekistan","C17246","UZB","['UZBEKISTAN']","Uzbekistan","A country in Central Asia, north of Afghanistan.","False","81e9199c-5595-4b83-a744-7da268932223","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17246"
"3559","Holy See","C17249","VAT","['VATICAN CITY STATE']","Holy See","An enclave of Rome (Italy).","False","bcb344ea-75e1-495d-aaac-b577d0cb0c32","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17249"
"3560","Saint Vincent and the Grenadines","C17114","VCT","['SAINT VINCENT AND THE GRENADINES']","Saint Vincent and the Grenadines","A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago.","False","b5c05cb6-9721-488f-ab37-8461e370f5ad","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17114"
"3561","Venezuela","C17250","VEN","['VENEZUELA']","Venezuela","A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana.","False","6411fee6-0ca5-4fcd-ad39-899aaab2c9cc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17250"
"3562","British Virgin Islands","C17653","VGB","['VIRGIN ISLANDS,BRITISH']","British Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","073d1501-cbbf-4fb0-95c2-050cfbd9f978","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17653"
"3563","United States Virgin Islands","C17255","VIR","['VIRGIN ISLANDS, U.S.']","United States Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","ef94e81d-4cf6-44cf-a160-6cdffb954ccf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17255"
"3564","Vietnam","C17252","VNM","['VIETNAM']","Vietnam","A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.","False","c518d360-cc47-4845-98ff-77c4b8b4d4d5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17252"
"3565","Vanuatu","C17247","VUT","['VANUATU']","Vanuatu","A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia.","False","474d9bf6-f878-4283-b5e2-47f9e1e5f242","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17247"
"3566","Wallis and Futuna Islands","C17259","WLF","['WALLIS AND FUTUNA']","Wallis and Futuna Islands","Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","7488ade8-727b-45ec-9cca-347e821d27ca","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17259"
"3567","Samoa","C17740","WSM","['SAMOA']","Samoa","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","c8ed4763-9d52-44d6-880b-5ffd26b5ba54","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17740"
"3568","Yemen","C17264","YEM","['YEMEN']","Yemen","A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia.","False","8e80e64e-8ac0-45f5-b371-1ed2959abc3f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17264"
"3569","South Africa","C17151","ZAF","['SOUTH AFRICA']","South Africa","A country in Southern Africa, at the southern tip of the continent of Africa.","False","b9a70756-e07b-462d-a794-bdbffc7b5370","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17151"
"3570","Zambia","C17267","ZMB","['ZAMBIA']","Zambia","A country in Southern Africa, east of Angola.","False","e02e4a28-6198-48be-bf8e-beacf5d9e2b3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17267"
"3571","Zimbabwe","C17268","ZWE","['ZIMBABWE']","Zimbabwe","A country in Southern Africa, between South Africa and Zambia.","False","17f5c5b9-2972-4c66-8428-a70513732726","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66786/C17268"
"3572","Diagnosis Group","C66787","TDIGRP","['Diagnosis Group']","CDISC SDTM Diagnosis Group Terminology","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","f97921bf-ab4c-485f-bbac-6e0d58339158","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66787"
"3573","Healthy Subject","C49651","HEALTHY SUBJECTS","[]","Healthy Subject","An individual who is or becomes a participant in a research study and has no significant health-related issues.  (NCI)","False","9cbc60b3-c384-40e8-8823-22f24baddfa0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66787/C49651"
"3574","Dictionary Name","C66788","DICTNAM","['Dictionary Name', 'Name of Dictionary']","CDISC SDTM Dictionary Name Terminology","A name given to a reference source that lists words and gives their meaning. (NCI)","False","1179a8e3-e70e-496f-9042-68575826eda6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788"
"3575","Thesaurus of Adverse Reaction Term Coding Symbols","C49471","COSTART","['Coding Symbols for a Thesaurus of Adverse Reaction Terms']","Thesaurus of Adverse Reaction Term Coding Symbols","A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)","False","d4f641c0-90b6-498e-95bb-f9b03e0d7366","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788/C49471"
"3576","International Classification of Diseases","C49474","ICD","['International Classification of Diseases']","International Classification of Diseases","A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)","False","ee0da8f1-8f19-47e0-b6f6-5e77a2bd0090","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788/C49474"
"3577","Logical Observation Identifiers Names and Codes","C49476","LOINC","['Logical Observation Identifiers Names and Codes']","Logical Observation Identifiers Names and Codes","Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)","False","e046d396-3a23-4e59-8a20-ce31048c1603","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788/C49476"
"3578","MedDRA","C43820","MedDRA","['Medical Dictionary for Regulatory Activities']","MedDRA","MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)","False","89cb43d1-eb12-424b-81c2-ec864ebfb3d4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788/C43820"
"3579","Systematized Nomenclature of Medicine","C53489","SNOMED","['Systematized Nomenclature of Medicine']","Systematized Nomenclature of Medicine","A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)","False","e8e46b5a-1f5a-4b10-a3de-b39f2b966bdc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788/C53489"
"3580","World Health Organization Adverse Reaction Terminology","C49468","WHOART","['World Health Organization Adverse Reaction Terms']","World Health Organization Adverse Reaction Terminology","A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)","False","ef08ef20-7509-4609-80c2-74a325c2d30d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788/C49468"
"3581","World Health Organization Drug Dictionary","C49475","WHODD","['World Health Organization Drug Dictionary']","World Health Organization Drug Dictionary","A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)","False","83181dc3-f410-45e4-80c1-ccf2bcd6ecb6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66788/C49475"
"3582","Not Done","C66789","ND","['Not Done']","CDISC SDTM Not DoneTerminology","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","ddc8259e-f3d1-4f97-aad7-ab959b78c045","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66789"
"3583","Not Done","C49484","NOT DONE","[]","Not Done","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","16466b9b-5627-438a-a898-e75530f513d0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66789/C49484"
"3584","Patient Ethnic Group","C66790","ETHNIC","['Patient Ethnic Group']","CDISC SDTM Patient Ethnic GroupTerminology","A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)","False","f6e96ec8-1f25-40d6-9473-a8fb9f75c9f3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66790"
"3585","Hispanic or Latino","C17459","HISPANIC OR LATINO","[]","Hispanic or Latino","A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)","False","94e95bad-0e1e-4a93-9af8-45c10d132e0c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66790/C17459"
"3586","Not Hispanic or Latino","C41222","NOT HISPANIC OR LATINO","[]","Not Hispanic or Latino","A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)","False","2bd396ae-2d35-4634-8f61-a813ad860472","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66790/C41222"
"3587","Not Stated","C43234","NOT REPORTED","['Not reported']","Not Stated","Not provided or available","False","8fd3c594-85c8-4e67-b1ce-468cca2c9adc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66790/C43234"
"3588","Unknown","C17998","UNKNOWN","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","ed901181-74ac-494f-81cb-edf717defba1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66790/C17998"
"3589","Pharmaceutical Dosage Form","C66726","FRM","['Pharmaceutical Dosage Form', 'Dose Form']","CDISC SDTM Pharmaceutical Dosage FormTerminology","The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.","False","89c212d4-6d5b-4c22-a4e2-69da15717803","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726"
"3590","Aerosol Dosage Form","C42887","AEROSOL","[]","Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)","False","a85dc2af-1595-4ffb-8b4a-f3f8e24d7b0a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42887"
"3591","Aerosol Foam Dosage Form","C42888","AEROSOL, FOAM","[]","Aerosol Foam Dosage Form","A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)","False","b2bc2bd7-f5e5-4a71-b233-cfaa3a1c7221","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42888"
"3592","Metered Aerosol Dosage Form","C42960","AEROSOL, METERED","[]","Metered Aerosol Dosage Form","A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)","False","3129b285-7e4d-433c-be16-0710f91ff7c8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42960"
"3593","Powder Aerosol Dosage Form","C42971","AEROSOL, POWDER","[]","Powder Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)","False","ab5a9720-80f0-4a11-a216-ee75323fe66a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42971"
"3594","Aerosol Spray Dosage Form","C42889","AEROSOL, SPRAY","[]","Aerosol Spray Dosage Form","An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)","False","1daddb8c-3893-4a07-b1a1-6a4ca123f0fe","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42889"
"3595","Chewable Bar Dosage Form","C42892","BAR, CHEWABLE","[]","Chewable Bar Dosage Form","A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)","False","b34c19b5-0e1a-4430-b240-53456e469caf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42892"
"3596","Bead Dosage Form","C42890","BEAD","[]","Bead Dosage Form","A solid dosage form in the shape of a small ball. (NCI)","False","5099cfc6-aa03-4a8c-900f-133708e62d97","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42890"
"3597","Extended Release Bead Implant Dosage Form","C43451","BEAD, IMPLANT, EXTENDED RELEASE","[]","Extended Release Bead Implant Dosage Form","A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form.  (NCI)","False","5eea7c21-e90c-45b4-8f0f-38a319a42dba","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C43451"
"3598","Block Dosage Form","C42891","BLOCK","[]","Block Dosage Form","Solid dosage form, usually in the shape of a square or rectangle. (NCI)","False","f9372cc3-b63a-4695-a675-0138cea8354c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42891"
"3599","Capsule Dosage Form","C25158","CAPSULE","[]","Capsule Dosage Form","A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)","False","b7b815b5-5be8-473e-b63e-fe3532322f25","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C25158"
"3600","Coated Capsule Dosage Form","C42895","CAPSULE, COATED","[]","Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)","False","f001532e-c961-4063-b85c-da8668079a98","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42895"
"3601","Coated Pellets in Capsule Dosage Form","C42896","CAPSULE, COATED PELLETS","[]","Coated Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)","False","911adc5b-1235-4f2c-b729-016adcdeaec4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42896"
"3602","Extended Release Coated Capsule Dosage Form","C42917","CAPSULE, COATED, EXTENDED RELEASE","[]","Extended Release Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","cc12199f-7c99-4729-8aa9-ab8b0cbb96c0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42917"
"3603","Delayed Release Capsule Dosage Form","C42902","CAPSULE, DELAYED RELEASE","[]","Delayed Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","51e089e5-fabd-487a-a945-a8866a9689a0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42902"
"3604","Delayed Release Pellets in Capsule Dosage Form","C42904","CAPSULE, DELAYED RELEASE PELLETS","[]","Delayed Release Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","ccd280c8-4190-4fd8-90d1-5f5ccd18e8ab","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42904"
"3605","Extended Release Capsule Dosage Form","C42916","CAPSULE, EXTENDED RELEASE","[]","Extended Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","e6a408f6-eaea-49db-ada0-d3a6a2c80a15","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42916"
"3606","Extended Release Film Coated Capsule Dosage Form","C42928","CAPSULE, FILM COATED, EXTENDED RELEASE","[]","Extended Release Film Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","8209b209-17b5-43a8-8817-bcc9dd814449","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42928"
"3607","Gelatin Coated Capsule Dosage Form","C42936","CAPSULE, GELATIN COATED","[]","Gelatin Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)","False","3bc097c4-281f-4f2c-830f-50a23c6447a2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42936"
"3608","Liquid Filled Capsule Dosage Form","C42954","CAPSULE, LIQUID FILLED","[]","Liquid Filled Capsule Dosage Form","A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)","False","8f5d6e24-badc-4f68-af48-1e0323406103","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42954"
"3609","Cement Dosage Form","C45414","CEMENT","[]","Cement Dosage Form","A substance that serves to produce solid union between two surfaces. (NCI)","False","8a2cc6fd-9880-4f01-b81e-b3a6e2433630","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C45414"
"3610","Cigarette Dosage Form","C42678","CIGARETTE","[]","Cigarette Dosage Form","A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)","False","71111148-0ce9-4d2d-a64f-e505b20488b6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42678"
"3611","Cloth Dosage Form","C60884","CLOTH","[]","Cloth Dosage Form","A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)","False","eba7d6c4-545f-4339-a983-bb7bcd7b5feb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60884"
"3612","Concentrate Dosage Form","C60891","CONCENTRATE","[]","Concentrate Dosage Form","A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)","False","78cb95c7-2542-451a-9286-972c5a648d8a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60891"
"3613","Cone Dosage Form","C42900","CONE","[]","Cone Dosage Form","A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)","False","deabdb09-6ac7-41dd-bb0b-25a6e7254610","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42900"
"3614","Extended Release Core Dosage Form","C42919","CORE, EXTENDED RELEASE","[]","Extended Release Core Dosage Form","An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)","False","7b603780-bfd2-4e24-81d3-e2fc3c43b589","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42919"
"3615","Cream Dosage Form","C28944","CREAM","[]","Cream Dosage Form","A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)","False","8c290a7e-1b75-47ba-98b4-dd44bb855e68","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C28944"
"3616","Augmented Cream Dosage Form","C60897","CREAM, AUGMENTED","[]","Augmented Cream Dosage Form","A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","4bbd8e21-adb9-497f-b5da-0234a3bab502","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60897"
"3617","Crystal Dosage Form","C42901","CRYSTAL","[]","Crystal Dosage Form","A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.","False","faf41096-4cd1-45ed-a494-7555a7a02e30","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42901"
"3618","Culture Dosage Form","C45415","CULTURE","[]","Culture Dosage Form","The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)","False","789c2620-4c50-47e4-8f7c-da6f84b3a9da","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C45415"
"3619","Diaphragm Dosage Form","C47890","DIAPHRAGM","[]","Diaphragm Dosage Form","A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)","False","4eb1797f-13c3-44e9-9c50-29a0247bf2eb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47890"
"3620","Disc Dosage Form","C43525","DISC","[]","Disc Dosage Form","A circular plate-like organ or structure. (FDA)","False","00a425db-c0dd-434b-b6a3-6efee060929f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C43525"
"3621","Douche Dosage Form","C42679","DOUCHE","[]","Douche Dosage Form","A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)","False","22f31e3a-efde-48de-8afa-97004b42c7f2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42679"
"3622","Dressing Dosage Form","C42763","DRESSING","[]","Dressing Dosage Form","The application of various materials for protecting a wound.(FDA)","False","0fb5b306-d555-48da-b5b2-c59b73733b69","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42763"
"3623","Drug Delivery System","C17423","DRUG DELIVERY SYSTEM","[]","Drug Delivery System","Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)","False","3ad2e774-b214-4a17-b929-f0a359a939a5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C17423"
"3624","Elixir Dosage Form","C42912","ELIXIR","[]","Elixir Dosage Form","A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)","False","86cd93ac-247a-41ed-afba-da1b775a66dc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42912"
"3625","Emulsion Dosage Form","C42913","EMULSION","[]","Emulsion Dosage Form","A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)","False","9013b69d-b9b1-451b-89f3-46c49c75f803","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42913"
"3626","Enema Dosage Form","C42915","ENEMA","[]","Enema Dosage Form","A rectal preparation for therapeutic, diagnostic, or nutritive purposes.  (NCI)","False","634a2f18-f154-43b3-8ade-ac1d1cce52b6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42915"
"3627","Extract Dosage Form","C42929","EXTRACT","[]","Extract Dosage Form","A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)","False","6ec54632-ee2a-47db-b985-ab2cee56aade","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42929"
"3628","Extended Release Fiber Dosage Form","C60926","FIBER, EXTENDED RELEASE","[]","Extended Release Fiber Dosage Form","A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","63042a04-5cd8-4a59-95e8-09f8e09446c4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60926"
"3629","Film Dosage Form","C42932","FILM","[]","Film Dosage Form","A thin layer or coating. (NCI)","False","cfa0b7b5-e365-4118-8dc5-c1341436f333","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42932"
"3630","Extended Release Film Dosage Form","C42920","FILM, EXTENDED RELEASE","[]","Extended Release Film Dosage Form","A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)","False","bc7f379c-6e06-4b2e-8eea-0774add2c411","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42920"
"3631","Soluble Film Dosage Form","C42984","FILM, SOLUBLE","[]","Soluble Film Dosage Form","A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)","False","d3bd9a6e-c079-4652-8859-69c9dceea529","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42984"
"3632","Dosage Form For Solution","C60927","FOR SOLUTION","[]","Dosage Form For Solution","A product, usually a solid, intended for solution prior to administration. (FDA)","False","96ef2d5f-76b2-443c-9cd5-0b661c7f8409","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60927"
"3633","Dosage Form For Suspension","C60928","FOR SUSPENSION","[]","Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration. (FDA)","False","731f5c3b-e7f7-4c1e-ac3b-81b99beaa307","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60928"
"3634","Extended Release Dosage Form For Suspension","C60929","FOR SUSPENSION, EXTENDED RELEASE","[]","Extended Release Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)","False","cc405bae-a007-4e5c-96d1-f37a47529978","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60929"
"3635","Gas Dosage Form","C42933","GAS","[]","Gas Dosage Form","Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)","False","8b6ec237-62fe-4f7c-b257-78126e73d82e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42933"
"3636","Gel Dosage Form","C42934","GEL","[]","Gel Dosage Form","A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2).  A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature.  It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)","False","c2f8f78a-f862-4985-b215-f6b774adbc64","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42934"
"3637","Dentifrice Gel Dosage Form","C42906","GEL, DENTIFRICE","[]","Dentifrice Gel Dosage Form","A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)","False","c85aad4c-21ab-4775-8531-f543459d5376","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42906"
"3638","Metered Gel Dosage Form","C60930","GEL, METERED","[]","Metered Gel Dosage Form","A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)","False","c939d180-83f9-4a74-a22d-337f390f89d8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60930"
"3639","Generator Dosage Form","C48193","GENERATOR","[]","Generator Dosage Form","An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)","False","30ec837f-30ff-4da8-92d1-9fb28f6d8a51","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C48193"
"3640","Globule Dosage Form","C42937","GLOBULE","[]","Globule Dosage Form","Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)","False","373e85f6-eccc-4da0-af42-64aa21893d05","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42937"
"3641","Graft Dosage Form","C45416","GRAFT","[]","Graft Dosage Form","A slip of skin or of other tissue for implantation. (NCI)","False","81ffc303-ca04-4363-8a50-8388e8efeff4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C45416"
"3642","Granule Dosage Form","C42938","GRANULE","[]","Granule Dosage Form","A small particle or grain. (NCI)","False","c673791e-2ed4-468c-be23-cd2d5d4f7980","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42938"
"3643","Delayed Release Granule Dosage Form","C42903","GRANULE, DELAYED RELEASE","[]","Delayed Release Granule Dosage Form","A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","e6d600ab-12d7-4af4-b315-c2d30c2a8598","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42903"
"3644","Effervescent Granule Dosage Form","C42909","GRANULE, EFFERVESCENT","[]","Effervescent Granule Dosage Form","A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)","False","3a86d84e-9db3-4982-a18c-2592944c2d48","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42909"
"3645","Granule For Solution Dosage Form","C42939","GRANULE, FOR SOLUTION","[]","Granule For Solution Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","a6c8677a-6a3b-4eb9-8ef2-5922b3e87cad","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42939"
"3646","Granule For Suspension Dosage Form","C42940","GRANULE, FOR SUSPENSION","[]","Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","d23aa5e5-1e7c-4dda-a1c4-468d32167535","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42940"
"3647","Extended Release Granule For Suspension Dosage Form","C42921","GRANULE, FOR SUSPENSION, EXTENDED RELEASE","[]","Extended Release Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)","False","f841946d-4b36-452a-bb07-8b4e95240553","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42921"
"3648","Gum Dosage Form","C42941","GUM","[]","Gum Dosage Form","A mucilaginous excretion from various plants. (NCI)","False","f1e981f2-463c-4dde-be54-641ac027345c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42941"
"3649","Chewing Gum Dosage Form","C42894","GUM, CHEWING","[]","Chewing Gum Dosage Form","A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)","False","54d9c008-a010-4511-a16a-cded63c8088c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42894"
"3650","Resin Gum Dosage Form","C42978","GUM, RESIN","[]","Resin Gum Dosage Form","Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)","False","028cfc6e-994a-4f04-a711-65f94b961b73","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42978"
"3651","Implant Dosage Form","C42942","IMPLANT","[]","Implant Dosage Form","A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)","False","4150db43-958d-4c49-b5dd-37d9c8396eed","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42942"
"3652","Inhalant Dosage Form","C42944","INHALANT","[]","Inhalant Dosage Form","A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)","False","685654ac-31df-400a-bdb6-3433ff8315c0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42944"
"3653","Liposomal Injection Dosage Form","C60931","INJECTABLE, LIPOSOMAL","[]","Liposomal Injection Dosage Form","An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)","False","7ef2442a-03ba-4363-9fff-7f3c17daebe2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60931"
"3654","Injectable Dosage Form","C42946","INJECTION","[]","Injectable Dosage Form","A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)","False","31b21017-5010-4815-9227-7f40b5c008c6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42946"
"3655","Emulsion for Injection Dosage Form","C42914","INJECTION, EMULSION","[]","Emulsion for Injection Dosage Form","An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)","False","2bf10b1b-83ed-4f15-970e-3c0ccd8ffe8d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42914"
"3656","Injectable Lipid Complex Dosage Form","C42950","INJECTION, LIPID COMPLEX","[]","Injectable Lipid Complex Dosage Form","[definition pending](FDA)","False","9ce79db6-675a-4ea8-b87c-2052dae1ae4d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42950"
"3657","Powder For Injectable Solution Dosage Form","C42974","INJECTION, POWDER, FOR SOLUTION","[]","Powder For Injectable Solution Dosage Form","A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)","False","9c9ad6bd-f1e9-452e-a7ba-3d19b3bbfdfe","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42974"
"3658","Powder For Injectable Suspension Dosage Form","C42976","INJECTION, POWDER, FOR SUSPENSION","[]","Powder For Injectable Suspension Dosage Form","A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)","False","a4fa76fc-c625-489c-ae05-a8a67c7676be","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42976"
"3659","Powder For Injectable Extended Release Suspension Dosage Form","C42977","INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE","[]","Powder For Injectable Extended Release Suspension Dosage Form","A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)","False","80e175e2-fcff-44fa-9f67-565875505f6b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42977"
"3660","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","C42959","INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION","[]","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)","False","b61e8e60-03c9-4142-a1f9-995d845da3d5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42959"
"3661","Lyophilized Powder For Injectable Solution Dosage Form","C42957","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","[]","Lyophilized Powder For Injectable Solution Dosage Form","A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)","False","945e5884-5ccf-45c8-b580-9ee42d61a81b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42957"
"3662","Lyophilized Powder For Injectable Suspension Dosage Form","C42958","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION","[]","Lyophilized Powder For Injectable Suspension Dosage Form","A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization (""freeze drying""), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)","False","b0704722-5f95-4b0e-964a-9239b07d3210","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42958"
"3663","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","C42956","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE","[]","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)","False","77cc146c-64ad-4065-8093-2d3854cc151d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42956"
"3664","Injectable Solution Dosage Form","C42945","INJECTION, SOLUTION","[]","Injectable Solution Dosage Form","A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)","False","a46f46fb-8f08-43c2-a06f-bcac9143eef3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42945"
"3665","Concentrate for Injectable Solution Dosage Form","C42899","INJECTION, SOLUTION, CONCENTRATE","[]","Concentrate for Injectable Solution Dosage Form","A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)","False","72dd195c-75b1-4bd4-be77-80f6f69ccade","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42899"
"3666","Injectable Suspension Dosage Form","C42995","INJECTION, SUSPENSION","[]","Injectable Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)","False","830d0112-5cf3-4634-9368-9bba40b99cb8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42995"
"3667","Injectable Extended Release Suspension Dosage Form","C42926","INJECTION, SUSPENSION, EXTENDED RELEASE","[]","Injectable Extended Release Suspension Dosage Form","A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","b55a5b20-1d1e-475f-aedd-540e478333e7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42926"
"3668","Injectable Liposomal Suspension Dosage Form","C42951","INJECTION, SUSPENSION, LIPOSOMAL","[]","Injectable Liposomal Suspension Dosage Form","A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)","False","2096452d-eaab-4bd1-8d7c-3f0c5be767a6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42951"
"3669","Injectable Sonicated Suspension Dosage Form","C42988","INJECTION, SUSPENSION, SONICATED","[]","Injectable Sonicated Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)","False","e741ac2f-8d30-4ced-a1a7-3c58c12402de","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42988"
"3670","Insert Dosage Form","C60933","INSERT","[]","Insert Dosage Form","A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)","False","07ee1b1b-9984-40f1-8070-cb3cb38d8a57","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60933"
"3671","Extended Release Insert Dosage Form","C42922","INSERT, EXTENDED RELEASE","[]","Extended Release Insert Dosage Form","A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)","False","80fdad5c-75e3-45cc-9edf-15ca92978a5b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42922"
"3672","Intrauterine Device Dosage Form","C47915","INTRAUTERINE DEVICE","[]","Intrauterine Device Dosage Form","A device inserted and left in the uterus to prevent effective conception. (NCI)","False","1ca79fa5-a0d6-4d65-a627-ba2b4d9af69b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47915"
"3673","Irrigant Dosage Form","C42947","IRRIGANT","[]","Irrigant Dosage Form","A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)","False","7aa66343-6b00-4c72-9697-a292392b9d53","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42947"
"3674","Jelly Dosage Form","C42948","JELLY","[]","Jelly Dosage Form","A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)","False","55f92e69-a542-4e6a-b41b-95a9b0809b82","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42948"
"3675","Kit Dosage Form","C47916","KIT","[]","Kit Dosage Form","A packaged collection of related material. (NCI)","False","de126c22-1e27-4e4a-b218-b89cd249c7cf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47916"
"3676","Dental Liner Dosage Form","C45413","LINER, DENTAL","[]","Dental Liner Dosage Form","A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)","False","f411a8cb-d0a7-40fc-9cd9-01e158940ead","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C45413"
"3677","Liniment Dosage Form","C42949","LINIMENT","[]","Liniment Dosage Form","A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)","False","48cd556e-82c5-465e-aa3d-e4f13af968ee","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42949"
"3678","Lipstick Dosage Form","C42952","LIPSTICK","[]","Lipstick Dosage Form","A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)","False","7ee793e4-d7ea-413c-85da-41dbff4046a8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42952"
"3679","Liquid Dosage Form","C42953","LIQUID","[]","Liquid Dosage Form","A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","e4da4902-432b-415f-a6ed-427258a444d6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42953"
"3680","Extended Release Liquid Dosage Form","C60934","LIQUID, EXTENDED RELEASE","[]","Extended Release Liquid Dosage Form","A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","b660d7e2-983d-41d2-b767-16b8dde5121d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60934"
"3681","Lotion Dosage Form","C29167","LOTION","[]","Lotion Dosage Form","An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)","False","b7744a72-cc10-40df-adf7-a2b4a8eecb20","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C29167"
"3682","Augmented Lotion Dosage Form","C60957","LOTION. AUGMENTED","[]","Augmented Lotion Dosage Form","A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","a9adbe37-7ab3-4180-8055-cf9c070adabb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60957"
"3683","Lotion Shampoo Dosage Form","C60958","LOTION/SHAMPOO","[]","Lotion Shampoo Dosage Form","A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)","False","c9384c08-da98-4196-b807-51733a00c647","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60958"
"3684","Lozenge Dosage Form","C42955","LOZENGE","[]","Lozenge Dosage Form","A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)","False","0de411d5-04ae-40f7-9a13-268842bce3a6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42955"
"3685","Mouthwash Dosage Form","C29269","MOUTHWASH","[]","Mouthwash Dosage Form","An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)","False","5611a395-9133-44af-8edb-6f8f5c83748a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C29269"
"3686","Dosage Form Not Applicable","C48624","NOT APPLICABLE","[]","Dosage Form Not Applicable","The use of a dosage form term is not relevant or appropriate. (NCI)","False","e4d38e8d-cf59-41a0-b4da-b31598da444c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C48624"
"3687","Oil Dosage Form","C42965","OIL","[]","Oil Dosage Form","An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)","False","c6d38de0-d1d4-422d-a70a-3f68c51f74e5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42965"
"3688","Ointment Dosage Form","C42966","OINTMENT","[]","Ointment Dosage Form","A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)","False","986420d0-245a-4250-8f0f-ad216902d2ca","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42966"
"3689","Augmented Ointment Dosage Form","C60984","OINTMENT, AUGMENTED","[]","Augmented Ointment Dosage Form","An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","4e7eb461-2e50-4f7f-90f0-70b1c5ca7db9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60984"
"3690","Packing Dosage Form","C47887","PACKING","[]","Packing Dosage Form","A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)","False","6eb80d66-a3e9-47ec-8e4d-4391a2f9fd41","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47887"
"3691","Paste Dosage Form","C42967","PASTE","[]","Paste Dosage Form","A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)","False","881380c1-c224-43a8-ba11-5fcdebf0b640","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42967"
"3692","Dentifrice Paste Dosage Form","C42907","PASTE, DENTIFRICE","[]","Dentifrice Paste Dosage Form","A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","522c32e6-6619-46a6-b992-5fc8d724869d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42907"
"3693","Pastille Dosage Form","C60985","PASTILLE","[]","Pastille Dosage Form","An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)","False","83c69ce8-e1aa-45a3-b77a-3d5dc7655f40","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60985"
"3694","Patch Dosage Form","C42968","PATCH","[]","Patch Dosage Form","A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body.  Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch.  Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body.  A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)","False","cb69489f-cd35-42b2-899e-24aa60ccb307","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42968"
"3695","Extended Release Patch Dosage Form","C42923","PATCH, EXTENDED RELEASE","[]","Extended Release Patch Dosage Form","A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","9d611420-4675-41a9-b5df-9d1911012ce9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42923"
"3696","Electrically Controlled Extended Release Patch Dosage Form","C42911","PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED","[]","Electrically Controlled Extended Release Patch Dosage Form","A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","2c54cabd-cc49-46e5-871e-13afd3ac854a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42911"
"3697","Pellet Dosage Form","C42969","PELLET","[]","Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)","False","81d54b18-945a-43d7-99a3-d8dca53be67e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42969"
"3698","Implantable Pellet Dosage Form","C42943","PELLET, IMPLANTABLE","[]","Implantable Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)","False","2f79aa6c-cd63-4e0c-a654-c68f855bf276","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42943"
"3699","Extended Release Coated Pellets Dosage Form","C42918","PELLETS, COATED, EXTENDED RELEASE","[]","Extended Release Coated Pellets Dosage Form","A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","354d03c8-e3b2-44cf-9909-d81b24e4ea80","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42918"
"3700","Pill Dosage Form","C25394","PILL","[]","Pill Dosage Form","A dose of medicine in the form of a small pellet. (NCI)","False","f5b30ff9-ba97-4257-8e4a-8fbe279553c7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C25394"
"3701","Plaster Dosage Form","C42970","PLASTER","[]","Plaster Dosage Form","Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)","False","aba17ff6-39d0-42cd-ad69-a7ecd8e4a4ee","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42970"
"3702","Poultice Dosage Form","C47913","POULTICE","[]","Poultice Dosage Form","A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)","False","952c64fc-7de6-402c-8be5-b53e3c8ce57b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47913"
"3703","Powder Dosage Form","C42972","POWDER","[]","Powder Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)","False","d903c96e-19ea-4e04-82dd-ca14a77da1bc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42972"
"3704","Dentifrice Powder Dosage Form","C42908","POWDER, DENTIFRICE","[]","Dentifrice Powder Dosage Form","A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","81b99c12-df59-45a1-b73f-6ea966e9291a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42908"
"3705","Powder for Solution Dosage Form","C42973","POWDER, FOR SOLUTION","[]","Powder for Solution Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)","False","df82900e-1567-49ad-82bb-3865d4bbfa29","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42973"
"3706","Powder for Suspension Dosage Form","C42975","POWDER, FOR SUSPENSION","[]","Powder for Suspension Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)","False","ef129047-cd62-433d-a602-49c7df2015a7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42975"
"3707","Metered Powder Dosage Form","C42961","POWDER, METERED","[]","Metered Powder Dosage Form","A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)","False","6eb6319c-e633-4388-adbd-a53777cb8aa3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42961"
"3708","Ring Dosage Form","C60988","RING","[]","Ring Dosage Form","A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)","False","9bcc9d46-f40b-4b34-8870-3078394cd2be","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60988"
"3709","Rinse Dosage Form","C42979","RINSE","[]","Rinse Dosage Form","A liquid used to cleanse by flushing. (NCI)","False","5b1efd92-6c04-48e6-9de8-a1c95ad9b64f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42979"
"3710","Salve Dosage Form","C42980","SALVE","[]","Salve Dosage Form","A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)","False","11c49707-80ad-41bf-ad35-cf11bf331fa9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42980"
"3711","Shampoo Dosage Form","C42981","SHAMPOO","[]","Shampoo Dosage Form","A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","c1e2e71c-c6b2-4375-9654-94584f29c69a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42981"
"3712","Shampoo Suspension Dosage Form","C42982","SHAMPOO, SUSPENSION","[]","Shampoo Suspension Dosage Form","A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","ef5c67d1-dcd3-458e-9be9-058eebccd7d6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42982"
"3713","Soap Dosage Form","C42983","SOAP","[]","Soap Dosage Form","Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)","False","d060a025-10b2-4d27-b622-d344eaba2cbc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42983"
"3714","Solution Dosage Form","C42986","SOLUTION","[]","Solution Dosage Form","A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)","False","a4e28938-4ac1-4ecd-b90b-579150559b0e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42986"
"3715","Concentrate for Solution Dosage Form","C42898","SOLUTION, CONCENTRATE","[]","Concentrate for Solution Dosage Form","A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)","False","226d286f-14dc-44e0-bc2c-b90a66a5deeb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42898"
"3716","Solution For Slush Dosage Form","C42987","SOLUTION, FOR SLUSH","[]","Solution For Slush Dosage Form","A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)","False","22106bbd-d968-49fe-9a14-b59d66041339","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42987"
"3717","Gel Forming Drops Solution Dosage Form","C60994","SOLUTION, GEL FORMING / DROPS","[]","Gel Forming Drops Solution Dosage Form","A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)","False","fa524c0b-b6f2-4b26-9dbc-03bd8212e76f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60994"
"3718","Extended Release Gel Forming Solution Dosage Form","C42935","SOLUTION, GEL FORMING, EXTENDED RELEASE","[]","Extended Release Gel Forming Solution Dosage Form","A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency","False","f5b660e3-23fe-4928-be1f-ee913b388b4b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42935"
"3719","Drops Solution Dosage Form","C60992","SOLUTION/ DROPS","[]","Drops Solution Dosage Form","A solution which is usually administered in a drop-wise fashion. (FDA)","False","6f58f303-c40b-49ab-a938-3ae820780bc3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60992"
"3720","Sponge Dosage Form","C47912","SPONGE","[]","Sponge Dosage Form","A porous, interlacing, absorbent material that contains a drug.  It is typically used for applying or introducing medication, or for cleansing.  A sponge usually retains its shape.(FDA)","False","4660d64c-b686-4888-841b-57341ed9b439","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47912"
"3721","Spray Dosage Form","C42989","SPRAY","[]","Spray Dosage Form","A liquid minutely divided as by a jet of air or steam. (NCI)","False","ce0a1f38-472c-4908-928d-d0e08669ab36","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42989"
"3722","Metered Spray Dosage Form","C42962","SPRAY, METERED","[]","Metered Spray Dosage Form","A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)","False","1969dd5d-e132-4bdc-8a19-d579a2a25628","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42962"
"3723","Spray Suspension Dosage Form","C42990","SPRAY, SUSPENSION","[]","Spray Suspension Dosage Form","A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)","False","2d8101ca-e8e9-47fc-a880-a604ea072299","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42990"
"3724","Stick Dosage Form","C42991","STICK","[]","Stick Dosage Form","A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)","False","5d418edc-0ecc-43e9-97ab-8e88c35b679a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42991"
"3725","Strip Dosage Form","C47914","STRIP","[]","Strip Dosage Form","A long narrow piece of material.","False","e194a2af-1b60-4395-8a60-0678248a0e92","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47914"
"3726","Suppository Dosage Form","C42993","SUPPOSITORY","[]","Suppository Dosage Form","A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)","False","16d8eac4-99bf-4f3a-82cc-b51ff0730e1b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42993"
"3727","Extended Release Suppository Dosage Form","C42924","SUPPOSITORY, EXTENDED RELEASE","[]","Extended Release Suppository Dosage Form","A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)","False","8b1d5967-37a3-45f4-a4ca-183b6676d09c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42924"
"3728","Suspension Dosage Form","C42994","SUSPENSION","[]","Suspension Dosage Form","A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","6b868e30-c5ff-4445-9d83-0201413bc5b6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42994"
"3729","Extended Release Suspension Dosage Form","C42925","SUSPENSION, EXTENDED RELEASE","[]","Extended Release Suspension Dosage Form","A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","51af3ad6-1073-4f03-a4f0-977598121fb7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42925"
"3730","Drops Suspension Dosage Form","C60995","SUSPENSION/DROPS","[]","Drops Suspension Dosage Form","A suspension which is usually administered in a dropwise fashion. (FDA)","False","ccbf4625-1e2b-4aba-a281-aab874ad43e0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60995"
"3731","Suture Dosage Form","C47889","SUTURE","[]","Suture Dosage Form","A strand or fiber used to hold wound edges in apposition during healing. (NCI)","False","525a112c-3d9a-4de3-99f9-8d270b77bd6f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47889"
"3732","Swab Dosage Form","C47898","SWAB","[]","Swab Dosage Form","A small piece of relatively flat absorbent material that contains a drug.  A swab may also be attached to one end of a small stick.  A swab is typically used for applying medication or for cleansing. (NCI)","False","889f386e-76c9-4464-9456-85935d4a8234","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47898"
"3733","Syrup Dosage Form","C42996","SYRUP","[]","Syrup Dosage Form","An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.  (NCI)","False","66511493-bd1d-4a46-99b8-9d1eae701f89","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42996"
"3734","Tablet Dosage Form","C42998","TABLET","[]","Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents.  (NCI)","False","195d29db-f80a-42b2-80c1-7a87530e04b4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42998"
"3735","Chewable Tablet Dosage Form","C42893","TABLET, CHEWABLE","[]","Chewable Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)","False","87df5a04-d90e-4fd5-861f-59a880df0754","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42893"
"3736","Coated Tablet Dosage Form","C42897","TABLET, COATED","[]","Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)","False","ca008ec4-4470-4ea3-a2c7-6c82295ab9f8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42897"
"3737","Tablet Coated Particles Dosage Form","C60997","TABLET, COATED PARTICLES","[]","Tablet Coated Particles Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)","False","5d76bbb2-d12f-4e90-a617-8d2461a30df6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C60997"
"3738","Delayed Release Tablet Dosage Form","C42905","TABLET, DELAYED RELEASE","[]","Delayed Release Tablet Dosage Form","A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","c54887e3-f6ea-4813-af20-bfda927b65bf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42905"
"3739","Delayed Release Particles Tablet Dosage Form","C42997","TABLET, DELAYED RELEASE PARTICLES","[]","Delayed Release Particles Tablet Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.  (NCI)","False","3886e29d-51bb-4b93-8fdd-fc810e7c5b77","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42997"
"3740","Effervescent Tablet Dosage Form","C42910","TABLET, EFFERVESCENT","[]","Effervescent Tablet Dosage Form","A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)","False","36c5c7b7-979a-4ec8-9684-a8fa2c2e36c5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42910"
"3741","Extended Release Tablet Dosage Form","C42927","TABLET, EXTENDED RELEASE","[]","Extended Release Tablet Dosage Form","A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)","False","f2de955f-958b-41ce-aa50-d74f1c76a68e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42927"
"3742","Film Coated Tablet Dosage Form","C42931","TABLET, FILM COATED","[]","Film Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)","False","5fc2919c-70c9-4417-9d5d-04f578434acb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42931"
"3743","Film Coated Extended Release Tablet Dosage Form","C42930","TABLET, FILM COATED, EXTENDED RELEASE","[]","Film Coated Extended Release Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)","False","28fc4f34-0ff8-43c1-9d1e-1d4556258053","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42930"
"3744","Tablet For Solution Dosage Form","C61004","TABLET, FOR SOLUTION","[]","Tablet For Solution Dosage Form","A tablet that forms a solution when placed in a liquid. (FDA)","False","b55c3050-71b5-4ba6-91c1-f6e25962777d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C61004"
"3745","Tablet For Suspension Dosage Form","C61005","TABLET, FOR SUSPENSION","[]","Tablet For Suspension Dosage Form","A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).","False","bf223ab6-ff29-42b0-8ea1-3bfec1d29deb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C61005"
"3746","Multilayered Tablet Dosage Form","C42964","TABLET, MULTILAYER","[]","Multilayered Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)","False","2f55f30a-616e-451e-b4d3-b9034691b898","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42964"
"3747","Multilayered Extended Release Tablet Dosage Form","C42963","TABLET, MULTILAYER, EXTENDED RELEASE","[]","Multilayered Extended Release Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)","False","333a1298-c6bf-469a-acd0-53414ea8b4b6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42963"
"3748","Orally Disintegrating Tablet Dosage Form","C42999","TABLET, ORALLY DISINTEGRATING","[]","Orally Disintegrating Tablet Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.  (NCI)","False","2422598f-7df0-46e1-b98d-14d99df2903b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42999"
"3749","Tablet Orally Disintegrating Delayed Release Dosage Form","C61006","TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE","[]","Tablet Orally Disintegrating Delayed Release Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)","False","d4b8364f-b929-479f-99e7-fe871e9d11bd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C61006"
"3750","Soluble Tablet Dosage Form","C42985","TABLET, SOLUBLE","[]","Soluble Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)","False","ed225ccd-df98-47fa-afa0-7790b6fe8a43","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42985"
"3751","Sugar Coated Tablet Dosage Form","C42992","TABLET, SUGAR COATED","[]","Sugar Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)","False","10187d5a-962e-4dc9-b918-91f82d14ccfb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C42992"
"3752","Tampon Dosage Form","C47892","TAMPON","[]","Tampon Dosage Form","A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)","False","34579865-9d3a-48b1-bbe2-15791ae268f0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47892"
"3753","Tape Dosage Form","C47897","TAPE","[]","Tape Dosage Form","A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)","False","9737ba30-47cf-43d9-b58b-4ad04d8a66c5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C47897"
"3754","Tincture Dosage Form","C43000","TINCTURE","[]","Tincture Dosage Form","An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.  (NCI)","False","2f90cd43-6eb8-4de0-b20c-0e0ad377ed7d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C43000"
"3755","Troche Dosage Form","C43001","TROCHE","[]","Troche Dosage Form","A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.  (NCI)","False","4a236406-97f6-4d6a-a91e-56ec11d6f2e0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C43001"
"3756","Unassigned Dosage Form","C43002","UNASSIGNED","[]","Unassigned Dosage Form","A dosage form has yet to be assigned.  (NCI)","False","95cd460a-92dd-45c2-804c-6ba679d5df1d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C43002"
"3757","Wafer Dosage Form","C43003","WAFER","[]","Wafer Dosage Form","A thin slice of material containing a medicinal agent.  (NCI)","False","90d9a848-9a97-4d34-8c0f-05c93535960c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66726/C43003"
"3758","Completion/Reason for Non-Completion","C66727","NCOMPLT","['Completion/Reason for Non-Completion']","CDISC SDTM Reason for Non-Completion Terminology","The reason that a subject was discontinued from a clinical trial.","False","627e0d99-3f98-4d67-bcbf-bee334de5c2f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727"
"3759","Adverse Event","C41331","ADVERSE EVENT","[]","Adverse Event","Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience.  (CDISC glossary)","False","960195e2-025d-4f0c-a5b1-699ec9114884","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C41331"
"3760","Complete","C25250","COMPLETED","[]","Complete","To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)","False","c59779a5-de0e-4387-a6e0-9c53aad51ebe","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C25250"
"3761","Death","C28554","DEATH","[]","Death","The absence of life or state of being dead. (NCI)","False","e9b64e5c-b4af-4b9d-99ba-80dbe7de029e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C28554"
"3762","Lack of Efficacy","C48226","LACK OF EFFICACY","[]","Lack of Efficacy","The lack of expected or desired effect related to a therapy. (NCI)","False","1f7b7d0c-0e1e-4d64-aa83-06005851c4e1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C48226"
"3763","Lost To Follow-up","C48227","LOST TO FOLLOW-UP","[]","Lost To Follow-up","The loss or lack of continuation of follow-up after a study has officially closed.  See Follow-up. (NCI)","False","e24e28f1-c8e5-4839-b08f-27099e980c5f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C48227"
"3764","Non-Compliance With Study Drug","C49631","NON-COMPLIANCE WITH STUDY DRUG","[]","Non-Compliance With Study Drug","An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)","False","cfed68a9-4483-40d1-8714-0dd7ad4b2ec4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C49631"
"3765","Other","C17649","OTHER","['Other']","Other","Different than the one(s) previously specified or mentioned. (NCI)","False","3e1e82d1-6f6b-4f97-a859-aa4767686298","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C17649"
"3766","Physician Decision","C48250","PHYSICIAN DECISION","[]","Physician Decision","A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)","False","59024f76-ebdb-4b33-9267-ba199a56745b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C48250"
"3767","Pregnancy","C25742","PREGNANCY","[]","Pregnancy","Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)","False","1e9a3db8-e05e-4221-8ad6-e390c20cec64","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C25742"
"3768","Progressive Disease","C35571","PROGRESSIVE DISEASE","[]","Progressive Disease","A disease process that is increasing in scope or severity. (NCI)","False","735d1fca-bd5a-466a-99fe-7364b47295db","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C35571"
"3769","Protocol Violation","C48251","PROTOCOL VIOLATION","[]","Protocol Violation","An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)","False","5753740d-106b-4484-9a83-06beecc84277","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C48251"
"3770","Recovery","C25746","RECOVERY","[]","Recovery","A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)","False","dd84c2e4-db60-48cf-9a5a-535d1574f6a3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C25746"
"3771","Trial Screen Failure","C49628","SCREEN FAILURE","[]","Trial Screen Failure","The potential subject who does not meet one or more criteria required for participation in a trial.","False","06366526-cb2e-4f13-b254-f4f16e555ded","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C49628"
"3772","Study Terminated By Sponsor","C49632","STUDY TERMINATED BY SPONSOR","[]","Study Terminated By Sponsor","An indication that a clinical study was stopped by its sponsor.  (NCI)","False","f802ce97-b1f7-4c0d-a207-cd49ee7dd745","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C49632"
"3773","Technical Problem","C49633","TECHNICAL PROBLEMS","[]","Technical Problem","A problem with some technical aspect of a clinical study, usually related to an instrument.  (NCI)","False","68e1f00e-d5fe-4895-b59b-57ff4e851b05","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C49633"
"3774","Withdrawal by Subject","C49634","WITHDRAWAL BY SUBJECT","[]","Withdrawal by Subject","An indication that a study participant has removed itself from the study.  (NCI)","False","3a54847d-9145-45fb-96cf-dc24751a06fa","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66727/C49634"
"3775","Relation to Reference Period","C66728","STENRF","['Relation to Reference Period']","CDISC SDTM Relation to Reference Period Terminology","The name of a code list that contains terms that reference timepoints within and without a defined time period.","False","e5140149-3b97-4c3c-a7c4-08d4a284944b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66728"
"3776","Status Post","C38008","AFTER","[]","Status Post","The time period following a point or another period of time. (NCI)","False","4b7b7341-1de3-4b45-b834-8eba379e03ae","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66728/C38008"
"3777","Prior","C25629","BEFORE","[]","Prior","Earlier in time or order. (NCI)","False","e009e5f4-a49f-420e-ad10-dd028c18b17b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66728/C25629"
"3778","During","C25490","DURING","[]","During","At some point in a given period of time. (NCI)","False","29db5ef2-66ac-41f6-9385-6203b74ae969","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66728/C25490"
"3779","During Or After","C49640","DURING/AFTER","[]","During Or After","Within a certain period of time or after a certain point or period in time. (NCI)","False","2e580cac-ba73-48ad-9d7f-2e3c6d77a3a8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66728/C49640"
"3780","Unknown","C17998","U","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","3bbb96a4-bdd5-470f-8bcb-fd26873939fe","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66728/C17998"
"3781","Route of Administration","C66729","ROUTE","['Route of Administration']","CDISC SDTM Route of Administration Terminology","The course by which a substance was administered in order to reach the site of action in the body.","False","e8ce8d2a-ea59-4885-a204-d5b7c4081576","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729"
"3782","Auricular Route of Administration","C38192","AURICULAR (OTIC)","[]","Auricular Route of Administration","Administration to or by way of the ear.(FDA)","False","230c0ad7-a1ad-40e2-9ac5-ec3098369e54","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38192"
"3783","Buccal Route of Administration","C38193","BUCCAL","[]","Buccal Route of Administration","Administration directed toward the cheek, generally from within the mouth.(FDA)","False","092794ed-edba-4900-a996-2cfbfe71ca23","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38193"
"3784","Conjunctival Route of Administration","C38194","CONJUNCTIVAL","[]","Conjunctival Route of Administration","Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball.(FDA)","False","bb685f08-41c7-4e80-908f-daec2b9f45a2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38194"
"3785","Cutaneous Route of Administration","C38675","CUTANEOUS","[]","Cutaneous Route of Administration","Administration to the skin.(FDA)","False","cced7567-7875-40c9-b0dd-6d27ab7a652a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38675"
"3786","Dental Route of Administration","C38197","DENTAL","[]","Dental Route of Administration","Administration to a tooth or teeth.(FDA)","False","b47d60b5-6dc1-4cfe-91da-f9bc91688242","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38197"
"3787","Electro-osmosis Route of Administration","C38633","ELECTRO-OSMOSIS","[]","Electro-osmosis Route of Administration","Administration of through the diffusion of substance through a membrane in an electric field.(FDA)","False","2a644e1d-325f-428e-af43-8deadc2373af","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38633"
"3788","Endocervical Route of Administration","C38205","ENDOCERVICAL","[]","Endocervical Route of Administration","Administration within the canal of the cervix uteri. Synonymous with the term intracervical.(FDA)","False","2383877d-f6d3-495e-9052-fb7c4febd91f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38205"
"3789","Endosinusial Route of Administration","C38206","ENDOSINUSIAL","[]","Endosinusial Route of Administration","Administration within the nasal sinuses of the head.(FDA)","False","a92bb043-09c2-4a7f-836d-7487c582467a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38206"
"3790","Endotracheal Route of Administration","C38208","ENDOTRACHEAL","[]","Endotracheal Route of Administration","Administration directly into the trachea. Synonymous with the term intratracheal.(FDA)","False","a20d5126-7d12-4eed-a03d-8ec5582bcf98","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38208"
"3791","Enteral Route of Administration","C38209","ENTERAL","[]","Enteral Route of Administration","Administration directly into the intestines.(FDA)","False","6b29022e-a0f1-4ebc-8b70-5b985e87953a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38209"
"3792","Epidural Route of Administration","C38210","EPIDURAL","[]","Epidural Route of Administration","Administration upon or over the dura mater.(FDA)","False","b5148f7f-ee97-46bb-a360-81d3618af934","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38210"
"3793","Extraamniotic Route of Administration","C38211","EXTRA-AMNIOTIC","[]","Extraamniotic Route of Administration","Administration to the outside of the membrane enveloping the fetus.(FDA)","False","65fb8502-1d69-46a8-a088-ac34886320a7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38211"
"3794","Extracorporeal Circulation Route of Administration","C38212","EXTRACORPOREAL","[]","Extracorporeal Circulation Route of Administration","Administration outside of the body.(FDA)","False","bd5ccd79-5815-42f4-aae7-767eb334974f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38212"
"3795","Administration Via Hemodialysis","C38200","HEMODIALYSIS","[]","Administration Via Hemodialysis","Administration through hemodialysate fluid.(FDA)","False","5eadec48-5855-487c-8dd4-e335bfa4c778","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38200"
"3796","Infiltration Route of Administration","C38215","INFILTRATION","[]","Infiltration Route of Administration","Administration that results in substances passing into tissue spaces or into cells.(FDA)","False","2d3f101c-7a40-4cfc-b88a-b5f251999350","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38215"
"3797","Interstitial Route of Administration","C38219","INTERSTITIAL","[]","Interstitial Route of Administration","Administration to or in the interstices of a tissue.(FDA)","False","2cf96056-65ef-46aa-9a62-0f574a251da7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38219"
"3798","Intraabdominal Route of Administration","C38220","INTRA-ABDOMINAL","[]","Intraabdominal Route of Administration","Administration within the abdomen.(FDA)","False","a20ed03e-eac0-43cb-a58b-beb64d28e511","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38220"
"3799","Intraamniotic Route of Administration","C38221","INTRA-AMNIOTIC","[]","Intraamniotic Route of Administration","Administration within the amnion.(FDA)","False","6d7e1171-49ec-4a7b-ba86-14fd9b853ba1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38221"
"3800","Intraarterial Route of Administration","C38222","INTRA-ARTERIAL","[]","Intraarterial Route of Administration","Administration within an artery or arteries.(FDA)","False","62cb74f1-d7dd-42ac-8040-1d0ba81f957e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38222"
"3801","Intraarticular Route of Administration","C38223","INTRA-ARTICULAR","[]","Intraarticular Route of Administration","Administration within a joint.(FDA)","False","dbfa6f76-734e-4e17-8ce3-091fa5c26a8a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38223"
"3802","Intrabiliary Route of Administration","C38224","INTRABILIARY","[]","Intrabiliary Route of Administration","Administration within the bile, bile ducts or gallbladder.(FDA)","False","8858138d-6ad5-4be7-bd8b-04f79132a20c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38224"
"3803","Intrabronchial Route of Administration","C38225","INTRABRONCHIAL","[]","Intrabronchial Route of Administration","Administration within a bronchus.(FDA)","False","d8cd062f-9b01-4e91-bf18-9a7bd2155a38","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38225"
"3804","Intrabursal Route of Administration","C38226","INTRABURSAL","[]","Intrabursal Route of Administration","Administration within a bursa.(FDA)","False","2cb3978d-d2eb-4ae7-8970-3b3d994f40b4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38226"
"3805","Intracardiac Route of Administration","C38227","INTRACARDIAC","[]","Intracardiac Route of Administration","Administration within the heart.(FDA)","False","83b42d0f-995b-447e-9120-056529628b9c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38227"
"3806","Intracartilaginous Route of Administration","C38228","INTRACARTILAGINOUS","[]","Intracartilaginous Route of Administration","Administration within a cartilage; endochondral.(FDA)","False","a4e33681-432c-4f93-b7d3-f1c8956dbd85","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38228"
"3807","Intracaudal Route of Administration","C38229","INTRACAUDAL","[]","Intracaudal Route of Administration","Administration within the cauda equina.(FDA)","False","677d41c6-845b-4ad4-94b3-7341355cf349","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38229"
"3808","Intracavernous Route of Administration","C38230","INTRACAVERNOUS","[]","Intracavernous Route of Administration","Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.(FDA)","False","53b15a93-5c3d-417d-af8a-23c66a075f03","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38230"
"3809","Intracavitary Route of Administration","C38231","INTRACAVITARY","[]","Intracavitary Route of Administration","Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound.(FDA)","False","dc10bcb1-4ca0-43d4-8737-06c2b0abea82","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38231"
"3810","Intracerebral Route of Administration","C38232","INTRACEREBRAL","[]","Intracerebral Route of Administration","Administration within the cerebrum.(FDA)","False","d88edf63-18e9-4f45-838e-cc7b704b5572","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38232"
"3811","Intracisternal Route of Administration","C38233","INTRACISTERNAL","[]","Intracisternal Route of Administration","Administration within the cisterna magna cerebellomedularis.(FDA)","False","87776ae3-9685-403e-b856-b22c7c4a8887","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38233"
"3812","Intracorneal Route of Administration","C38234","INTRACORNEAL","[]","Intracorneal Route of Administration","Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).(FDA)","False","a012214f-d32c-4528-b93e-1bb86767d4e1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38234"
"3813","Intracoronal Dental Route of Administration","C38217","INTRACORONAL, DENTAL","[]","Intracoronal Dental Route of Administration","Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck.(FDA)","False","11665399-946b-4261-b3b4-c8a20a7a3aed","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38217"
"3814","Intracoronary Route of Administration","C38218","INTRACORONARY","[]","Intracoronary Route of Administration","Administration within the coronary arteries.(FDA)","False","b15848ff-47d2-4d5b-9c0c-bf799a5d14e9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38218"
"3815","Intracorporus Cavernosum Route of Administration","C38235","INTRACORPORUS CAVERNOSUM","[]","Intracorporus Cavernosum Route of Administration","Administration within the dilatable spaces of the corporus cavernosa of the penis.(FDA)","False","524be6d1-221b-45f8-9479-82dfa1ea212c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38235"
"3816","Intradermal Route of Administration","C38238","INTRADERMAL","[]","Intradermal Route of Administration","Administration within the dermis.(FDA)","False","7978e751-758d-4ba3-9d71-356d872f775e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38238"
"3817","Intradiscal Route of Administration","C38239","INTRADISCAL","[]","Intradiscal Route of Administration","Administration within a disc.(FDA)","False","22ea8cee-50cb-4189-bab8-e259b5bdcd36","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38239"
"3818","Intraductal Route of Administration","C38240","INTRADUCTAL","[]","Intraductal Route of Administration","Administration within the duct of a gland.(FDA)","False","24f867d1-1b4b-4b0f-8599-656e95c9c48b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38240"
"3819","Intraduodenal Route of Administration","C38241","INTRADUODENAL","[]","Intraduodenal Route of Administration","Administration within the duodenum.(FDA)","False","92b520ab-6e36-4836-bbfd-c9f389ba900f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38241"
"3820","Intradural Route of Administration","C38242","INTRADURAL","[]","Intradural Route of Administration","Administration within or beneath the dura.(FDA)","False","ab46187c-4958-45a7-aef4-5a9ac20ac3bd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38242"
"3821","Intraepidermal Route of Administration","C38243","INTRAEPIDERMAL","[]","Intraepidermal Route of Administration","Administration within the epidermis.(FDA)","False","d6eb6a4c-a6ff-43d5-8fab-402361926802","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38243"
"3822","Intraesophageal Route of Administration","C38245","INTRAESOPHAGEAL","[]","Intraesophageal Route of Administration","Administration within the esophagus.(FDA)","False","4adda43d-a5ce-4b42-b2fb-58e095c5714e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38245"
"3823","Intragastric Route of Administration","C38246","INTRAGASTRIC","[]","Intragastric Route of Administration","Administration within the stomach.(FDA)","False","9fb0fc72-e8ec-4787-b9d3-ba1e27e98815","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38246"
"3824","Intragingival Route of Administration","C38247","INTRAGINGIVAL","[]","Intragingival Route of Administration","Administration within the gingivae.(FDA)","False","d605eb02-ccb2-46c8-b201-8362dc09b35b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38247"
"3825","Intraileal Route of Administration","C38249","INTRAILEAL","[]","Intraileal Route of Administration","Administration within the distal portion of the small intestine, from the jejunum to the cecum.(FDA)","False","61e2add9-d73f-4273-a845-0b6186efe2f5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38249"
"3826","Intralesional Route of Administration","C38250","INTRALESIONAL","[]","Intralesional Route of Administration","Administration within or introduced directly into a localized lesion.(FDA)","False","18fdafe3-3ca9-4e23-bdfd-59011344f5c6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38250"
"3827","Intraluminal Route of Administration","C38251","INTRALUMINAL","[]","Intraluminal Route of Administration","Administration within the lumen of a tube.(FDA)","False","4b6e2c8d-3b1b-4918-85b8-7462995bcc5d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38251"
"3828","Intralymphatic Route of Administration","C38252","INTRALYMPHATIC","[]","Intralymphatic Route of Administration","Administration within the lymph.(FDA)","False","292bb58d-909d-44ad-aa26-4ff34936d244","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38252"
"3829","Intramedullary Route of Administration","C38253","INTRAMEDULLARY","[]","Intramedullary Route of Administration","Administration within the marrow cavity of a bone.(FDA)","False","991aa213-57af-4347-b836-d6871bb11ccb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38253"
"3830","Intrameningeal Route of Administration","C38254","INTRAMENINGEAL","[]","Intrameningeal Route of Administration","Administration within the meninges (the three membranes that envelope the brain and spinal cord).(FDA)","False","4032eb4f-e6cb-4475-8c3a-16b5b08e02da","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38254"
"3831","Intramuscular Route of Administration","C28161","INTRAMUSCULAR","[]","Intramuscular Route of Administration","Administration within a muscle. (FDA)","False","96627b33-c4d6-40a2-8202-174b7f035d0d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C28161"
"3832","Intraocular Route of Administration","C38255","INTRAOCULAR","[]","Intraocular Route of Administration","Administration within the eye.(FDA)","False","156e07cb-4f2d-43ee-9001-4f4519475a94","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38255"
"3833","Intraovarian Route of Administration","C38256","INTRAOVARIAN","[]","Intraovarian Route of Administration","Administration within the ovary.(FDA)","False","37cbba16-09cd-424f-8e36-517304ae869c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38256"
"3834","Intrapericardial Route of Administration","C38257","INTRAPERICARDIAL","[]","Intrapericardial Route of Administration","Administration within the pericardium.(FDA)","False","091f088f-0ec9-4a14-adca-847136d17a35","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38257"
"3835","Intraperitoneal Route of Administration","C38258","INTRAPERITONEAL","[]","Intraperitoneal Route of Administration","Administration within the peritoneal cavity.(FDA)","False","0cd70ddc-8ea0-4f90-bb5d-63e81e27767b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38258"
"3836","Intrapleural Route of Administration","C38259","INTRAPLEURAL","[]","Intrapleural Route of Administration","Administration within the pleura.(FDA)","False","d753b5f9-c45d-49dd-bb00-8af9a74e727d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38259"
"3837","Intraprostatic Route of Administration","C38260","INTRAPROSTATIC","[]","Intraprostatic Route of Administration","Administration within the prostate gland.(FDA)","False","c325e1af-e8af-408c-8120-f8302f6bb56e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38260"
"3838","Intrapulmonary Route of Administration","C38261","INTRAPULMONARY","[]","Intrapulmonary Route of Administration","Administration within the lungs or its bronchi.(FDA)","False","29739426-a814-4eb1-a0e4-34512686048f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38261"
"3839","Intrasinal Route of Administration","C38262","INTRASINAL","[]","Intrasinal Route of Administration","Administration within the nasal or periorbital sinuses.(FDA)","False","8e6912ed-bcfb-4572-be65-8e6c93d3f2df","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38262"
"3840","Intraspinal Route of Administration","C38263","INTRASPINAL","[]","Intraspinal Route of Administration","Administration within the vertebral column.(FDA)","False","34c80ea0-6ba6-4448-98bb-34bfda6a83f0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38263"
"3841","Intrasynovial Route of Administration","C38264","INTRASYNOVIAL","[]","Intrasynovial Route of Administration","Administration within the synovial cavity of a joint.(FDA)","False","cd27077f-26e6-45ce-81fb-bd1c219eb29e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38264"
"3842","Intratendinous Route of Administration","C38265","INTRATENDINOUS","[]","Intratendinous Route of Administration","Administration within a tendon.(FDA)","False","c2b5b088-b456-4d39-93f3-dbb800c6cb0a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38265"
"3843","Intratesticular Route of Administration","C38266","INTRATESTICULAR","[]","Intratesticular Route of Administration","Administration within the testicle.(FDA)","False","8a8daeae-f06f-4de1-b599-4065f06b4782","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38266"
"3844","Intrathecal Route of Administration","C38267","INTRATHECAL","[]","Intrathecal Route of Administration","Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.(FDA)","False","4d827f5d-36ca-4916-b378-3c91453f267f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38267"
"3845","Endothoracic Route of Administration","C38207","INTRATHORACIC","[]","Endothoracic Route of Administration","Administration within the thorax (internal to the ribs); synonymous with the term endothoracic.(FDA)","False","d9f1c20e-9aac-4ca2-9de0-71f11fe1c5b9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38207"
"3846","Intratubular Route of Administration","C38268","INTRATUBULAR","[]","Intratubular Route of Administration","Administration within the tubules of an organ.(FDA)","False","6229fd14-abb4-4872-b5c6-24bae94c7a8f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38268"
"3847","Intratumoral Route of Administration","C38269","INTRATUMOR","['Intratumor Route of Administration']","Intratumoral Route of Administration","Administration within a tumor.(FDA)","False","95441fec-ef45-4dda-bdeb-c7609b5158bc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38269"
"3848","Intratympanic Route of Administration","C38270","INTRATYMPANIC","[]","Intratympanic Route of Administration","Administration within the auris media.(FDA)","False","68bd930d-6aae-4d80-9791-f6eebf95489e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38270"
"3849","Intrauterine Route of Administration","C38272","INTRAUTERINE","[]","Intrauterine Route of Administration","Administration within the uterus.(FDA)","False","dd7cb3b7-8b39-49ca-8670-5a0fbd741191","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38272"
"3850","Intravascular Route of Administration","C38273","INTRAVASCULAR","[]","Intravascular Route of Administration","Administration within a vessel or vessels.(FDA)","False","301f373b-a8d5-49db-8338-8025bbf5d37a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38273"
"3851","Intravenous Route of Administration","C38276","INTRAVENOUS","[]","Intravenous Route of Administration","Administration within or into a vein or veins.(FDA)","False","cca48466-1972-45ba-9788-0a6ac5be31e9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38276"
"3852","Intravenous Bolus","C38274","INTRAVENOUS BOLUS","[]","Intravenous Bolus","Administration within or into a vein or veins all at once.(FDA)","False","d2144535-1f2f-45ef-98b6-ba805d4cd222","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38274"
"3853","Intravenous Drip","C38279","INTRAVENOUS DRIP","[]","Intravenous Drip","Administration within or into a vein or veins over a sustained period of time.(FDA)","False","29940b7a-93ac-4f2b-87a6-e9bf1448ca23","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38279"
"3854","Intraventricular Route of Administration","C38277","INTRAVENTRICULAR","[]","Intraventricular Route of Administration","Administration within a ventricle.(FDA)","False","68a31afc-a4fe-443d-8269-e64fbabc139e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38277"
"3855","Intravesical Route of Administration","C38278","INTRAVESICAL","[]","Intravesical Route of Administration","Administration within the bladder.(FDA)","False","0838aac0-db9c-425f-8da6-adbe2beb0a3a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38278"
"3856","Intravitreal Route of Administration","C38280","INTRAVITREAL","[]","Intravitreal Route of Administration","Administration within the vitreous body of the eye.(FDA)","False","c6325309-bb64-4a0d-b63f-83a70e049943","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38280"
"3857","Iontophoresis Route of Administration","C38203","IONTOPHORESIS","[]","Iontophoresis Route of Administration","Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body.(FDA)","False","1bd1c0a8-db9a-4848-972e-09b5a5f19edc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38203"
"3858","Irrigation-Route of Administration","C38281","IRRIGATION","[]","Irrigation-Route of Administration","Administration to bathe or flush open wounds or body cavities.(FDA)","False","6ac0b0be-f4ee-48e4-908a-ff3e1eb02111","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38281"
"3859","Laryngeal Route of Administration","C38282","LARYNGEAL","[]","Laryngeal Route of Administration","Administration directly upon the larynx.(FDA)","False","07719b15-b150-4c32-a12d-012f9f9dce03","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38282"
"3860","Nasal Route of Administration","C38284","NASAL","[]","Nasal Route of Administration","Administration to the nose; administered by way of the nose.(FDA)","False","c202940a-c628-4595-8402-96f69fa71f03","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38284"
"3861","Nasogastric Route of Administration","C38285","NASOGASTRIC","[]","Nasogastric Route of Administration","Administration through the nose and into the stomach, usually by means of a tube.(FDA)","False","91e023cb-5851-4dea-97cf-adcc316a66a0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38285"
"3862","Route of Administration Not Applicable","C48623","NOT APPLICABLE","[]","Route of Administration Not Applicable","Routes of administration are not applicable.(FDA)","False","d0ab6bf2-cd6a-4248-9f3d-e14690765210","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C48623"
"3863","Occlusive Dressing Technique","C38286","OCCLUSIVE DRESSING TECHNIQUE","[]","Occlusive Dressing Technique","Administration by the topical route which is then covered by a dressing which occludes the area.(FDA)","False","ce219a37-7b78-428d-9324-1eefe05b2f59","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38286"
"3864","Ophthalmic Route of Administration","C38287","OPHTHALMIC","[]","Ophthalmic Route of Administration","Administration to the external eye.(FDA)","False","c8bf7c67-9fb1-4eb6-a72c-171dc30c472e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38287"
"3865","Oral Route of Administration","C38288","ORAL","[]","Oral Route of Administration","Administration to or by way of the mouth.(FDA)","False","d5e0cfbb-f3a2-4c81-b1a6-f9b5c2dd5161","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38288"
"3866","Oropharyngeal Route of Administration","C38289","OROPHARYNGEAL","[]","Oropharyngeal Route of Administration","Administration directly to the mouth and pharynx.(FDA)","False","638ef0a4-e457-498f-a9dd-0464cc037771","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38289"
"3867","Other Route of Administration","C38290","OTHER","[]","Other Route of Administration","Administration is different from others on this list.(FDA)","False","a942abbb-8e4b-41c6-976d-7845fc68da9d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38290"
"3868","Parenteral Route of Administration","C38291","PARENTERAL","[]","Parenteral Route of Administration","Administration by injection, infusion, or implantation.(FDA)","False","3039ee15-7af0-497f-b2d2-bacfb0635f8f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38291"
"3869","Percutaneous Route of Administration","C38676","PERCUTANEOUS","[]","Percutaneous Route of Administration","Administration through the skin.(FDA)","False","63dee1f9-8e67-4181-b6b7-bc900c587154","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38676"
"3870","Periarticular Route of Administration","C38292","PERIARTICULAR","[]","Periarticular Route of Administration","Administration around a joint.(FDA)","False","4aa40905-204c-48d7-b692-385085c9e4e0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38292"
"3871","Peridural Route of Administration","C38677","PERIDURAL","[]","Peridural Route of Administration","Administration to the outside of the dura mater of the spinal cord.(FDA)","False","8128836d-80fe-40f9-8cf9-3b2ac6663540","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38677"
"3872","Perineural Route of Administration","C38293","PERINEURAL","[]","Perineural Route of Administration","Administration surrounding a nerve or nerves.(FDA)","False","ecc2de72-3009-4e68-91ba-6a5064c17bb6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38293"
"3873","Periodontal Route of Administration","C38294","PERIODONTAL","[]","Periodontal Route of Administration","Administration around a tooth.(FDA)","False","51f10c39-f395-415d-89cb-a464320810c3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38294"
"3874","Rectal Route of Administration","C38295","RECTAL","[]","Rectal Route of Administration","Administration to the rectum.(FDA)","False","6c3025ac-92a5-4112-bb2c-c161aa2a15ed","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38295"
"3875","Inhalation Route of Administration","C38216","RESPIRATORY (INHALATION)","[]","Inhalation Route of Administration","Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)","False","f21f3ee3-1e4a-4e07-8a5b-408b5cc47aa5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38216"
"3876","Retrobulbar Route of Administration","C38296","RETROBULBAR","[]","Retrobulbar Route of Administration","Administration behind the pons or behind the eyeball.(FDA)","False","29fbdd5c-3d75-48d5-bd32-f8061b4feaf5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38296"
"3877","Soft Tissue Route Of Administration","C38198","SOFT TISSUE","[]","Soft Tissue Route Of Administration","Administration into any soft tissue.(FDA)","False","59debb0b-99bf-494d-b2d8-d8294eb9e1d1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38198"
"3878","Subarachnoid Route of Administration","C38297","SUBARACHNOID","[]","Subarachnoid Route of Administration","Administration beneath the arachnoid.(FDA)","False","ffb3c613-6fc5-4c39-b732-427c19e65687","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38297"
"3879","Subconjunctival Route of Administration","C38298","SUBCONJUNCTIVAL","[]","Subconjunctival Route of Administration","Administration beneath the conjunctiva.(FDA)","False","13d2b825-6e86-4bb6-8d14-253a6c6564a2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38298"
"3880","Subcutaneous Route of Administration","C38299","SUBCUTANEOUS","[]","Subcutaneous Route of Administration","Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)","False","fb08a4e5-6f35-460c-84ef-2146ee725902","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38299"
"3881","Sublingual Route of Administration","C38300","SUBLINGUAL","[]","Sublingual Route of Administration","Administration beneath the tongue.(FDA)","False","47327a82-0a04-474c-89ed-d1a779b7a139","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38300"
"3882","Submucosal Route of Administration","C38301","SUBMUCOSAL","[]","Submucosal Route of Administration","Administration beneath the mucous membrane.(FDA)","False","5edff493-2b23-4a46-8fda-580652138e49","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38301"
"3883","Topical Route of Administration","C38304","TOPICAL","[]","Topical Route of Administration","Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.(FDA)","False","8c4e930d-d13b-4219-826a-6e27998a61f8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38304"
"3884","Transdermal Route of Administration","C38305","TRANSDERMAL","[]","Transdermal Route of Administration","Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)","False","90a2eceb-8db0-41ef-bed9-ca8e0aa16385","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38305"
"3885","Mucosal Route of Administration","C38283","TRANSMUCOSAL","[]","Mucosal Route of Administration","Administration across the mucosa.(FDA)","False","40c82005-753b-47aa-8bbb-35b684294202","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38283"
"3886","Transplacental Route of Administration","C38307","TRANSPLACENTAL","[]","Transplacental Route of Administration","Administration through or across the placenta.(FDA)","False","49f31a08-add0-4975-b182-165bccb3da22","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38307"
"3887","Transtracheal Route of Administration","C38308","TRANSTRACHEAL","[]","Transtracheal Route of Administration","Administration through the wall of the trachea.(FDA)","False","6b02093c-cdf1-4ca1-9458-59146f79c64a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38308"
"3888","Transtympanic Route of Administration","C38309","TRANSTYMPANIC","[]","Transtympanic Route of Administration","Administration across or through the tympanic cavity.(FDA)","False","2edf8720-8481-4ffe-8a8f-28fedbefdbcc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38309"
"3889","Unassigned Route of Administration","C38310","UNASSIGNED","[]","Unassigned Route of Administration","Route of administration has not yet been assigned.(FDA)","False","4e6c767d-f223-438d-b0d8-aa155a12a42a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38310"
"3890","Unknown Route of Administration","C38311","UNKNOWN","[]","Unknown Route of Administration","Route of administration is unknown.(FDA)","False","7ab8a875-7ebb-43d7-a18c-f56b3630b5b2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38311"
"3891","Ureteral Route of Administration","C38312","URETERAL","[]","Ureteral Route of Administration","Administration into the ureter.(FDA)","False","273f56aa-9fb4-4e93-aee6-96b673db0c69","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38312"
"3892","Intraurethral Route of Administration","C38271","URETHRAL","[]","Intraurethral Route of Administration","Administration into the urethra.(FDA)","False","8fa434cd-b2be-45ce-833a-9166b7caa269","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38271"
"3893","Vaginal Route of Administration","C38313","VAGINAL","[]","Vaginal Route of Administration","Administration into the vagina.(FDA)","False","15540543-cb12-4b70-bd53-635f6b2e3061","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66729/C38313"
"3894","Severity/Intensity Scale for Adverse Events","C66769","AESEV","['Severity/Intensity Scale for Adverse Events']","CDISC SDTM Severity Intensity Scale for Adverse Event Terminology","A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)","False","eea9a848-6f62-4134-8f3c-389e02585730","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66769"
"3895","Mild Adverse Event","C41338","MILD","['Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","41c0c32e-283a-4c8e-a4cb-e2886d3569f6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66769/C41338"
"3896","Moderate Adverse Event","C41339","MODERATE","['Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","5d6ef8eb-465a-4fab-8db2-dca9ca554eee","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66769/C41339"
"3897","Severe Adverse Event","C41340","SEVERE","['Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","dda0cdf1-e68b-4968-88f6-933710d7a09c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66769/C41340"
"3898","Sex","C66731","SEX","['Sex']","CDISC SDTM Sex of Individual Terminology","The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)","False","70d91c1e-cddf-4e1d-a507-8e62a666336b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66731"
"3899","Female","C16576","F","['Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","778456a3-bfd6-4f90-9c5e-983b29fc1f33","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66731/C16576"
"3900","Male","C20197","M","['Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","c0177752-8d6a-4203-bce4-b332023e34ac","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66731/C20197"
"3901","Unknown","C17998","U","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","4def8c29-eb94-4357-a006-9f7e85b6c7b4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66731/C17998"
"3902","Intersex","C45908","UN","['Undifferentiated']","Intersex","A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)","False","1ebe5c80-a38c-4936-8947-d448646b1ee2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66731/C45908"
"3903","Sex of Participants","C66732","SEXPOP","['Sex of Participants']","CDISC SDTM Sex of Study Group Terminology","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","30046a17-5300-4b5b-bf3f-10146fc852f3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66732"
"3904","Both","C49636","BOTH","[]","Both","One and the other; relating to or being two in conjunction. (NCI)","False","2b46e3fe-8416-4350-a3d5-689e272d4c46","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66732/C49636"
"3905","Female","C16576","F","['Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","f9857e5d-9de6-4ed6-8c2e-201d99dca0ea","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66732/C16576"
"3906","Male","C20197","M","['Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","3afe4707-af00-4c7d-a935-b558121dd1d4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66732/C20197"
"3907","Size","C66733","SIZE","['Size']","CDISC SDTM Size Terminology","The physical magnitude of something. (NCI)","False","ab08afb0-17e8-4018-bc7c-2dc4cdc7f21a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66733"
"3908","Large","C49508","LARGE","[]","Large","Of considerable or relatively great size, extent, or capacity. (NCI)","False","760c56c5-f53c-4ac3-afde-76cd45c0f640","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66733/C49508"
"3909","Medium","C49507","MEDIUM","[]","Medium","Mid-way between small and large in number, quantity, magnitude or extent. (NCI)","False","dc3a9f89-83fd-40b2-b4fc-3b6636a86d85","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66733/C49507"
"3910","Small","C25376","SMALL","[]","Small","Limited in number, quantity, magnitude or extent. (NCI)","False","b88fe05f-ea61-4ef6-9bfc-63f5129c56f0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66733/C25376"
"3911","Domain Abbreviation","C66734","DOMAIN","['Domain Abbreviation']","CDISC SDTM Submission Domain Abbreviation Terminology","A unique, 2-character domain code used in the regulatory submission process.  The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)","False","7cd722d8-1587-4515-abc5-e6f9e4e12986","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734"
"3912","Analysis Dataset Domain","C49563","AD","['Analysis Dataset']","Analysis Dataset Domain","Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.","False","beecc1eb-49ec-4f7a-8b28-8eb3b204f686","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49563"
"3913","Adverse Event Domain","C49562","AE","['Adverse Events']","Adverse Event Domain","Adverse events may be captured either as free text or a pre-specified list of terms.","False","340472eb-86b6-40d6-bc82-b47f2e5fcc66","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49562"
"3914","Autopsy Domain","C49565","AU","['Autopsy']","Autopsy Domain","Additional data about deaths, specific to findings from autopsies.","False","79df5ad7-7396-426d-b96c-63196eb25183","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49565"
"3915","Bone Mineral Density Data Domain","C49566","BM","['Bone Mineral Density (BMD) Data']","Bone Mineral Density Data Domain","Findings resulting from evaluations of bone mineral density.","False","b8c94d33-99fd-4d0f-a3b9-2c5f7b9e1e60","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49566"
"3916","Biopsy Domain","C49567","BR","['Biopsy']","Biopsy Domain","Findings resulting from biopsies.","False","1eda6ff1-bc51-45e3-ae80-2f7f2958a0b6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49567"
"3917","Concomitant Medication Domain","C49568","CM","['Concomitant Meds']","Concomitant Medication Domain","Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.","False","b896d8e8-a684-4d56-9445-dc9acc6ac302","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49568"
"3918","Comment Domain","C49569","CO","['Comments']","Comment Domain","The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.","False","f43e98d2-7691-4cb4-9bea-9ab83a0f85a2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49569"
"3919","Drug Accountability Domain","C49578","DA","['Drug Accountability']","Drug Accountability Domain","Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.","False","728621a1-0abe-43d5-b8e0-66244c5e8218","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49578"
"3920","Disease Characteristics Domain","C49570","DC","['Disease Characteristics']","Disease Characteristics Domain","Data related to the characteristics of a specific disease state under study for a subject.","False","102594e2-6425-4fcc-9598-931b00145470","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49570"
"3921","Demographics Domain","C49572","DM","['Demographics']","Demographics Domain","The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study.  It is the parent domain for all other observations for human clinical subjects","False","be050100-86b8-40da-9b04-3aa1d5e68fec","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49572"
"3922","Disposition Domain","C49576","DS","['Disposition']","Disposition Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)","False","111eff1d-851a-49bd-b744-e0d41584978d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49576"
"3923","Protocol Deviations Domain","C49585","DV","['Protocol Deviations']","Protocol Deviations Domain","The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.","False","0457c9e9-3180-4608-bf1b-30976147d91f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49585"
"3924","Electroencephalogram Domain","C49625","EE","['Electroencephalogram']","Electroencephalogram Domain","Findings resulting from electroencephalogram (EEG) tests.","False","34ac543d-1834-4024-af76-d77375789206","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49625"
"3925","Electrocardiogram Domain","C49626","EG","['Electrocardiogram']","Electrocardiogram Domain","Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.","False","380f587b-82d1-4e0d-acb4-c36884eed66c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49626"
"3926","Exposure Domain","C49587","EX","['Exposure']","Exposure Domain","The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.","False","f56a66ff-7e9b-407f-80fe-2fa7e4207ac4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49587"
"3927","Family History Domain","C49588","FH","['Family History']","Family History Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)","False","71ac8da7-fa91-44f3-bf45-3f3cf47f3353","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49588"
"3928","Healthcare Resource Utilization Domain","C49589","HU","['Healthcare Resource Utilization']","Healthcare Resource Utilization Domain","Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.","False","db2936a0-cd14-4bc6-b8e9-97f04ed88bff","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49589"
"3929","Inclusion Exclusion Domain","C61536","IE","['Inclusion/Exclusion']","Inclusion Exclusion Domain","The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.","False","6e1244de-90c0-4971-9a55-bc4b2aa69960","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C61536"
"3930","Laboratory Data Domain","C49592","LB","['Laboratory Data']","Laboratory Data Domain","Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.","False","055cfc52-fa9d-496c-bca0-5a7b265e1c6f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49592"
"3931","Microbiology Specimen Domain","C49602","MB","['Microbiology']","Microbiology Specimen Domain","Microbiology specimen findings, including gram stain results, and organisms found.","False","84cd59d6-e779-404b-acaf-944a3dc95e5a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49602"
"3932","Medical History Domain","C49603","MH","['Medical History']","Medical History Domain","The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.","False","52e80b43-e4e7-4be2-8b7f-90956ea5edea","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49603"
"3933","Meal Data Domain","C49604","ML","['Meal Data']","Meal Data Domain","Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.","False","2aede064-2680-43de-8704-821e12459004","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49604"
"3934","Microbiology Susceptibility Domain","C61531","MS","['Microbiology Susceptibility']","Microbiology Susceptibility Domain","This includes microbiology susceptibility test results, plus results of any other organism-related tests.","False","0dacf657-acd6-4ad3-b29e-54fad4340aaa","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C61531"
"3935","Organ Measurement Domain","C49605","OM","['Organ Measurements']","Organ Measurement Domain","Findings from organ measurement evaluations.","False","726f6576-7448-40d4-9185-c3d010a49515","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49605"
"3936","Pharmacokinetic Concentration Domain","C49606","PC","['Pharmacokinetic Concentration']","Pharmacokinetic Concentration Domain","Concentrations of drugs/metabolites in fluids or tissues as a function of time.","False","4f0f3676-8514-42c1-a9f5-45fb979dd74f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49606"
"3937","Physical Exam Domain","C49608","PE","['Physical Exam']","Physical Exam Domain","Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.","False","edf2beb3-6e50-4356-bf92-a10ae09d6465","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49608"
"3938","Pharmacogenomics Domain","C61529","PG","['Pharmacogenomics']","Pharmacogenomics Domain","Pharmacogenomics findings that initially focus on genotype and gene expression data.","False","63bed397-9e00-4fb7-acc4-91220a21de18","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C61529"
"3939","Pharmacokinetic Parameters Domain","C49607","PP","['Pharmacokinetic Parameters']","Pharmacokinetic Parameters Domain","Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.","False","dc232531-5931-4359-9556-03917ea89460","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49607"
"3940","Questionnaire Domain","C49609","QS","['Questionnaires']","Questionnaire Domain","Questionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).","False","f1751c15-f56b-4aba-871f-3e68af1a7e94","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49609"
"3941","Subject Characteristics Domain","C49610","SC","['Subject Characteristics']","Subject Characteristics Domain","The subject characteristics domain is for data not collected in other domains that is subject-related. Examples: subject initials, other race details, eye color, childbearing status, etc.","False","be2b8949-67a7-4452-9dd4-60c5bce10034","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49610"
"3942","Subject Element Domain","C49616","SE","['Subject Element']","Subject Element Domain","The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.","False","8df3194b-d078-4ee1-9e31-5893dd71ad26","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49616"
"3943","Surgery Domain","C49611","SG","['Surgery']","Surgery Domain","Surgical information.","False","cc901d29-2ab6-493d-8c5f-dc1597066b0a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49611"
"3944","Skin Test Domain","C49612","SK","['Skin Test']","Skin Test Domain","Findings from diagnostic skin tests.","False","9e8ee086-8b76-4c39-99e9-7f2e3eaf0b63","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49612"
"3945","Sleep Polysomnography Domain","C49613","SL","['Sleep Polysomnography Data']","Sleep Polysomnography Domain","Findings from diagnostic sleep tests (polysomnography).","False","d7675b59-83eb-4558-83f4-5334e5c171f4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49613"
"3946","Stress Exercise Test Data Domain","C49614","ST","['Stress (Exercise) Test Data']","Stress Exercise Test Data Domain","Findings from exercise stress tests.","False","5dc5ff0e-5c96-4be0-bdba-51d9849efaf2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49614"
"3947","Substance Use Domain","C49615","SU","['Substance Use']","Substance Use Domain","The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.","False","1ff256c8-c202-43a8-b077-c4a00702fc7f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49615"
"3948","Subject Visits Domain","C49617","SV","['Subject Visits']","Subject Visits Domain","The subject visits table describes the actual start and end data/time for each visit of each individual subject.","False","caa4523e-db89-4dc4-867b-e52f156026e0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49617"
"3949","Trial Arms Domain","C49618","TA","['Trial Arms']","Trial Arms Domain","The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.","False","e1799c74-b09b-417e-929b-c1023b2c9eea","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49618"
"3950","Trial Elements Domain","C49619","TE","['TE', 'Trial Elements']","Trial Elements Domain","The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.","False","f9e60aaa-a0b6-4e79-ada2-59dc5808c11b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49619"
"3951","Trial Inclusion and Exclusion Criteria Domain","C49620","TI","['Trial Inclusion/Exclusion Criteria']","Trial Inclusion and Exclusion Criteria Domain","The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.","False","9c8ca3fa-2134-4db7-ab60-eb219c47b5a8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49620"
"3952","Trial Summary Domain","C53483","TS","['Trial Summary']","Trial Summary Domain","The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.","False","c965fdcd-ec7f-45c2-872f-4497e48abf1b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C53483"
"3953","Trial Visits Domain","C49621","TV","['Trial Visits']","Trial Visits Domain","The trial visits table describes the planned order and number of visits in the study within each arm.","False","6e9fe7fd-a6ac-456f-aed9-4523cb5dd551","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49621"
"3954","Vital Signs Domain","C49622","VS","['Vital Signs']","Vital Signs Domain","Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.","False","91262a3b-2da4-4a6d-a1bc-52472e44fe6b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66734/C49622"
"3955","Trial Blinding Schema","C66735","TBLIND","['Trial Blinding Schema']","CDISC SDTM Trial Blinding Schema Terminology","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","2ad3672b-abd4-4e78-aee5-e6425160eac7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66735"
"3956","Double Blind Study","C15228","DOUBLE BLIND","[]","Double Blind Study","A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)","False","e6f7df70-f3b2-4127-b50a-64aa8074f92e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66735/C15228"
"3957","Open Label Study","C49659","OPEN LABEL","[]","Open Label Study","A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)","False","52276474-45ab-4e31-82d1-9279f8e30239","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66735/C49659"
"3958","Single Blind Study","C28233","SINGLE BLIND","[]","Single Blind Study","A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)","False","e1300b9a-3d65-4fe3-a4e9-a5f77d7efa66","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66735/C28233"
"3959","Trial Indication Type","C66736","TINDTP","['Trial Indication Type']","CDISC SDTM Trial Indication Type Terminology","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)","False","9d9f42f2-2af5-4a84-9c67-ef3dffbc5145","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66736"
"3960","Cure Study","C49654","CURE","[]","Cure Study","A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition.  (NCI)","False","845a4b75-5b60-4b67-bee2-b28d90ccb372","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66736/C49654"
"3961","Diagnosis Study","C49653","DIAGNOSIS","[]","Diagnosis Study","A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition.  (NCI)","False","8c3a918f-22aa-4922-9550-4c5e93b28581","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66736/C49653"
"3962","Adverse Effect Mitigation Study","C49655","MITIGATION","[]","Adverse Effect Mitigation Study","A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen.  (NCI)","False","2c0bb1f7-02e0-4f1e-b0f4-e9e5c79e1002","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66736/C49655"
"3963","Prevention Study","C49657","PREVENTION","[]","Prevention Study","A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.","False","d50c3038-2016-47fb-9fe7-e617089ce6f0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66736/C49657"
"3964","Treatment Study","C49656","TREATMENT","[]","Treatment Study","A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.","False","aa6f1793-28ca-452c-87b3-753343ce751a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66736/C49656"
"3965","Trial Phase","C66737","TPHASE","['Trial Phase']","CDISC SDTM Trial Phase Terminology","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","18b1a7cf-6b8f-4c32-bce2-1969f2d30a6c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737"
"3966","Phase I Trial","C15600","Phase I Trial","['Trial Phase 1', '1']","Phase I Trial","The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drugs pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes.  [After FDA CDER Handbook, ICH E8] (CDISC glossary)","False","c4fd1c95-5f82-4ab4-a281-39cd6c4d8981","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C15600"
"3967","Phase I/II Trial","C15693","Phase I/II Trial","['Trial Phase 1-2', '1-2']","Phase I/II Trial","A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.","False","c63688b0-b988-4165-8467-3b42187e7914","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C15693"
"3968","Phase II Trial","C15601","Phase II Trial","['Trial Phase 2', '2']","Phase II Trial","Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","817d5873-534b-4682-b8d4-52c238835c69","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C15601"
"3969","Phase II/III Trial","C15694","Phase II/III Trial","['Trial Phase 2-3', '2-3']","Phase II/III Trial","A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.","False","c0351f40-1e00-4da4-92ec-bad257b633d1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C15694"
"3970","Phase IIa Trial","C49686","Phase IIa Trial","['Trial Phase 2A', '2A']","Phase IIa Trial","A clinical research protocol generally refered to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)","False","bc88a49f-e0ea-4f79-9a2b-df8bf1bebdcc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C49686"
"3971","Phase IIb Trial","C49688","Phase IIb Trial","['Trial Phase 2B', '2B']","Phase IIb Trial","A clinical research protocol generally refered to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)","False","b83f7587-a654-45df-9fd0-ca51258b23d6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C49688"
"3972","Phase III Trial","C15602","Phase III Trial","['Trial Phase 3', '3']","Phase III Trial","Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefitrisk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","b10ff245-168d-4fd6-b560-3938639282eb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C15602"
"3973","Phase IIIa Trial","C49687","Phase IIIaTrial","['Trial Phase 3A', '3A']","Phase IIIa Trial","A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.","False","25522f4f-2cb5-4c5d-9eae-05b2a572653f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C49687"
"3974","Phase IIIb Trial","C49689","Phase IIIb Trial","['Trial Phase 3B', '3B']","Phase IIIb Trial","A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.","False","ea683c6b-5a19-4642-9626-e50a5bf527a2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C49689"
"3975","Phase IV Trial","C15603","Phase IV Trial","['Trial Phase 4', '4']","Phase IV Trial","Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drugs risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","a8c08ed2-da76-4ffd-b76a-180452d16ee5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C15603"
"3976","Phase V Trial","C47865","Phase V Trial","['Trial Phase 5', '5']","Phase V Trial","Postmarketing surveillance is sometimes referred to as Phase V.","False","96e54c20-2b69-4871-9dec-607f77db6459","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C47865"
"3977","Not Applicable","C48660","","[]","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","c7ae5c6c-a7a3-4ac0-b008-00c1743ee3c0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66737/C48660"
"3978","Trial Summary Parameter Test Code","C66738","TSPARMCD","['Trial Summary Parameter Test Code']","CDISC SDTM Trial Summary Parameter Terminology by Code","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","4f5d21e1-f376-410e-b346-d59319e64057","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738"
"3979","Test Product Added to Existing Treatment","C49703","ADDON","['Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","439482c1-ea10-48cb-bf77-29d1950bbe64","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49703"
"3980","Adverse Event Dictionary","C49700","AEDICT","['Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","e278d5bd-3c0c-432c-b6cf-9e29bd2387a1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49700"
"3981","Planned Maximum Age of Subjects","C49694","AGEMAX","['Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","cca7b58a-8ddf-4ec1-9e0e-65567a4240cb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49694"
"3982","Planned Minimum Age of Subjects","C49693","AGEMIN","['Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","734418ae-bae3-4cfe-a5e9-d97cd9c3a4df","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49693"
"3983","Age Group","C20587","AGESPAN","['Age Group']","Age Group","Subgroups of populations based on age. (NCI)","False","2584f722-6e2a-415b-945a-511f4c945101","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C20587"
"3984","Age Unit","C50400","AGEU","['Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","5d83ecc3-307c-417b-a9a5-13f05885dc09","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C50400"
"3985","Dose","C25488","DOSE","['Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","1ec26045-55c5-433c-9d1b-2d928bd5d8ff","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C25488"
"3986","Drug Dictionary","C49701","DRUGDICT","['Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","75744e90-b414-4b1f-a981-94e79cb57365","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49701"
"3987","Trial Length","C49697","LENGTH","['Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","ea0e6cef-011e-4f25-b615-7dfc8df5010f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49697"
"3988","Medical History Dictionary","C49702","MHDICT","['Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","eccfd9dc-a488-48bb-9e68-19dd17239a3c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49702"
"3989","Planned Subject Number","C49692","PLANSUB","['Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","61cab024-2f07-425a-b8df-d9d1a584427b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49692"
"3990","Randomization","C25196","RANDOM","['Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","fe3be29d-60dd-4464-8912-a5bd2548a840","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C25196"
"3991","Route of Administration","C38114","ROUTE","['Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","ca7ea34d-40c4-4d9f-9b1a-24efac1ffce0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C38114"
"3992","Sex of Study Group","C49696","SEXPOP","['Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","5a0733f3-785d-4db2-9141-858791561a28","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49696"
"3993","Study Stop Rules","C49698","STOPRULE","['Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","d03feab7-9307-48f1-a44e-dcfba12d76fe","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49698"
"3994","Trial Blinding Schema","C49658","TBLIND","['Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","e1bb0c97-8606-419c-927a-63bb58cde19b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49658"
"3995","Control Type","C49647","TCNTRL","['Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","7e2a6137-ee8d-44ca-af30-09e7447b0d2d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49647"
"3996","Diagnosis Group","C49650","TDIGRP","['Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","e9d2c71c-0c44-4ee5-8dd6-18dc2d73c38f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49650"
"3997","Trial Indication Type","C49652","TINDTP","['Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","06ceb7f9-4e01-404c-9cad-2484e2244dd8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49652"
"3998","Trial Title","C49802","TITLE","['Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","e2e11346-be61-46bd-beee-3056c174b66d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49802"
"3999","Trial Phase","C48281","TPHASE","['Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","31944450-9130-4bcb-b227-1b4468cd3672","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C48281"
"4000","Trial Type","C49660","TTYPE","['Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","9f6db8bb-13ec-43cd-91ba-52a04b7af903","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66738/C49660"
"4001","Trial Summary Parameter Test Name","C67152","TSPARM","['Trial Summary Parameter Test Name']","CDISC SDTM Trial Summary Parameter Terminology by Name","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","7a6e2edb-3897-4b1c-bf25-4b34ed2bf6d9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152"
"4002","Test Product Added to Existing Treatment","C49703","Added on to Existing Treatments","['Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","371f7491-4cc3-4a38-9076-d5df2019941d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49703"
"4003","Adverse Event Dictionary","C49700","Adverse Event Dictionary","['Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","8cbdd6a8-172f-40ed-a55c-71ee7fd6518f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49700"
"4004","Planned Maximum Age of Subjects","C49694","Planned Maximum Age of Subjects","['Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","4be214f3-4ec8-4d52-bff1-d9acfd19e111","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49694"
"4005","Planned Minimum Age of Subjects","C49693","Planned Minimum Age of Subjects","['Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","7b98a39e-fc58-4727-8040-d0112ff68ad2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49693"
"4006","Age Group","C20587","Age Group","['Age Group']","Age Group","Subgroups of populations based on age. (NCI)","False","b857653e-a62b-45dc-82d6-96d7882bd5e5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C20587"
"4007","Age Unit","C50400","Age Unit","['Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","361442d8-eb46-4ce1-b13f-ab7c21c68164","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C50400"
"4008","Dose","C25488","Dose per Administration","['Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","47717521-4211-4b07-a77e-8258fe3508be","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C25488"
"4009","Drug Dictionary","C49701","Drug Dictionary","['Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","ea695133-16e8-497b-8f9b-a6e02092897f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49701"
"4010","Trial Length","C49697","Trial Length","['Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","485c957f-3a50-43af-82cc-8521cead710b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49697"
"4011","Medical History Dictionary","C49702","Medical History Dictionary","['Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","fb8d99d3-7fda-4bea-99fb-498884c41ffa","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49702"
"4012","Planned Subject Number","C49692","Planned Number of Subjects","['Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","432c9ffe-3e55-4d44-821b-16a14be1ba30","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49692"
"4013","Randomization","C25196","Trial is Randomized","['Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","0501dbc2-38ef-49b4-afa1-a3e2120f4e59","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C25196"
"4014","Route of Administration","C38114","Route of Administration","['Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","f09c436d-9368-4819-828e-30eebbb993ab","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C38114"
"4015","Sex of Study Group","C49696","Sex of Participants","['Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","66447e5a-0a58-4523-85b7-abd3016fc478","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49696"
"4016","Study Stop Rules","C49698","Study Stop Rules","['Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","721dc7a2-e191-409d-8219-4fde0aaae307","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49698"
"4017","Trial Blinding Schema","C49658","Trial Blinding Schema","['Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","21c16452-cffb-472a-86fe-8ba8eb251108","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49658"
"4018","Control Type","C49647","Control Type","['Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","9030dc66-7419-432e-aa4b-3ee476c18d0d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49647"
"4019","Diagnosis Group","C49650","Diagnosis Group","['Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","8197bff6-0123-460d-9324-bc274fe1703b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49650"
"4020","Trial Indication Type","C49652","Trial Indication Type","['Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","47b81957-b4b7-4754-b9d4-89086cf37f07","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49652"
"4021","Trial Title","C49802","Trial Title","['Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","d7933b77-182e-4fb5-9ac1-17dd11e03cb5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49802"
"4022","Trial Phase","C48281","Trial Phase Classification","['Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","d7dd831e-6e99-4595-acea-5b097ffaf480","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C48281"
"4023","Trial Type","C49660","Trial Type","['Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","8d601e26-f502-4cd1-8d2e-0fa0aa72ccf4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67152/C49660"
"4024","Trial Type","C66739","TTYPE","['Trial Type']","CDISC SDTM Trial Type Terminology","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","051a9558-171b-4ce6-ba93-efc66e28e594","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739"
"4025","Bioavailability Study","C49664","BIO-AVAILABILITY","[]","Bioavailability Study","A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)","False","36a417fd-4744-4383-b659-c6c93e9f086f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C49664"
"4026","Therapeutic Equivalency Study","C49665","BIO-EQUIVALENCE","[]","Therapeutic Equivalency Study","A study most often used to compare the efficacy of different formulations to treat a given disease.  It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)","False","0b9c559a-f576-4c98-8ef3-af1ac44e0dd6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C49665"
"4027","Efficacy Study","C49666","EFFICACY","[]","Efficacy Study","A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)","False","4b36f4e6-f33c-47dd-b5b6-45f9b87a6e6b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C49666"
"4028","Pharmacodynamic Study","C49662","PHARMACODYNAMIC","[]","Pharmacodynamic Study","A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)","False","6b39b4fa-35b7-422a-8348-b04733e1e1ef","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C49662"
"4029","Pharmacoeconomic Study","C39493","PHARMACOECONOMIC","[]","Pharmacoeconomic Study","A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)","False","8e4cdb46-52b0-411c-ae99-dc54986a9d95","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C39493"
"4030","Pharmacogenomic Study","C49661","PHARMACOGENOMIC","[]","Pharmacogenomic Study","A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)","False","7abfd4e4-cc44-4220-864c-52feec0cc427","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C49661"
"4031","Pharmacokinetic Study","C49663","PHARMACOKINETIC","[]","Pharmacokinetic Study","A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)","False","2c9ed46d-25db-46e2-8785-be0589d5e5b0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C49663"
"4032","Safety Study","C49667","SAFETY","[]","Safety Study","A study of the relative safety of treatment of a disease. Usually this is a Phase I or II trial. (NCI)","False","7b857546-e90a-413c-b0c5-9d1a0b944551","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66739/C49667"
"4033","Units for Vital Signs Results","C66770","VSRESU","['Units for Vital Signs Results']","CDISC SDTM Unit for Vital Sign Result Terminology","The unit used to record and describe the result of a test investigating a vital sign. (NCI)","False","34e2a793-d2be-4cee-978a-e969618a76ae","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770"
"4034","Percentage","C25613","%","['Percentage']","Percentage","A fraction or ratio with 100 understood as the denominator. (NCI)","False","1beff167-792f-4040-b19f-2b107a2a7ee6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C25613"
"4035","Beats per Minute","C49673","BEATS/MIN","['Beats per Minute']","Beats per Minute","The number of heartbeats measured per minute time. (NCI)","False","ac2b83fe-80ab-4952-8bb9-51e2727f65de","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C49673"
"4036","Breaths per Minute","C49674","BREATHS/MIN","['Breaths per Minute']","Breaths per Minute","The number of breaths (inhalation and exhalation) taken per minute time. (NCI)","False","86a71d9e-fe28-4ec5-86b4-568577d78a25","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C49674"
"4037","Degree Celsius","C42559","C","['Degree Celsius']","Degree Celsius","A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)","False","02f90dea-cfe2-4495-9d96-08f9bab171ea","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C42559"
"4038","Centimeter","C49668","cm","['Centimeter']","Centimeter","A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)","False","2ee53a9c-b204-44f0-84ea-37aef3eafc0f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C49668"
"4039","Degree Fahrenheit","C44277","F","['Degree Fahrenheit']","Degree Fahrenheit","The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724.  In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)","False","2c148a60-b958-4606-8c8a-bd68efe1c567","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C44277"
"4040","Gram","C48155","g","['Gram']","Gram","A metric unit of mass equal to one one thousandth of a kilogram. (NCI)","False","d3a8110e-0cfd-4f6a-a322-84ee14d753bd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C48155"
"4041","Inch","C48500","IN","['Inch']","Inch","A traditional unit of length equal to 2.54 centimeters. (NCI)","False","bb67bc4d-d13a-432a-9173-ab06b4c80e2e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C48500"
"4042","Kilogram","C28252","kg","['Kilogram']","Kilogram","The basic SI unit of mass.  It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)","False","39ef56d0-5809-4b44-a514-483acb4b878d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C28252"
"4043","Kilogram Per Square Meter","C49671","kg/m2","['Kilogram Per Square Meter']","Kilogram Per Square Meter","The SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)","False","7f3a5680-a13b-44a2-9511-488cb67ee7e4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C49671"
"4044","Pound","C48531","LB","['Pound']","Pound","A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)","False","c96e9123-1112-42b5-a6a6-71d27644f5c9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C48531"
"4045","Square Meter","C42569","m2","['Square Meter']","Square Meter","The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)","False","484103da-7043-4398-b48f-bb94b23b91fb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C42569"
"4046","Millimeter of Mercury","C49670","mmHg","['Millimeter of Mercury']","Millimeter of Mercury","A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)","False","f72c848f-d780-44d4-bcea-04c46318cc47","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C49670"
"4047","Ohm","C42554","ohm","['ohm']","Ohm","A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens. (NCI)","False","7c89e49d-c5a1-4b11-9d8a-b1e6909ec551","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66770/C42554"
"4048","Vital Signs Test Code","C66741","VSTESTCD","['Vital Signs Test Code']","CDISC SDTM Vital Sign Terminology by Code","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","a8f06a52-ae91-4972-8b97-bb15300ea1c7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741"
"4049","Body Mass Index","C16358","BMI","['Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","2ff193cf-c0a8-41b5-ae9c-7819f845f4a7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C16358"
"4050","Adipose Tissue","C12472","BODYFAT","['Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","2e758cfc-f4a2-4e62-98e8-e168748c31ac","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C12472"
"4051","Body Surface Area","C25157","BSA","['Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","0109d04b-d5e2-40bb-9506-c2abec731785","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C25157"
"4052","Diastolic Blood Pressure","C25299","DIABP","['Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","a2c19032-ce40-44be-b7e2-f78fbe479128","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C25299"
"4053","Body Frame Size","C49680","FRMSIZE","['Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","feadb04b-6891-4f00-9670-f39f50c70734","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C49680"
"4054","Height","C25347","HEIGHT","['Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","2070862d-389b-40e4-abaf-50dac1b2f052","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C25347"
"4055","Heart Rate","C49677","HR","['Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","741b488f-8e6c-4866-a2d1-998b4ed48c93","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C49677"
"4056","Mean Arterial Pressure","C49679","MAP","['Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","499a76cb-b5cf-44f3-b16e-297c7b624d13","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C49679"
"4057","Pulse Rate","C49676","PULSE","['Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","96d465c3-8e74-41ca-af13-f66422da8576","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C49676"
"4058","Respiratory Rate","C49678","RESP","['Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","671d3c1f-ee15-43b1-9a2e-27659fd1a02e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C49678"
"4059","Systolic Blood Pressure","C25298","SYSBP","['Systolic Blood']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","c6ed268d-d17e-48b5-8ced-f2ff12f14894","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C25298"
"4060","Temperature","C25206","TEMP","['Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","107d14b9-6687-40a2-948c-6d05ba756cc4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C25206"
"4061","Weight","C25208","WEIGHT","['Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","6d80de5a-54ee-4e33-afe9-b9e879b0eda5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66741/C25208"
"4062","Vital Signs Test Name ","C67153","VSTEST","['Vital Signs Test Name']","CDISC SDTM Vital Sign Terminology  by Name","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","fa0d33e7-9dcd-4266-9fbc-7d98588367d1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153"
"4063","Body Mass Index","C16358","Body Mass Index","['Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","2cdc26a2-2631-4c18-a9a4-d8134dfaea0e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C16358"
"4064","Adipose Tissue","C12472","Adipose Tissue","['Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","994645bc-e283-4354-b110-8cc8d6068b18","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C12472"
"4065","Body Surface Area","C25157","Body Surface Area","['Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","82162c62-55b0-4b53-82db-460277920168","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C25157"
"4066","Diastolic Blood Pressure","C25299","Diastolic Blood Pressure","['Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","e99e73c9-b698-474b-94c7-b7fceb02235e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C25299"
"4067","Body Frame Size","C49680","Body Frame Size","['Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","5f6e6c15-b8e2-4ae6-b987-a519e6a0c7b8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C49680"
"4068","Height","C25347","Height","['Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","415c3cf3-ed8a-4b93-ac4f-bb0382bc3357","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C25347"
"4069","Heart Rate","C49677","Heart Rate","['Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","270e2d7a-ffe5-4dae-b611-f361b1c2fd3a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C49677"
"4070","Mean Arterial Pressure","C49679","Mean Arterial Pressure","['Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","01e669a8-8fc5-4d31-8ae9-2906d48003da","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C49679"
"4071","Pulse Rate","C49676","Pulse Rate","['Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","51ff0ae4-5abb-42e3-823b-e956838dbf2f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C49676"
"4072","Respiratory Rate","C49678","Respiratory Rate","['Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","255e7165-05b5-4a6a-90b0-f9ca5dc9c691","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C49678"
"4073","Systolic Blood Pressure","C25298","Systolic Blood Pressure","['Systolic Blood Pressure']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","d25d419b-79e2-41da-b7fa-a6859f444295","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C25298"
"4074","Temperature","C25206","Temperature","['Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","849d4c0b-c2c4-47d3-9fa4-53d05d561fb5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C25206"
"4075","Weight","C25208","Weight","['Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","46699055-2d1a-42e8-9d73-e9f68caaffcf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67153/C25208"
"4076","No Yes Response","C66742","NY","['No Yes Response']","CDISC SDTM Yes No Unknown or Not Applicable Response Terminology","A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.","False","8542707a-afa6-4f85-afee-c74549cfce82","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66742"
"4077","No","C49487","N","['No']","No","The non-affirmative response to a question. (NCI)","False","fefb254d-792c-4041-b4c2-decd3e0ab95f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66742/C49487"
"4078","Not Applicable","C48660","","[]","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","5bef85a8-deb8-4544-8b01-3fc25e839f33","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66742/C48660"
"4079","Unknown","C17998","U","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","5eab77c9-3d55-43f2-8a11-f67010b6ada1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66742/C17998"
"4080","Yes","C49488","Y","['Yes']","Yes","The affirmative response to a question. (NCI)","False","fb2adc10-08a9-4523-9c6f-98ed51ceb59f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C66742/C49488"
"4081","Laboratory Test Code","C65047","LBTESTCD","['Laboratory Test Code']","CDISC SDTM Laboratory Test Terminology by Code","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","7e51e082-f9cc-469f-832c-f3f3aaed142a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047"
"4082","Anisocytosis","C35266","ANISO","['Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","d03d60da-99af-4db0-bb0b-0358f6811a04","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C35266"
"4083","Poikilocytosis","C35267","POIKILO","['Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","5b232ea1-d51b-4c89-865d-b21ed1ef7da3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C35267"
"4084","Total Bilirubin","C38037","BILI","['Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","7ce43aa7-4b4c-42d8-9841-cf97d6ade9d9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C38037"
"4085","Partial Thromboplastin Time","C38462","APTT","['Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","ee4089d7-0b65-47eb-9e40-e244d1e0d3da","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C38462"
"4086","Plasma Glucose Measurement","C41376","GLUC","['Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","3dc36b50-f915-4048-8c1c-0dab666b9ab1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C41376"
"4087","pH","C45997","PH","['pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","bd33d3cc-c564-4e7d-9633-8735fdd4afff","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C45997"
"4088","Erythrocyte Count","C51946","RBC","['Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","757fd250-49d8-4d61-a3ff-d73c3c75eacf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C51946"
"4089","Reticulocyte Count","C51947","RETI","['Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","74f23c1d-4742-4088-8832-645b11aa7aed","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C51947"
"4090","Leukocyte Count","C51948","WBC","['Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","52f0ed0c-0b03-42ee-b20e-3fe461dae125","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C51948"
"4091","Lymphocyte Count","C51949","LYM","['Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","b0eafc51-46dc-4585-92c6-b642dddef0ce","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C51949"
"4092","Platelet Count","C51951","PLAT","['Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","b38d741e-405b-4815-b2fd-2d0b9c48fe36","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C51951"
"4093","Blood Urea Nitrogen Measurement","C61019","BUN","['Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","bdf0b3e2-e17d-45b6-b692-f172467f95d5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C61019"
"4094","Serum Total Cholesterol Measurement","C61032","CHOL","['Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","5ad7b347-f716-420e-baa4-436a21177803","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C61032"
"4095","Serum HDL Cholesterol Measurement","C61041","HDL","['HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","9802dcc5-32b7-42cd-a9f7-d4b417b6b2a6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C61041"
"4096","Serum LDL Cholesterol Measurement","C61042","LDL","['LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","cc87f9ee-302d-4d4e-910e-a60b04e4fa85","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C61042"
"4097","Prothrombin Time","C62656","PT","['Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","5167609b-387b-441d-b826-9c7b5d7a4cc1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C62656"
"4098","Absolute Neutrophil Count","C63321","NEUT","['Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","8254927d-392e-4144-a6bb-ddebf72a7f0f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C63321"
"4099","Albumin Measurement","C64431","ALB","['Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","b7b72b45-d111-4ddf-bc0a-1ecf4de202ef","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64431"
"4100","Alkaline Phosphatase Measurement","C64432","ALP","['Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","83f9db2f-ef4b-460c-b4ac-7e3849342b46","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64432"
"4101","Alanine Aminotransferase Measurement","C64433","ALT","['Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","674fc3db-a6c6-43bf-8199-8d1707e36dc4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64433"
"4102","Amylase Measurement","C64434","AMYLASE","['Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","8a8740cf-9bf5-478b-b0af-c02be0c4afb0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64434"
"4103","Aspartate Aminotransferase Measurement","C64467","AST","['Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","b1276231-7a58-496d-a97a-d891f320c55f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64467"
"4104","Bacterial Count","C64469","BACT","['Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","83bfcbc9-b2c9-4f5d-8fb4-a6eb632a730f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64469"
"4105","Total Basophil Count","C64470","BASO","['Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","2ee94e8c-4e0c-4c9e-a6f8-572b4df1d223","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64470"
"4106","Basophil To Leukocyte Ratio","C64471","BASOLE","['Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","60032eaf-4c28-4761-b940-a80ede8202d2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64471"
"4107","Direct Bilirubin Measurement","C64481","BILDIR","['Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","c4126886-1c34-40c7-86af-c393500511ad","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64481"
"4108","Indirect Bilirubin Measurement","C64483","BILIND","['Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","e05ad01c-88d1-4fec-81d9-69ff9eda2c1a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64483"
"4109","Blast To Leukocyte Ratio","C64487","BLASTLE","['Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","27ce6ae4-83de-48b2-90da-3cb465236283","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64487"
"4110","Calcium Measurement","C64488","CA","['Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","f29ac9f4-f32e-4a36-bf72-9bac59f3472d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64488"
"4111","Creatine Kinase Measurement","C64489","CK","['Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","7de45a07-2591-481e-bf38-600e0fd504f7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64489"
"4112","Creatine Kinase BB Measurement","C64490","CKBB","['Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","d1bf3ea5-1066-4b20-a55d-8facd866b1ea","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64490"
"4113","Creatine Kinase MB Measurement","C64491","CKMB","['Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","9e40475c-90a1-4c38-a873-334048be71d5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64491"
"4114","Creatine Kinase MM Measurement","C64494","CKMM","['Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","bcc6de88-633f-4136-a054-577bde44caad","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64494"
"4115","Chloride Measurement","C64495","CL","['Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","44523cc3-1bbf-4da1-86bd-5f90ddd2aa75","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64495"
"4116","Carbon Dioxide Measurement","C64545","CO2","['Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","60f79f5f-d72c-49b9-af2a-662015df4efd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64545"
"4117","Color Assessment","C64546","COLOR","['Color']","Color Assessment","A measurement of the color of a biological specimen.","False","c255db83-800d-4f91-a190-9224e3a810f3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64546"
"4118","Creatinine Measurement","C64547","CREAT","['Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","b4c16764-cf93-4504-af2c-2f9d9b36a346","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64547"
"4119","C-Reactive Protein Measurement","C64548","CRP","['C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","e362c9b8-bedb-4de2-a491-c4ad8bafcbf1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64548"
"4120","Elliptocyte Count","C64549","ELLIPCY","['Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","57097aaf-d07d-497e-9603-068e814177a4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64549"
"4121","Eosinophil Count","C64550","EOS","['Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","e18afb70-0468-4735-bf9a-54452292b46e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64550"
"4122","Eosinophil To Leukocyte Ratio","C64604","EOSLE","['Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","dafc9b3e-b0af-4e3c-93f9-b2a6dbf20773","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64604"
"4123","Epithelial Cell Count","C64605","EPIC","['Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","329b49d1-c4e6-4d44-9566-9d9c19fc695f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64605"
"4124","Fibrinogen Measurement","C64606","FIBRINO","['Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","681e1c2a-d0c8-464d-8573-0f2ba30a9bb1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64606"
"4125","Hematocrit","C64796","HCT","['Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","85f9b68d-9c93-425f-af69-f280b78e1ecb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64796"
"4126","Erythrocyte Mean Corpuscular Hemoglobin","C64797","MCH","['Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","d566b72e-5417-4346-93da-942312663da3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64797"
"4127","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","MCHC","['Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","3315a3ff-a368-4cc3-829d-e78234e9174c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64798"
"4128","Erythrocyte Mean Corpuscular Volume","C64799","MCV","['Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","3c0c1a1d-1589-448b-a427-a7bcf39faee3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64799"
"4129","Erythrocyte Distribution Width Measurement","C64800","RDW","['Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","705798c7-c53b-4fab-ac6b-5d9b6da7404d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64800"
"4130","Dacryocyte Analysis","C64801","TEARDCY","['Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","580d441e-2b8d-4d52-bd17-c6055f064150","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64801"
"4131","Hypochromia","C64802","HYPO","['Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","c8cf82e4-fb37-4167-aa71-ba485043bc91","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64802"
"4132","Polychromasia","C64803","POLYCHR","['Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","93a8aca4-fc54-4a32-94ad-fbd82881c9d8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64803"
"4133","International Normalized Ratio of Prothrombin Time","C64805","INR","['Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","de71e614-c116-44ad-9842-42e807e775ff","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64805"
"4134","Serum VLDL Cholesterol Measurement","C64806","VLDL","['VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","829511c5-730f-4a17-89df-e6063b51316e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64806"
"4135","Triacylglycerol Lipase Measurement","C64807","LIPASE","['Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","c8ded728-fd56-473a-8d60-9e2b74eb203d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64807"
"4136","Sodium Measurement","C64809","SODIUM","['Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","ffd6176f-1cad-4852-8492-5e899fbfdb25","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64809"
"4137","Nitrite Measurement","C64810","NITRITE","['Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","3300e534-bd45-48a5-ae59-3a4b0bc2200f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64810"
"4138","Triglyceride Measurement","C64812","TRIG","['Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","a2bc6fbf-9104-40a4-9533-2585d5844459","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64812"
"4139","Thyrotropin Measurement","C64813","TSH","['Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","76c66bf5-522f-4318-8be9-fa2d24cf573d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64813"
"4140","Urate Measurement","C64814","URATE","['Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","53ee8714-5662-48e2-bfdb-86e1eae89e29","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64814"
"4141","Urea Measurement","C64815","UREA","['Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","a6526e66-58fe-4ae1-8748-b4fb3479e892","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64815"
"4142","Urobilinogen Measurement","C64816","UROBIL","['Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","c0f4ad6f-5fe8-46c1-91ec-f4988b67af4f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64816"
"4143","Vitamin B12 Measurement","C64817","VITB12","['Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","5d8bc16c-64f5-4506-ae2b-d77c2b4ac601","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64817"
"4144","Atypical Lymphocyte Count","C64818","LYMAT","['Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","d1be36bc-0bec-4d34-ac5b-0c7c9919d8fe","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64818"
"4145","Atypical Lymphocyte To Leukocyte Ratio","C64819","LYMATLE","['Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","667f0ddd-6301-4fe1-a629-5b530d5e1755","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64819"
"4146","Lymphocyte To Leukocyte Ratio","C64820","LYMLE","['Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","a29aa39c-8598-4a8c-a435-acb39bf2bb32","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64820"
"4147","Macrocyte Count","C64821","MACROCY","['Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","852921ef-d96e-485a-b37e-3ec4cdb5a8bf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64821"
"4148","Microcyte Count","C64822","MICROCY","['Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","c7ae7b9e-29e2-4b51-bb64-5d05c927fe8f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64822"
"4149","Monocyte Count","C64823","MONO","['Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","5afeb669-f5af-42c0-8290-af885cd97675","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64823"
"4150","Monocyte To Leukocyte Ratio","C64824","MONOLE","['Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","79453481-75c6-40be-9437-bb43e5aadd73","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64824"
"4151","Myeloblast To Leukocyte Ratio","C64825","MYBLALE","['Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","429896cd-4d93-4ea8-ac29-c727d07445de","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64825"
"4152","Myelocyte To Leukocyte Ratio","C64826","MYCYLE","['Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","19d42606-589f-4e21-8704-4233ce66adda","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64826"
"4153","Neutrophil To Leukocyte Ratio","C64827","NEUTLE","['Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","fd08000c-1df0-4cc1-8388-378831ef7367","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64827"
"4154","Reticulocyte To Erythrocyte Ratio","C64828","RETIRBC","['Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","83c2d4cc-29bd-434b-8f91-e792cf00656d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64828"
"4155","Prolymphocyte To Leukocyte Ratio","C64829","PRLYMLE","['Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","92156429-ea2d-4653-99b0-58bef9f79f96","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64829"
"4156","Neutrophil Band Form Count","C64830","NEUTB","['Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","e0cf5cee-aaea-4788-ab1b-4df42cc32cd1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64830"
"4157","Neutrophil Band Form To Leukocyte Ratio","C64831","NEUTBLE","['Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","0ba51e3b-9b89-4041-a93e-c68140275422","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64831"
"4158","Specific Gravity","C64832","SPGRAV","['Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","bb31f39b-a866-45fd-82d5-b769f5518565","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64832"
"4159","Magnesium Measurement","C64840","MG","['Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","ba91e463-4226-4101-b1d8-709af07425f7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64840"
"4160","Gamma Glutamyl Transpeptidase Measurement","C64847","GGT","['Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","ced407a6-61de-4fe1-ab90-1ca8e6b10c07","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64847"
"4161","Hemoglobin Measurement","C64848","HGB","['Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","a437c366-b121-4532-a692-e6df0af81432","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64848"
"4162","Glycosylated Hemoglobin Measurement","C64849","HBA1C","['Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","ced5b19d-1b52-4c1d-a93b-5accee1ed311","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64849"
"4163","Hepatitis B Virus Surface Antigen Measurement","C64850","HBSAG","['Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","4dd3f52a-aebb-4e82-a0c3-a83cf616823d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64850"
"4164","Choriogonadotropin Beta Measurement","C64851","HCG","['Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","89630b76-08b0-4b11-aaca-a52cfa93a7eb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64851"
"4165","Potassium Measurement","C64853","K","['Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","d0ff9304-b827-4e23-a596-76a50cc93d7d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64853"
"4166","Ketone Measurement","C64854","KETONES","['Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","c6f547c6-8434-4c84-8425-7f700815ca4f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64854"
"4167","Lactate Dehydrogenase Measurement","C64855","LDH","['Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","6ee38011-7010-45bc-8353-2c0f432d2faf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64855"
"4168","Leukocyte Esterase Measurement","C64856","LEUKASE","['Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","3a90f8fb-fe82-4b16-a430-9acdd4ab72ea","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64856"
"4169","Phosphate Measurement","C64857","PHOS","['Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","d992abd1-db8e-4455-aaf7-e3150a192b5b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64857"
"4170","Total Protein Measurement","C64858","PROT","['Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","77ab2c73-b9c9-4f4d-86cc-2268f57a8598","dataset/cdisc/ct/sc/2007-05-31/sdtm/C65047/C64858"
"4171","Laboratory Test Name ","C67154","LBTEST","['Laboratory Test Name']","CDISC SDTM Laboratory Test Terminology by Name","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","4a52fcd9-2730-4c28-ad4e-5ef4018fc1aa","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154"
"4172","Anisocytosis","C35266","Anisocytosis","['Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","061e1356-d47d-408d-a493-95ee6f0e0ce6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C35266"
"4173","Poikilocytosis","C35267","Poikilocytes","['Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","460744f1-1faf-4199-b3df-8b39ebbfa7ea","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C35267"
"4174","Total Bilirubin","C38037","Bilirubin","['Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","579d91f0-8126-491e-b40a-335791ed3373","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C38037"
"4175","Partial Thromboplastin Time","C38462","Activated Partial Thromboplastin Time","['Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","dd87d4e4-f48d-4093-85e0-e1200c649324","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C38462"
"4176","Plasma Glucose Measurement","C41376","Glucose","['Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","7f148f02-341f-4d4e-a413-0f71b77d21df","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C41376"
"4177","pH","C45997","pH","['pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","3d656b86-9b2b-41e2-a316-6e91f87161e5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C45997"
"4178","Erythrocyte Count","C51946","Erythrocytes","['Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","729254b8-13e1-41cc-baff-2fc398247422","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C51946"
"4179","Reticulocyte Count","C51947","Reticulocytes","['Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","68763a35-076e-4c69-a575-0112585591bd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C51947"
"4180","Leukocyte Count","C51948","Leukocytes","['Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","8a430546-5373-499c-8774-3d21d912371a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C51948"
"4181","Lymphocyte Count","C51949","Lymphocytes","['Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","cd522788-324a-410b-ba5a-3664e5eee90a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C51949"
"4182","Platelet Count","C51951","Platelet","['Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","40b7904d-d134-4bc5-986b-0d7f0df341a4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C51951"
"4183","Blood Urea Nitrogen Measurement","C61019","Blood Urea Nitrogen","['Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","82ae9112-8007-40d3-8276-d0a352ab06bb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C61019"
"4184","Serum Total Cholesterol Measurement","C61032","Cholesterol","['Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","7090b3d9-3a45-4915-99d2-f9a95cc92fbc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C61032"
"4185","Serum HDL Cholesterol Measurement","C61041","HDL Cholesterol","['HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","a4fa8500-fe4a-4137-9c77-57018181fe24","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C61041"
"4186","Serum LDL Cholesterol Measurement","C61042","LDL Cholesterol","['LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","b611eb5b-6ee8-4efb-bbaf-aa2304e835f1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C61042"
"4187","Prothrombin Time","C62656","Prothrombin Time","['Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","dcefe7e0-2cf8-4573-8649-74cd16edef2e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C62656"
"4188","Absolute Neutrophil Count","C63321","Neutrophils","['Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","81fb9349-d6cb-4491-964a-27c3bee3cb2d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C63321"
"4189","Albumin Measurement","C64431","Albumin","['Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","e9fb3dd6-b584-4c52-9073-ece72983de18","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64431"
"4190","Alkaline Phosphatase Measurement","C64432","Alkaline Phosphatase","['Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","b3cf69c3-4bc4-4965-8eb9-7fb48dc25f18","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64432"
"4191","Alanine Aminotransferase Measurement","C64433","Alanine Aminotransferase","['Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","f10d6af0-5d19-4898-bdaa-9a73866fae38","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64433"
"4192","Amylase Measurement","C64434","Amylase","['Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","0e941848-38e9-4b27-bcec-0d64a93a258d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64434"
"4193","Aspartate Aminotransferase Measurement","C64467","Aspartate Aminotransferase","['Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","5b2e7f12-fcdc-4ea4-a1ea-fa45559d4f7c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64467"
"4194","Bacterial Count","C64469","Bacteria","['Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","87e084fa-5132-4f72-8b4d-906a5e48d42c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64469"
"4195","Total Basophil Count","C64470","Basophils","['Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","aef62863-bc4f-4dbe-8d8d-6eb2e4d630c8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64470"
"4196","Basophil To Leukocyte Ratio","C64471","Basophils/Leukocytes","['Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","1ce03c4c-02aa-4097-aa20-03d0f6b8b560","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64471"
"4197","Direct Bilirubin Measurement","C64481","Direct Bilirubin","['Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","2996c940-89d1-4f3e-9847-4232cd7aa702","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64481"
"4198","Indirect Bilirubin Measurement","C64483","Indirect Bilirubin","['Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","75b71164-308c-461b-b021-9588b593d666","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64483"
"4199","Blast To Leukocyte Ratio","C64487","Blasts/Leukocytes","['Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","ef79d738-1fa1-4978-946d-62f009f3331a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64487"
"4200","Calcium Measurement","C64488","Calcium","['Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","cd79be47-81a4-45a5-881c-648e4bfc2b73","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64488"
"4201","Creatine Kinase Measurement","C64489","Creatine Kinase","['Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","b7145cdf-29b9-4af9-8f99-a41feeee870d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64489"
"4202","Creatine Kinase BB Measurement","C64490","Creatine Kinase BB","['Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","31ea23c3-1838-41a9-af39-0332c29c9349","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64490"
"4203","Creatine Kinase MB Measurement","C64491","Creatine Kinase MB","['Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","73e36d11-1e4c-4e95-b642-d3eac9d4f236","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64491"
"4204","Creatine Kinase MM Measurement","C64494","Creatine Kinase MM","['Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","133545b9-f28f-4fbb-8116-fc0130c3fcfd","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64494"
"4205","Chloride Measurement","C64495","Chloride","['Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","1946a286-044f-482c-81b6-4ea5b7184ea0","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64495"
"4206","Carbon Dioxide Measurement","C64545","Carbon Dioxide","['Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","85b60e71-b12f-415d-891a-34a0f4413050","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64545"
"4207","Color Assessment","C64546","Color","['Color']","Color Assessment","A measurement of the color of a biological specimen.","False","8d4a3c4e-ed9e-407f-b688-d98ae8b32b91","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64546"
"4208","Creatinine Measurement","C64547","Creatinine","['Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","1c659177-c443-44d0-9130-6f6d3ca60b5b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64547"
"4209","C-Reactive Protein Measurement","C64548","C Reactive Protein","['C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","45f15cbc-6cbd-48ac-8e9e-0f066b86d2b4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64548"
"4210","Elliptocyte Count","C64549","Elliptocytes","['Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","b46ad24c-2437-424b-87be-bc5e3aa9c78b","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64549"
"4211","Eosinophil Count","C64550","Eosinophils","['Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","6d82cefa-91ac-4e8b-b9bf-9653b71d3c9e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64550"
"4212","Eosinophil To Leukocyte Ratio","C64604","Eosinophils/Leukocytes","['Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","c29e23d3-f74b-42b9-8fcc-d490ff3f40ad","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64604"
"4213","Epithelial Cell Count","C64605","Epithelial Cells","['Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","59123079-ea72-4d09-80df-6838c89f14e4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64605"
"4214","Fibrinogen Measurement","C64606","Fibrinogen","['Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","dcaf5f7a-ffd4-42ef-ae70-1f8fdf74de68","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64606"
"4215","Hematocrit","C64796","Hematocrit","['Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","0d0c5ed8-fd88-4b8b-98bf-d8173bc26b78","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64796"
"4216","Erythrocyte Mean Corpuscular Hemoglobin","C64797","Ery. Mean Corpuscular Hemoglobin","['Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","129e9236-e886-4078-bfcc-7c042c77c079","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64797"
"4217","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","Ery. Mean Corpuscular HB Concentration","['Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","b3e55416-6220-425e-a29d-20f37482325f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64798"
"4218","Erythrocyte Mean Corpuscular Volume","C64799","Ery. Mean Corpuscular Volume","['Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","c7ca93d0-829f-424c-a37e-2f93cfcaaefb","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64799"
"4219","Erythrocyte Distribution Width Measurement","C64800","Erythrocytes Distribution Width","['Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","cd1d4750-dc10-4785-b649-ad82ba9991c7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64800"
"4220","Dacryocyte Analysis","C64801","Dacryocytes","['Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","1ce7f751-0003-44aa-af58-67ead3d79d17","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64801"
"4221","Hypochromia","C64802","Hypochromia","['Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","4085c05c-a6d7-49ed-936e-7d48aeafbcc1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64802"
"4222","Polychromasia","C64803","Polychromasia","['Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","01c58d1c-d61a-472b-aed8-17339fc66dde","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64803"
"4223","International Normalized Ratio of Prothrombin Time","C64805","Prothrombin Intl. Normalized Ratio","['Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","8c72ab35-a6ff-4fdb-bbcc-66b06de24834","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64805"
"4224","Serum VLDL Cholesterol Measurement","C64806","VLDL Cholesterol","['VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","2a657af1-aeec-46cd-b6da-24487ff61ef6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64806"
"4225","Triacylglycerol Lipase Measurement","C64807","Triacylglycerol Lipase","['Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","f2c8b1eb-a3e7-458b-bb20-75e69d95b414","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64807"
"4226","Sodium Measurement","C64809","Sodium","['Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","3e9d34e1-14a5-43c7-9c6e-1a96fc223f05","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64809"
"4227","Nitrite Measurement","C64810","Nitrite","['Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","d9566a5f-b81e-45c9-8076-71cb0cb8af2c","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64810"
"4228","Triglyceride Measurement","C64812","Triglycerides","['Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","495d8458-0089-4b34-a1c1-3b88614512b3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64812"
"4229","Thyrotropin Measurement","C64813","Thyrotropin","['Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","2d4e57a9-3b42-4849-9aed-123375e1bf11","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64813"
"4230","Urate Measurement","C64814","Urate","['Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","a7eeca4b-b124-4e81-ab5d-10b7e055e622","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64814"
"4231","Urea Measurement","C64815","Urea","['Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","3cf2aa39-132c-4ad8-9a82-7b4b04928caf","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64815"
"4232","Urobilinogen Measurement","C64816","Urobilinogen","['Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","8cfd3f7c-2c24-42be-8eda-e96df9c0b0aa","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64816"
"4233","Vitamin B12 Measurement","C64817","Vitamin B12","['Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","1fb1c255-abd7-4011-bb1e-3e5779a7a6fc","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64817"
"4234","Atypical Lymphocyte Count","C64818","Lymphocytes Atypical","['Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","f0dade16-78fd-4050-a62c-1a178c3e5700","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64818"
"4235","Atypical Lymphocyte To Leukocyte Ratio","C64819","Lymphocytes Atypical/Leukocytes","['Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","5d051ae4-38cd-43b7-8ec6-1c756a750f10","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64819"
"4236","Lymphocyte To Leukocyte Ratio","C64820","Lymphocytes/Leukocytes","['Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","e652141f-9c67-4526-a30b-f25954261061","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64820"
"4237","Macrocyte Count","C64821","Macrocytes","['Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","9408d705-5f2d-46a5-abfe-88ec8ed30a80","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64821"
"4238","Microcyte Count","C64822","Microcytes","['Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","45cc1683-f868-4585-9052-038df15b0a8d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64822"
"4239","Monocyte Count","C64823","Monocytes","['Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","e8c25845-f017-439a-b9ac-9855bb791b98","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64823"
"4240","Monocyte To Leukocyte Ratio","C64824","Monocytes/Leukocytes","['Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","11cdfdfb-1e4e-4131-9173-5f3ee15225c5","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64824"
"4241","Myeloblast To Leukocyte Ratio","C64825","Myeloblasts/Leukocytes","['Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","3df53cdd-fefd-4d1d-aac7-02ed09a7f6f9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64825"
"4242","Myelocyte To Leukocyte Ratio","C64826","Myelocytes/Leukocytes","['Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","5f3d5d08-43fd-416d-9d99-1f32dcb394f6","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64826"
"4243","Neutrophil To Leukocyte Ratio","C64827","Neutrophils/Leukocytes","['Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","fb843f7e-6fce-4215-a27c-4f053e4b1ff3","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64827"
"4244","Reticulocyte To Erythrocyte Ratio","C64828","Reticulocytes/Erythrocytes","['Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","a4b0af40-4faf-4d03-9121-3d350a79bbf1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64828"
"4245","Prolymphocyte To Leukocyte Ratio","C64829","Prolymphocytes/Leukocytes","['Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","887d77f9-7e86-4943-892c-7674c71a8ff4","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64829"
"4246","Neutrophil Band Form Count","C64830","Neutrophils Band Form","['Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","d996cce4-c514-4e47-b7a0-7cb48357a0c7","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64830"
"4247","Neutrophil Band Form To Leukocyte Ratio","C64831","Neutrophils Band Form/Leukocytes","['Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","e2407815-13b1-44c9-907e-4a36352ec497","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64831"
"4248","Specific Gravity","C64832","Specific Gravity","['Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","3653bd29-6dd7-4205-b084-9878996205d9","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64832"
"4249","Magnesium Measurement","C64840","Magnesium","['Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","3ba99765-2db1-4cb2-a927-3f78f6cc2425","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64840"
"4250","Gamma Glutamyl Transpeptidase Measurement","C64847","Gamma Glutamyl Transferase","['Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","40f429d3-8ce5-4716-b361-1efe703ce6e1","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64847"
"4251","Hemoglobin Measurement","C64848","Hemoglobin","['Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","93a62aee-432f-4a7f-a1f1-aa6a496bc722","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64848"
"4252","Glycosylated Hemoglobin Measurement","C64849","Hemoglobin A1C","['Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","ea587c52-e10a-4519-9c72-374de10eac5e","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64849"
"4253","Hepatitis B Virus Surface Antigen Measurement","C64850","Hepatitis B Virus Surface Antigen","['Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","88d7dc42-64e2-407b-983d-380f61c08f2a","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64850"
"4254","Choriogonadotropin Beta Measurement","C64851","Choriogonadotropin Beta","['Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","d7f1d914-4206-420c-9d82-d549eb61621d","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64851"
"4255","Potassium Measurement","C64853","Potassium","['Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","0169c910-11eb-4d22-845b-1fb2b455d7de","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64853"
"4256","Ketone Measurement","C64854","Ketones","['Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","7113cdbd-dab4-4e83-b75d-48e008c913a2","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64854"
"4257","Lactate Dehydrogenase Measurement","C64855","Lactate Dehydrogenase","['Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","cea275b9-0bfb-46bb-a822-b15a4faac1f8","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64855"
"4258","Leukocyte Esterase Measurement","C64856","Leukocyte Esterase","['Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","3af694e9-2bd3-49c7-8acd-b8993522192f","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64856"
"4259","Phosphate Measurement","C64857","Phosphate","['Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","6cbf79a5-b25b-4f7e-9b17-eda2038a0927","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64857"
"4260","Total Protein Measurement","C64858","Protein","['Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","5b0d0736-8183-4c96-bb4b-54ecaecc02ae","dataset/cdisc/ct/sc/2007-05-31/sdtm/C67154/C64858"
"4261","Action Taken with Study Treatment ","C66767","ACN","['Action Taken with Study Treatment']","CDISC SDTM Action Taken with Study Treatment Terminology","The reason that changes were made to the therapy under study. (NCI)","False","4ef09448-7757-424a-84c0-78f1b190e808","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767"
"4262","Dose Increased","C49503","DOSE INCREASED","[]","Dose Increased","An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)","False","b9d0095c-f042-4960-a7c0-6668824ef64f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767/C49503"
"4263","Dose Not Changed","C49504","DOSE NOT CHANGED","[]","Dose Not Changed","An indication that a medication schedule was maintained. (NCI)","False","c1417a9f-eb94-4c40-805f-df054131ce8f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767/C49504"
"4264","Dose Reduced","C49505","DOSE REDUCED","[]","Dose Reduced","An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)","False","7877c6c4-ded6-47bf-b5e3-e47e50067ea3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767/C49505"
"4265","Drug Interrupted","C49501","DRUG INTERRUPTED","[]","Drug Interrupted","An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)","False","fd8dd909-2300-4a10-82df-51e4db93a7d1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767/C49501"
"4266","Drug Withdrawn","C49502","DRUG WITHDRAWN","[]","Drug Withdrawn","An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)","False","38400b5e-b969-4ef8-a59f-f26330570e6b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767/C49502"
"4267","Not Applicable","C48660","NOT APPLICABLE","[]","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","57ee03eb-8169-45d3-b79e-81c29a43447e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767/C48660"
"4268","Unknown","C17998","UNKNOWN","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","f8ff2fe1-780d-46c9-9d14-2f14344520fb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66767/C17998"
"4269","Outcome of Event","C66768","OUT","['Outcome of Event']","CDISC SDTM Adverse Event Outcome Terminology","A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)","False","adfd87a5-aa01-48ba-ac2d-f1cb84e4a444","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66768"
"4270","Death Related to Adverse Event","C48275","FATAL","['Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","771bfd43-ec5c-4a93-8fd8-09ac9571e907","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66768/C48275"
"4271","Not Recovered or Not Resolved","C49494","NOT RECOVERED/NOT RESOLVED","[]","Not Recovered or Not Resolved","One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)","False","c37568ea-0219-48ad-8f94-e74a7e44c11b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66768/C49494"
"4272","Recovered or Resolved","C49498","RECOVERED/RESOLVED","[]","Recovered or Resolved","One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)","False","79c839dd-8d07-473a-a12d-46b0f37e58de","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66768/C49498"
"4273","Recovered or Resolved with Sequelae","C49495","RECOVERED/RESOLVED WITH SEQUELAE","[]","Recovered or Resolved with Sequelae","One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)","False","aedb155b-b04d-4f32-bcfd-b5e03af06add","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66768/C49495"
"4274","Recovering or Resolving","C49496","RECOVERING/RESOLVING","[]","Recovering or Resolving","One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)","False","6a32d6a5-f616-489c-ac8c-d7d8d0cd3475","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66768/C49496"
"4275","Unknown","C17998","UNKNOWN","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","f45d3e57-f4cf-40e7-a466-b4cf577fd649","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66768/C17998"
"4276","Age Span","C66780","AGESPAN","['Age Span']","CDISC SDTM Age GroupTerminology","Subgroups of populations based on age. (NCI)","False","73861cc4-bbac-40ba-b4fb-321f8d5f70b6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780"
"4277","Adolescent","C27954","ADOLESCENT (12-17 YEARS)","[]","Adolescent","A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)","False","be4c00a1-1c74-4c7d-85d5-2bcc1c8d1f2b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C27954"
"4278","Adult 18-65 Years Old","C49685","ADULT (18-65)","[]","Adult 18-65 Years Old","A person from 18 years to 65 years of age. (NCI)","False","a099edc6-12f3-46e6-87d9-ee87b6f6ac4c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C49685"
"4279","Children 2-11 Years Old","C49683","CHILDREN (2-11 YEARS)","[]","Children 2-11 Years Old","A person from 2 years to 11 years of age. (NCI)","False","a849a65a-34ec-445f-b92d-66adfc2d7e07","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C49683"
"4280","Elderly","C16268","ELDERLY (> 65)","[]","Elderly","An age group comprised by people 65 years of age and older. (NCI) ","False","a9af873b-4590-40c3-bf21-b64b413035ba","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C16268"
"4281","In Utero","C49641","IN UTERO","[]","In Utero","The period of time during which the embryo or foetus is present in the uterus of the female. Also describes the location of the embryo or foetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)","False","05b54853-04ad-41f6-95ff-53669a9dfc5d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C49641"
"4282","Infant And Toddler","C49643","INFANT AND TODDLER (28 DAYS - 23 MONTHS)","[]","Infant And Toddler","A person from 28 days to 23 months of age. (NCI)","False","78dd9a0c-425b-40aa-99d3-02d099c3b05f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C49643"
"4283","Newborn","C16731","NEWBORN (0-27 DAYS)","[]","Newborn","An infant during the first month after birth. (NCI)","False","a3354d40-cb0f-423e-9c28-65d0dbe97189","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C16731"
"4284","Preterm Newborn Infant","C49642","PRETERM NEWBORN INFANTS","[]","Preterm Newborn Infant","An infant born prior to completion of the normal gestation period. (NCI)","False","ca6050d9-3275-47e6-bd3e-ef88a06513d7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66780/C49642"
"4285","Age Unit","C66781","AGEU","['Age Unit']","CDISC SDTM Age UnitTerminology","Those units of time that are routinely used to express the age of a person. (NCI)","False","1b9d04c3-2f52-4628-a15e-19f2d5ca8669","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66781"
"4286","Day","C25301","DAYS","[]","Day","The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day. (NCI)","False","3456146b-d200-4228-8a1f-9ff286f9f1e0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66781/C25301"
"4287","Hour","C25529","HOURS","[]","Hour","A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)","False","bffc76e8-84ab-4328-9fba-c8d1490129aa","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66781/C25529"
"4288","Month","C29846","MONTHS","[]","Month","One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)","False","b5c491bd-a40c-4a30-bdfb-e5b4397d620b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66781/C29846"
"4289","Week","C29844","WEEKS","[]","Week","Any period of seven consecutive days. (NCI)","False","612ff85b-120e-4780-b623-d35bba0e65d9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66781/C29844"
"4290","Year","C29848","YEARS","[]","Year","The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)","False","f3fc18d3-8c0d-446e-aba8-eb8004771442","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66781/C29848"
"4291","Category for Inclusion/Exclusion","C66797","IECAT","['Category for Inclusion/Exclusion']","CDISC SDTM Category of Inclusion And Or ExclusionTerminology","A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)","False","60daa82f-6f37-4f11-a9ba-daadcf884e7f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66797"
"4292","Exclusion","C25370","EXCLUSION","[]","Exclusion","List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)","False","f2703166-2a01-4407-99a8-b4e2260b68d6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66797/C25370"
"4293","Inclusion","C25532","INCLUSION","[]","Inclusion","The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study.  NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)","False","44bfe25c-1433-4467-9cd2-69d30c714bdf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66797/C25532"
"4294","CDISC System Organ Class","C66783","SOC","['CDISC System Organ Class']","CDISC SDTM System Organ Class Terminology","Terms at the highest level of the CDISC system organ class terminology.","False","37a5000e-d23f-475c-b651-137ac0e507ae","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783"
"4295","Hematopoietic and Lymphoid System Disorder","C35814","BLOOD AND LYMPHATIC SYSTEM DISORDERS","[]","Hematopoietic and Lymphoid System Disorder","Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","b5fd782e-89a5-432f-8428-0e56366a4438","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C35814"
"4296","Heart Disorder","C3079","CARDIAC DISORDERS","[]","Heart Disorder","Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","521db6c0-573d-42ac-a228-a2f093ec8e80","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C3079"
"4297","Congenital, Familial and Genetic Disorder Class","C49399","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","[]","Congenital, Familial and Genetic Disorder Class","A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characterstic set of symptoms and signs. (NCI)","False","9167433f-ac54-45e9-8227-8fe1c0ca624e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C49399"
"4298","Ear and Labyrinth Disorder Class","C49400","EAR AND LABYRINTH DISORDERS","[]","Ear and Labyrinth Disorder Class","Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)","False","14363178-03ce-4668-bd5f-730cab82dba0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C49400"
"4299","Endocrine Disorder","C3009","ENDOCRINE DISORDERS","[]","Endocrine Disorder","Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","3e9f0967-5deb-4690-b483-750f949ca700","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C3009"
"4300","Eye Disorder","C26767","EYE DISORDERS","[]","Eye Disorder","Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)","False","89992d2b-5b26-4c43-9c0a-442bc2fd35be","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C26767"
"4301","Gastrointestinal Disorder","C2990","GASTROINTESTINAL DISORDERS","[]","Gastrointestinal Disorder","Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)","False","bc24e9b8-1de5-4f00-934a-9f8416491dee","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C2990"
"4302","General Disorders and Administration Site Conditions Class","C49401","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","[]","General Disorders and Administration Site Conditions Class","A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)","False","87f19f36-eb9e-40c4-9268-7e830ee8e983","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C49401"
"4303","Liver and Biliary Tract Disorder","C3959","HEPATOBILIARY DISORDERS","[]","Liver and Biliary Tract Disorder","Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)","False","01dcd39d-79db-4cb4-a090-58e08167d2fe","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C3959"
"4304","Immune System Disorder","C3507","IMMUNE SYSTEM DISORDERS","[]","Immune System Disorder","A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)","False","52aa6e87-923e-444c-a487-e69494d5d60c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C3507"
"4305","Infectious Disorder","C26726","INFECTIONS AND INFESTATIONS","[]","Infectious Disorder","A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)","False","02a1b937-50ee-442a-90d6-bd2b617b582a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C26726"
"4306","Injury, Poisoning and Procedural Complication Class","C49402","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","[]","Injury, Poisoning and Procedural Complication Class","A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)","False","83156fdd-a25d-4bb0-889e-322cb88afb20","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C49402"
"4307","Investigation","C41198","INVESTIGATIONS","[]","Investigation","The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)","False","38096f22-ebc0-4fb7-8dfa-6d1361688b08","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C41198"
"4308","Metabolism and Nutrition Disorder Class","C49403","METABOLISM AND NUTRITION DISORDERS","[]","Metabolism and Nutrition Disorder Class","A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)","False","706d70e7-35fa-48d1-9b7c-11c9fa9946e6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C49403"
"4309","Connective and Soft Tissue Disorder","C27574","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","[]","Connective and Soft Tissue Disorder","Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)","False","b5b9eed4-57d9-467d-ad75-1224439d6243","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C27574"
"4310","Neoplasm","C3262","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","[]","Neoplasm","An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)","False","1d4c1ef5-2594-4c0e-a2d7-da7e782a54e8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C3262"
"4311","Nervous System Disorder","C26835","NERVOUS SYSTEM DISORDERS","[]","Nervous System Disorder","Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","2c14b8aa-4e38-4a0f-b0c5-811793e79cdb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C26835"
"4312","Pregnancy, Puerperium and Perinatal Condition Class","C49404","PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS","[]","Pregnancy, Puerperium and Perinatal Condition Class","A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)","False","f0f5f460-93d9-4d42-8dc7-7d5c4fa78517","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C49404"
"4313","Psychiatric Disorder","C2893","PSYCHIATRIC DISORDERS","[]","Psychiatric Disorder","Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)","False","54f4b04c-137f-4ca4-9843-6aea5c741216","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C2893"
"4314","Urinary System Disorder","C3430","RENAL AND URINARY DISORDERS","[]","Urinary System Disorder","Disorders of any part of the urologic system. (NCI)","False","5096aada-b602-4f9e-9b60-d9893eb7284c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C3430"
"4315","Reproductive System and Breast Disorder Class","C49405","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","[]","Reproductive System and Breast Disorder Class","Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)","False","bcb67160-b304-4a51-b350-b2e7900b5af0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C49405"
"4316","Respiratory and Thoracic Disorder","C27669","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","[]","Respiratory and Thoracic Disorder","Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)","False","1aeb6491-00d5-4fc3-9e41-ccb9e3088fdc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C27669"
"4317","Skin Disorder","C3371","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","[]","Skin Disorder","Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)","False","b7d27856-8a89-4919-9789-fd29fdf67449","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C3371"
"4318","Social Circumstances","C20188","SOCIAL CIRCUMSTANCES","[]","Social Circumstances","A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)","False","b94c3c99-93ef-4f1b-9351-6adbbcd0b734","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C20188"
"4319","Procedure","C25218","SURGICAL AND MEDICAL PROCEDURES","[]","Procedure","A particular course of action intended to achieve a result. (NCI)","False","9cf7d9c7-71f9-463c-8ad7-89a8fcc2575d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C25218"
"4320","Vascular Disorder","C35117","VASCULAR DISORDERS","[]","Vascular Disorder","Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)","False","56160c76-8606-469c-9cb3-c4d6b4d0925f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66783/C35117"
"4321","Common Terminology Criteria for Adverse Events","C66784","TOXGR","['Common Terminology Criteria for Adverse Events']","CDISC SDTM CommonTerminology Criteria for Adverse Event Grade Terminology","A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)","False","90fb228e-ce9d-4877-92eb-162b9a4d0a22","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66784"
"4322","Mild Adverse Event","C41338","1","['Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","5d06505e-bf1b-48e9-94e6-1138c9d65455","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66784/C41338"
"4323","Moderate Adverse Event","C41339","2","['Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","ee7debb1-fe13-43d5-b89e-b9dc72ae45c7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66784/C41339"
"4324","Severe Adverse Event","C41340","3","['Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","2cea2a78-c810-4a89-a921-e4d8d591b33b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66784/C41340"
"4325","Life Threatening or Disabling Adverse Event","C41337","4","['Grade 4', '4']","Life Threatening or Disabling Adverse Event","An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.","False","9b8ac093-3330-4463-a3c2-3af3ad3d40e1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66784/C41337"
"4326","Death Related to Adverse Event","C48275","5","['Grade 5', '5']","Death Related to Adverse Event","The termination of life as a result of an adverse event. (NCI)","False","f04b3a31-4315-496e-87f8-cc1c29a29e95","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66784/C48275"
"4327","Control Type","C66785","TCNTRL","['Control Type', 'Type of Control']","CDISC SDTM Control Type Terminology","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","1061ee93-da36-4ca3-a71b-4bcb6ed6c642","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66785"
"4328","Active Control","C49649","ACTIVE","[]","Active Control","A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].","False","ca41522e-fc41-4720-b1da-0cb019eef30c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66785/C49649"
"4329","None","C41132","NONE","[]","None","No person or thing, nobody, not any. (NCI)","False","c1723dbd-e38f-42ba-af77-666ab1852320","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66785/C41132"
"4330","Placebo Control","C49648","PLACEBO","[]","Placebo Control","Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)","False","15242333-e50d-479b-8a5d-c73750d37deb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66785/C49648"
"4331","Country","C66786","COUNTRY","['Country']","CDISC SDTM Country Terminology","A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)","False","7a2ddd0a-d5eb-4019-8e8b-e9060007b4f4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786"
"4332","Aruba","C17884","ABW","['ARUBA']","Aruba","Island in the Caribbean Sea, north of Venezuela.","False","c227c89a-ccb5-4300-895a-992c408125b9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17884"
"4333","Afghanistan","C16267","AFG","['AFGHANISTAN']","Afghanistan","A country in Southern Asia, north and west of Pakistan, east of Iran.","False","ff2ee2af-ae0d-4994-8fa8-8e890896b6e2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16267"
"4334","Angola","C16292","AGO","['ANGOLA']","Angola","A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo.","False","371e114a-ebcd-44b5-81b5-a043059746c6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16292"
"4335","Anguilla","C20133","AIA","['ANGUILLA']","Anguilla","An island in the Caribbean Sea, east of Puerto Rico.","False","a5a89dd8-3bb7-49fe-8c8c-697462605d8f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20133"
"4336","Aland Islands","C44481","ALA","['ALAND ISLANDS']","Aland Islands","An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland.","False","e6da86c4-af2e-4df3-abfb-d5cc28c1414e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C44481"
"4337","Albania","C16271","ALB","['ALBANIA']","Albania","A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro.","False","20348da7-a30c-4dda-8845-881fa018b2d1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16271"
"4338","Andorra","C16289","AND","['ANDORRA']","Andorra","A country in Southwestern Europe, between France and Spain.","False","99f386ac-1030-492a-9f56-6263abf85d12","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16289"
"4339","Netherlands Antilles","C16904","ANT","['NETHERLANDS ANTILLES']","Netherlands Antilles","A country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands.","False","bc8d3ed4-ddaa-4f10-aef5-9aa8f600bdf5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16904"
"4340","United Arab Emirates","C17232","ARE","['UNITED ARAB EMIRATES']","United Arab Emirates","A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia.","False","81c87347-e126-45a1-9b85-4c19f0a3db2c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17232"
"4341","Argentina","C16305","ARG","['ARGENTINA']","Argentina","A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.","False","eae0b9e2-4dec-4d37-b461-2a3895b75450","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16305"
"4342","Armenia","C16306","ARM","['ARMENIA']","Armenia","A country in Southwestern Asia, east of Turkey.","False","05da40d6-56a5-43a3-b3f4-4278401713d2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16306"
"4343","American Samoa","C17739","ASM","['AMERICAN SAMOA']","American Samoa","A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand.","False","b4966cd1-afc8-4d86-9269-54f0f5d5eec0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17739"
"4344","Antarctica","C18007","ATA","['ANTARCTICA']","Antarctica","The continent lying mostly south of the Antarctic Circle.","False","4e6a6e25-4576-4fa2-9bf6-dba97ef7f5e8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C18007"
"4345","French Southern Territories","C20105","ATF","['FRENCH SOUTHERN TERRITORIES']","French Southern Territories","Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia.","False","a4a919b6-cdb4-442a-baa3-0650cfe203b3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20105"
"4346","Antigua and Barbuda","C16303","ATG","['ANTIGUA AND BARBUDA']","Antigua and Barbuda","Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico.","False","2e51aeef-d573-4293-95f8-67afabe4823a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16303"
"4347","Australia","C16311","AUS","['AUSTRALIA']","Australia","The continent between the Indian Ocean and the South Pacific Ocean.","False","39e17039-877a-4481-bbb8-6072ad93eed5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16311"
"4348","Austria","C16312","AUT","['AUSTRIA']","Austria","A country in Central Europe, north of Italy and Slovenia.","False","1577636e-8b43-40a6-a052-21c31d3564f5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16312"
"4349","Azerbaijan","C16316","AZE","['AZERBAIJAN']","Azerbaijan","A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia.","False","05f6f957-ee26-44cf-bda6-0fda0359d228","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16316"
"4350","Burundi","C16371","BDI","['BURUNDI']","Burundi","A country in Central Africa, east of Democratic Republic of the Congo.","False","b4b4343e-aad8-4317-8d6a-2c34f1cee53b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16371"
"4351","Belgium","C16329","BEL","['BELGIUM']","Belgium","A country in Western Europe, bordering the North Sea, between France and the Netherlands.","False","fc3590db-60bb-47f6-a231-5fa97ac1e22c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16329"
"4352","Benin Republic","C16333","BEN","['BENIN REPUBLIC']","Benin Republic","A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo.","False","22e2356e-adaf-4fbe-9225-0c99b5c13fc0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16333"
"4353","Burkina Faso","C16369","BFA","['BURKINA FASO']","Burkina Faso","A country in Western Africa, north of Ghana.","False","f3511c5c-9f49-49bb-81d5-f3ff7fa8a259","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16369"
"4354","Bangladesh","C16323","BGD","['BANGLADESH']","Bangladesh","A country in Southern Asia, bordering the Bay of Bengal, between Burma and India.","False","af75e5c1-ccff-4808-9c8e-b5824defdfc6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16323"
"4355","Bulgaria","C16368","BGR","['BULGARIA']","Bulgaria","A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey.","False","3169985b-1905-4700-9ed1-77435d05304e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16368"
"4356","Bahrain","C16322","BHR","['BAHRAIN']","Bahrain","An archipelago in the Persian Gulf, east of Saudi Arabia.","False","50bf2cc2-6c0f-4bdf-9568-cf4f304254e4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16322"
"4357","Bahamas","C16321","BHS","['BAHAMAS']","Bahamas","A chain of islands in the North Atlantic Ocean, southeast of Florida.","False","45e015a2-3764-4c7c-b497-0fdf4e26bf8b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16321"
"4358","Bosnia-Herzegovina","C16361","BIH","['BOSNIA-HERZEGOVINA']","Bosnia-Herzegovina","A country in Southeastern Europe, bordering the Adriatic Sea and Croatia.","False","159506bc-e92e-426b-971f-77a69dd7e013","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16361"
"4359","Belarus","C16372","BLR","['BELARUS']","Belarus","A country in Eastern Europe, east of Poland.","False","631d4969-ddf7-4e07-8423-200d7b00cbab","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16372"
"4360","Belize","C16331","BLZ","['BELIZE']","Belize","A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico.","False","fceb6905-6474-4f8a-ab51-25a835a6f1d2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16331"
"4361","Bermuda","C16334","BMU","['BERMUDA']","Bermuda","No Definition","False","1e5798c6-59ef-4233-b84f-93f975921897","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16334"
"4362","Bolivia","C16359","BOL","['BOLIVIA']","Bolivia","A country in Central South America, southwest of Brazil.","False","3edec3a5-4db7-4d6d-b3e6-d1b9094f4ea6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16359"
"4363","Brazil","C16364","BRA","['BRAZIL']","Brazil","A country in Eastern South America, bordering the Atlantic Ocean.","False","89df1e5f-84a2-4442-91a4-c5fd70e747ca","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16364"
"4364","Barbados","C16324","BRB","['BARBADOS']","Barbados","An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","d8529e84-bce5-4e46-b11f-1ca6f87a9f9f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16324"
"4365","Brunei Darussalam","C16367","BRN","['BRUNEI']","Brunei Darussalam","A country in Southeastern Asia, bordering the South China Sea and Malaysia.","False","59f6f5b2-898f-4756-a46d-a6058305a92b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16367"
"4366","Bhutan","C16336","BTN","['BHUTAN']","Bhutan","A country in Southern Asia, between China and India.","False","ea3ce3a0-dd08-46c6-ac8f-b6d8fae25ac1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16336"
"4367","Bouvet Island","C20104","BVT","['BOUVET ISLAND']","Bouvet Island","An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa).","False","3c2a9b0d-44f5-49a4-83e0-da55a4379797","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20104"
"4368","Botswana","C16363","BWA","['BOTSWANA']","Botswana","A country in Southern Africa, north of South Africa.","False","2515d0af-56d3-40b8-a775-fd108629c790","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16363"
"4369","Central African Republic","C16409","CAF","['CENTRAL AFRICAN REPUBLIC']","Central African Republic","A country in Central Africa, north of Democratic Republic of the Congo.","False","c8efde96-87c7-48cc-87b3-3e45887f9ed0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16409"
"4370","Canada","C16380","CAN","['CANADA']","Canada","A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US.","False","8ff707c3-cf4f-46a1-a89d-1f10fdc5d579","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16380"
"4371","Cocos (Keeling) Islands","C16445","CCK","['COCOS (KEELING) ISLANDS']","Cocos (Keeling) Islands","A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka.","False","9f90e492-73f8-43b2-bc25-ae2f09a43dce","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16445"
"4372","Switzerland","C17181","CHE","['SWITZERLAND']","Switzerland","A country in Central Europe, east of France, north of Italy.","False","42f0c701-f12e-402b-8f3f-80972876e3d4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17181"
"4373","Chile","C16427","CHL","['CHILE']","Chile","A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru.","False","0c79a67c-d730-4007-bb48-181cfd0fe403","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16427"
"4374","China","C16428","CHN","['CHINA']","China","A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam.","False","b4ad0e65-4b03-4dec-b8ad-1dc463196ef7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16428"
"4375","Cote d'Ivoire","C16762","CIV","[""COTE D'IVOIRE""]","Cote d'Ivoire","A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia.","False","cf242094-db41-4193-9c6a-960772637e29","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16762"
"4376","Cameroon","C16379","CMR","['CAMEROON']","Cameroon","A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria.","False","14a54ed8-3f89-417f-98ac-b907d021e243","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16379"
"4377","Democratic Republic of the Congo","C17266","COD","['DEMOCRATIC REPUBLIC OF THE CONGO']","Democratic Republic of the Congo","A country in Central Africa, northeast of Angola.","False","fbb9bf6d-320c-4f6f-8011-73bffe00900e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17266"
"4378","Congo","C16467","COG","['CONGO']","Congo","A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon.","False","c76f29da-3487-4b5e-8a2a-719b9b06482e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16467"
"4379","Cook Islands","C16469","COK","['COOK ISLANDS']","Cook Islands","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","25620b83-2b37-4386-8c02-ad93b1d97e22","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16469"
"4380","Colombia","C16449","COL","['COLOMBIA']","Colombia","A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama.","False","9cf181f1-14a7-4387-947e-362e14eb642f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16449"
"4381","Comoros","C16458","COM","['COMOROS']","Comoros","A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique.","False","f97978f9-55a7-4d14-bc69-3096192b18ca","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16458"
"4382","Cape Verde","C16382","CPV","['CAPE VERDE']","Cape Verde","A group of islands in the North Atlantic Ocean, west of Senegal.","False","55b72e14-828c-4c05-b51f-98593250c2b7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16382"
"4383","Costa Rica","C16470","CRI","['COSTA RICA']","Costa Rica","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama.","False","bf8b0328-ba87-4552-82f9-74d98dd84d22","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16470"
"4384","Cuba","C16477","CUB","['CUBA']","Cuba","An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida.","False","47aa1f72-cce3-442a-801e-bccada424dc0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16477"
"4385","Christmas Island","C44482","CXR","['CHRISTMAS ISLAND']","Christmas Island","An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia.","False","28d63252-2879-4a3a-87d4-3b9e7a093f62","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C44482"
"4386","Cayman Islands","C16391","CYM","['CAYMAN ISLANDS']","Cayman Islands","An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras.","False","79258623-51c5-4b96-8264-827e5bda8fae","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16391"
"4387","Cyprus","C16480","CYP","['CYPRUS']","Cyprus","An island in the Mediterranean Sea, south of Turkey.","False","ea53a5a9-8326-4ed8-84ff-31f9ddfdc3ae","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16480"
"4388","Czech Republic","C17668","CZE","['CZECH REPUBLIC']","Czech Republic","A country in Central Europe, southeast of Germany.","False","35159c3e-a4c6-4b8d-94f3-910af144530f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17668"
"4389","Germany","C16636","DEU","['GERMANY']","Germany","A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark.","False","fba459dd-8ab3-40a0-acec-221edf34e08c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16636"
"4390","Djibouti","C16506","DJI","['DJIBOUTI']","Djibouti","A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia.","False","677e7276-ea31-4a81-9e89-9fb100ed8e54","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16506"
"4391","Dominica","C16519","DMA","['DOMINICA']","Dominica","An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago.","False","d4ac9c47-9cbc-443c-b302-15212382518a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16519"
"4392","Denmark","C16496","DNK","['DENMARK']","Denmark","A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn).","False","9abcd470-fcd0-4e18-a591-1880915ffa74","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16496"
"4393","Dominican Republic","C16520","DOM","['DOMINICAN REPUBLIC']","Dominican Republic","A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti.","False","8c7e5358-02a4-43d2-870b-deda7fc66b9b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16520"
"4394","Algeria","C16274","DZA","['ALGERIA']","Algeria","A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia.","False","375c4642-f4f0-4cc0-8f2e-702dad3b6ad2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16274"
"4395","Ecuador","C16528","ECU","['ECUADOR']","Ecuador","A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.","False","f5ce039c-8430-4eda-8036-52bca301edd4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16528"
"4396","Egypt","C16530","EGY","['EGYPT']","Egypt","A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip.","False","cba0c724-ac22-45c3-991a-d8279e347ec7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16530"
"4397","Eritrea","C16558","ERI","['ERITREA']","Eritrea","A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan.","False","0d285500-bb78-4328-b337-2585cdf1bd58","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16558"
"4398","Western Sahara","C20113","ESH","['WESTERN SAHARA']","Western Sahara","A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.","False","f22e022a-1cb9-461c-bd52-3e71e7f1d935","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20113"
"4399","Spain","C17152","ESP","['SPAIN']","Spain","A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France.","False","38c8d748-c693-4499-921a-90131b0a6b5d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17152"
"4400","Estonia","C16562","EST","['ESTONIA']","Estonia","A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia.","False","ce109668-e1e9-4c05-a84d-94e3dd35b8e2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16562"
"4401","Ethiopia","C16563","ETH","['ETHIOPIA']","Ethiopia","A country in Eastern Africa, west of Somalia.","False","a7cb9b7c-8bde-4036-a0dc-52b58e672f00","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16563"
"4402","Finland","C16584","FIN","['FINLAND']","Finland","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia.","False","2b60e3a5-4a59-490a-95ea-e068ecfe2827","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16584"
"4403","Fiji","C16582","FJI","['FIJI']","Fiji","An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","89b79562-dfa0-489a-a7e4-afaa5a4f3558","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16582"
"4404","Falkland Islands","C17954","FLK","['FALKLAND ISLANDS']","Falkland Islands","Islands in the South Atlantic Ocean, east of southern Argentina.","False","5061725a-7563-4188-bc7b-9d3ec5a99327","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17954"
"4405","France","C16592","FRA","['FRANCE']","France","A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain.","False","a17dbdb3-2f72-479f-96bb-59770f54d993","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16592"
"4406","Faroe Islands","C16573","FRO","['FAROE ISLANDS']","Faroe Islands","An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway.","False","fa92e7b5-6aa5-4920-a132-e9c162d58bef","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16573"
"4407","Federated States of Micronesia","C17881","FSM","['MICRONESIA, FEDERATED STATES OF']","Federated States of Micronesia","An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia.","False","cfab29b4-6aac-43f3-b071-f3982192c7e9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17881"
"4408","Gabon","C16596","GAB","['GABON']","Gabon","A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea.","False","0d638d16-b8ef-469a-8355-eea00a5b4e58","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16596"
"4409","United Kingdom","C17233","GBR","['UNITED KINGDOM']","United Kingdom","A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France.","False","d52f82d8-0bd3-41c8-a8f7-f05dac84bea2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17233"
"4410","Georgia","C16634","GEO","['GEORGIA']","Georgia","A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia.","False","158cd7e7-e659-4d8c-ac0e-4445d8a403ad","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16634"
"4411","Guernsey","C64375","GGY","['GUERNSEY']","Guernsey","The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK.","False","e5fd51d7-ca28-44aa-ae45-a0819cdd0189","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C64375"
"4412","Ghana","C26330","GHA","['GHANA']","Ghana","A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo.","False","df5d1199-74d1-4f3d-8712-e7c91552223a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C26330"
"4413","Gibraltar","C16638","GIB","['GIBRALTAR']","Gibraltar","A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain.","False","bb4673da-3ae7-4bca-8688-89bb3688db60","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16638"
"4414","Guinea","C16655","GIN","['GUINEA']","Guinea","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone.","False","45d49177-5fb2-4012-90e3-9f10c3b6fc97","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16655"
"4415","Guadeloupe","C16651","GLP","['GUADELOUPE']","Guadeloupe","Islands in the eastern Caribbean Sea, southeast of Puerto Rico.","False","73861e48-00dc-4440-9757-b242b73d88cf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16651"
"4416","Gambia","C16598","GMB","['GAMBIA']","Gambia","A country in Western Africa, bordering the North Atlantic Ocean and Senegal.","False","06b1b9ce-0b73-406c-9d51-bec3617a9e10","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16598"
"4417","Guinea-Bissau","C16656","GNB","['GUINEA-BISSAU']","Guinea-Bissau","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal.","False","df175a77-ea70-47c8-85e3-d9589dcb9f74","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16656"
"4418","Equatorial Guinea","C16557","GNQ","['EQUATORIAL GUINEA']","Equatorial Guinea","A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands.","False","00bb0f45-c0b3-4558-b560-14a7aee240d0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16557"
"4419","Greece","C16645","GRC","['GREECE']","Greece","A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey.","False","15def1dc-6c42-40b9-b5fc-1b5589bf67c2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16645"
"4420","Grenada","C16647","GRD","['GRENADA']","Grenada","An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago.","False","15587872-5b37-4457-ba33-e1275e318d05","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16647"
"4421","Greenland","C16646","GRL","['GREENLAND']","Greenland","An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.","False","958d6202-12a0-442e-a925-401d4f4d0781","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16646"
"4422","Guatemala","C16654","GTM","['GUATEMALA']","Guatemala","A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico.","False","83f8ad52-ee0d-48ca-8650-85d745726d83","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16654"
"4423","French Guiana","C16593","GUF","['FRENCH GUIANA']","French Guiana","A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname.","False","df9498ad-0668-4476-9398-507625b26ae4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16593"
"4424","Guam","C16652","GUM","['GUAM']","Guam","Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","4a4aaf14-1edd-4bbd-ba24-77b1165aa2bf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16652"
"4425","Guyana","C16657","GUY","['GUYANA']","Guyana","A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.","False","86d22d84-db6a-4a8a-96a3-7dbc894c57f9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16657"
"4426","Hong Kong","C16695","HKG","['HKG', 'HONG KONG']","Hong Kong","A special administrative region of China, bordering the South China Sea and China.","False","ec0273c8-9232-4264-a242-b4922b83e44f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16695"
"4427","Heard Island and McDonald Islands","C20106","HMD","['HEARD ISLAND AND MCDONALD ISLANDS']","Heard Island and McDonald Islands","Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica.","False","3a590318-4820-4d71-9349-535785bc230e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20106"
"4428","Honduras","C16694","HND","['HONDURAS']","Honduras","A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua.","False","3ce21172-ec15-440a-93a2-5a41d67a2447","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16694"
"4429","Croatia","C16474","HRV","['CROATIA']","Croatia","A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia.","False","43c01087-aa26-4a90-ade7-6cec47403849","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16474"
"4430","Haiti","C16660","HTI","['HAITI']","Haiti","A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic.","False","1df65060-7521-4f22-a528-812b07f3fe9d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16660"
"4431","Hungary","C16699","HUN","['HUNGARY']","Hungary","A country in Central Europe, northwest of Romania.","False","f31dc224-7332-48dc-a2ab-3b584a9468d9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16699"
"4432","Indonesia","C16728","IDN","['INDONESIA']","Indonesia","A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean.","False","c3ea759b-8ed5-41d2-a658-948e65ab98d4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16728"
"4433","India","C16727","IND","['INDIA']","India","A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.","False","b786b640-5eb4-49eb-a388-4dac461572af","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16727"
"4434","British Indian Ocean Territory","C16365","IOT","['BRITISH INDIAN OCEAN TERRITORY']","British Indian Ocean Territory","An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia.","False","5ee9699c-7828-464f-8a34-6940a726e1b1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16365"
"4435","Ireland","C16757","IRL","['IRELAND']","Ireland","A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain.","False","9253f2f6-0032-414b-a2fb-dc308160c4af","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16757"
"4436","Iran","C16755","IRN","['IRAN']","Iran","A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.","False","4e5b0264-24d7-4931-80df-0c0e22ca8812","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16755"
"4437","Iraq","C16756","IRQ","['IRAQ']","Iraq","A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait.","False","6ec6ee55-3d2e-4501-a350-4f0c12a9ca2d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16756"
"4438","Iceland","C16704","ISL","['ICELAND']","Iceland","A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK.","False","57ae88e2-d541-4e15-aa7a-7d9e34221e2c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16704"
"4439","Israel","C16760","ISR","['ISRAEL']","Israel","A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon.","False","c421e2bd-5d57-474d-be31-13879f85d008","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16760"
"4440","Italy","C16761","ITA","['ITALY']","Italy","A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.","False","781df82f-7c81-4557-ab86-82b06dd8748e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16761"
"4441","Jamaica","C16763","JAM","['JAMAICA']","Jamaica","An island in the Caribbean Sea, south of Cuba.","False","a40681db-07ba-4af6-bace-6f5693006db8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16763"
"4442","Jordan","C16765","JOR","['JORDAN']","Jordan","A country in the Middle East, northwest of Saudi Arabia.","False","70b0949a-d292-4354-9416-9c5c8d5cdaf8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16765"
"4443","Japan","C16764","JPN","['JAPAN']","Japan","A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula.","False","ea504904-2770-4d89-a3ee-4cd24826378f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16764"
"4444","Jersey","C64374","JRE","['JERSEY']","Jersey","Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK.","False","ea7f2859-765a-415c-8d04-c702da40d882","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C64374"
"4445","Kazakhstan","C20107","KAZ","['KAZAKHSTAN']","Kazakhstan","A country in Central Asia, northwest of China.","False","3a6a11ec-0cbb-40ff-a2b5-576aaafb21b7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20107"
"4446","Kenya","C16769","KEN","['KENYA']","Kenya","A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania.","False","62ca83f3-17cc-4167-b978-e16df85caaac","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16769"
"4447","Kyrgyzstan","C16771","KGZ","['KYRGYZSTAN']","Kyrgyzstan","A country in Central Asia, west of China.","False","2b492a14-f9da-45d2-b6c6-e08cb74aae26","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16771"
"4448","Cambodia","C16378","KHM","['CAMBODIA']","Cambodia","A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos.","False","c1832d2a-57f7-4378-9cbf-66e939c4b81f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16378"
"4449","Kiribati","C16639","KIR","['KIRIBATI']","Kiribati","A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia.","False","e6242f3e-2d78-46cf-a015-d41518205fc0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16639"
"4450","Saint Kitts and Nevis","C17885","KNA","['SAINT KITTS AND NEVIS']","Saint Kitts and Nevis","Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago.","False","9bc927f9-c3ba-4466-bded-edb89a666a5c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17885"
"4451","South Korea","C16774","KOR","['SOUTH KOREA']","South Korea","A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea.","False","88d4d2ee-046e-46f3-83e3-7d495f85e971","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16774"
"4452","Kuwait","C16775","KWT","['KUWAIT']","Kuwait","A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia.","False","20f90694-b694-4158-9dc5-665bd872ced1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16775"
"4453","Lao People's Democratic Republic","C16780","LAO","[""LAO PEOPLE'S DEMOCRATIC REPUBLIC""]","Lao People's Democratic Republic","A country in Southeastern Asia, northeast of Thailand, west of Vietnam.","False","d0edfaed-cc47-4842-9b10-a7cba8acd9eb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16780"
"4454","Lebanon","C16784","LBN","['LEBANON']","Lebanon","A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria.","False","adf96306-604f-4f96-91b7-3976cc8bc0e3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16784"
"4455","Liberia","C16791","LBR","['LIBERIA']","Liberia","A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone.","False","01909c66-517c-4530-bb06-a0cb77ecc1aa","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16791"
"4456","Libyan Arab Jamahiriya","C16793","LBY","['LIBYAN ARAB JAMAHIRIYA']","Libyan Arab Jamahiriya","A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia.","False","0a450027-7279-4776-97e0-af3ea5361a26","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16793"
"4457","Saint Lucia","C17113","LCA","['SAINT LUCIA']","Saint Lucia","A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago.","False","c11e129f-aad6-4751-a0dd-30fde6895a81","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17113"
"4458","Liechtenstein","C16794","LIE","['LIECHTENSTEIN']","Liechtenstein","A country in Central Europe, between Austria and Switzerland.","False","4fee7cf2-21dd-4ae2-9fbb-f2b801c5e9f8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16794"
"4459","Sri Lanka","C17163","LKA","['SRI LANKA']","Sri Lanka","A country in Southern Asia, occupying an island in the Indian Ocean, south of India.","False","0118ac53-719c-42fd-9a6e-60c64db77350","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17163"
"4460","Lesotho","C16787","LSO","['LESOTHO']","Lesotho","A country in Southern Africa, an enclave of South Africa.","False","fcaf0492-c841-4d91-9186-7fabf0b491eb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16787"
"4461","Lithuania","C16799","LTU","['LITHUANIA']","Lithuania","A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia.","False","14600ef1-d63a-4410-8569-84aa6cfa30a4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16799"
"4462","Luxembourg","C16803","LUX","['LUXEMBOURG']","Luxembourg","A country in Western Europe, between France, Belgium, and Germany.","False","51b745bc-854e-4373-bd9e-8de9c0e2cb17","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16803"
"4463","Latvia","C16783","LVA","['LATVIA']","Latvia","A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania.","False","88a530eb-83d2-4ef6-a340-61f219084b15","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16783"
"4464","Macao","C16807","MAC","['MACAO']","Macao","A country in Eastern Asia, bordering the South China Sea and China.","False","cc5808d9-3d8e-45ca-99e6-615137b86095","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16807"
"4465","Morocco","C16878","MAR","['MOROCCO']","Morocco","A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara.","False","ed3c3450-83c2-4345-a12e-108250d58b8a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16878"
"4466","Monaco","C16874","MCO","['MONACO']","Monaco","A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.","False","95bfa31e-f6e2-4347-ae27-1aa535d4288b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16874"
"4467","Moldova","C16871","MDA","['MOLDOVA, REPUBLIC OF']","Moldova","A country in Eastern Europe, northeast of Romania.","False","0c7b364c-0462-4206-bd3a-9a229b641032","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16871"
"4468","Madagascar","C16808","MDG","['MADAGASCAR']","Madagascar","A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique.","False","9771deb2-1412-47b7-92a7-f43ca94868ae","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16808"
"4469","Maldives","C16815","MDV","['MALDIVES']","Maldives","A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India.","False","e79aabc5-f152-4654-9547-7ae3c9779434","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16815"
"4470","Mexico","C16850","MEX","['MEXICO']","Mexico","A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US.","False","ef1a0646-8d5a-46f5-969c-1e8d12a29a02","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16850"
"4471","Marshall Islands","C16822","MHL","['MARSHALL ISLANDS']","Marshall Islands","A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","0d86fb63-b0a3-48dc-86f9-3fe2d01bdc67","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16822"
"4472","Republic of Macedonia","C17654","MKD","['REPUBLIC OF MACEDONIA']","Republic of Macedonia","A country in Southeastern Europe, north of Greece.","False","e16c3cc7-60d3-4a2c-b944-c4a0fc825c0c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17654"
"4473","Mali","C16816","MLI","['MALI']","Mali","A country in Western Africa, southwest of Algeria.","False","381d7f60-c07e-4ab2-a788-99cbf13ae756","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16816"
"4474","Malta","C16817","MLT","['MALTA']","Malta","A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy).","False","2c1d288b-e864-47a1-be21-a43c56902187","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16817"
"4475","Myanmar","C16370","MMR","['MYANMAR']","Myanmar","A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand.","False","6497df36-9d5e-4074-bac8-91e618848087","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16370"
"4476","Montenegro","C64378","MNE","['MONTENEGRO']","Montenegro","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","61c9274f-cdfa-406f-bc03-5490bf6b1900","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C64378"
"4477","Mongolia","C16875","MNG","['MONGOLIA']","Mongolia","A country in Northern Asia, between China and Russia.","False","b15f0ad9-77f5-4459-b1c8-b42457ce1f63","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16875"
"4478","Northern Mariana Islands","C17882","MNP","['NORTHERN MARIANA ISLANDS']","Northern Mariana Islands","A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.","False","a5f587d0-bfa7-48ff-a4c7-3b558c4ead38","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17882"
"4479","Mozambique","C16882","MOZ","['MOZAMBIQUE']","Mozambique","A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania.","False","18b1d833-d1db-40ae-b75a-4384fa0a7ca7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16882"
"4480","Mauritania","C16826","MRT","['MAURITANIA']","Mauritania","A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara.","False","3fb321d9-2497-4155-a2bf-3d20789706f5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16826"
"4481","Montserrat","C16876","MSR","['MONTSERRAT']","Montserrat","A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico.","False","3bd401c0-9e47-4b3a-9003-6e9222da63ea","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16876"
"4482","Martinique","C16823","MTQ","['MARTINIQUE']","Martinique","An island in the Caribbean Sea, north of Trinidad and Tobago.","False","36a33217-16c5-472c-b807-adad75051b85","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16823"
"4483","Mauritius","C16827","MUS","['MAURITIUS']","Mauritius","A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","333bdf22-87cf-4419-b067-4dcc47cac5f0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16827"
"4484","Malawi","C16813","MWI","['MALAWI']","Malawi","A country in Southern Africa, east of Zambia.","False","87dd67ea-0636-4a80-85f2-9e8783d172c5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16813"
"4485","Malaysia","C16814","MYS","['MALAYSIA']","Malaysia","A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam.","False","0cf132c7-c17c-4f16-90c1-2f7740744fad","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16814"
"4486","Mayotte","C16828","MYT","['MAYOTTE']","Mayotte","A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique.","False","c01ef721-c9d1-4c3e-8e55-2e66bbd6b4c9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16828"
"4487","Namibia","C16891","NAM","['NAMIBIA']","Namibia","A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa.","False","98d41e95-b8d5-4e7e-a1f1-65305868f288","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16891"
"4488","New Caledonia","C16913","NCL","['NEW CALEDONIA']","New Caledonia","A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia.","False","9926a89f-eca9-4255-8450-1709c1486804","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16913"
"4489","Niger","C16916","NER","['NIGER']","Niger","A country in Western Africa, southeast of Algeria.","False","cd2e7958-e134-4831-a71a-e240788d7c5d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16916"
"4490","Norfolk Island","C16919","NFK","['NORFOLK ISLAND']","Norfolk Island","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia.","False","6a02580b-50c6-4674-9dc9-5eeb7e2b89b9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16919"
"4491","Nigeria","C16917","NGA","['NIGERIA']","Nigeria","A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon.","False","f57e15a2-45e9-496a-8937-2572566bb252","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16917"
"4492","Nicaragua","C16915","NIC","['NICARAGUA']","Nicaragua","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras.","False","4d403768-ecc1-409e-9f08-5b666ea1c36f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16915"
"4493","Niue","C16918","NIU","['NIUE']","Niue","A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga.","False","b1ead6a5-f371-4259-901c-47a1f1ee8167","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16918"
"4494","Netherlands","C16903","NLD","['NETHERLANDS']","Netherlands","A country in Western Europe, bordering the North Sea, between Belgium and Germany.","False","2ff53a8a-e32b-4027-947a-a7049d103823","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16903"
"4495","Norway","C16920","NOR","['NORWAY']","Norway","A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden.","False","60aca9fd-65fc-4da4-9e44-2a853822f4ca","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16920"
"4496","Nepal","C16901","NPL","['NEPAL']","Nepal","A country in Southern Asia, between China and India.","False","b64fb381-0767-46dc-9352-97dc52cf0be4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16901"
"4497","Nauru","C16896","NRU","['NAURU']","Nauru","A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands.","False","a82b362f-de65-4996-abc7-c7cd7733ed36","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16896"
"4498","New Zealand","C16914","NZL","['NEW ZEALAND']","New Zealand","A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia.","False","b3dbbf93-6c30-4c72-ad09-6c872a6096cc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16914"
"4499","Oman","C16933","OMN","['OMAN']","Oman","A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates.","False","ded4a1a0-fe49-4dd6-bb4e-a21b773f0704","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16933"
"4500","Pakistan","C16949","PAK","['PAKISTAN']","Pakistan","A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north.","False","aacccf21-9f4d-4c97-8c67-ec78cf9acf73","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16949"
"4501","Panama","C16951","PAN","['PANAMA']","Panama","A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica.","False","24fdba60-8ea7-41cd-832f-894cb8b85831","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16951"
"4502","Pitcairn Island","C16993","PCN","['PITCAIRN']","Pitcairn Island","A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.","False","cc8896b0-c355-4692-8bfc-77e8a30484dd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16993"
"4503","Peru","C16972","PER","['PERU']","Peru","A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador.","False","c044c0b5-c29e-4084-b038-e07c3ef44ba0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16972"
"4504","Philippines","C16978","PHL","['PHILIPPINES']","Philippines","A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam.","False","e553592b-df8f-42dc-92da-7c50c205c4dc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16978"
"4505","Palau","C17733","PLW","['PALAU']","Palau","A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines.","False","684c19c0-0675-4ca0-bedc-ead3204ded63","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17733"
"4506","Papua New Guinea","C16952","PNG","['PAPUA NEW GUINEA']","Papua New Guinea","A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia.","False","b00700d8-3013-4892-8c63-9571f0ae9c02","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16952"
"4507","Poland","C17002","POL","['POLAND']","Poland","A country in Central Europe, east of Germany.","False","59a51858-7912-4a5a-b208-08874f7579eb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17002"
"4508","Puerto Rico","C17043","PRI","['PUERTO RICO']","Puerto Rico","An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic.","False","df4b69b1-b2d9-4864-ba0e-3a3fd0f499c0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17043"
"4509","North Korea","C16773","PRK","['NORTH KOREA']","North Korea","A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea.","False","ba604455-5f4f-46dd-87f6-ad92ef965c0c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16773"
"4510","Portugal","C17006","PRT","['PORTUGAL']","Portugal","A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain.","False","54b4b1c4-9ca5-48dd-967d-5328415f667d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17006"
"4511","Paraguay","C16953","PRY","['PARAGUAY']","Paraguay","A country in Central South America, northeast of Argentina.","False","3040d561-e0e8-43a9-bbd6-925e4b195ca7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16953"
"4512","Palestinian Territory, Occupied","C20110","PSE","['PALESTINIAN TERRITORY, OCCUPIED']","Palestinian Territory, Occupied","A collective name for the West Bank and the Gaza Strip, two territories in Palestine.","False","709c7c6b-f96d-486f-8952-e24ee10d3695","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20110"
"4513","French Polynesia","C16594","PYF","['FRENCH POLYNESIA']","French Polynesia","An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia.","False","485a39ac-6424-40d4-b6ac-baed3ae031e6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16594"
"4514","Qatar","C17045","QAT","['QATAR']","Qatar","A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia.","False","421b6993-6460-4dfa-9f5c-f7ba3880c9fe","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17045"
"4515","Reunion","C17095","REU","['REUNION']","Reunion","An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.","False","1457f25c-f8c0-4520-aa03-4a7a48b6d127","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17095"
"4516","Romania","C17108","ROU","['ROMANIA']","Romania","A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine.","False","e3d56a17-2e6a-456f-b72c-bd12ed881073","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17108"
"4517","Russia","C17111","RUS","['RUSSIAN FEDERATION']","Russia","A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean.","False","758ce0dd-4349-4ad3-aa20-6d3637db6817","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17111"
"4518","Rwanda","C17112","RWA","['RWANDA']","Rwanda","A country in Central Africa, east of Democratic Republic of the Congo.","False","bb2f0d47-6f0b-44da-8fc6-c1148da662de","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17112"
"4519","Saudi Arabia","C17117","SAU","['SAUDI ARABIA']","Saudi Arabia","A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen.","False","14907163-3ebc-467d-9562-a84de980bc55","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17117"
"4520","Serbia","C64377","SCG","['SERBIA']","Serbia","A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).","False","8b3c4ea6-d31e-454f-b94e-da452f117567","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C64377"
"4521","Sudan","C17170","SDN","['SUDAN']","Sudan","A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea.","False","3da81313-09ee-45af-8864-528cadb73a72","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17170"
"4522","Senegal","C17121","SEN","['SENEGAL']","Senegal","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania.","False","0de4b5f6-9c55-4a4a-a9ab-9c3a1b471528","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17121"
"4523","Singapore","C17134","SGP","['SINGAPORE']","Singapore","A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia.","False","35d754ed-dad3-47dd-8fc7-20271c1eaacd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17134"
"4524","South Georgia and the South Sandwich Islands","C20111","SGS","['SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS']","South Georgia and the South Sandwich Islands","A group of islands in the South Atlantic Ocean, east of the tip of South America.","False","e9a4cc0a-9734-4384-a4db-9e933a6055be","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20111"
"4525","Saint Helena","C17164","SHN","['SAINT HELENA']","Saint Helena","Islands in the South Atlantic Ocean, about midway between South America and Africa.","False","8b0ec72a-9222-4cae-bffd-60ef0a1202c3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17164"
"4526","Svalbard and Jan Mayen","C17178","SJM","['SVALBARD AND JAN MAYEN']","Svalbard and Jan Mayen","Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway.","False","a777bd87-e732-4cea-aa07-20316f8ee789","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17178"
"4527","Solomon Islands","C17148","SLB","['SOLOMON ISLANDS']","Solomon Islands","A group of islands in the South Pacific Ocean, east of Papua New Guinea.","False","6fc4c61e-bea2-4b5e-96f9-99abe56eadef","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17148"
"4528","Sierra Leone","C17130","SLE","['SIERRA LEONE']","Sierra Leone","A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia.","False","8a1c0943-c817-429c-a90a-122a314c3938","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17130"
"4529","El Salvador","C16532","SLV","['EL SALVADOR']","El Salvador","A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras.","False","c46b66f8-9532-4fe6-99d2-08f21c31df6d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16532"
"4530","San Marino","C17115","SMR","['SAN MARINO']","San Marino","A country in Southern Europe, an enclave in central Italy.","False","df65b8dc-5de1-43a3-9085-f7d27bbf48d9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17115"
"4531","Somalia","C17149","SOM","['SOMALIA']","Somalia","A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia.","False","f0a8495b-62fe-4fb7-8523-91c651bad374","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17149"
"4532","Saint Pierre and Miquelon","C17165","SPM","['SAINT PIERRE AND MIQUELON']","Saint Pierre and Miquelon","A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada).","False","a347ea79-d06b-40ce-a315-5036b92aa512","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17165"
"4533","Sao Tome and Principe","C17116","STP","['SAO TOME AND PRINCIPE']","Sao Tome and Principe","A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon.","False","a119a0cd-b94c-4bb5-8f44-b62a21867e20","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17116"
"4534","Suriname","C17175","SUR","['SURINAME']","Suriname","A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana.","False","06da5b85-809f-44d4-bc7a-769e12f5016e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17175"
"4535","Slovakia","C17669","SVK","['SLOVAKIA']","Slovakia","A country in Central Europe, south of Poland.","False","06132b18-d21a-49a6-b36c-2606cfaac3d0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17669"
"4536","Slovenia","C17138","SVN","['SLOVENIA']","Slovenia","A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia.","False","f70e47a0-7037-4704-b869-43e6477748c1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17138"
"4537","Sweden","C17180","SWE","['SWEDEN']","Sweden","A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway.","False","9a668d10-59be-499b-8072-fa5bfecaa66a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17180"
"4538","Swaziland","C17179","SWZ","['SWAZILAND']","Swaziland","A country in Southern Africa, between Mozambique and South Africa.","False","fefcd353-42a8-40a4-929f-24b9c45b7d24","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17179"
"4539","Seychelles","C17129","SYC","['SEYCHELLES']","Seychelles","A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar.","False","bccb6b81-f33c-413d-9eb7-f78d3e4e976b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17129"
"4540","Syria","C17182","SYR","['SYRIAN ARAB REPUBLIC']","Syria","A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey.","False","ae96f8d1-746c-4cae-acbc-7d32084d1955","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17182"
"4541","Turks and Caicos Islands","C17224","TCA","['TURKS AND CAICOS ISLANDS']","Turks and Caicos Islands","Two island groups in the North Atlantic Ocean, southeast of The Bahamas.","False","1d285252-72c6-4e38-b649-0c4d738ff45f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17224"
"4542","Chad","C16412","TCD","['CHAD']","Chad","A country in Central Africa, south of Libya.","False","27b4a7b8-7817-4046-9d18-f164df68e6a6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C16412"
"4543","Togo","C17202","TGO","['TOGO']","Togo","A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana.","False","0a8da686-fcac-4603-9a6d-20b72045c8c3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17202"
"4544","Thailand","C17192","THA","['THAILAND']","Thailand","A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma.","False","261c5642-9c68-4ed3-acfb-cfb320eaacca","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17192"
"4545","Tajikistan","C17183","TJK","['TAJIKISTAN']","Tajikistan","A country in Central Asia, west of China.","False","74898c9f-58de-4e71-b4e5-cb0b873c9ca9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17183"
"4546","Tokelau","C17704","TKL","['TOKELAU']","Tokelau","A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","8349ba58-489a-4a72-889b-66bce840e3f0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17704"
"4547","Turkmenistan","C17223","TKM","['TURKMENISTAN']","Turkmenistan","A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan.","False","17a31ecc-f14c-41c3-8880-f2be6b9de92d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17223"
"4548","Timor-Leste","C17200","TLS","['TIMOR-LESTE']","Timor-Leste","A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco.","False","c6c35cdb-1d94-4caa-9d21-045fa805d6b8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17200"
"4549","Tonga","C17205","TON","['TONGA']","Tonga","An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","e2db228d-5ab7-45eb-a5df-c00e9c79da23","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17205"
"4550","Trinidad and Tobago","C17217","TTO","['TRINIDAD AND TOBAGO']","Trinidad and Tobago","Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.","False","a373c204-ce66-4d97-b48a-2905998d51a3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17217"
"4551","Tunisia","C17221","TUN","['TUNISIA']","Tunisia","A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya.","False","f98faf99-e324-48c0-adac-3b85f555a47d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17221"
"4552","Turkey","C17222","TUR","['TURKEY']","Turkey","A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria.","False","69402ffe-c855-4bb7-825c-a4644c18a867","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17222"
"4553","Tuvalu","C17225","TUV","['TUVALU']","Tuvalu","An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia.","False","f725e028-97ef-4bd0-8845-0f41a1dd67c8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17225"
"4554","Taiwan","C17184","TWN","['TAIWAN']","Taiwan","A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China.","False","0eada366-9832-405a-b271-526985980c86","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17184"
"4555","Tanzania","C17185","TZA","['TANZANIA, UNITED REPUBLIC OF']","Tanzania","A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique.","False","52e5ff4f-dbc5-43c0-8183-7e13fd5fa8b4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17185"
"4556","Uganda","C17228","UGA","['UGANDA']","Uganda","A country in Eastern Africa, west of Kenya.","False","82356b47-0b02-4a99-a1ac-45a5d2536046","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17228"
"4557","Ukraine","C17229","UKR","['UKRAINE']","Ukraine","A country in Eastern Europe, bordering the Black Sea, between Poland and Russia.","False","210d1424-3c45-4edf-bca9-0a7189bfed85","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17229"
"4558","United States Minor Outlying Islands","C20112","UMI","['UNITED STATES MINOR OUTLYING ISLANDS']","United States Minor Outlying Islands","The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).","False","cf0226f9-f21f-4b53-8e6a-5b1005305c6f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C20112"
"4559","Uruguay","C17244","URY","['URUGUAY']","Uruguay","A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil.","False","42a8ed03-a5c2-4021-928f-9cfdf37bec30","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17244"
"4560","United States","C17234","USA","['UNITED STATES']","United States","A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico.","False","ccefbbdd-adec-465f-81eb-2d04eb618ebd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17234"
"4561","Uzbekistan","C17246","UZB","['UZBEKISTAN']","Uzbekistan","A country in Central Asia, north of Afghanistan.","False","d38087bc-b825-4b67-9f9d-b7bdd4ce86fa","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17246"
"4562","Holy See","C17249","VAT","['VATICAN CITY STATE']","Holy See","An enclave of Rome (Italy).","False","b02b648e-c801-4ffa-81dd-24e577a8cd59","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17249"
"4563","Saint Vincent and the Grenadines","C17114","VCT","['SAINT VINCENT AND THE GRENADINES']","Saint Vincent and the Grenadines","A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago.","False","4e831ac4-174b-4def-9741-193f2e6dff2c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17114"
"4564","Venezuela","C17250","VEN","['VENEZUELA']","Venezuela","A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana.","False","916f5be3-7f39-4269-85f5-82826f08ef62","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17250"
"4565","British Virgin Islands","C17653","VGB","['VIRGIN ISLANDS,BRITISH']","British Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","b1ea9506-c8f2-4ee9-b5f2-b558b1e704a3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17653"
"4566","United States Virgin Islands","C17255","VIR","['VIRGIN ISLANDS, U.S.']","United States Virgin Islands","Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.","False","f00e1a0c-ca00-4626-866f-b3fd1ea5ae57","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17255"
"4567","Vietnam","C17252","VNM","['VIETNAM']","Vietnam","A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.","False","3cb39b80-2435-46b7-bf7b-cb7d7628b575","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17252"
"4568","Vanuatu","C17247","VUT","['VANUATU']","Vanuatu","A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia.","False","fb36d996-0e7b-4dd4-b3da-aea98e5ae015","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17247"
"4569","Wallis and Futuna Islands","C17259","WLF","['WALLIS AND FUTUNA']","Wallis and Futuna Islands","Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.","False","66a19d22-fbd5-48fb-ba38-144723bcf605","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17259"
"4570","Samoa","C17740","WSM","['SAMOA']","Samoa","A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.","False","059b785d-4393-425f-aad1-883767da7069","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17740"
"4571","Yemen","C17264","YEM","['YEMEN']","Yemen","A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia.","False","69fe3f23-7103-4dfd-b503-6865fda6d38b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17264"
"4572","South Africa","C17151","ZAF","['SOUTH AFRICA']","South Africa","A country in Southern Africa, at the southern tip of the continent of Africa.","False","8dc8e68b-837b-40cd-8049-1977d7f20419","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17151"
"4573","Zambia","C17267","ZMB","['ZAMBIA']","Zambia","A country in Southern Africa, east of Angola.","False","1da5e5cb-b6e2-4c55-8781-13c7577f24f3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17267"
"4574","Zimbabwe","C17268","ZWE","['ZIMBABWE']","Zimbabwe","A country in Southern Africa, between South Africa and Zambia.","False","c13f8272-623b-444e-912e-cb69c22ac2a7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66786/C17268"
"4575","Diagnosis Group","C66787","TDIGRP","['Diagnosis Group']","CDISC SDTM Diagnosis Group Terminology","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","0a00296f-11d6-4019-a106-ef37642d6d44","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66787"
"4576","Healthy Subject","C49651","HEALTHY SUBJECTS","[]","Healthy Subject","An individual who is or becomes a participant in a research study and has no significant health-related issues.  (NCI)","False","ebde92ec-7532-4c86-977f-5568fdc07686","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66787/C49651"
"4577","Dictionary Name","C66788","DICTNAM","['Dictionary Name', 'Name of Dictionary']","CDISC SDTM Dictionary Name Terminology","A name given to a reference source that lists words and gives their meaning. (NCI)","False","79a21445-58b2-4941-8514-fd9bc20dcd69","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788"
"4578","Thesaurus of Adverse Reaction Term Coding Symbols","C49471","COSTART","['Coding Symbols for a Thesaurus of Adverse Reaction Terms']","Thesaurus of Adverse Reaction Term Coding Symbols","A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)","False","ea32d981-ae3e-4e86-995e-4bcfa6b1467b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788/C49471"
"4579","International Classification of Diseases","C49474","ICD","['International Classification of Diseases']","International Classification of Diseases","A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)","False","146140fe-0d91-456c-9c13-eb731f8deb3e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788/C49474"
"4580","Logical Observation Identifiers Names and Codes","C49476","LOINC","['Logical Observation Identifiers Names and Codes']","Logical Observation Identifiers Names and Codes","Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)","False","0cbb9056-5b7a-4baf-85d0-59b949cc9148","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788/C49476"
"4581","MedDRA","C43820","MedDRA","['Medical Dictionary for Regulatory Activities']","MedDRA","MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)","False","cf4c5dc6-034e-4a91-9d72-83e8dc913679","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788/C43820"
"4582","Systematized Nomenclature of Medicine","C53489","SNOMED","['Systematized Nomenclature of Medicine']","Systematized Nomenclature of Medicine","A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)","False","8ff6c939-7743-4f09-9ba5-94fe966539d8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788/C53489"
"4583","World Health Organization Adverse Reaction Terminology","C49468","WHOART","['World Health Organization Adverse Reaction Terms']","World Health Organization Adverse Reaction Terminology","A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)","False","c32c233a-d680-4eca-8561-e7f8c07c30ba","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788/C49468"
"4584","World Health Organization Drug Dictionary","C49475","WHODD","['World Health Organization Drug Dictionary']","World Health Organization Drug Dictionary","A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)","False","443d0edf-21bf-46aa-b901-0dba1b98adb4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66788/C49475"
"4585","Not Done","C66789","ND","['Not Done']","CDISC SDTM Not DoneTerminology","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","92bb3891-c5e4-46ec-8e0c-a04fd7e7a836","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66789"
"4586","Not Done","C49484","NOT DONE","[]","Not Done","Indicates a task, process or examination that has either not been initiated or completed. (NCI)","False","ad1c0658-9587-448e-9082-9f461c8bda4a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66789/C49484"
"4587","Patient Ethnic Group","C66790","ETHNIC","['Patient Ethnic Group']","CDISC SDTM Patient Ethnic GroupTerminology","A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)","False","7c597641-0134-471e-9186-eb91a1099245","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66790"
"4588","Hispanic or Latino","C17459","HISPANIC OR LATINO","[]","Hispanic or Latino","A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)","False","7b31e661-75a9-4878-9714-c908e315e470","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66790/C17459"
"4589","Not Hispanic or Latino","C41222","NOT HISPANIC OR LATINO","[]","Not Hispanic or Latino","A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)","False","106bed5f-967f-4b6b-a601-f169e9d6491e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66790/C41222"
"4590","Not Stated","C43234","NOT REPORTED","['Not reported']","Not Stated","Not provided or available","False","76152813-d9ba-43fc-9342-f407559a3716","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66790/C43234"
"4591","Unknown","C17998","UNKNOWN","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","043b0288-c234-4081-9b9d-feacdfbcb1d1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66790/C17998"
"4592","Pharmaceutical Dosage Form","C66726","FRM","['Pharmaceutical Dosage Form', 'Dose Form']","CDISC SDTM Pharmaceutical Dosage FormTerminology","The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.","False","9dbd7b8d-04c9-4286-998f-61865bc49e5c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726"
"4593","Aerosol Dosage Form","C42887","AEROSOL","[]","Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)","False","abe6b3ba-8e85-432f-bec3-e99fd3623cab","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42887"
"4594","Aerosol Foam Dosage Form","C42888","AEROSOL, FOAM","[]","Aerosol Foam Dosage Form","A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)","False","216c4001-fb87-4f48-856d-41d93df17346","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42888"
"4595","Metered Aerosol Dosage Form","C42960","AEROSOL, METERED","[]","Metered Aerosol Dosage Form","A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)","False","cabad979-298d-4db0-9e26-a0cba04e5ce7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42960"
"4596","Powder Aerosol Dosage Form","C42971","AEROSOL, POWDER","[]","Powder Aerosol Dosage Form","A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)","False","35c9c52d-425c-4969-9390-d110dee74946","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42971"
"4597","Aerosol Spray Dosage Form","C42889","AEROSOL, SPRAY","[]","Aerosol Spray Dosage Form","An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)","False","9f5abc72-4b5a-49cb-bcf4-a7c79e93f5dd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42889"
"4598","Chewable Bar Dosage Form","C42892","BAR, CHEWABLE","[]","Chewable Bar Dosage Form","A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)","False","6190c7ec-e9b2-481f-9adb-6a001051fc4d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42892"
"4599","Bead Dosage Form","C42890","BEAD","[]","Bead Dosage Form","A solid dosage form in the shape of a small ball. (NCI)","False","014a9446-a25e-4def-ba68-7e08086d2962","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42890"
"4600","Extended Release Bead Implant Dosage Form","C43451","BEAD, IMPLANT, EXTENDED RELEASE","[]","Extended Release Bead Implant Dosage Form","A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form.  (NCI)","False","81168983-a37b-4d74-8d34-724342ad7eda","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C43451"
"4601","Block Dosage Form","C42891","BLOCK","[]","Block Dosage Form","Solid dosage form, usually in the shape of a square or rectangle. (NCI)","False","ec724f59-4250-489e-8f4a-d547beec9a17","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42891"
"4602","Capsule Dosage Form","C25158","CAPSULE","[]","Capsule Dosage Form","A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)","False","6af3eedc-4bab-4420-bf0a-c4633f629b2d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C25158"
"4603","Coated Capsule Dosage Form","C42895","CAPSULE, COATED","[]","Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)","False","71c5710f-7611-4b51-9a00-05107c901f4c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42895"
"4604","Coated Pellets in Capsule Dosage Form","C42896","CAPSULE, COATED PELLETS","[]","Coated Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)","False","c862e7ba-d7a3-4638-9a30-1fa5e366c73b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42896"
"4605","Extended Release Coated Capsule Dosage Form","C42917","CAPSULE, COATED, EXTENDED RELEASE","[]","Extended Release Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","ed5f9208-c446-4493-9d0e-1ebf1f5fa4d0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42917"
"4606","Delayed Release Capsule Dosage Form","C42902","CAPSULE, DELAYED RELEASE","[]","Delayed Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","5734add1-4e73-4b34-a531-dc78a46ad89f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42902"
"4607","Delayed Release Pellets in Capsule Dosage Form","C42904","CAPSULE, DELAYED RELEASE PELLETS","[]","Delayed Release Pellets in Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","cf9b8693-76cf-449a-a44b-eaf427f11a7f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42904"
"4608","Extended Release Capsule Dosage Form","C42916","CAPSULE, EXTENDED RELEASE","[]","Extended Release Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","f4dee1b8-8c93-4d06-acd9-7324aec67ac3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42916"
"4609","Extended Release Film Coated Capsule Dosage Form","C42928","CAPSULE, FILM COATED, EXTENDED RELEASE","[]","Extended Release Film Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or ""shell"" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","8c6aa78d-922c-4a86-a6af-7cce40bac832","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42928"
"4610","Gelatin Coated Capsule Dosage Form","C42936","CAPSULE, GELATIN COATED","[]","Gelatin Coated Capsule Dosage Form","A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)","False","574a8626-f728-4af5-bcd5-5a9cffca90d7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42936"
"4611","Liquid Filled Capsule Dosage Form","C42954","CAPSULE, LIQUID FILLED","[]","Liquid Filled Capsule Dosage Form","A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)","False","86b8b9c3-1527-4034-8df6-017228c59faa","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42954"
"4612","Cement Dosage Form","C45414","CEMENT","[]","Cement Dosage Form","A substance that serves to produce solid union between two surfaces. (NCI)","False","612fd033-daff-471b-a0bc-3f48bead8aac","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C45414"
"4613","Cigarette Dosage Form","C42678","CIGARETTE","[]","Cigarette Dosage Form","A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)","False","be4a6fc9-5be2-4127-9dfa-d6004c48af16","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42678"
"4614","Cloth Dosage Form","C60884","CLOTH","[]","Cloth Dosage Form","A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)","False","21db4589-c56c-4bd6-9079-769be5e739c8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60884"
"4615","Concentrate Dosage Form","C60891","CONCENTRATE","[]","Concentrate Dosage Form","A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)","False","b04e9faa-d7b1-4e56-9153-af6724f374b7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60891"
"4616","Cone Dosage Form","C42900","CONE","[]","Cone Dosage Form","A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)","False","932016e9-b0d5-4fd1-8ea4-2a805836a479","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42900"
"4617","Extended Release Core Dosage Form","C42919","CORE, EXTENDED RELEASE","[]","Extended Release Core Dosage Form","An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)","False","348dc2bf-8ffb-4630-8cd8-8bf582b5978c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42919"
"4618","Cream Dosage Form","C28944","CREAM","[]","Cream Dosage Form","A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)","False","5059e920-0c61-468a-a92f-d2bcbfa9162d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C28944"
"4619","Augmented Cream Dosage Form","C60897","CREAM, AUGMENTED","[]","Augmented Cream Dosage Form","A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","445188a6-1882-4539-8b03-ab70ad164db2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60897"
"4620","Crystal Dosage Form","C42901","CRYSTAL","[]","Crystal Dosage Form","A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.","False","4f42a3da-096b-43f4-8b1d-37c6d5d6d330","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42901"
"4621","Culture Dosage Form","C45415","CULTURE","[]","Culture Dosage Form","The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)","False","e99a7955-240d-483a-84b5-37e8673b4504","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C45415"
"4622","Diaphragm Dosage Form","C47890","DIAPHRAGM","[]","Diaphragm Dosage Form","A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)","False","2f9e9f54-5867-4acb-8f83-c7620a8a7fa6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47890"
"4623","Disc Dosage Form","C43525","DISC","[]","Disc Dosage Form","A circular plate-like organ or structure. (FDA)","False","4d8fe742-b2c7-4df7-8343-6df50b547182","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C43525"
"4624","Douche Dosage Form","C42679","DOUCHE","[]","Douche Dosage Form","A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)","False","e2612a2a-9c57-4c1b-ab55-a2a11af5e5fb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42679"
"4625","Dressing Dosage Form","C42763","DRESSING","[]","Dressing Dosage Form","The application of various materials for protecting a wound.(FDA)","False","7925982e-ff10-4ad6-b810-c1a302e6fa33","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42763"
"4626","Drug Delivery System","C17423","DRUG DELIVERY SYSTEM","[]","Drug Delivery System","Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)","False","d771464b-57ae-4bee-b2a0-9a283c253522","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C17423"
"4627","Elixir Dosage Form","C42912","ELIXIR","[]","Elixir Dosage Form","A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)","False","12b4e43a-01b8-4412-9f42-094101b8fc9a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42912"
"4628","Emulsion Dosage Form","C42913","EMULSION","[]","Emulsion Dosage Form","A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)","False","6d389275-85c5-4e87-903d-16c8eebee1f2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42913"
"4629","Enema Dosage Form","C42915","ENEMA","[]","Enema Dosage Form","A rectal preparation for therapeutic, diagnostic, or nutritive purposes.  (NCI)","False","5d82e0a4-9225-47c3-9f38-8ec4e965b1dc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42915"
"4630","Extract Dosage Form","C42929","EXTRACT","[]","Extract Dosage Form","A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)","False","19bc8111-c1e9-4005-b159-1669ed6e796a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42929"
"4631","Extended Release Fiber Dosage Form","C60926","FIBER, EXTENDED RELEASE","[]","Extended Release Fiber Dosage Form","A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","2558c990-0249-40a7-a11f-7db047c6174e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60926"
"4632","Film Dosage Form","C42932","FILM","[]","Film Dosage Form","A thin layer or coating. (NCI)","False","39c8f728-74ac-4449-8690-05614b306e9d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42932"
"4633","Extended Release Film Dosage Form","C42920","FILM, EXTENDED RELEASE","[]","Extended Release Film Dosage Form","A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)","False","b3ba3883-b1bf-4065-ac77-61c236ad5f87","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42920"
"4634","Soluble Film Dosage Form","C42984","FILM, SOLUBLE","[]","Soluble Film Dosage Form","A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)","False","d7b9ac77-f3bb-4888-a1c7-eaf3886b5d6a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42984"
"4635","Dosage Form For Solution","C60927","FOR SOLUTION","[]","Dosage Form For Solution","A product, usually a solid, intended for solution prior to administration. (FDA)","False","e05e0592-c4b0-4808-b382-fc5a2f4d2122","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60927"
"4636","Dosage Form For Suspension","C60928","FOR SUSPENSION","[]","Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration. (FDA)","False","909d114b-c307-406e-a934-5c2ab4a4e057","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60928"
"4637","Extended Release Dosage Form For Suspension","C60929","FOR SUSPENSION, EXTENDED RELEASE","[]","Extended Release Dosage Form For Suspension","A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)","False","bf5b55f1-d8c7-41c5-9240-11c33a04ad49","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60929"
"4638","Gas Dosage Form","C42933","GAS","[]","Gas Dosage Form","Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)","False","0fb69903-fa53-4e34-9049-a2a44259eca4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42933"
"4639","Gel Dosage Form","C42934","GEL","[]","Gel Dosage Form","A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2).  A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature.  It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)","False","5ea15e57-5936-4424-8407-4e48f0d2dc35","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42934"
"4640","Dentifrice Gel Dosage Form","C42906","GEL, DENTIFRICE","[]","Dentifrice Gel Dosage Form","A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)","False","c660231b-47e3-4d31-a6a2-246932115df4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42906"
"4641","Metered Gel Dosage Form","C60930","GEL, METERED","[]","Metered Gel Dosage Form","A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)","False","fd67ea29-cdf0-49b1-ac01-43396169aca1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60930"
"4642","Generator Dosage Form","C48193","GENERATOR","[]","Generator Dosage Form","An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)","False","0926148d-9c01-4f41-9cf0-59cc4adf22ce","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C48193"
"4643","Globule Dosage Form","C42937","GLOBULE","[]","Globule Dosage Form","Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)","False","0700ecdf-2b58-40a2-89c7-1c3421b98486","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42937"
"4644","Graft Dosage Form","C45416","GRAFT","[]","Graft Dosage Form","A slip of skin or of other tissue for implantation. (NCI)","False","eb9ecc39-3e64-451c-8e37-ec840ca3f165","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C45416"
"4645","Granule Dosage Form","C42938","GRANULE","[]","Granule Dosage Form","A small particle or grain. (NCI)","False","6c27c31b-c99d-4d42-a6af-c0853876b120","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42938"
"4646","Delayed Release Granule Dosage Form","C42903","GRANULE, DELAYED RELEASE","[]","Delayed Release Granule Dosage Form","A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)","False","f6f97322-5c0a-4ff6-b00a-5ba6b7ff9715","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42903"
"4647","Effervescent Granule Dosage Form","C42909","GRANULE, EFFERVESCENT","[]","Effervescent Granule Dosage Form","A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)","False","a17588d6-3e6a-4269-a6af-717a2829f741","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42909"
"4648","Granule For Solution Dosage Form","C42939","GRANULE, FOR SOLUTION","[]","Granule For Solution Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","eecd8b31-bde1-48c8-8061-2e81bd4a7d79","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42939"
"4649","Granule For Suspension Dosage Form","C42940","GRANULE, FOR SUSPENSION","[]","Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)","False","ae5523d6-c6e1-4ba0-a66a-a498ea750e96","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42940"
"4650","Extended Release Granule For Suspension Dosage Form","C42921","GRANULE, FOR SUSPENSION, EXTENDED RELEASE","[]","Extended Release Granule For Suspension Dosage Form","A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)","False","b9563bc7-0681-498f-ae55-ac25c3162912","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42921"
"4651","Gum Dosage Form","C42941","GUM","[]","Gum Dosage Form","A mucilaginous excretion from various plants. (NCI)","False","39581bf4-ae7a-406d-81be-d032f84b2d9d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42941"
"4652","Chewing Gum Dosage Form","C42894","GUM, CHEWING","[]","Chewing Gum Dosage Form","A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)","False","915d1bab-f039-4f4e-8f42-a03910029a2a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42894"
"4653","Resin Gum Dosage Form","C42978","GUM, RESIN","[]","Resin Gum Dosage Form","Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)","False","733d9832-e946-42c8-94e8-da49e1896dcc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42978"
"4654","Implant Dosage Form","C42942","IMPLANT","[]","Implant Dosage Form","A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)","False","72769866-aee5-4703-af4f-050ffc476a12","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42942"
"4655","Inhalant Dosage Form","C42944","INHALANT","[]","Inhalant Dosage Form","A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)","False","68c4f2e9-079c-4265-ac95-a3da462ebfb1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42944"
"4656","Liposomal Injection Dosage Form","C60931","INJECTABLE, LIPOSOMAL","[]","Liposomal Injection Dosage Form","An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)","False","7217da7f-3db2-4a87-92ea-68220e7296e9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60931"
"4657","Injectable Dosage Form","C42946","INJECTION","[]","Injectable Dosage Form","A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)","False","71bf2284-0bc1-40a6-a8d0-df3ab786b893","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42946"
"4658","Emulsion for Injection Dosage Form","C42914","INJECTION, EMULSION","[]","Emulsion for Injection Dosage Form","An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)","False","e55b0571-0f7a-40f9-9e60-a042a5e87b11","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42914"
"4659","Injectable Lipid Complex Dosage Form","C42950","INJECTION, LIPID COMPLEX","[]","Injectable Lipid Complex Dosage Form","[definition pending](FDA)","False","3741b34b-14bd-48dd-9c2f-194505f31c69","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42950"
"4660","Powder For Injectable Solution Dosage Form","C42974","INJECTION, POWDER, FOR SOLUTION","[]","Powder For Injectable Solution Dosage Form","A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)","False","47e66207-c5c5-48b7-b42f-69e1df80bb7a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42974"
"4661","Powder For Injectable Suspension Dosage Form","C42976","INJECTION, POWDER, FOR SUSPENSION","[]","Powder For Injectable Suspension Dosage Form","A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)","False","21b57eff-1abd-48d9-a1a9-88fd5b22b9bf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42976"
"4662","Powder For Injectable Extended Release Suspension Dosage Form","C42977","INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE","[]","Powder For Injectable Extended Release Suspension Dosage Form","A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)","False","4681ad62-47ef-448e-8dea-7c7928508bae","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42977"
"4663","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","C42959","INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION","[]","Lyophilized Powder For Injectable Liposomal Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)","False","b44123ab-b2fc-47f2-860a-5eeff44b2c0d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42959"
"4664","Lyophilized Powder For Injectable Solution Dosage Form","C42957","INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","[]","Lyophilized Powder For Injectable Solution Dosage Form","A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)","False","70d60b7f-a3ba-403f-ba9a-6de8acbdde2c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42957"
"4665","Lyophilized Powder For Injectable Suspension Dosage Form","C42958","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION","[]","Lyophilized Powder For Injectable Suspension Dosage Form","A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization (""freeze drying""), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)","False","26121871-c5a5-46f4-b89c-82aec4218358","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42958"
"4666","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","C42956","INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE","[]","Lyophilized Powder For Extended Release Injectable Suspension Dosage Form","A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)","False","6d0718c5-d8bf-409f-b21a-88ef00a1414f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42956"
"4667","Injectable Solution Dosage Form","C42945","INJECTION, SOLUTION","[]","Injectable Solution Dosage Form","A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)","False","b907c82e-5903-45f9-8277-20f73f7c7981","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42945"
"4668","Concentrate for Injectable Solution Dosage Form","C42899","INJECTION, SOLUTION, CONCENTRATE","[]","Concentrate for Injectable Solution Dosage Form","A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)","False","8e460fb2-8f45-4ffc-aec1-cac49e5e8e31","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42899"
"4669","Injectable Suspension Dosage Form","C42995","INJECTION, SUSPENSION","[]","Injectable Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)","False","39821c62-1222-4d95-9886-adbcfbde1381","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42995"
"4670","Injectable Extended Release Suspension Dosage Form","C42926","INJECTION, SUSPENSION, EXTENDED RELEASE","[]","Injectable Extended Release Suspension Dosage Form","A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","1d83edd2-1538-4f10-9ad5-90f23a01f00e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42926"
"4671","Injectable Liposomal Suspension Dosage Form","C42951","INJECTION, SUSPENSION, LIPOSOMAL","[]","Injectable Liposomal Suspension Dosage Form","A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)","False","a2e83251-3767-4120-90aa-2e27041f2548","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42951"
"4672","Injectable Sonicated Suspension Dosage Form","C42988","INJECTION, SUSPENSION, SONICATED","[]","Injectable Sonicated Suspension Dosage Form","A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)","False","3c266ba5-150b-4833-9275-03771851fd2c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42988"
"4673","Insert Dosage Form","C60933","INSERT","[]","Insert Dosage Form","A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)","False","82a48977-4ab5-44f1-bdc5-baf36c6624c0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60933"
"4674","Extended Release Insert Dosage Form","C42922","INSERT, EXTENDED RELEASE","[]","Extended Release Insert Dosage Form","A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)","False","b99eae55-bd05-4e70-88e2-bfeda5e12c45","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42922"
"4675","Intrauterine Device Dosage Form","C47915","INTRAUTERINE DEVICE","[]","Intrauterine Device Dosage Form","A device inserted and left in the uterus to prevent effective conception. (NCI)","False","bdfc438b-816a-4d58-a04a-4135858b9979","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47915"
"4676","Irrigant Dosage Form","C42947","IRRIGANT","[]","Irrigant Dosage Form","A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)","False","dc931c23-902e-4c05-b67d-e1ed529f0a48","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42947"
"4677","Jelly Dosage Form","C42948","JELLY","[]","Jelly Dosage Form","A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)","False","26e2409a-4645-4e8b-9750-0d53025c650c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42948"
"4678","Kit Dosage Form","C47916","KIT","[]","Kit Dosage Form","A packaged collection of related material. (NCI)","False","8a631155-042c-4632-b699-f6621ec2d174","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47916"
"4679","Dental Liner Dosage Form","C45413","LINER, DENTAL","[]","Dental Liner Dosage Form","A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)","False","056e08a5-33a4-4dd2-8ba9-16b48b8a8b1e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C45413"
"4680","Liniment Dosage Form","C42949","LINIMENT","[]","Liniment Dosage Form","A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)","False","83735417-3766-40e7-897e-7e47ed45ab9d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42949"
"4681","Lipstick Dosage Form","C42952","LIPSTICK","[]","Lipstick Dosage Form","A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)","False","73c35663-c0c6-469a-850d-08f648c9beca","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42952"
"4682","Liquid Dosage Form","C42953","LIQUID","[]","Liquid Dosage Form","A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","013c594c-f859-4b41-a70b-6011d5466348","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42953"
"4683","Extended Release Liquid Dosage Form","C60934","LIQUID, EXTENDED RELEASE","[]","Extended Release Liquid Dosage Form","A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)","False","04a236ae-b362-4906-a5c8-d3385ea1e1c3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60934"
"4684","Lotion Dosage Form","C29167","LOTION","[]","Lotion Dosage Form","An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)","False","cb11d908-1405-4322-8df6-bfec3fb9dfa5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C29167"
"4685","Augmented Lotion Dosage Form","C60957","LOTION. AUGMENTED","[]","Augmented Lotion Dosage Form","A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","2ec3e73b-c3ea-46a4-baa4-2cc8caf9205d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60957"
"4686","Lotion Shampoo Dosage Form","C60958","LOTION/SHAMPOO","[]","Lotion Shampoo Dosage Form","A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)","False","6ada4f82-60fe-4e9b-b21e-d242f5105018","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60958"
"4687","Lozenge Dosage Form","C42955","LOZENGE","[]","Lozenge Dosage Form","A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)","False","10d32b07-08d7-4faf-8ef0-e78e84f5baa6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42955"
"4688","Mouthwash Dosage Form","C29269","MOUTHWASH","[]","Mouthwash Dosage Form","An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)","False","4d30ba48-c2af-4ba0-ac0f-e0589c000fa2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C29269"
"4689","Dosage Form Not Applicable","C48624","NOT APPLICABLE","[]","Dosage Form Not Applicable","The use of a dosage form term is not relevant or appropriate. (NCI)","False","8941131a-b463-44fc-bc10-ed8327414461","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C48624"
"4690","Oil Dosage Form","C42965","OIL","[]","Oil Dosage Form","An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)","False","e5aa05d9-2be6-4149-8c04-4912409e4d30","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42965"
"4691","Ointment Dosage Form","C42966","OINTMENT","[]","Ointment Dosage Form","A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)","False","74c2fbde-2803-4326-9bdc-cec9af369882","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42966"
"4692","Augmented Ointment Dosage Form","C60984","OINTMENT, AUGMENTED","[]","Augmented Ointment Dosage Form","An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)","False","d532ce07-50cd-42e0-b8ef-878370b0b2c7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60984"
"4693","Packing Dosage Form","C47887","PACKING","[]","Packing Dosage Form","A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)","False","bd3997e5-b2f2-4159-87de-a481f0db0d45","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47887"
"4694","Paste Dosage Form","C42967","PASTE","[]","Paste Dosage Form","A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)","False","f57c7882-9c29-49e2-953f-74ecf18e6efb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42967"
"4695","Dentifrice Paste Dosage Form","C42907","PASTE, DENTIFRICE","[]","Dentifrice Paste Dosage Form","A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","35f979b6-6855-468d-8990-42992113c198","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42907"
"4696","Pastille Dosage Form","C60985","PASTILLE","[]","Pastille Dosage Form","An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)","False","4834c812-ff13-464d-b2f2-65b8f1dfc22e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60985"
"4697","Patch Dosage Form","C42968","PATCH","[]","Patch Dosage Form","A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body.  Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch.  Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body.  A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)","False","3fe73d11-bfb7-41c6-8021-7712ea9ebfb8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42968"
"4698","Extended Release Patch Dosage Form","C42923","PATCH, EXTENDED RELEASE","[]","Extended Release Patch Dosage Form","A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","6660b8d4-b5ff-413f-a2dd-eb219aacf9db","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42923"
"4699","Electrically Controlled Extended Release Patch Dosage Form","C42911","PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED","[]","Electrically Controlled Extended Release Patch Dosage Form","A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","9d820793-2a1a-4b22-9f60-2ea63ae36088","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42911"
"4700","Pellet Dosage Form","C42969","PELLET","[]","Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)","False","7a6e0df2-267e-49c6-bb37-e204cb0fbe58","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42969"
"4701","Implantable Pellet Dosage Form","C42943","PELLET, IMPLANTABLE","[]","Implantable Pellet Dosage Form","A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)","False","cb6bbf0f-cf77-4517-a805-abcb41ac2e13","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42943"
"4702","Extended Release Coated Pellets Dosage Form","C42918","PELLETS, COATED, EXTENDED RELEASE","[]","Extended Release Coated Pellets Dosage Form","A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)","False","735248d4-c954-4ae6-84ab-d6a5b208703a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42918"
"4703","Pill Dosage Form","C25394","PILL","[]","Pill Dosage Form","A dose of medicine in the form of a small pellet. (NCI)","False","d2729ba7-1323-4e78-9dfe-2244cb30c43d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C25394"
"4704","Plaster Dosage Form","C42970","PLASTER","[]","Plaster Dosage Form","Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)","False","27235077-1b82-4faa-9798-7e57502de81d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42970"
"4705","Poultice Dosage Form","C47913","POULTICE","[]","Poultice Dosage Form","A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)","False","1fa48a75-0bf3-48da-bd5d-f6c09cfd411e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47913"
"4706","Powder Dosage Form","C42972","POWDER","[]","Powder Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)","False","5ac4294d-5e31-4b5d-b25b-e660b6bed706","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42972"
"4707","Dentifrice Powder Dosage Form","C42908","POWDER, DENTIFRICE","[]","Dentifrice Powder Dosage Form","A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)","False","4f33cfee-f44d-49d1-a509-d0539f6414c6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42908"
"4708","Powder for Solution Dosage Form","C42973","POWDER, FOR SOLUTION","[]","Powder for Solution Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)","False","829ca34b-9db4-42d8-a5aa-2fdb37beacbb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42973"
"4709","Powder for Suspension Dosage Form","C42975","POWDER, FOR SUSPENSION","[]","Powder for Suspension Dosage Form","An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)","False","b21a8b83-cc51-4fe4-b36a-03ade5cfcde3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42975"
"4710","Metered Powder Dosage Form","C42961","POWDER, METERED","[]","Metered Powder Dosage Form","A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)","False","7e162e55-41b8-48ce-838d-2cfac3851687","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42961"
"4711","Ring Dosage Form","C60988","RING","[]","Ring Dosage Form","A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)","False","a1bec65b-0256-48c7-bed9-58fa7527a87a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60988"
"4712","Rinse Dosage Form","C42979","RINSE","[]","Rinse Dosage Form","A liquid used to cleanse by flushing. (NCI)","False","9f075c03-98c7-44f4-91c7-17f70d5b5a81","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42979"
"4713","Salve Dosage Form","C42980","SALVE","[]","Salve Dosage Form","A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)","False","aee47382-a284-43c4-b5c7-7bf27fa4b602","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42980"
"4714","Shampoo Dosage Form","C42981","SHAMPOO","[]","Shampoo Dosage Form","A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","b83da6f7-848d-49cf-946c-db8c867fde9a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42981"
"4715","Shampoo Suspension Dosage Form","C42982","SHAMPOO, SUSPENSION","[]","Shampoo Suspension Dosage Form","A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)","False","4a2f3868-a09c-4c76-8246-d510171d00a9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42982"
"4716","Soap Dosage Form","C42983","SOAP","[]","Soap Dosage Form","Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)","False","5daae73b-933d-4b69-91d5-2b3b0f8f4a3e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42983"
"4717","Solution Dosage Form","C42986","SOLUTION","[]","Solution Dosage Form","A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)","False","e687ce5c-5b4c-4e25-a209-d7cbc835e311","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42986"
"4718","Concentrate for Solution Dosage Form","C42898","SOLUTION, CONCENTRATE","[]","Concentrate for Solution Dosage Form","A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)","False","5d295d59-f9fd-4246-a1c8-f7f0d4c2ea04","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42898"
"4719","Solution For Slush Dosage Form","C42987","SOLUTION, FOR SLUSH","[]","Solution For Slush Dosage Form","A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)","False","d69e5fb3-f6d3-4813-bd5c-4c9711a5dee9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42987"
"4720","Gel Forming Drops Solution Dosage Form","C60994","SOLUTION, GEL FORMING / DROPS","[]","Gel Forming Drops Solution Dosage Form","A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)","False","560f2028-54ca-48a5-b376-a59db0c5c104","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60994"
"4721","Extended Release Gel Forming Solution Dosage Form","C42935","SOLUTION, GEL FORMING, EXTENDED RELEASE","[]","Extended Release Gel Forming Solution Dosage Form","A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency","False","4300ca13-8ddf-4d76-8ccf-c50f018f0b4e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42935"
"4722","Drops Solution Dosage Form","C60992","SOLUTION/ DROPS","[]","Drops Solution Dosage Form","A solution which is usually administered in a drop-wise fashion. (FDA)","False","e5e63417-0cf0-4df1-b3e6-4e3c09ee810d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60992"
"4723","Sponge Dosage Form","C47912","SPONGE","[]","Sponge Dosage Form","A porous, interlacing, absorbent material that contains a drug.  It is typically used for applying or introducing medication, or for cleansing.  A sponge usually retains its shape.(FDA)","False","fcfdbc5b-4ae2-491d-9438-4bcec3edad08","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47912"
"4724","Spray Dosage Form","C42989","SPRAY","[]","Spray Dosage Form","A liquid minutely divided as by a jet of air or steam. (NCI)","False","af6f3dd8-3a6a-4298-90ce-8eb6025cb054","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42989"
"4725","Metered Spray Dosage Form","C42962","SPRAY, METERED","[]","Metered Spray Dosage Form","A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)","False","2a6f8f87-3bcd-48d0-933f-3821c74735a7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42962"
"4726","Spray Suspension Dosage Form","C42990","SPRAY, SUSPENSION","[]","Spray Suspension Dosage Form","A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)","False","ae8847cc-54b0-46cf-b66e-2f9547b132fc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42990"
"4727","Stick Dosage Form","C42991","STICK","[]","Stick Dosage Form","A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)","False","a7321710-f87f-4bc9-8c9d-ffb8dfe3431f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42991"
"4728","Strip Dosage Form","C47914","STRIP","[]","Strip Dosage Form","A long narrow piece of material.","False","22423fed-4727-46d0-b7fe-26babcc2c710","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47914"
"4729","Suppository Dosage Form","C42993","SUPPOSITORY","[]","Suppository Dosage Form","A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)","False","12d90d73-4fb3-4d7c-9795-6d22a518fd7b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42993"
"4730","Extended Release Suppository Dosage Form","C42924","SUPPOSITORY, EXTENDED RELEASE","[]","Extended Release Suppository Dosage Form","A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)","False","e9fe9c80-fd24-4eca-ad1b-c410d5d8765d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42924"
"4731","Suspension Dosage Form","C42994","SUSPENSION","[]","Suspension Dosage Form","A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)","False","ead8ce1c-f563-49b0-8215-c110653e9fcd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42994"
"4732","Extended Release Suspension Dosage Form","C42925","SUSPENSION, EXTENDED RELEASE","[]","Extended Release Suspension Dosage Form","A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)","False","23c25e44-bca6-48e6-8bca-135377d37ac1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42925"
"4733","Drops Suspension Dosage Form","C60995","SUSPENSION/DROPS","[]","Drops Suspension Dosage Form","A suspension which is usually administered in a dropwise fashion. (FDA)","False","4abcde91-8d2e-4303-a1f3-ac58ecffb8fc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60995"
"4734","Suture Dosage Form","C47889","SUTURE","[]","Suture Dosage Form","A strand or fiber used to hold wound edges in apposition during healing. (NCI)","False","23d543d7-68fc-4ae7-8cdf-653c08661eab","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47889"
"4735","Swab Dosage Form","C47898","SWAB","[]","Swab Dosage Form","A small piece of relatively flat absorbent material that contains a drug.  A swab may also be attached to one end of a small stick.  A swab is typically used for applying medication or for cleansing. (NCI)","False","5d42e11f-70ac-4aab-818c-748b52ea4f13","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47898"
"4736","Syrup Dosage Form","C42996","SYRUP","[]","Syrup Dosage Form","An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.  (NCI)","False","720b2d99-1cf1-481d-ba75-df0da9224752","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42996"
"4737","Tablet Dosage Form","C42998","TABLET","[]","Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents.  (NCI)","False","8b8da180-bb8b-4bac-bf22-b1aba7d870ad","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42998"
"4738","Chewable Tablet Dosage Form","C42893","TABLET, CHEWABLE","[]","Chewable Tablet Dosage Form","A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)","False","7c3243fa-0c7f-428a-a946-afaa923dd36a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42893"
"4739","Coated Tablet Dosage Form","C42897","TABLET, COATED","[]","Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)","False","a7ac081b-007b-4200-bcb9-831c5ab20ab0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42897"
"4740","Tablet Coated Particles Dosage Form","C60997","TABLET, COATED PARTICLES","[]","Tablet Coated Particles Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)","False","dec0c765-5884-40fc-8aeb-bca01f991d22","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C60997"
"4741","Delayed Release Tablet Dosage Form","C42905","TABLET, DELAYED RELEASE","[]","Delayed Release Tablet Dosage Form","A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)","False","8d2e76b3-0a04-4ae4-808a-ca7d2263d1d5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42905"
"4742","Delayed Release Particles Tablet Dosage Form","C42997","TABLET, DELAYED RELEASE PARTICLES","[]","Delayed Release Particles Tablet Dosage Form","A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.  (NCI)","False","30e7c0ef-e2e1-4ee2-8fec-b4dc06d8257f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42997"
"4743","Effervescent Tablet Dosage Form","C42910","TABLET, EFFERVESCENT","[]","Effervescent Tablet Dosage Form","A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)","False","5981060b-6810-4fd0-b676-8b6287777abd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42910"
"4744","Extended Release Tablet Dosage Form","C42927","TABLET, EXTENDED RELEASE","[]","Extended Release Tablet Dosage Form","A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)","False","3c9698a6-1b11-4682-bee1-b5af8336f02a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42927"
"4745","Film Coated Tablet Dosage Form","C42931","TABLET, FILM COATED","[]","Film Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)","False","c62f417e-6df3-4cc4-9a03-20803276db84","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42931"
"4746","Film Coated Extended Release Tablet Dosage Form","C42930","TABLET, FILM COATED, EXTENDED RELEASE","[]","Film Coated Extended Release Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)","False","4b5615d6-f27b-4577-8d37-502c02c34d27","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42930"
"4747","Tablet For Solution Dosage Form","C61004","TABLET, FOR SOLUTION","[]","Tablet For Solution Dosage Form","A tablet that forms a solution when placed in a liquid. (FDA)","False","93312dba-788a-4ac9-aedf-133083b815aa","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C61004"
"4748","Tablet For Suspension Dosage Form","C61005","TABLET, FOR SUSPENSION","[]","Tablet For Suspension Dosage Form","A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).","False","d4bab50f-c6cb-488d-b7f7-4362eacbf6d9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C61005"
"4749","Multilayered Tablet Dosage Form","C42964","TABLET, MULTILAYER","[]","Multilayered Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)","False","031aaa9a-0763-4305-a0d2-7237a8d8df5a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42964"
"4750","Multilayered Extended Release Tablet Dosage Form","C42963","TABLET, MULTILAYER, EXTENDED RELEASE","[]","Multilayered Extended Release Tablet Dosage Form","A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)","False","f3aa4540-edd3-4f31-a60e-ebc67f16421e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42963"
"4751","Orally Disintegrating Tablet Dosage Form","C42999","TABLET, ORALLY DISINTEGRATING","[]","Orally Disintegrating Tablet Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.  (NCI)","False","8dc3cf88-066a-4379-800f-be9f26a92278","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42999"
"4752","Tablet Orally Disintegrating Delayed Release Dosage Form","C61006","TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE","[]","Tablet Orally Disintegrating Delayed Release Dosage Form","A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)","False","2fc13d75-b5ea-4f88-b62e-468ea3c2034b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C61006"
"4753","Soluble Tablet Dosage Form","C42985","TABLET, SOLUBLE","[]","Soluble Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)","False","dd24c51d-74c2-4e0d-a090-4e68b2c6d51b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42985"
"4754","Sugar Coated Tablet Dosage Form","C42992","TABLET, SUGAR COATED","[]","Sugar Coated Tablet Dosage Form","A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)","False","ee53c260-8d41-4bc2-a91b-a158f5fceaa9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C42992"
"4755","Tampon Dosage Form","C47892","TAMPON","[]","Tampon Dosage Form","A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)","False","a0ac689a-f8b3-4110-b653-bd1da9e96364","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47892"
"4756","Tape Dosage Form","C47897","TAPE","[]","Tape Dosage Form","A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)","False","72d82423-68e8-49f5-9b6a-3399377bf53b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C47897"
"4757","Tincture Dosage Form","C43000","TINCTURE","[]","Tincture Dosage Form","An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.  (NCI)","False","2a5f85df-0d38-4678-bf32-6349555770ec","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C43000"
"4758","Troche Dosage Form","C43001","TROCHE","[]","Troche Dosage Form","A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.  (NCI)","False","36d02718-b167-4fb8-a952-ab66a513d99c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C43001"
"4759","Unassigned Dosage Form","C43002","UNASSIGNED","[]","Unassigned Dosage Form","A dosage form has yet to be assigned.  (NCI)","False","12c00617-3a55-429b-b19a-7cd2a1ed87d8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C43002"
"4760","Wafer Dosage Form","C43003","WAFER","[]","Wafer Dosage Form","A thin slice of material containing a medicinal agent.  (NCI)","False","6fa6fcce-a78f-48ce-a4c3-f46b4ac376da","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66726/C43003"
"4761","Completion/Reason for Non-Completion","C66727","NCOMPLT","['Completion/Reason for Non-Completion']","CDISC SDTM Reason for Non-Completion Terminology","The reason that a subject was discontinued from a clinical trial.","False","d3bfafbc-b607-4cfb-a201-3dd5a993472d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727"
"4762","Adverse Event","C41331","ADVERSE EVENT","[]","Adverse Event","Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience.  (CDISC glossary)","False","7cc2e72d-3433-4843-93f5-dd9cddfa2171","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C41331"
"4763","Complete","C25250","COMPLETED","[]","Complete","To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)","False","e4b6ddb4-d0bf-453e-8412-27e8918a9d52","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C25250"
"4764","Death","C28554","DEATH","[]","Death","The absence of life or state of being dead. (NCI)","False","9e40e8ed-f21d-408a-b61e-95bfbe0a8092","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C28554"
"4765","Lack of Efficacy","C48226","LACK OF EFFICACY","[]","Lack of Efficacy","The lack of expected or desired effect related to a therapy. (NCI)","False","f28879e3-9b81-43e3-af66-a256e18d6750","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C48226"
"4766","Lost To Follow-up","C48227","LOST TO FOLLOW-UP","[]","Lost To Follow-up","The loss or lack of continuation of follow-up after a study has officially closed.  See Follow-up. (NCI)","False","8db9cd20-62ba-4f9d-bc32-18e6ff939349","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C48227"
"4767","Non-Compliance With Study Drug","C49631","NON-COMPLIANCE WITH STUDY DRUG","[]","Non-Compliance With Study Drug","An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)","False","c9b9fb07-e7e7-449b-8c6f-6e9b7622f573","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C49631"
"4768","Other","C17649","OTHER","['Other']","Other","Different than the one(s) previously specified or mentioned. (NCI)","False","beca8690-f6f5-474a-b48f-71081841a4ce","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C17649"
"4769","Physician Decision","C48250","PHYSICIAN DECISION","[]","Physician Decision","A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)","False","c7c122be-9cac-4043-bf80-501eed9cbdc3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C48250"
"4770","Pregnancy","C25742","PREGNANCY","[]","Pregnancy","Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)","False","cbc93edc-e745-4c9c-b6fc-557babd8bee5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C25742"
"4771","Progressive Disease","C35571","PROGRESSIVE DISEASE","[]","Progressive Disease","A disease process that is increasing in scope or severity. (NCI)","False","fb4e88f4-853b-4b8c-ad42-eb821f9e41f4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C35571"
"4772","Protocol Violation","C48251","PROTOCOL VIOLATION","[]","Protocol Violation","An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)","False","16ed0d7c-d8ae-44ef-9317-52498da299c2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C48251"
"4773","Recovery","C25746","RECOVERY","[]","Recovery","A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)","False","33ab88eb-bb70-454c-9ab1-6771d4a3b79b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C25746"
"4774","Trial Screen Failure","C49628","SCREEN FAILURE","[]","Trial Screen Failure","The potential subject who does not meet one or more criteria required for participation in a trial.","False","9dc6fbaa-6d6c-43d8-9dca-9b72c9c2244b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C49628"
"4775","Study Terminated By Sponsor","C49632","STUDY TERMINATED BY SPONSOR","[]","Study Terminated By Sponsor","An indication that a clinical study was stopped by its sponsor.  (NCI)","False","efbd6c08-1495-46b3-b24b-57113c694c58","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C49632"
"4776","Technical Problem","C49633","TECHNICAL PROBLEMS","[]","Technical Problem","A problem with some technical aspect of a clinical study, usually related to an instrument.  (NCI)","False","cb64d519-982b-4340-b13c-f9710d934573","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C49633"
"4777","Withdrawal by Subject","C49634","WITHDRAWAL BY SUBJECT","[]","Withdrawal by Subject","An indication that a study participant has removed itself from the study.  (NCI)","False","50621da6-3d43-490d-9b78-6f50e3a203ea","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66727/C49634"
"4778","Relation to Reference Period","C66728","STENRF","['Relation to Reference Period']","CDISC SDTM Relation to Reference Period Terminology","The name of a code list that contains terms that reference timepoints within and without a defined time period.","False","1eae40e5-3261-41a7-8b80-21cee81e0d8b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66728"
"4779","Status Post","C38008","AFTER","[]","Status Post","The time period following a point or another period of time. (NCI)","False","74cdc3a6-1d59-4156-98bc-8039374feee4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66728/C38008"
"4780","Prior","C25629","BEFORE","[]","Prior","Earlier in time or order. (NCI)","False","46ac24a4-bff6-46d1-9006-90bb991a7721","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66728/C25629"
"4781","During","C25490","DURING","[]","During","At some point in a given period of time. (NCI)","False","89dc80a9-17ce-438a-97d2-5a3df9ee2498","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66728/C25490"
"4782","During Or After","C49640","DURING/AFTER","[]","During Or After","Within a certain period of time or after a certain point or period in time. (NCI)","False","137de492-a439-4725-be6e-058459b0ccd2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66728/C49640"
"4783","Unknown","C17998","U","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","38a07abd-a1b8-4f84-80ce-b00614264953","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66728/C17998"
"4784","Route of Administration","C66729","ROUTE","['Route of Administration']","CDISC SDTM Route of Administration Terminology","The course by which a substance was administered in order to reach the site of action in the body.","False","81899797-4ca3-4e9d-8942-75e25eac802b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729"
"4785","Auricular Route of Administration","C38192","AURICULAR (OTIC)","[]","Auricular Route of Administration","Administration to or by way of the ear.(FDA)","False","6f04d6f3-8b98-45d6-ad3b-1d08148b53e7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38192"
"4786","Buccal Route of Administration","C38193","BUCCAL","[]","Buccal Route of Administration","Administration directed toward the cheek, generally from within the mouth.(FDA)","False","0344e87e-a2df-4936-bf72-4ec6fa9037fd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38193"
"4787","Conjunctival Route of Administration","C38194","CONJUNCTIVAL","[]","Conjunctival Route of Administration","Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball.(FDA)","False","8ab3d3ad-df11-463f-ba28-5a24a7a43ed1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38194"
"4788","Cutaneous Route of Administration","C38675","CUTANEOUS","[]","Cutaneous Route of Administration","Administration to the skin.(FDA)","False","fe7ddf56-1d33-4d21-a4d0-81a48c091a33","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38675"
"4789","Dental Route of Administration","C38197","DENTAL","[]","Dental Route of Administration","Administration to a tooth or teeth.(FDA)","False","365be8c1-0a47-4d9d-97b3-06470fa6d922","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38197"
"4790","Electro-osmosis Route of Administration","C38633","ELECTRO-OSMOSIS","[]","Electro-osmosis Route of Administration","Administration of through the diffusion of substance through a membrane in an electric field.(FDA)","False","e57457c9-7e5f-43a8-91b9-f5fd60175534","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38633"
"4791","Endocervical Route of Administration","C38205","ENDOCERVICAL","[]","Endocervical Route of Administration","Administration within the canal of the cervix uteri. Synonymous with the term intracervical.(FDA)","False","fcdee48c-ecde-46e8-bd57-f870388f41b3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38205"
"4792","Endosinusial Route of Administration","C38206","ENDOSINUSIAL","[]","Endosinusial Route of Administration","Administration within the nasal sinuses of the head.(FDA)","False","76675227-984f-4ead-aa95-d11a00d50ab5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38206"
"4793","Endotracheal Route of Administration","C38208","ENDOTRACHEAL","[]","Endotracheal Route of Administration","Administration directly into the trachea. Synonymous with the term intratracheal.(FDA)","False","0177198c-ea91-4eae-bfed-1e1cdb6c9280","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38208"
"4794","Enteral Route of Administration","C38209","ENTERAL","[]","Enteral Route of Administration","Administration directly into the intestines.(FDA)","False","22f60876-1339-4e25-a0dc-508d7465c30e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38209"
"4795","Epidural Route of Administration","C38210","EPIDURAL","[]","Epidural Route of Administration","Administration upon or over the dura mater.(FDA)","False","9e98216e-239d-4e75-89df-c94788e311d8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38210"
"4796","Extraamniotic Route of Administration","C38211","EXTRA-AMNIOTIC","[]","Extraamniotic Route of Administration","Administration to the outside of the membrane enveloping the fetus.(FDA)","False","6374e74d-1157-4261-a642-133e0160ca62","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38211"
"4797","Extracorporeal Circulation Route of Administration","C38212","EXTRACORPOREAL","[]","Extracorporeal Circulation Route of Administration","Administration outside of the body.(FDA)","False","37178a1a-b4a6-4239-b201-16a0e7e9f142","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38212"
"4798","Administration Via Hemodialysis","C38200","HEMODIALYSIS","[]","Administration Via Hemodialysis","Administration through hemodialysate fluid.(FDA)","False","0ffc94e8-4bd8-40e0-b658-d6e3276476d5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38200"
"4799","Infiltration Route of Administration","C38215","INFILTRATION","[]","Infiltration Route of Administration","Administration that results in substances passing into tissue spaces or into cells.(FDA)","False","5747f590-d213-479a-a7d1-7f1d6e73242e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38215"
"4800","Interstitial Route of Administration","C38219","INTERSTITIAL","[]","Interstitial Route of Administration","Administration to or in the interstices of a tissue.(FDA)","False","d5efa428-7f0e-46a9-9740-fbc1eae4b8d6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38219"
"4801","Intraabdominal Route of Administration","C38220","INTRA-ABDOMINAL","[]","Intraabdominal Route of Administration","Administration within the abdomen.(FDA)","False","287ea8ce-5c37-4d97-8007-af985508a776","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38220"
"4802","Intraamniotic Route of Administration","C38221","INTRA-AMNIOTIC","[]","Intraamniotic Route of Administration","Administration within the amnion.(FDA)","False","7c425ef2-1717-44c0-8f9f-309f229db59b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38221"
"4803","Intraarterial Route of Administration","C38222","INTRA-ARTERIAL","[]","Intraarterial Route of Administration","Administration within an artery or arteries.(FDA)","False","ecbeb654-4c3b-44b4-9d2a-538253d8bba4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38222"
"4804","Intraarticular Route of Administration","C38223","INTRA-ARTICULAR","[]","Intraarticular Route of Administration","Administration within a joint.(FDA)","False","d552be04-19a6-49fd-a7f4-70daccd440ec","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38223"
"4805","Intrabiliary Route of Administration","C38224","INTRABILIARY","[]","Intrabiliary Route of Administration","Administration within the bile, bile ducts or gallbladder.(FDA)","False","15daa625-24bb-4974-83ec-9e5e5d73445c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38224"
"4806","Intrabronchial Route of Administration","C38225","INTRABRONCHIAL","[]","Intrabronchial Route of Administration","Administration within a bronchus.(FDA)","False","e5c1f909-bbd4-4779-9302-533d5de09add","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38225"
"4807","Intrabursal Route of Administration","C38226","INTRABURSAL","[]","Intrabursal Route of Administration","Administration within a bursa.(FDA)","False","42c3babb-4e23-4914-8d66-e0e7bca68afc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38226"
"4808","Intracardiac Route of Administration","C38227","INTRACARDIAC","[]","Intracardiac Route of Administration","Administration within the heart.(FDA)","False","28f21205-a3d0-4c45-8141-6c1428374b49","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38227"
"4809","Intracartilaginous Route of Administration","C38228","INTRACARTILAGINOUS","[]","Intracartilaginous Route of Administration","Administration within a cartilage; endochondral.(FDA)","False","8930f534-ba4f-4e1a-827f-e84c04a7457b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38228"
"4810","Intracaudal Route of Administration","C38229","INTRACAUDAL","[]","Intracaudal Route of Administration","Administration within the cauda equina.(FDA)","False","c562c603-1b02-4a4d-b506-00b55860402f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38229"
"4811","Intracavernous Route of Administration","C38230","INTRACAVERNOUS","[]","Intracavernous Route of Administration","Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.(FDA)","False","929ae53b-79d4-4cb2-9b7e-83a6243c338e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38230"
"4812","Intracavitary Route of Administration","C38231","INTRACAVITARY","[]","Intracavitary Route of Administration","Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound.(FDA)","False","82d44baf-d3c4-4a51-90fc-0ae00eeed78b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38231"
"4813","Intracerebral Route of Administration","C38232","INTRACEREBRAL","[]","Intracerebral Route of Administration","Administration within the cerebrum.(FDA)","False","79037443-8118-4094-8083-2aa572ddd1a6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38232"
"4814","Intracisternal Route of Administration","C38233","INTRACISTERNAL","[]","Intracisternal Route of Administration","Administration within the cisterna magna cerebellomedularis.(FDA)","False","3af236c3-0d53-4c59-b32a-e0d13efcc518","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38233"
"4815","Intracorneal Route of Administration","C38234","INTRACORNEAL","[]","Intracorneal Route of Administration","Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).(FDA)","False","589b5196-318d-4ded-bf74-e5c813aed94b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38234"
"4816","Intracoronal Dental Route of Administration","C38217","INTRACORONAL, DENTAL","[]","Intracoronal Dental Route of Administration","Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck.(FDA)","False","86e932ae-1c78-40c0-a5fe-4e09e2239334","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38217"
"4817","Intracoronary Route of Administration","C38218","INTRACORONARY","[]","Intracoronary Route of Administration","Administration within the coronary arteries.(FDA)","False","35ef2fc2-03f1-4b53-8e0d-a659c9ff3f51","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38218"
"4818","Intracorporus Cavernosum Route of Administration","C38235","INTRACORPORUS CAVERNOSUM","[]","Intracorporus Cavernosum Route of Administration","Administration within the dilatable spaces of the corporus cavernosa of the penis.(FDA)","False","956a8f29-16c9-4262-b06b-b9abd274349a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38235"
"4819","Intradermal Route of Administration","C38238","INTRADERMAL","[]","Intradermal Route of Administration","Administration within the dermis.(FDA)","False","8f16018f-637e-4172-af69-27eca031dc71","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38238"
"4820","Intradiscal Route of Administration","C38239","INTRADISCAL","[]","Intradiscal Route of Administration","Administration within a disc.(FDA)","False","7d1e782d-2762-4aa4-9395-ae59cf8c78ff","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38239"
"4821","Intraductal Route of Administration","C38240","INTRADUCTAL","[]","Intraductal Route of Administration","Administration within the duct of a gland.(FDA)","False","16c9625d-fdd7-4e18-8ada-380f1eeeea37","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38240"
"4822","Intraduodenal Route of Administration","C38241","INTRADUODENAL","[]","Intraduodenal Route of Administration","Administration within the duodenum.(FDA)","False","9b4c1351-d1b9-451c-ab74-fed1ced3aa09","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38241"
"4823","Intradural Route of Administration","C38242","INTRADURAL","[]","Intradural Route of Administration","Administration within or beneath the dura.(FDA)","False","9146fd95-6bf6-4b61-b5dc-d0aeb336f8bf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38242"
"4824","Intraepidermal Route of Administration","C38243","INTRAEPIDERMAL","[]","Intraepidermal Route of Administration","Administration within the epidermis.(FDA)","False","86aee873-e4bd-4038-b08c-fd9b1a8279ad","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38243"
"4825","Intraesophageal Route of Administration","C38245","INTRAESOPHAGEAL","[]","Intraesophageal Route of Administration","Administration within the esophagus.(FDA)","False","1e01bba5-a3f1-4565-be1e-2c559d26e38a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38245"
"4826","Intragastric Route of Administration","C38246","INTRAGASTRIC","[]","Intragastric Route of Administration","Administration within the stomach.(FDA)","False","26463f85-2f30-4c3b-a239-185ca9b8412c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38246"
"4827","Intragingival Route of Administration","C38247","INTRAGINGIVAL","[]","Intragingival Route of Administration","Administration within the gingivae.(FDA)","False","9cadc5dd-2227-42ad-ae83-48653beb03c8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38247"
"4828","Intraileal Route of Administration","C38249","INTRAILEAL","[]","Intraileal Route of Administration","Administration within the distal portion of the small intestine, from the jejunum to the cecum.(FDA)","False","cdd9882a-1c96-4119-b248-2c5d615268e0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38249"
"4829","Intralesional Route of Administration","C38250","INTRALESIONAL","[]","Intralesional Route of Administration","Administration within or introduced directly into a localized lesion.(FDA)","False","55fca8ab-636d-4776-a9b2-b69c3eafcdfb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38250"
"4830","Intraluminal Route of Administration","C38251","INTRALUMINAL","[]","Intraluminal Route of Administration","Administration within the lumen of a tube.(FDA)","False","d2461db2-15d0-475d-9fb4-a7ea7666c7d2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38251"
"4831","Intralymphatic Route of Administration","C38252","INTRALYMPHATIC","[]","Intralymphatic Route of Administration","Administration within the lymph.(FDA)","False","4f0956cc-0187-4e17-bf6d-ce705bbc7d77","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38252"
"4832","Intramedullary Route of Administration","C38253","INTRAMEDULLARY","[]","Intramedullary Route of Administration","Administration within the marrow cavity of a bone.(FDA)","False","ca4099d4-363f-4ff9-9a30-336c773f1509","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38253"
"4833","Intrameningeal Route of Administration","C38254","INTRAMENINGEAL","[]","Intrameningeal Route of Administration","Administration within the meninges (the three membranes that envelope the brain and spinal cord).(FDA)","False","57cdbf62-1b81-40cf-847f-c1009fe60e5b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38254"
"4834","Intramuscular Route of Administration","C28161","INTRAMUSCULAR","[]","Intramuscular Route of Administration","Administration within a muscle. (FDA)","False","85c78a8c-8c6c-4a06-9c86-c829e190989d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C28161"
"4835","Intraocular Route of Administration","C38255","INTRAOCULAR","[]","Intraocular Route of Administration","Administration within the eye.(FDA)","False","b823855c-0484-41a8-9e7b-6c25457d3ba6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38255"
"4836","Intraovarian Route of Administration","C38256","INTRAOVARIAN","[]","Intraovarian Route of Administration","Administration within the ovary.(FDA)","False","9c44f14a-2026-4205-a6d0-8ba690b4887f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38256"
"4837","Intrapericardial Route of Administration","C38257","INTRAPERICARDIAL","[]","Intrapericardial Route of Administration","Administration within the pericardium.(FDA)","False","d6dd7c05-46e5-4460-b315-273c4037d845","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38257"
"4838","Intraperitoneal Route of Administration","C38258","INTRAPERITONEAL","[]","Intraperitoneal Route of Administration","Administration within the peritoneal cavity.(FDA)","False","dac038cd-cf48-4d01-98f4-72aecac98a4c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38258"
"4839","Intrapleural Route of Administration","C38259","INTRAPLEURAL","[]","Intrapleural Route of Administration","Administration within the pleura.(FDA)","False","bbd4a572-c1bd-4356-aaa9-f3847189558b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38259"
"4840","Intraprostatic Route of Administration","C38260","INTRAPROSTATIC","[]","Intraprostatic Route of Administration","Administration within the prostate gland.(FDA)","False","525d79fe-3c1a-4a94-927c-ffb6816ccde0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38260"
"4841","Intrapulmonary Route of Administration","C38261","INTRAPULMONARY","[]","Intrapulmonary Route of Administration","Administration within the lungs or its bronchi.(FDA)","False","e1444619-76cf-46fc-b9e0-cecd8a7983f4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38261"
"4842","Intrasinal Route of Administration","C38262","INTRASINAL","[]","Intrasinal Route of Administration","Administration within the nasal or periorbital sinuses.(FDA)","False","1e52d4fb-5528-4991-9a6b-d5d735c3a709","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38262"
"4843","Intraspinal Route of Administration","C38263","INTRASPINAL","[]","Intraspinal Route of Administration","Administration within the vertebral column.(FDA)","False","65f04fc2-a7cc-4855-bb1f-757985f6e00b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38263"
"4844","Intrasynovial Route of Administration","C38264","INTRASYNOVIAL","[]","Intrasynovial Route of Administration","Administration within the synovial cavity of a joint.(FDA)","False","f64b86de-c290-4017-a72a-f6b1d1ab84d7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38264"
"4845","Intratendinous Route of Administration","C38265","INTRATENDINOUS","[]","Intratendinous Route of Administration","Administration within a tendon.(FDA)","False","550ac1ad-7ee4-4436-acc0-21f4e936bd3a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38265"
"4846","Intratesticular Route of Administration","C38266","INTRATESTICULAR","[]","Intratesticular Route of Administration","Administration within the testicle.(FDA)","False","f067bf35-b241-4e18-bd41-9c4ad63f9c42","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38266"
"4847","Intrathecal Route of Administration","C38267","INTRATHECAL","[]","Intrathecal Route of Administration","Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.(FDA)","False","68ac5f59-8d95-46f0-9e22-0e0980dda2f2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38267"
"4848","Endothoracic Route of Administration","C38207","INTRATHORACIC","[]","Endothoracic Route of Administration","Administration within the thorax (internal to the ribs); synonymous with the term endothoracic.(FDA)","False","434870b1-d324-467a-b90e-c94116f893ea","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38207"
"4849","Intratubular Route of Administration","C38268","INTRATUBULAR","[]","Intratubular Route of Administration","Administration within the tubules of an organ.(FDA)","False","beee9d34-17b4-45c2-9ed2-c7b8e1acae33","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38268"
"4850","Intratumoral Route of Administration","C38269","INTRATUMOR","['Intratumor Route of Administration']","Intratumoral Route of Administration","Administration within a tumor.(FDA)","False","4d7f33f7-a0e6-4926-ad8b-451da3f1e62b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38269"
"4851","Intratympanic Route of Administration","C38270","INTRATYMPANIC","[]","Intratympanic Route of Administration","Administration within the auris media.(FDA)","False","9658d4be-1183-461e-b342-c7ca773f39b5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38270"
"4852","Intrauterine Route of Administration","C38272","INTRAUTERINE","[]","Intrauterine Route of Administration","Administration within the uterus.(FDA)","False","def16bf7-5076-4dd9-b6da-d98fd7264999","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38272"
"4853","Intravascular Route of Administration","C38273","INTRAVASCULAR","[]","Intravascular Route of Administration","Administration within a vessel or vessels.(FDA)","False","da68004d-3514-443c-8ef8-ad4ea91c40c9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38273"
"4854","Intravenous Route of Administration","C38276","INTRAVENOUS","[]","Intravenous Route of Administration","Administration within or into a vein or veins.(FDA)","False","998e17c2-00e3-4d1b-b3ac-c522f9445cc5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38276"
"4855","Intravenous Bolus","C38274","INTRAVENOUS BOLUS","[]","Intravenous Bolus","Administration within or into a vein or veins all at once.(FDA)","False","cc7008c9-c36f-4624-85c7-87eb37ed4790","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38274"
"4856","Intravenous Drip","C38279","INTRAVENOUS DRIP","[]","Intravenous Drip","Administration within or into a vein or veins over a sustained period of time.(FDA)","False","4b9a5433-43e3-48de-8978-9d01b9fcc21c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38279"
"4857","Intraventricular Route of Administration","C38277","INTRAVENTRICULAR","[]","Intraventricular Route of Administration","Administration within a ventricle.(FDA)","False","384a9610-095d-4af6-bd33-5539430368b1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38277"
"4858","Intravesical Route of Administration","C38278","INTRAVESICAL","[]","Intravesical Route of Administration","Administration within the bladder.(FDA)","False","c7ececf9-efd8-4a18-8417-cf03d55e18db","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38278"
"4859","Intravitreal Route of Administration","C38280","INTRAVITREAL","[]","Intravitreal Route of Administration","Administration within the vitreous body of the eye.(FDA)","False","1a1a8a8e-8f2f-4c26-b798-97aed2844048","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38280"
"4860","Iontophoresis Route of Administration","C38203","IONTOPHORESIS","[]","Iontophoresis Route of Administration","Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body.(FDA)","False","a4a62512-f546-4da0-94a7-cda4db8d35d6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38203"
"4861","Irrigation-Route of Administration","C38281","IRRIGATION","[]","Irrigation-Route of Administration","Administration to bathe or flush open wounds or body cavities.(FDA)","False","7e3392e6-9637-45be-a4c1-bec9fe2b2478","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38281"
"4862","Laryngeal Route of Administration","C38282","LARYNGEAL","[]","Laryngeal Route of Administration","Administration directly upon the larynx.(FDA)","False","e40193fe-6fcc-40d6-bce4-b775240d4058","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38282"
"4863","Nasal Route of Administration","C38284","NASAL","[]","Nasal Route of Administration","Administration to the nose; administered by way of the nose.(FDA)","False","1b342238-ac6c-4dcd-b42f-8d7447fd0b60","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38284"
"4864","Nasogastric Route of Administration","C38285","NASOGASTRIC","[]","Nasogastric Route of Administration","Administration through the nose and into the stomach, usually by means of a tube.(FDA)","False","fced7ade-a5b4-4ea8-87cd-7f6509d48476","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38285"
"4865","Route of Administration Not Applicable","C48623","NOT APPLICABLE","[]","Route of Administration Not Applicable","Routes of administration are not applicable.(FDA)","False","dc928bb2-5cb9-411b-996b-2eb732abb533","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C48623"
"4866","Occlusive Dressing Technique","C38286","OCCLUSIVE DRESSING TECHNIQUE","[]","Occlusive Dressing Technique","Administration by the topical route which is then covered by a dressing which occludes the area.(FDA)","False","4eba70d2-2788-436c-beff-3086f9891673","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38286"
"4867","Ophthalmic Route of Administration","C38287","OPHTHALMIC","[]","Ophthalmic Route of Administration","Administration to the external eye.(FDA)","False","df2409c7-9940-4f25-aea8-905f4fd78a71","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38287"
"4868","Oral Route of Administration","C38288","ORAL","[]","Oral Route of Administration","Administration to or by way of the mouth.(FDA)","False","a045b081-9a38-4362-a82a-e2f7e9f5a3cd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38288"
"4869","Oropharyngeal Route of Administration","C38289","OROPHARYNGEAL","[]","Oropharyngeal Route of Administration","Administration directly to the mouth and pharynx.(FDA)","False","e0c6d762-f883-4840-9779-9480bc073b88","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38289"
"4870","Other Route of Administration","C38290","OTHER","[]","Other Route of Administration","Administration is different from others on this list.(FDA)","False","9bfe06dc-33a9-4258-8c4e-372a488ca6d4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38290"
"4871","Parenteral Route of Administration","C38291","PARENTERAL","[]","Parenteral Route of Administration","Administration by injection, infusion, or implantation.(FDA)","False","09f2f193-9698-40f1-8c12-7443d7ebd196","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38291"
"4872","Percutaneous Route of Administration","C38676","PERCUTANEOUS","[]","Percutaneous Route of Administration","Administration through the skin.(FDA)","False","5e800927-0ddf-4dfb-8c34-9ddac99438a5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38676"
"4873","Periarticular Route of Administration","C38292","PERIARTICULAR","[]","Periarticular Route of Administration","Administration around a joint.(FDA)","False","b39f16c9-34be-49f9-930e-2b7afd0efc05","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38292"
"4874","Peridural Route of Administration","C38677","PERIDURAL","[]","Peridural Route of Administration","Administration to the outside of the dura mater of the spinal cord.(FDA)","False","bed33b0e-ab32-4f07-bde6-e31a7113f1b0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38677"
"4875","Perineural Route of Administration","C38293","PERINEURAL","[]","Perineural Route of Administration","Administration surrounding a nerve or nerves.(FDA)","False","ee1cf9b0-c422-48ef-a0a4-0205fc652fa4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38293"
"4876","Periodontal Route of Administration","C38294","PERIODONTAL","[]","Periodontal Route of Administration","Administration around a tooth.(FDA)","False","e5f86550-0b38-4a77-8931-61a3f520bc74","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38294"
"4877","Rectal Route of Administration","C38295","RECTAL","[]","Rectal Route of Administration","Administration to the rectum.(FDA)","False","c33a2f48-0cd6-46a9-b52d-17ba5118687d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38295"
"4878","Inhalation Route of Administration","C38216","RESPIRATORY (INHALATION)","[]","Inhalation Route of Administration","Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)","False","420cbe22-092e-4b89-8094-0ba64211cdb6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38216"
"4879","Retrobulbar Route of Administration","C38296","RETROBULBAR","[]","Retrobulbar Route of Administration","Administration behind the pons or behind the eyeball.(FDA)","False","3373662a-5f38-417b-a882-1dede9f3477e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38296"
"4880","Soft Tissue Route Of Administration","C38198","SOFT TISSUE","[]","Soft Tissue Route Of Administration","Administration into any soft tissue.(FDA)","False","7ed3b746-67b5-4760-9619-fc4bbf320988","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38198"
"4881","Subarachnoid Route of Administration","C38297","SUBARACHNOID","[]","Subarachnoid Route of Administration","Administration beneath the arachnoid.(FDA)","False","8a4e3f6d-729d-452e-a64c-222c22d851f5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38297"
"4882","Subconjunctival Route of Administration","C38298","SUBCONJUNCTIVAL","[]","Subconjunctival Route of Administration","Administration beneath the conjunctiva.(FDA)","False","f0196cf7-179e-463d-b64b-fb6735c93067","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38298"
"4883","Subcutaneous Route of Administration","C38299","SUBCUTANEOUS","[]","Subcutaneous Route of Administration","Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)","False","86cd1b18-ef3f-476d-9a15-a395657d1c86","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38299"
"4884","Sublingual Route of Administration","C38300","SUBLINGUAL","[]","Sublingual Route of Administration","Administration beneath the tongue.(FDA)","False","01bd49ca-0788-4ded-be3e-fb0ab60ba911","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38300"
"4885","Submucosal Route of Administration","C38301","SUBMUCOSAL","[]","Submucosal Route of Administration","Administration beneath the mucous membrane.(FDA)","False","9aade759-ce0e-4d6c-add9-5711d1df48e9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38301"
"4886","Topical Route of Administration","C38304","TOPICAL","[]","Topical Route of Administration","Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.(FDA)","False","ea47daa6-e803-47e8-85fa-aa8efb69b142","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38304"
"4887","Transdermal Route of Administration","C38305","TRANSDERMAL","[]","Transdermal Route of Administration","Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)","False","b7f45739-2b7d-4fb5-b4f7-f31e3c953819","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38305"
"4888","Mucosal Route of Administration","C38283","TRANSMUCOSAL","[]","Mucosal Route of Administration","Administration across the mucosa.(FDA)","False","18a7ccb4-4220-4c47-8e9b-ec4e44f3b319","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38283"
"4889","Transplacental Route of Administration","C38307","TRANSPLACENTAL","[]","Transplacental Route of Administration","Administration through or across the placenta.(FDA)","False","7b192647-df48-46af-8164-1a487bb50593","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38307"
"4890","Transtracheal Route of Administration","C38308","TRANSTRACHEAL","[]","Transtracheal Route of Administration","Administration through the wall of the trachea.(FDA)","False","4424e7fa-586a-4ab9-ac2c-18fa30c2fa54","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38308"
"4891","Transtympanic Route of Administration","C38309","TRANSTYMPANIC","[]","Transtympanic Route of Administration","Administration across or through the tympanic cavity.(FDA)","False","edb71ece-73dc-438b-8754-8019c3b62326","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38309"
"4892","Unassigned Route of Administration","C38310","UNASSIGNED","[]","Unassigned Route of Administration","Route of administration has not yet been assigned.(FDA)","False","5b49dd89-c2aa-4986-8a4f-b699a144fa69","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38310"
"4893","Unknown Route of Administration","C38311","UNKNOWN","[]","Unknown Route of Administration","Route of administration is unknown.(FDA)","False","03073836-6884-46d0-832d-4d7c1a4a0965","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38311"
"4894","Ureteral Route of Administration","C38312","URETERAL","[]","Ureteral Route of Administration","Administration into the ureter.(FDA)","False","e3b60a40-eaa0-45cf-b109-79fe9696aec1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38312"
"4895","Intraurethral Route of Administration","C38271","URETHRAL","[]","Intraurethral Route of Administration","Administration into the urethra.(FDA)","False","016b5408-d0d0-44f4-91a2-4eb0d7925a3a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38271"
"4896","Vaginal Route of Administration","C38313","VAGINAL","[]","Vaginal Route of Administration","Administration into the vagina.(FDA)","False","19505b0b-80a6-4d4a-8283-728c0f45f0f3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66729/C38313"
"4897","Severity/Intensity Scale for Adverse Events","C66769","AESEV","['Severity/Intensity Scale for Adverse Events']","CDISC SDTM Severity Intensity Scale for Adverse Event Terminology","A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)","False","9885dffb-5d00-401f-8f14-2c07cdcfe98f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66769"
"4898","Mild Adverse Event","C41338","MILD","['Grade 1', '1']","Mild Adverse Event","A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.","False","e3a799aa-68d1-4bed-8257-18f46055d3b1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66769/C41338"
"4899","Moderate Adverse Event","C41339","MODERATE","['Grade 2', '2']","Moderate Adverse Event","A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.","False","65f75480-2591-46f7-85d4-304694f7de75","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66769/C41339"
"4900","Severe Adverse Event","C41340","SEVERE","['Grade 3', '3']","Severe Adverse Event","A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.","False","488f882b-97eb-4dc4-b0bc-0189f24e8511","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66769/C41340"
"4901","Sex","C66731","SEX","['Sex']","CDISC SDTM Sex of Individual Terminology","The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)","False","66d55e39-ac31-44f6-b9c3-5dddb76590d5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66731"
"4902","Female","C16576","F","['Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","72e122b3-cb52-48be-98b1-85e32b5f1483","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66731/C16576"
"4903","Male","C20197","M","['Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","a73edc6a-eaea-4cf4-88dc-7a3c08c40da4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66731/C20197"
"4904","Unknown","C17998","U","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","3e9a1d72-4d0a-448f-b948-f80750b31f8d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66731/C17998"
"4905","Intersex","C45908","UN","['Undifferentiated']","Intersex","A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)","False","1b2bd7ab-3a38-43ba-810f-0232e99834b1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66731/C45908"
"4906","Sex of Participants","C66732","SEXPOP","['Sex of Participants']","CDISC SDTM Sex of Study Group Terminology","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","d3044557-072d-499e-85ab-ba5222c2545c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66732"
"4907","Both","C49636","BOTH","[]","Both","One and the other; relating to or being two in conjunction. (NCI)","False","d52fcdb3-9462-4fc5-9a22-208f6f04d25a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66732/C49636"
"4908","Female","C16576","F","['Female']","Female","A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)","False","6719f0c9-b185-4727-8872-c1ddcd760533","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66732/C16576"
"4909","Male","C20197","M","['Male']","Male","A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)","False","c4ebc607-c48d-455b-a38d-3ee8a2609475","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66732/C20197"
"4910","Size","C66733","SIZE","['Size']","CDISC SDTM Size Terminology","The physical magnitude of something. (NCI)","False","999f84f5-b140-477a-b9aa-3644aedfd668","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66733"
"4911","Large","C49508","LARGE","[]","Large","Of considerable or relatively great size, extent, or capacity. (NCI)","False","8d0e0be6-dbab-4a47-9899-70b065859b98","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66733/C49508"
"4912","Medium","C49507","MEDIUM","[]","Medium","Mid-way between small and large in number, quantity, magnitude or extent. (NCI)","False","7c3cd291-3f5e-4a62-b659-e5d2013e1983","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66733/C49507"
"4913","Small","C25376","SMALL","[]","Small","Limited in number, quantity, magnitude or extent. (NCI)","False","c32a7ab4-c821-4dc2-8a61-d4136543e418","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66733/C25376"
"4914","Domain Abbreviation","C66734","DOMAIN","['Domain Abbreviation']","CDISC SDTM Submission Domain Abbreviation Terminology","A unique, 2-character domain code used in the regulatory submission process.  The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)","False","e628f1b5-b626-4ee5-b2a3-3276fe31550b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734"
"4915","Analysis Dataset Domain","C49563","AD","['Analysis Dataset']","Analysis Dataset Domain","Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.","False","e6ba7371-fd4c-44b1-91e0-85454cb712e4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49563"
"4916","Adverse Event Domain","C49562","AE","['Adverse Events']","Adverse Event Domain","Adverse events may be captured either as free text or a pre-specified list of terms.","False","9e95ae3d-56fa-4924-a78e-c2b578068b3c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49562"
"4917","Autopsy Domain","C49565","AU","['Autopsy']","Autopsy Domain","Additional data about deaths, specific to findings from autopsies.","False","0f209cdd-9ced-4181-adbb-3794670fa1e3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49565"
"4918","Bone Mineral Density Data Domain","C49566","BM","['Bone Mineral Density (BMD) Data']","Bone Mineral Density Data Domain","Findings resulting from evaluations of bone mineral density.","False","dbfc66cb-b06a-4704-be31-710074a5b9e3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49566"
"4919","Biopsy Domain","C49567","BR","['Biopsy']","Biopsy Domain","Findings resulting from biopsies.","False","bd045846-d74f-4b7d-877d-6c603c593418","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49567"
"4920","Concomitant Medication Domain","C49568","CM","['Concomitant Meds']","Concomitant Medication Domain","Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.","False","0235dd0b-7239-4960-a8fd-a2da3ebd0c1d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49568"
"4921","Comment Domain","C49569","CO","['Comments']","Comment Domain","The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.","False","a41fc20b-fa3d-4c34-a58f-751f4937445c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49569"
"4922","Drug Accountability Domain","C49578","DA","['Drug Accountability']","Drug Accountability Domain","Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.","False","f9499d42-240c-437b-b58b-b778c61d8f15","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49578"
"4923","Disease Characteristics Domain","C49570","DC","['Disease Characteristics']","Disease Characteristics Domain","Data related to the characteristics of a specific disease state under study for a subject.","False","36651421-c674-4878-a9d0-67100939ec9f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49570"
"4924","Demographics Domain","C49572","DM","['Demographics']","Demographics Domain","The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study.  It is the parent domain for all other observations for human clinical subjects","False","019f752f-67b6-45a3-9312-d02bd84fdea5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49572"
"4925","Disposition Domain","C49576","DS","['Disposition']","Disposition Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)","False","51a69d90-7501-44be-82da-a9b6e3222cab","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49576"
"4926","Protocol Deviations Domain","C49585","DV","['Protocol Deviations']","Protocol Deviations Domain","The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.","False","e947ecd4-c57d-4970-8e5c-7ba06c3b9c01","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49585"
"4927","Electroencephalogram Domain","C49625","EE","['Electroencephalogram']","Electroencephalogram Domain","Findings resulting from electroencephalogram (EEG) tests.","False","7f358659-e080-409a-b626-2bba8a83a213","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49625"
"4928","Electrocardiogram Domain","C49626","EG","['Electrocardiogram']","Electrocardiogram Domain","Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.","False","dc824b52-09bf-4ccb-bf68-39a4932804a0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49626"
"4929","Exposure Domain","C49587","EX","['Exposure']","Exposure Domain","The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.","False","1eb7c84a-046f-4782-9210-5121143bf9af","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49587"
"4930","Family History Domain","C49588","FH","['Family History']","Family History Domain","A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)","False","4eda5d9e-b026-4c98-995d-dd2ad8a2bf30","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49588"
"4931","Healthcare Resource Utilization Domain","C49589","HU","['Healthcare Resource Utilization']","Healthcare Resource Utilization Domain","Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.","False","2e3b92c1-a5b9-4b14-8d03-e7cf810ae449","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49589"
"4932","Inclusion Exclusion Domain","C61536","IE","['Inclusion/Exclusion']","Inclusion Exclusion Domain","The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.","False","b6eb4ad3-b260-425f-ac95-ab9082c5d77a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C61536"
"4933","Laboratory Data Domain","C49592","LB","['Laboratory Data']","Laboratory Data Domain","Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.","False","5e7fd7ba-877d-4197-b3e9-bb3d28736eb0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49592"
"4934","Microbiology Specimen Domain","C49602","MB","['Microbiology']","Microbiology Specimen Domain","Microbiology specimen findings, including gram stain results, and organisms found.","False","d1c1423d-526e-4257-a540-04f76abc8dae","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49602"
"4935","Medical History Domain","C49603","MH","['Medical History']","Medical History Domain","The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.","False","62eea5a0-294b-4230-81cb-60ac2f04b81c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49603"
"4936","Meal Data Domain","C49604","ML","['Meal Data']","Meal Data Domain","Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.","False","a179b3e2-fe32-475c-b0bf-39dccc7e3edf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49604"
"4937","Microbiology Susceptibility Domain","C61531","MS","['Microbiology Susceptibility']","Microbiology Susceptibility Domain","This includes microbiology susceptibility test results, plus results of any other organism-related tests.","False","a1eb6827-bd62-4781-bb91-73d7ab2da7cf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C61531"
"4938","Organ Measurement Domain","C49605","OM","['Organ Measurements']","Organ Measurement Domain","Findings from organ measurement evaluations.","False","098a3bcc-a9f1-4bf3-ace4-1fe259f64c16","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49605"
"4939","Pharmacokinetic Concentration Domain","C49606","PC","['Pharmacokinetic Concentration']","Pharmacokinetic Concentration Domain","Concentrations of drugs/metabolites in fluids or tissues as a function of time.","False","25a4bf5a-36bf-4c4b-9907-b06321a71f2b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49606"
"4940","Physical Exam Domain","C49608","PE","['Physical Exam']","Physical Exam Domain","Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.","False","502f7d9c-e010-4b11-8141-c8ea2d86f395","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49608"
"4941","Pharmacogenomics Domain","C61529","PG","['Pharmacogenomics']","Pharmacogenomics Domain","Pharmacogenomics findings that initially focus on genotype and gene expression data.","False","da5ea3be-56ed-4af4-8a8c-168726db7751","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C61529"
"4942","Pharmacokinetic Parameters Domain","C49607","PP","['Pharmacokinetic Parameters']","Pharmacokinetic Parameters Domain","Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.","False","ca1a05e6-611e-4bb5-96d7-03c2394bd1bd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49607"
"4943","Questionnaire Domain","C49609","QS","['Questionnaires']","Questionnaire Domain","Questionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).","False","cbc94032-e0fe-49f8-865a-73d6efa1b276","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49609"
"4944","Subject Characteristics Domain","C49610","SC","['Subject Characteristics']","Subject Characteristics Domain","The subject characteristics domain is for data not collected in other domains that is subject-related. Examples: subject initials, other race details, eye color, childbearing status, etc.","False","4469b2ac-b5ee-44a6-be8f-7036b91f1233","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49610"
"4945","Subject Element Domain","C49616","SE","['Subject Element']","Subject Element Domain","The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.","False","e78d0dd2-5674-4e95-b569-66eb803093d8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49616"
"4946","Surgery Domain","C49611","SG","['Surgery']","Surgery Domain","Surgical information.","False","28017a19-e104-4e99-9118-a8c482bd589c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49611"
"4947","Skin Test Domain","C49612","SK","['Skin Test']","Skin Test Domain","Findings from diagnostic skin tests.","False","ab419a3b-71a6-4ecc-815f-0e397f1eef00","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49612"
"4948","Sleep Polysomnography Domain","C49613","SL","['Sleep Polysomnography Data']","Sleep Polysomnography Domain","Findings from diagnostic sleep tests (polysomnography).","False","42fdce93-1c2d-4bf4-9f46-97f624b36ac6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49613"
"4949","Stress Exercise Test Data Domain","C49614","ST","['Stress (Exercise) Test Data']","Stress Exercise Test Data Domain","Findings from exercise stress tests.","False","5da0ab7c-5f33-40e7-90ec-c0d7ebf948ba","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49614"
"4950","Substance Use Domain","C49615","SU","['Substance Use']","Substance Use Domain","The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.","False","42c44e06-43c4-4c23-90c8-b5052755222c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49615"
"4951","Subject Visits Domain","C49617","SV","['Subject Visits']","Subject Visits Domain","The subject visits table describes the actual start and end data/time for each visit of each individual subject.","False","fdda4037-927c-4bcb-b1b6-6ac5363027c3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49617"
"4952","Trial Arms Domain","C49618","TA","['Trial Arms']","Trial Arms Domain","The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.","False","4bb714b8-b6bc-4120-8df7-0cda94f3141d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49618"
"4953","Trial Elements Domain","C49619","TE","['TE', 'Trial Elements']","Trial Elements Domain","The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.","False","f37cc117-cb15-4a07-8923-560b74e3053a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49619"
"4954","Trial Inclusion and Exclusion Criteria Domain","C49620","TI","['Trial Inclusion/Exclusion Criteria']","Trial Inclusion and Exclusion Criteria Domain","The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.","False","541f70da-58ec-4d62-ab8f-7e3e121f19fe","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49620"
"4955","Trial Summary Domain","C53483","TS","['Trial Summary']","Trial Summary Domain","The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.","False","66d71c37-738e-4811-82d3-68392dc2bd6d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C53483"
"4956","Trial Visits Domain","C49621","TV","['Trial Visits']","Trial Visits Domain","The trial visits table describes the planned order and number of visits in the study within each arm.","False","2008235f-65d7-4b53-8567-adb6f78c8ba3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49621"
"4957","Vital Signs Domain","C49622","VS","['Vital Signs']","Vital Signs Domain","Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.","False","54cfc73f-8565-4fbd-8541-2de56d6a515e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66734/C49622"
"4958","Trial Blinding Schema","C66735","TBLIND","['Trial Blinding Schema']","CDISC SDTM Trial Blinding Schema Terminology","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","5804f045-7f7b-4eb5-980e-67cce72c5e00","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66735"
"4959","Double Blind Study","C15228","DOUBLE BLIND","[]","Double Blind Study","A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)","False","7404a94e-8fe1-4312-b0e4-922efa97a3cd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66735/C15228"
"4960","Open Label Study","C49659","OPEN LABEL","[]","Open Label Study","A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)","False","5b2d7873-b19c-479a-b781-a5d0c123a64b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66735/C49659"
"4961","Single Blind Study","C28233","SINGLE BLIND","[]","Single Blind Study","A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)","False","0dd86807-c5aa-42cd-843d-52165d6f6373","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66735/C28233"
"4962","Trial Indication Type","C66736","TINDTP","['Trial Indication Type']","CDISC SDTM Trial Indication Type Terminology","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)","False","88229f14-3d5b-4557-bbbc-79648458f332","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66736"
"4963","Cure Study","C49654","CURE","[]","Cure Study","A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition.  (NCI)","False","5134e80c-621e-4f28-ab2b-1cbc9cc46504","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66736/C49654"
"4964","Diagnosis Study","C49653","DIAGNOSIS","[]","Diagnosis Study","A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition.  (NCI)","False","7b604715-e957-41bc-826e-433993cada52","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66736/C49653"
"4965","Adverse Effect Mitigation Study","C49655","MITIGATION","[]","Adverse Effect Mitigation Study","A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen.  (NCI)","False","69bb829a-2ce5-4746-a1f2-687aead888bb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66736/C49655"
"4966","Prevention Study","C49657","PREVENTION","[]","Prevention Study","A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.","False","d33b17f3-0f6c-47bf-9235-a011ff36dde3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66736/C49657"
"4967","Treatment Study","C49656","TREATMENT","[]","Treatment Study","A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.","False","3d5365e5-ac9c-4f12-a11a-801a4d3d6aeb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66736/C49656"
"4968","Trial Phase","C66737","TPHASE","['Trial Phase']","CDISC SDTM Trial Phase Terminology","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","fec2d0ca-95c9-4ff2-ab13-70d06255f2bf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737"
"4969","Phase I Trial","C15600","Phase I Trial","['Trial Phase 1', '1']","Phase I Trial","The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drugs pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes.  [After FDA CDER Handbook, ICH E8] (CDISC glossary)","False","c46c3b4a-e3e3-4e79-862c-da1aa0639165","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C15600"
"4970","Phase I/II Trial","C15693","Phase I/II Trial","['Trial Phase 1-2', '1-2']","Phase I/II Trial","A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.","False","6ed506e6-e2d0-4f94-80b1-a0175ed0e89f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C15693"
"4971","Phase II Trial","C15601","Phase II Trial","['Trial Phase 2', '2']","Phase II Trial","Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","152e41fd-bd8c-4d0a-abef-80732637fe68","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C15601"
"4972","Phase II/III Trial","C15694","Phase II/III Trial","['Trial Phase 2-3', '2-3']","Phase II/III Trial","A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.","False","318e491f-ae6c-403e-8b4e-23de3ea8e0f3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C15694"
"4973","Phase IIa Trial","C49686","Phase IIa Trial","['Trial Phase 2A', '2A']","Phase IIa Trial","A clinical research protocol generally refered to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)","False","0a182f89-ac7c-48c3-8621-4f1d15435b64","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C49686"
"4974","Phase IIb Trial","C49688","Phase IIb Trial","['Trial Phase 2B', '2B']","Phase IIb Trial","A clinical research protocol generally refered to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)","False","3350d767-3633-4a97-9b33-cc9cfa509d25","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C49688"
"4975","Phase III Trial","C15602","Phase III Trial","['Trial Phase 3', '3']","Phase III Trial","Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefitrisk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","537aa099-ebb9-4fab-80a7-64695f4e7c1b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C15602"
"4976","Phase IIIa Trial","C49687","Phase IIIaTrial","['Trial Phase 3A', '3A']","Phase IIIa Trial","A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.","False","a5634b65-5ee7-48dc-a0f3-ce508bf79d72","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C49687"
"4977","Phase IIIb Trial","C49689","Phase IIIb Trial","['Trial Phase 3B', '3B']","Phase IIIb Trial","A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.","False","f9537286-2f97-4b6a-a3a4-b789fd9a899c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C49689"
"4978","Phase IV Trial","C15603","Phase IV Trial","['Trial Phase 4', '4']","Phase IV Trial","Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drugs risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)","False","a760a130-ccb2-47e4-80c2-142900b290c4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C15603"
"4979","Phase V Trial","C47865","Phase V Trial","['Trial Phase 5', '5']","Phase V Trial","Postmarketing surveillance is sometimes referred to as Phase V.","False","cee2db05-ecfe-4b8a-9920-79e72983530f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C47865"
"4980","Not Applicable","C48660","","[]","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","827a0589-fb13-46db-a5b0-7af56ba51cbe","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66737/C48660"
"4981","Trial Summary Parameter Test Code","C66738","TSPARMCD","['Trial Summary Parameter Test Code']","CDISC SDTM Trial Summary Parameter Terminology by Code","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","3b44779c-1759-4a12-ad03-d9fb72ca2925","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738"
"4982","Test Product Added to Existing Treatment","C49703","ADDON","['Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","26ae571e-91aa-4972-a453-f05ea6a36bf2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49703"
"4983","Adverse Event Dictionary","C49700","AEDICT","['Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","aa437740-1abb-4cdc-ae71-a370549ba3fc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49700"
"4984","Planned Maximum Age of Subjects","C49694","AGEMAX","['Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","12f7a14e-b3af-417e-924c-1fe01f2a9de3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49694"
"4985","Planned Minimum Age of Subjects","C49693","AGEMIN","['Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","964e950b-9d1f-416b-9807-9607753828e3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49693"
"4986","Age Group","C20587","AGESPAN","['Age Span']","Age Group","Subgroups of populations based on age. (NCI)","False","b42be741-5e04-4aa5-b430-dda675474cdd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C20587"
"4987","Age Unit","C50400","AGEU","['Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","b5b64638-3249-45a6-b171-456b99e2bb54","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C50400"
"4988","Dose","C25488","DOSE","['Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","90262c83-c77e-4ab8-bb15-510e0928b11f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C25488"
"4989","Drug Dictionary","C49701","DRUGDICT","['Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","37412684-3920-44a8-a5d2-150eb696bb8d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49701"
"4990","Trial Length","C49697","LENGTH","['Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","845dcd6b-82de-4259-820b-de9118f6eabc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49697"
"4991","Medical History Dictionary","C49702","MHDICT","['Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","4585682f-7692-4666-8415-5a5b53309e33","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49702"
"4992","Planned Subject Number","C49692","PLANSUB","['Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","da8e6f0b-710e-48b1-8ef6-101c9c9ad7b8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49692"
"4993","Randomization","C25196","RANDOM","['Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","39e79916-e749-457f-96c1-5460bac958ea","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C25196"
"4994","Route of Administration","C38114","ROUTE","['Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","9eaa50f9-4983-4273-a6ca-d6e5fa050d23","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C38114"
"4995","Sex of Study Group","C49696","SEXPOP","['Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","98a843f6-6f68-496b-b8c4-601cd3e4af70","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49696"
"4996","Study Stop Rules","C49698","STOPRULE","['Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","ef5a22e8-3248-4f8d-8d58-672dbe7ef0eb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49698"
"4997","Trial Blinding Schema","C49658","TBLIND","['Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","95399d39-b221-465e-a054-750c746473e2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49658"
"4998","Control Type","C49647","TCNTRL","['Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","5202219a-2135-47aa-8d39-d3169fe85082","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49647"
"4999","Diagnosis Group","C49650","TDIGRP","['Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","c8ea0129-50af-45a2-9ab4-ad8f88201fc7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49650"
"5000","Trial Indication Type","C49652","TINDTP","['Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","0cc52bb7-efb2-4561-b651-ded9f0b4d025","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49652"
"5001","Trial Title","C49802","TITLE","['Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","9acf9306-7697-4231-992e-3ceebe95d663","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49802"
"5002","Trial Phase","C48281","TPHASE","['Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","7468ccec-ae9c-4e06-a2c2-e3944d4f0004","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C48281"
"5003","Trial Type","C49660","TTYPE","['Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","524c2c0c-da8f-45c3-9cca-5c8c082dee94","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66738/C49660"
"5004","Trial Summary Parameter Test Name","C67152","TSPARM","['Trial Summary Parameter Test Name']","CDISC SDTM Trial Summary Parameter Terminology by Name","Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)","False","6504ff13-1d89-4fd0-bee4-1501d6b4112e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152"
"5005","Test Product Added to Existing Treatment","C49703","Added on to Existing Treatments","['Added on to Existing Treatments']","Test Product Added to Existing Treatment","The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.","False","0c9977e6-0441-4ae4-b378-a3cccf9c34c2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49703"
"5006","Adverse Event Dictionary","C49700","Adverse Event Dictionary","['Adverse Event Dictionary']","Adverse Event Dictionary","A reference source that provides meanings of words related to adverse events. (NCI)","False","eb107c21-a24b-47ef-a0ac-d132f94ee36d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49700"
"5007","Planned Maximum Age of Subjects","C49694","Planned Maximum Age of Subjects","['Planned Maximum Age of Subjects']","Planned Maximum Age of Subjects","The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)","False","fd9390bc-f29e-4cea-9ab1-cbfceee78f40","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49694"
"5008","Planned Minimum Age of Subjects","C49693","Planned Minimum Age of Subjects","['Planned Minimum Age of Subjects']","Planned Minimum Age of Subjects","The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)","False","35ca4288-e332-4d1a-827d-ca94e9ba9df6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49693"
"5009","Age Group","C20587","Age Group","['Age Group']","Age Group","Subgroups of populations based on age. (NCI)","False","e07e1f60-01a1-4530-a47b-adc7793ec125","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C20587"
"5010","Age Unit","C50400","Age Unit","['Age Unit']","Age Unit","Those units of time that are routinely used to express the age of a person. (NCI)","False","733eac22-3f21-41f4-b465-ee2765458b25","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C50400"
"5011","Dose","C25488","Dose per Administration","['Dose per Administration']","Dose","The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)","False","2680e4ec-2cfe-4ff3-9567-ea58ad58efb3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C25488"
"5012","Drug Dictionary","C49701","Drug Dictionary","['Drug Dictionary']","Drug Dictionary","A reference source that provides meanings of words related to drugs. (NCI)","False","ebd99c2a-d5d4-478d-b728-760a851218cb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49701"
"5013","Trial Length","C49697","Trial Length","['Trial Length']","Trial Length","The anticipated length of a clinical trial measured as a unit of time. (NCI)","False","db5609a9-3bc9-4984-8144-12dbc7b8dc8f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49697"
"5014","Medical History Dictionary","C49702","Medical History Dictionary","['Medical History Dictionary']","Medical History Dictionary","A reference source that provides meanings of words related to medical history. (NCI)","False","dcf46efa-04b1-4aa1-afbd-2d496e7d06e6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49702"
"5015","Planned Subject Number","C49692","Planned Number of Subjects","['Planned Number of Subjects']","Planned Subject Number","The number of subjects entered in a clinical trial. (NCI)","False","d560c18c-99b2-44e4-894f-ac85be74d148","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49692"
"5016","Randomization","C25196","Trial is Randomized","['Trial is Randomized']","Randomization","The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)","False","7ccba179-8da9-45e5-86e7-3b25a826778f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C25196"
"5017","Route of Administration","C38114","Route of Administration","['Route of Administration']","Route of Administration","The course by which a substance was administered in order to reach the site of action in the body.","False","d291571f-8d26-41dc-b17d-e125498bbb36","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C38114"
"5018","Sex of Study Group","C49696","Sex of Participants","['Sex of Participants']","Sex of Study Group","The specific sex, either male, female, or mixed of the subject group being studied. (NCI)","False","9eae4944-dc88-4307-85fb-7baf1c0d6432","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49696"
"5019","Study Stop Rules","C49698","Study Stop Rules","['Study Stop Rules']","Study Stop Rules","The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)","False","a2897173-f6a2-45c6-a8ae-d6e6ebb7c9d1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49698"
"5020","Trial Blinding Schema","C49658","Trial Blinding Schema","['Trial Blinding Schema']","Trial Blinding Schema","The name of a code list that contains terms to define the type of blinding for the trial. (NCI)","False","a505cf04-93d7-4208-a30f-a0524cf0f015","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49658"
"5021","Control Type","C49647","Control Type","['Control Type']","Control Type","Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).","False","e807f62b-64f9-426d-94a0-d4e0c69ec9b8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49647"
"5022","Diagnosis Group","C49650","Diagnosis Group","['Diagnosis Group']","Diagnosis Group","A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)","False","ce165833-448e-442c-9877-c389356af79a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49650"
"5023","Trial Indication Type","C49652","Trial Indication Type","['Trial Indication Type']","Trial Indication Type","The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)","False","fece558c-5b38-4b59-92fa-f572ba4441ff","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49652"
"5024","Trial Title","C49802","Trial Title","['Trial Title']","Trial Title","The name of a clinical trial. (NCI)","False","0086f2a1-2b6d-4e7d-a5fa-010fbcd248f3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49802"
"5025","Trial Phase","C48281","Trial Phase Classification","['Trial Phase Classification']","Trial Phase","Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)","False","7f4221a9-2a45-40c2-a319-628cf8b6c546","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C48281"
"5026","Trial Type","C49660","Trial Type","['Trial Type']","Trial Type","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","e40920e5-d9fc-41f1-8299-f0dd76f9a092","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67152/C49660"
"5027","Trial Type","C66739","TTYPE","['Trial Type']","CDISC SDTM Trial Type Terminology","The type of clinical trial performed e.g. efficacy, safety. (NCI)","False","fe870d69-ea12-43d0-b1db-c3a58e91f247","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739"
"5028","Bioavailability Study","C49664","BIO-AVAILABILITY","[]","Bioavailability Study","A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)","False","37e4073f-b487-4440-ad5b-b04411e597b3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C49664"
"5029","Therapeutic Equivalency Study","C49665","BIO-EQUIVALENCE","[]","Therapeutic Equivalency Study","A study most often used to compare the efficacy of different formulations to treat a given disease.  It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)","False","85078b3d-f289-438d-8234-2ac3a44cd982","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C49665"
"5030","Efficacy Study","C49666","EFFICACY","[]","Efficacy Study","A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)","False","64d0d2b3-3bc6-40e0-8712-dafe3a3ac2c9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C49666"
"5031","Pharmacodynamic Study","C49662","PHARMACODYNAMIC","[]","Pharmacodynamic Study","A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)","False","bd1253f1-af24-4206-a2f6-580a0bebd369","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C49662"
"5032","Pharmacoeconomic Study","C39493","PHARMACOECONOMIC","[]","Pharmacoeconomic Study","A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)","False","380f78d7-489f-4e51-a0aa-cdfd9765656a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C39493"
"5033","Pharmacogenomic Study","C49661","PHARMACOGENOMIC","[]","Pharmacogenomic Study","A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)","False","90460123-2ba8-4910-9f25-1eb6358623d0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C49661"
"5034","Pharmacokinetic Study","C49663","PHARMACOKINETIC","[]","Pharmacokinetic Study","A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)","False","e8d564d7-3725-462e-945f-a912cf8df15c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C49663"
"5035","Safety Study","C49667","SAFETY","[]","Safety Study","A study of the relative safety of treatment of a disease. Usually this is a Phase I or II trial. (NCI)","False","45d66957-039c-4fc6-8c36-f5e045f88b13","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66739/C49667"
"5036","Units for Vital Signs Results","C66770","VSRESU","['Units for Vital Signs Results']","CDISC SDTM Unit for Vital Sign Result Terminology","The unit used to record and describe the result of a test investigating a vital sign. (NCI)","False","a4a9efd1-4963-4393-baa8-900829d453e1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770"
"5037","Percentage","C25613","%","['Percentage']","Percentage","A fraction or ratio with 100 understood as the denominator. (NCI)","False","28ee5022-f209-432d-802e-0607c06ac8e3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C25613"
"5038","Beats per Minute","C49673","BEATS/MIN","['Beats per Minute']","Beats per Minute","The number of heartbeats measured per minute time. (NCI)","False","0c4d2322-21a2-47cc-8e0a-89943a7ab81a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C49673"
"5039","Breaths per Minute","C49674","BREATHS/MIN","['Breaths per Minute']","Breaths per Minute","The number of breaths (inhalation and exhalation) taken per minute time. (NCI)","False","43b331fc-54e5-40f4-9a29-66ce1b4838e7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C49674"
"5040","Degree Celsius","C42559","C","['Degree Celsius']","Degree Celsius","A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)","False","a2b964b7-43f3-4572-a214-a37c71eb3333","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C42559"
"5041","Centimeter","C49668","cm","['Centimeter']","Centimeter","A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)","False","7d1d52b7-81e7-4d3d-807d-c199098af68d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C49668"
"5042","Degree Fahrenheit","C44277","F","['Degree Fahrenheit']","Degree Fahrenheit","The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724.  In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)","False","ebc7b475-872c-4e94-a5d3-a6682546e45c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C44277"
"5043","Gram","C48155","g","['Gram']","Gram","A metric unit of mass equal to one one thousandth of a kilogram. (NCI)","False","5a4ebad0-1ddc-40a9-8e17-da89528167c3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C48155"
"5044","Inch","C48500","IN","['Inch']","Inch","A traditional unit of length equal to 2.54 centimeters. (NCI)","False","8b91668c-9227-4da9-82a1-bbfc783709a9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C48500"
"5045","Kilogram","C28252","kg","['Kilogram']","Kilogram","The basic SI unit of mass.  It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)","False","b3cc28b1-3bfd-4df1-b9bb-08f77cc4218b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C28252"
"5046","Kilogram Per Square Meter","C49671","kg/m2","['Kilogram Per Square Meter']","Kilogram Per Square Meter","The SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)","False","d4633067-83dc-4773-b1b7-427183594f88","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C49671"
"5047","Pound","C48531","LB","['Pound']","Pound","A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)","False","5b1fc9b2-bdea-4161-b2ac-be917628314b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C48531"
"5048","Square Meter","C42569","m2","['Square Meter']","Square Meter","The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)","False","2aa584b1-12e1-49dd-b199-f53c4a3ba0f6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C42569"
"5049","Millimeter of Mercury","C49670","mmHg","['Millimeter of Mercury']","Millimeter of Mercury","A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)","False","f3909edc-4ecf-4176-8b42-4bf360c29aa5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C49670"
"5050","Ohm","C42554","ohm","['ohm']","Ohm","A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens. (NCI)","False","efcb6402-059f-400d-96a8-0f6bfdb0a0c1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66770/C42554"
"5051","Vital Signs Test Code","C66741","VSTESTCD","['Vital Signs Test Code']","CDISC SDTM Vital Sign Terminology by Code","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","a4815194-f64c-4eb5-9d89-d41bfd50c3a8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741"
"5052","Body Mass Index","C16358","BMI","['Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","c466074d-6628-461a-8514-e4572f752dd3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C16358"
"5053","Adipose Tissue","C12472","BODYFAT","['Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","f4d975f0-dc43-46bf-8ea5-78f5e191cb95","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C12472"
"5054","Body Surface Area","C25157","BSA","['Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","20a97478-e28b-4805-acb9-4bc3b3f00ab5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C25157"
"5055","Diastolic Blood Pressure","C25299","DIABP","['Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","6b311142-4bde-4388-8b94-fd654071b0f9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C25299"
"5056","Body Frame Size","C49680","FRMSIZE","['Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","d5343cc3-e7d1-4e03-a05a-ee23e6bed47d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C49680"
"5057","Height","C25347","HEIGHT","['Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","4e3884ee-23a4-464f-b85c-5d0899996b3a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C25347"
"5058","Heart Rate","C49677","HR","['Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","5e4deb8c-c0d1-40cf-ba7c-684711611aef","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C49677"
"5059","Mean Arterial Pressure","C49679","MAP","['Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","2c51ea8f-5b80-4d5e-8a3d-71787c12b2fc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C49679"
"5060","Pulse Rate","C49676","PULSE","['Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","0400dd01-f47d-4aa1-88a6-3262d64594e3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C49676"
"5061","Respiratory Rate","C49678","RESP","['Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","9aa19ac4-cf0c-436c-9289-4541c38238a6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C49678"
"5062","Systolic Blood Pressure","C25298","SYSBP","['Systolic Blood']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","d2d0b37a-7117-481e-8963-71c404f4f2a7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C25298"
"5063","Temperature","C25206","TEMP","['Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","642ba4a0-b44e-4ca6-bec7-ab046be632e9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C25206"
"5064","Weight","C25208","WEIGHT","['Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","86fe3cbd-f532-432b-aef8-406987a4139f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66741/C25208"
"5065","Vital Signs Test Name ","C67153","VSTEST","['Vital Signs Test Name']","CDISC SDTM Vital Sign Terminology  by Name","The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)","False","f8424696-dd60-4c78-b90e-42d44f571f31","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153"
"5066","Body Mass Index","C16358","Body Mass Index","['Body Mass Index']","Body Mass Index","A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)","False","aa770b48-1014-4e9a-a801-0d2ae7ad8afd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C16358"
"5067","Adipose Tissue","C12472","Adipose Tissue","['Adipose Tissue']","Adipose Tissue","A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.","False","fb00fb13-918b-4a96-8480-46a86a75d9c2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C12472"
"5068","Body Surface Area","C25157","Body Surface Area","['Body Surface Area']","Body Surface Area","A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)","False","073deb70-0d6f-4b98-9688-7f74a71c1776","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C25157"
"5069","Diastolic Blood Pressure","C25299","Diastolic Blood Pressure","['Diastolic Blood Pressure']","Diastolic Blood Pressure","The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)","False","b1300b9d-efc2-4472-9da3-8e5ee1f4a0fa","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C25299"
"5070","Body Frame Size","C49680","Body Frame Size","['Body Frame Size']","Body Frame Size","The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)","False","39d404fc-c000-483a-9cfd-13a91898d517","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C49680"
"5071","Height","C25347","Height","['Height']","Height","The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)","False","122b29aa-bb19-4963-b9df-d917f0da7d45","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C25347"
"5072","Heart Rate","C49677","Heart Rate","['Heart Rate']","Heart Rate","The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)","False","929492d1-95f6-485b-abed-e4a926c34f55","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C49677"
"5073","Mean Arterial Pressure","C49679","Mean Arterial Pressure","['Mean Arterial Pressure']","Mean Arterial Pressure","The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)","False","635a9ff7-0e81-4de5-88d7-f7bec913da1c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C49679"
"5074","Pulse Rate","C49676","Pulse Rate","['Pulse Rate']","Pulse Rate","The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)","False","c4d99801-a311-44d4-a7d5-d6915c6ee8c2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C49676"
"5075","Respiratory Rate","C49678","Respiratory Rate","['Respiratory Rate']","Respiratory Rate","The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)","False","7b6d6fe8-2323-40a4-86bc-335c56291472","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C49678"
"5076","Systolic Blood Pressure","C25298","Systolic Blood Pressure","['Systolic Blood Pressure']","Systolic Blood Pressure","The blood pressure during the contraction of the left ventricle of the heart.","False","b3aa4d39-85b9-42d2-a108-d15aa889c30d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C25298"
"5077","Temperature","C25206","Temperature","['Temperature']","Temperature","The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)","False","27a9d03e-9a8b-4e7c-8e70-77da1d2c11f8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C25206"
"5078","Weight","C25208","Weight","['Weight']","Weight","The vertical force exerted by a mass as a result of gravity. (NCI)","False","d8e3ea64-28bc-48ed-98f9-1375d5cc8e3a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67153/C25208"
"5079","No Yes Response","C66742","NY","['No Yes Response']","CDISC SDTM Yes No Unknown or Not Applicable Response Terminology","A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.","False","6b7ea6aa-5f61-4665-809e-1a5049abe8d8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66742"
"5080","No","C49487","N","['No']","No","The non-affirmative response to a question. (NCI)","False","d926de94-6a1e-4bc9-9e37-cfad6c78c7d1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66742/C49487"
"5081","Not Applicable","C48660","","[]","Not Applicable","Determination of a value is not relevant in the current context. (NCI)","False","4844bef2-bf0b-47b3-ac97-04ba695cb785","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66742/C48660"
"5082","Unknown","C17998","U","['U', 'Unknown']","Unknown","Not known, not observed, not recorded, or refused. (NCI)","False","90be92a8-5dce-4584-9eff-0bbbaa3fafd9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66742/C17998"
"5083","Yes","C49488","Y","['Yes']","Yes","The affirmative response to a question. (NCI)","False","ee5d3a80-ba5a-425f-9459-99a657ecdf19","dataset/cdisc/ct/sc/2007-06-05/sdtm/C66742/C49488"
"5084","Laboratory Test Code","C65047","LBTESTCD","['Laboratory Test Code']","CDISC SDTM Laboratory Test Terminology by Code","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","39b0154e-389f-4b79-aaf4-6b4495c9e92c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047"
"5085","Anisocytosis","C35266","ANISO","['Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","83a680b5-451d-4499-92b6-735fa7363167","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C35266"
"5086","Poikilocytosis","C35267","POIKILO","['Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","931d8cd0-dd99-4020-8341-409c30e3d32a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C35267"
"5087","Total Bilirubin","C38037","BILI","['Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","32eed794-3bcc-47dd-bb6f-23df75a5f49f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C38037"
"5088","Partial Thromboplastin Time","C38462","APTT","['Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","80449ac5-ac3d-4486-8ae9-83abaa3706d0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C38462"
"5089","Plasma Glucose Measurement","C41376","GLUC","['Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","eb0eecd5-5b5e-4a93-8e05-0a146b711061","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C41376"
"5090","pH","C45997","PH","['pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","cf55be0c-1eee-49da-b355-c2a53eb1a425","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C45997"
"5091","Erythrocyte Count","C51946","RBC","['Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","a65709b5-fba6-443a-a1e4-48a137b8a134","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C51946"
"5092","Reticulocyte Count","C51947","RETI","['Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","3ed51d87-6254-4fd7-9fc9-198cad979931","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C51947"
"5093","Leukocyte Count","C51948","WBC","['Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","e35408ff-cbe3-47b4-ac4b-48a8e009db65","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C51948"
"5094","Lymphocyte Count","C51949","LYM","['Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","426ee955-c173-4862-8ed2-17dcd7a7630e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C51949"
"5095","Platelet Count","C51951","PLAT","['Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","7fbac26f-5751-445d-810f-e64f133b98bb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C51951"
"5096","Blood Urea Nitrogen Measurement","C61019","BUN","['Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","6204bdc3-f927-4dcf-96d9-e985547fe0e1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C61019"
"5097","Serum Total Cholesterol Measurement","C61032","CHOL","['Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","82a28bda-5bc4-4944-8678-496c37310248","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C61032"
"5098","Serum HDL Cholesterol Measurement","C61041","HDL","['HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","b506a955-51e1-44bb-a4f3-364b6b1d171f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C61041"
"5099","Serum LDL Cholesterol Measurement","C61042","LDL","['LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","b27dad9b-9fb9-4127-a1d7-12a6f205e354","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C61042"
"5100","Prothrombin Time","C62656","PT","['Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","2dfe19de-f300-4558-bc6c-e6755db3a066","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C62656"
"5101","Absolute Neutrophil Count","C63321","NEUT","['Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","148aeaa3-0628-4b77-a49b-2bf476862752","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C63321"
"5102","Albumin Measurement","C64431","ALB","['Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","fe8e8a24-03d8-4406-aaa0-fba03119f897","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64431"
"5103","Alkaline Phosphatase Measurement","C64432","ALP","['Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","07f1ac8c-8154-4d66-a3b8-615830234efd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64432"
"5104","Alanine Aminotransferase Measurement","C64433","ALT","['Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","56b7ea14-5979-4f28-9713-8604d057ef22","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64433"
"5105","Amylase Measurement","C64434","AMYLASE","['Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","21b43e1c-f838-4106-83e4-9a6a12f230b7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64434"
"5106","Aspartate Aminotransferase Measurement","C64467","AST","['Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","c7a4e2ff-04fe-437a-9fe4-cb470a74bab2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64467"
"5107","Bacterial Count","C64469","BACT","['Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","f2333793-2738-44b8-8a77-70e0a1c0c64d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64469"
"5108","Total Basophil Count","C64470","BASO","['Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","6208d924-2b5b-47a7-aa48-e0ba3a7d5585","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64470"
"5109","Basophil To Leukocyte Ratio","C64471","BASOLE","['Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","0d5f43d3-a76e-47e3-bacd-07ec693991c1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64471"
"5110","Direct Bilirubin Measurement","C64481","BILDIR","['Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","939efb0f-d571-4374-9fa2-c56f3277f1d6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64481"
"5111","Indirect Bilirubin Measurement","C64483","BILIND","['Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","60c31533-6120-4c59-98c9-8c278aa0165f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64483"
"5112","Blast To Leukocyte Ratio","C64487","BLASTLE","['Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","1c1027d0-a247-45cf-ac16-5f669875ca54","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64487"
"5113","Calcium Measurement","C64488","CA","['Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","b2c0b1c4-009e-42d7-8f2c-2214c63a9619","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64488"
"5114","Creatine Kinase Measurement","C64489","CK","['Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","909598d2-a800-441b-8f47-02342be4532d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64489"
"5115","Creatine Kinase BB Measurement","C64490","CKBB","['Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","d0a0a998-a9b4-4f50-8d68-904ae9e8f4e4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64490"
"5116","Creatine Kinase MB Measurement","C64491","CKMB","['Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","91d42179-3676-42bc-9f17-8445fe6943ee","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64491"
"5117","Creatine Kinase MM Measurement","C64494","CKMM","['Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","76d0f409-f34c-40f0-a451-cb6ed23e8429","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64494"
"5118","Chloride Measurement","C64495","CL","['Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","f46e5af0-a8ac-4e4a-ae31-68889e9128bf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64495"
"5119","Carbon Dioxide Measurement","C64545","CO2","['Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","bd0cb6ba-84ad-4019-9a6d-7df34b83da6d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64545"
"5120","Color Assessment","C64546","COLOR","['Color']","Color Assessment","A measurement of the color of a biological specimen.","False","c81666a7-ca48-4044-b692-31740b1900ca","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64546"
"5121","Creatinine Measurement","C64547","CREAT","['Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","fee956ce-8056-4dbe-afe4-438507162fa8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64547"
"5122","C-Reactive Protein Measurement","C64548","CRP","['C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","5dfeef94-bb04-4b13-8e16-291d089ce82a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64548"
"5123","Elliptocyte Count","C64549","ELLIPCY","['Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","08f553cd-4139-4b45-8c8b-da1048ae6b4c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64549"
"5124","Eosinophil Count","C64550","EOS","['Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","48b9da5a-c0a7-4a88-9bc9-773ad8d2a1d1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64550"
"5125","Eosinophil To Leukocyte Ratio","C64604","EOSLE","['Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","edce13ee-155b-4c06-969b-b8837c5a25ba","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64604"
"5126","Epithelial Cell Count","C64605","EPIC","['Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","a7e797d8-ba45-4ca2-a3f1-b961b7d845c9","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64605"
"5127","Fibrinogen Measurement","C64606","FIBRINO","['Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","4bbaf87e-dc91-4d10-885b-2b90833d0a57","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64606"
"5128","Hematocrit","C64796","HCT","['Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","aafbad91-f688-4059-b1cb-9bfb7894b06a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64796"
"5129","Erythrocyte Mean Corpuscular Hemoglobin","C64797","MCH","['Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","9515f056-82bb-470f-be2d-bf09d364f0ad","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64797"
"5130","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","MCHC","['Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","d096bfc9-5ff2-4c40-a444-daa3b8fef35f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64798"
"5131","Erythrocyte Mean Corpuscular Volume","C64799","MCV","['Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","d0fc07f3-5fbd-4811-81be-3ac7a01e9f08","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64799"
"5132","Erythrocyte Distribution Width Measurement","C64800","RDW","['Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","42701f3e-450b-4a1e-a061-a67a591b4382","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64800"
"5133","Dacryocyte Analysis","C64801","TEARDCY","['Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","8978e2d6-099e-4c75-8886-cda54893d594","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64801"
"5134","Hypochromia","C64802","HYPO","['Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","1544aeac-b40f-4e1f-9331-162cb83cd41a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64802"
"5135","Polychromasia","C64803","POLYCHR","['Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","d28313bb-8e6d-4b10-ab8d-bcdc8b160279","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64803"
"5136","International Normalized Ratio of Prothrombin Time","C64805","INR","['Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","240866ff-01a5-4f36-a98a-6790a6692102","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64805"
"5137","Serum VLDL Cholesterol Measurement","C64806","VLDL","['VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","511dc8cb-6a8c-4db5-ac97-27cbd72639a7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64806"
"5138","Triacylglycerol Lipase Measurement","C64807","LIPASE","['Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","316d8426-fc40-4b53-a1f5-7b807cb1f9fd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64807"
"5139","Sodium Measurement","C64809","SODIUM","['Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","3ca26e57-492a-4241-8b3c-142e6f328215","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64809"
"5140","Nitrite Measurement","C64810","NITRITE","['Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","879bedf8-5a1d-410e-8241-6ede5d5ac091","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64810"
"5141","Triglyceride Measurement","C64812","TRIG","['Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","003f81e6-56e1-48b6-bb26-1689e943378b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64812"
"5142","Thyrotropin Measurement","C64813","TSH","['Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","37a9a8fb-d9f7-4472-9438-da67b7919982","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64813"
"5143","Urate Measurement","C64814","URATE","['Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","ae538482-442b-46e2-8962-a6891bd76770","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64814"
"5144","Urea Measurement","C64815","UREA","['Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","b93fe866-e944-425e-a763-de8b32e38d68","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64815"
"5145","Urobilinogen Measurement","C64816","UROBIL","['Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","d3193716-b1df-4149-95da-8dfe73f7bd45","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64816"
"5146","Vitamin B12 Measurement","C64817","VITB12","['Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","5292f124-3c08-4491-ae73-7164723836a0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64817"
"5147","Atypical Lymphocyte Count","C64818","LYMAT","['Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","c4e586e0-3ec0-45c5-a626-8f783df0ae15","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64818"
"5148","Atypical Lymphocyte To Leukocyte Ratio","C64819","LYMATLE","['Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","c3fd5dbb-bbff-4b4e-bc98-144598538e0c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64819"
"5149","Lymphocyte To Leukocyte Ratio","C64820","LYMLE","['Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","61342e30-96a4-4b52-8975-0b5b101dd548","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64820"
"5150","Macrocyte Count","C64821","MACROCY","['Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","d76343fc-fe52-4a11-999e-2551b93ea241","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64821"
"5151","Microcyte Count","C64822","MICROCY","['Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","b577eb86-0382-4c96-8b9d-063fe66ca300","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64822"
"5152","Monocyte Count","C64823","MONO","['Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","1466b6fb-169a-4916-8dd8-e09b5207145c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64823"
"5153","Monocyte To Leukocyte Ratio","C64824","MONOLE","['Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","5f3c6a58-b3f3-466a-ac67-2b07aa43bbcb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64824"
"5154","Myeloblast To Leukocyte Ratio","C64825","MYBLALE","['Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","19988870-d3e7-42ba-8e06-d1ef9fe93216","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64825"
"5155","Myelocyte To Leukocyte Ratio","C64826","MYCYLE","['Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","0cdf8e07-b6fc-43ae-9209-31a381295f33","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64826"
"5156","Neutrophil To Leukocyte Ratio","C64827","NEUTLE","['Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","9d493b35-b1db-467a-963b-6b0716de5f65","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64827"
"5157","Reticulocyte To Erythrocyte Ratio","C64828","RETIRBC","['Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","199dbe0c-6da9-4a96-885a-6b1e40e2d883","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64828"
"5158","Prolymphocyte To Leukocyte Ratio","C64829","PRLYMLE","['Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","092aa65f-c676-44ae-95f9-0bcced5bf8b8","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64829"
"5159","Neutrophil Band Form Count","C64830","NEUTB","['Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","1d7a0ecd-4203-4de5-871f-5131546b45d5","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64830"
"5160","Neutrophil Band Form To Leukocyte Ratio","C64831","NEUTBLE","['Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","402ba26f-d811-462b-946b-5df3fca8c089","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64831"
"5161","Specific Gravity","C64832","SPGRAV","['Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","bd6506ea-d63d-4958-8b72-56a858e5660c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64832"
"5162","Magnesium Measurement","C64840","MG","['Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","46465299-68e6-4eba-99b0-c3a8434db267","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64840"
"5163","Gamma Glutamyl Transpeptidase Measurement","C64847","GGT","['Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","6d38e0a4-f5bd-4e43-9a32-663a6559d99c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64847"
"5164","Hemoglobin Measurement","C64848","HGB","['Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","a18d74d3-6e84-4b99-ac4d-3990abf9501a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64848"
"5165","Glycosylated Hemoglobin Measurement","C64849","HBA1C","['Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","017e02ce-7ae2-41f5-a342-1fd8bd414e0f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64849"
"5166","Hepatitis B Virus Surface Antigen Measurement","C64850","HBSAG","['Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","1a4c3f3f-3918-48d1-989c-ec87d7266d05","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64850"
"5167","Choriogonadotropin Beta Measurement","C64851","HCG","['Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","efb13018-07c5-42e1-be9c-ef83803e4529","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64851"
"5168","Potassium Measurement","C64853","K","['Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","da60b8ee-ee27-4df6-ba36-c9306811a236","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64853"
"5169","Ketone Measurement","C64854","KETONES","['Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","6ea7ff9f-bd26-4daf-9a8c-2dc1e6edacf1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64854"
"5170","Lactate Dehydrogenase Measurement","C64855","LDH","['Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","f0da5be7-ab5c-4d82-8b96-9419d4f1611c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64855"
"5171","Leukocyte Esterase Measurement","C64856","LEUKASE","['Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","9c03fddb-196a-4cb3-9f20-67b3e8e555ff","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64856"
"5172","Phosphate Measurement","C64857","PHOS","['Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","65e1ff71-a462-41ff-a32f-a1edb3e56766","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64857"
"5173","Total Protein Measurement","C64858","PROT","['Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","b504ee43-1232-4540-a65f-c06af941b018","dataset/cdisc/ct/sc/2007-06-05/sdtm/C65047/C64858"
"5174","Laboratory Test Name ","C67154","LBTEST","['Laboratory Test Name']","CDISC SDTM Laboratory Test Terminology by Name","Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation Model.","False","040d4c98-fa97-4d35-9456-03acdb9737cb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154"
"5175","Anisocytosis","C35266","Anisocytosis","['Anisocytosis']","Anisocytosis","A measurement of the inequality in the size of the red blood cells in a whole blood specimen.","False","6fe38897-1ca2-422a-ac79-1f5bffb2d0f3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C35266"
"5176","Poikilocytosis","C35267","Poikilocytes","['Poikilocytes']","Poikilocytosis","A measurement of the odd-shaped erythrocytes in a whole blood specimen.","False","8479913a-5a9d-4cd1-a580-773c4a1f9e8e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C35267"
"5177","Total Bilirubin","C38037","Bilirubin","['Bilirubin']","Total Bilirubin","A measurement of the total bilirubin in a biological specimen.","False","e0cba045-9820-4887-b003-1699ad96f13c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C38037"
"5178","Partial Thromboplastin Time","C38462","Activated Partial Thromboplastin Time","['Activated Partial Thromboplastin Time']","Partial Thromboplastin Time","A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","False","3a9c1cb8-7522-426a-83ea-bbcdab488ce3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C38462"
"5179","Plasma Glucose Measurement","C41376","Glucose","['Glucose']","Plasma Glucose Measurement","A measurement of the glucose in a biological specimen.","False","c4eb728a-f1cb-4a43-8713-965394427053","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C41376"
"5180","pH","C45997","pH","['pH']","pH","A measure of the acidity or alkalinity of a fluid on a scale of 0 to 14.","False","50eeff68-55a7-4e55-84d0-8bc127201591","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C45997"
"5181","Erythrocyte Count","C51946","Erythrocytes","['Erythrocytes']","Erythrocyte Count","A count of the total erythrocytes per unit of a biological specimen.","False","599688fa-bdc8-4d0f-909a-6744a648e813","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C51946"
"5182","Reticulocyte Count","C51947","Reticulocytes","['Reticulocytes']","Reticulocyte Count","A count of the reticulocytes per unit of a biological specimen.","False","53e9d84d-e3b6-47c1-af56-e52b31ee3eff","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C51947"
"5183","Leukocyte Count","C51948","Leukocytes","['Leukocytes']","Leukocyte Count","A count of the leukocytes per unit of a biological specimen.","False","66069747-2e69-4a35-951f-78485d9b534e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C51948"
"5184","Lymphocyte Count","C51949","Lymphocytes","['Lymphocytes']","Lymphocyte Count","A count of the lymphocytes per unit of a biological specimen.","False","3fde537e-9726-4a74-bed8-03b2dca81586","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C51949"
"5185","Platelet Count","C51951","Platelet","['Platelet']","Platelet Count","A count of the platelets per unit of a biological specimen.","False","4f4a8f22-e225-40f9-8356-6b1c7a3ca4b3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C51951"
"5186","Blood Urea Nitrogen Measurement","C61019","Blood Urea Nitrogen","['Blood Urea Nitrogen']","Blood Urea Nitrogen Measurement","A measurement of the urea nitrogen in a blood specimen.","False","a4a9aec2-85cc-4315-862c-42511a3efc39","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C61019"
"5187","Serum Total Cholesterol Measurement","C61032","Cholesterol","['Cholesterol']","Serum Total Cholesterol Measurement","A measurement of the cholesterol in a biological specimen.","False","6f0df760-46a7-451f-8bd4-9bd972097890","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C61032"
"5188","Serum HDL Cholesterol Measurement","C61041","HDL Cholesterol","['HDL Cholesterol']","Serum HDL Cholesterol Measurement","A measurement of the high density lipoprotein cholesterol in a biological specimen.","False","fa810ef7-cf11-4dce-8d49-003fce9b4e8c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C61041"
"5189","Serum LDL Cholesterol Measurement","C61042","LDL Cholesterol","['LDL Cholesterol']","Serum LDL Cholesterol Measurement","A measurement of the low density lipoprotein cholesterol in a biological specimen.","False","dddc7cce-bc31-4071-a643-3ebf53239a89","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C61042"
"5190","Prothrombin Time","C62656","Prothrombin Time","['Prothrombin Time']","Prothrombin Time","A blood clotting measurement that evaluates the extrinsic pathway of coagulation and is expressed in units of time or percent activity.","False","670b464c-afd1-459a-a7b0-5ca21eb3367b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C62656"
"5191","Absolute Neutrophil Count","C63321","Neutrophils","['Neutrophils']","Absolute Neutrophil Count","A count of the neutrophils per unit of a biological specimen.","False","7c817a48-0fbd-4440-b699-0a9d52310a1b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C63321"
"5192","Albumin Measurement","C64431","Albumin","['Albumin']","Albumin Measurement","A measurement of the albumin protein in a biological specimen.","False","72a46981-5df5-4171-805a-d965c695730b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64431"
"5193","Alkaline Phosphatase Measurement","C64432","Alkaline Phosphatase","['Alkaline Phosphatase']","Alkaline Phosphatase Measurement","A measurement of the alkaline phosphatase in a biological specimen.","False","d322c39c-81c1-4944-b4e5-f463e7f90ca7","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64432"
"5194","Alanine Aminotransferase Measurement","C64433","Alanine Aminotransferase","['Alanine Aminotransferase']","Alanine Aminotransferase Measurement","A measurement of the alanine aminotransferase in a biological specimen.","False","b8001576-d353-40af-a852-28f68345bf69","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64433"
"5195","Amylase Measurement","C64434","Amylase","['Amylase']","Amylase Measurement","A measurement of the pancreatic enzyme amylase in a biological specimen.","False","55e81b64-cf41-4b23-a539-4038e377c2ce","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64434"
"5196","Aspartate Aminotransferase Measurement","C64467","Aspartate Aminotransferase","['Aspartate Aminotransferase']","Aspartate Aminotransferase Measurement","A measurement of the aspartate aminotransferase in a biological specimen.","False","635f5c2b-cde8-4b47-9d84-370424160785","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64467"
"5197","Bacterial Count","C64469","Bacteria","['Bacteria']","Bacterial Count","A measurement of the bacteria in a biological specimen.","False","41800df4-8983-49b0-9de3-d37455f187fd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64469"
"5198","Total Basophil Count","C64470","Basophils","['Basophils']","Total Basophil Count","A count of the basophils per unit of a biological specimen.","False","8eb00e25-cc80-4b30-9805-1010bc3d624d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64470"
"5199","Basophil To Leukocyte Ratio","C64471","Basophils/Leukocytes","['Basophils/Leukocytes']","Basophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the basophils to leukocytes in a biological specimen.","False","d412e85c-9cca-48bf-bba3-f8567f04e937","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64471"
"5200","Direct Bilirubin Measurement","C64481","Direct Bilirubin","['Direct Bilirubin']","Direct Bilirubin Measurement","A measurement of the conjugated or water-soluble bilirubin in a biological specimen.","False","65e4cb02-bfd7-4464-9773-61f50d4ee6eb","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64481"
"5201","Indirect Bilirubin Measurement","C64483","Indirect Bilirubin","['Indirect Bilirubin']","Indirect Bilirubin Measurement","A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.","False","a9fd3068-b9d2-4bd7-a26b-9525acd752c3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64483"
"5202","Blast To Leukocyte Ratio","C64487","Blasts/Leukocytes","['Blasts/Leukocytes']","Blast To Leukocyte Ratio","A relative measure (ratio or percentage) of the blasts to leukocytes in a biological specimen.","False","13ccb667-67e7-4c8a-a528-3e90d544f580","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64487"
"5203","Calcium Measurement","C64488","Calcium","['Calcium']","Calcium Measurement","A measurement of the calcium in a biological specimen.","False","2e82f80f-8541-4d02-ada8-8d56847e97d4","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64488"
"5204","Creatine Kinase Measurement","C64489","Creatine Kinase","['Creatine Kinase']","Creatine Kinase Measurement","A measurement of the total creatine kinase in a biological specimen.","False","e3839fcd-0078-4775-bee2-ba49a499473a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64489"
"5205","Creatine Kinase BB Measurement","C64490","Creatine Kinase BB","['Creatine Kinase BB']","Creatine Kinase BB Measurement","A measurement of the homozygous B-type creatine kinase in a biological specimen.","False","cfc902ee-6d60-4abc-8192-51d5e9c40713","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64490"
"5206","Creatine Kinase MB Measurement","C64491","Creatine Kinase MB","['Creatine Kinase MB']","Creatine Kinase MB Measurement","A measurement of the heterozygous MB-type creatine kinase in a biological specimen.","False","bef35ee8-0fe1-4e23-b356-7a94e8c44859","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64491"
"5207","Creatine Kinase MM Measurement","C64494","Creatine Kinase MM","['Creatine Kinase MM']","Creatine Kinase MM Measurement","A measurement of the homozygous M-type creatine kinase in a biological specimen.","False","4e51271e-89e8-4711-9d8f-e5b276cb2103","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64494"
"5208","Chloride Measurement","C64495","Chloride","['Chloride']","Chloride Measurement","A measurement of the chloride in a biological specimen.","False","494c0be9-1e58-4701-a8de-5c7ea7a0ceaf","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64495"
"5209","Carbon Dioxide Measurement","C64545","Carbon Dioxide","['Carbon Dioxide']","Carbon Dioxide Measurement","A measurement of the carbon dioxide gas in a biological specimen.","False","aa120286-7d80-42b1-a324-2610beca1715","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64545"
"5210","Color Assessment","C64546","Color","['Color']","Color Assessment","A measurement of the color of a biological specimen.","False","7d6232d6-4088-48a0-91bf-9ecfeba0d64f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64546"
"5211","Creatinine Measurement","C64547","Creatinine","['Creatinine']","Creatinine Measurement","A measurement of the creatinine in a biological specimen.","False","876a5337-e7b3-41f5-93db-efd16e471a1a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64547"
"5212","C-Reactive Protein Measurement","C64548","C Reactive Protein","['C Reactive Protein']","C-Reactive Protein Measurement","A measurement of the C reactive protein in a biological specimen.","False","4f016b47-3960-4dd8-ab75-5b8aacfe90ca","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64548"
"5213","Elliptocyte Count","C64549","Elliptocytes","['Elliptocytes']","Elliptocyte Count","A count of the elliptocytes per unit of a biological specimen.","False","627a40d9-818f-49ee-8d5c-ec972e87bb35","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64549"
"5214","Eosinophil Count","C64550","Eosinophils","['Eosinophils']","Eosinophil Count","A count of the eosinophils per unit of a biological specimen.","False","2b1ba374-a8fa-43d1-a454-3ae6fce8e43e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64550"
"5215","Eosinophil To Leukocyte Ratio","C64604","Eosinophils/Leukocytes","['Eosinophils/Leukocytes']","Eosinophil To Leukocyte Ratio","A relative measure (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.","False","2fe18411-3de3-4aad-a899-799547c7fe04","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64604"
"5216","Epithelial Cell Count","C64605","Epithelial Cells","['Epithelial Cells']","Epithelial Cell Count","A measurement of the epithelial cells in a biological specimen.","False","df988d18-69fb-4ff4-9f31-bbaefcc8be14","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64605"
"5217","Fibrinogen Measurement","C64606","Fibrinogen","['Fibrinogen']","Fibrinogen Measurement","A measurement of the fibrinogen in a biological specimen.","False","6cc5412b-f699-477b-8d1c-2a4e7021eafd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64606"
"5218","Hematocrit","C64796","Hematocrit","['Hematocrit']","Hematocrit","The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).","False","52b10d0f-ea76-46b6-accd-d45a0413f6ed","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64796"
"5219","Erythrocyte Mean Corpuscular Hemoglobin","C64797","Ery. Mean Corpuscular Hemoglobin","['Ery. Mean Corpuscular Hemoglobin']","Erythrocyte Mean Corpuscular Hemoglobin","A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.","False","9c7a51dd-6261-4ceb-8709-23b493e2e543","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64797"
"5220","Erythrocyte Mean Corpuscular Hemoglobin Concentration","C64798","Ery. Mean Corpuscular HB Concentration","['Ery. Mean Corpuscular HB Concentration']","Erythrocyte Mean Corpuscular Hemoglobin Concentration","A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.","False","81043769-5d13-4347-9cde-51f32e42cf8e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64798"
"5221","Erythrocyte Mean Corpuscular Volume","C64799","Ery. Mean Corpuscular Volume","['Ery. Mean Corpuscular Volume']","Erythrocyte Mean Corpuscular Volume","A quantitative measurement of the mean volume of erythrocytes in a biological specimen.","False","a41341df-83af-4153-89bb-76baf99c614d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64799"
"5222","Erythrocyte Distribution Width Measurement","C64800","Erythrocytes Distribution Width","['Erythrocytes Distribution Width']","Erythrocyte Distribution Width Measurement","A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.","False","22420ed9-4d45-4b48-9fe9-d21392e7031e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64800"
"5223","Dacryocyte Analysis","C64801","Dacryocytes","['Dacryocytes']","Dacryocyte Analysis","A count of dacryocytes in unit of a biological specimen.","False","e0e6362a-b484-478f-a420-3eecac00cf19","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64801"
"5224","Hypochromia","C64802","Hypochromia","['Hypochromia']","Hypochromia","An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.","False","3d3b994b-cb1b-4a19-a966-de9606972ebc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64802"
"5225","Polychromasia","C64803","Polychromasia","['Polychromasia']","Polychromasia","A measurement of the blue-staining characteristic of newly generated erythrocytes.","False","0ea80d02-adeb-48a0-a57f-7c4d29f663b0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64803"
"5226","International Normalized Ratio of Prothrombin Time","C64805","Prothrombin Intl. Normalized Ratio","['Prothrombin Intl. Normalized Ratio']","International Normalized Ratio of Prothrombin Time","A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.","False","8ae7fb6c-179a-466e-b97b-585094441814","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64805"
"5227","Serum VLDL Cholesterol Measurement","C64806","VLDL Cholesterol","['VLDL Cholesterol']","Serum VLDL Cholesterol Measurement","A measurement of the very low density lipoprotein cholesterol in a biological specimen.","False","b1f7c2eb-a816-4234-b0a7-30a37051cb6a","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64806"
"5228","Triacylglycerol Lipase Measurement","C64807","Triacylglycerol Lipase","['Triacylglycerol Lipase']","Triacylglycerol Lipase Measurement","A measurement of the pancreatic lipase in a biological specimen.","False","f0cf601c-6f6d-468d-a487-f2d2aa0ed63d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64807"
"5229","Sodium Measurement","C64809","Sodium","['Sodium']","Sodium Measurement","A measurement of the sodium in a biological specimen.","False","f8cfced1-3c02-4fd2-905e-1705e9442fdc","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64809"
"5230","Nitrite Measurement","C64810","Nitrite","['Nitrite']","Nitrite Measurement","A measurement of the nitrite in a urine specimen.","False","742633b0-0491-41d2-b81e-914afe774b14","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64810"
"5231","Triglyceride Measurement","C64812","Triglycerides","['Triglycerides']","Triglyceride Measurement","A measurement of the triglycerides in a biological specimen.","False","30f93ea6-8610-4ee3-b31a-11e60928f28e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64812"
"5232","Thyrotropin Measurement","C64813","Thyrotropin","['Thyrotropin']","Thyrotropin Measurement","A measurement of the thyrotropin in a biological specimen.","False","7023e6ef-9c65-41c2-904a-7cd2ebe02ea0","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64813"
"5233","Urate Measurement","C64814","Urate","['Urate']","Urate Measurement","A measurement of the urate in a biological specimen.","False","ee7de8c1-c36e-403a-9bb9-53e1b52062f3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64814"
"5234","Urea Measurement","C64815","Urea","['Urea']","Urea Measurement","A measurement of the urea in a biological specimen.","False","1a737f2f-d320-465a-8041-6463c7518617","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64815"
"5235","Urobilinogen Measurement","C64816","Urobilinogen","['Urobilinogen']","Urobilinogen Measurement","A measurement of the urobilinogen in a biological specimen.","False","db88e205-c7be-4448-8d0a-8b3520e2bc7d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64816"
"5236","Vitamin B12 Measurement","C64817","Vitamin B12","['Vitamin B12']","Vitamin B12 Measurement","A measurement of the Vitamin B12 in a serum specimen.","False","aafa0935-c2a5-4896-a5dd-12f5e591b5a1","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64817"
"5237","Atypical Lymphocyte Count","C64818","Lymphocytes Atypical","['Lymphocytes Atypical']","Atypical Lymphocyte Count","A count of the atypical lymphocytes per unit of a biological specimen.","False","f2c5aba0-3a4e-4046-97f5-4baf53998902","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64818"
"5238","Atypical Lymphocyte To Leukocyte Ratio","C64819","Lymphocytes Atypical/Leukocytes","['Lymphocytes Atypical/Leukocytes']","Atypical Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.","False","8dc8ada6-f95a-4267-86bc-2a696387926c","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64819"
"5239","Lymphocyte To Leukocyte Ratio","C64820","Lymphocytes/Leukocytes","['Lymphocytes/Leukocytes']","Lymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.","False","e57405f0-e6cd-4baf-a49c-0ff4d7eb3810","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64820"
"5240","Macrocyte Count","C64821","Macrocytes","['Macrocytes']","Macrocyte Count","A count of the macrocytes per unit of a biological specimen.","False","bccdb9f6-05b5-441a-81a2-223c7966d617","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64821"
"5241","Microcyte Count","C64822","Microcytes","['Microcytes']","Microcyte Count","A count of the microcytes per unit of a biological specimen.","False","58994ad9-60f6-44cb-80b0-d9afe2ecc708","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64822"
"5242","Monocyte Count","C64823","Monocytes","['Monocytes']","Monocyte Count","A count of the monocytes per unit of a biological specimen.","False","cb1121ad-785a-42b8-ab74-06c80c221d0b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64823"
"5243","Monocyte To Leukocyte Ratio","C64824","Monocytes/Leukocytes","['Monocytes/Leukocytes']","Monocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the monocytes to leukocytes in a biological specimen.","False","e64d0f87-10eb-4f20-8cc7-9f710afb290e","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64824"
"5244","Myeloblast To Leukocyte Ratio","C64825","Myeloblasts/Leukocytes","['Myeloblasts/Leukocytes']","Myeloblast To Leukocyte Ratio","A relative measure (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.","False","7edb9b2e-5d47-4a9e-9080-8abe980454aa","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64825"
"5245","Myelocyte To Leukocyte Ratio","C64826","Myelocytes/Leukocytes","['Myelocytes/Leukocytes']","Myelocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.","False","cc778251-efd0-4c8a-a24a-29e4433a7d16","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64826"
"5246","Neutrophil To Leukocyte Ratio","C64827","Neutrophils/Leukocytes","['Neutrophils/Leukocytes']","Neutrophil To Leukocyte Ratio","The determination of the ratio of neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.","False","7c32abbc-b808-44b5-91ad-6b5f2148a20d","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64827"
"5247","Reticulocyte To Erythrocyte Ratio","C64828","Reticulocytes/Erythrocytes","['Reticulocytes/Erythrocytes']","Reticulocyte To Erythrocyte Ratio","A relative measure (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.","False","9b626ae8-a29e-4930-b6f7-fd149f95e0ab","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64828"
"5248","Prolymphocyte To Leukocyte Ratio","C64829","Prolymphocytes/Leukocytes","['Prolymphocytes/Leukocytes']","Prolymphocyte To Leukocyte Ratio","A relative measure (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.","False","d581dc3d-588d-4953-a791-20dfeb8d46f3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64829"
"5249","Neutrophil Band Form Count","C64830","Neutrophils Band Form","['Neutrophils Band Form']","Neutrophil Band Form Count","A count of the banded neutrophils per unit of a biological specimen.","False","4a541263-b316-4bbe-91d3-9524482206d2","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64830"
"5250","Neutrophil Band Form To Leukocyte Ratio","C64831","Neutrophils Band Form/Leukocytes","['Neutrophils Band Form/Leukocytes']","Neutrophil Band Form To Leukocyte Ratio","A relative measure (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.","False","58d57d06-bea2-4bb7-b5a9-ca71af1b09b6","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64831"
"5251","Specific Gravity","C64832","Specific Gravity","['Specific Gravity']","Specific Gravity","A ratio of the density of a fluid to the density of water.","False","94edc6ff-6ddc-41d8-8fb6-e737d701775b","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64832"
"5252","Magnesium Measurement","C64840","Magnesium","['Magnesium']","Magnesium Measurement","A measurement of the magnesium in a biological specimen.","False","2b16be0d-ac0c-4a6b-8378-8c79711af19f","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64840"
"5253","Gamma Glutamyl Transpeptidase Measurement","C64847","Gamma Glutamyl Transferase","['Gamma Glutamyl Transferase']","Gamma Glutamyl Transpeptidase Measurement","A measurement of the gamma glutamyl transpeptidase in a biological specimen.","False","f76f8cb5-2340-4b78-816c-c2e2220446cd","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64847"
"5254","Hemoglobin Measurement","C64848","Hemoglobin","['Hemoglobin']","Hemoglobin Measurement","A measurement of the hemoglobin in a biological specimen.","False","d792c504-8d44-405b-a2ab-219e4560f713","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64848"
"5255","Glycosylated Hemoglobin Measurement","C64849","Hemoglobin A1C","['Hemoglobin A1C']","Glycosylated Hemoglobin Measurement","A measurement of the glycosylated hemoglobin in a biological specimen.","False","7144e68f-7241-4440-a74b-71c0a7bd6dba","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64849"
"5256","Hepatitis B Virus Surface Antigen Measurement","C64850","Hepatitis B Virus Surface Antigen","['Hepatitis B Virus Surface Antigen']","Hepatitis B Virus Surface Antigen Measurement","A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.","False","913ea217-f95d-49cc-b602-0b76215eb497","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64850"
"5257","Choriogonadotropin Beta Measurement","C64851","Choriogonadotropin Beta","['Choriogonadotropin Beta']","Choriogonadotropin Beta Measurement","A measurement of the Choriogonadotropin Beta in a biological specimen.","False","9c583118-e0de-4d21-b068-71a72f583975","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64851"
"5258","Potassium Measurement","C64853","Potassium","['Potassium']","Potassium Measurement","A measurement of the potassium in a biological specimen.","False","131dbf62-3f20-4176-a809-0c6d75fee937","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64853"
"5259","Ketone Measurement","C64854","Ketones","['Ketones']","Ketone Measurement","A measurement of the ketones in a biological specimen.","False","2b2b5df2-d2d0-44fd-a947-3b3745cd9913","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64854"
"5260","Lactate Dehydrogenase Measurement","C64855","Lactate Dehydrogenase","['Lactate Dehydrogenase']","Lactate Dehydrogenase Measurement","A measurement of the lactate dehydrogenase in a biological specimen.","False","cd99ffe4-d9bc-4da7-8026-bbb026458f93","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64855"
"5261","Leukocyte Esterase Measurement","C64856","Leukocyte Esterase","['Leukocyte Esterase']","Leukocyte Esterase Measurement","A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.","False","ddfb4c08-ab17-421e-8cd0-d1b5bc8c3889","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64856"
"5262","Phosphate Measurement","C64857","Phosphate","['Phosphate']","Phosphate Measurement","A measurement of the phosphate in a biological specimen.","False","05c8cc1f-4d5c-44ef-9636-673fcccec8c3","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64857"
"5263","Total Protein Measurement","C64858","Protein","['Protein']","Total Protein Measurement","A measurement of a group of complex organic macromolecules composed of one or more alpha-L-amino acid chains in a biological specimen.","False","88dc6311-ce43-4c52-b450-87b0a0655952","dataset/cdisc/ct/sc/2007-06-05/sdtm/C67154/C64858"
